10 Nov 2022
29 June 2023
8 Jul 2021
January 17, 2025
June 26, 2025
March 9, 2023
May 12, 2023
May 30, 2025
Contact:
Stephan Schurer
schurer at med dot miami dot edu
Contact:
Stephan Schurer
stephan dot schurer at gmail dot com
Contact:
Stephan Schurer
stephan dot schurer at med dot miami dot edu
Contact: Stephan Schurer stephan dot schurer at med dot miami dot edu
Created by:
Hande Küçük McGinty, Janice Kranz, Joseph Ostrow, Alex Clark, Yu Lin, Saminda Abeyruwan, Uma Vempati, Kunie Sakurai, Vance Lemmon, Ubbo Visser, John Turner, Nicolette Ross, Joan Glenny-Pescov, Jiaming Hu, Caty Chung, Stephan Schurer*
Created by:
Hande Küçük McGinty, Janice Kranz, Joseph Ostrow, Alex Clark, Yu Lin, Saminda Abeyruwan, Uma Vempati, Kunie Sakurai, Vance Lemmon, Ubbo Visser, John Turner, Stephan Schurer*
Created by:
Hande Küçük McGinty, Janice Kranz, Joseph Ostrow, Alex Clark, Yu Lin, Saminda Abeyruwan, Uma Vempati, Kunie Sakurai, Vance Lemmon, Ubbo Visser, John Turner, add_name, Stephan Schurer*
Created by:
Hande Küçük McGinty, Janice Kranz, Joseph Ostrow, Alex Clark, Yu Lin, Saminda Abeyruwan, Uma Vempati, Kunie Sakurai, Vance Lemmon, Ubbo Visser, John Turner,colette Ross, Joan Glenny-Pescov, Jiaming Hu, Caty Chung, Stephan Schurer*
Created by:
Saminda Abeyruwan, Caty Chung, Hande Küçük McGinty, Janice Kranz, Joseph Ostrow, Alex Clark, Yu Lin, Uma Vempati, Kunie Sakurai, Vance Lemmon, Ubbo Visser, John Turner, Nicolette Ross, Joan Glenny-Pescov, Jiaming Hu, Stephan Schurer*
Created by: Caty Chung, Nicolette Ross, Joan Glenny-Pescov, Jiaming Hu, Stephan Schurer*
There is a one-to-one correspondance with rdf:label value and concept descriptions. Concept description starts with the prefix BAO_.
contact: Stephan Schurer: stephan dot schurer at gmail dot com
created by:
Uma Vempati, Hande Küçük, Ubbo Visser, Saminda Abeyruwan, Kunie Sakurai, Vance Lemmon, Stephan Schurer*
BAO
BioAssay Ontology
Bioassay ontology
bioassay ontology
2.1
2.7.2
2.7.4
2.7.5
2.8.12
2.8.15
2.8.16
2.8.2
2.8.6
An annotation property that represents an ID used in the NIH LINCS project.
Oliver He, Jiangan Xie, Jie Zheng
LINCS ID
An annotation property that represents a PubMed BioAssay Identifier accession number.
Oliver He
https://pubchem.ncbi.nlm.nih.gov/help.html
PubChem AID
editor preferred label
editor preferred term
The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
editor preferred label
editor preferred label
editor preferred term
editor preferred term
editor preferred term~editor preferred label
example
example of usage
A phrase describing how a class name should be used. May also include other kinds of examples that facilitate immediate understanding of a class semantics, such as widely known prototypical subclasses or instances of the class. Although essential for high level terms, examples for low level terms (e.g., Affymetrix HU133 array) are not
A phrase describing how a term should be used and/or a citation to a work which uses it. May also include other kinds of examples that facilitate immediate understanding, such as widely know prototypes or instances of a class, or cases where a relation is said to hold.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
IAO:0000112
uberon
example_of_usage
true
example_of_usage
example of usage
example of usage
has curation status
PERSON:Alan Ruttenberg
PERSON:Bill Bug
PERSON:Melanie Courtot
OBI_0000281
has curation status
has curation status
definition
The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
A property representing the English language definitions of what NCI means by the concept. They may also include information about the definition's source and attribution in a form that can easily be interpreted by software.
The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
The official definition.
2012-04-05:
Barry Smith
The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible.
Can you fix to something like:
A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.
Alan Ruttenberg
Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria.
On the specifics of the proposed definition:
We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition.
Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable.
We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.
2012-04-05:
Barry Smith
The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible.
Can you fix to something like:
A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property.
Alan Ruttenberg
Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria.
On the specifics of the proposed definition:
We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition.
Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable.
We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
DEFINITION
definition
textual definition
definition
editor note
An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obfoundry.org/obo/obi>
IAO:0000116
uberon
editor_note
true
editor_note
editor note
editor note
term editor
Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people
20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115.
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
term editor
term editor
alternative term
An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
alternative term
alternative term
definition source
formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007
PERSON:Daniel Schober
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w
definition source
definition source
An administrative note of use for a curator but of no use for a user
IAO:0000232
uberon
curator_notes
true
curator_notes
curator note
curator note
curator notes
the URI for an OBI Terms ticket at sourceforge, such as https://sourceforge.net/p/obi/obi-terms/772/
An IRI or similar locator for a request or discussion of an ontology term.
IAO:0000233
uberon
external
term_tracker_item
true
true
term_tracker_item
The 'tracker item' can associate a tracker with a specific ontology term.
term tracker item
term tracker item
imported from
For external terms/classes, the ontology from which the term was imported
PERSON:Alan Ruttenberg
PERSON:Melanie Courtot
GROUP:OBI:<http://purl.obolibrary.org/obo/obi>
imported from
imported from
IAO_0000125
Use on obsolete terms, relating the term to another term that can be used as a substitute
Add as annotation triples in the granting ontology
Person:Alan Ruttenberg
term replaced by
An association that specifies one of three data types for a particular variable, String, Code or Number.
A23
Conceptual Entity
Has_PCDC_Data_Type
Has_PCDC_Data_Type
Has_PCDC_Data_Type
An association that shows which Permissible Values are possible for a specific PCDC EWS Variable concept.
A29
Conceptual Entity
Has_PCDC_EWS_Permissible_Value
Has_PCDC_EWS_Permissible_Value
Has_PCDC_EWS_Permissible_Value
An association that that connects a concept representing a GDC value to any associated GDC property concept(s).
A32
Conceptual Entity
Is_Value_For_GDC_Property
Is_Value_For_GDC_Property
Is_Value_For_GDC_Property
An association that shows which Permissible Values are possible for a specific PCDC GCT Variable.
A34
Conceptual Entity
Has_PCDC_GCT_Permissible_Value
Has_PCDC_GCT_Permissible_Value
Has_PCDC_GCT_Permissible_Value
An association that shows which Permissible Values are possible for a specific PCDC OS Variable.
A38
Conceptual Entity
Has_PCDC_OS_Permissible_Value
Has_PCDC_OS_Permissible_Value
Has_PCDC_OS_Permissible_Value
An association that shows which Permissible Values are possible for a specific PCDC HL Variable.
A39
Conceptual Entity
Has_PCDC_HL_Permissible_Value
Has_PCDC_HL_Permissible_Value
Has_PCDC_HL_Permissible_Value
An association that shows which Permissible Values are possible for a specific DIPG/DMG Variable.
A40
Conceptual Entity
Has_DIPG_DMG_Permissible_Value
Has_DIPG_DMG_Permissible_Value
Has_DIPG_DMG_Permissible_Value
true
A property representing a concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.
NHC0
Conceptual Entity
code
code
code
A property that represents a description of the sort of thing or category to which a concept belongs in the context of the UMLS semantic network.
P106
Conceptual Entity
Semantic Type
Semantic_Type
In general, applying semantic types aids in allowing users (or computer programs) to draw conclusions about concepts by virtue of the categories to which they have been assigned. We use a set of semantic types developed for the UMLS Metathesaurus. There are currently 134 semantic types in the UMLS.
Semantic_Type
Semantic_Type
A property representing an alternative Preferred Name for use in some NCI systems.
P107
Conceptual Entity
Display Name
Display_Name
Display Name
Display_Name
Display_Name
A property representing the word or phrase that NCI uses by preference to refer to the concept.
P108
Conceptual Entity
Preferred Name
Preferred_Name
Preferred Name
Preferred Term
Preferred_Name
Preferred_Name
A property representing the concept unique identifier (CUI) assigned by the National Library of Medicine (NLM). If a concept in any NCI-maintained knowledgebase exists in the NLM Unified Medical Language System (UMLS), NCI includes the NLM CUI among the information we provide about the concept.
P207
Conceptual Entity
UMLS CUI
UMLS_CUI
UMLS_CUI
UMLS_CUI
A property representing the concept unique identifier (CUI) for those concepts that appear in NCI Metathesaurus but not in the National Library of Medicine Unified Medical Language System (NLM UMLS).
P208
Conceptual Entity
NCI Metathesaurus CUI
NCI_META_CUI
NCI_META_CUI
NCI_META_CUI
A property is used to indicate when a non-EVS entity has contributed to, and has a stake in, a concept. This is used where such entities, within or outside NCI, have indicated the need to be able to track their own concepts. A single concept can have multiple instances of this property if multiple entities have such a defined stake.
P322
Conceptual Entity
Contributing Source
Contributing_Source
Contributing_Source
Contributing_Source
A property representing the English language definition of a concept from a source other than NCI.
P325
Conceptual Entity
[source] Definition
ALT_DEFINITION
ALT_DEFINITION
ALT_DEFINITION
true
A property representing a retired unique concept identifier created and stored as Concept Name by legacy EVS software. Use of these values was long discouraged, but continued as late as 2009 when creation of new values ceased and Concept Name was retired. Legacy values are intended solely to help resolve and update earlier coding.
P366
Conceptual Entity
Legacy Concept Name
Legacy Concept Name
Legacy_Concept_Name
Legacy Concept Name
A property representing that a term in another terminology has been mapped to a term in NCIt and describes the relationship between the mapped terms.
P375
Conceptual Entity
Maps_To
Maps_To
Maps_To
A property representing notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept.
P98
Conceptual Entity
DesignNote
DesignNote
DesignNote
DesignNote
An alternative term used by the IEDB.
IEDB alternative term
tooth SubClassOf 'never in taxon' value 'Aves'
x never in taxon T if and only if T is a class, and x does not instantiate the class expression "in taxon some T". Note that this is a shortcut relation, and should be used as a hasValue restriction in OWL.
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
PREFIX owl: <http://www.w3.org/2002/07/owl#>
PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162>
PREFIX never_in_taxon: <http://purl.obolibrary.org/obo/RO_0002161>
CONSTRUCT {
in_taxon: a owl:ObjectProperty .
a owl:Restriction ;
owl:onProperty in_taxon: ;
owl:someValuesFrom ?taxon
] .
?x rdfs:subClassOf [
a owl:Restriction ;
owl:onProperty in_taxon: ;
owl:someValuesFrom [
a owl:Class ;
owl:complementOf ?taxon
]
] .
}
WHERE {
?x never_in_taxon: ?taxon .
}
RO:0002161
uberon
never_in_taxon
true
true
never_in_taxon
never in taxon
A is mutually_spatially_disjoint_with B if both A and B are classes, and there exists no p such that p is part_of some A and p is part_of some B.
PREFIX owl: <http://www.w3.org/2002/07/owl#>
PREFIX part_of: <http://purl.obolibrary.org/obo/BFO_0000050>
PREFIX mutually_spatially_disjoint_with: <http://purl.obolibrary.org/obo/RO_0002171>
CONSTRUCT {
part_of: a owl:ObjectProperty .
[
a owl:Restriction ;
owl:onProperty part_of: ;
owl:someValuesFrom ?x ;
a owl:Restriction ;
owl:onProperty part_of: ;
owl:someValuesFrom ?y
]
]
}
WHERE {
?x mutually_spatially_disjoint_with: ?y .
}
RO:0002171
uberon
mutually_spatially_disjoint_with
true
true
mutually_spatially_disjoint_with
mutually spatially disjoint with
mutually spatially disjoint with
https://github.com/obophenotype/uberon/wiki/Part-disjointness-Design-Pattern
S present_in_taxon T if some instance of T has some S. This does not means that all instances of T have an S - it may only be certain life stages or sexes that have S
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
PREFIX owl: <http://www.w3.org/2002/07/owl#>
PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162>
PREFIX present_in_taxon: <http://purl.obolibrary.org/obo/RO_0002175>
CONSTRUCT {
in_taxon: a owl:ObjectProperty .
?witness rdfs:label ?label .
?witness rdfs:subClassOf ?x .
?witness rdfs:subClassOf [
a owl:Restriction ;
owl:onProperty in_taxon: ;
owl:someValuesFrom ?taxon
] .
}
WHERE {
?x present_in_taxon: ?taxon .
BIND(IRI(CONCAT(
"http://purl.obolibrary.org/obo/RO_0002175#",
MD5(STR(?x)),
"-",
MD5(STR(?taxon))
)) as ?witness)
BIND(CONCAT(STR(?x), " in taxon ", STR(?taxon)) AS ?label)
}
RO:0002175
uberon
present_in_taxon
true
true
present_in_taxon
The SPARQL expansion for this relation introduces new named classes into the ontology. For this reason it is likely that the expansion should only be performed during a QC pipeline; the expanded output should usually not be included in a published version of the ontology.
present in taxon
present in taxon
'anterior end of organism' is-opposite-of 'posterior end of organism'
'increase in temperature' is-opposite-of 'decrease in temperature'
x is the opposite of y if there exists some distance metric M, and there exists no z such as M(x,z) <= M(x,y) or M(y,z) <= M(y,x).
RO:0002604
quality
is_opposite_of
true
true
is_opposite_of
is opposite of
is_opposite_of
An alternate textual definition for a class taken unmodified from an external source. This definition may have been used to derive a generalized definition for the new class.
UBPROP:0000001
uberon
external_definition
true
external_definition
This annotation property may be replaced with an annotation property from an external ontology such as IAO
external_definition
A textual description of an axiom loss in this ontology compared to an external ontology.
UBPROP:0000002
uberon
axiom_lost_from_external_ontology
true
axiom_lost_from_external_ontology
This annotation property may be replaced with an annotation property from an external ontology such as IAO
axiom_lost_from_external_ontology
Notes on the homology status of this class.
UBPROP:0000003
uberon
homology_notes
true
homology_notes
This annotation property may be replaced with an annotation property from an external ontology such as IAO
homology_notes
Used to connect a class to an adjectival form of its label. For example, a class with label 'intestine' may have a relational adjective 'intestinal'.
UBPROP:0000007
uberon
has_relational_adjective
true
has_relational_adjective
has_relational_adjective
Notes on the how instances of this class vary across species.
UBPROP:0000008
uberon
taxon_notes
true
taxon_notes
taxon_notes
Notes on the evolved function of instances of this class.
This annotation property may be replaced with an annotation property from an external ontology such as IAO
UBPROP:0000009
uberon
function_notes
true
function_notes
function_notes
Notes on the structure, composition or histology of instances of this class.
This annotation property may be replaced with an annotation property from an external ontology such as IAO
UBPROP:0000010
uberon
structure_notes
true
structure_notes
structure_notes
Notes on the ontogenic development of instances of this class.
This annotation property may be replaced with an annotation property from an external ontology such as IAO
UBPROP:0000011
uberon
development_notes
true
development_notes
development_notes
Notes on how similar or equivalent classes are represented in other ontologies.
This annotation property may be replaced with an annotation property from an external ontology such as IAO
UBPROP:0000012
uberon
external_ontology_notes
true
external_ontology_notes
external_ontology_notes
FMA has terms like 'set of X'. In general we do not include set-of terms in uberon, but provide a mapping between the singular form and the FMA set term
UBPROP:0000202
uberon
fma_set_term
true
fma_set_term
fma_set_term
http://purl.org/dc/terms/contributor
uberon
dc-contributor
true
dc-contributor
contributor
consider
created_by
creation_date
has_alternative_id
An alternative label for a class or property which has a more general meaning than the preferred name/primary label.
https://github.com/information-artifact-ontology/ontology-metadata/issues/18
has broad synonym
has_broad_synonym
https://github.com/information-artifact-ontology/ontology-metadata/issues/18
disease characteristic (MONDO:0021125) has cross-reference (http://www.geneontology.org/formats/oboInOwl#hasDbXref) "NCIT:C41009"^^xsd:string
An annotation property that links an ontology entity or a statement to a prefixed identifier or URI.
Reference database or publication source.
has cross-reference
database_cross_reference
An alternative label for a class or property which has the exact same meaning than the preferred name/primary label.
A property representing a fully qualified synonym, contains the string, term type, source, and an optional source code if appropriate. Each subfield is deliniated to facilitate interpretation by software.
An alternative label for a given entity such as a commonly used abbreviation or synonym.
https://github.com/information-artifact-ontology/ontology-metadata/issues/20
FULL_SYN
Synonym with Source Data
has exact synonym
alternative_term
has exact synonym
has_exact_synonym
https://github.com/information-artifact-ontology/ontology-metadata/issues/20
An alternative label for a class or property which has a more specific meaning than the preferred name/primary label.
https://github.com/information-artifact-ontology/ontology-metadata/issues/19
has narrow synonym
has_narrow_synonym
https://github.com/information-artifact-ontology/ontology-metadata/issues/19
Name space of the ontology.
disease_ontology
has_obo_namespace
An alternative label for a class or property that has been used synonymously with the primary term name, but the usage is not strictly correct.
https://github.com/information-artifact-ontology/ontology-metadata/issues/21
has related synonym
has_related_synonym
https://github.com/information-artifact-ontology/ontology-metadata/issues/21
An identifier for an individual entity.
An identifier is an information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity.
id
An association that connects the concept defining a particular terminology subset with concepts that belong to this subset.
Concept_In_Subset
in subset
in_subset
shorthand
Comment.
comment
Is defined by.
rdfs:isDefinedBy
A human readable name for this class.
label
label
http://www.w3.org/2000/01/rdf-schema#seeAlso
seeAlso
spatial
uberon
seeAlso
true
seeAlso
see also
A skos concept mapping used to link two concepts, indicating a high degree of confidence that the concepts can be used interchangeably.
has exact match
A skos concept mapping used to state a hierarchical mapping link between two concepts where the DO concept is narrow (DO represents subtypes) and the xref is broad.
has narrower match
http://xmlns.com/foaf/0.1/depiction
uberon
depiction
true
depiction
depiction
has temperature unit
has marker
is substrate of
is marker of
stains
has orthogonal assay design
has response unit
has concentration unit
has perturbagen
has mode of action
has assay format
has detection method
has endpoint
has measure group
has assay stage
has target
has assay method
has specification
is orthogonal assay design of
has assay kit
has curve fit specification
has percent response
has concentration
is perturbagen of
is assay method of
has inducer
is regulated by
has transcription factor
is measure group of
is related assay to
Assay performed to confirm activity of compounds identified in the primary screen. It can be performed as replicate measurements at a single screening concentration or as concentration-response assay.
is confirmatory assay of
Counter assays typically follow concentration-response assays to confirm the biological activity of chemical entities identified in the primary assays. Counter assays eliminate active compounds that do not act on the intended target. They are performed using related targets, e.g. a receptor isoform, a homologous gene, etc which are functionally distinct from the intended target.
Counter assays are also performed to eliminate cytotoxic compounds. The actives from the primary assay are tested on cultured cells and the cell death is estimated commonly by measuring ATP concentration.
Other example for a counter assays a FRET assay when the primary assay used absorption readout; luminescence readout when the primary assay measured fluorescence intensity, etc.
is counter assay of
Same target, design, technology, format, but not necessarily the same throughput. For example primary, confirmatory, and concentration-response could be related by 'is identical to'
is identical assay of
is alternate assay format of
is assay format of
is endpoint of
is regulator of
is specification of
has alternate assay format
is target of
is detection method of
has manufacturer
has assay control
has primary assay
has confirmatory assay
has counter assay
has summary assay
has variant construct assay
is variant construct assay of
has parental cell line assay
is parental cell line assay of
has compound toxicity assay
is compound toxicity assay of
is primary assay of
has selectivity assay
is selectivity assay of
has alternate target assay
is alternate target assay of
has alternate cell line assay
is alternate cell line assay of
has alternate organism assay
is alternate organism assay of
has alternate confirmatory assay
is alternate confirmatory assay of
has orthogonal assay technology
is orthogonal assay technology of
has alternate assay type
is alternate assay type of
has alternate assay conditions
is alternate assay conditions of
has lead optimization assay
is lead optimization assay of
has physicochemical profiling assay
is physicochemical profiling assay of
has compound fluorescence assay
is compound fluorescence assay of
has compound aggregation assay
is compound aggregation assay of
has compound redox-activity assay
is compound redox-activity assay of
is summary assay of
has identical assay
based on normalization
has measured entity
detects
catalyzed by
has cell line
has form
involves biological process
has assay phase characteristic
is indicator of
has purity unit
encodes
is measured entity of
has quality
uses assay kit
has assay kit component
uses as substrate
has time unit
has substrate
is binding site of
tagged with
has detected entity
is cell line of
has assay protocol
is assay protocol of
has associated disease
is associated disease of
has assay readout content
has assay readout content parametricity
has assay source
has assay title
has bioassay type
is bioassay type of
has assay readout type
has signal direction
has endpoint modifier
has phenotype
is phenotype of
is localized in
has concentration throughput
has repetition throughput
uses detection instrument
has assay footprint
silences
has gene symbol
is role of
is unit of
has unit
is detected by
has antibody source
recombinantly expressed in
has preparation method
has organism
has assay medium
has assay serum
is grown in
is transfected into
has role
reports
has binding site
has function
involves molecular function
phenotype of
c stands in this relationship to p if and only if there exists some p' such that c is capable_of p', and p' is part_of p.
has function in
http://www.obofoundry.org/ro/#OBO_REL:part_of
part of
has phenotype
has part
derives into
See also BFO_0001009
derives from
occurs in
bearer of
inheres in
contains process
X connected_to Y if and only if X and Y share a fiat boundary.
connected to
http://www.obofoundry.org/ro/#OBO_REL:has_participant
has participant
participates in
is derived from
detects phenotype
has indicator
is described by
quantifies
has molecular phenotype
has morphological phenotype
has positive control
has negative control
has experimental setting
has response value
has temperature value
has percent response value
has id value
has DNA sequence
has ID
has display info
has date
has purity value
has concentration value
has time value
has concentration-point number
has passage number
has cell count
This describes the number of repeats of an entity (e.g., artificial regulatory element, cDNA, etc.) present in a DNA construct.
has copy number
This describes the number of repeats of a gene of interest cloned in a DNA construct.
has gene copy number
This describes the number of repeats of a cDNA of interest cloned in a DNA construct.
has cDNA copy number
This describes the number of repeats of an artificial regulatory element present in a DNA construct.
has artificial regulatory region copy number
has sequence
has protein sequence
has nucleic acid sequence
has RNA sequence
has shRNA sense sequence
has enzyme reaction temperature value
has sense strand sequence
has anti-sense strand sequence
has assay deposition date
A biosafety level is the level of biocontainment required to isolate hazardous biological agents in an enclosed facility. The levels of containment range from the lowest biosafety level of 1 to the highest at level 4.
The levels are as follows:
BSL1:
Suitable for work involving well-characterized agents not known to consistently cause disease in immunocompetent adult humans, and present minimal potential hazard to laboratory personnel and the environment (definition from CDC).
BSL2:
Suitable for work involving agents that pose moderate hazards to personnel and the environment. It differs from BSL-1 in that 1) laboratory personnel have specific training in handling pathogenic agents and are supervised by scientists competent in handling infectious agents and associated procedures; 2) access to the laboratory is restricted when work is being conducted; and 3) all procedures in which infectious aerosols or splashes may be created are conducted in BSCs or other physical containment equipment (definition from CDC).
BSL3:
Suitable for clinical, diagnostic, teaching, research, or production facilities where work is performed with indigenous or exotic agents that may cause serious or potentially lethal disease through inhalation route exposure. Laboratory personnel must receive specific training in handling pathogenic and potentially lethal agents, and must be supervised by scientists competent in handling infectious agents and associated procedures. All procedures involving the manipulation of infectious materials must be conducted within BSCs, other physical containment devices, or by personnel wearing appropriate personal protective equipment (definition from CDC).
BSL4:
has biosafety level
pH approximates the negative logarithm (base 10) of the molar concentration of dissolved hydronium ions in a solution.
has assay pH value
It is the force per unit area applied in a direction perpendicular to the surface of an object in an assay.
has assay pressure value
has cell modification temperature value
has perturbagen incubation temperature value
has substrate incubation temperature value
It is the temperature at which the biological experiment was conducted.
has assay temperature value
It is the interval of time between the addition of a perturbagen, substrate or cell modification and the measurement of change, as observed by a detection method in the bioassay.
has incubation time value
It is the interval of time between the cell modification, namely transient transfection of plasmid DNA/ siRNA, viral transduction, etc and the measurement of change, as observed by a detection method in the bioassay.
has cell modification time value
has coupled substrate incubation time value
It is the interval of time between the enzyme activity measurement in a kinetic assay.
has enzyme reaction time value
It is the interval of time between the addition of a perturbagen and the measurement of change, as observed by a detection method in the bioassay.
has perturbagen incubation time value
It is the interval of time between the addition of an enzyme substrate and the measurement of change, as observed by a detection/ readout in a bioassay.
has substrate incubation time value
has coupled substrate incubation temperature value
The number of replicate measurements (repetitions) per concentration value used.
has repetition point-number
has wavelength value
is input data value of
has sequence position
The nucleotide number in the sense strand of a gene that marks the beginning and end of the shRNA probe.
has shRNA probe sense sequence position
The nucleotide number in the sense strand of a gene that marks the beginning and end of the siRNA probe.
has siRNA probe sense sequence position
has ligand incubation time value
The value (in conjunction with the signal direction) used to determine perturbagens of interest (hits.) Perturbagens with a readout value beyond the threshold in the direction of interest are considered active in the assay.
has activity threshold value
has excitation wavelength value
has emission wavelength value
has absorbance wavelength value
has recommended name
has value
reports assay measurment value
EC 5.4.99.7 (lanosterol synthase) inhibitor
EC 5.4.99.7 (lanosterol synthase) inhibitor
EC 5.4.99.* (intramolecular transferase transferring other groups) inhibitor
EC 5.4.99.* (intramolecular transferase transferring other groups) inhibitors
EC 5.4.99.* inhibitor
EC 5.4.99.* inhibitors
inhibitor of intramolecular transferase transferring other groups
inhibitors of intramolecular transferase transferring other groups
intramolecular transferase transferring other groups inhibitor
intramolecular transferase transferring other groups inhibitors
EC 5.4.99.* (intramolecular transferase transferring other groups) inhibitor
zidovudine
3'-azido-3'-deoxythymidine
AZT
Azidothymidine
Retrovir
Zidovudin
Zidovudinum
zidovudine
zidovudine
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitors
EC 1.14.11.29 inhibitor
EC 1.14.11.29 inhibitors
HIF hydroxylase inhibitor
HIF hydroxylase inhibitors
hypoxia-inducible factor-L-proline, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating) inhibitor
hypoxia-inducible factor-L-proline, 2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating) inhibitors
prolyl 4-hydroxylase inhibitor
prolyl 4-hydroxylase inhibitors
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor
EC 2.6.1.40 [(R)-3-amino-2-methylpropionate--pyruvate transaminase] inhibitor
(R)-3-amino-2-methylpropanoate:pyruvate aminotransferase inhibitor
(R)-3-amino-2-methylpropanoate:pyruvate aminotransferase inhibitors
(R)-3-amino-2-methylpropionate transaminase inhibitor
(R)-3-amino-2-methylpropionate transaminase inhibitors
(R)-3-amino-2-methylpropionate--pyruvate aminotransferase inhibitor
(R)-3-amino-2-methylpropionate--pyruvate aminotransferase inhibitors
D-3-aminoisobutyrate--pyruvate aminotransferase inhibitor
D-3-aminoisobutyrate--pyruvate aminotransferase inhibitors
D-3-aminoisobutyrate--pyruvate transaminase inhibitor
D-3-aminoisobutyrate--pyruvate transaminase inhibitors
D-3-aminoisobutyrate-pyruvate aminotransferase inhibitor
D-3-aminoisobutyrate-pyruvate aminotransferase inhibitors
D-3-aminoisobutyrate-pyruvate transaminase inhibitor
D-3-aminoisobutyrate-pyruvate transaminase inhibitors
D-AIBAT inhibitor
D-AIBAT inhibitors
D-beta-aminoisobutyrate:pyruvate aminotransferase inhibitor
D-beta-aminoisobutyrate:pyruvate aminotransferase inhibitors
EC 2.6.1.40 [(R)-3-amino-2-methylpropionate--pyruvate transaminase] inhibitors
EC 2.6.1.40 inhibitor
EC 2.6.1.40 inhibitors
beta-aminoisobutyrate--pyruvate aminotransferase inhibitor
beta-aminoisobutyrate--pyruvate aminotransferase inhibitors
beta-aminoisobutyrate--pyruvate transaminase inhibitor
beta-aminoisobutyrate--pyruvate transaminase inhibitors
beta-aminoisobutyrate-pyruvate aminotransferase inhibitor
beta-aminoisobutyrate-pyruvate aminotransferase inhibitors
EC 2.6.1.40 [(R)-3-amino-2-methylpropionate--pyruvate transaminase] inhibitor
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor
EC 2.1.1.8 (histamine N-methyltransferase) inhibitors
EC 2.1.1.8 inhibitor
EC 2.1.1.8 inhibitors
S-adenosyl-L-methionine:histamine N-tele-methyltransferase inhibitor
S-adenosyl-L-methionine:histamine N-tele-methyltransferase inhibitors
S-adenosylmethionine-histamine N-methyltransferase inhibitor
S-adenosylmethionine-histamine N-methyltransferase inhibitors
histamine 1-methyltransferase inhibitor
histamine 1-methyltransferase inhibitors
histamine methyltransferase inhibitor
histamine methyltransferase inhibitors
histamine-methylating enzyme inhibitor
histamine-methylating enzyme inhibitors
imidazolemethyltransferase inhibitor
imidazolemethyltransferase inhibitors
EC 2.1.1.8 (histamine N-methyltransferase) inhibitor
calmodulin antagonist
calmodulin antagonist
IP3 receptor antagonist
D-myo-inositol 1,4,5-trisphosphate receptor antagonist
D-myo-inositol 1,4,5-trisphosphate receptor antagonists
IP3 antagonist
IP3 antagonists
IP3 receptor antagonists
InsP3R antagonist
InsP3R antagonists
inositol trisphosphate receptor antagonist
inositol trisphosphate receptor antagonists
IP3 receptor antagonist
adenosine A2B receptor agonist
A2B agonist
A2B agonists
A2B receptor agonist
A2B receptor agonists
adenosine A2B receptor agonists
adenosine A2B receptor agonist
Wnt signalling activator
Wnt signaling activator
Wnt signaling activators
Wnt signalling activators
Wnt signalling activator
formyl peptide receptor agonist
FPR agonist
FPR agonists
formyl peptide receptor agonists
formyl peptide receptor agonist
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
AOF2 inhibitor
AOF2 inhibitors
BHC110 inhibitor
BHC110 inhibitors
CPRF inhibitor
CPRF inhibitors
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitors
EC 1.14.99.66 inhibitor
EC 1.14.99.66 inhibitors
KDM1A inhibitor
KDM1A inhibitors
KIAA0601 inhibitor
KIAA0601 inhibitors
LSD1 inhibitor
LSD1 inhibitors
[histone H3]-dimethyl-L-lysine(4)FAD-dependent demethylase 1A inhibitor
[histone H3]-dimethyl-L-lysine(4)FAD-dependent demethylase 1A inhibitors
amine oxidase (flavin containing) domain 2 inhibitor
amine oxidase (flavin containing) domain 2 inhibitors
lysine (K)-specific demethylase 1A inhibitor
lysine (K)-specific demethylase 1A inhibitors
lysine demethylase 1A inhibitor
lysine demethylase 1A inhibitors
lysine-specific demethylase 1A inhibitor
lysine-specific demethylase 1A inhibitors
lysine-specific histone demethylase 1A inhibitor
lysine-specific histone demethylase 1A inhibitors
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
hyaluronic acid synthesis inhibitor
HA inhibitor
HA inhibitors
HA synthesis inhibitor
HA synthesis inhibitors
hyaluronic acid inhibitor
hyaluronic acid inhibitors
hyaluronic acid synthesis inhibitors
hyaluronic acid synthesis inhibitor
Mycoplasma genitalium metabolite
Mycoplasma genitalium metabolites
Mycoplasma genitalium metabolite
teichoic acid biosynthesis inhibitor
TarO inhibitor
TarO inhibitors
teichoic acid biosynthesis inhibitors
teichoic acid biosynthesis inhibitor
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
DNA duplicase inhibitor
DNA duplicase inhibitors
DNA nucleotidyltransferase (DNA-directed) inhibitor
DNA nucleotidyltransferase (DNA-directed) inhibitors
DNA nucleotidyltransferase inhibitor
DNA nucleotidyltransferase inhibitors
DNA polymerase I inhibitor
DNA polymerase I inhibitors
DNA polymerase II inhibitor
DNA polymerase II inhibitors
DNA polymerase III inhibitor
DNA polymerase III inhibitors
DNA polymerase alpha inhibitor
DNA polymerase alpha inhibitors
DNA polymerase beta inhibitor
DNA polymerase beta inhibitors
DNA polymerase gamma inhibitor
DNA polymerase gamma inhibitors
DNA polymerase inhibitor
DNA polymerase inhibitors
DNA replicase inhibitor
DNA replicase inhibitors
DNA-dependent DNA polymerase inhibitor
DNA-dependent DNA polymerase inhibitors
DNA-directed DNA polymerase (EC 2.7.7.7) inhibitor
DNA-directed DNA polymerase (EC 2.7.7.7) inhibitors
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitors
EC 2.7.7.7 inhibitor
EC 2.7.7.7 inhibitors
Klenow fragment inhibitor
Klenow fragment inhibitors
Taq DNA polymerase inhibitor
Taq DNA polymerase inhibitors
Taq Pol I inhibitor
Taq Pol I inhibitors
Tca DNA polymerase inhibitor
Tca DNA polymerase inhibitors
deoxynucleate polymerase inhibitor
deoxynucleate polymerase inhibitors
deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) inhibitor
deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (DNA-directed) inhibitors
deoxyribonucleate nucleotidyltransferase inhibitor
deoxyribonucleate nucleotidyltransferase inhibitors
deoxyribonucleic acid duplicase inhibitor
deoxyribonucleic acid duplicase inhibitors
deoxyribonucleic acid polymerase inhibitor
deoxyribonucleic acid polymerase inhibitors
deoxyribonucleic duplicase inhibitor
deoxyribonucleic duplicase inhibitors
deoxyribonucleic polymerase I inhibitor
deoxyribonucleic polymerase I inhibitors
deoxyribonucleic polymerase inhibitor
deoxyribonucleic polymerase inhibitors
duplicase inhibitor
duplicase inhibitors
sequenase inhibitor
sequenase inhibitors
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor
ATP:[elongation factor 2] phosphotransferase inhibitor
ATP:[elongation factor 2] phosphotransferase inhibitors
Ca/CaM-kinase III inhibitor
Ca/CaM-kinase III inhibitors
CaM kinase III inhibitor
CaM kinase III inhibitors
EC 2.7.11.20 (elongation factor 2 kinase) inhibitors
EC 2.7.11.20 inhibitor
EC 2.7.11.20 inhibitors
EF2K inhibitor
EF2K inhibitors
STK19 inhibitor
STK19 inhibitors
calmodulin-dependent protein kinase III inhibitor
calmodulin-dependent protein kinase III inhibitors
eEF2 kinase inhibitor
eEF2 kinase inhibitors
eEF2K inhibitor
eEF2K inhibitors
elongation factor 2 kinase (EC 2.7.11.20) inhibitor
elongation factor 2 kinase (EC 2.7.11.20) inhibitors
elongation factor 2 kinase inhibitor
elongation factor 2 kinase inhibitors
EC 2.7.11.20 (elongation factor 2 kinase) inhibitor
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
ATP phosphohydrolase (channel-conductance-controlling) inhibitor
ATP phosphohydrolase (channel-conductance-controlling) inhibitors
CFTR inhibitor
CFTR inhibitors
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitors
EC 3.6.3.49 inhibitor
EC 3.6.3.49 inhibitors
channel-conductance-controlling ATPase (EC 3.6.3.49) inhibitor
channel-conductance-controlling ATPase (EC 3.6.3.49) inhibitors
channel-conductance-controlling ATPase inhibitor
channel-conductance-controlling ATPase inhibitors
cystic fibrosis conductance regulator inhibitor
cystic fibrosis conductance regulator inhibitors
cystic fibrosis transmembrane conductance regulator inhibitor
cystic fibrosis transmembrane conductance regulator inhibitors
cystic-fibrosis membrane-conductance-regulating protein inhibitor
cystic-fibrosis membrane-conductance-regulating protein inhibitors
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
dopamine receptor D2 antagonist
D2 receptor antagonist
D2R antagonist
dopamine receptor D2 antagonist
RUNX1 inhibitor
AML1 inhibitor
AML1 inhibitors
CBFA2 inhibitor
CBFA2 inhibitors
RUNX1 inhibitors
acute myeloid leukemia 1 protein inhibitor
acute myeloid leukemia 1 protein inhibitors
core-binding factor subunit alpha-2 inhibitor
core-binding factor subunit alpha-2 inhibitors
core-binding factor subunit alpha2 inhibitor
core-binding factor subunit alpha2 inhibitors
runt-related transcription factor 1 inhibitor
runt-related transcription factor 1 inhibitors
RUNX1 inhibitor
melatonin receptor antagonist
melatonin receptor antagonists
melatonin receptor antagonist
HIV-1 Tat inhibitor
HIV-1 Tat antagonist
HIV-1 Tat antagonists
HIV-1 Tat inhibitors
HIV-1 trans-activator of transcription antagonist
HIV-1 trans-activator of transcription antagonists
human immunodeficiency virus type 1 Tat antagonist
human immunodeficiency virus type 1 Tat antagonists
human immunodeficiency virus type 1 Tat inhibitor
human immunodeficiency virus type 1 Tat inhibitors
human immunodeficiency virus type 1 trans-activator of transcription antagonist
human immunodeficiency virus type 1 trans-activator of transcription antagonists
HIV-1 Tat inhibitor
EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor
ATP:caldesmon O-phosphotransferase inhibitor
ATP:caldesmon O-phosphotransferase inhibitors
ATP:protein phosphotransferase ((2+)/calmodulin-dependent) inhibitor
ATP:protein phosphotransferase ((2+)/calmodulin-dependent) inhibitors
CAM PKII inhibitor
CAM PKII inhibitors
Ca(2+)/calmodulin-dependent microtubule-associated protein 2 kinase inhibitor
Ca(2+)/calmodulin-dependent microtubule-associated protein 2 kinase inhibitors
Ca(2+)/calmodulin-dependent protein kinase (EC 2.7.11.17) inhibitor
Ca(2+)/calmodulin-dependent protein kinase (EC 2.7.11.17) inhibitors
Ca(2+)/calmodulin-dependent protein kinase 1 inhibitor
Ca(2+)/calmodulin-dependent protein kinase 1 inhibitors
Ca(2+)/calmodulin-dependent protein kinase II inhibitor
Ca(2+)/calmodulin-dependent protein kinase II inhibitors
Ca(2+)/calmodulin-dependent protein kinase IV inhibitor
Ca(2+)/calmodulin-dependent protein kinase IV inhibitors
Ca(2+)/calmodulin-dependent protein kinase inhibitor
Ca(2+)/calmodulin-dependent protein kinase inhibitors
Ca(2+)/calmodulin-dependent protein kinase kinase beta inhibitor
Ca(2+)/calmodulin-dependent protein kinase kinase beta inhibitors
Ca(2+)/calmodulin-dependent protein kinase kinase inhibitor
Ca(2+)/calmodulin-dependent protein kinase kinase inhibitors
CaM kinase II inhibitor
CaM kinase II inhibitors
CaM kinase inhibitor
CaM kinase inhibitors
CaM-regulated serine/threonine kinase inhibitor
CaM-regulated serine/threonine kinase inhibitors
CaMKI inhibitor
CaMKI inhibitors
CaMKII inhibitor
CaMKII inhibitors
CaMKIV inhibitor
CaMKIV inhibitors
CaMKKalpha inhibitor
CaMKKalpha inhibitors
CaMKKbeta inhibitor
CaMKKbeta inhibitors
EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitors
EC 2.7.11.17 inhibitor
EC 2.7.11.17 inhibitors
STK20 inhibitor
STK20 inhibitors
caldesmon kinase (phosphorylating) inhibitor
caldesmon kinase (phosphorylating) inhibitors
caldesmon kinase inhibitor
caldesmon kinase inhibitors
calmodulin-dependent kinase II inhibitor
calmodulin-dependent kinase II inhibitors
microtubule-associated protein 2 kinase inhibitor
microtubule-associated protein 2 kinase inhibitors
EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor
dopamine receptor D1 agonist
D1 agonist
D1 agonists
dopamine D1 receptor agonist
dopamine D1 receptor agonists
dopamine receptor D1 agonists
dopamine receptor D1 agonist
SMO receptor agonist
SMO receptor agonists
smoothened agonist
smoothened agonists
smoothened receptor agonist
smoothened receptor agonists
SMO receptor agonist
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor
4-trimethylammoniobutanoate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating) inhibitor
4-trimethylammoniobutanoate,2-oxoglutarate:oxygen oxidoreductase (3-hydroxylating) inhibitors
BBOX inhibitor
BBOX inhibitors
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitors
EC 1.14.11.1 inhibitor
EC 1.14.11.1 inhibitors
alpha-butyrobetaine hydroxylase inhibitor
alpha-butyrobetaine hydroxylase inhibitors
butyrobetaine hydroxylase inhibitor
butyrobetaine hydroxylase inhibitors
gamma-butyrobetaine hydroxylase inhibitor
gamma-butyrobetaine hydroxylase inhibitors
EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor
hydrogen acceptor
A
hydrogen acceptor
EC 1.13.11.11 (tryptophan 2,3-dioxygenase) inhibitor
EC 1.13.11.11 (tryptophan 2,3-dioxygenase) inhibitors
EC 1.13.11.11 inhibitor
EC 1.13.11.11 inhibitors
L-tryptophan 2,3-dioxygenase inhibitor
L-tryptophan 2,3-dioxygenase inhibitors
L-tryptophan pyrrolase inhibitor
L-tryptophan pyrrolase inhibitors
L-tryptophan:oxygen 2,3-oxidoreductase (decyclizing) inhibitor
L-tryptophan:oxygen 2,3-oxidoreductase (decyclizing) inhibitors
L-tryptophan:oxygen 2,3-oxidoreductase (ring-opening) inhibitor
L-tryptophan:oxygen 2,3-oxidoreductase (ring-opening) inhibitors
TDO inhibitor
TDO inhibitors
indolamine 2,3-dioxygenase inhibitor
indolamine 2,3-dioxygenase inhibitors
indoleamine 2,3-dioxygenase inhibitor
indoleamine 2,3-dioxygenase inhibitors
tryptamin 2,3-dioxygenase inhibitor
tryptamin 2,3-dioxygenase inhibitors
tryptamine 2,3-dioxygenase inhibitor
tryptamine 2,3-dioxygenase inhibitors
tryptophan 2,3-dioxygenase (EC 1.13.11.11) inhibitor
tryptophan 2,3-dioxygenase (EC 1.13.11.11) inhibitors
tryptophan 2,3-dioxygenase inhibitor
tryptophan 2,3-dioxygenase inhibitors
tryptophan oxygenase inhibitor
tryptophan oxygenase inhibitors
tryptophan peroxidase inhibitor
tryptophan peroxidase inhibitors
tryptophan pyrrolase inhibitor
tryptophan pyrrolase inhibitors
tryptophanase inhibitor
tryptophanase inhibitors
EC 1.13.11.11 (tryptophan 2,3-dioxygenase) inhibitor
herbicide safener
herbicide safeners
herbicide safener
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitors
EC 1.14.11.2 inhibitor
EC 1.14.11.2 inhibitors
collagen proline hydroxylase inhibitor
collagen proline hydroxylase inhibitors
hydroxylase, collagen proline inhibitor
hydroxylase, collagen proline inhibitors
peptidyl proline hydroxylase inhibitor
peptidyl proline hydroxylase inhibitors
procollagen-L-proline,2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating) inhibitor
procollagen-L-proline,2-oxoglutarate:oxygen oxidoreductase (4-hydroxylating) inhibitors
procollagen-proline 4-dioxygenase inhibitor
procollagen-proline 4-dioxygenase inhibitors
procollagen-proline dioxygenase (EC 1.14.11.2) inhibitor
procollagen-proline dioxygenase (EC 1.14.11.2) inhibitors
procollagen-proline dioxygenase inhibitor
procollagen-proline dioxygenase inhibitors
procollagen-proline,2-oxoglutarate-4-dioxygenase inhibitor
procollagen-proline,2-oxoglutarate-4-dioxygenase inhibitors
proline hydroxylase inhibitor
proline hydroxylase inhibitors
proline protocollagen hydroxylase inhibitor
proline protocollagen hydroxylase inhibitors
proline, 2-oxoglutarate dioxygenase inhibitor
proline, 2-oxoglutarate dioxygenase inhibitors
proline,2-oxoglutarate 4-dioxygenase inhibitor
proline,2-oxoglutarate 4-dioxygenase inhibitors
prolyl 4-hydroxylase inhibitor
prolyl 4-hydroxylase inhibitors
prolyl hydroxylase inhibitor
prolyl hydroxylase inhibitors
prolyl-glycyl-peptide, 2-oxoglutarate:oxygen oxidoreductase, 4-hydroxylating inhibitor
prolyl-glycyl-peptide, 2-oxoglutarate:oxygen oxidoreductase, 4-hydroxylating inhibitors
prolylprotocollagen dioxygenase inhibitor
prolylprotocollagen dioxygenase inhibitors
prolylprotocollagen hydroxylase inhibitor
prolylprotocollagen hydroxylase inhibitors
protocollagen hydroxylase inhibitor
protocollagen hydroxylase inhibitors
protocollagen proline 4-hydroxylase inhibitor
protocollagen proline 4-hydroxylase inhibitors
protocollagen proline dioxygenase inhibitor
protocollagen proline dioxygenase inhibitors
protocollagen proline hydroxylase inhibitor
protocollagen proline hydroxylase inhibitors
protocollagen prolyl hydroxylase inhibitor
protocollagen prolyl hydroxylase inhibitors
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor
EC 3.2.1.23 (beta-galactosidase) inhibitor
EC 3.2.1.23 (beta-galactosidase) inhibitors
EC 3.2.1.23 inhibitor
EC 3.2.1.23 inhibitors
S 2107 inhibitor
S 2107 inhibitors
beta-D-galactanase inhibitor
beta-D-galactanase inhibitors
beta-D-galactoside galactohydrolase inhibitor
beta-D-galactoside galactohydrolase inhibitors
beta-D-lactosidase inhibitor
beta-D-lactosidase inhibitors
beta-lactosidase inhibitor
beta-lactosidase inhibitors
exo-(1->4)-beta-D-galactanase inhibitor
exo-(1->4)-beta-D-galactanase inhibitors
hydrolact inhibitor
hydrolact inhibitors
lactase inhibitor
lactase inhibitors
lactozym inhibitor
lactozym inhibitors
maxilact inhibitor
maxilact inhibitors
oryzatym inhibitor
oryzatym inhibitors
sumiklat inhibitor
sumiklat inhibitors
trilactase inhibitor
trilactase inhibitors
EC 3.2.1.23 (beta-galactosidase) inhibitor
TRPM4 channel inhibitor
TRPM4 channel inhibitors
Transient receptor potential cation channel subfamily M member 4 inhibitor
Transient receptor potential cation channel subfamily M member 4 inhibitors
melastatin 4 inhibitor
melastatin 4 inhibitors
TRPM4 channel inhibitor
xenoantigen
xenoantigens
xenoantigen
bleaching agent
bleaching agent
EC 3.6.5.* (hydrolases acting on GTP; involved in cellular and subcellular movement) inhibitor
EC 3.6.5.* (hydrolases acting on GTP; involved in cellular and subcellular movement) inhibitors
EC 3.6.5.* (hydrolases acting on GTP; involved in cellular and subcellular movement) inhibitor
EC 3.6.5.5 (dynamin GTPase) inhibitor
EC 3.6.5.5 (dynamin GTPase) inhibitors
EC 3.6.5.5 inhibitor
EC 3.6.5.5 inhibitors
GTP phosphohydrolase (vesicle-releasing) inhibitor
GTP phosphohydrolase (vesicle-releasing) inhibitors
dynamin GTPase (EC 3.6.5.5) inhibitor
dynamin GTPase (EC 3.6.5.5) inhibitors
dynamin GTPase inhibitor
dynamin GTPase inhibitors
EC 3.6.5.5 (dynamin GTPase) inhibitor
farnesoid X receptor agonist
BAR agonist
BAR agonists
FXR agonist
FXR agonists
bile acid receptor agonist
bile acid receptor agonists
farnesoid X receptor agonists
farnesoid X receptor agonist
radiosensitizing agent
radiosensitiser
radiosensitisers
radiosensitising agent
radiosensitising agents
radiosensitizer
radiosensitizers
radiosensitizing agents
radiosensitizing agent
5-hydroxytryptamine 2A receptor inverse agonist
5-hydroxytryptamine (2A) receptor inverse agonist
5-hydroxytryptamine (2A) receptor inverse agonists
5-hydroxytryptamine 2A receptor inverse agonists
5HT(2A) inverse agonist
5HT(2A) inverse agonists
5HT2A inverse agonists
5HT2Ainverse agonist
5-hydroxytryptamine 2A receptor inverse agonist
B-cell lymphoma 2 inhibitor
B-cell lymphoma 2 inhibitors
Bcl-2 inhibitor
Bcl-2 inhibitors
B-cell lymphoma 2 inhibitor
lymphocyte function-associated antigen-1 antagonist
LFA-1 antagonist
LFA-1 antagonists
lymphocyte function-associated antigen-1 antagonists
lymphocyte function-associated antigen-1 antagonist
chemical hybridisation agent
chemical hybridisation agents
chemical hybridization agent
chemical hybridization agents
chemical hybridisation agent
fatty acid oxidation inhibitor
fatty acid oxidation inhibitors
fatty acid oxidation inhibitor
EC 2.4.1.17 (glucuronosyltransferase) inhibitor
1-naphthol glucuronyltransferase inhibitor
1-naphthol glucuronyltransferase inhibitors
1-naphthol-UDP-glucuronosyltransferase inhibitor
1-naphthol-UDP-glucuronosyltransferase inhibitors
17-OH steroid UDPGT inhibitor
17-OH steroid UDPGT inhibitors
17beta-hydroxysteroid UDP-glucuronosyltransferase inhibitor
17beta-hydroxysteroid UDP-glucuronosyltransferase inhibitors
3-OH androgenic UDPGT inhibitor
3-OH androgenic UDPGT inhibitors
3alpha-hydroxysteroid UDP-glucuronosyltransferase inhibitor
3alpha-hydroxysteroid UDP-glucuronosyltransferase inhibitors
4-hydroxybiphenyl UDP-glucuronosyltransferase inhibitor
4-hydroxybiphenyl UDP-glucuronosyltransferase inhibitors
EC 2.4.1.17 (glucuronosyltransferase) inhibitors
EC 2.4.1.17 inhibitor
EC 2.4.1.17 inhibitors
UDP glucuronic acid transferase inhibitors
UDP glucuronosyltransferase inhibitor
UDP glucuronosyltransferase inhibitors
UDP glucuronyltransferase inhibitor
UDP glucuronyltransferase inhibitors
UDP-alpha-D-glucuronate beta-D-glucuronosyltransferase (acceptor-unspecific; conformation-inverting) inhibitor
UDP-alpha-D-glucuronate beta-D-glucuronosyltransferase (acceptor-unspecific; conformation-inverting) inhibitors
UDP-glucuronate beta-D-glucuronosyltransferase (acceptor-unspecific) inhibitor
UDP-glucuronate beta-D-glucuronosyltransferase (acceptor-unspecific) inhibitors
UDP-glucuronyltransferase inhibitor
UDP-glucuronyltransferase inhibitors
UDPGA transferase inhibitor
UDPGA transferase inhibitors
UDPGA-glucuronyltransferase inhibitor
UDPGA-glucuronyltransferase inhibitors
UDPGT inhibitor
UDPGT inhibitors
glucuronosyltransferase inhibitor
glucuronosyltransferase inhibitors
uridine 5'-diphosphoglucuronyltransferase inhibitor
uridine 5'-diphosphoglucuronyltransferase inhibitors
uridine diphosphate glucuronyltransferase inhibitor
uridine diphosphate glucuronyltransferase inhibitors
uridine diphosphoglucuronosyltransferase inhibitor
uridine diphosphoglucuronosyltransferase inhibitors
uridine diphosphoglucuronyltransferase inhibitor
uridine diphosphoglucuronyltransferase inhibitors
EC 2.4.1.17 (glucuronosyltransferase) inhibitor
neuropeptide Y receptor antagonist
neuropeptide Y receptor antagonists
neuropeptide Y receptor antagonist
salt-inducible kinase 2 inhibitor
SIK2 inhibitor
SIK2 inhibitors
SNF1LK2 inhibitor
SNF1LK2 inhibitors
salt-inducible kinase 2 inhibitors
serine/threonine-protein kinase SIK2 inhibitor
salt-inducible kinase 2 inhibitor
EC 2.5.1.46 (deoxyhypusine synthase) inhibitor
(4-aminobutyl)lysine synthase inhibitor
(4-aminobutyl)lysine synthase inhibitors
DHS inhibitor
DHS inhibitors
EC 2.5.1.46 (deoxyhypusine synthase) inhibitors
EC 2.5.1.46 inhibitor
EC 2.5.1.46 inhibitors
[eIF-5A]-deoxyhypusine synthase inhibitor
[eIF-5A]-deoxyhypusine synthase inhibitors
[eIF5A-precursor]-lysine:spermidine 4-aminobutyltransferase (propane-1,3-diamine-forming) inhibitor
[eIF5A-precursor]-lysine:spermidine 4-aminobutyltransferase (propane-1,3-diamine-forming) inhibitors
spermidine dehydrogenase inhibitor
spermidine dehydrogenase inhibitors
spermidine:eIF5A-lysine 4-aminobutyltransferase (propane-1,3-diamine-forming) inhibitor
spermidine:eIF5A-lysine 4-aminobutyltransferase (propane-1,3-diamine-forming) inhibitors
EC 2.5.1.46 (deoxyhypusine synthase) inhibitor
hypoxia-inducible factor pathway activator
HIF pathway activator
HIF pathway activators
hypoxia activator
hypoxia activators
hypoxia-inducible factor pathway activators
hypoxia-inducible factor pathway activator
EC 1.15.1.1 (superoxide dismutase) inhibitor
EC 1.15.1.1 (superoxide dismutase) inhibitor
lipopolysaccharide biosynthesis inhibitor
lipopolysaccharide biosynthesis inhibitors
lipopolysaccharide biosynthesis inhibitor
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitors
EC 3.5.1.108 inhibitor
EC 3.5.1.108 inhibitors
LpxC deacetylase inhibitor
LpxC deacetylase inhibitors
LpxC enzyme inhibitor
LpxC enzyme inhibitors
LpxC inhibitor
LpxC inhibitors
UDP-(3-O-(R-3-hydroxymyristoyl))-N-acetylglucosamine deacetylase inhibitor
UDP-(3-O-(R-3-hydroxymyristoyl))-N-acetylglucosamine deacetylase inhibitors
UDP-(3-O-acyl)-N-acetylglucosamine deacetylase inhibitor
UDP-(3-O-acyl)-N-acetylglucosamine deacetylase inhibitors
UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase inhibitor
UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase inhibitors
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase inhibitor
UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase inhibitors
UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetyl-alpha-D-glucosamine amidohydrolase inhibitor
UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetyl-alpha-D-glucosamine amidohydrolase inhibitors
UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine amidohydrolase inhibitor
UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine amidohydrolase inhibitors
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase inhibitor
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase inhibitors
UDP-3-O-acyl-GlcNAc deacetylase inhibitor
UDP-3-O-acyl-GlcNAc deacetylase inhibitors
deacetylase LpxC inhibitor
deacetylase LpxC inhibitors
EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor
antidote to barbiturate poisoning
antidote to barbiturate overdose
antidote to barbiturate poisoning
platelet-activating factor receptor antagonist
PAF antagonist
PAF antagonists
platelet-activating factor receptor antagonists
platelet-activating factor receptor antagonist
EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor
E3 component of alpha-ketoacid dehydrogenase complexes inhibitor
E3 component of alpha-ketoacid dehydrogenase complexes inhibitors
EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitors
EC 1.8.1.4 inhibitor
EC 1.8.1.4 inhibitors
L-protein inhibitor
L-protein inhibitors
LDP-Glc inhibitor
LDP-Glc inhibitors
LDP-Val inhibitor
LDP-Val inhibitors
dehydrolipoate dehydrogenase inhibitor
dehydrolipoate dehydrogenase inhibitors
diaphorase inhibitor
diaphorase inhibitors
dihydrolipoamide dehydrogenase inhibitor
dihydrolipoamide dehydrogenase inhibitors
dihydrolipoamide:NAD(+) oxidoreductase inhibitor
dihydrolipoamide:NAD(+) oxidoreductase inhibitors
dihydrolipoic dehydrogenase inhibitor
dihydrolipoic dehydrogenase inhibitors
dihydrothioctic dehydrogenase inhibitor
dihydrothioctic dehydrogenase inhibitors
glycine-cleavage system L-protein inhibitor
glycine-cleavage system L-protein inhibitors
lipoamide dehydrogenase (NADH) inhibitor
lipoamide dehydrogenase (NADH) inhibitors
lipoamide oxidoreductase (NADH) inhibitor
lipoamide oxidoreductase (NADH) inhibitors
lipoamide reductase (NADH) inhibitor
lipoamide reductase (NADH) inhibitors
lipoamide reductase inhibitor
lipoamide reductase inhibitors
lipoate dehydrogenase inhibitor
lipoate dehydrogenase inhibitors
lipoic acid dehydrogenase inhibitor
lipoic acid dehydrogenase inhibitors
lipoyl dehydrogenase inhibitor
lipoyl dehydrogenase inhibitors
protein-6-N-(dihydrolipoyl)lysine:NAD(+) oxidoreductase inhibitor
protein-6-N-(dihydrolipoyl)lysine:NAD(+) oxidoreductase inhibitors
protein-N(6)-(dihydrolipoyl)lysine:NAD(+) oxidoreductase inhibitor
protein-N(6)-(dihydrolipoyl)lysine:NAD(+) oxidoreductase inhibitors
EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor
EC 2.4.2.8 (hypoxanthine phosphoribosyltransferase) inhibitor
6-hydroxypurine phosphoribosyltransferase inhibitor
6-mercaptopurine phosphoribosyltransferase inhibitor
EC 2.4.2.8 (hypoxanthine phosphoribosyltransferase) inhibitors
EC 2.4.2.8 inhibitor
EC 2.4.2.8 inhibitors
GMP pyrophosphorylase inhibitor
GPRT inhibitor
HGPRTase inhibitor
HPRT inhibitor
IMP pyrophosphorylase inhibitor
IMP-GMP pyrophosphorylase inhibitor
IMP:diphosphate phospho-D-ribosyltransferase inhibitor
guanine phosphoribosyltransferase inhibitor
guanine-hypoxanthine phosphoribosyltransferase inhibitor
guanosine 5'-phosphate pyrophosphorylase inhibitor
guanosine phosphoribosyltransferase inhibitor
guanylate pyrophosphorylase inhibitor
guanylic pyrophosphorylase inhibitor
hypoxanthine phosphoribosyltransferase (EC 2.4.2.8) inhibitor
hypoxanthine phosphoribosyltransferase (EC 2.4.2.8) inhibitors
hypoxanthine phosphoribosyltransferase inhibitor
hypoxanthine phosphoribosyltransferase inhibitors
hypoxanthine-guanine phosphoribosyltransferase inhibitor
inosinate pyrophosphorylase inhibitor
inosine 5'-phosphate pyrophosphorylas inhibitore
inosinic acid pyrophosphorylase inhibitor
inosinic pyrophosphorylase inhibitor
purine-6-thiol phosphoribosyltransferase inhibitor
transphosphoribosidase inhibitor
EC 2.4.2.8 (hypoxanthine phosphoribosyltransferase) inhibitor
EC 1.11.1.7 (peroxidase) inhibitor
Arthromyces ramosus peroxidase inhibitor
Arthromyces ramosus peroxidase inhibitors
Coprinus cinereus peroxidase inhibitor
Coprinus cinereus peroxidase inhibitors
EC 1.11.1.7 (peroxidase) inhibitors
EC 1.11.1.7 inhibitor
EC 1.11.1.7 inhibitors
HRP inhibitor
HRP inhibitors
Japanese radish peroxidase inhibitor
Japanese radish peroxidase inhibitors
extensin peroxidase inhibitor
extensin peroxidase inhibitors
guaiacol peroxidase inhibitor
guaiacol peroxidase inhibitors
heme peroxidase inhibitor
heme peroxidase inhibitors
horseradish peroxidase (HRP) inhibitor
horseradish peroxidase (HRP) inhibitors
horseradish peroxidase inhibitor
horseradish peroxidase inhibitors
lactoperoxidase inhibitor
lactoperoxidase inhibitors
oxyperoxidase inhibitor
oxyperoxidase inhibitors
peroxidase (EC 1.11.1.7) inhibitor
peroxidase (EC 1.11.1.7) inhibitors
peroxidase inhibitor
peroxidase inhibitors
phenolic donor:hydrogen-peroxide oxidoreductase inhibitor
phenolic donor:hydrogen-peroxide oxidoreductase inhibitors
plant peroxidase inhibitor
plant peroxidase inhibitors
protoheme peroxidase inhibitor
protoheme peroxidase inhibitors
pyrocatechol peroxidase inhibitor
pyrocatechol peroxidase inhibitors
scopoletin peroxidase inhibitor
scopoletin peroxidase inhibitors
soybean peroxidase (SBP) inhibitor
soybean peroxidase (SBP) inhibitors
EC 1.11.1.7 (peroxidase) inhibitor
LRH-1 antagonist
LRH-1 antagonists
NR5A2 antagonist
NR5A2 antagonists
liver receptor homolog-1 antagonist
liver receptor homolog-1 antagonists
liver receptor homologue-1 antagonist
liver receptor homologue-1 antagonists
nuclear receptor subfamily 5 group A member 2 antagonist
nuclear receptor subfamily 5 group A member 2 antagonists
LRH-1 antagonist
propesticide
pro-pesticide
pro-pesticides
propesticides
propesticide
proinsecticide
pro-insecticide
pro-insecticides
proinsecticides
proinsecticide
profungicide
pro-fungicide
pro-fungicides
profungicides
profungicide
proherbicide
pro-herbicide
pro-herbicides
proherbicides
proherbicide
proacaricide
pro-acaricide
pro-acaricides
proacaricides
proacaricide
prosafener
pro-safener
pro-safeners
prosafeners
prosafener
S100 calcium-binding protein B inhibitor
S100 calcium-binding protein B inhibitors
S100B inhibitor
S100B inhibitors
S100 calcium-binding protein B inhibitor
pro-agent
pro-agents
proagent
proagents
pro-agent
antidote to sarin poisoning
antidote to sarin poisoning
EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor
1-aminocyclopropane-1-carboxylate synthase inhibitor
1-aminocyclopropane-1-carboxylate synthase inhibitors
1-aminocyclopropane-1-carboxylate synthetase inhibitor
1-aminocyclopropane-1-carboxylate synthetase inhibitors
1-aminocyclopropane-1-carboxylic acid synthase inhibitor
1-aminocyclopropane-1-carboxylic acid synthase inhibitors
1-aminocyclopropanecarboxylate synthase inhibitor
1-aminocyclopropanecarboxylate synthase inhibitors
ACC synthase inhibitor
ACC synthase inhibitors
EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitors
EC 4.4.1.14 inhibitor
EC 4.4.1.14 inhibitors
S-adenosyl-L-methionine methylthioadenosine-lyase (1-aminocyclopropane-1-carboxylate-forming) inhibitor
S-adenosyl-L-methionine methylthioadenosine-lyase (1-aminocyclopropane-1-carboxylate-forming) inhibitors
S-adenosyl-L-methionine methylthioadenosine-lyase inhibitor
S-adenosyl-L-methionine methylthioadenosine-lyase inhibitors
aminocyclopropanecarboxylate synthase inhibitor
aminocyclopropanecarboxylate synthase inhibitors
aminocyclopropanecarboxylic acid synthase inhibitor
aminocyclopropanecarboxylic acid synthase inhibitors
EC 4.4.1.14 (1-aminocyclopropane-1-carboxylate synthase) inhibitor
eukaryotic initiation factor 4F inhibitor
eIF4F inhibitor
eIF4F inhibitors
eukaryotic initiation factor 4F inhibitors
eukaryotic initiation factor 4F inhibitor
bromodomain-containing protein 4 inhibitor
BRD4 inhibitor
BRD4 inhibitors
bromodomain-containing protein 4 inhibitors
bromodomain-containing protein 4 inhibitor
EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor
ATP:[receptor-protein] phosphotransferase inhibitor
ATP:[receptor-protein] phosphotransferase inhibitors
EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitors
EC 2.7.11.30 inhibitor
EC 2.7.11.30 inhibitors
STK13 inhibitor
STK13 inhibitors
TGF-beta kinase inhibitor
TGF-beta kinase inhibitors
activin receptor kinase inhibitor
activin receptor kinase inhibitors
inhibitor of receptor protein serine/threonine kinase
receptor protein serine/threonine kinase (EC 2.7.11.30) inhibitor
receptor protein serine/threonine kinase (EC 2.7.11.30) inhibitors
receptor protein serine/threonine kinase inhibitor
receptor protein serine/threonine kinase inhibitors
receptor serine/threonine protein kinase inhibitor
receptor serine/threonine protein kinase inhibitors
receptor type I serine/threonine protein kinase inhibitor
receptor type I serine/threonine protein kinase inhibitors
receptor type II serine/threonine protein kinase inhibitor
receptor type II serine/threonine protein kinase inhibitors
EC 2.7.11.30 (receptor protein serine/threonine kinase) inhibitor
capsaicin receptor agonist
TRPV1 agonist
TRPV1 agonists
capsaicin agonist
capsaicin agonists
capsaicin receptor agonists
transient receptor potential cation channel subfamily V member 1 agonist
transient receptor potential cation channel subfamily V member 1 agonists
vanilloid receptor 1 agonist
vanilloid receptor 1 agonists
capsaicin receptor agonist
antihypotensive agent
antihypotensive agents
pressor
pressors
vasopressor agent
vasopressor agents
antihypotensive agent
TRPA1 channel agonist
TRPA1 channel agonists
transient receptor potential ankyrin 1 agonist
transient receptor potential ankyrin 1 agonists
transient receptor potential cation channel A1 agonist
transient receptor potential cation channel A1 agonists
TRPA1 channel agonist
EC 2.5.1.48 (cystathionine gamma-synthase) inhibitor
4-O-succinyl-L-homoserine:L-cysteine S-(3-amino-3-carboxypropyl)transferase inhibitor
4-O-succinyl-L-homoserine:L-cysteine S-(3-amino-3-carboxypropyl)transferase inhibitors
EC 2.5.1.48 (cystathionine gamma-synthase) inhibitors
EC 2.5.1.48 inhibitor
EC 2.5.1.48 inhibitors
O(4)-succinyl-L-homoserine:L-cysteine S-(3-amino-3-carboxypropyl)transferase inhibitor
O(4)-succinyl-L-homoserine:L-cysteine S-(3-amino-3-carboxypropyl)transferase inhibitors
O-succinyl-L-homoserine succinate-lyase (adding cysteine) inhibitor
O-succinyl-L-homoserine succinate-lyase (adding cysteine) inhibitors
O-succinylhomoserine (thiol)-lyase inhibitor
O-succinylhomoserine (thiol)-lyase inhibitors
O-succinylhomoserine synthase inhibitor
O-succinylhomoserine synthase inhibitors
O-succinylhomoserine synthetase inhibitor
O-succinylhomoserine synthetase inhibitors
cystathionine gamma-synthase inhibitor
cystathionine gamma-synthase inhibitors
cystathionine synthase inhibitor
cystathionine synthase inhibitors
cystathionine synthetase inhibitor
cystathionine synthetase inhibitors
homoserine O-transsuccinylase inhibitor
homoserine O-transsuccinylase inhibitors
homoserine transsuccinylase inhibitor
homoserine transsuccinylase inhibitors
EC 2.5.1.48 (cystathionine gamma-synthase) inhibitor
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor
11beta-hydroxy steroid dehydrogenase inhibitor
11beta-hydroxy steroid dehydrogenase inhibitors
11beta-hydroxysteroid dehydrogenase inhibitor
11beta-hydroxysteroid dehydrogenase inhibitors
11beta-hydroxysteroid dehydrogenase type 1 inhibitor
11beta-hydroxysteroid dehydrogenase type 1 inhibitors
11beta-hydroxysteroid:NADP(+) 11-oxidoreductase inhibitor
11beta-hydroxysteroid:NADP(+) 11-oxidoreductase inhibitors
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitors
EC 1.1.1.146 inhibitor
EC 1.1.1.146 inhibitors
beta-hydroxysteroid dehydrogenase inhibitor
beta-hydroxysteroid dehydrogenase inhibitors
corticosteroid 11-reductase inhibitor
corticosteroid 11-reductase inhibitors
corticosteroid 11beta-dehydrogenase inhibitor
corticosteroid 11beta-dehydrogenase inhibitors
dehydrogenase, 11beta-hydroxy steroid inhibitor
dehydrogenase, 11beta-hydroxy steroid inhibitors
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor
Papio hamadryas metabolite
P. hamadryas metabolite
P. hamadryas metabolites
Papio hamadryas metabolites
Papio hamadryas metabolite
anxiogenic
anxiogenics
panicogenic
panicogenics
anxiogenic
EC 3.4.22.56 (caspase-3) inhibitor
CASP-3 inhibitor
CASP-3 inhibitors
CPP32 inhibitor
CPP32 inhibitors
EC 3.4.22.56 (caspase-3) inhibitors
EC 3.4.22.56 inhibitor
EC 3.4.22.56 inhibitors
apopain inhibitor
apopain inhibitors
caspase-3 (EC 3.4.22.56) inhibitor
caspase-3 (EC 3.4.22.56) inhibitors
caspase-3 inhibitor
caspase-3 inhibitors
yama protein inhibitor
yama protein inhibitors
EC 3.4.22.56 (caspase-3) inhibitor
endocrine disruptor
endocrine disrupting chemical
endocrine disrupting chemicals
endocrine disrupting compound
endocrine disrupting compounds
endocrine disruptors
endocrine-disrupting chemical
endocrine-disrupting chemicals
hormonally active agent
hormonally active agents
endocrine disruptor
ATPase motor cytoplasmic dynein inhibitor
ATPase motor cytoplasmic dynein inhibitors
ATPase motor cytoplasmic dynein inhibitor
inorganic acid
inorganic acids
mineral acid
mineral acids
inorganic acid
neuropeptide Y2 receptor agonist
neuropeptide Y2 receptor agonist
carotenoid biosynthesis inhibitor
carotenogenesis inhibitor
carotenogenesis inhibitors
carotenoid biosynthesis inhibitors
carotenoid-biosynthesis inhibitor
carotenoid-biosynthesis inhibitors
carotenoid biosynthesis inhibitor
RhoA inhibitor
Ras homolog gene family, member A inhibitor
Ras homolog gene family, member A inhibitors
RhoA GTPase inhibitor
RhoA GTPase inhibitors
RhoA inhibitors
RhoA inhibitor
RhoC inhibitor
Ras homolog gene family, member C inhibitor
Ras homolog gene family, member C inhibitors
RhoC GTPase inhibitor
RhoC GTPase inhibitors
RhoC inhibitors
RhoC inhibitor
EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor
7alpha-HSDH inhibitor
7alpha-HSDH inhibitors
7alpha-hydroxy steroid dehydrogenase inhibitor
7alpha-hydroxy steroid dehydrogenase inhibitors
7alpha-hydroxysteroid dehydrogenase inhibitor
7alpha-hydroxysteroid dehydrogenase inhibitors
7alpha-hydroxysteroid:NAD+ 7-oxidoreductase inhibitor
7alpha-hydroxysteroid:NAD+ 7-oxidoreductase inhibitors
EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitors
EC 1.1.1.159 inhibitor
EC 1.1.1.159 inhibitors
EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor
angiotensin receptor agonist
angiotensin receptor agonists
angiotensin receptor agonist
autophagy inducer
autophagocytosis inducer
autophagocytosis inducers
autophagy inducers
autophagy inducer
prostaglandin receptor antagonist
prostaglandin receptor antagonists
prostanoid receptor antagonist
prostanoid receptor antagonists
prostaglandin receptor antagonist
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitors
EC 6.3.5.* (carbon-nitrogen ligases with glutamine as amido-N-donor) inhibitor
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor
CAD inhibitor
CAD inhibitors
CPS inhibitor
CPS inhibitors
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitors
EC 6.3.5.5 inhibitor
EC 6.3.5.5 inhibitors
GD-CPSase inhibitor
GD-CPSase inhibitors
HCO3(-):L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitor
HCO3(-):L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitors
carA inhibitor
carA inhibitors
carB inhibitor
carB inhibitors
carbamoyl phosphate synthetase inhibitor
carbamoyl phosphate synthetase inhibitors
carbamoyl-phosphate synthase (glutamine-hydrolysing) (EC 6.3.5.5) inhibitor
carbamoyl-phosphate synthase (glutamine-hydrolysing) (EC 6.3.5.5) inhibitors
carbamoyl-phosphate synthetase (glutamine-hydrolysing) inhibitor
carbamoyl-phosphate synthetase (glutamine-hydrolysing) inhibitors
carbamoylphosphate synthetase II inhibitor
carbamoylphosphate synthetase II inhibitors
carbamyl phosphate synthetase (glutamine) inhibitor
carbamyl phosphate synthetase (glutamine) inhibitors
carbon-dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitor
carbon-dioxide:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitors
glutamine-dependent carbamoyl-phosphate synthase inhibitor
glutamine-dependent carbamoyl-phosphate synthase inhibitors
glutamine-dependent carbamyl phosphate synthetase inhibitor
glutamine-dependent carbamyl phosphate synthetase inhibitors
hydrogen-carbonate:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitor
hydrogen-carbonate:L-glutamine amido-ligase (ADP-forming, carbamate-phosphorylating) inhibitors
EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor
EC 6.3.4.* (other carbon--nitrogen ligases) inhibitor
EC 6.3.4.* (other carbon--nitrogen ligases) inhibitors
EC 6.3.4.* inhibitor
EC 6.3.4.* inhibitors
EC 6.3.4.* (other carbon--nitrogen ligases) inhibitor
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor
CTP synthase (glutamine hydrolyzing) (EC6.3.4.2) inhibitor
CTP synthase (glutamine hydrolyzing) (EC6.3.4.2) inhibitors
CTP synthase (glutamine hydrolyzing) inhibitor
CTP synthase (glutamine hydrolyzing) inhibitors
CTP synthetase inhibitor
CTP synthetase inhibitors
CTPS inhibitor
CTPS inhibitors
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitors
EC 6.3.4.2 inhibitor
EC 6.3.4.2 inhibitors
UTP--ammonia ligase inhibitor
UTP-ammonia ligase inhibitors
UTP:L-glutamine amido-ligase (ADP-forming) inhibitor
UTP:L-glutamine amido-ligase (ADP-forming) inhibitors
cytidine triphosphate synthetase inhibitor
cytidine triphosphate synthetase inhibitors
pyrG inhibitor
pyrG inhibitors
uridine triphosphate aminase inhibitor
uridine triphosphate aminase inhibitors
EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
2-N-formyl-1-N-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
2-N-formyl-1-N-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
5'-phosphoribosylformylglycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
5'-phosphoribosylformylglycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitors
EC 6.3.5.3 inhibitor
EC 6.3.5.3 inhibitors
FGAM synthase inhibitor
FGAM synthase inhibitors
FGAM synthetase inhibitor
FGAM synthetase inhibitors
FGAR amidotransferase inhibitor
FGAR amidotransferase inhibitors
FGARAT inhibitor
FGARAT inhibitors
N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitor
N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide:L-glutamine amido-ligase (ADP-forming) inhibitors
formylglycinamide ribonucloetide amidotransferase inhibitor
formylglycinamide ribonucloetide amidotransferase inhibitors
formylglycinamide ribotide amidotransferase inhibitor
formylglycinamide ribotide amidotransferase inhibitors
phosphoribosylformylglycinamidine synthase inhibitor
phosphoribosylformylglycinamidine synthase inhibitors
phosphoribosylformylglycinamidine synthetase inhibitor
phosphoribosylformylglycinamidine synthetase inhibitors
phosphoribosylformylglycineamidine synthetase inhibitor
phosphoribosylformylglycineamidine synthetase inhibitors
EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitors
EC 6.3.5.2 inhibitor
EC 6.3.5.2 inhibitors
GMP synthase (glutamine-hydrolysing) inhibitor
GMP synthase (glutamine-hydrolysing) inhibitors
GMP synthetase (glutamine-hydrolysing) inhibitor
GMP synthetase (glutamine-hydrolysing) inhibitors
guanosine 5'-monophosphate synthetase inhibitor
guanosine 5'-monophosphate synthetase inhibitors
guanosine monophosphate synthetase (glutamine-hydrolyzing) inhibitor
guanosine monophosphate synthetase (glutamine-hydrolyzing) inhibitors
guanylate synthetase (glutamine-hydrolyzing) inhibitor
guanylate synthetase (glutamine-hydrolyzing) inhibitors
xanthosine 5'-phosphate amidotransferase inhibitor
xanthosine 5'-phosphate amidotransferase inhibitors
xanthosine-5'-phosphate:L-glutamine amido-ligase (AMP-forming) inhibitor
xanthosine-5'-phosphate:L-glutamine amido-ligase (AMP-forming) inhibitors
EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor
glutamine antagonist
glutamine antagonists
glutamine antagonist
EC 4.1.1.39 (ribulose-bisphosphate carboxylase) inhibitor
3-phospho-D-glycerate carboxy-lyase (dimerizing) inhibitor
3-phospho-D-glycerate carboxy-lyase (dimerizing) inhibitors
3-phospho-D-glycerate carboxy-lyase (dimerizing; D-ribulose-1,5-bisphosphate-forming) inhibitor
3-phospho-D-glycerate carboxy-lyase (dimerizing; D-ribulose-1,5-bisphosphate-forming) inhibitors
D-ribulose 1,5-bisphosphate carboxylase inhibitor
D-ribulose 1,5-bisphosphate carboxylase inhibitors
D-ribulose 1,5-diphosphate carboxylase inhibitor
D-ribulose 1,5-diphosphate carboxylase inhibitors
EC 4.1.1.39 (ribulose-bisphosphate carboxylase) inhibitors
EC 4.1.1.39 inhibitor
EC 4.1.1.39 inhibitors
RuBP carboxylase inhibitor
RuBP carboxylase inhibitors
RuBisCO inhibitor
RuBisCO inhibitors
carboxydismutase inhibitor
carboxydismutase inhibitors
diphosphoribulose carboxylase inhibitor
diphosphoribulose carboxylase inhibitors
ribulose 1,5-bisphosphate carboxylase inhibitor
ribulose 1,5-bisphosphate carboxylase inhibitors
ribulose 1,5-bisphosphate carboxylase/oxygenase inhibitor
ribulose 1,5-bisphosphate carboxylase/oxygenase inhibitors
ribulose 1,5-diphosphate carboxylase inhibitor
ribulose 1,5-diphosphate carboxylase inhibitors
ribulose 1,5-diphosphate carboxylase/oxygenase inhibitor
ribulose 1,5-diphosphate carboxylase/oxygenase inhibitors
ribulose bisphosphate carboxylase/oxygenase inhibitor
ribulose bisphosphate carboxylase/oxygenase inhibitors
ribulose diphosphate carboxylase inhibitor
ribulose diphosphate carboxylase inhibitors
ribulose diphosphate carboxylase/oxygenase inhibitor
ribulose diphosphate carboxylase/oxygenase inhibitors
ribulose-bisphosphate carboxylase inhibitor
ribulose-bisphosphate carboxylase inhibitors
rubisco inhibitor
rubisco inhibitors
EC 4.1.1.39 (ribulose-bisphosphate carboxylase) inhibitor
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor
5'-phosphoribosylpyrophosphate amidotransferase inhibitor
5'-phosphoribosylpyrophosphate amidotransferase inhibitors
5-phospho-beta-D-ribosylamine:diphosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating) inhibitor
5-phospho-beta-D-ribosylamine:diphosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating) inhibitors
5-phosphoribosyl-1-pyrophosphate amidotransferase inhibitor
5-phosphoribosyl-1-pyrophosphate amidotransferase inhibitors
5-phosphoribosylamine:diphosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating) inhibitor
5-phosphoribosylamine:diphosphate phospho-alpha-D-ribosyltransferase (glutamate-amidating) inhibitors
5-phosphororibosyl-1-pyrophosphate amidotransferase inhibitor
5-phosphororibosyl-1-pyrophosphate amidotransferase inhibitors
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitors
EC 2.4.2.14 inhibitor
EC 2.4.2.14 inhibitors
alpha-5-phosphoribosyl-1-pyrophosphate amidotransferase inhibitor
alpha-5-phosphoribosyl-1-pyrophosphate amidotransferase inhibitors
amidophosphoribosyltransferase (EC 2.4.2.14) inhibitor
amidophosphoribosyltransferase (EC 2.4.2.14) inhibitors
amidophosphoribosyltransferase inhibitor
amidophosphoribosyltransferase inhibitors
glutamine 5-phosphoribosylpyrophosphate amidotransferase inhibitor
glutamine 5-phosphoribosylpyrophosphate amidotransferase inhibitors
glutamine phosphoribosyldiphosphate amidotransferase inhibitor
glutamine phosphoribosyldiphosphate amidotransferase inhibitors
glutamine phosphoribosylpyrophosphate amidotransferase inhibitor
glutamine phosphoribosylpyrophosphate amidotransferase inhibitors
glutamine ribosylpyrophosphate 5-phosphate amidotransferase inhibitor
glutamine ribosylpyrophosphate 5-phosphate amidotransferase inhibitors
phosphoribose pyrophosphate amidotransferase inhibitor
phosphoribose pyrophosphate amidotransferase inhibitors
phosphoribosyl pyrophosphate amidotransferase inhibitor
phosphoribosyl pyrophosphate amidotransferase inhibitors
phosphoribosyldiphosphate 5-amidotransferase inhibitor
phosphoribosyldiphosphate 5-amidotransferase inhibitors
phosphoribosylpyrophosphate glutamyl amidotransferase inhibitor
phosphoribosylpyrophosphate glutamyl amidotransferase inhibitors
EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
DPN synthetase inhibitor
DPN synthetase inhibitors
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitors
EC 6.3.5.1 inhibitor
EC 6.3.5.1 inhibitors
NAD synthetase (glutamine-hydrolysing) inhibitor
NAD synthetase (glutamine-hydrolysing) inhibitors
NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitor
NAD(+) synthase (glutamine-hydrolysing) (EC 6.3.5.1) inhibitors
NAD(+) synthase (glutamine-hydrolysing) inhibitor
NAD(+) synthase (glutamine-hydrolysing) inhibitors
NAD(+) synthetase (glutamine-hydrolyzing) inhibitor
NAD(+) synthetase (glutamine-hydrolyzing) inhibitors
deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitor
deamido-NAD(+):L-glutamine amido-ligase (AMP-forming) inhibitors
desamidonicotinamide adenine dinucleotide amidotransferase inhibitor
desamidonicotinamide adenine dinucleotide amidotransferase inhibitors
nicotinamide adenine dinucleotide synthetase (glutamine) inhibitor
nicotinamide adenine dinucleotide synthetase (glutamine) inhibitors
EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor
AS inhibitor
AS inhibitors
AS-B inhibitor
AS-B inhibitors
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitors
EC 6.3.5.4 inhibitor
EC 6.3.5.4 inhibitors
L-aspartate:L-glutamine amido-ligase (AMP-forming) inhibitor
L-aspartate:L-glutamine amido-ligase (AMP-forming) inhibitors
asparagine synthase (glutamine-hydrolysing) (EC 6.3.5.4) inhibitor
asparagine synthase (glutamine-hydrolysing) (EC 6.3.5.4) inhibitors
asparagine synthase (glutamine-hydrolysing) inhibitor
asparagine synthase (glutamine-hydrolysing) inhibitors
asparagine synthetase (glutamine-hydrolysing) inhibitor
asparagine synthetase (glutamine-hydrolysing) inhibitors
asparagine synthetase B inhibitor
asparagine synthetase B inhibitors
glutamine-dependent asparagine synthetase inhibitor
glutamine-dependent asparagine synthetase inhibitors
EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor
quorum sensing inhibitor
QS inhibitor
QS inhibitors
QSI
QSIs
quorum sensing inhibitors
quorum sensing inhibitor
thromboxane A2 agonist
TXA2/PGH2 agonist
TXA2/PGH2 agonists
TXA2/PGH2 receptor agonist
TXA2/PGH2 receptor agonists
thromboxane A2 agonists
thromboxane A2 receptor agonist
thromboxane A2 receptor agonists
thromboxane A2 agonist
PERK inhibitor
PERK inhibitors
PKR-like endoplasmic reticulum kinase inhibitor
PKR-like endoplasmic reticulum kinase inhibitors
protein kinase R-like endoplasmic reticulum kinase inhibitor
protein kinase R-like endoplasmic reticulum kinase inhibitors
PERK inhibitor
LIM kinase inhibitor
LIM kinase inhibitors
LIM kinase inhibitor
cis-Golgi ArfGEF GBF inhibitor
cis-Golgi ArfGEF GBF inhibitor
IP3 receptor agonist
D-myo-inositol 1,4,5-trisphosphate receptor agonist
D-myo-inositol 1,4,5-trisphosphate receptor agonists
IP3 agonist
IP3 agonists
IP3 receptor agonists
InsP3R agonist
InsP3R agonists
inositol trisphosphate receptor agonist
inositol trisphosphate receptor agonists
IP3 receptor agonist
EC 2.4.1.255 (protein O-GlcNAc transferase) inhibitor
EC 2.4.1.255 (protein O-GlcNAc transferase) inhibitors
EC 2.4.1.255 inhibitor
EC 2.4.1.255 inhibitors
O-GlcNAc transferase inhibitor
O-GlcNAc transferase inhibitors
O-linked N-acetylglucosaminyltransferase inhibitor
O-linked N-acetylglucosaminyltransferase inhibitors
OGTase inhibitor
OGTase inhibitors
UDP-N-acetyl-D-glucosamine:protein-O-beta-N-acetyl-D-glucosaminyl transferase inhibitor
UDP-N-acetyl-D-glucosamine:protein-O-beta-N-acetyl-D-glucosaminyl transferase inhibitors
protein O-GlcNAc transferase (EC 2.4.1.255) inhibitor
protein O-GlcNAc transferase (EC 2.4.1.255) inhibitors
protein O-GlcNAc transferase inhibitor
protein O-GlcNAc transferase inhibitors
protein O-linked beta-N-acetylglucosamine transferase inhibitor
protein O-linked beta-N-acetylglucosamine transferase inhibitors
uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase inhibitor
uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase inhibitors
EC 2.4.1.255 (protein O-GlcNAc transferase) inhibitor
melanin-concentrating hormone receptor antagonist
MCHR agonist
MCHR agonists
melanin-concentrating hormone receptor antagonists
melanin-concentrating hormone receptor antagonist
nicotinic acid adenine dinucleotide phosphate receptor antagonist
NAADP antagonist
NAADP antagonists
NAADP receptor antagonist
NAADP receptor antagonists
nicotinic acid adenine dinucleotide phosphate receptor antagonists
nicotinic acid adenine dinucleotide phosphate receptor antagonist
peptide probe
peptide probe
EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor
EC 1.14.17.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen and with reduced ascorbate as one donor, and incorporation of one atom of oxygen) inhibitor
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor
(3,4-dihydroxyphenethylamine)beta-mono-oxygenase inhibitor
(3,4-dihydroxyphenethylamine)beta-mono-oxygenase inhibitors
3,4-dihydroxyphenethylamine beta-oxidase inhibitor
3,4-dihydroxyphenethylamine beta-oxidase inhibitors
3,4-dihydroxyphenethylamine,ascorbate:oxygen oxidoreductase (beta-hydroxylating) inhibitor
3,4-dihydroxyphenethylamine,ascorbate:oxygen oxidoreductase (beta-hydroxylating) inhibitors
4-(2-aminoethyl)pyrocatechol beta-oxidase inhibitor
4-(2-aminoethyl)pyrocatechol beta-oxidase inhibitors
DbetaH inhibitor
DbetaH inhibitors
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitors
EC 1.14.17.1 inhibitor
EC 1.14.17.1 inhibitors
MDBH (membrane-associated dopamine beta-monooxygenase) inhibitor
MDBH (membrane-associated dopamine beta-monooxygenase) inhibitors
SDBH (soluble dopamine beta-monooxygenase) inhibitor
SDBH (soluble dopamine beta-monooxygenase) inhibitors
dopa beta-hydroxylase inhibitor
dopa beta-hydroxylase inhibitors
dopamine beta-hydroxylase inhibitor
dopamine beta-hydroxylase inhibitors
dopamine beta-monooxygenase (EC 1.14.17.1) inhibitor
dopamine beta-monooxygenase (EC 1.14.17.1) inhibitors
dopamine beta-monooxygenase inhibitor
dopamine beta-monooxygenase inhibitors
dopamine beta-oxidase inhibitor
dopamine beta-oxidase inhibitors
dopamine hydroxylase inhibitor
dopamine hydroxylase inhibitors
dopamine-B-hydroxylase inhibitor
dopamine-B-hydroxylase inhibitors
oxygenase, dopamine beta-mono-phenylamine beta-hydroxylase inhibitor
oxygenase, dopamine beta-mono-phenylamine beta-hydroxylase inhibitors
EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor
TRP channel blocker
TRP channel blockers
transient receptor potential channel blocker
transient receptor potential channel blockers
TRP channel blocker
sensitiser
sensitisers
sensitizer
sensitizers
sensitiser
vitamin D receptor agonist
VDR agonist
VDR agonists
calcitriol receptor agonist
calcitriol receptor agonists
vitamin D nuclear receptor agonist
vitamin D nuclear receptor agonists
vitamin D receptor agonists
vitamin D receptor agonist
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitors
EC 1.3.1.9 inhibitor
EC 1.3.1.9 inhibitors
ENR inhibitor
ENR inhibitors
NADH-enoyl acyl carrier protein reductase inhibitor
NADH-enoyl acyl carrier protein reductase inhibitors
NADH-specific enoyl-ACP reductase inhibitor
NADH-specific enoyl-ACP reductase inhibitors
acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitor
acyl-[acyl-carrier-protein]:NAD+ oxidoreductase inhibitors
enoyl-ACP reductase inhibitor
enoyl-ACP reductase inhibitors
enoyl-[acyl carrier protein] reductase inhibitor
enoyl-[acyl carrier protein] reductase inhibitors
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor
EC 4.1.1.17 (ornithine decarboxylase) inhibitor
EC 4.1.1.17 (ornithine decarboxylase) inhibitors
EC 4.1.1.17 inhibitor
EC 4.1.1.17 inhibitors
L-ornithine carboxy-lyase (putrescine-forming) inhibitor
L-ornithine carboxy-lyase (putrescine-forming) inhibitors
L-ornithine carboxy-lyase inhibitor
L-ornithine carboxy-lyase inhibitors
ODC inhibitor
ODC inhibitors
SpeC inhibitor
SpeC inhibitors
EC 4.1.1.17 (ornithine decarboxylase) inhibitor
Jacobaea metabolite
Jacobaea metabolites
Jacobaea metabolite
lysophosphatidic acid receptor 3 agonist
LPA3 agonist
LPA3 agonists
LPAR3 agonist
LPAR3 agonists
lysophosphatidic acid receptor 3 agonists
lysophosphatidic acid receptor 3 agonist
survivin suppressant
survivin suppressants
survivin suppressor
survivin suppressors
survivin suppressant
TRPV4 agonist
OSM9-like transient receptor potential channel, member 4 agonist
OSM9-like transient receptor potential channel, member 4 agonists
OTRPC4 agonist
OTRPC4 agonists
TRPV4 agonists
VR-OAC agonist
VR-OAC agonists
transient receptor potential +agonist
transient receptor potential cation channel subfamily V member 4 agonist
transient receptor potential cation channel subfamily V member 4 agonists
transient receptor potential vanilloid 4 agonists
transient receptor vanilloid-4 agonist
transient receptor vanilloid-4 agonists
vanilloid-receptor related osmotically activated channel agonist
vanilloid-receptor related osmotically activated channel agonists
TRPV4 agonist
Camellia sinensis metabolite
C. sinensis metabolite
C. sinensis metabolites
Camellia sinensis metabolites
Camellia sinensis metabolite
Brassica napus metabolite
Brassica napus metabolites
rapeseed metabolite
rapeseed metabolites
Brassica napus metabolite
calcium-dependent antibiotics
Ca(2+)-dependent antibiotic
Ca(2+)-dependent antibiotics
Ca-dependent antibiotic
Ca-dependent antibiotics
calcium-dependent antibiotic
calcium-dependent antibiotics
EC 1.1.1.37 (malate dehydrogenase) inhibitor
(S)-malate:NAD(+) oxidoreductase inhibitor
(S)-malate:NAD(+) oxidoreductase inhibitors
EC 1.1.1.37 (malate dehydrogenase) inhibitors
EC 1.1.1.37 inhibitor
EC 1.1.1.37 inhibitors
L-malate dehydrogenase inhibitor
L-malate dehydrogenase inhibitors
L-malate-NAD(+) oxidoreductase inhibitor
L-malate-NAD(+) oxidoreductase inhibitors
MDH inhibitor
MDH inhibitors
NAD-L-malate dehydrogenase inhibitor
NAD-L-malate dehydrogenase inhibitors
NAD-dependent malate dehydrogenase inhibitor
NAD-dependent malate dehydrogenase inhibitors
NAD-dependent malic dehydrogenase inhibitor
NAD-dependent malic dehydrogenase inhibitors
NAD-linked malate dehydrogenase inhibitor
NAD-linked malate dehydrogenase inhibitors
NAD-malate dehydrogenase inhibitor
NAD-malate dehydrogenase inhibitors
NAD-malic dehydrogenase inhibitor
NAD-malic dehydrogenase inhibitors
NAD-specific malate dehydrogenase inhibitor
NAD-specific malate dehydrogenase inhibitors
malate (NAD) dehydrogenase inhibitor
malate (NAD) dehydrogenase inhibitors
malate dehydrogenase (EC 1.1.1.37) inhibitor
malate dehydrogenase (EC 1.1.1.37) inhibitors
malate dehydrogenase inhibitor
malate dehydrogenase inhibitors
malic acid dehydrogenase inhibitor
malic acid dehydrogenase inhibitors
malic dehydrogenase inhibitor
malic dehydrogenase inhibitors
EC 1.1.1.37 (malate dehydrogenase) inhibitor
specialised pro-resolving mediator
SPM
SPMs
specialised pro-resolving mediators
specialised proresolving mediator
specialised proresolving mediators
specialized pro-resolving mediator
specialized pro-resolving mediators
specialized proresolving mediator
specialized proresolving mediators
specialised pro-resolving mediator
neurokinin-3 receptor antagonist
NK-3 receptor antagonist
NK-3 receptor antagonists
NK3 receptor antagonist
NK3 receptor antagonists
NK3R antagonist
NK3R antagonists
neurokinin-3 receptor antagonists
neurokinin-3 receptor antagonist
tropomyosin-related kinase B receptor agonist
TrkB receptor agonist
TrkB receptor agonists
tropomyosin-related kinase B receptor agonists
tropomyosin-related kinase B receptor agonist
TRPV1 agonist
TRPV1 agonists
capsaicin receptor agonist
capsaicin receptor agonists
transient receptor potential cation channel subfamily V member 1 agonist
transient receptor potential cation channel subfamily V member 1 agonists
transient receptor potential vanilloid 1 agonist
transient receptor potential vanilloid 1 agonists
vanilloid receptor 1 agonist
vanilloid receptor 1 agonists
TRPV1 agonist
Arabidopsis thaliana metabolite
Arabidopsis thaliana metabolites
Arabidopsis thaliana metabolite
secreted frizzled-related protein 1 inhibitor
SFRP1 inhibitor
SFRP1 inhibitors
sFRP-1 inhibitor
sFRP-1 inhibitors
secreted frizzled-related protein 1 inhibitors
secreted frizzled-related protein-1 inhibitor
secreted frizzled-related protein-1 inhibitors
secreted frizzled-related protein 1 inhibitor
Hedgehog signaling pathway inhibitor
Hedgehog pathway inhibitor
Hedgehog pathway inhibitors
Hedgehog signaling pathway inhibitors
Hedgehog signaling pathway inhibitor
glioma-associated oncogene inhibitor
GLI inhibitor
GLI inhibitors
glioma-associated oncogene inhibitors
glioma-associated oncogene inhibitor
neuropeptide FF receptor antagonist
NPFF receptor antagonist
NPFF receptor antagonists
NPFFR antagonist
NPFFR antagonists
neuropeptide FF receptor antagonists
neuropeptide FF receptor antagonist
neuropeptide FF receptor agonist
NPFF receptor agonist
NPFF receptor agonists
neuropeptide FF receptor agonists
neuropeptide FF receptor agonist
kisspeptin receptor agonist
kisspeptin receptor agonists
kisspeptin receptor agonist
quinone outside inhibitor
QOI
QOIs
Qo inhibitor
Qo inhibitors
quinone outside inhibitors
quinone outside inhibitor
pronematicide
pronematicides
pronematocide
pronematocides
pronematicide
5-hydroxytryptamine 2B receptor agonist
5-HT2B agonist
5-HT2B agonists
5-HT2B receptor agonist
5-HT2B receptor agonists
5-hydroxytryptamine 2B receptor agonists
5-hydroxytryptamine receptor 2B agonist
5-hydroxytryptamine receptor 2B agonists
serotonin receptor 2B agonist
serotonin receptor 2B agonists
5-hydroxytryptamine 2B receptor agonist
5-hydroxytryptamine 2C receptor agonist
5-HT2C receptor agonist
5-HT2C receptor agonists
5-HT2c agonist
5-HT2c agonists
5-hydroxytryptamine 2C receptor agonists
5-hydroxytryptamine receptor 2C agonist
5-hydroxytryptamine receptor 2C agonists
serotonin receptor 2C agonist
serotonin receptor 2C agonists
5-hydroxytryptamine 2C receptor agonist
EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor
(6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate,[reduced NADPH-hemoprotein reductase]:oxygen oxidoreductase (20-hydroxylating) inhibitor
(6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate,[reduced NADPH-hemoprotein reductase]:oxygen oxidoreductase (20-hydroxylating) inhibitors
CYP4F2 inhibitor
CYP4F2 inhibitors
CYP4F3 inhibitor
CYP4F3 inhibitors
EC 1.14.13.30 inhibitor
EC 1.14.13.30 inhibitors
EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitors
EC 1.14.14.94 inhibitor
EC 1.14.14.94 inhibitors
LTB4 20-hydroxylase inhibitor
LTB4 20-hydroxylase inhibitors
LTB4 omega-hydroxylase inhibitor
LTB4 omega-hydroxylase inhibitors
leucotriene-B4 omega-hydroxylase inhibitor
leucotriene-B4 omega-hydroxylase inhibitors
leukotriene-B4 20-hydroxylase inhibitor
leukotriene-B4 20-hydroxylase inhibitors
leukotriene-B4 20-monooxygenase (EC 1.14.14.94) inhibitors
leukotriene-B4 20-monooxygenase inhibitor
leukotriene-B4 20-monooxygenase inhibitors
EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor
1-hydroxylase inhibitor
1-hydroxylase inhibitors
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitors
EC 1.14.15.3 inhibitor
EC 1.14.15.3 inhibitors
alkane 1-hydroxylase inhibitor
alkane 1-hydroxylase inhibitors
alkane 1-monooxygenase (EC 1.14.15.3) inhibitor
alkane 1-monooxygenase (EC 1.14.15.3) inhibitors
alkane 1-monooxygenase inhibitor
alkane 1-monooxygenase inhibitors
alkane hydroxylase inhibitor
alkane hydroxylase inhibitors
alkane monooxygenase inhibitor
alkane monooxygenase inhibitors
alkane,reduced-rubredoxin:oxygen 1-oxidoreductase inhibitor
alkane,reduced-rubredoxin:oxygen 1-oxidoreductase inhibitors
fatty acid omega-hydroxylase inhibitor
fatty acid omega-hydroxylase inhibitors
omega-hydroxylase inhibitor
omega-hydroxylase inhibitors
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor
EC 4.1.1.15 (glutamate decarboxylase) inhibitor
EC 4.1.1.15 (glutamate decarboxylase) inhibitors
EC 4.1.1.15 inhibitor
EC 4.1.1.15 inhibitors
L-aspartate-alpha-decarboxylase inhibitor
L-aspartate-alpha-decarboxylase inhibitors
L-glutamate 1-carboxy-lyase (4-aminobutanoate-forming) inhibitor
L-glutamate 1-carboxy-lyase (4-aminobutanoate-forming) inhibitors
L-glutamate 1-carboxy-lyase inhibitor
L-glutamate 1-carboxy-lyase inhibitors
L-glutamate alpha-decarboxylase inhibitor
L-glutamate alpha-decarboxylase inhibitors
L-glutamic acid decarboxylase inhibitor
L-glutamic acid decarboxylase inhibitors
L-glutamic decarboxylase inhibitor
L-glutamic decarboxylase inhibitors
aspartate 1-decarboxylase inhibitor
aspartate 1-decarboxylase inhibitors
aspartic alpha-decarboxylase inhibitor
aspartic alpha-decarboxylase inhibitors
cysteic acid decarboxylase inhibitor
cysteic acid decarboxylase inhibitors
gamma-glutamate decarboxylase inhibitor
gamma-glutamate decarboxylase inhibitors
glutamate decarboxylase (EC 4.1.1.15) inhibitor
glutamate decarboxylase (EC 4.1.1.15) inhibitors
glutamate decarboxylase inhibitor
glutamate decarboxylase inhibitors
EC 4.1.1.15 (glutamate decarboxylase) inhibitor
tau aggregation inhibitor
TAI
tau aggregation inhibitor
tau aggregation inhibitors
tau protein aggregation inhibitor
tau protein aggregation inhibitors
tau-aggregation inhibitor
tau-aggregation inhibitors
tau aggregation inhibitor
EC 2.5.1.117 (homogentisate solanesyltransferase) inhibitor
EC 2.5.1.117 (homogentisate solanesyltransferase) inhibitor
TRPV channel modulator
TRPV channel modulators
transient receptor potential (vanilloid) channel modulator
transient receptor potential (vanilloid) channel modulators
TRPV channel modulator
TRP channel modulator
TRP channel modulators
TRP channel modulator
EC 3.3.2.10 (soluble epoxide hydrolase) inhibitor
sEHi
soluble epoxide hydrolase inhibitor
soluble epoxide hydrolase inhibitors
EC 3.3.2.10 (soluble epoxide hydrolase) inhibitor
GABAB receptor agonist
GABAB receptor agonist
EC 2.1.3.* (carboxy- and carbamoyltransferases) inhibitor
EC 2.1.3.* (carboxy- and carbamoyltransferases) inhibitors
EC 2.1.3.* (carboxytransferase and carbamoyltransferase) inhibitor
EC 2.1.3.* (carboxytransferase and carbamoyltransferase) inhibitors
EC 2.1.3.* inhibitor
EC 2.1.3.* inhibitors
carboxy- and carbamoyltransferase (EC 2.1.3.*) inhibitor
carboxy- and carbamoyltransferase (EC 2.1.3.*) inhibitors
EC 2.1.3.* (carboxy- and carbamoyltransferases) inhibitor
EC 2.1.3.3 (ornithine carbamoyltransferase) inhibitor
EC 2.1.3.3 (ornithine carbamoyltransferase) inhibitors
EC 2.1.3.3 inhibitor
EC 2.1.3.3 inhibitors
L-ornithine carbamoyltransferase inhibitor
L-ornithine carbamoyltransferase inhibitors
L-ornithine carbamyltransferase inhibitor
L-ornithine carbamyltransferase inhibitors
L-ornithine transcarbamylase inhibitor
L-ornithine transcarbamylase inhibitors
OTC inhibitor
OTC inhibitors
carbamoyl-phosphate:L-ornithine carbamoyltransferase inhibitor
carbamoyl-phosphate:L-ornithine carbamoyltransferase inhibitors
carbamylphosphate-ornithine transcarbamylase inhibitor
carbamylphosphate-ornithine transcarbamylase inhibitors
citrulline phosphorylase inhibitor
citrulline phosphorylase inhibitors
ornithine carbamoyltransferase (EC 2.1.3.3) inhibitor
ornithine carbamoyltransferase (EC 2.1.3.3) inhibitors
ornithine carbamoyltransferase inhibitor
ornithine carbamoyltransferase inhibitors
ornithine carbamyltransferase inhibitor
ornithine carbamyltransferase inhibitors
ornithine transcarbamylase inhibitor
ornithine transcarbamylase inhibitors
EC 2.1.3.3 (ornithine carbamoyltransferase) inhibitor
impurity
contaminant
contaminants
impurities
impurity
impurity
peptide allergen
allergenic peptide
peptide allergen
carbohydrate allergen
allergenic carbohydrate
allergenic carbohydrate derivative
carbohydrate allergen
ceramide allergen
allergenic ceramide
ceramide allergen
EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor
CYP51 inhibitor
CYP51 inhibitors
EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitors
EC 1.14.14.154 inhibitor
EC 1.14.14.154 inhibitors
ERG11 inhibitor
ERG11 inhibitors
cytochrome P450 51 inhibitor
cytochrome P450 51 inhibitors
lanosterol 14-demethylase inhibitor
lanosterol 14-demethylase inhibitors
lanosterol 14alpha-demethylase inhibitor
lanosterol 14alpha-demethylase inhibitors
obtusufoliol 14-demethylase inhibitor
obtusufoliol 14-demethylase inhibitors
oxidoreductase (14-methyl cleaving) inhibitors
sterol 14-demethylase inhibitor
sterol 14-demethylase inhibitors
sterol 14alpha-demethylase (EC 1.14.14.154) inhibitor
sterol 14alpha-demethylase (EC 1.14.14.154) inhibitors
sterol 14alpha-demethylase inhibitor
sterol 14alpha-demethylase inhibitors
sterol,[reduced NADPH--hemoprotein reductase]:oxygen inhibitor
sterol,[reduced NADPH--hemoprotein reductase]:oxygen oxidoreductase (14-methyl cleaving) inhibitor
EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor
EC 2.7.1.40 (pyruvate kinase) inhibitor
EC 2.7.1.40 inhibitor
EC 2.7.1.40 inhibitors
phosphoenol transphosphorylase inhibitor
phosphoenol transphosphorylase inhibitors
phosphoenolpyruvate kinase inhibitor
phosphoenolpyruvate kinase inhibitors
pyruvate kinase inhibitor
pyruvate kinase inhibitors
EC 2.7.1.40 (pyruvate kinase) inhibitor
EC 1.14.15.6 cholesterol monooxygenase (side-chain-cleaving) inhibitor
C27-side chain cleavage enzyme inhibitor
C27-side chain cleavage enzyme inhibitors
EC 1.14.15.6 inhibitor
EC 1.14.15.6 inhibitors
cholesterol 20-22-desmolase inhibitor
cholesterol 20-22-desmolase inhibitors
cholesterol C20-22 desmolase inhibitor
cholesterol C20-22 desmolase inhibitors
cholesterol desmolase inhibitor
cholesterol desmolase inhibitors
cholesterol monooxygenase (side-chain-cleaving) inhibitor
cholesterol monooxygenase (side-chain-cleaving) inhibitors
cholesterol side-chain cleavage enzyme inhibitor
cholesterol side-chain cleavage enzyme inhibitors
cholesterol side-chain-cleaving enzyme inhibitor
cholesterol side-chain-cleaving enzyme inhibitors
cytochrome P-450scc inhibitor
cytochrome P-450scc inhibitors
steroid 20-22 desmolase inhibitor
steroid 20-22 desmolase inhibitors
steroid 20-22-lyase inhibitor
steroid 20-22-lyase inhibitors
EC 1.14.15.6 cholesterol monooxygenase (side-chain-cleaving) inhibitor
EC 1.4.3.2 (L-amino-acid oxidase) inhibitor
EC 1.4.3.2 (L-amino-acid oxidase) inhibitors
EC 1.4.3.2 inhibitor
EC 1.4.3.2 inhibitors
L-amino-acid oxidase inhibitor
L-amino-acid oxidase inhibitor (EC 1.4.3.2) inhibitor
L-amino-acid oxidase inhibitor (EC 1.4.3.2) inhibitors
L-amino-acid oxidase inhibitors
L-amino-acid:oxygen oxidoreductase (deaminating) inhibitor
L-amino-acid:oxygen oxidoreductase (deaminating) inhibitors
ophio-amino-acid oxidase inhibitor
ophio-amino-acid oxidase inhibitors
EC 1.4.3.2 (L-amino-acid oxidase) inhibitor
EC 2.6.1.2 (alanine transaminase) inhibitor
EC 2.6.1.2 (alanine transaminase) inhibitor
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor
(6-phosphofructo-2-kinase) inhibitors
6-phosphofructo-2-kinase (phosphorylating) inhibitor
6-phosphofructo-2-kinase (phosphorylating) inhibitors
6-phosphofructo-2-kinase inhibitor
6-phosphofructo-2-kinase inhibitors
6-phosphofructose 2-kinase inhibitor
6-phosphofructose 2-kinase inhibitors
EC 2.7.1.105 inhibitor
EC 2.7.1.105 inhibitors
fructose 6-phosphate 2-kinase inhibitor
fructose 6-phosphate 2-kinase inhibitors
phosphofructokinase 2 inhibitor
phosphofructokinase 2 inhibitors
EC 2.7.1.105 (6-phosphofructo-2-kinase) inhibitor
EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor
EC 3.1.1.64 (retinoid isomerohydrolase) inhibitors
EC 3.1.1.64 inhibitor
EC 3.1.1.64 inhibitors
RPE65 inhibitor
RPE65 inhibitors
all-trans-retinol isomerase:hydrolase inhibitor
all-trans-retinol isomerase:hydrolase inhibitors
all-trans-retinyl-palmitate hydrolase inhibitor
all-trans-retinyl-palmitate hydrolase inhibitors
all-trans-retinylester 11-cis isomerohydrolase inhibitor
all-trans-retinylester 11-cis isomerohydrolase inhibitors
retinoid isomerohydrolase inhibitor
retinoid isomerohydrolase inhibitors
retinol isomerase inhibitor
retinol isomerase inhibitors
EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor
tumour antigen
tumour antigens
tumour antigen
C5a receptor antagonist
C5AR1 antagonist
C5AR1 antagonists
C5a receptor antagonists
CD88 antagonist
CD88 antagonists
cluster of differentiation 88 antagonist
cluster of differentiation 88 antagonists
complement component 5a receptor 1 antagonist
complement component 5a receptor 1 antagonists
C5a receptor antagonist
EC 3.6.5.2 (small monomeric GTPase) inhibitor
EC 3.6.5.2 (small monomeric GTPase) inhibitor
sphingosine-1-phosphate receptor antagonist
EDG receptor antagonist
S1P receptor antagonist
S1P receptor antagonists
SIP antagonist
SIP antagonists
sphingosine 1-phosphate receptor antagonist
sphingosine 1-phosphate receptor antagonists
sphingosine-1-phosphate receptor antagonists
sphingosine-1-phosphate receptor antagonist
sphingosine-1-phosphate receptor 3 antagonist
S1PR3 antagonist
S1PR3 antagonists
sphingosine-1-phosphate receptor 3 antagonists
sphingosine-1-phosphate receptor 3 antagonist
sphingosine-1-phosphate receptor 1 antagonist
S1PR1 antagonist
S1PR1 antagonists
sphingosine-1-phosphate receptor 1 antagonists
sphingosine-1-phosphate receptor 1 antagonist
antispermatogenic agent
antispermatogenic
antispermatogenic agents
antispermatogenics
antispermatogenic agent
hyaluronan synthesis inhibitor
HA synthesis inhibitor
HA synthesis inhibitors
hyaluronan synthesis inhibitors
hyaluronic acid synthesis inhibitor
hyaluronic acid synthesis inhibitors
hyaluronan synthesis inhibitor
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
EC 1.1.1.42 inhibitor
EC 1.1.1.42 inhibitors
IDH inhibitor
IDH inhibitors
IDP inhibitor
IDP inhibitors
IDP1 inhibitor
IDP1 inhibitors
IDP2 inhibitor
IDP2 inhibitors
IDP3 inhibitor
IDP3 inhibitors
NADP isocitric dehydrogenase inhibitor
NADP isocitric dehydrogenase inhibitors
NADP(+)-ICDH inhibitor
NADP(+)-ICDH inhibitors
NADP(+)-IDH inhibitor
NADP(+)-IDH inhibitors
NADP(+)-linked isocitrate dehydrogenase inhibitor
NADP(+)-linked isocitrate dehydrogenase inhibitors
NADP-dependent isocitrate dehydrogenase inhibitor
NADP-dependent isocitrate dehydrogenase inhibitors
NADP-dependent isocitric dehydrogenase inhibitor
NADP-dependent isocitric dehydrogenase inhibitors
NADP-linked isocitrate dehydrogenase inhibitor
NADP-linked isocitrate dehydrogenase inhibitors
NADP-specific isocitrate dehydrogenase inhibitor
NADP-specific isocitrate dehydrogenase inhibitors
dual-cofactor-specific isocitrate dehydrogenase inhibitor
dual-cofactor-specific isocitrate dehydrogenase inhibitors
isocitrate (NADP) dehydrogenase inhibitor
isocitrate (NADP) dehydrogenase inhibitors
isocitrate (nicotinamide adenine dinucleotide phosphate) dehydrogenase inhibitor
isocitrate (nicotinamide adenine dinucleotide phosphate) dehydrogenase inhibitors
isocitrate dehydrogenase (NADP(+)) inhibitor
isocitrate dehydrogenase (NADP(+)) inhibitors
isocitrate dehydrogenase (NADP-dependent) inhibitor
isocitrate dehydrogenase (NADP-dependent) inhibitors
isocitrate dehydrogenase inhibitor
isocitrate dehydrogenase inhibitors
oxalosuccinate decarboxylase inhibitor
oxalosuccinate decarboxylase inhibitors
oxalsuccinic decarboxylase inhibitor
oxalsuccinic decarboxylase inhibitors
triphosphopyridine nucleotide-linked isocitrate dehydrogenase-oxalosuccinate carboxylase inhibitor
triphosphopyridine nucleotide-linked isocitrate dehydrogenase-oxalosuccinate carboxylase inhibitors
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
EC 2.7.11.21 (polo kinase) inhibitor
Cdc5 inhibitor
Cdc5 inhibitors
Cdc5p inhibitor
Cdc5p inhibitors
EC 2.7.11.21 (polo kinase) inhibitors
EC 2.7.11.21 inhibitor
EC 2.7.11.21 inhibitors
PLK inhibitor
PLK inhibitors
Plk inhibitor
Plk inhibitors
Plk1 inhibitor
Plk1 inhibitors
Plo1 inhibitor
Plo1 inhibitors
STK21 inhibitor
STK21 inhibitors
polo kinase inhibitor
polo kinase inhibitors
polo serine-threonine kinase inhibitor
polo serine-threonine kinase inhibitors
polo-like kinase 1 inhibitor
polo-like kinase 1 inhibitors
polo-like kinase inhibitor
polo-like kinase inhibitors
serine/threonine-specific Drosophila kinase polo inhibitor
serine/threonine-specific Drosophila kinase polo inhibitors
EC 2.7.11.21 (polo kinase) inhibitor
uncoupling protein inhibitor
UCP inhibitor
UCP inhibitors
mitochondrial uncoupling protein inhibitor
mitochondrial uncoupling protein inhibitors
uncoupling protein inhibitors
uncoupling protein inhibitor
C-X-C chemokine receptor type 4 antagonist
C-X-C chemokine receptor type 4 antagonists
C-X-C motif chemokine receptor 4 antagonist
C-X-C motif chemokine receptor 4 antagonists
CD184 antagonist
CD184 antagonists
CXCR-4 antagonist
CXCR-4 antagonists
CXCR4 antagonist
CXCR4 antagonists
chemokine (C-X-C motif) receptor 4 antagonist
chemokine (C-X-C motif) receptor 4 antagonists
fusin antagonist
fusin antagonists
C-X-C chemokine receptor type 4 antagonist
GABAA receptor antagonist
GABAA receptor antagonist
forkhead box protein O1 inhibitor
FOXO1 inhibitor
FOXO1 inhibitors
Foxo1 inhibitor
Foxo1 inhibitors
forkhead box protein O1 inhibitors
forkhead in rhabdomyosarcoma inhibitor
forkhead in rhabdomyosarcoma inhibitors
forkhead box protein O1 inhibitor
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor
ASA dehydrogenase inhibitor
ASA dehydrogenase inhibitors
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitors
EC 1.2.1.11 inhibitor
EC 1.2.1.11 inhibitors
L-aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating) inhibitor
L-aspartate-4-semialdehyde:NADP+ oxidoreductase (phosphorylating) inhibitors
L-aspartate-beta-semialdehyde:NADP oxidoreductase (phosporylating) inhibitor
L-aspartate-beta-semialdehyde:NADP oxidoreductase (phosporylating) inhibitors
aspartate semialdehyde dehydrogenase inhibitor
aspartate semialdehyde dehydrogenase inhibitors
aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) inhibitor
aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) inhibitors
aspartate-semialdehyde dehydrogenase inhibitor
aspartate-semialdehyde dehydrogenase inhibitors
aspartic beta-semialdehyde dehydrogenase inhibitor
aspartic beta-semialdehyde dehydrogenase inhibitors
aspartic semialdehyde dehydrogenase inhibitor
aspartic semialdehyde dehydrogenase inhibitors
EC 1.2.1.11 (aspartate-semialdehyde dehydrogenase) inhibitor
antiatherosclerotic agent
anti-atherosclerotic agent
anti-atherosclerotic agents
anti-atherosclerotic drug
anti-atherosclerotic drugs
antiatherosclerotic agent
antiatherosclerotic agents
antiatherosclerotic drug
antiatherosclerotic drugs
antiatherosclerotic agent
5-hydroxytryptamine 2A receptor agonist
5-HT2A agonist
5-HT2A agonists
5-HT2A receptor agonist
5-HT2A receptor agonists
5-hydroxytryptamine 2A receptor agonists
5-hydroxytryptamine receptor 2A agonist
5-hydroxytryptamine receptor 2A agonists
serotonin receptor 2A agonist
serotonin receptor 2A agonists
5-hydroxytryptamine 2A receptor agonist
ryanoid insecticide
ryanoid insecticide
ryanodine receptor antagonist
ryanodine receptor antagonist
CB2 receptor agonist
CB2 receptor agonist
CB2 receptor agonists
CB2R agonist
CB2R agonists
cannabinoid receptor 2 agonist
cannabinoid receptor 2 agonists
cannabinoid receptor type 2 agonist
cannabinoid receptor type 2 agonists
type 2 cannabinoid receptor agonist
type 2 cannabinoid receptor agonists
CB2 receptor agonist
oneirogen
oneirogens
oneirogen
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
3C-like protease inhibitor
3C-like protease inhibitors
3cLpro inhibitor
3cLpro inhibitors
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitors
EC 3.4.22.69 inhibitor
EC 3.4.22.69 inhibitors
Mpro inhibitor
Mpro inhibitors
SARS 3C-like protease inhibitor
SARS 3C-like protease inhibitors
SARS coronavirus 3CL protease inhibitor
SARS coronavirus 3CL protease inhibitors
SARS coronavirus main peptidase inhibitor
SARS coronavirus main peptidase inhibitors
SARS coronavirus main protease inhibitor
SARS coronavirus main protease inhibitors
SARS coronavirus main proteinase inhibitor
SARS coronavirus main proteinase inhibitors
SARS-CoV 3CLpro enzyme inhibitor
SARS-CoV 3CLpro enzyme inhibitors
SARS-CoV Mpro inhibitor
SARS-CoV Mpro inhibitors
SARS-CoV main protease inhibitor
SARS-CoV main protease inhibitors
coronavirus 3C-like protease inhibitor
coronavirus 3C-like protease inhibitors
severe acute respiratory syndrome coronavirus main protease inhibitor
severe acute respiratory syndrome coronavirus main protease inhibitors
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor
ACE-2 inhibitor
ACE-2 inhibitors
ACE2 inhibitor
ACE2 inhibitors
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitors
EC 3.4.17.23 inhibitor
EC 3.4.17.23 inhibitors
angiotensin converting enzyme 2 inhibitor
angiotensin converting enzyme 2 inhibitors
angiotensin converting enzyme-2 inhibitor
angiotensin converting enzyme-2 inhibitors
angiotensin-converting enzyme 2 inhibitor
angiotensin-converting enzyme 2 inhibitors
hACE2 inhibitor
hACE2 inhibitors
EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor
EC 3.4.17* (metallocarboxypeptidase) inhibitor
EC 3.4.17* (metallocarboxypeptidase) inhibitor
EC 3.4.17* (metallocarboxypeptidase) inhibitors
EC 3.4.17.* inhibitor
EC 3.4.17.* inhibitors
metallocarboxypeptidase inhibitor
metallocarboxypeptidase inhibitors
EC 3.4.17* (metallocarboxypeptidase) inhibitor
nitrification inhibitor
nitrification inhibitors
nitrification inhibitor
spin trapping reagent
spin trap
spin trapping reagents
spin traps
spin trapping reagent
emetic
emetics
emetic
anticoronaviral agent
anti-coronaviral agent
anti-coronaviral agents
anti-coronavirus agent
anti-coronavirus agents
anticoronaviral agent
anticoronaviral agents
anticoronaviral drug
anticoronaviral drugs
anticoronavirus agent
anticoronavirus agents
anticoronviral agent
anticoronviral agents
anticoronaviral agent
EC 2.3.3.8 (ATP citrate synthase) inhibitor
ATP citrate (pro-S)-lyase inhibitor
ATP citrate (pro-S)-lyase inhibitors
ATP citrate lyase inhibitor
ATP citrate lyase inhibitors
ATP citrate synthase inhibitor
ATP citrate synthase inhibitors
ATP-citric lyase inhibitor
ATP-citric lyase inhibitors
ATP:citrate oxaloacetate-lyase [(pro-S)-CH2COO(-)->acetyl-CoA] (ATP-dephosphorylating) inhibitor
ATP:citrate oxaloacetate-lyase [(pro-S)-CH2COO(-)->acetyl-CoA] (ATP-dephosphorylating) inhibitors
EC 2.3.3.8 (ATP citrate synthase) inhibitor
EC 2.3.3.8 (ATP citrate synthase) inhibitors
EC 2.3.3.8 inhibitor
EC 2.3.3.8 inhibitors
acetyl-CoA:oxaloacetate acetyltransferase (isomerizing, ADP-phosphorylating) inhibitor
acetyl-CoA:oxaloacetate acetyltransferase (isomerizing, ADP-phosphorylating) inhibitors
adenosine triphosphate citrate lyase inhibitor
adenosine triphosphate citrate lyase inhibitors
citrate cleavage enzyme inhibitor
citrate cleavage enzyme inhibitors
citrate-ATP lyase inhibitor
citrate-ATP lyase inhibitors
citric cleavage enzyme inhibitor
citric cleavage enzyme inhibitors
EC 2.3.3.8 (ATP citrate synthase) inhibitor
EC 3.4.21.36 (pancreatic elastase) inhibitor
EC 3.4.21.36 (pancreatic elastase) inhibitors
EC 3.4.21.36 inhibitor
EC 3.4.21.36 inhibitors
elastase inhibitor
elastase inhibitors
elaszym inhibitor
elaszym inhibitors
pancreatic elastase (EC 3.4.21.36) inhibitor
pancreatic elastase (EC 3.4.21.36) inhibitors
pancreatic elastase I inhibitor
pancreatic elastase I inhibitors
pancreatic elastase inhibitor
pancreatic elastase inhibitors
pancreatopeptidase E inhibitor
pancreatopeptidase E inhibitors
serine elastase inhibitor
serine elastase inhibitors
EC 3.4.21.36 (pancreatic elastase) inhibitor
chemokine receptor 2 antagonist
C-C chemokine receptor type 2 antagonist
C-C chemokine receptor type 2 antagonists
CCR-2 antagonist
CCR-2 antagonists
CCR2 antagonist
CCR2 antagonists
CD192 antagonist
CD192 antagonists
CKR-2B antagonist
CKR-2B antagonists
chemokine receptor 2 antagonists
chemokine receptor 2 antagonist
SERCA activator
EC 7.2.2.10 activator
EC 7.2.2.10 activators
SERCA activators
Sarcoplasmic/Endoplasmic Reticulum Calcium-ATPase activator
Sarcoplasmic/Endoplasmic Reticulum Calcium-ATPase activators
SERCA activator
electron donor
Elektronendonator
donneur d'electron
electron donor
electron donor
acceptor
A
Acceptor
Akzeptor
Hydrogen-acceptor
Oxidized donor
accepteur
acceptor
topoisomerase II inhibitor
topoisomerase II inhibitor
MAIT cell agonist
MAIT cell agonists
mucosal associated invariant T cell agonist
mucosal associated invariant T cell agonists
MAIT cell agonist
G-15
(3Ar,4R,9bS)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
GPER antagonist
G-15
G-1
1-(4-(6-Bromobenzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone
GPER agonist
G-1
EC 3.4.21.75 (furin) inhibitor
EC 3.4.21.75 (furin) inhibitors
EC 3.4.21.75 inhibitor
EC 3.4.21.75 inhibitors
PACE inhibitor
PACE inhibitors
PC1 inhibitor
PC1 inhibitors
SPC3 inhibitor
SPC3 inhibitors
dibasic processing enzyme inhibitor
dibasic processing enzyme inhibitors
furin convertase inhibitor
furin convertase inhibitors
furin inhibitor
furin inhibitors
paired basic amino acid cleaving enzyme inhibitor
paired basic amino acid cleaving enzyme inhibitors
paired basic amino acid converting enzyme inhibitor
paired basic amino acid converting enzyme inhibitors
prohormone convertase inhibitor
prohormone convertase inhibitors
proprotein convertase inhibitor
proprotein convertase inhibitors
serine proteinase PACE inhibitor
serine proteinase PACE inhibitors
EC 3.4.21.75 (furin) inhibitor
EC 2.4.1.109 (dolichyl-phosphate-mannose-protein mannosyltransferase) inhibitor
EC 2.4.1.109 (dolichyl-phosphate-mannose-protein mannosyltransferase) inhibitors
EC 2.4.1.109 inhibitor
EC 2.4.1.109 inhibitors
PMT inhibitor
PMT inhibitors
dolichol phosphomannose-protein mannosyltransferase inhibitor
dolichol phosphomannose-protein mannosyltransferase inhibitors
dolichyl-D-mannosyl-phosphate:protein O-D-mannosyltransferase inhibitor
dolichyl-D-mannosyl-phosphate:protein O-D-mannosyltransferase inhibitors
dolichyl-phosphate-D-mannose:protein O-D-mannosyltransferase inhibitor
dolichyl-phosphate-D-mannose:protein O-D-mannosyltransferase inhibitors
dolichyl-phosphate-mannose--protein mannosyltransferase inhibitor
dolichyl-phosphate-mannose--protein mannosyltransferase inhibitors
protein O-D-mannosyltransferase inhibitor
protein O-D-mannosyltransferase inhibitors
EC 2.4.1.109 (dolichyl-phosphate-mannose-protein mannosyltransferase) inhibitor
Furafylline
3-(uran-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione
Furafylline
EC 3.4.23.15 (renin) inhibitor
EC 3.4.23.15 (renin) inhibitors
EC 3.4.23.15 inhibitor
EC 3.4.23.15 inhibitors
angiotensin-forming enzyme inhibitor
angiotensin-forming enzyme inhibitors
angiotensinogenase inhibitor
angiotensinogenase inhibitors
renin inhibitor
renin inhibitors
EC 3.4.23.15 (renin) inhibitor
copper chelator
copper chelate
copper chelating agent
copper chelating agents
copper chelator
copper chelators
copper chelator
neuropilin receptor antagonist
NRP antagonist
NRP antagonists
neuropilin receptor antagonists
neuropilin receptor antagonist
kappa-opioid receptor antagonist
kappa-opioid antagonist
kappa-opioid antagonists
kappa-opioid receptor antagonists
kappa-opioid receptor antagonist
piscicide
piscicides
piscicide
ovicide
ovicides
ovicide
CPSF3 inhibitor
CPSF-73 inhibitor
CPSF-73 inhibitors
CPSF3 inhibitors
CPSF73 inhibitor
CPSF73 inhibitors
cleavage and polyadenylation specific factor 3 inhibitor
cleavage and polyadenylation specific factor 3 inhibitors
cleavage and polyadenylation specificity factor 73 KDa subunit inhibitor
cleavage and polyadenylation specificity factor 73 KDa subunit inhibitors
cleavage and polyadenylation specificity factor subunit 3 inhibitor
cleavage and polyadenylation specificity factor subunit 3 inhibitors
CPSF3 inhibitor
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
EC 6.1.1.6 (lysine--tRNA ligase) inhibitors
EC 6.1.1.6 inhibitor
EC 6.1.1.6 inhibitors
L-lysine-transfer RNA ligase inhibitor
L-lysine-transfer RNA ligase inhibitors
L-lysine:tRNA(Lys) ligase (AMP-forming) inhibitor
L-lysine:tRNA(Lys) ligase (AMP-forming) inhibitors
LysRS inhibitor
LysRS inhibitors
lysine translase inhibitor
lysine translase inhibitors
lysine--tRNA ligase inhibitor
lysine--tRNA ligase inhibitors
lysine-tRNA synthetase inhibitor
lysine-tRNA synthetase inhibitors
lysyl-tRNA synthetase inhibitor
lysyl-tRNA synthetase inhibitors
lysyl-transfer RNA synthetase inhibitor
lysyl-transfer RNA synthetase inhibitors
lysyl-transfer ribonucleate synthetase inhibitor
lysyl-transfer ribonucleate synthetase inhibitors
EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitors
EZH2 inhibitor
EZH2 inhibitors
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
necroptosis inhibitor
necroptosis inhibitors
necroptosis inhibitor
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
3D polymerase inhibitor
3D polymerase inhibitors
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitors
EC 2.7.7.48 inhibitor
EC 2.7.7.48 inhibitors
PB1 proteins inhibitor
PB1 proteins inhibitors
PB2 proteins inhibitor
PB2 proteins inhibitors
Q-beta replicase inhibitor
Q-beta replicase inhibitors
RDRP inhibitor
RDRP inhibitors
RNA nucleotidyltransferase (RNA-directed) inhibitor
RNA nucleotidyltransferase (RNA-directed) inhibitors
RNA replicase inhibitor
RNA replicase inhibitors
RNA synthetase inhibitor
RNA synthetase inhibitors
RNA transcriptase inhibitor
RNA transcriptase inhibitors
RNA-dependent RNA polymerase inhibitor
RNA-dependent RNA polymerase inhibitors
RNA-dependent RNA replicase inhibitor
RNA-dependent RNA replicase inhibitors
RNA-dependent ribonucleate nucleotidyltransferase inhibitor
RNA-dependent ribonucleate nucleotidyltransferase inhibitors
RNA-directed RNA polymerase inhibitor
RNA-directed RNA polymerase inhibitors
phage f2 replicase inhibitor
phage f2 replicase inhibitors
polymerase L inhibitor
polymerase L inhibitors
ribonucleic acid replicas inhibitor
ribonucleic acid replicas inhibitors
ribonucleic acid-dependent ribonucleate nucleotidyltransferase inhibitor
ribonucleic acid-dependent ribonucleate nucleotidyltransferase inhibitors
ribonucleic acid-dependent ribonucleic acid polymeras inhibitor
ribonucleic acid-dependent ribonucleic acid polymeras inhibitors
ribonucleic replicase inhibitor
ribonucleic replicase inhibitors
ribonucleic synthetase inhibitor
ribonucleic synthetase inhibitors
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
antiamoebic agent
amebicide
amebicides
amoebicide
amoebicides
anti-amoebic agent
anti-amoebic agents
anti-amoebic drug
anti-amoebic drugs
antiamoebic
antiamoebic agents
antiamoebic drug
antiamoebic drugs
antiamoebics
antiamoebic agent
EC 2.1.1.348 (mRNA m6A methyltransferase) inhibitor
EC 2.1.1.348 (mRNA m6A methyltransferase) inhibitors
EC 2.1.1.348 inhibitor
EC 2.1.1.348 inhibitors
METTL14 inhibitor
METTL14 inhibitors
METTL3 inhibitor
METTL3 inhibitors
EC 2.1.1.348 (mRNA m6A methyltransferase) inhibitor
EC 2.6.1.11 (acetylornithine transaminase) inhibitor
2-N-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase inhibitor
2-N-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase inhibitors
ACOAT inhibitor
ACOAT inhibitors
EC 2.6.1.11 (acetylornithine transaminase) inhibitors
EC 2.6.1.11 inhibitor
EC 2.6.1.11 inhibitors
N(2)-acetyl-L-ornithine:2-oxoglutarate aminotransferase inhibitor
N(2)-acetyl-L-ornithine:2-oxoglutarate aminotransferase inhibitors
N(2)-acetylornithine 5-transaminase inhibitor
N(2)-acetylornithine 5-transaminase inhibitors
N-acetylornithine aminotransferase inhibitor
N-acetylornithine aminotransferase inhibitors
N-acetylornithine-delta-transaminase inhibitor
N-acetylornithine-delta-transaminase inhibitors
acetylornithine 5-aminotransferase inhibitor
acetylornithine 5-aminotransferase inhibitors
acetylornithine aminotransferase inhibitor
acetylornithine aminotransferase inhibitors
acetylornithine delta-transaminase inhibitor
acetylornithine delta-transaminase inhibitors
acetylornithine transaminase inhibitor
acetylornithine transaminase inhibitors
succinylornithine aminotransferase inhibitor
succinylornithine aminotransferase inhibitors
EC 2.6.1.11 (acetylornithine transaminase) inhibitor
antimicrobial cosmetic preservative
antimicrobial cosmetic preservatives
antimicrobial cosmetic preservative
ferroptosis inhibitor
ferroptosis inhibitors
ferroptosis inhibitor
ferroptosis inducer
ferroptosis inducers
ferroptosis inducer
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitors
EC 3.1.3.25 inhibitor
EC 3.1.3.25 inhibitors
IMPase inhibitor
IMPase inhibitors
L-myo-inositol-1-phosphate phosphatase inhibitor
L-myo-inositol-1-phosphate phosphatase inhibitors
inositol 1-phosphatase inhibitor
inositol 1-phosphatase inhibitors
inositol monophosphatase inhibitor
inositol monophosphatase inhibitors
inositol monophosphate phosphatase inhibitor
inositol monophosphate phosphatase inhibitors
inositol phosphatase inhibitor
inositol phosphatase inhibitors
inositol phosphate phosphatase inhibitor
inositol phosphate phosphatase inhibitors
inositol-1(or 4)-monophosphatase inhibitor
inositol-1(or 4)-monophosphatase inhibitors
inositol-phosphate phosphatase inhibitor
inositol-phosphate phosphatase inhibitors
myo-inositol 1-phosphatase inhibitor
myo-inositol 1-phosphatase inhibitors
myo-inositol monophosphatase inhibitor
myo-inositol monophosphatase inhibitors
myo-inositol-1(or 4)-monophosphatase inhibitor
myo-inositol-1(or 4)-monophosphatase inhibitors
myo-inositol-1(or 4)-phosphate phosphohydrolase inhibitor
myo-inositol-1(or 4)-phosphate phosphohydrolase inhibitors
myo-inositol-1-phosphatase inhibitor
myo-inositol-1-phosphatase inhibitors
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor
voltage-dependent anion channel inhibitor
VDAC blocker
VDAC blockers
VDAC inhibitor
VDAC inhibitors
voltage-dependent anion channel blocker
voltage-dependent anion channel blockers
voltage-dependent anion channel inhibitors
voltage-dependent anion-selective channel blocker
voltage-dependent anion-selective channel blockers
voltage-dependent anion-selective channel inhibitor
voltage-dependent anion-selective channel inhibitors
voltage-dependent anion channel inhibitor
thioredoxin inhibitor
TRX inhibitor
TRX inhibitors
TRX1 inhibitor
TRX1 inhibitors
TXN inhibitor
TXN inhibitors
thioredoxin inhibitors
thioredoxin inhibitor
testosterone
17beta-Hydroxy-4-androsten-3-one
17beta-hydroxy-4-androsten-3-one
17beta-hydroxyandrost-4-en-3-one
4-androsten-17beta-ol-3-one
Androderm
TESTOSTERONE
Testosteron
Testosterone
testosterona
testosterone
testosteronum
testosterone
hydrogen donor
AH2
Donor
Hydrogen-donor
Reduced acceptor
hydrogen donor
EC 1.11.1.9 (glutathione peroxidase) inhibitor
EC 1.11.1.9 (glutathione peroxidase) inhibitors
EC 1.11.1.9 inhibitor
EC 1.11.1.9 inhibitors
GSH peroxidase inhibitor
GSH peroxidase inhibitors
glutathione peroxidase inhibitor
glutathione peroxidase inhibitors
reduced glutathione peroxidase inhibitor
reduced glutathione peroxidase inhibitors
selenium-glutathione peroxidase inhibitor
selenium-glutathione peroxidase inhibitors
EC 1.11.1.9 (glutathione peroxidase) inhibitor
actin polymerisation inducer
actin polymerisation enhancer
actin polymerisation enhancers
actin polymerisation inducers
inducer of actin polymerization
inducers of actin polymerization
actin polymerisation inducer
geroprotector
anti-aging agent
anti-aging agents
anti-aging drug
anti-aging drugs
geroprotective agent
geroprotective agents
geroprotectors
geroprotector
ferroptosis suppressor protein 1 inhibitor
AIFM2 inhibitor
AIFM2 inhibitors
FSP1 inhibitor
FSP1 inhibitors
apoptosis-inducing factor mitochondria-associated 2 inhibitor
apoptosis-inducing factor mitochondria-associated 2 inhibitors
ferroptosis suppressor protein 1 inhibitors
ferroptosis suppressor protein 1 inhibitor
electron acceptor
Elektronenakzeptor
Oxidized donor
electron acceptor
electron acceptor
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitors
EC 2.7.11.2 inhibitor
EC 2.7.11.2 inhibitors
PDH kinase inhibitor
PDH kinase inhibitors
PDHK inhibitor
PDHK inhibitors
PDK inhibitor
PDK inhibitors
PDK1 inhibitor
PDK1 inhibitors
PDK2 inhibitor
PDK2 inhibitors
PDK3 inhibitor
PDK3 inhibitors
PDK4 inhibitor
PDK4 inhibitors
STK1 inhibitor
STK1 inhibitors
[pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor
[pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitors
pyruvate dehydrogenase (acetyl-transferring) kinase inhibitor
pyruvate dehydrogenase (acetyl-transferring) kinase inhibitors
pyruvate dehydrogenase kinase (phosphorylating) inhibitor
pyruvate dehydrogenase kinase (phosphorylating) inhibitors
pyruvate dehydrogenase kinase activator protein inhibitor
pyruvate dehydrogenase kinase activator protein inhibitors
pyruvate dehydrogenase kinase inhibitor
pyruvate dehydrogenase kinase inhibitors
EC 2.7.11.2 - [pyruvate dehydrogenase (acetyl-transferring)] kinase inhibitor
somatostatin receptor agonist
SRIF agonist
SRIF agonists
SS-R agonist
SS-R agonists
SSR agonist
SSR agonists
SSTR agonist
SSTR agonists
somatostatin receptor agonists
somatostatin receptor agonist
donor
Donator
Donor
donneur
donor
(S)-Mephenytoin
(5S)-5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
(S)-Mephenytoin
neoantigen
neoantigens
neoantigen
EC 2.3.2.52 (beta-N-acetylhexosaminidase) inhibitor
EC 2.3.2.52 (beta-N-acetylhexosaminidase) inhibitors
EC 3.2.1.52 inhibitor
EC 3.2.1.52 inhibitors
N-acetyl-beta-D-hexosaminidase inhibitor
N-acetyl-beta-D-hexosaminidase inhibitors
N-acetyl-beta-hexosaminidase inhibitor
N-acetyl-beta-hexosaminidase inhibitors
N-acetylhexosaminidase inhibitor
N-acetylhexosaminidase inhibitors
beta-D-N-acetylhexosaminidase inhibitor
beta-D-N-acetylhexosaminidase inhibitors
beta-D-hexosaminidase inhibitor
beta-D-hexosaminidase inhibitors
beta-N-acetyl-D-hexosaminidase inhibitor
beta-N-acetyl-D-hexosaminidase inhibitors
beta-N-acetylglucosaminidase inhibitor
beta-N-acetylglucosaminidase inhibitors
beta-N-acetylhexosaminidase inhibitor
beta-N-acetylhexosaminidase inhibitors
beta-acetylaminodeoxyhexosidase inhibitor
beta-acetylaminodeoxyhexosidase inhibitors
beta-acetylhexosaminidinase inhibitor
beta-acetylhexosaminidinase inhibitors
beta-hexosaminidase inhibitor
beta-hexosaminidase inhibitors
hexosaminidase A inhibitor
hexosaminidase A inhibitors
hexosaminidase inhibitor
hexosaminidase inhibitors
EC 2.3.2.52 (beta-N-acetylhexosaminidase) inhibitor
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitor
CA4H inhibitor
CA4H inhibitors
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitors
EC 1.14.14.91 inhibitor
EC 1.14.14.91 inhibitors
cinnamate 4-hydroxylase inhibitor
cinnamate 4-hydroxylase inhibitors
cinnamate 4-monooxygenase inhibitor
cinnamate 4-monooxygenase inhibitors
cinnamate hydroxylase inhibitor
cinnamate hydroxylase inhibitors
cinnamic 4-hydroxylase inhibitor
cinnamic 4-hydroxylase inhibitors
cinnamic acid 4-hydroxylase inhibitor
cinnamic acid 4-hydroxylase inhibitors
cinnamic acid 4-monooxygenase inhibitor
cinnamic acid 4-monooxygenase inhibitors
cinnamic acid p-hydroxylase inhibitor
cinnamic acid p-hydroxylase inhibitors
cytochrome P450 cinnamate 4-hydroxylase inhibitor
cytochrome P450 cinnamate 4-hydroxylase inhibitors
t-cinnamic acid hydroxylase inhibitor
t-cinnamic acid hydroxylase inhibitors
trans-cinnamate 4-hydroxylase inhibitor
trans-cinnamate 4-hydroxylase inhibitors
trans-cinnamate 4-monooxygenase inhibitor
trans-cinnamate 4-monooxygenase inhibitors
trans-cinnamic acid 4-hydroxylase inhibitor
trans-cinnamic acid 4-hydroxylase inhibitors
EC 1.14.14.91 ( trans-cinnamate 4-monooxygenase) inhibitor
EC 3.4.21.61 (kexin) inhibitor
EC 3.4.21.61 (kexin) inhibitors
EC 3.4.21.61 inhibitor
EC 3.4.21.61 inhibitors
Kex 2p proteinase inhibitor
Kex 2p proteinase inhibitors
Kex2 endopeptidase inhibitor
Kex2 endopeptidase inhibitors
Kex2 endoprotease inhibitor
Kex2 endoprotease inhibitors
Kex2 endoproteinase inhibitor
Kex2 endoproteinase inhibitors
Kex2 protease inhibitor
Kex2 protease inhibitors
Kex2 proteinase inhibitor
Kex2 proteinase inhibitors
Kex2-like endoproteinase inhibitor
Kex2-like endoproteinase inhibitors
Kex2-like precursor protein processing endoprotease inhibitor
Kex2-like precursor protein processing endoprotease inhibitors
andrenorphin-Gly-generating enzyme inhibitor
andrenorphin-Gly-generating enzyme inhibitors
endoproteinase Kex2p inhibitor
endoproteinase Kex2p inhibitors
gene KEX2 dibasic proteinase inhibitor
gene KEX2 dibasic proteinase inhibitors
kexin inhibitor
kexin inhibitors
paired-basic endopeptidase inhibitor
paired-basic endopeptidase inhibitors
prohormone-processing KEX2 proteinase inhibitor
prohormone-processing KEX2 proteinase inhibitors
prohormone-processing endoprotease inhibitor
prohormone-processing endoprotease inhibitors
prohormone-processing proteinase inhibitor
prohormone-processing proteinase inhibitors
proprotein convertase inhibitor
proprotein convertase inhibitors
protease KEX2 inhibitor
protease KEX2 inhibitors
proteinase Kex2p inhibitor
proteinase Kex2p inhibitors
proteinase yscF inhibitor
proteinase yscF inhibitors
yeast KEX2 protease inhibitor
yeast KEX2 protease inhibitors
EC 3.4.21.61 (kexin) inhibitor
PAR2 negative allosteric modulator
PAR2 negative allosteric modulator
protease-activated receptor-2 antagonist
G-protein coupled receptor 11 antagonist
G-protein coupled receptor 11 antagonists
GPR11 antagonist
GPR11 antagonists
PAR-2 antagonist
PAR-2 antagonists
PAR2 antagonist
PAR2 antagonists
coagulation factor II (thrombin) receptor-like 1 antagonist
coagulation factor II (thrombin) receptor-like 1 antagonists
protease-activated receptor 2 antagonist
protease-activated receptor 2 antagonists
protease-activated receptor-2 antagonists
protease-activated receptor-2 antagonist
sigma receptor modulator
sigma receptor modulators
sigma-receptor modulator
sigma-receptor modulators
sigma receptor modulator
sigma-2 receptor agonist
sigma 2 receptor agonist
sigma 2 receptor agonists
sigma-2 receptor agonists
sigma2 receptor agonist
sigma2 receptor agonists
sigma2R agonist
sigma2R agonists
sigma-2 receptor agonist
ceramide mimetic
ceramide mimetics
ceramide mimetic
EC 3.2.1.24 (alpha-mannosidase) inhibitor
1,2-alpha-D-mannosidase inhibitor
1,2-alpha-D-mannosidase inhibitors
1,2-alpha-mannosidase inhibitor
1,2-alpha-mannosidase inhibitors
EC 3.2.1.24 (alpha-mannosidase) inhibitors
EC 3.2.1.24 inhibitor
EC 3.2.1.24 inhibitors
alpha-D-mannopyranosidase inhibitor
alpha-D-mannopyranosidase inhibitors
alpha-D-mannosidase inhibitor
alpha-D-mannosidase inhibitors
alpha-mannosidase inhibitor
alpha-mannosidase inhibitors
exo-alpha-mannosidase inhibitor
exo-alpha-mannosidase inhibitors
p-nitrophenyl-alpha-mannosidase inhibitor
p-nitrophenyl-alpha-mannosidase inhibitors
EC 3.2.1.24 (alpha-mannosidase) inhibitor
CB1 receptor agonist
CB1 receptor agonist
CB1 receptor agonists
CB1R agonist
CB1R agonists
cannabinoid receptor 1 agonist
cannabinoid receptor 1 agonists
cannabinoid receptor type 1 agonist
cannabinoid receptor type 1 agonists
type 1 cannabinoid receptor agonist
type 1 cannabinoid receptor agonists
CB1 receptor agonist
elicitor
elicitors
elicitor
EC 6.2.1.45 (E1 ubiquitin-activating enzyme) inhibitor
E1 inhibitor
E1 inhibitors
E1 ubiquitin-activating enzyme inhibitor
E1 ubiquitin-activating enzyme inhibitors
EC 6.2.1.45 (E1 ubiquitin-activating enzyme) inhibitors
EC 6.2.1.45 inhibitor
EC 6.2.1.45 inhibitors
ubiquitin activating enzyme inhibitor
ubiquitin activating enzyme inhibitors
ubiquitin-activating enzyme E1 inhibitor
ubiquitin-activating enzyme E1 inhibitors
EC 6.2.1.45 (E1 ubiquitin-activating enzyme) inhibitor
neurokinin-1 receptor agonist
NK-1 receptor agonist
NK-1 receptor agonists
NK1 receptor agonist
NK1 receptor agonists
neurokinin-1 receptor agonists
neurokinin-1 receptor agonist
protease-activated receptor-1 agonist
PAR-1 agonist
PAR-1 agonists
PAR-1 receptor agonist
PAR-1 receptor agonists
PAR1 agonist
PAR1 agonists
coagulation factor II (thrombin) receptor agonist
coagulation factor II (thrombin) receptor agonists
coagulation factor II receptor agonist
coagulation factor II receptor agonists
coagulation factor II thrombin receptor agonist
coagulation factor II thrombin receptor agonists
protease activated receptor 1 agonist
protease activated receptor 1 agonists
protease-activated receptor 1 agonist
protease-activated receptor 1 agonists
protease-activated receptor-1 agonists
proteinase-activated receptor 1 agonist
proteinase-activated receptor 1 agonists
protease-activated receptor-1 agonist
piezo1 agonist
PIEZO1 agonist
PIEZO1 agonists
piezo type mechanosensitive ion channel component 1 agonist
piezo type mechanosensitive ion channel component 1 agonists
piezo-type mechanosensitive ion channel component 1 agonist
piezo-type mechanosensitive ion channel component 1 agonists
piezo1 agonists
piezo1 agonist
mitochondrial calcium uniporter inhibitor
MCU inhibitor
MCU inhibitors
mitochondrial calcium uniporter blocker
mitochondrial calcium uniporter blockers
mitochondrial calcium uniporter inhibitors
mitochondrial calcium uniporter inhibitor
gastric inhibitory polypeptide receptor agonist
GIP agonist
GIP agonists
GIP receptor agonist
GIP receptor agonists
GIP-R agonist
GIP-R agonists
GIPR agonist
GIPR agonists
gastric inhibitory polypeptide receptor agonists
glucose-dependent insulinotropic polypeptide receptor agonist
glucose-dependent insulinotropic polypeptide receptor agonists
gastric inhibitory polypeptide receptor agonist
T-type calcium channel blocker
T-type calcium channel antagonist
T-type calcium channel antagonists
T-type calcium channel blockers
T-type calcium channel blocker
aquaretic
aquaretic agent
aquaretic agents
aquaretics
aquaretic
antimyopathic agent
antimyopathic agents
antimyopathic drug
antimyopathic drugs
antimyopathic agent
NOD1 agonist
CARD4 agonist
CARD4 agonists
CLR7.1 agonist
CLR7.1 agonists
NOD1 agonists
caspase recruitment domain-containing protein 4 agonist
caspase recruitment domain-containing protein 4 agonists
nucleotide binding oligomerization domain containing 1 agonist
nucleotide binding oligomerization domain containing 1 agonists
nucleotide-binding oligomerization domain-containing protein 1 agonist
nucleotide-binding oligomerization domain-containing protein 1 agonists
NOD1 agonist
activator
activators
activator
enzyme activator
enzyme activators
enzyme activator
Grace_C1_2023
Hezinglila Grace compound 1
Grace_C1_2023
EC 2.6.1.13 (ornithine aminotransferase) inhibitor
EC 2.6.1.13 (ornithine aminotransferase) inhibitors
EC 2.6.1.13 inhibitor
EC 2.6.1.13 inhibitors
L-ornithine 5-aminotransferase inhibitor
L-ornithine 5-aminotransferase inhibitors
L-ornithine aminotransferase inhibitor
L-ornithine aminotransferase inhibitors
L-ornithine:alpha-ketoglutarate -aminotransferase inhibitor
L-ornithine:alpha-ketoglutarate -aminotransferase inhibitors
OAT inhibitor
OAT inhibitors
ornithine 5-aminotransferase inhibitor
ornithine 5-aminotransferase inhibitors
ornithine aminotransferase inhibitor
ornithine aminotransferase inhibitors
ornithine delta-transaminase inhibitor
ornithine delta-transaminase inhibitors
ornithine transaminase inhibitor
ornithine transaminase inhibitors
ornithine--oxo-acid transaminase inhibitor
ornithine--oxo-acid transaminase inhibitors
ornithine-2-oxoacid aminotransferase inhibitor
ornithine-2-oxoacid aminotransferase inhibitors
ornithine-alpha-ketoglutarate aminotransferase inhibitor
ornithine-alpha-ketoglutarate aminotransferase inhibitors
ornithine-keto acid aminotransferase inhibitor
ornithine-keto acid aminotransferase inhibitors
ornithine-keto acid transaminase inhibitor
ornithine-keto acid transaminase inhibitors
ornithine-ketoglutarate aminotransferase inhibitor
ornithine-ketoglutarate aminotransferase inhibitors
ornithine-oxo acid aminotransferase inhibitor
ornithine-oxo acid aminotransferase inhibitors
ornithine:alpha-oxoglutarate transaminase inhibitor
ornithine:alpha-oxoglutarate transaminase inhibitors
EC 2.6.1.13 (ornithine aminotransferase) inhibitor
insulin-like growth factor-binding protein inhibitor
IGFBP inhibitor
IGFBP inhibitors
insulin-like growth factor-binding protein inhibitors
insulin-like growth factor-binding protein inhibitor
EC 2.7.12.1 (dual-specificity kinase) inhibitor
ADK1 inhibitor
ADK1 inhibitors
Arabidopsis dual specificity kinase 1 inhibitor
Arabidopsis dual specificity kinase 1 inhibitors
CLK1 inhibitor
CLK1 inhibitors
EC 2.7.12.1 (dual-specificity kinase) inhibitors
EC 2.7.12.1 inhibitor
EC 2.7.12.1 inhibitors
Mps1p inhibitor
Mps1p inhibitors
dDYRK2 inhibitor
dDYRK2 inhibitors
dual-specificity kinase inhibitor
dual-specificity kinase inhibitors
EC 2.7.12.1 (dual-specificity kinase) inhibitor
PCNA inhibitor
PCNA inhibitors
proliferating cell nuclear antigen inhibitor
proliferating cell nuclear antigen inhibitors
PCNA inhibitor
sphingosine-1-phosphate receptor 2 antagonist
EDG-5 antagonist
EDG-5 antagonists
EDG5 antagonist
EDG5 antagonists
S1P2 antagonist
S1P2 antagonists
S1PR2 antagonist
S1PR2 antagonists
sphingosine-1-phosphate receptor 2 antagonists
sphingosine-1-phosphate receptor 2 antagonist
EC 3.5.3.1 (arginase) inhibitor
EC 3.5.3.1 (arginase) inhibitors
EC 3.5.3.1 inhibitor
EC 3.5.3.1 inhibitors
L-arginase inhibitor
L-arginase inhibitors
arginase inhibitor
arginase inhibitors
arginine amidinase inhibitor
arginine amidinase inhibitors
arginine transamidinase inhibitor
arginine transamidinase inhibitors
canavanase inhibitor
canavanase inhibitors
EC 3.5.3.1 (arginase) inhibitor
EC 3.5.3.* (non-peptide linear amidine C-N hydrolase) inhibitor
EC 3.5.3.* (non-peptide linear amidine C-N hydrolase) inhibitors
EC 3.5.3.* inhibitor
EC 3.5.3.* inhibitors
non-peptide linear amidine C-N hydrolase (EC 3.5.3.*) inhibitor
non-peptide linear amidine C-N hydrolase (EC 3.5.3.*) inhibitors
EC 3.5.3.* (non-peptide linear amidine C-N hydrolase) inhibitor
calcitonin gene-related peptide receptor antagonist
CGRP antagonist
CGRP antagonists
calcitonin gene-related peptide receptor antagonists
calcitonin gene-related peptide receptor antagonist
Rac1 inhibitor
Rac-1 inhibitor
Rac-1 inhibitors
Rac1 inhibitors
Ras-related C3 botulinum toxin substrate 1 inhibitor
Ras-related C3 botulinum toxin substrate 1 inhibitors
Rac1 inhibitor
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor
3-enol-pyruvoylshikimate-5-phosphate synthase inhibitor
3-enol-pyruvoylshikimate-5-phosphate synthase inhibitors
3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) inhibitor
3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) inhibitors
3-phosphoshikimate 1-carboxyvinyltransferase inhibitor
3-phosphoshikimate 1-carboxyvinyltransferase inhibitors
5-enolpyruvylshikimate-3-phosphate synthase inhibitor
5-enolpyruvylshikimate-3-phosphate synthase inhibitors
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitors
EC 2.5.1.19 inhibitor
EC 2.5.1.19 inhibitors
EPSP synthase inhibitor
EPSP synthase inhibitors
phosphoenolpyruvate:3-phosphoshikimate 5-O-(1-carboxyvinyl)-transferase inhibitor
phosphoenolpyruvate:3-phosphoshikimate 5-O-(1-carboxyvinyl)-transferase inhibitors
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor
ATP synthase inhibitor
ATP synthase inhibitor
acaricide
Akarizid
Akarizide
acaricides
miticide
acaricide
EC 2.2.1.6 (acetolactate synthase) inhibitor
EC 2.2.1.6 (acetolactate synthase) inhibitors
EC 2.2.1.6 inhibitor
EC 2.2.1.6 inhibitors
acetohydroxy acid synthetase inhibitor
acetohydroxy acid synthetase inhibitors
acetohydroxyacid synthase inhibitor
acetohydroxyacid synthase inhibitors
acetolactate pyruvate-lyase (carboxylating) inhibitor
acetolactate pyruvate-lyase (carboxylating) inhibitors
acetolactate synthase (EC 2.2.1.6) inhibitor
acetolactate synthase (EC 2.2.1.6) inhibitors
acetolactate synthase inhibitor
acetolactate synthase inhibitors
acetolactic synthetase inhibitor
acetolactic synthetase inhibitors
alpha-acetohydroxy acid synthetase inhibitor
alpha-acetohydroxy acid synthetase inhibitors
alpha-acetohydroxyacid synthase inhibitor
alpha-acetohydroxyacid synthase inhibitors
alpha-acetolactate synthase inhibitor
alpha-acetolactate synthase inhibitors
alpha-acetolactate synthetase inhibitor
alpha-acetolactate synthetase inhibitors
pyruvate:pyruvate acetaldehydetransferase (decarboxylating) inhibitor
pyruvate:pyruvate acetaldehydetransferase (decarboxylating) inhibitors
EC 2.2.1.6 (acetolactate synthase) inhibitor
alicyclic antibiotics
alicyclic antibiotics
aliphatic antibiotics
aliphatic antibiotics
alkylating agent
alkylating agent
alpha-1-microglobulin-Ig alpha complex chromophores
alpha-1-microglobulin-Ig alpha complex chromophores
amino acid derivative antibiotics
amino acid derivative antibiotics
antiauxins
antiauxins
antifeedant
antifeedants
antifeedant
antioxidant
antioxidants
antioxydant
antoxidant
antioxidant
antiviral agent
anti-viral agent
anti-viral agents
antiviral
antiviral agents
antivirals
antiviral agent
auxin
auxins
auxin
base
Base
Base1
Base2
Basen
Nucleobase
base
bases
base
phytogenic insecticide
botanical insecticide
botanical insecticides
phytogenic insecticides
phytogenic insecticide
calcium ionophore
calcium ionophores
calcium ionophore
EC 4.2.1.1 (carbonic anhydrase) inhibitor
EC 4.2.1.1 (carbonic anhydrase) inhibitors
EC 4.2.1.1 inhibitor
EC 4.2.1.1 inhibitors
anhydrase inhibitor
anhydrase inhibitors
carbonate anhydrase inhibitor
carbonate anhydrase inhibitors
carbonate dehydratase inhibitor
carbonate dehydratase inhibitors
carbonate hydro-lyase (carbon-dioxide-forming) inhibitor
carbonate hydro-lyase (carbon-dioxide-forming) inhibitors
carbonate hydro-lyase inhibitor
carbonate hydro-lyase inhibitors
carbonic acid anhydrase inhibitor
carbonic acid anhydrase inhibitors
carbonic anhydrase (EC 4.2.1.1) inhibitor
carbonic anhydrase (EC 4.2.1.1) inhibitors
carbonic anhydrase A inhibitor
carbonic anhydrase A inhibitors
carbonic anhydrase inhibitor
carbonic anhydrase inhibitors
carboxyanhydrase inhibitor
carboxyanhydrase inhibitors
EC 4.2.1.1 (carbonic anhydrase) inhibitor
chemosterilant
chemosterilants
chemosterilant
chitin synthesis inhibitor
chitin synthesis inhibitor
chromophore
chromophore
chromophores
chromophore
coenzyme
coenzyme
coenzymes
coenzyme
cofactor
cofactor
cofactors
cofactor
compatible osmolytes
compatible osmolytes
molecular entity
entidad molecular
entidades moleculares
entite moleculaire
molecular entities
molecular entity
molekulare Entitaet
molecular entity
cytochrome-b6f complex inhibitor
cytochrome-b6f complex inhibitor
cytokinin
cytokinin
defoliant
Defoliationsmittel
Entlaubungsmittel
defoliants
defoliant
drug
drugs
medicine
drug
ecdysone antagonists
ecdysone antagonists
enzyme inhibitor
enzyme inhibitor
enzyme inhibitors
inhibidor enzimatico
inhibidores enzimaticos
inhibiteur enzymatique
inhibiteurs enzymatiques
enzyme inhibitor
estradiol
estra-1,3,5(10)-triene-3,17-diol
oestradiol
estradiol
ethylene releasers
ethylene releasers
fat-soluble vitamin (role)
fat-soluble vitamin
fat-soluble vitamins
fettloesliche Vitamine
fat-soluble vitamin (role)
iron(3+) chelator
iron(3+) chelator
fungicide
fungicides
fungicide
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitors
EC 6.3.1.2 inhibitor
EC 6.3.1.2 inhibitors
L-glutamate:ammonia ligase (ADP-forming) inhibitor
L-glutamate:ammonia ligase (ADP-forming) inhibitors
L-glutamine synthetase inhibitor
L-glutamine synthetase inhibitors
glutamate--ammonia ligase (EC 6.3.1.2) inhibitor
glutamate--ammonia ligase (EC 6.3.1.2) inhibitors
glutamate--ammonia ligase inhibitor
glutamate--ammonia ligase inhibitors
glutamine synthetase inhibitor
glutamine synthetase inhibitors
glutamylhydroxamic synthetase inhibitor
glutamylhydroxamic synthetase inhibitors
EC 6.3.1.2 (glutamate--ammonia ligase) inhibitor
group transfer coenzymes
group transfer coenzymes
biological role
biological function
biological role
herbicide
Herbizid
Unkrautbekaempfungsmittel
Unkrautvertilgungsmittel
Wildkrautbekaempfungsmittel
herbicides
herbicide
hormone
endocrine
hormones
hormone
insect attractant
insect attractants
insect attractant
insect growth regulator
insect growth regulators
insect growth regulator
insecticide
insecticides
insecticide
intercalator
agente intercalante
intercalating agent
intercalating agents
intercalating ligands
intercalators
intercalator
ionophore
ionophore
ionophores
ionophore
iron ionophore
iron ionophores
iron ionophore
jasmonates
jasmonates
juvenile hormone antagonists
juvenile hormone antagonists
juvenile hormone mimic
juvenile hormone mimic
luciferin
luciferin
metabolite
metabolite
metabolites
primary metabolites
secondary metabolites
metabolite
mitochondrial respiratory-chain inhibitor
mitochondrial electron transport chain inhibitors
mitochondrial electron-transport chain inhibitor
mitochondrial respiratory chain inhibitors
mitochondrial respiratory-chain inhibitor
mutagen
mutagene
mutagenes
mutagenic agent
mutageno
mutagenos
mutagens
mutagen
mycotoxin
fungal toxins
mycotoxins
mycotoxin
nematicide
nematicides
nematocide
nematocides
nematicide
neurotransmitter
neurotransmitters
neurotransmitter
neonicotinoid insectide
neonicotinoid insectides
nicotinoid insectide
nicotinoid insectides
neonicotinoid insectide
nodulation factor
NF
nod factor
nodulation factors
nodulation factor
nucleoside antibiotic
nucleoside antibiotic
osmolyte
osmolytes
osmolyte
oxidized luciferins
oxidized luciferins
pesticide synergist
pesticide synergists
pesticide synergist
pesticide
Pestizid
Pestizide
pesticide
pesticides
pesticide
pheromone
ectohormone
feromone
pheromone
pheromones
pheromone
phosphorus containing antibiotics
phosphorus containing antibiotics
photosynthetic electron-transport chain inhibitor
photosynthetic electron-transport chain inhibitor
photosystem-I inhibitor
photosystem-I inhibitor
photosystem-II inhibitor
photosystem-II inhibitor
phytoalexin
phytoalexins
phytoalexin
biological pigment
pigments
biological pigment
plant growth regulator
plant growth regulators
plant growth regulator
plant growth stimulator
plant growth stimulators
plant growth stimulator
precocenes
precocenes
prosthetic group
groupe prosthetique
prosthetic group
prosthetic groups
prosthetic group
pyrethroid insecticide
pyrethroid insecticides
pyrethroid insecticide
semiochemical
semiochemicals
semiochemical
sideramine
sideramine
siderophore
ferrioxamine
ferrioxamines
ironophore
siderochrome
siderochromes
siderophore
siderophores
siderophore
amodiaquine
4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol
Amodiaquine
amodiaquina
amodiaquine
amodiaquinum
amodiaquine
synthetic auxin
synthetic auxins
synthetic auxin
systemic acquired resistance inducing compounds
systemic acquired resistance inducing compounds
toxin
toxin
toxins
toxin
micronutrient
micronutrients
trace elements
micronutrient
volatile oil component
essential oil component
essential oil components
ethereal oil component
ethereal oil components
volatile oil components
volatile oil component
water-soluble vitamin (role)
wasserloesliche Vitamine
water-soluble vitamin
water-soluble vitamins
water-soluble vitamin (role)
xenobiotic organic ethers
xenobiotic organic ethers
detergent
Detergents
detergent
detergent
quinidine
(+)-Quinidine
(+)-quinidine
(8R,9S)-quinidine
(9S)-6'-methoxycinchonan-9-ol
(R)-(6-methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
6-methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
CIN-QUIN
Chinidin
Conchinin
Kinidin
Quinidine
alpha-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
beta-quinine
chinidinum
conquinine
pitayine
quinidina
quinidine
quinidine
bupropion
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
Bupropion
bupropion
vitamin (role)
vitamin
vitamina
vitaminas
vitamine
vitamines
vitamins
vitaminum
vitamin (role)
antitubercular agent
antitubercular
antitubercular agents
antitubercular drug
antitubercular drugs
tuberculostatic agent
antitubercular agent
application
application
molecular messenger
chemical messenger
molecular messenger
antimicrobial agent
Antibiotika
Antibiotikum
antibiotic
antibiotics
antibiotique
antimicrobial
antimicrobial agents
antimicrobials
microbicide
microbicides
antimicrobial agent
antibacterial agent
antibacterial agents
antibacterials
bactericide
bactericides
antibacterial agent
nutrient
nutrients
nutrient
agrochemical
agrichemical
agrichemicals
agricultural chemicals
agrochemicals
agrochemical
fertilizer
fertiliser
fertilizers
fertilizer
rodenticide
rodenticides
rodenticide
avicide
avicides
avicide
food
food material
food materials
food role
foods
foodstuff
foodstuffs
food
fuel
fuel
diagnostic agent
diagnostic aid
diagnostic agent
reagent
reactif
reactivo
reagent
reagents
reagent
molluscicide
molluscicides
molluscicide
macronutrient
macronutrients
macronutrient
surfactant
surface active agent
surfactant
surfactants
surfactant
lumiphore
luminophore
lumiphore
lumiphore
tracer
tracer
tracer
chemical tracer
chemical tracer
chemical tracer
isotopic tracer
isotopic tracer
isotopic tracer
radioactive tracer
radioactive tracer
radioactive tracer
physical tracer
physical tracer
physical tracer
label
label
label
spin label
spin label
spin label
radioactive label
radioactive label
radioactive label
plant growth retardant
plant growth inhibitor
plant growth inhibitors
plant growth retardants
plant growth retardant
antimetabolite
antimetabolite
antimetabolites
antimetabolite
inhibitor
inhibidor
inhibiteur
inhibitor
inhibitors
inhibitor
catalyst
Katalysator
catalizador
catalyseur
catalyst
catalyst
effector
effector
enzyme modulator
effector
buffer
buffer compound
buffer compounds
buffer
spin probe
spin probe
spin probe
fossil fuel
fossil fuel
fossil fuel
nuclear fuel
nuclear fuel
nuclear fuel
radiopharmaceutical
radiopharmaceuticals
radiopharmaceutical
central nervous system stimulant
CNS stimulant
analeptic
analeptic agent
analeptic drug
analeptics
central nervous system stimulant
central stimulant
central nervous system stimulant
antiinfective agent
anti-infective agents
anti-infective drugs
antiinfective agents
antiinfective drug
antiinfective agent
antiparasitic agent
antiparasitic drugs
antiparasitics
parasiticides
antiparasitic agent
anthelminthic drug
anthelminthic
anthelminthics
anthelmintic
anthelmintics
antihelminth
antihelmintico
vermifuge
anthelminthic drug
antinematodal drug
antinematodal agent
antinematodal drugs
antinematodals
antinematodal drug
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
ACE inhibitor
ACE inhibitors
DCP inhibitor
DCP inhibitors
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitors
EC 3.4.15.1 inhibitor
EC 3.4.15.1 inhibitors
PDH inhibitor
PDH inhibitors
angiotensin I-converting enzyme inhibitor
angiotensin I-converting enzyme inhibitors
angiotensin-converting enzyme inhibitor
angiotensin-converting enzyme inhibitors
carboxycathepsin inhibitor
carboxycathepsin inhibitors
dipeptidase inhibitor
dipeptidase inhibitors
dipeptide hydrolase inhibitor
dipeptide hydrolase inhibitors
dipeptidyl carboxypeptidase I inhibitor
dipeptidyl carboxypeptidase I inhibitors
dipeptidyl carboxypeptidase inhibitor
dipeptidyl carboxypeptidase inhibitors
endothelial cell peptidyl dipeptidase inhibitor
endothelial cell peptidyl dipeptidase inhibitors
kininase II inhibitor
kininase II inhibitors
peptidase P inhibitor
peptidase P inhibitors
peptidyl dipeptidase A inhibitor
peptidyl dipeptidase A inhibitors
peptidyl dipeptidase I inhibitor
peptidyl dipeptidase I inhibitors
peptidyl dipeptidase-4 inhibitor
peptidyl dipeptidase-4 inhibitors
peptidyl dipeptide hydrolase inhibitor
peptidyl dipeptide hydrolase inhibitors
peptidyl-dipeptidase A (EC 3.4.15.1) inhibitor
peptidyl-dipeptidase A (EC 3.4.15.1) inhibitors
peptidyl-dipeptidase A inhibitor
peptidyl-dipeptidase A inhibitors
peptidyl-dipeptide hydrolase inhibitor
peptidyl-dipeptide hydrolase inhibitors
peptidyldipeptide hydrolase inhibitor
peptidyldipeptide hydrolase inhibitors
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
antidepressant
antidepressant drugs
antidepressants
thymoanaleptics
thymoleptic drugs
thymoleptics
antidepressant
central nervous system drug
CNS agent
CNS drugs
central nervous system agents
central nervous system drug
psychotropic drug
psychoactive agent
psychoactive drugs
psychopharmaceuticals
psychotropic drugs
psychotropic drug
anti-inflammatory drug
anti-inflammatory drugs
antiinflammatory agent
antiinflammatory drug
antiinflammatory drugs
anti-inflammatory drug
tranquilizing drug
ataractics
tranquilising drug
tranquilizing drugs
tranquillising agent
tranquillizing agents
tranquilizing drug
anxiolytic drug
anti-anxiety agents
anti-anxiety drugs
anxiolytic agents
anxiolytics
minor tranquilisers
minor tranquilizers
minor tranquilizing agents
anxiolytic drug
non-steroidal anti-inflammatory drug
NSAID
NSAIDs
non-steroidal anti-inflammatory agent
non-steroidal anti-inflammatory drugs
non-steroidal anti-inflammatory drug
antipsychotic agent
Neuroleptikum
antipsychotic agents
antipsychotic drug
antipsychotic drugs
antipsychotics
antipsychotiques
grosser Tranquilizer
major tranquilizers
major tranquilizing agents
neuroleptic
neuroleptic agents
neuroleptics
neuroleptique
neuroleptiques
antipsychotic agent
antimanic drug
antimanic agent
antimanic drugs
antimanics
antimanic drug
analgesic
analgesic
non-narcotic analgesic
non-narcotic analgesic
opioid analgesic
narcotic
narcotic analgesic
narcotic analgesics
narcotics
opioid analgesics
opioid analgesic
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
CoA-independent aldehyde dehydrogenase inhibitor
CoA-independent aldehyde dehydrogenase inhibitors
EC 1.2.1.3 (aldehyde dehydrogenase (NAD(+))) inhibitor
EC 1.2.1.3 (aldehyde dehydrogenase (NAD(+))) inhibitors
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitors
EC 1.2.1.3 inhibitor
EC 1.2.1.3 inhibitors
NAD-aldehyde dehydrogenase inhibitor
NAD-aldehyde dehydrogenase inhibitors
NAD-dependent 4-hydroxynonenal dehydrogenase inhibitor
NAD-dependent 4-hydroxynonenal dehydrogenase inhibitors
NAD-dependent aldehyde dehydrogenase inhibitor
NAD-dependent aldehyde dehydrogenase inhibitors
NAD-linked aldehyde dehydrogenase inhibitor
NAD-linked aldehyde dehydrogenase inhibitors
aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3) inhibitor
aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3) inhibitors
aldehyde dehydrogenase (NAD(+)) inhibitor
aldehyde dehydrogenase (NAD(+)) inhibitors
aldehyde dehydrogenase (NAD) inhibitor
aldehyde dehydrogenase (NAD) inhibitors
aldehyde dehydrogenase inhibitor
aldehyde dehydrogenase inhibitors
m-methylbenzaldehyde dehydrogenase inhibitor
m-methylbenzaldehyde dehydrogenase inhibitors
propionaldehyde dehydrogenase inhibitor
propionaldehyde dehydrogenase inhibitors
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
central nervous system depressant
CNS depressants
central nervous system depressants
central nervous system depressant
antipyretic
anti-pyretic
antipyretic
androgen antagonist
antiandrogen
androgen antagonist
diuretic
diuretics
diuretic
hallucinogen
hallucinogenic agents
hallucinogenic drugs
hallucinogens
psychedelic agents
psychedelics
hallucinogen
beta-adrenergic agonist
beta-adrenergic agonists
beta-adrenergic receptor agonist
beta-adrenoceptor agonists
beta-adrenergic agonist
bronchodilator agent
bronchodilator
bronchodilator agents
broncholytic agent
bronchodilator agent
sympathomimetic agent
sympathomimetic
sympathomimetics
sympathomimetic agent
hypoglycemic agent
antidiabetic
antihyperglycemic
antihyperglycemic agent
antihyperglycemic agents
antihyperglycemic drug
antihyperglycemic drugs
antihyperglycemics
hypoglycemic agents
hypoglycemic drug
hypoglycemic drugs
hypoglycemic agent
beta-adrenergic antagonist
beta-adrenergic antagonists
beta-adrenergic blocker
beta-adrenergic blockers
beta-adrenergic receptor blockaders
beta-adrenoceptor antagonists
beta-blocker
beta-blockers
beta-adrenergic antagonist
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitor
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate,hydrogen-donor:oxygen oxidoreductase inhibitors
(PG)H synthase inhibitor
(PG)H synthase inhibitors
COX inhibitor
EC 1.14.99.1 (cyclooxygenase) inhibitor
EC 1.14.99.1 (cyclooxygenase) inhibitors
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitors
EC 1.14.99.1 inhibitor
EC 1.14.99.1 inhibitors
PG synthetase inhibitor
PG synthetase inhibitors
cyclooxygenase (EC 1.14.99.1) inhibitor
cyclooxygenase (EC 1.14.99.1) inhibitors
cyclooxygenase inhibitor
cyclooxygenase inhibitors
fatty acid cyclooxygenase inhibitor
fatty acid cyclooxygenase inhibitors
prostaglandin G/H synthase inhibitor
prostaglandin G/H synthase inhibitors
prostaglandin endoperoxide synthetase inhibitor
prostaglandin endoperoxide synthetase inhibitors
prostaglandin synthase inhibitor
prostaglandin synthase inhibitors
prostaglandin synthetase inhibitor
prostaglandin synthetase inhibitors
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor
cardiovascular drug
cardiovascular agent
cardiovascular drugs
cardiovascular drug
alpha-adrenergic agonist
alpha-adrenergic agonists
alpha-adrenergic receptor agonist
alpha-adrenoceptor agonists
alpha-adrenergic agonist
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitors
EC 3.1.3.48 inhibitor
EC 3.1.3.48 inhibitors
PPT-phosphatase inhibitor
PPT-phosphatase inhibitors
PTP-phosphatase inhibitor
PTP-phosphatase inhibitors
PTPase inhibitor
PTPase inhibitors
[phosphotyrosine]protein phosphatase inhibitor
[phosphotyrosine]protein phosphatase inhibitors
phosphoprotein phosphatase (phosphotyrosine) inhibitor
phosphoprotein phosphatase (phosphotyrosine) inhibitors
phosphotyrosine histone phosphatase inhibitor
phosphotyrosine histone phosphatase inhibitors
phosphotyrosine phosphatase inhibitor
phosphotyrosine phosphatase inhibitors
phosphotyrosine protein phosphatase inhibitor
phosphotyrosine protein phosphatase inhibitors
phosphotyrosylprotein phosphatase inhibitor
phosphotyrosylprotein phosphatase inhibitors
protein phosphotyrosine phosphatase inhibitor
protein phosphotyrosine phosphatase inhibitors
protein tyrosine phosphatase inhibitor
protein tyrosine phosphatase inhibitors
protein-tyrosine-phosphatase (EC 3.1.3.48) inhibitor
protein-tyrosine-phosphatase (EC 3.1.3.48) inhibitors
protein-tyrosine-phosphatase inhibitor
protein-tyrosine-phosphatase inhibitors
protein-tyrosine-phosphate phosphohydrolase inhibitor
protein-tyrosine-phosphate phosphohydrolase inhibitors
tyrosine O-phosphate phosphatase inhibitor
tyrosine O-phosphate phosphatase inhibitors
tyrosylprotein phosphatase inhibitor
tyrosylprotein phosphatase inhibitors
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
antineoplastic agent
anticancer agent
anticancer agents
antineoplastic
antineoplastic agents
cytostatic
antineoplastic agent
flavouring agent
flavoring agent
flavoring agents
flavour enhancer
flavour enhancers
flavouring agents
flavouring agent
vasodilator agent
vasodilator
vasodilator agents
vasodilator agent
anticonvulsant
Antiepileptika
Antiepileptikum
Antikonvulsiva
Antikonvulsivum
anti-convulsant
anti-convulsants
anti-convulsive agent
anti-convulsive agents
anticonvulsants
anticonvulsive agent
anticonvulsive agents
antiepileptic
antiepileptics
antiepileptique
antiepileptiques
anticonvulsant
EC 3.5.2.6 (beta-lactamase) inhibitor
EC 3.5.2.6 (beta-lactamase) inhibitors
EC 3.5.2.6 inhibitor
EC 3.5.2.6 inhibitors
ampicillinase inhibitor
ampicillinase inhibitors
beta-lactam hydrolase inhibitor
beta-lactam hydrolase inhibitors
beta-lactamase (EC 3.5.2.6) inhibitor
beta-lactamase (EC 3.5.2.6) inhibitors
beta-lactamase A, B, C inhibitor
beta-lactamase A, B, C inhibitors
beta-lactamase AME I inhibitor
beta-lactamase AME I inhibitors
beta-lactamase I-III inhibitor
beta-lactamase I-III inhibitors
beta-lactamase inhibitor
beta-lactamase inhibitors
cephalosporin-beta-lactamase inhibitor
cephalosporin-beta-lactamase inhibitors
cephalosporinase inhibitor
cephalosporinase inhibitors
exopenicillinase inhibitor
exopenicillinase inhibitors
neutrapen inhibitor
neutrapen inhibitors
penicillin amido-beta-lactamhydrolase inhibitor
penicillin amido-beta-lactamhydrolase inhibitors
penicillin beta-lactamase inhibitor
penicillin beta-lactamase inhibitors
penicillinase I, II inhibitor
penicillinase I, II inhibitors
penicillinase inhibitor
penicillinase inhibitors
EC 3.5.2.6 (beta-lactamase) inhibitor
EC 1.17.3.2 (xanthine oxidase) inhibitor
EC 1.17.3.2 (xanthine oxidase) inhibitors
EC 1.17.3.2 inhibitor
EC 1.17.3.2 inhibitors
Schardinger enzyme inhibitor
Schardinger enzyme inhibitors
hypoxanthine oxidase inhibitor
hypoxanthine oxidase inhibitors
hypoxanthine-xanthine oxidase inhibitor
hypoxanthine-xanthine oxidase inhibitors
hypoxanthine:oxygen oxidoreductase inhibitor
hypoxanthine:oxygen oxidoreductase inhibitors
xanthine oxidase (EC 1.17.3.2) inhibitor
xanthine oxidase (EC 1.17.3.2) inhibitors
xanthine oxidase inhibitor
xanthine oxidase inhibitors
xanthine oxidoreductase inhibitor
xanthine oxidoreductase inhibitors
xanthine:O2 oxidoreductase inhibitor
xanthine:O2 oxidoreductase inhibitors
xanthine:oxygen oxidoreductase inhibitor
xanthine:oxygen oxidoreductase inhibitors
xanthine:xanthine oxidase inhibitor
xanthine:xanthine oxidase inhibitors
EC 1.17.3.2 (xanthine oxidase) inhibitor
adrenergic uptake inhibitor
ARI
NERI
NRI
adrenergic reuptake inhibitor
adrenergic reuptake inhibitors
adrenergic uptake inhibitors
norepinephrine reuptake inhibitor
norepinephrine reuptake inhibitors
adrenergic uptake inhibitor
HIV protease inhibitor
HIV protease inhibitors
HIV protease inhibitor
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
HMG-CoA reductase inhibitor
HMG-CoA reductase inhibitors
hydroxymethylglutaryl-CoA reductase inhibitor
hydroxymethylglutaryl-CoA reductase inhibitors
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
antihypertensive agent
antihypertensive
antihypertensive agents
antihypertensive drug
antihypertensive drugs
antihypertensive agent
histamine agonist
histamine agonists
histamine agonist
antilipemic drug
antihyperlipemic
antihyperlipemics
antihyperlipidaemic agent
antihyperlipidaemic agents
antihyperlipidaemic drug
antihyperlipidaemic drugs
antihyperlipidemic
antihyperlipidemic agent
antihyperlipidemic agents
antihyperlipidemic drug
antihyperlipidemic drugs
antihyperlipidemics
antilipemic
antilipemic drugs
antilipemics
hypolipidemic agent
hypolipidemic agents
lipid-lowering agent
lipid-lowering agents
lipid-lowering drug
lipid-lowering drugs
antilipemic drug
antiplatyhelmintic drug
antiplatyhelmintic agent
antiplatyhelmintic drugs
antiplatyhelmintic drug
xenobiotic
Xenobiotic
xenobiotic
xenobiotic compounds
xenobiotics
xenobiotic
immunosuppressive agent
immunosuppressant
immunosuppressive agents
inmunosupresor
immunosuppressive agent
sedative
hypnotics
hypnotics and sedatives
sedative drug
sedatives
sedatives and hypnotics
sedative
antifungal agent
antifungal
antifungal agents
antifungal drug
antifungal drugs
antifungals
antifungal agent
leprostatic drug
leprostatic
leprostatic agent
leprostatic drugs
leprostatic drug
coccidiostat
anticoccidial agent
coccidiostats
coccidiostat
antiprotozoal drug
antiprotozoal agent
antiprotozoal agents
antiprotozoal drugs
antiprotozoal drug
anticholesteremic drug
anticholesteremic
anticholesteremic agent
anticholesteremic drugs
antihypercholesterolemic
antihypercholesterolemic agent
antihypercholesterolemic agents
antihypercholesterolemic drug
antihypercholesterolemic drugs
antihypercholesterolemics
cholesterol inhibitor
cholesterol-lowering agent
cholesterol-lowering agents
cholesterol-lowering drug
cholesterol-lowering drugs
hypocholesteremic agent
anticholesteremic drug
uricosuric drug
uricosuric agent
uricosuric drugs
uricosuric drug
antirheumatic drug
anti-rheumatic drugs
antirheumatic agent
antirheumatic drugs
antirheumatic drug
gout suppressant
gout suppressants
gout suppressant
renal agent
renal agents
renal agent
lipoxygenase inhibitor
lipooxygenase inhibitor
lipoxygenase inhibitors
lipoxygenase inhibitor
serotonergic agonist
5-HT agonist
5-hydroxytryptamine agonist
serotonergic agonists
serotonin agonist
serotonin agonists
serotonergic agonist
neurotransmitter agent
neurotransmitter agents
neurotransmitter agent
antimicrobial drug
antimicrobial drugs
antimicrobial drug
antiviral drug
anti-viral drug
anti-virus drug
antiviral drugs
antiviral drug
antibacterial drug
antibacterial drugs
antibacterial drug
antitreponemal drug
antitreponemal agent
antitreponemal drugs
antitreponemal drug
antisyphilitic drug
antisyphilitic agent
antisyphilitic agents
antisyphilitic drugs
antisyphilitics
antisyphilitic drug
acaricide drug
acaricide drugs
acaricide drug
oxytocic
oxytocic
oxytocic agents
oxytocic drugs
uterine stimulants
oxytocic
taurocholate
2-[(3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate
taurocholate
taurocholate
local anaesthetic
Lokalanaesthetikum
anesthesique local
local anaesthetic
local anaesthetics
local anesthetics
local anaesthetic
trypanocidal drug
antitrypanosomal agent
antitrypanosomal agents
antitrypanosomal drug
antitrypanosomal drugs
trypanocidal drugs
trypanocide
trypanosomicidal agents
trypanocidal drug
anabolic agent
anabolic agent
interferon inducer
interferon inducers
interferon inducer
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor
3-hydroxy 3-methylglutaryl coenzymeA reductase phosphatase inhibitor
3-hydroxy 3-methylglutaryl coenzymeA reductase phosphatase inhibitors
Aspergillus awamori acid protein phosphatase inhibitor
Aspergillus awamori acid protein phosphatase inhibitors
BCKDH phosphatase inhibitor
BCKDH phosphatase inhibitors
EC 3.1.3.16 (protein serine/threonine phosphatase) inhibitors
EC 3.1.3.16 inhibitor
EC 3.1.3.16 inhibitors
HMG-CoA reductase phosphatase inhibitor
HMG-CoA reductase phosphatase inhibitors
branched-chain alpha-keto acid dehydrogenase phosphatase inhibitor
branched-chain alpha-keto acid dehydrogenase phosphatase inhibitors
calcineurin inhibitor
calcineurin inhibitors
casein phosphatase inhibitor
casein phosphatase inhibitors
phosphatase 2A inhibitor
phosphatase 2A inhibitors
phosphatase 2B inhibitor
phosphatase 2B inhibitors
phosphatase C-II inhibitor
phosphatase C-II inhibitors
phosphatase H-II inhibitor
phosphatase H-II inhibitors
phosphatase I inhibitor
phosphatase I inhibitors
phosphatase IB inhibitor
phosphatase IB inhibitors
phosphatase II inhibitor
phosphatase II inhibitors
phosphatase III inhibitor
phosphatase III inhibitors
phosphatase IV inhibitor
phosphatase IV inhibitors
phosphatase SP inhibitor
phosphatase SP inhibitors
phosphoprotein phosphatase (EC 3.1.3.16) inhibitor
phosphoprotein phosphatase (EC 3.1.3.16) inhibitors
phosphoprotein phosphatase inhibitor
phosphoprotein phosphatase inhibitors
phosphoprotein phosphohydrolase inhibitor
phosphoprotein phosphohydrolase inhibitors
phosphopyruvate dehydrogenase phosphatase inhibitor
phosphopyruvate dehydrogenase phosphatase inhibitors
phosphospectrin phosphatase inhibitor
phosphospectrin phosphatase inhibitors
polycation modulated (PCM-) phosphatase inhibitor
polycation modulated (PCM-) phosphatase inhibitors
protein D phosphatase inhibitor
protein D phosphatase inhibitors
protein phosphatase inhibitor
protein phosphatase inhibitors
protein phosphatase-1 inhibitor
protein phosphatase-1 inhibitors
protein phosphatase-2A inhibitor
protein phosphatase-2A inhibitors
protein phosphatase-2B inhibitor
protein phosphatase-2B inhibitors
protein phosphatase-2C inhibitor
protein phosphatase-2C inhibitors
protein serine/threonine phosphatase (EC 3.1.3.16) inhibitors
protein serine/threonine phosphatase inhibitor
protein serine/threonine phosphatase inhibitors
serine/threonine specific protein phosphatase inhibitor
serine/threonine specific protein phosphatase inhibitors
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor
diagnostic imaging agent
diagnostic imaging agent
MRI contrast agent
MRI contrast agent
radioactive imaging agent
radioactive imaging agent
ultrasound contrast agent
ultrasound contrast agent
radioopaque medium
contrast media
radiocontrast agent
radiocontrast agents
radioopaque media
radiopaque media
radiopaque medium
radioopaque medium
EC 2.7.7.6 (RNA polymerase) inhibitor
C RNA formation factors inhibitor
C RNA formation factors inhibitors
C ribonucleic acid formation factors inhibitor
C ribonucleic acid formation factors inhibitors
DNA-dependent RNA nucleotidyltransferase inhibitor
DNA-dependent RNA nucleotidyltransferase inhibitors
DNA-dependent RNA polymerase inhibitor
DNA-dependent RNA polymerase inhibitors
DNA-dependent ribonucleate nucleotidyltransferase inhibitor
DNA-dependent ribonucleate nucleotidyltransferase inhibitors
DNA-directed RNA polymerase inhibitor
DNA-directed RNA polymerase inhibitors
DNA-directed nucleoside-triphosphate:RNA nucleotidyltransferase inhibitor
DNA-directed nucleoside-triphosphate:RNA nucleotidyltransferase inhibitors
EC 2.7.7.6 (RNA polymerase) inhibitors
EC 2.7.7.6 inhibitor
EC 2.7.7.6 inhibitors
RNA nucleotidyltransferase (DNA-directed) inhibitor
RNA nucleotidyltransferase (DNA-directed) inhibitors
RNA nucleotidyltransferase inhibitor
RNA nucleotidyltransferase inhibitors
RNA polymerase (EC 2.7.7.6) inhibitor
RNA polymerase (EC 2.7.7.6) inhibitors
RNA polymerase I inhibitor
RNA polymerase I inhibitors
RNA polymerase II inhibitor
RNA polymerase II inhibitors
RNA polymerase III inhibitor
RNA polymerase III inhibitors
RNA polymerase inhibitor
RNA polymerase inhibitors
RNA transcriptase inhibitor
RNA transcriptase inhibitors
deoxyribonucleic acid-dependent ribonucleic acid polymerase inhibitor
deoxyribonucleic acid-dependent ribonucleic acid polymerase inhibitors
directed RNA polymerase inhibitor
nucleoside-triphosphate:RNA nucleotidyltransferase (DNA-directed) inhibitor
nucleoside-triphosphate:RNA nucleotidyltransferase (DNA-directed) inhibitors
ribonucleate nucleotidyltransferase inhibitor
ribonucleate nucleotidyltransferase inhibitors
ribonucleate polymerase inhibitor
ribonucleate polymerase inhibitors
ribonucleic acid nucleotidyltransferase inhibitor
ribonucleic acid nucleotidyltransferase inhibitors
ribonucleic acid polymerase inhibitor
ribonucleic acid polymerase inhibitors
ribonucleic acid transcriptase inhibitor
ribonucleic acid transcriptase inhibitors
ribonucleic polymerase inhibitor
ribonucleic polymerase inhibitors
ribonucleic transcriptase inhibitor
ribonucleic transcriptase inhibitors
transcriptase inhibitor
transcriptase inhibitors
EC 2.7.7.6 (RNA polymerase) inhibitor
acid
Acid
Saeure
Saeuren
acid
acide
acido
acids
acid
protease inhibitor
protease inhibitors
protease inhibitor
protein kinase inhibitor
protein kinase inhibitors
protein kinase inhibitor
EC 2.7.11.13 (protein kinase C) inhibitor
ATP:protein phosphotransferase (diacylglycerol-dependent) inhibitor
ATP:protein phosphotransferase (diacylglycerol-dependent) inhibitors
EC 2.7.11.13 (protein kinase C) inhibitors
EC 2.7.11.13 inhibitor
EC 2.7.11.13 inhibitors
PKC inhibitor
PKC inhibitors
PKCalpha inhibitor
PKCalpha inhibitors
PKCbeta inhibitor
PKCbeta inhibitors
PKCdelta inhibitor
PKCdelta inhibitors
PKCepsilon inhibitor
PKCepsilon inhibitors
PKCgamma inhibitor
PKCgamma inhibitors
PKCzeta inhibitor
PKCzeta inhibitors
PKN3 inhibitor
PKN3 inhibitors
Pkc1p inhibitor
Pkc1p inhibitors
STK24 inhibitor
STK24 inhibitors
cPKC inhibitor
cPKC inhibitors
cPKCalpha inhibitor
cPKCalpha inhibitors
cPKCbeta inhibitor
cPKCbeta inhibitors
cPKCgamma inhibitor
cPKCgamma inhibitors
calcium-dependent protein kinase C inhibitor
calcium-dependent protein kinase C inhibitors
calcium-independent protein kinase C inhibitor
calcium-independent protein kinase C inhibitors
calcium/phospholipid dependent protein kinase inhibitor
calcium/phospholipid dependent protein kinase inhibitors
nPKC inhibitor
nPKC inhibitors
nPKCdelta inhibitor
nPKCdelta inhibitors
nPKCepsilon inhibitor
nPKCepsilon inhibitors
nPKCeta inhibitor
nPKCeta inhibitors
nPKCtheta inhibitor
nPKCtheta inhibitors
protein kinase C (EC 2.7.11.13) inhibitor
protein kinase C (EC 2.7.11.13) inhibitors
protein kinase C inhibitor
protein kinase C inhibitors
protein kinase Cepsilon inhibitor
protein kinase Cepsilon inhibitors
EC 2.7.11.13 (protein kinase C) inhibitor
EC 3.1.1.8 (cholinesterase) inhibitor
BChE inhibitor
BChE inhibitors
BtChoEase inhibitor
BtChoEase inhibitors
EC 3.1.1.8 (cholinesterase) inhibitors
EC 3.1.1.8 inhibitor
EC 3.1.1.8 inhibitors
anticholineesterase inhibitor
anticholineesterase inhibitors
anticholinesterase
anticholinesterases
benzoylcholinesterase inhibitor
benzoylcholinesterase inhibitors
butyrylcholine esterase inhibitor
butyrylcholine esterase inhibitors
butyrylcholinesterase inhibitor
butyrylcholinesterase inhibitors
choline esterase II (unspecific) inhibitor
choline esterase II (unspecific) inhibitors
choline esterase inhibitor
choline esterase inhibitors
cholinesterase (EC 3.1.1.8) inhibitor
cholinesterase (EC 3.1.1.8) inhibitors
cholinesterase inhibitor
non-specific cholinesterase inhibitor
non-specific cholinesterase inhibitors
propionylcholinesterase inhibitor
propionylcholinesterase inhibitors
pseudocholinesterase inhibitor
pseudocholinesterase inhibitors
EC 3.1.1.8 (cholinesterase) inhibitor
growth hormone
GH
Somatotropin
Wachstumshormon
growth hormones
growth hormone
plant hormone
phytohormone
phytohormones
plant growth factor
plant growth factors
plant growth hormone
plant growth hormones
plant hormones
plant hormone
adrenergic agonist
adrenergic agonists
adrenergic receptor agonist
adrenoceptor agonists
adrenomimetic
adrenomimetics
adrenergic agonist
adrenergic antagonist
adrenergic antagonists
adrenergic blockaders
adrenergic blocker
adrenergic blockers
adrenergic receptor blockaders
adrenoceptor antagonists
adrenergic antagonist
alpha-adrenergic antagonist
alpha-adrenergic antagonists
alpha-adrenergic blocker
alpha-adrenergic blockers
alpha-adrenergic receptor blockaders
alpha-adrenoceptor antagonists
alpha-adrenergic antagonist
phenothiazine antipsychotic drug
phenothiazine antipsychotic drugs
phenothiazine antipsychotics
phenothiazine neuroleptics
phenothiazine antipsychotic drug
H1-receptor antagonist
H1 antihistaminics
H1 receptor antagonists
H1 receptor blockaders
H1-receptor antagonists
H1-receptor blocker
H1-receptor blockers
classical antihistamines
classical antihistaminics
H1-receptor antagonist
histamine antagonist
antihistamine
antihistamines
antihistaminico
antihistaminics
histamine receptor blocker
histamine receptor blockers
histamine antagonist
histaminergic drug
histamine agents
histamine drugs
histaminergic agent
histaminergic agents
histaminergic drugs
histaminergic drug
dye
Farbstoff
Farbstoffe
colorante
colorantes
dyes
teinture
teintures
dye
H2-receptor antagonist
H2 receptor antagonists
H2 receptor blockaders
H2-receptor blocker
H2-receptor blockers
histamine H2 receptor antagonist
histamine H2 receptor antagonists
H2-receptor antagonist
adrenergic agent
adrenergic agents
adrenergic drug
adrenergic drugs
adrenergic neuron agents
adrenergics
adrenergic agent
triazine insecticide
triazine insecticide
antimalarial
antimalarials
antimalarial
anti-arrhythmia drug
anti-arrhythmia agent
antiarrhythmic agent
anti-arrhythmia drug
cardiotonic drug
cardiotonic drugs
cardiotonic drug
phytosiderophore
Phytosiderophor
phytosiderophores
phytosiderophore
iron chelator
iron chelating agents
iron chelators
iron chelator
chelator
Chelating agent
Metal chelator
chelating agents
chelators
complexon
chelator
iron(2+) chelator
iron(2+) chelator
calcium channel blocker
calcium channel antagonist
calcium channel antagonists
calcium channel blockers
calcium channel blocker
phytotoxin
phytotoxins
phytotoxin
DNA polymerase inhibitor
DNA polymerase inhibitor
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor
4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) inhibitor
4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) inhibitors
4-hydroxyphenylpyruvate dioxygenase inhibitor
4-hydroxyphenylpyruvate dioxygenase inhibitors
4-hydroxyphenylpyruvate hydroxylase inhibitor
4-hydroxyphenylpyruvate hydroxylase inhibitors
4-hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating) inhibitor
4-hydroxyphenylpyruvate:oxygen oxidoreductase (hydroxylating, decarboxylating) inhibitors
4-hydroxyphenylpyruvic acid dioxygenase inhibitor
4-hydroxyphenylpyruvic acid dioxygenase inhibitors
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitors
EC 1.13.11.27 inhibitor
EC 1.13.11.27 inhibitors
HPPD inhibitor
HPPD inhibitors
p-hydroxyphenylpyruvate dioxygenase inhibitor
p-hydroxyphenylpyruvate dioxygenase inhibitors
p-hydroxyphenylpyruvate hydroxylase inhibitor
p-hydroxyphenylpyruvate hydroxylase inhibitors
p-hydroxyphenylpyruvate oxidase inhibitor
p-hydroxyphenylpyruvate oxidase inhibitors
p-hydroxyphenylpyruvic acid hydroxylase inhibitor
p-hydroxyphenylpyruvic acid hydroxylase inhibitors
p-hydroxyphenylpyruvic hydroxylase inhibitor
p-hydroxyphenylpyruvic hydroxylase inhibitors
p-hydroxyphenylpyruvic oxidase inhibitor
p-hydroxyphenylpyruvic oxidase inhibitors
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor
cholinergic drug
cholinergic agent
cholinergic drugs
cholinomimetic
cholinergic drug
cholinergic agonist
acetylcholine agonist
acetylcholine agonists
acetylcholine receptor agonist
cholinergic agonists
cholinomimetic
cholinomimetics
cholinergic agonist
muscarinic agonist
muscarinic acetylcholine receptor agonist
muscarinic agonists
muscarinic cholinergic agonist
muscarinic cholinergic agonists
muscarinic agonist
ecdysone agonist
ecdysone agonists
ecdysone mimetic
ecdysone agonist
carbamate insecticide
carbamate insecticides
carbamate insecticide
EC 3.1.1.7 (acetylcholinesterase) inhibitor
AChEI
AcCholE inhibitor
AcCholE inhibitors
EC 3.1.1.7 (acetylcholinesterase) inhibitors
EC 3.1.1.7 inhibitor
EC 3.1.1.7 inhibitors
acetyl.beta-methylcholinesterase inhibitor
acetyl.beta-methylcholinesterase inhibitors
acetylcholine acetylhydrolase inhibitor
acetylcholine acetylhydrolase inhibitors
acetylcholine esterase inhibitor
acetylcholine hydrolase inhibitor
acetylcholine hydrolase inhibitors
acetylcholinesterase (EC 3.1.1.7) inhibitor
acetylcholinesterase (EC 3.1.1.7) inhibitors
acetylcholinesterase inhibitor
acetylcholinesterase inhibitors
acetylthiocholinesterase inhibitor
acetylthiocholinesterase inhibitors
choline esterase I inhibitor
choline esterase I inhibitors
cholinesterase inhibitor
cholinesterase inhibitors
true cholinesterase inhibitor
true cholinesterase inhibitors
EC 3.1.1.7 (acetylcholinesterase) inhibitor
electron-transport chain inhibitor
electron-transport chain inhibitor
respiratory-chain inhibitor
respiratory-chain inhibitor
mitochondrial NADH:ubiquinone reductase inhibitor
mitochondrial NADH dehydrogenase inhibitor
mitochondrial complex I inhibitor
mitochondrial complex I inhibitors
mitochondrial NADH:ubiquinone reductase inhibitor
mitochondrial cytochrome-bc1 complex inhibitor
mitochondrial complex III inhibitor
mitochondrial complex III inhibitors
mitochondrial cytochrome-bc1 complex inhibitor
EC 1.9.3.1 (cytochrome c oxidase) inhibitor
CcO inhibitor
EC 1.9.3.1 (cytochrome c oxidase) inhibitors
EC 1.9.3.1 inhibitor
EC 1.9.3.1 inhibitors
NADH cytochrome c oxidase inhibitor
NADH cytochrome c oxidase inhibitors
Warburg's respiratory enzyme inhibitor
Warburg's respiratory enzyme inhibitors
complex IV (mitochondrial electron transport) inhibitor
complex IV (mitochondrial electron transport) inhibitors
cytochrome a3 inhibitor
cytochrome a3 inhibitors
cytochrome aa3 inhibitor
cytochrome aa3 inhibitors
cytochrome c oxidase (EC 1.9.3.1) inhibitor
cytochrome c oxidase (EC 1.9.3.1) inhibitors
cytochrome c oxidase inhibitor
cytochrome c oxidase inhibitors
cytochrome oxidase inhibitor
cytochrome oxidase inhibitors
cytochrome-c oxidase inhibitor
cytochrome-c oxidase inhibitors
ferrocytochrome c oxidase inhibitor
ferrocytochrome c oxidase inhibitors
ferrocytochrome-c:oxygen oxidoreductase inhibitor
ferrocytochrome-c:oxygen oxidoreductase inhibitors
indophenol oxidase inhibitor
indophenol oxidase inhibitors
indophenolase inhibitor
indophenolase inhibitors
mitochondrial complex IV inhibitor
mitochondrial complex IV inhibitors
mitochondrial cytochrome-c oxidase inhibitors
EC 1.9.3.1 (cytochrome c oxidase) inhibitor
cytochrome-bc1 complex inhibitor
cytochrome-bc1 complex inhibitor
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
DPNH-coenzyme Q reductase inhibitor
DPNH-ubiquinone reductase inhibitor
EC 1.6.5.3 (NADH:ubiquinone reductase (H(+)-translocating)) inhibitor
EC 1.6.5.3 (NADH:ubiquinone reductase (H(+)-translocating)) inhibitors
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitors
EC 1.6.5.3 inhibitor
EC 1.6.5.3 inhibitors
NADH coenzyme Q1 reductase inhibitor
NADH coenzyme Q1 reductase inhibitors
NADH dehydrogenase (ubiquinone) inhibitor
NADH dehydrogenase (ubiquinone) inhibitors
NADH-CoQ oxidoreductase inhibitor
NADH-CoQ oxidoreductase inhibitors
NADH-CoQ reductase inhibitor
NADH-CoQ reductase inhibitors
NADH-Q6 oxidoreductase inhibitor
NADH-coenzyme Q oxidoreductase inhibitors
NADH-coenzyme Q reductase inhibitor
NADH-coenzyme Q reductase inhibitors
NADH-ubiquinone oxidoreductase inhibitor
NADH-ubiquinone oxidoreductase inhibitors
NADH-ubiquinone reductase inhibitor
NADH-ubiquinone reductase inhibitors
NADH-ubiquinone-1 reductase inhibitor
NADH-ubiquinone-1 reductase inhibitors
NADH2 dehydrogenase (ubiquinone) inhibitor
NADH:ubiquinone oxidoreductase complex inhibitor
NADH:ubiquinone oxidoreductase inhibitor
NADH:ubiquinone oxidoreductase inhibitors
NADH:ubiquinone reductase (H(+)-translocating) inhibitor
NADH:ubiquinone reductase (H(+)-translocating) inhibitors
NADH:ubiquinone reductase (H+-translocating) inhibitor
NADH:ubiquinone reductase inhibitor
coenzyme Q reductase
complex 1 dehydrogenase inhibitor
complex I (NADH:Q1 oxidoreductase) inhibitors
complex I (electron transport chain) inhibitors
complex I (mitochondrial electron transport) inhibitors
dihydronicotinamide adenine dinucleotide-coenzyme Q reductase inhibitor
electron transfer complex I inhibitor
electron transfer complex I inhibitors
mitochondrial electron transport complex 1 inhibitor
mitochondrial electron transport complex I inhibitor
mitochondrial electron transport complex I inhibitors
reduced nicotinamide adenine dinucleotide-coenzyme Q reductase inhibitor
reduced nicotinamide adenine dinucleotide-coenzyme Q reductase inhibitors
type 1 dehydrogenase inhibitor
type 1 dehydrogenase inhibitors
ubiquinone reductase inhibitor
ubiquinone reductase inhibitors
EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
rosuvastatin
(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid
rosuvastatin
rosuvastatin
EC 1.4.3.4 (monoamine oxidase) inhibitor
EC 1.4.3.4 (monoamine oxidase) inhibitors
EC 1.4.3.4 inhibitor
EC 1.4.3.4 inhibitors
MAO A inhibitor
MAO A inhibitors
MAO B inhibitor
MAO B inhibitors
MAO inhibitor
MAO inhibitors
MAO-A inhibitor
MAO-A inhibitors
MAO-B inhibitor
MAO-B inhibitors
adrenalin oxidase inhibitor
adrenalin oxidase inhibitors
adrenaline oxidase inhibitor
adrenaline oxidase inhibitors
amine oxidase (flavin-containing) inhibitor
amine oxidase (flavin-containing) inhibitors
amine:oxygen oxidoreductase (deaminating) (flavin-containing) inhibitor
amine:oxygen oxidoreductase (deaminating) (flavin-containing) inhibitors
amine:oxygen oxidoreductase (deaminating) inhibitor
amine:oxygen oxidoreductase (deaminating) inhibitors
epinephrine oxidase inhibitor
epinephrine oxidase inhibitors
monoamine oxidase (EC 1.4.3.4) inhibitor
monoamine oxidase (EC 1.4.3.4) inhibitors
monoamine oxidase A inhibitor
monoamine oxidase A inhibitors
monoamine oxidase B inhibitor
monoamine oxidase B inhibitors
monoamine oxidase inhibitor
monoamine oxidase inhibitors
monoamine:O2 oxidoreductase (deaminating) inhibitor
monoamine:O2 oxidoreductase (deaminating) inhibitors
serotonin deaminase inhibitor
serotonin deaminase inhibitors
tyraminase inhibitor
tyraminase inhibitors
tyramine oxidase inhibitor
tyramine oxidase inhibitors
EC 1.4.3.4 (monoamine oxidase) inhibitor
membrane transport modulator
membrane transport modulators
membrane transport modulator
sodium channel blocker
Na channel blocker
sodium channel blockers
sodium channel blocker
voltage-gated sodium channel blocker
Nav channel blocker
Nav channel blockers
voltage-dependent sodium channel blockers
voltage-gated sodium channel blocker
tyrosine kinase inhibitor
TKI inhibitor
TKI inhibitors
protein tyrosine kinase inhibitor
protein tyrosine kinase inhibitors
tyrosine kinase inhibitors
tyrphostin
tyrphostins
tyrosine kinase inhibitor
pediculicide
pediculicides
pediculicide
calcium channel agonist
calcium channel activator
calcium channel activators
calcium channel agonists
calcium channel agonist
calcium channel modulator
calcium channel modulators
calcium channel modulator
ryanodine receptor modulator
RyR modulator
ryanodine receptor modulators
ryanodine-sensitive calcium channel modulator
ryanodine-sensitive calcium-release channel modulator
ryanodine receptor modulator
nonionic surfactant
non-ionic surfactant
nonionic surfactants
nonionic surfactant
blood substitute
artificial blood
blood substitutes
oxygen carrier
blood substitute
anaesthetic
Anaesthetika
Anaesthetikum
anaesthetic
anaesthetics
anesthetic agent
anesthetic drug
anesthetics
anaesthetic
general anaesthetic
Allgemeinanaesthetika
Allgemeinanaesthetikum
general anaesthetic
general anaesthetics
general anesthetics
general anaesthetic
inhalation anaesthetic
Inhalationsanaesthetika
Inhalationsanaesthetikum
Inhalationsnarkotika
Inhalationsnarkotikum
anesthetic gases
inhalation anesthetics
inhalation anaesthetic
intravenous anaesthetic
i.v.-Anaesthetika
i.v.-Anaesthetikum
intravenous anesthetics
intravenous anaesthetic
schistosomicide drug
antischistosoma
antischistosomal drug
schistosomicide
schistosomicide drugs
schistosomicides
schistosomicide drug
ectoparasiticide
ectoparasiticides
ectoparasiticide
GABA-gated chloride channel antagonist
GABA-gated chloride channel antagonists
GABA-gated chloride channel antagonist
sodium channel modulator
sodium channel modulators
sodium channel modulator
Good's buffer substance
Good buffer substance
Good's buffer
Good's buffers
Good's buffer substance
pyrethroid ester insecticide
pyrethroid ester insecticides
pyrethroid ester insecticide
Bronsted acid
Bronsted acid
Bronsted-Saeure
acide de Bronsted
donneur d'hydron
hydron donor
Bronsted acid
Bronsted base
Bronsted base
Bronsted-Base
accepteur d'hydron
base de Bronsted
hydron acceptor
Bronsted base
Lewis acid
Lewis acid
Lewis-Saeure
accepteur d'une paire d'electrons
acide de Lewis
electron acceptor
electron-pair acceptor
Lewis acid
Lewis base
Lewis base
Lewis-Base
base de Lewis
donneur d'une paire d'electrons
electron donor
Lewis base
antibiotic insecticide
antibiotic insecticide
antibiotic pesticide
antibiotic pesticide
antibiotic acaricide
antibiotic acaricide
antibiotic nematicide
antibiotic nematicide
pyrethroid ester acaricide
pyrethroid ester acaricide
fumigant
fumigant pesticide
fumigants
fumigant
fumigant insecticide
fumigant insecticides
fumigant insecticide
sulfite ester acaricide
sulfite ester acaricide
mite growth regulator
mite growth regulator
growth regulator
growth regulators
growth regulator
tetrazine acaricide
tetrazine acaricide
pyrethroid ether insecticide
pyrethroid ether insecticides
pyrethroid ether insecticide
pyrethroid ether acaricide
pyrethroid ether acaricides
pyrethroid ether acaricide
homopteran inhibitor of chitin biosynthesis
homopteran inhibitor of chitin biosynthesis
lepidopteran inhibitor of chitin biosynthesis
lepidopteran inhibitor of chitin biosynthesis
bridged diphenyl acaricide
bridged diphenyl acaricides
bridged diphenyl acaricide
dinitrophenol insecticide
dinitrophenol insecticides
dinitrophenol insecticide
fluorescent probe
fluorescent probe
antiglaucoma drug
anti-glaucoma agent
anti-glaucoma agents
anti-glaucoma drug
anti-glaucoma drugs
antiglaucoma agent
antiglaucoma drugs
antiglaucoma drug
dextromethorphan
(+)-3-methoxy-N-methylmorphinan
(+)-dextromethorphan
(4aS,10S,10aS)-6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene
(9alpha,13alpha,14alpha)-3-methoxy-17-methylmorphinan
3-methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan
Albutussin
Antussan
BA 2666
BA-2666
Balminil DM
Benylin DM
Calmylin
D-methorphan
DXM
Delsym
Dextromorphan
Medicon
Romilar
Tusilan
d-Methorphan
destrometerfano
dextromethorfan
dextromethorphan
dextromethorphane
dextromethorphanum
dextrometorfano
dextromethorphan
propofol
2,6-BIS(1-METHYLETHYL)PHENOL
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)phenol
2,6-bis(propan-2-yl)phenol
Diprivan
Disoprivan
Disoprofol
Propofol
Rapinovet
propofol
propofolum
propofol
troleandomycin
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-12-[(4-O-acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-{[2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-6-yl acetate
Oleandocetine
Oleandomycin triacetate
Oleandomycin triacetyl ester
Triacetyloleandomycin
Triacetyloleandomycinum
Tribiocillina
Triocetin
troleandomicina
troleandomycin
troleandomycine
troleandomycinum
troleandomycin
trifluoperazine
10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
Trifluoperazine
trifluoperazina
trifluoperazine
trifluoperazinum
trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
trifluoroperazine
trifluperazine
trifluoperazine
solvent
Loesungsmittel
solvant
solvents
solvent
diclofenac
2-((2,6-dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-dichlorophenyl)amino]benzeneacetic acid
Diclofenac
[2-(2,6-dichloroanilino)phenyl]acetic acid
diclofenac
diclofenac acid
diclofenaco
diclofenacum
diclofenamic acid
{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid
diclofenac
indicator
Indikator
indicator
photosensitizing agent
photosensitising agent
photosensitizing agent
nicotinic acetylcholine receptor agonist
muscarinic agonists
nicotinic acetylcholine receptor agonists
nicotinic agonist
nicotinic agonists
nicotinic acetylcholine receptor agonist
protein synthesis inhibitor
protein synthesis antagonist
protein synthesis antagonists
protein synthesis inhibitors
protein synthesis inhibitor
antiseptic drug
antiseptic
antiseptic agent
antiseptic agents
antiseptics
local antiinfective agents
local microbicides
topical antiinfective agents
topical microbicides
antiseptic drug
disinfectant
Desinfektionsmittel
desinfectant
disinfectants
disinfecting agent
disinfectant
serotonergic drug
serotonergic agents
serotonergic drugs
serotonin drugs
serotonergic drug
serotonergic antagonist
5-HT antagonists
5-hydroxytryptamine antagonists
antiserotonergic agents
serotonin antagonists
serotonin blockaders
serotonergic antagonist
fragrance
Parfuem
aroma
arome
essence
parfum
perfume
scent
fragrance
serine proteinase inhibitor
serine proteinase inhibitors
serine proteinase inhibitor
polar solvent
polar solvent
polar solvents
polar solvent
non-polar solvent
non-polar solvent
protic solvent
protogenic solvent
protic solvent
aprotic solvent
aprotic solvent
polar aprotic solvent
dipolar aprotic solvent
polar aprotic solvent
protophilic solvent
HBA solvent
hydrogen bond acceptor solvent
protophilic solvent
protophilic solvent
amphiprotic solvent
amphiprotic solvent
amphiprotic solvent
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
COMT inhibitor
COMT inhibitors
EC 2.1.1.6 (catechol O-methyltransferase) inhibitors
EC 2.1.1.6 inhibitor
EC 2.1.1.6 inhibitors
S-adenosyl-L-methionine:catechol O-methyltransferase inhibitor
S-adenosyl-L-methionine:catechol O-methyltransferase inhibitors
catechol O-methyltransferase (EC 2.1.1.6) inhibitor
catechol O-methyltransferase (EC 2.1.1.6) inhibitors
catechol O-methyltransferase inhibitor
catechol O-methyltransferase inhibitors
catechol methyltransferase inhibitor
catechol methyltransferase inhibitors
catecholamine O-methyltransferase inhibitor
catecholamine O-methyltransferase inhibitors
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
antiparkinson drug
antiparkinson agent
antiparkinson drug
angiogenesis inhibitor
angiogenesis antagonist
angiostatic agents
anti-angiogenic agent
angiogenesis inhibitor
topical anaesthetic
topical anaesthetics
topical anesthetic
topical anaesthetic
calcimimetic
calcimimetics
calcimimetic
alpha-adrenergic drug
alpha-adrenergic drugs
alpha-adrenergic drug
beta-adrenergic drug
beta-adrenergic drugs
beta-adrenergic drug
EC 1.1.1.21 (aldehyde reductase) inhibitor
ALR2 inhibitor
ALR2 inhibitors
EC 1.1.1.21 (aldehyde reductase) inhibitors
EC 1.1.1.21 inhibitor
EC 1.1.1.21 inhibitors
NADPH-aldopentose reductase inhibitor
NADPH-aldopentose reductase inhibitors
NADPH-aldose reductase inhibitor
NADPH-aldose reductase inhibitors
aldehyde reductase (EC 1.1.1.21) inhibitor
aldehyde reductase (EC 1.1.1.21) inhibitors
aldehyde reductase inhibitor
aldehyde reductase inhibitors
alditol:NAD(P)(+) 1-oxidoreductase inhibitor
alditol:NAD(P)(+) 1-oxidoreductase inhibitors
alditol:NADP oxidoreductase inhibitor
alditol:NADP oxidoreductase inhibitors
alditol:NADP(+) 1-oxidoreductase inhibitor
alditol:NADP(+) 1-oxidoreductase inhibitors
aldose reductase inhibitor
aldose reductase inhibitors
polyol dehydrogenase (NADP(+)) inhibitor
polyol dehydrogenase (NADP(+)) inhibitors
EC 1.1.1.21 (aldehyde reductase) inhibitor
dopaminergic agent
dopamine agent
dopamine agents
dopamine drug
dopamine drugs
dopaminergic agents
dopaminergic agent
dopaminergic antagonist
dopamine antagonist
dopamine blocker
dopamine receptor antagonist
dopaminergic antagonists
dopaminergic antagonist
radical scavenger
free radical scavengers
free-radical scavenger
radical scavenger
gamma-secretase modulator
Gamma-secretase modulator
Gamma-secretase modulators
gamma secretase modulator
gamma secretase modulators
gamma-secretase modulator
gamma-secretase modulators
gamma-secretase modulator
antifibrinolytic drug
antifibrinolytic agent
antifibrinolytic agents
antifibrinolytic drugs
antifibrinolytic drug
fibrin modulating drug
fibrin modulating agent
fibrin modulating agents
fibrin modulating drugs
fibrin modulating drug
agonist
agonist
agonista
agoniste
agonists
agonist
antagonist
antagonist
antagonista
antagoniste
antagonists
antagonist
estropipate
Estropipate
Piperazine estrone sulfate
estropipate
cholinergic antagonist
Anticholinergika
Anticholinergikum
acetylcholine antagonists
acetylcholine receptor antagonist
agent anticholinergique
agente anticolinergico
agentes anticolinergicos
anticholinergic agents
anticholinergics
anticholinergiques
anticolinergicos
cholinergic-blocking agents
cholinergic antagonist
muscarinic antagonist
Antimuskarinika
Antimuskarinikum
agente antimuscarinico
agentes antimuscarinicos
agents antimuscariniques
antimuscarinic agents
antimuscarinicos
muscarinic acetylcholine receptor antagonist
muscarinic antagonists
muscarinic antagonist
nicotinic antagonist
agente antinicotinico
agentes antinicotinicos
agents antinicotiniques
antinicotinicos
nicotinic acetylcholine receptor antagonist
nicotinic acetylcholine receptor antagonists
nicotinic antagonists
nicotinic cholinergic antagonist
nicotinic cholinergic antagonists
nicotinic antagonist
bile acid metabolite
bile acid metabolites
bile salt metabolite
bile acid metabolite
hormone antagonist
hormone antagonists
hormone antagonist
prostaglandin antagonist
prostaglandin inhibitor
prostaglandin antagonist
drug metabolite
drug metabolites
drug metabolite
peripheral nervous system drug
peripheral nervous system agent
peripheral nervous system drugs
peripheral nervous system drug
leukotriene antagonist
LTRA
leukotriene antagonists
leukotriene receptor antagonist
leukotriene receptor antagonists
leukotriene antagonist
anti-asthmatic drug
anti-asthmatic agent
anti-asthmatic agents
anti-asthmatic drugs
anti-asthmatic drug
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
(K(+) + H(+))-ATPase inhibitor
(K(+) + H(+))-ATPase inhibitors
ATP phosphohydrolase (H(+)/K(+)-exchanging) inhibitor
ATP phosphohydrolase (H(+)/K(+)-exchanging) inhibitors
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitors
EC 3.6.3.10 inhibitor
EC 3.6.3.10 inhibitors
H(+)-K(+)-ATPase inhibitor
H(+)-K(+)-ATPase inhibitors
H(+)/K(+)-ATPase inhibitor
H(+)/K(+)-ATPase inhibitors
H(+)/K(+)-exchanging ATPase inhibitor
H(+)/K(+)-exchanging ATPase inhibitors
H,K-ATPase inhibitor
H,K-ATPase inhibitors
proton pump inhibitor
proton pump inhibitors
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
anti-ulcer drug
anti-ulcer agent
anti-ulcer agents
anti-ulcer drugs
anti-ulcer drug
CETP inhibitor
CETP inhibitors
cholesteryl ester transfer protein inhibitor
CETP inhibitor
contraceptive drug
contraceptive agent
contraceptive drugs
contraceptive drug
female contraceptive drug
female contraceptive agent
female contraceptive drugs
female contraceptive drug
oral contraceptive
oral contraceptives
oral contraceptive
synthetic oral contraceptive
synthetic oral contraceptives
synthetic oral contraceptive
excitatory amino acid agonist
excitatory amino acid agonists
excitatory amino acid receptor agonist
excitatory amino acid receptor agonists
excitatory amino acid agonist
sex hormone
Geschlechtshormon
Geschlechtshormone
Sexualhormon
Sexualhormone
hormone sexuelle
hormones sexuelles
sex hormones
sex hormone
androgen
Androgen
Androgene
androgene
androgenes
androgeno
androgenos
androgens
androgen
estrogen
Estrogene
Oestrogen
Oestrogene
estrogene
estrogenes
estrogenes Hormon
estrogeno
estrogenos
estrogens
oestrogen
oestrogene
oestrogenes
oestrogens
estrogen
mu-opioid receptor antagonist
mu-opioid antagonist
mu-opioid antagonists
mu-opioid receptor antagonists
mu-opioid receptor antagonist
bronchoconstrictor agent
bronchoconstrictor agents
bronchoconstrictor drug
bronchoconstrictor agent
keratolytic drug
desquamating agent
keratolytic agent
keratolytic drugs
skin-peeling agent
keratolytic drug
dermatologic drug
dermatologic agent
dermatologic drugs
dermatological agent
dermatologic drug
P450 inhibitor
CYP2D6 inhibitor
CYP2D6 inhibitors
P450 inhibitors
cytochrome P450 inhibitor
cytochrome P450 inhibitors
P450 inhibitor
ion transport inhibitor
ion transport inhibitors
ion-transport inhibitor
ion-transport inhibitors
ion transport inhibitor
fatty acid synthesis inhibitor
fatty acid synthesis inhibitors
fatty acid synthesis inhibitor
provitamin
provitamins
provitamin
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
EC 3.1.4.* (phosphoric diester hydrolase) inhibitors
phosphodiesterase inhibitor
phosphodiesterase inhibitors
phosphoric diester hydrolase (EC 3.1.4.*) inhibitor
phosphoric diester hydrolase (EC 3.1.4.*) inhibitors
phosphoric diester hydrolase inhibitor
phosphoric diester hydrolase inhibitors
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
cholinesterase reactivator
cholinesterase reactivators
cholinesterase reactivator
enzyme reactivator
enzyme reactivators
enzyme reactivator
antidote
antidotes
antidote
hematologic agent
hematologic agents
hematologic agent
anticoagulant
anticoagulante
anticoagulants
anticoagulant
prodrug
Prodrugs
prodrug
protective agent
chemoprotectant
chemoprotectants
chemoprotective agent
chemoprotective agents
protective agents
protective agent
GABA modulator
GABA modulators
GABA modulator
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor
ADH inhibitor
ADH inhibitors
EC 1.1.1.1 (alcohol dehydrogenase) inhibitors
EC 1.1.1.1 inhibitor
EC 1.1.1.1 inhibitors
NAD-dependent alcohol dehydrogenase inhibitor
NAD-dependent alcohol dehydrogenase inhibitors
NAD-specific aromatic alcohol dehydrogenase inhibitor
NAD-specific aromatic alcohol dehydrogenase inhibitors
NADH-alcohol dehydrogenase inhibitor
NADH-alcohol dehydrogenase inhibitors
NADH-aldehyde dehydrogenase inhibitor
NADH-aldehyde dehydrogenase inhibitors
alcohol dehydrogenase (EC 1.1.1.1) inhibitor
alcohol dehydrogenase (EC 1.1.1.1) inhibitors
alcohol dehydrogenase (NAD) inhibitor
alcohol dehydrogenase (NAD) inhibitors
alcohol dehydrogenase inhibitor
alcohol dehydrogenase inhibitors
alcohol:NAD+ oxidoreductase inhibitor
alcohol:NAD+ oxidoreductase inhibitors
aldehyde reductase inhibitor
aldehyde reductase inhibitors
aliphatic alcohol dehydrogenase inhibitor
aliphatic alcohol dehydrogenase inhibitors
ethanol dehydrogenase inhibitor
ethanol dehydrogenase inhibitors
primary alcohol dehydrogenase inhibitor
primary alcohol dehydrogenase inhibitors
yeast alcohol dehydrogenase inhibitor
yeast alcohol dehydrogenase inhibitors
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor
esomeprazole
(-)-omeprazole
(S)-(-)-omeprazole
(S)-omeprazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
Alenia
Escz
Esofag
Inexium paranova
esomeprazol
esomeprazole
esomeprazolum
esomeprazole
EC 5.99.1.2 (DNA topoisomerase) inhibitor
DNA topoisomerase inhibitor
DNA topoisomerase inhibitors
EC 5.99.1.2 (DNA topoisomerase) inhibitors
EC 5.99.1.2 (topoisomerase I) inhibitor
EC 5.99.1.2 (topoisomerase I) inhibitors
EC 5.99.1.2 inhibitor
EC 5.99.1.2 inhibitors
topoisomerase I (EC 5.99.1.2) inhibitor
topoisomerase I (EC 5.99.1.2) inhibitors
topoisomerase I inhibitor
topoisomerase I inhibitors
type I DNA topoisomerase inhibitor
type I DNA topoisomerase inhibitors
EC 5.99.1.2 (DNA topoisomerase) inhibitor
parasympatholytic
parasympatholytics
parasympatholytic
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitors
EC 2.4.1.80 inhibitor
EC 2.4.1.80 inhibitors
UDP-glucose:N-acylsphingosine D-glucosyltransferase inhibitor
UDP-glucose:N-acylsphingosine D-glucosyltransferase inhibitors
UDP-glucose:ceramide glucosyltransferase inhibitor
UDP-glucose:ceramide glucosyltransferase inhibitors
ceramide glucosyltransferase (EC 2.4.1.80) inhibitor
ceramide glucosyltransferase (EC 2.4.1.80) inhibitors
ceramide glucosyltransferase inhibitor
ceramide glucosyltransferase inhibitors
ceramide:UDP-glucose glucosyltransferase inhibitor
ceramide:UDP-glucose glucosyltransferase inhibitors
ceramide:UDPGlc glucosyltransferase inhibitor
ceramide:UDPGlc glucosyltransferase inhibitors
glucosylceramide synthase inhibitor
glucosylceramide synthase inhibitors
uridine diphosphoglucose-ceramide glucosyltransferase inhibitor
uridine diphosphoglucose-ceramide glucosyltransferase inhibitors
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
DT diaphorase inhibitor
EC 1.6.5.2 (NAD(P)H dehydrogenase (quinone)) inhibitor
EC 1.6.5.2 (NAD(P)H dehydrogenase (quinone)) inhibitors
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitors
EC 1.6.5.2 inhibitor
EC 1.6.5.2 inhibitors
NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) inhibitor
NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) inhibitors
NAD(P)H dehydrogenase (quinone) inhibitor
NAD(P)H dehydrogenase (quinone) inhibitors
NAD(P)H dehydrogenase inhibitor
NAD(P)H dehydrogenase inhibitors
NAD(P)H menadione reductase inhibitor
NAD(P)H menadione reductase inhibitors
NAD(P)H-quinone dehydrogenase inhibitor
NAD(P)H-quinone dehydrogenase inhibitors
NAD(P)H-quinone oxidoreductase inhibitor
NAD(P)H-quinone oxidoreductase inhibitors
NAD(P)H2 dehydrogenase (quinone) inhibitor
NAD(P)H2 dehydrogenase (quinone) inhibitors
NAD(P)H: menadione oxidoreductase inhibitor
NAD(P)H: menadione oxidoreductase inhibitors
NAD(P)H:(quinone-acceptor)oxidoreductase inhibitor
NAD(P)H:(quinone-acceptor)oxidoreductase inhibitors
NAD(P)H:quinone oxidoreductase inhibitor
NAD(P)H:quinone oxidoreductase inhibitors
NADH-menadione reductase inhibitor
NADH-menadione reductase inhibitors
NQO1 inhibitor
NQO1 inhibitors
QR1 inhibitor
QR1 inhibitors
dehydrogenase, reduced nicotinamide adenine dinucleotide (phosphate, quinone) inhibitor
dehydrogenase, reduced nicotinamide adenine dinucleotide (phosphate, quinone) inhibitors
diaphorase inhibitor
diaphorase inhibitors
flavoprotein NAD(P)H-quinone reductase inhibitor
flavoprotein NAD(P)H-quinone reductase inhibitors
menadione oxidoreductase inhibitor
menadione oxidoreductase inhibitors
menadione reductase inhibitor
menadione reductase inhibitors
naphthoquinone reductase inhibitor
naphthoquinone reductase inhibitors
p-benzoquinone reductase inhibitor
p-benzoquinone reductase inhibitors
phylloquinone reductase inhibitor
phylloquinone reductase inhibitors
quinone reductase inhibitor
quinone reductase inhibitors
reduced NAD(P)H dehydrogenase inhibitor
reduced NAD(P)H dehydrogenase inhibitors
reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase inhibitor
reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase inhibitors
viologen accepting pyridine nucleotide oxidoreductase inhibitor
viologen accepting pyridine nucleotide oxidoreductase inhibitors
vitamin K reductase inhibitor
vitamin K reductase inhibitors
vitamin-K reductase inhibitor
vitamin-K reductase inhibitors
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
probe
probe
acid-base indicator
Saeure-Base-Indikator
Saeure-Base-Indikatoren
acid-base indicator
indicador acido-base
indicateur acide-base
acid-base indicator
visual indicator
indicador visual
indicateur visuel
visual indicator
visual indicator
adsorption indicator
adsorption indicator
indicador de adsorcion
indicateur par adsorption
adsorption indicator
colour indicator
colour indicator
indicador de color
indicateur colore
indicateurs colores
colour indicator
one-colour indicator
indicador monocolor
indicador monocromico
indicateur monocolore
one-colour indicator
one-colour indicator
two-colour indicator
indicador bicolor
indicateur bicolore
two-colour indicator
two-colour indicator
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor
EC 1.6.3.1 inhibitor
EC 1.6.3.1 inhibitors
EC 1.6.3.1. (NAD(P)H oxidase (H2O2-forming)) inhibitor
EC 1.6.3.1. (NAD(P)H oxidase (H2O2-forming)) inhibitors
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitors
NAD(P)H oxidase (H2O2-forming) (EC 1.6.3.1) inhibitor
NAD(P)H oxidase (H2O2-forming) (EC 1.6.3.1) inhibitors
NAD(P)H oxidase (H2O2-forming) inhibitor
NAD(P)H oxidase (H2O2-forming) inhibitors
NAD(P)H oxidase inhibitor
NAD(P)H oxidase inhibitors
NAD(P)H:oxygen oxidoreductase (H2O2-forming) inhibitor
NAD(P)H:oxygen oxidoreductase (H2O2-forming) inhibitors
NAD(P)H:oxygen oxidoreductase inhibitor
NAD(P)H:oxygen oxidoreductase inhibitors
NADPH oxidase inhibitor
NADPH oxidase inhibitors
THOX2 inhibitor
THOX2 inhibitors
ThOX inhibitor
ThOX inhibitors
dual oxidase inhibitor
dual oxidase inhibitors
p138tox inhibitor
p138tox inhibitors
thyroid NADPH oxidase inhibitor
thyroid NADPH oxidase inhibitors
thyroid oxidase 2 inhibitor
thyroid oxidase 2 inhibitors
thyroid oxidase inhibitor
thyroid oxidase inhibitors
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor
platelet aggregation inhibitor
platelet aggregation inhibitors
platelet aggregation inhibitor
platelet glycoprotein-IIb/IIIa receptor antagonist
GPIIb/IIIa antagonist
GPIIb/IIIa antagonists
fibrinogen receptor antagonist
fibrinogen receptor antagonists
glycoprotein-IIb/IIIa receptor antagonist
glycoprotein-IIb/IIIa receptor antagonists
platelet glycoprotein-IIb/IIIa receptor antagonists
platelet glycoprotein-IIb/IIIa receptor antagonist
adenosine phosphodiesterase inhibitor
adenosine phosphodiesterase inhibitor
EC 3.5.4.4 (adenosine deaminase) inhibitor
ADA inhibitor
EC 3.5.4.4 (adenosine deaminase) inhibitors
EC 3.5.4.4 inhibitor
EC 3.5.4.4 inhibitors
adenosine aminohydrolase inhibitor
adenosine aminohydrolase inhibitors
adenosine deaminase (EC 3.5.4.4) inhibitor
adenosine deaminase (EC 3.5.4.4) inhibitors
adenosine deaminase inhibitor
adenosine deaminase inhibitors
deoxyadenosine deaminase inhibitor
deoxyadenosine deaminase inhibitors
EC 3.5.4.4 (adenosine deaminase) inhibitor
EC 3.1.1.4 (phospholipase A2) inhibitor
EC 3.1.1.4 (phospholipase A2) inhibitors
EC 3.1.1.4 inhibitor
EC 3.1.1.4 inhibitors
lecithinase A inhibitor
lecithinase A inhibitors
phosphatidase inhibitor
phosphatidase inhibitors
phosphatidolipase inhibitor
phosphatidolipase inhibitors
phosphatidylcholine 2-acylhydrolase inhibitor
phosphatidylcholine 2-acylhydrolase inhibitors
phospholipase A inhibitor
phospholipase A inhibitors
phospholipase A2 (EC 3.1.1.4) inhibitor
phospholipase A2 (EC 3.1.1.4) inhibitors
phospholipase A2 inhibitor
phospholipase A2 inhibitors
EC 3.1.1.4 (phospholipase A2) inhibitor
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
(2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl-diphosphate:4-aminobenzoate 2-amino-4-hydroxydihydropteridine-6-methenyltransferase inhibitor
(2-amino-4-hydroxy-7,8-dihydropteridin-6-yl)methyl-diphosphate:4-aminobenzoate 2-amino-4-hydroxydihydropteridine-6-methenyltransferase inhibitors
2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine-diphosphate:4-aminobenzoate 2-amino-4-hydroxydihydropteridine-6-methenyltransferase inhibitor
2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine-diphosphate:4-aminobenzoate 2-amino-4-hydroxydihydropteridine-6-methenyltransferase inhibitors
7,8-dihydropteroate synthase inhibitor
7,8-dihydropteroate synthase inhibitors
7,8-dihydropteroate synthetase inhibitor
7,8-dihydropteroate synthetase inhibitors
7,8-dihydropteroic acid synthetase inhibitor
7,8-dihydropteroic acid synthetase inhibitors
DHPS inhibitor
DHPS inhibitors
EC 2.5.1.15 (dihydropteroate synthase) inhibitors
EC 2.5.1.15 inhibitor
EC 2.5.1.15 inhibitors
dihydropteroate diphosphorylase inhibitor
dihydropteroate diphosphorylase inhibitors
dihydropteroate pyrophosphorylase inhibitor
dihydropteroate pyrophosphorylase inhibitors
dihydropteroate synthase (EC 2.5.1.15) inhibitor
dihydropteroate synthase (EC 2.5.1.15) inhibitors
dihydropteroate synthase inhibitor
dihydropteroate synthase inhibitors
dihydropteroate synthetase inhibitor
dihydropteroate synthetase inhibitors
dihydropteroic synthetase inhibitor
dihydropteroic synthetase inhibitors
EC 2.5.1.15 (dihydropteroate synthase) inhibitor
laxative
aperient
aperients
laxante
laxatives
purgative
purgatives
laxative
osmotic diuretic
osmotic diuretic
sweetening agent
sweetener
sweeteners
sweetening agent
appetite depressant
appetite depressant
potassium channel blocker
potassium channel blocker
potassium channel modulator
potassium channel modulator
mydriatic agent
mydriatics
mydriatic agent
vasoconstrictor agent
vasoconstrictor agent
protein denaturant
protein denaturant
nitric oxide donor
NO donor
NO donors
NO generator
NO generators
NO releasing agent
NO releasing agents
nitric oxide donors
nitric oxide generators
nitric oxide releasing agent
nitric oxide releasing agents
nitric oxide donor
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor
3',5'-cyclic nucleoside monophosphate phosphodiesterase inhibitor
3',5'-cyclic nucleoside monophosphate phosphodiesterase inhibitors
3',5'-cyclic-nucleotide 5'-nucleotidohydrolase inhibitor
3',5'-cyclic-nucleotide 5'-nucleotidohydrolase inhibitors
3',5'-cyclic-nucleotide phosphodiesterase inhibitor
3',5'-cyclic-nucleotide phosphodiesterase inhibitors
3',5'-cyclonucleotide phosphodiesterase inhibitor
3',5'-cyclonucleotide phosphodiesterase inhibitors
3',5'-nucleotide phosphodiesterase inhibitor
3',5'-nucleotide phosphodiesterase inhibitors
3': 5'-monophosphate phosphodiesterase (cyclic CMP) inhibitor
3': 5'-monophosphate phosphodiesterase (cyclic CMP) inhibitors
3':5'-cyclic nucleotide 5'-nucleotidohydrolase inhibitor
3':5'-cyclic nucleotide 5'-nucleotidohydrolase inhibitors
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitors
EC 3.1.4.17 inhibitor
EC 3.1.4.17 inhibitors
PDE inhibitor
PDE inhibitors
cyclic 3',5'-mononucleotide phosphodiesterase inhibitor
cyclic 3',5'-mononucleotide phosphodiesterase inhibitors
cyclic 3',5'-nucleotide phosphodiesterase inhibitor
cyclic 3',5'-nucleotide phosphodiesterase inhibitors
cyclic 3',5'-phosphodiesterase inhibitor
cyclic 3',5'-phosphodiesterase inhibitors
cyclic 3',5-nucleotide monophosphate phosphodiesterase inhibitor
cyclic 3',5-nucleotide monophosphate phosphodiesterase inhibitors
cyclic AMP phosphodiesterase inhibitor
cyclic AMP phosphodiesterase inhibitors
cyclic nucleotide phosphodiesterase inhibitor
cyclic nucleotide phosphodiesterase inhibitors
cytidine 3':5'-monophosphate phosphodiesterase (cyclic CMP) inhibitor
cytidine 3':5'-monophosphate phosphodiesterase (cyclic CMP) inhibitors
nucleoside 3',5'-cyclic phosphate diesterase inhibitor
nucleoside 3',5'-cyclic phosphate diesterase inhibitors
nucleoside-3',5-monophosphate phosphodiesterase inhibitor
nucleoside-3',5-monophosphate phosphodiesterase inhibitors
phosphodiesterase III inhibitor
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor
EC 3.2.1.1 (alpha-amylase) inhibitor
1,4-alpha-D-glucan glucanohydrolase inhibitor
1,4-alpha-D-glucan glucanohydrolase inhibitors
4-alpha-D-glucan glucanohydrolase inhibitor
4-alpha-D-glucan glucanohydrolase inhibitors
EC 3.2.1.1 (alpha-amylase) inhibitors
EC 3.2.1.1 inhibitor
EC 3.2.1.1 inhibitors
Taka-amylase A inhibitor
Taka-amylase A inhibitors
alpha-amylase (EC 3.2.1.1) inhibitor
alpha-amylase (EC 3.2.1.1) inhibitors
alpha-amylase inhibitor
alpha-amylase inhibitors
endoamylase inhibitor
endoamylase inhibitors
glycogenase inhibitor
glycogenase inhibitors
EC 3.2.1.1 (alpha-amylase) inhibitor
cyclooxygenase 2 inhibitor
COX-2 inhibitor
COX-2 inhibitors
PGHS-2 inhibitor
PGHS-2 inhibitors
cyclo-oxygenase 2 inhibitor
cyclo-oxygenase 2 inhibitors
cyclo-oxygenase-2 inhibitor
cyclo-oxygenase-2 inhibitors
cyclooxygenase 2 inhibitors
cyclooxygenase-2 inhibitor
cyclooxygenase-2 inhibitors
prostaglandin H synthase-2 inhibitor
prostaglandin H synthase-2 inhibitors
prostaglandin-endoperoxide synthase 2 inhibitor
prostaglandin-endoperoxide synthase 2 inhibitors
cyclooxygenase 2 inhibitor
cyclooxygenase 1 inhibitor
COX-1 inhibitor
COX-1 inhibitors
PTGS1 inhibitor
PTGS1 inhibitors
cyclo-oxygenase 1 inhibitor
cyclo-oxygenase 1 inhibitors
cyclooxygenase 1 inhibitors
cyclooxygenase-1 inhibitor
cyclooxygenase-1 inhibitors
prostaglandin G/H synthase 1 inhibitor
prostaglandin G/H synthase 1 inhibitors
prostaglandin H2 synthase 1 inhibitor
prostaglandin H2 synthase 1 inhibitors
prostaglandin-endoperoxide synthase 1 inhibitor
prostaglandin-endoperoxide synthase 1 inhibitors
cyclooxygenase 1 inhibitor
EC 3.5.1.5 (urease) inhibitor
EC 3.5.1.5 (urease) inhibitors
EC 3.5.1.5 inhibitor
EC 3.5.1.5 inhibitors
urea amidohydrolase inhibitor
urea amidohydrolase inhibitors
urease (EC 3.5.1.5) inhibitor
urease (EC 3.5.1.5) inhibitors
urease inhibitor
urease inhibitors
EC 3.5.1.5 (urease) inhibitor
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
(2E,6E)-farnesyl diphosphate synthetase inhibitor
(2E,6E)-farnesyl diphosphate synthetase inhibitors
DMAPP:IPP-dimethylallyltransferase inhibitor
DMAPP:IPP-dimethylallyltransferase inhibitors
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitors
EC 2.5.1.1 inhibitor
EC 2.5.1.1 inhibitors
dimethylallyl-diphosphate:isopentenyl-diphosphate dimethylallyltranstransferase inhibitor
dimethylallyl-diphosphate:isopentenyl-diphosphate dimethylallyltranstransferase inhibitors
dimethylallyltransferase inhibitor
dimethylallyltransferase inhibitors
dimethylallyltranstransferase (EC 2.5.1.1) inhibitor
dimethylallyltranstransferase (EC 2.5.1.1) inhibitors
dimethylallyltranstransferase inhibitor
dimethylallyltranstransferase inhibitors
diprenyltransferase inhibitor
diprenyltransferase inhibitors
geranyl pyrophosphate synthase inhibitor
geranyl pyrophosphate synthase inhibitors
geranyl pyrophosphate synthetase inhibitor
geranyl pyrophosphate synthetase inhibitors
geranyl-diphosphate synthase inhibitor
geranyl-diphosphate synthase inhibitors
prenyltransferase inhibitor
prenyltransferase inhibitors
trans-farnesyl pyrophosphate synthetase inhibitor
trans-farnesyl pyrophosphate synthetase inhibitors
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
bone density conservation agent
anti-osteopenia agent
anti-osteopenia agents
anti-osteopenia drug
anti-osteopenia drugs
anti-osteoporosis agent
anti-osteoporosis agents
anti-osteoporosis drug
anti-osteoporosis drugs
anti-osteoporotic
anti-osteoporotic agent
anti-osteoporotic agents
anti-osteoporotic drug
anti-osteoporotic drugs
anti-osteoporotics
antiosteoporotic
antiosteoporotics
bone density conservation agents
bone density conservation drug
bone density conservation drugs
bone density conservation agent
matrix metalloproteinase inhibitor
MMPI
matrix metalloproteinase inhibitors
matrix metalloproteinase inhibitor
antithyroid drug
antithyroid agent
antithyroid agents
antithyroid drugs
antithyroid drug
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
7,8-dihydrofolate reductase inhibitor
7,8-dihydrofolate reductase inhibitors
DHFR inhibitor
DHFR inhibitors
EC 1.5.1.3 (dihydrofolate reductase) inhibitors
EC 1.5.1.3 inhibitor
EC 1.5.1.3 inhibitors
NADPH-dihydrofolate reductase inhibitor
NADPH-dihydrofolate reductase inhibitors
dihydrofolate reductase (EC 1.5.1.3) inhibitor
dihydrofolate reductase (EC 1.5.1.3) inhibitors
dihydrofolate reductase inhibitor
dihydrofolate reductase inhibitors
dihydrofolic acid reductase inhibitor
dihydrofolic acid reductase inhibitors
dihydrofolic reductase inhibitor
dihydrofolic reductase inhibitors
folic acid reductase inhibitor
folic acid reductase inhibitors
folic reductase inhibitor
folic reductase inhibitors
tetrahydrofolate dehydrogenase inhibitor
tetrahydrofolate dehydrogenase inhibitors
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
cross-linking reagent
cross-linking reagents
cross-linking reagent
antitrichomonal drug
antitrichomonal agent
antitrichomonal drug
reproductive control drug
reproductive control agent
reproductive control drugs
reproductive control drug
abortifacient
abortifacient agent
abortifacient agents
abortifacient drug
abortifacient drugs
abortifacients
abortifacient
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitors
EC 2.4.1.129 inhibitor
EC 2.4.1.129 inhibitors
PBP3 inhibitor
PG-II inhibitor
PG-II inhibitors
[poly-N-acetyl-D-glucosaminyl-(1->4)-(N-acetyl-D-muramoylpentapeptide)]-diphosphoundecaprenol:[N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide]-diphosphoundecaprenol disaccharidetransferase inhibitor
[poly-N-acetyl-D-glucosaminyl-(1->4)-(N-acetyl-D-muramoylpentapeptide)]-diphosphoundecaprenol:[N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide]-diphosphoundecaprenol disaccharidetransferase inhibitors
bactoprenyldiphospho-N-acetylmuramoyl-(N-acetyl-D-glucosaminyl)-pentapeptide:peptidoglycan N-acetylmuramoyl-N-acetyl-D-glucosaminyltransferase inhibitor
bactoprenyldiphospho-N-acetylmuramoyl-(N-acetyl-D-glucosaminyl)-pentapeptide:peptidoglycan N-acetylmuramoyl-N-acetyl-D-glucosaminyltransferase inhibitors
penicillin binding protein 1B inhibitor
penicillin binding protein 1B inhibitors
penicillin binding protein 3 inhibitor
penicillin binding protein 3 inhibitors
peptidoglycan glycosyltransferase (EC 2.4.1.129) inhibitor
peptidoglycan glycosyltransferase (EC 2.4.1.129) inhibitors
peptidoglycan glycosyltransferase inhibitor
peptidoglycan glycosyltransferase inhibitors
peptidoglycan transglycosylase inhibitor
peptidoglycan transglycosylase inhibitors
undecaprenyldiphospho-(N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide):undecaprenyldiphospho-(N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide) disaccharidetransferase inhibitor
undecaprenyldiphospho-(N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide):undecaprenyldiphospho-(N-acetyl-D-glucosaminyl-(1->4)-N-acetyl-D-muramoylpentapeptide) disaccharidetransferase inhibitors
EC 2.4.1.129 (peptidoglycan glycosyltransferase) inhibitor
montelukast
(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
MONTELUKAST
Montelukast
montelukast
{1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
montelukast
nutraceutical
Dietary Supplement
Food Supplementation
Nutritional supplement
nutraceutical
estrogen receptor modulator
estrogen receptor modulator
retinoic acid receptor alpha/beta agonist
RAR alpha/beta agonist
retinoic acid receptor alpha/beta agonist
progestogen
gestagen
gestagens
progestagen
progestagens
progestogens
progestogen
antipsoriatic
antipsoriatic agent
antipsoriatic drug
antipsoriatic
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
DNA gyrase inhibitor
DNA gyrase inhibitors
DNA topoisomerase (ATP-hydrolysing) (EC 5.99.1.3) inhibitor
DNA topoisomerase (ATP-hydrolysing) (EC 5.99.1.3) inhibitors
DNA topoisomerase (ATP-hydrolysing) inhibitor
DNA topoisomerase (ATP-hydrolysing) inhibitors
DNA topoisomerase II inhibitor
DNA topoisomerase II inhibitors
EC 5.99.1.3 (DNA topoisomerase (ATP-hydrolysing)) inhibitor
EC 5.99.1.3 (DNA topoisomerase (ATP-hydrolysing)) inhibitors
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitors
EC 5.99.1.3 inhibitor
EC 5.99.1.3 inhibitors
inhibitor of type II topoisomerase
inhibitors of type II topoisomerase
topoisomerase II inhibitor
topoisomerase II inhibitors
topoisomerase-II inhibitor
topoisomerase-II inhibitors
type II DNA topoisomerase inhibitor
type II DNA topoisomerase inhibitors
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
anti-estrogen
anti-estrogenic agent
anti-estrogenic drug
anti-oestrogen
anti-oestrogenic agent
anti-oestrogenic drug
antiestrogen
antiestrogenic agent
antiestrogenic drug
antioestrogen
antioestrogenic agent
antioestrogenic drug
anti-estrogen
appetite enhancer
appetite enhancing drug
appetite stimulant
orexigenic
appetite enhancer
appetite regulator
appetite regulators
appetite regulator
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) (EC 1.3.1.22) inhibitor
3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) (EC 1.3.1.22) inhibitors
3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) inhibitor
3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+)) inhibitors
3-oxo-5alpha-steroid 4-dehydrogenase inhibitor
3-oxo-5alpha-steroid 4-dehydrogenase inhibitors
3-oxo-5alpha-steroid:NADP+ Delta(4)-oxidoreductase inhibitor
3-oxo-5alpha-steroid:NADP+ Delta(4)-oxidoreductase inhibitors
3-oxosteroid 5alpha-reductase inhibitor
3-oxosteroid Delta4-dehydrogenase inhibitor
4-ene-3-oxosteroid 5alpha-reductase inhibitor
4-ene-5alpha-reductase inhibitor
5alpha-oxidoreductase inhibitor
5alpha-oxidoreductase inhibitors
5alpha-reductase inhibitor
5alpha-reductase inhibitors
Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitor
Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitors
EC 1.3.1.22 (3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))) inhibitor
EC 1.3.1.22 (3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))) inhibitors
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitors
EC 1.3.1.22 inhibitor
EC 1.3.1.22 inhibitors
cholest-4-en-3-one 5alpha-reductase inhibitor
cholestenone 5alpha-reductase inhibitor
cholestenone 5alpha-reductase inhibitors
reduced nicotinamide adenine dinucleotide phosphate:Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitor
reduced nicotinamide adenine dinucleotide phosphate:Delta(4)-3-ketosteroid 5alpha-oxidoreductase inhibitors
steroid 5alpha-hydrogenase inhibitor
steroid 5alpha-hydrogenase inhibitors
steroid 5alpha-reductase inhibitor
steroid 5alpha-reductase inhibitors
testosterone 5alpha-reductase inhibitor
testosterone 5alpha-reductase inhibitors
testosterone Delta(4)-5alpha-reductase inhibitor
testosterone Delta(4)-5alpha-reductase inhibitors
testosterone Delta(4)-hydrogenase inhibitor
testosterone Delta(4)-hydrogenase inhibitors
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor
3beta (or 20alpha)-hydroxysteroid dehydrogenase inhibitor
3beta (or 20alpha)-hydroxysteroid dehydrogenase inhibitors
3beta(or 20alpha)-hydroxysteroid dehydrogenase (EC 1.1.1.210) inhibitor
3beta(or 20alpha)-hydroxysteroid dehydrogenase (EC 1.1.1.210) inhibitors
3beta(or 20alpha)-hydroxysteroid dehydrogenase inhibitor
3beta(or 20alpha)-hydroxysteroid dehydrogenase inhibitors
3beta(or 20alpha)-hydroxysteroid:NADP(+) oxidoreductase inhibitor
3beta(or 20alpha)-hydroxysteroid:NADP(+) oxidoreductase inhibitors
3beta,20alpha-hydroxysteroid oxidoreductase inhibitor
3beta,20alpha-hydroxysteroid oxidoreductase inhibitors
3beta-HSD
3beta-hydroxysteroid dehydrogenase
3beta-hydroxysteroid dehydrogenase inhibitor
EC 1.1.1.210 (3beta(or 20alpha)-hydroxysteroid dehydrogenase) inhibitor
EC 1.1.1.210 (3beta(or 20alpha)-hydroxysteroid dehydrogenase) inhibitors
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitors
EC 1.1.1.210 inhibitor
EC 1.1.1.210 inhibitors
dehydrogenase, 3beta,20alpha-hydroxy steroid inhibitor
dehydrogenase, 3beta,20alpha-hydroxy steroid inhibitors
progesterone reductase inhibitor
progesterone reductase inhibitors
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor
EC 1.14.14.14 (aromatase) inhibitor
EC 1.14.14.14 (aromatase) inhibitors
EC 1.14.14.14 inhibitor
EC 1.14.14.14 inhibitors
aromatase (EC 1.14.14.14) inhibitor
aromatase (EC 1.14.14.14) inhibitors
aromatase inhibitor
aromatase inhibitors
estrogen synthase inhibitor
estrogen synthase inhibitors
estrogen synthetase inhibitor
estrogen synthetase inhibitors
oestrogen synthase inhibitor
oestrogen synthase inhibitors
oestrogen synthetase inhibitor
oestrogen synthetase inhibitors
EC 1.14.14.14 (aromatase) inhibitor
estrogen receptor antagonist
estrogen receptor antagonists
estrogen receptor antagonist
antiparathyroid drug
antiparathyroid agent
antiparathyroid agents
antiparathyroid drugs
antiparathyroid drug
estrogen antagonist
oestrogen antagonist
estrogen antagonist
antimineralocorticoid
antimineralocorticoid
aldosterone antagonist
aldosterone antagonist
immunomodulator
Biomodulator
Immune factor
Immunologic factor
Immunological factor
immunomodulators
immunomodulator
immunological adjuvant
Immunoactivator
Immunoadjuvant
Immunologic adjuvant
Immunopotentiator
Immunostimulant
immunological adjuvant
antiatherogenic agent
anti-atherogenic agent
anti-atherogenic agents
anti-atherogenic drug
anti-atherogenic drugs
antiatherogenic agent
antiatherogenic agents
antiatherogenic drug
antiatherogenic drugs
antiatherogenic agent
anti-allergic agent
anti-allergic agents
anti-allergic drug
anti-allergic drugs
anti-allergic agent
insulin-sensitizing drug
PPAR-gamma agonist
PPAR-gamma agonists
PPARgamma agonist
PPARgamma agonists
glitazonas
glitazone drug
glitazones
insulin sensitisers
insulin sensitizers
insulin-sensitising drug
insulin-sensitizing agent
peroxisome proliferator-activated receptor gamma agonist
peroxisome proliferator-activated receptor gamma agonists
proliferator activated receptor gamma agonist
proliferator activated receptor gamma agonists
thiazolidinediones
tiazolidinedionas
insulin-sensitizing drug
genotoxin
genotoxic agent
genotoxic agents
genotoxins
genotoxin
carcinogenic agent
agente carcinogeno
cancerigene
cancerogene
carcinogen
carcinogene
carcinogenic agents
carcinogeno
carcinogens
carcinogenic agent
allergen
alergeno
allergene
allergenic agent
allergen
teratogenic agent
agent teratogene
teratogen
teratogeno
teratogenic agent
deaminating agent
deaminating agent
hepatotoxic agent
agente hepatotoxico
hepatotoxic agents
hepatotoxicant
hepatotoxicants
hepatotoxin
hepatotoxins
hepatoxic agent
hepatoxicant
hepatotoxic agent
nephrotoxic agent
agente nefrotoxico
nephrotoxicant
nephrotoxic agent
neurotoxin
agente neurotoxico
nerve poison
nerve poisons
neurotoxic agent
neurotoxic agents
neurotoxicant
neurotoxins
neurotoxin
cardiotoxic agent
cardiotoxicant
cardiotoxic agent
fixative
fixating agent
fixating agents
fixation agent
fixative
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
1-phosphatidylinositol 3-kinase inhibitor
1-phosphatidylinositol 3-kinase inhibitors
ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase inhibitor
ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase inhibitors
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitors
EC 2.7.1.137 inhibitor
EC 2.7.1.137 inhibitors
PI(3)K inhibitor
PI(3)K inhibitors
PI-3 kinase inhibitor
PI-3 kinase inhibitors
PI3-kinase inhibitor
PI3-kinase inhibitors
PI3K inhibitor
PI3K inhibitors
PtdIns-3-kinase inhibitor
PtdIns-3-kinase inhibitors
Vps34p inhibitor
Vps34p inhibitors
phosphatidylinositol 3-kinase (EC 2.7.1.137) inhibitor
phosphatidylinositol 3-kinase (EC 2.7.1.137) inhibitors
phosphatidylinositol 3-kinase inhibitor
phosphatidylinositol 3-kinase inhibitors
phosphatidylinositol-3-OH kinase inhibitor
phosphatidylinositol-3-OH kinase inhibitors
phosphoinositide 3-kinase inhibitor
phosphoinositide 3-kinase inhibitors
type I phosphatidylinositol kinase inhibitor
type I phosphatidylinositol kinase inhibitors
type III phosphoinositide 3-kinase inhibitor
type III phosphoinositide 3-kinase inhibitors
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
lipid kinase inhibitor
lipid kinase inhibitors
lipid kinase inhibitor
antiemetic
anti-emetic
anti-emetics
antiemetico
antiemetics
antiemetic
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
A-kinase inhibitor
A-kinase inhibitors
AP50 kinase inhibitor
AP50 kinase inhibitors
ATP-protein transphosphorylase inhibitor
ATP-protein transphosphorylase inhibitors
ATP:protein phosphotransferase (non-specific) inhibitor
ATP:protein phosphotransferase (non-specific) inhibitors
BR serine/threonine-protein kinase 2 inhibitor
BR serine/threonine-protein kinase 2 inhibitors
CK-2 inhibitor
CK-2 inhibitors
CKI inhibitor
CKI inhibitors
CKII inhibitor
CKII inhibitors
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitors
EC 2.7.11.1 inhibitor
EC 2.7.11.1 inhibitors
HIPK2 inhibitor
HIPK2 inhibitors
Hpr kinase inhibitor
Hpr kinase inhibitors
M phase-specific cdc2 kinase inhibitor
M phase-specific cdc2 kinase inhibitors
MKNK2 inhibitor
MKNK2 inhibitors
PAK-1 inhibitor
PAK-1 inhibitors
PAK1 inhibitor
PAK1 inhibitors
PKA inhibitor
PKA inhibitors
Prp4 protein kinase inhibitor
Prp4 protein kinase inhibitors
Raf kinase inhibitor
Raf kinase inhibitors
Raf-1 inhibitor
Raf-1 inhibitors
STK32 inhibitor
STK32 inhibitors
T-antigen kinase inhibitor
T-antigen kinase inhibitors
WEE1Hu inhibitor
WEE1Hu inhibitors
Wee 1-like kinase inhibitor
Wee 1-like kinase inhibitors
Wee-kinase inhibitor
Wee-kinase inhibitors
betaIIPKC inhibitor
betaIIPKC inhibitors
cAMP-dependent protein kinase A inhibitor
cAMP-dependent protein kinase A inhibitors
cAMP-dependent protein kinase inhibitor
cAMP-dependent protein kinase inhibitors
cGMP-dependent protein kinase inhibitor
cGMP-dependent protein kinase inhibitors
calcium-dependent protein kinase C inhibitor
calcium-dependent protein kinase C inhibitors
calcium/phospholipid-dependent protein kinase inhibitor
calcium/phospholipid-dependent protein kinase inhibitors
casein kinase (phosphorylating) inhibitor
casein kinase (phosphorylating) inhibitors
casein kinase 2 inhibitor
casein kinase 2 inhibitors
casein kinase I inhibitor
casein kinase I inhibitors
casein kinase II inhibitor
casein kinase II inhibitors
casein kinase inhibitor
casein kinase inhibitors
cyclic AMP-dependent protein kinase A inhibitor
cyclic AMP-dependent protein kinase A inhibitors
cyclic AMP-dependent protein kinase inhibitor
cyclic AMP-dependent protein kinase inhibitors
cyclic monophosphate-dependent protein kinase inhibitor
cyclic monophosphate-dependent protein kinase inhibitors
cyclic nucleotide-dependent protein kinase inhibitor
cyclic nucleotide-dependent protein kinase inhibitors
cyclin-dependent kinase inhibitor
cyclin-dependent kinase inhibitors
dsk1 inhibitor
dsk1 inhibitors
epsilon PKC inhibitor
epsilon PKC inhibitors
glycogen synthase a kinase inhibitor
glycogen synthase a kinase inhibitors
glycogen synthase kinase inhibitor
glycogen synthase kinase inhibitors
hydroxyalkyl-protein kinase inhibitor
hydroxyalkyl-protein kinase inhibitors
mitogen-activated S6 kinase inhibitor
mitogen-activated S6 kinase inhibitors
non-specific serine/threonine protein kinase (EC 2.7.11.1) inhibitor
non-specific serine/threonine protein kinase (EC 2.7.11.1) inhibitors
non-specific serine/threonine protein kinase inhibitor
non-specific serine/threonine protein kinase inhibitors
p21 activated kinase-1 inhibitor
p21 activated kinase-1 inhibitors
p82 kinase inhibitor
p82 kinase inhibitors
phosphorylase b kinase kinase inhibitor
phosphorylase b kinase kinase inhibitors
protein glutamyl kinase inhibitor
protein glutamyl kinase inhibitors
protein kinase (phosphorylating) inhibitor
protein kinase (phosphorylating) inhibitors
protein kinase A inhibitor
protein kinase A inhibitors
protein kinase CK2 inhibitor
protein kinase CK2 inhibitors
protein kinase p58 inhibitor
protein kinase p58 inhibitors
protein phosphokinase inhibitor
protein phosphokinase inhibitors
protein serine kinase inhibitor
protein serine kinase inhibitors
protein serine-threonine kinase inhibitor
protein serine-threonine kinase inhibitors
protein-aspartyl kinase inhibitor
protein-aspartyl kinase inhibitors
protein-cysteine kinase inhibitor
protein-cysteine kinase inhibitors
protein-serine kinase inhibitor
protein-serine kinase inhibitors
protein-serine/threonine kinase inhibitors
ribosomal S6 protein kinase inhibitor
ribosomal S6 protein kinase inhibitors
ribosomal protein S6 kinase II inhibitor
ribosomal protein S6 kinase II inhibitors
serine kinase inhibitor
serine kinase inhibitors
serine protein kinase inhibitor
serine protein kinase inhibitors
serine(threonine) protein kinase inhibitor
serine(threonine) protein kinase inhibitors
serine-specific protein kinase inhibitor
serine-specific protein kinase inhibitors
serine/threonine protein kinase inhibitor
serine/threonine protein kinase inhibitors
threonine-specific protein kinase inhibitor
threonine-specific protein kinase inhibitors
twitchin kinase inhibitor
twitchin kinase inhibitors
type-2 casein kinase inhibitor
type-2 casein kinase inhibitors
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
angiogenesis modulating agent
angiogenesis modulating agent
serotonin uptake inhibitor
SSRI
serotonin reuptake inhibitor
serotonin uptake inhibitor
dopamine uptake inhibitor
DARI
DRI
dopamine reuptake inhibitor
dopamine reuptake inhibitors
dopamine uptake inhibitors
dopamine uptake inhibitor
hormone agonist
hormone agonist
hormone receptor modulator
hormone receptor modulators
hormone receptor modulator
dopamine agonist
Agonista dopaminergico
Dopamine receptor agonist
Dopaminergic agonist
dopamine agonist
miotic
Miotico
miotics
miotic
antifouling biocide
Antifoulant
Antifouling agent
Marine pesticide
antifouling biocide
chemical role
chemical role
protecting group
Schutzgruppe
Schutzgruppen
groupe protecteur
protective group
protecting group
fluorescent dye
fluorescent dyes
fluorescent dye
Wittig reagent
Wittig reagents
reactif de Wittig
reactivo de Wittig
reactivos de Wittig
Wittig reagent
antitussive
anti-tussive
cough suppressant
cough suppressants
antitussive
fluorochrome
fluorochromes
fluorochrome
Grignard reagent
Grignards Reagens
Grignard reagent
gelator
gelator
swelling agent
swelling agent
drying control chemical additive
drying control chemical additive
muscle relaxant
muscle relaxants
muscle relaxant
neuromuscular agent
neuromuscular agent
GABA agonist
GABA agonists
GABA receptor agonist
GABA receptor agonists
gamma-aminobutyric acid receptor agonist
gamma-aminobutyric acid receptor agonists
GABA agonist
GABA agent
GABA agent
endothelin receptor antagonist
ERA
endothelin receptor antagonist
endothelin A receptor antagonist
endothelin A receptor antagonist
partial prostacyclin agonist
partial prostacyclin agonist
biochemical role
biochemical role
biophysical role
biophysical role
aetiopathogenetic role
etiopathogenetic agent
etiopathogenetic role
aetiopathogenetic role
pharmacological role
pharmacological role
physiological role
physiological role
ligand
ligands
ligand
photochemical role
photochemical roles
photochemical role
photobiochemical role
photobiochemical role
pharmaceutical
farmaco
medicament
pharmaceuticals
pharmaceutical
squaraine dye
squaraine dye
mitogen
mitogens
mitogen
sterol methyltransferase inhibitor
sterol methyltransferase inhibitor
EC 3.2.1.* (glycosidase) inhibitor
EC 3.2.1.* (glycosidase) inhibitors
EC 3.2.1.* inhibitor
EC 3.2.1.* inhibitors
glycosidase (EC 3.2.1.*) inhibitor
glycosidase (EC 3.2.1.*) inhibitors
glycosidase inhibitor
glycosidase inhibitors
glycoside hydrolase inhibitors
EC 3.2.1.* (glycosidase) inhibitor
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
EC 3.2.1.18 (exo-alpha-sialidase) inhibitors
EC 3.2.1.18 inhibitor
EC 3.2.1.18 inhibitors
N-acylneuraminate glycohydrolase inhibitor
N-acylneuraminate glycohydrolase inhibitors
acetylneuraminidase inhibitor
acetylneuraminidase inhibitors
acetylneuraminyl hydrolase inhibitor
acetylneuraminyl hydrolase inhibitors
alpha-neuraminidase inhibitor
alpha-neuraminidase inhibitors
exo-alpha-sialidase (EC 3.2.1.18) inhibitor
exo-alpha-sialidase (EC 3.2.1.18) inhibitors
exo-alpha-sialidase inhibitor
exo-alpha-sialidase inhibitors
neuraminidase inhibitor
neuraminidase inhibitors
sialidase inhibitor
sialidase inhibitors
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
EC 3.1.26.13 (retroviral ribonuclease H) inhibitor
EC 3.1.26.13 (retroviral ribonuclease H) inhibitors
EC 3.1.26.13 inhibitor
EC 3.1.26.13 inhibitors
HIV RNase H inhibitor
HIV RNase H inhibitors
HIV-1 RNase H inhibitor
HIV-1 RNase H inhibitors
HIV-1 ribonuclease H inhibitor
HIV-1 ribonuclease H inhibitors
RT/RNase H inhibitor
RT/RNase H inhibitors
retroviral reverse transcriptase RNaseH inhibitor
retroviral reverse transcriptase RNaseH inhibitors
retroviral ribonuclease H (EC 3.1.26.13) inhibitor
retroviral ribonuclease H (EC 3.1.26.13) inhibitors
retroviral ribonuclease H inhibitor
EC 3.1.26.13 (retroviral ribonuclease H) inhibitor
proteasome inhibitor
proteasome inhibitors
proteasome inhibitor
phosphate protecting group
phosphate protecting groups
phosphate protecting group
carboxylic acid protecting group
carboxylic acid protecting groups
carboxylic acid protecting group
epitope
antigenic determinant
epitope function
epitope role
epitope
adenosine A2A receptor antagonist
adenosine A2A receptor antagonists
adenosine A2A receptor antagonist
P2Y2 receptor agonist
P2Y2 receptor agonists
P2Y2 receptor agonist
tissue adhesive
tissue adhesives
tissue adhesive
GHB receptor agonist
GHB receptor agonists
GHB receptor agonist
chain carrier
chain carriers
chain carrier
topoisomerase IV inhibitor
topoisomerase IV inhibitors
topoisomerase IV inhibitor
EC 1.4.3.22 (diamine oxidase) inhibitor
EC 1.4.3.22 (diamine oxidase) inhibitors
EC 1.4.3.22 inhibitor
EC 1.4.3.22 inhibitors
diamine oxidase (EC 1.4.3.22) inhibitor
diamine oxidase (EC 1.4.3.22) inhibitors
diamine oxidase inhibitor
diamine oxidase inhibitors
histaminase inhibitor
histaminase inhibitors
histamine:oxygen oxidoreductase (deaminating) inhibitor
histamine:oxygen oxidoreductase (deaminating) inhibitors
EC 1.4.3.22 (diamine oxidase) inhibitor
EC 1.1.1.205 (IMP dehydrogenase) inhibitor
EC 1.1.1.205 (IMP dehydrogenase) inhibitors
EC 1.1.1.205 inhibitor
EC 1.1.1.205 inhibitors
IMP dehydrogenase (EC 1.1.1.205) inhibitor
IMP dehydrogenase (EC 1.1.1.205) inhibitors
IMP dehydrogenase inhibitor
IMP dehydrogenase inhibitors
IMP oxidoreductase inhibitor
IMP oxidoreductase inhibitors
IMP:NAD(+) oxidoreductase inhibitor
IMP:NAD(+) oxidoreductase inhibitors
inosinate dehydrogenase inhibitor
inosinate dehydrogenase inhibitors
inosine 5'-monophosphate dehydrogenase inhibitors
inosine monophosphate dehydrogenase inhibitor
inosine monophosphate dehydrogenase inhibitors
inosine monophosphate oxidoreductase inhibitor
inosine monophosphate oxidoreductase inhibitors
inosinic acid dehydrogenase inhibitor
inosinic acid dehydrogenase inhibitors
EC 1.1.1.205 (IMP dehydrogenase) inhibitor
HIV-1 reverse transcriptase inhibitor
HIV-1 reverse transcriptase inhibitors
reverse transcriptase inhibitor
reverse transcriptase inhibitors
HIV-1 reverse transcriptase inhibitor
antispasmodic drug
antispasmodics
antispasmodic drug
mu-opioid receptor agonist
mu opioid agonist
mu-opioid agonists
mu-opioid receptor agonists
mu-opioid receptor agonist
antidiarrhoeal drug
antidiarrheal
antidiarrheal agent
antidiarrheal agents
antidiarrheal drug
antidiarrheal drugs
antidiarrheals
antidiarrhoeal
antidiarrhoeal agent
antidiarrhoeal agents
antidiarrhoeal drugs
antidiarrhoeals
antiperistaltic
antiperistaltic agent
antiperistaltic agents
antiperistaltic drug
antiperistaltic drugs
antiperistaltics
antidiarrhoeal drug
gastrointestinal drug
gastrointestinal agent
gastrointestinal agents
gastrointestinal drugs
gastrointestinal drug
vitamin K antagonist
vitamin K antagonists
vitamin K antagonist
neurokinin-1 receptor antagonist
NK-1 receptor antagonist
NK-1 receptor antagonists
NK1 receptor antagonist
NK1 receptor antagonists
neurokinin-1 receptor antagonists
neurokinin-1 receptor antagonist
substance P receptor antagonist
substance P receptor antagonists
substance P receptor antagonist
antiseborrheic
antiseborrheic agent
antiseborrheic agents
antiseborrheic drug
antiseborrheics
antiseborrheic
EC 6.3.2.* (acid--D-amino-acid ligase) inhibitor
EC 6.3.2.* (acid--D-amino-acid ligase (peptide synthase)) inhibitor
EC 6.3.2.* (acid--D-amino-acid ligase (peptide synthase)) inhibitors
EC 6.3.2.* (acid--D-amino-acid ligase) inhibitors
EC 6.3.2.* (acid--amino-acid ligase) inhibitor
EC 6.3.2.* (acid--amino-acid ligase) inhibitors
EC 6.3.2.* [acid--D-amino-acid ligase (peptide synthase)] inhibitor
EC 6.3.2.* [acid--D-amino-acid ligase (peptide synthase)] inhibitors
EC 6.3.2.* inhibitor
EC 6.3.2.* inhibitors
acid--amino-acid ligase inhibitor
acid--amino-acid ligase inhibitors
peptide synthase inhibitor
peptide synthase inhibitors
EC 6.3.2.* (acid--D-amino-acid ligase) inhibitor
EC 3.4.24.* (metalloendopeptidase) inhibitor
EC 3.4.24.* (metalloendopeptidase) inhibitors
EC 3.4.24.* inhibitor
EC 3.4.24.* inhibitors
inhibitor of metalloendopeptidases
inhibitor of metalloendopeptidases (EC 3.4.24.*)
inhibitors of metalloendopeptidases
inhibitors of metalloendopeptidases (EC 3.4.24.*)
metalloendopeptidase (EC 3.4.24.*) inhibitor
metalloendopeptidase (EC 3.4.24.*) inhibitors
metalloendopeptidase inhibitors
EC 3.4.24.* (metalloendopeptidase) inhibitor
antigen
antigens
antigen
biomarker
biological marker
biomarker
hapten
haptens
hapten
GnRH antagonist
GnRH antagonists
gonadotrophin-releasing hormone antagonist
gonadotrophin-releasing hormone antagonists
GnRH antagonist
EC 3.4.21.* (serine endopeptidase) inhibitor
EC 3.4.21.* (serine endopeptidase) inhibitors
EC 3.4.21.* inhibitor
EC 3.4.21.* inhibitors
inhibitor of serine endopeptidase (EC 3.4.21.*)
inhibitor of serine endopeptidase (EC 3.4.21.*)s
serine endopeptidase inhibitor
serine endopeptidase inhibitors
EC 3.4.21.* (serine endopeptidase) inhibitor
kappa-opioid receptor agonist
kappa-opioid agonist
kappa-opioid receptor agonists
kappa-opioid receptor agonist
delta-opioid receptor antagonist
delta-opioid antagonist
delta-opioid antagonists
delta-opioid receptor antagonist
EC 1.14.13.132 (squalene monooxygenase) inhibitor
EC 1.14.13.132 (squalene monooxygenase) inhibitors
squalene 2,3-oxidocyclase inhibitor
squalene 2,3-oxidocyclase inhibitors
squalene epoxidase inhibitor
squalene epoxidase inhibitors
squalene hydroxylase inhibitor
squalene hydroxylase inhibitors
squalene monooxygenase (EC 1.14.13.132) inhibitor
squalene monooxygenase (EC 1.14.13.132) inhibitors
squalene monooxygenase inhibitor
squalene monooxygenase inhibitors
squalene oxydocyclase inhibitor
squalene oxydocyclase inhibitors
squalene-2,3-epoxidase inhibitor
squalene-2,3-epoxidase inhibitors
squalene-2,3-epoxide cyclase inhibitor
squalene-2,3-epoxide cyclase inhibitors
EC 1.14.13.132 (squalene monooxygenase) inhibitor
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
5-hydroxytryptophan decarboxylase inhibitor
5-hydroxytryptophan decarboxylase inhibitors
DOPA decarboxylase inhibitor
DOPA decarboxylase inhibitors
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitors
EC 4.1.1.28 inhibitor
EC 4.1.1.28 inhibitors
L-DOPA decarboxylase inhibitor
L-DOPA decarboxylase inhibitors
aromatic amino acid decarboxylase inhibitor
aromatic amino acid decarboxylase inhibitors
aromatic-L-amino-acid decarboxylase (EC 4.1.1.28) inhibitor
aromatic-L-amino-acid decarboxylase (EC 4.1.1.28) inhibitors
aromatic-L-amino-acid decarboxylase inhibitor
aromatic-L-amino-acid decarboxylase inhibitors
hydroxytryptophan decarboxylase inhibitor
hydroxytryptophan decarboxylase inhibitors
tryptophan decarboxylase inhibitor
tryptophan decarboxylase inhibitors
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
EC 3.4.13.* (dipeptidase) inhibitor
EC 3.4.13.* (dipeptidase) inhibitors
EC 3.4.13.* inhibitor
EC 3.4.13.* inhibitors
dipeptidase inhibitor
dipeptidase inhibitors
EC 3.4.13.* (dipeptidase) inhibitor
DNA synthesis inhibitor
DNA synthesis inhibitors
DNA synthesis inhibitor
phosphoantigen
phosphoantigens
phosphoantigen
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
3-oxosphinganine synthetase inhibitor
3-oxosphinganine synthetase inhibitors
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitors
EC 2.3.1.50 inhibitor
EC 2.3.1.50 inhibitors
SPT inhibitor
SPT inhibitors
acyl-CoA:serine C-2 acyltransferase (decarboxylating) inhibitor
acyl-CoA:serine C-2 acyltransferase (decarboxylating) inhibitors
palmitoyl-CoA:L-serine C-palmitoyltransferase (decarboxylating) inhibitor
palmitoyl-CoA:L-serine C-palmitoyltransferase (decarboxylating) inhibitors
serine C-palmitoyltransferase (EC 2.3.1.50) inhibitor
serine C-palmitoyltransferase (EC 2.3.1.50) inhibitors
serine C-palmitoyltransferase inhibitor
serine C-palmitoyltransferase inhibitors
serine palmitoyltransferase inhibitor
serine palmitoyltransferase inhibitors
EC 2.3.1.50 (serine C-palmitoyltransferase) inhibitor
EC 2.4.1.16 (chitin synthase) inhibitor
EC 2.4.1.16 (chitin synthase) inhibitors
EC 2.4.1.16 inhibitor
EC 2.4.1.16 inhibitors
UDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyl-transferase inhibitor
UDP-N-acetyl-D-glucosamine:chitin 4-beta-N-acetylglucosaminyl-transferase inhibitors
chitin synthase (EC 2.4.1.16) inhibitor
chitin synthase (EC 2.4.1.16) inhibitors
chitin synthase inhibitor
chitin synthase inhibitors
chitin synthesis inhibitor
chitin synthesis inhibitors
chitin synthetase inhibitor
chitin synthetase inhibitors
chitin-UDP N-acetylglucosaminyltransferase inhibitor
chitin-UDP N-acetylglucosaminyltransferase inhibitors
chitin-UDP acetyl-glucosaminyl transferase inhibitor
chitin-UDP acetyl-glucosaminyl transferase inhibitors
chitin-uridine diphosphate acetylglucosaminyltransferase inhibitor
chitin-uridine diphosphate acetylglucosaminyltransferase inhibitors
trans-N-acetylglucosaminosylase inhibitor
trans-N-acetylglucosaminosylase inhibitors
EC 2.4.1.16 (chitin synthase) inhibitor
vasopressin receptor antagonist
antidiuretic hormone inhibitor
antidiuretic hormone inhibitors
arginine vasopressin receptor antagonist
arginine vasopressin receptor antagonists
argipressin receptor antagonist
argipressin receptor antagonists
vasopressin receptor antagonists
vasopressin receptor antagonist
antipruritic drug
anti-itching drug
anti-itching drugs
antipruritic agent
antipruritic agents
antipruritic drugs
antipruritic drug
vasopressin receptor agonist
antidiuretic hormone agonist
antidiuretic hormone agonists
arginine vasopressin receptor agonist
arginine vasopressin receptor agonists
argipressin receptor agonist
argipressin receptor agonists
vasopressin receptor agonists
vasopressin receptor agonist
electrophilic reagent
electrophile
electrophiles
electrophilic reagents
electrophilic reagent
nucleophilic reagent
nucleophile
nucleophiles
nucleophilic reagents
nucleophilic reagent
chromatographic reagent
derivatising reagents
derivatizing reagent
derivatizing reagents
chromatographic reagent
bolaamphiphile
alpha-omega-type surfactant
bolaamphiphiles
bolaform surfactant
bolaphile
bolaamphiphile
progestin
progestins
progestin
antihyperplasia drug
antihypergenesis drug
antihypergenesis drugs
antihyperplasia drugs
antihyperplastic
antihyperplasia drug
depigmentation drug
depigmentation agent
depigmentation agents
depigmentation drugs
depigmentor
depigmentors
depigmentation drug
HIV fusion inhibitor
HIV entry inhibitor
HIV entry inhibitors
HIV fusion inhibitors
HIV fusion inhibitor
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
DNA nucleotidyltransferase (RNA-directed) inhibitor
DNA nucleotidyltransferase (RNA-directed) inhibitors
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitors
EC 2.7.7.49 inhibitor
EC 2.7.7.49 inhibitors
RNA revertase inhibitor
RNA revertase inhibitors
RNA-dependent DNA polymerase inhibitor
RNA-dependent DNA polymerase inhibitors
RNA-dependent deoxyribonucleate nucleotidyltransferase inhibitor
RNA-dependent deoxyribonucleate nucleotidyltransferase inhibitors
RNA-directed DNA polymerase (EC 2.7.7.49) inhibitor
RNA-directed DNA polymerase (EC 2.7.7.49) inhibitors
RNA-directed DNA polymerase inhibitor
RNA-directed DNA polymerase inhibitors
RNA-instructed DNA polymerase inhibitor
RNA-instructed DNA polymerase inhibitors
RT inhibitor
RT inhibitors
deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed) inhibitor
deoxynucleoside-triphosphate:DNA deoxynucleotidyltransferase (RNA-directed) inhibitors
reverse transcriptase inhibitor
reverse transcriptase inhibitors
revertase inhibitor
revertase inhibitors
telomerase inhibitor
telomerase inhibitors
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
amphiphile
amphiphiles
amphiphile
EC 1.14.18.1 (tyrosinase) inhibitor
EC 1.14.18.1 (tyrosinase) inhibitors
EC 1.14.18.1 inhibitor
EC 1.14.18.1 inhibitors
L-tyrosine,L-dopa:oxygen oxidoreductase inhibitor
L-tyrosine,L-dopa:oxygen oxidoreductase inhibitors
NN-acetyl-6-hydroxytryptophan oxidase inhibitor
NN-acetyl-6-hydroxytryptophan oxidase inhibitors
O-diphenol:O2 oxidoreductase inhibitor
O-diphenol:O2 oxidoreductase inhibitors
cresolase inhibitor
cresolase inhibitors
monophenol dihydroxyphenylalanine:oxygen oxidoreductase inhibitor
monophenol dihydroxyphenylalanine:oxygen oxidoreductase inhibitors
monophenol monooxidase inhibitor
monophenol monooxidase inhibitors
monophenol monooxygenase inhibitor
monophenol monooxygenase inhibitors
monophenol oxidase inhibitor
monophenol oxidase inhibitors
monophenol, dihydroxy-L-phenylalanine oxygen oxidoreductase inhibitor
monophenol, dihydroxy-L-phenylalanine oxygen oxidoreductase inhibitors
monophenolase inhibitor
monophenolase inhibitors
phenol oxidase inhibitor
phenol oxidase inhibitors
phenolase inhibitor
phenolase inhibitors
tyrosinase (EC 1.14.18.1) inhibitor
tyrosinase (EC 1.14.18.1) inhibitors
tyrosinase inhibitor
tyrosinase inhibitors
tyrosine-dopa oxidase inhibitor
tyrosine-dopa oxidase inhibitors
EC 1.14.18.1 (tyrosinase) inhibitor
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
ATP phosphohydrolase (Ca(2+)-transporting) inhibitor
ATP phosphohydrolase (Ca(2+)-transporting) inhibitors
Ca(2+)-pumping ATPase inhibitor
Ca(2+)-pumping ATPase inhibitors
Ca(2+)-transporting ATPase (EC 3.6.3.8) inhibitor
Ca(2+)-transporting ATPase (EC 3.6.3.8) inhibitors
Ca(2+)-transporting ATPase inhibitor
Ca(2+)-transporting ATPase inhibitors
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitors
SERCA inhibitor
SERCA inhibitors
calcium pump inhibitor
calcium pump inhibitors
plasma membrane Ca-ATPase inhibitor
plasma membrane Ca-ATPase inhibitors
sarco(endo)plasmic reticulum Ca(2+)-ATPase inhibitor
sarco(endo)plasmic reticulum Ca(2+)-ATPase inhibitors
sarcoplasmic reticulum ATPase inhibitor
sarcoplasmic reticulum ATPase inhibitors
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
mimotope
antigenic determinant mimic
epitope mimic
mimeotope
mimeotope function
mimeotope role
mimetope
mimotope function
mimotope role
mimotope
EC 3.4.* (hydrolases acting on peptide bond) inhibitor
EC 3.4.* (hydrolase acting on peptide bond) inhibitor
EC 3.4.* (hydrolase acting on peptide bonds) inhibitors
EC 3.4.* (hydrolases acting on peptide bond) inhibitors
EC 3.4.* (peptidase) inhibitor
EC 3.4.* (peptidase) inhibitors
EC 3.4.* inhibitor
EC 3.4.* inhibitors
inhibitor of hydrolases acting on peptide bond (EC 3.4.*)
inhibitors of hydrolases acting on peptide bond (EC 3.4.*)
peptidase inhibitors
protease inhibitor
protease inhibitors
EC 3.4.* (hydrolases acting on peptide bond) inhibitor
EC 3.5.1.2 (glutaminase) inhibitor
EC 3.5.1.2 (glutaminase) inhibitors
EC 3.5.1.2 inhibitor
EC 3.5.1.2 inhibitors
L-glutaminase inhibitor
L-glutaminase inhibitors
L-glutamine amidohydrolase inhibitor
L-glutamine amidohydrolase inhibitors
glutaminase (EC 3.5.1.2) inhibitor
glutaminase (EC 3.5.1.2) inhibitors
glutaminase I inhibitor
glutaminase I inhibitors
glutaminase inhibitor
glutaminase inhibitors
glutamine aminohydrolase inhibitor
glutamine aminohydrolase inhibitors
EC 3.5.1.2 (glutaminase) inhibitor
thyroid hormone
thyroid hormones
thyroid hormone
phenoxy herbicide
phenoxy herbicides
phenoxy herbicide
opioid agent
opioid agents
opioid agent
mu-opioid agent
mu-opioid agents
mu-opioid agent
delta-opioid agent
delta-opioid agents
delta-opioid agent
kappa-opioid agent
kappa-opioid agents
kappa-opioid agent
opioid receptor antagonist
opiate antagonist
opiate antagonists
opioid antagonist
opioid antagonists
opioid receptor antagonists
opioid receptor antagonist
opioid receptor agonist
opiate agonist
opiate agonists
opioid agonist
opioid agonists
opioid receptor agonists
opioid receptor agonist
NMDA receptor antagonist
N-methyl-D-aspartate receptor antagonist
N-methyl-D-aspartate receptor antagonists
NMDA receptor antagonists
NMDAR antagonist
NMDAR antagonists
NMDA receptor antagonist
chiral reagent
chiral reagent
glucagon receptor antagonist
glucagon receptor antagonists
glucagon receptor antagonist
EC 4.2.1.20 (tryptophan synthase) inhibitor
EC 4.2.1.20 (tryptophan synthase) inhibitors
EC 4.2.1.20 inhibitor
EC 4.2.1.20 inhibitors
L-serine hydro-lyase (adding indoleglycerol-phosphate) inhibitor
L-serine hydro-lyase (adding indoleglycerol-phosphate) inhibitors
L-tryptophan synthetase inhibitor
L-tryptophan synthetase inhibitors
indoleglycerol phosphate aldolase inhibitor
indoleglycerol phosphate aldolase inhibitors
tryptophan desmolase inhibitor
tryptophan desmolase inhibitors
tryptophan synthase (EC 4.2.1.20) inhibitor
tryptophan synthase (EC 4.2.1.20) inhibitors
tryptophan synthase inhibitor
tryptophan synthase inhibitors
tryptophan synthetase inhibitor
tryptophan synthetase inhibitors
EC 4.2.1.20 (tryptophan synthase) inhibitor
affinity label
affinity labels
affinity label
excitatory amino acid antagonist
EAA receptor antagonist
EAA receptor antagonists
excitatory amino acid antagonists
excitatory amino acid receptor antagonist
excitatory amino acid receptor antagonists
excitatory amino acid antagonist
anaesthesia adjuvant
anaesthesia adjuvants
anaesthestic adjuvant
anaesthestic adjuvants
anaesthesia adjuvant
adjuvant
adjuvants
adjuvant
immunogen
immunogen
tubulin modulator
tubulin modulators
tubulin modulator
EC 2.5.1.9 (riboflavin synthase) inhibitor
6,7-dimethyl-8-(1-D-ribityl)lumazine:6,7-dimethyl-8-(1-D-ribityl)lumazine 2,3-butanediyltransferase inhibitor
6,7-dimethyl-8-(1-D-ribityl)lumazine:6,7-dimethyl-8-(1-D-ribityl)lumazine 2,3-butanediyltransferase inhibitors
EC 2.5.1.9 (riboflavin synthase) inhibitors
EC 2.5.1.9 inhibitor
EC 2.5.1.9 inhibitors
heavy riboflavin synthase inhibitor
heavy riboflavin synthase inhibitors
light riboflavin synthase inhibitor
light riboflavin synthase inhibitors
riboflavin synthase (EC 2.5.1.9) inhibitor
riboflavin synthase (EC 2.5.1.9) inhibitors
riboflavin synthase inhibitor
riboflavin synthase inhibitors
riboflavin synthetase inhibitor
riboflavin synthetase inhibitors
riboflavine synthase inhibitor
riboflavine synthase inhibitors
riboflavine synthetase inhibitor
riboflavine synthetase inhibitors
EC 2.5.1.9 (riboflavin synthase) inhibitor
nephrotoxin
nephrotoxins
nephrotoxin
angiotensin receptor antagonist
angiotensin receptor antagonists
angiotensin receptor antagonist
bile therapy drug
bile therapy agent
bile therapy agents
bile therapy drugs
bile therapy drug
EC 3.5.1.98 (histone deacetylase) inhibitor
EC 3.5.1.98 (histone deacetylase) inhibitors
EC 3.5.1.98 inhibitor
EC 3.5.1.98 inhibitors
HDAC inhibitor
HDAC inhibitors
HDACi
HDACis
HDI
HDIs
histone amidohydrolase inhibitor
histone amidohydrolase inhibitors
histone deacetylase (EC 3.5.1.98) inhibitor
histone deacetylase (EC 3.5.1.98) inhibitors
histone deacetylase inhibitor
histone deacetylase inhibitors
EC 3.5.1.98 (histone deacetylase) inhibitor
inositol phosphorylceramide synthase inhibitor
inositol phosphorylceramide synthase inhibitor
EC 1.14.13.39 (nitric oxide synthase) inhibitor
EC 1.14.13.39 (nitric oxide synthase) inhibitors
EC 1.14.13.39 inhibitor
EC 1.14.13.39 inhibitors
NADPH-diaphorase inhibitor
NADPH-diaphorase inhibitors
NO synthase inhibitor
NO synthase inhibitors
endothelium-derived relaxation factor-forming enzyme inhibitor
endothelium-derived relaxation factor-forming enzyme inhibitors
endothelium-derived relaxing factor synthase inhibitor
endothelium-derived relaxing factor synthase inhibitors
nitric oxide synthase (EC 1.14.13.39) inhibitor
nitric oxide synthase (EC 1.14.13.39) inhibitors
nitric oxide synthase inhibitor
nitric oxide synthase inhibitors
nitric oxide synthetase inhibitor
nitric oxide synthetase inhibitors
nitric-oxide synthetase inhibitor
nitric-oxide synthetase inhibitors
EC 1.14.13.39 (nitric oxide synthase) inhibitor
microtubule-stabilising agent
microtubule stabilising agent
microtubule stabilising role
microtubule stabilizing agent
microtubule stabilizing agents
microtubule stabilizing role
microtubule-stabilising agents
microtubule-stabilizing agent
microtubule-stabilising agent
microtubule-destabilising agent
microtubule destabilising agent
microtubule destabilising agents
microtubule destabilising role
microtubule destabilizing role
microtubule-destabilising agents
microtubule-destabilizing agent
microtubule-destabilizing agents
microtubule-destabilising agent
metabotropic glutamate receptor agonist
mGluRs agonist
metabotropic glutamate receptor agonists
metabotropic glutamate receptor agonist
acyl donor
acyl donor
EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor
EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitors
EC 1.4.7.1 inhibitor
EC 1.4.7.1 inhibitors
L-glutamate:ferredoxin oxidoreductase (transaminating) inhibitor
L-glutamate:ferredoxin oxidoreductase (transaminating) inhibitors
ferredoxin-dependent glutamate synthase inhibitor
ferredoxin-dependent glutamate synthase inhibitors
ferredoxin-glutamate synthase inhibitor
ferredoxin-glutamate synthase inhibitors
glutamate synthase (ferredoxin) (EC 1.4.7.1) inhibitor
glutamate synthase (ferredoxin) (EC 1.4.7.1) inhibitors
glutamate synthase (ferredoxin) inhibitor
glutamate synthase (ferredoxin) inhibitors
glutamate synthase (ferredoxin-dependent) inhibitor
glutamate synthase (ferredoxin-dependent) inhibitors
glutamate synthase inhibitor
glutamate synthase inhibitors
EC 1.4.7.1 [glutamate synthase (ferredoxin)] inhibitor
allelochemical
allelochemicals
allelochemical
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
AATK inhibitor
AATYK inhibitor
AATYK2 inhibitor
AATYK3 inhibitor
ACH inhibitor
ALK inhibitor
ALK inhibitors
ARK inhibitor
ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitor
ATP:[protein]-L-tyrosine O-phosphotransferase (receptor-type) inhibitors
AXL inhibitor
BRT inhibitor
Bek inhibitor
Bfgfr inhibitor
Bsk inhibitor
C-FMS inhibitor
CAK inhibitor
CCK4 inhibitor
CD115 inhibitor
CD135 inhibitor
CDw135 inhibitor
CFD1 inhibitor
CKIT inhibitor
CSF1R inhibitor
Cek1 inhibitor
Cek10 inhibitor
Cek11 inhibitor
Cek2 inhibitor
Cek3 inhibitor
Cek5 inhibitor
Cek6 inhibitor
Cek7 inhibitor
DAlk inhibitor
DDR1 inhibitor
DDR2 inhibitor
DKFZp434C1418 inhibitor
DRT inhibitor
DTK inhibitor
Dek inhibitor
Drosophila Eph kinase inhibitor
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitors
EC 2.7.10.1 inhibitor
EC 2.7.10.1 inhibitors
ECK inhibitor
EDDR1 inhibitor
EGFR inhibitor
EPH inhibitor
EPHA1 inhibitor
EPHA2 inhibitor
EPHA6 inhibitor
EPHA7 inhibitor
EPHA8 inhibitor
EPHB1 inhibitor
EPHB2 inhibitor
EPHB3 inhibitor
EPHB4 inhibitor
EPHT inhibitor
EPHT2 inhibitor
EPHT3 inhibitor
EPHX inhibitor
ERBB inhibitor
ERBB1 inhibitor
ERBB2 inhibitor
ERBB3 inhibitor
ERBB4 inhibitor
ERK inhibitor
Ebk inhibitor
Eek inhibitor
Ehk2 inhibitor
Ehk3 inhibitor
Elk inhibitor
EphB5 inhibitor
Eyk inhibitor
FGFR1 inhibitor
FGFR2 inhibitor
FGFR3 inhibitor
FGFR4 inhibitor
FLG inhibitor
FLK1 inhibitor
FLK2 inhibitor
FLT1 inhibitor
FLT2 inhibitor
FLT3 inhibitor
FLT4 inhibitor
FMS inhibitor
Fv2 inhibitor
HBGFR inhibitor
HEK11 inhibitor
HEK2 inhibitor
HEK3 inhibitor
HEK5 inhibitor
HEK6 inhibitor
HEP inhibitor
HER2 inhibitor
HER3 inhibitor
HER4 inhibitor
HGFR inhibitor
HSCR1 inhibitor
HTK inhibitor
IGF1R inhibitor
INSR inhibitor
INSRR inhibitor
IR inhibitor
IRR inhibitor
JTK12 inhibitor
JTK13 inhibitor
JTK14 inhibitor
JWS inhibitor
K-SAM inhibitor
KDR inhibitor
KGFR inhibitor
KIA0641 inhibitor
KIAA1079 inhibitor
KIAA1459 inhibitor
KIT inhibitor
KLG inhibitor
Kil inhibitor
Kin15 inhibitor
Kin16 inhibitor
LTK inhibitor
MCF3 inhibitor
MEN2A/B inhibitor
MER inhibitor
MERTK inhibitor
MEhk1 inhibitor
MST1R inhibitor
MTC1 inhibitor
MUSK inhibitor
Mdk1 inhibitor
Mdk2 inhibitor
Mdk5 inhibitor
Mep inhibitor
Mlk1 inhibitor
Mlk2 inhibitor
Mrk inhibitor
Myk1 inhibitor
N-SAM inhibitor
NEP inhibitor
NET inhibitor
NGL inhibitor
NOK inhibitor
NTRK1 inhibitor
NTRK2 inhibitor
NTRK3 inhibitor
NTRK4 inhibitor
NTRKR1 inhibitor
NTRKR2 inhibitor
NTRKR3 inhibitor
NYK inhibitor
Neu inhibitor
Nsk2 inhibitor
Nuk inhibitor
PCL inhibitor
PDGFR inhibitor
PDGFRA inhibitor
PDGFRB inhibitor
PHB6 inhibitor
PTK inhibitor
PTK3 inhibitor
PTK7 inhibitor
RET inhibitor
RON inhibitor
ROR1 inhibitor
ROR2 inhibitor
ROS1 inhibitor
RSE inhibitor
RTK inhibitor
RYK inhibitor
SEA inhibitor
SKY inhibitor
STK inhibitor
STK1 inhibitor
Sek2 inhibitor
Sek3 inhibitor
Sek4 inhibitor
Sfr inhibitor
TEK inhibitor
TIE inhibitor
TIE1 inhibitor
TIE2 inhibitor
TIF inhibitor
TKT inhibitor
TRK inhibitor
TRKA inhibitor
TRKB inhibitor
TRKC inhibitor
TRKE inhibitor
TYK1 inhibitor
TYRO10 inhibitor
TYRO3 inhibitor
TYRO7 inhibitor
Tyro11 inhibitor
Tyro5 inhibitor
Tyro6 inhibitor
UFO inhibitor
VEGFR1 inhibitor
VEGFR2 inhibitor
VEGFR3 inhibitor
Vik inhibitor
YK1 inhibitor
Yrk inhibitor
anaplastic lymphoma kinase inhibitor
anaplastic lymphoma kinase inhibitors
ephrin-B3 receptor tyrosine kinase inhibitor
insulin receptor protein-tyrosine kinase inhibitor
neurite outgrowth regulating kinase inhibitor
nork inhibitor
novel oncogene with kinase-domain inhibitor
receptor protein tyrosine kinase inhibitor
receptor protein-tyrosine kinase (EC 2.7.10.1) inhibitor
receptor protein-tyrosine kinase (EC 2.7.10.1) inhibitors
receptor protein-tyrosine kinase inhibitor
receptor protein-tyrosine kinase inhibitors
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
signalling molecule
signal molecule
signal molecules
signaling molecule
signaling molecules
signalling molecules
signalling molecule
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitors
EC 2.3.1.24 inhibitor
EC 2.3.1.24 inhibitors
acyl-CoA:sphingosine N-acyltransferase inhibitor
acyl-CoA:sphingosine N-acyltransferase inhibitors
ceramide synthase inhibitor
ceramide synthase inhibitors
ceramide synthetase inhibitor
ceramide synthetase inhibitors
sphingosine N-acyltransferase (EC 2.3.1.24) inhibitor
sphingosine N-acyltransferase (EC 2.3.1.24) inhibitors
sphingosine N-acyltransferase inhibitor
sphingosine N-acyltransferase inhibitors
sphingosine acyltransferase inhibitor
sphingosine acyltransferase inhibitors
EC 2.3.1.24 (sphingosine N-acyltransferase) inhibitor
EC 4.2.1.3 (aconitate hydratase) inhibitor
2-methylaconitate hydratase inhibitor
2-methylaconitate hydratase inhibitors
4.2.1.3 inhibitor
4.2.1.3 inhibitors
AcnB inhibitor
AcnB inhibitors
EC 4.2.1.3 (aconitate hydratase) inhibitors
aconitase inhibitor
aconitase inhibitors
aconitate hydratase (EC 4.2.1.3) inhibitor
aconitate hydratase (EC 4.2.1.3) inhibitors
aconitate hydratase inhibitor
aconitate hydratase inhibitors
cis-aconitase inhibitor
cis-aconitase inhibitors
citrate hydro-lyase inhibitor
citrate hydro-lyase inhibitors
citrate(isocitrate) hydro-lyase (cis-aconitate-forming) inhibitor
citrate(isocitrate) hydro-lyase (cis-aconitate-forming) inhibitors
citrate(isocitrate) hydro-lyase inhibitor
citrate(isocitrate) hydro-lyase inhibitors
EC 4.2.1.3 (aconitate hydratase) inhibitor
EC 3.11.1.3 (phosphonopyruvate hydrolase) inhibitor
EC 3.11.1.3 (phosphonopyruvate hydrolase) inhibitors
EC 3.11.1.3 inhibitor
EC 3.11.1.3 inhibitors
PPH inhibitor
PPH inhibitors
phosphonopyruvate hydrolase (EC 3.11.1.3) inhibitor
phosphonopyruvate hydrolase (EC 3.11.1.3) inhibitors
phosphonopyruvate hydrolase inhibitor
phosphonopyruvate hydrolase inhibitors
EC 3.11.1.3 (phosphonopyruvate hydrolase) inhibitor
glycine receptor antagonist
glycine receptor antagonists
glycine receptor antagonist
fuel additive
fuel additives
fuel enhancer
fuel additive
hepatoprotective agent
antihepatotoxic agent
hepatoprotective agents
hepatoprotector
hepatoprotective agent
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitors
EC 4.3.1.24 inhibitor
EC 4.3.1.24 inhibitors
L-phenylalanine ammonia-lyase (trans-cinnamate-forming) inhibitor
L-phenylalanine ammonia-lyase (trans-cinnamate-forming) inhibitors
L-phenylalanine ammonia-lyase inhibitor
L-phenylalanine ammonia-lyase inhibitors
PAL inhibitor
PAL inhibitors
Phe ammonia-lyase inhibitor
Phe ammonia-lyase inhibitors
phenylalanine ammonia-lyase (EC 4.3.1.24) inhibitor
phenylalanine ammonia-lyase (EC 4.3.1.24) inhibitors
phenylalanine ammonia-lyase inhibitor
phenylalanine ammonia-lyase inhibitors
phenylalanine ammonium-lyase inhibitor
phenylalanine ammonium-lyase inhibitors
phenylalanine deaminase inhibitor
phenylalanine deaminase inhibitors
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor
EC 1.2.3.1 (aldehyde oxidase) inhibitor
EC 1.2.3.1 (aldehyde oxidase) inhibitors
EC 1.2.3.1 inhibitor
EC 1.2.3.1 inhibitors
aldehyde oxidase (EC 1.2.3.1) inhibitor
aldehyde oxidase (EC 1.2.3.1) inhibitors
aldehyde oxidase inhibitor
aldehyde oxidase inhibitors
aldehyde:oxygen oxidoreductase inhibitor
aldehyde:oxygen oxidoreductase inhibitors
quinoline oxidase inhibitor
quinoline oxidase inhibitors
retinal oxidase inhibitor
retinal oxidase inhibitors
retinoic acid synthase inhibitor
retinoic acid synthase inhibitors
EC 1.2.3.1 (aldehyde oxidase) inhibitor
odorant receptor agonist
odorant receptor agonist
tankyrase inhibitor
tankyrase inhibitors
tankyrase inhibitor
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
ADP-ribosyltransferase (polymerising) inhibitor
ADP-ribosyltransferase (polymerising) inhibitors
ADP-ribosyltransferase (polymerizing) inhibitor
ADP-ribosyltransferase (polymerizing) inhibitors
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitors
EC 2.4.2.30 inhibitor
EC 2.4.2.30 inhibitors
NAD(+) ADP-ribosyltransferase (EC 2.4.2.30) inhibitor
NAD(+) ADP-ribosyltransferase (EC 2.4.2.30) inhibitors
NAD(+) ADP-ribosyltransferase inhibitor
NAD(+) ADP-ribosyltransferase inhibitors
NAD(+):poly(ADP-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitor
NAD(+):poly(ADP-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitors
NAD(+):poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitor
NAD(+):poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitors
PARP
PARPs
poly(ADP-ribose) polymerase inhibitor
poly(ADP-ribose) polymerase inhibitors
poly(ADP-ribose) synthase inhibitor
poly(ADP-ribose) synthase inhibitors
poly(ADP-ribose) synthetase inhibitor
poly(ADP-ribose) synthetase inhibitors
poly(adenosine diphosphate ribose) polymerase inhibitor
poly(adenosine diphosphate ribose) polymerase inhibitors
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
axin stabilizer
axin stabilizer
sialyltransferase inhibitor
sialyltransferase inhibitors
sialyltransferase inhibitor
emulsifier
emulgent
emulgents
emulsifiers
emulsifier
food emulsifier
food emulsifiers
food emulsifier
osteogenesis regulator
osteogenesis regulators
osteogenesis regulator
phase-transfer catalyst
PTC
phase transfer catalyst
phase transfer catalysts
phase-transfer catalysts
phase-transfer catalyst
crystallisation adjutant
crystallisation adjutants
crystallization adjutant
crystallization adjutants
crystallisation adjutant
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitors
EC 2.4.2.1 inhibitor
EC 2.4.2.1 inhibitors
PNPase inhibitor
PNPase inhibitors
PUNPI inhibitor
PUNPI inhibitors
PUNPII inhibitor
PUNPII inhibitors
inosine phosphorylase inhibitor
inosine phosphorylase inhibitors
inosine-guanosine phosphorylase inhibitor
inosine-guanosine phosphorylase inhibitors
nucleotide phosphatase inhibitor
nucleotide phosphatase inhibitors
purine deoxynucleoside phosphorylase inhibitor
purine deoxynucleoside phosphorylase inhibitors
purine deoxyribonucleoside phosphorylase inhibitor
purine deoxyribonucleoside phosphorylase inhibitors
purine nucleoside phosphorylase inhibitor
purine nucleoside phosphorylase inhibitors
purine ribonucleoside phosphorylase inhibitor
purine ribonucleoside phosphorylase inhibitors
purine-nucleoside phosphorylase (EC 2.4.2.1) inhibitor
purine-nucleoside phosphorylase (EC 2.4.2.1) inhibitors
purine-nucleoside phosphorylase inhibitor
purine-nucleoside phosphorylase inhibitors
purine-nucleoside:phosphate ribosyltransferase inhibitor
purine-nucleoside:phosphate ribosyltransferase inhibitors
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
sphingosine-1-phosphate receptor agonist
EDG receptor agonist
S1P receptor agonist
S1P receptor agonists
SIP agonist
SIP agonists
sphingosine 1-phosphate receptor agonist
sphingosine 1-phosphate receptor agonists
sphingosine-1-phosphate receptor agonists
sphingosine-1-phosphate receptor agonist
insulin release inhibitor
insulin release inhibitor
EC 1.1.3.13 (alcohol oxidase) inhibitor
EC 1.1.3.13 (alcohol oxidase) inhibitors
EC 1.1.3.13 inhibitor
EC 1.1.3.13 inhibitors
alcohol oxidase (EC 1.1.3.13) inhibitor
alcohol oxidase (EC 1.1.3.13) inhibitors
alcohol oxidase inhibitor
alcohol oxidase inhibitors
alcohol:oxygen oxidoreductase inhibitor
alcohol:oxygen oxidoreductase inhibitors
ethanol oxidase inhibitor
ethanol oxidase inhibitors
EC 1.1.3.13 (alcohol oxidase) inhibitor
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor
EC 4.2.1.22 (cystathionine beta-synthase) inhibitors
EC 4.2.1.22 inhibitor
EC 4.2.1.22 inhibitors
L-serine hydro-lyase (adding homocysteine) inhibitor
L-serine hydro-lyase (adding homocysteine) inhibitors
L-serine hydro-lyase (adding homocysteine; L-cystathionine-forming) inhibitor
L-serine hydro-lyase (adding homocysteine; L-cystathionine-forming) inhibitors
beta-thionase inhibitor
beta-thionase inhibitors
cystathionine beta-synthase (EC 4.2.1.22) inhibitor
cystathionine beta-synthase (EC 4.2.1.22) inhibitors
cystathionine beta-synthase inhibitor
cystathionine beta-synthase inhibitors
cystathionine-beta-synthase inhibitor
cystathionine-beta-synthase inhibitors
cysteine synthase inhibitor
cysteine synthase inhibitors
methylcysteine synthase inhibitor
methylcysteine synthase inhibitors
serine sulfhydrase inhibitor
serine sulfhydrase inhibitors
serine sulfhydrylase inhibitor
serine sulfhydrylase inhibitors
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor
EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor
CPT I (outer membrane carnitine palmitoyl transferase) inhibitor
CPT I (outer membrane carnitine palmitoyl transferase) inhibitors
CPT inhibitor
CPT inhibitors
CPT-A inhibitor
CPT-A inhibitors
CPT-B inhibitor
CPT-B inhibitors
CPTi inhibitor
CPTi inhibitors
CPTo inhibitor
CPTo inhibitors
CTP-1 inhibitor
CTP-1 inhibitors
EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitors
EC 2.3.1.21 inhibitor
EC 2.3.1.21 inhibitors
L-carnitine palmitoyltransferase inhibitor
L-carnitine palmitoyltransferase inhibitors
acylcarnitine transferase inhibitor
acylcarnitine transferase inhibitors
carnitine O-palmitoyltransferase (EC 2.3.1.21) inhibitor
carnitine O-palmitoyltransferase (EC 2.3.1.21) inhibitors
carnitine O-palmitoyltransferase inhibitor
carnitine O-palmitoyltransferase inhibitors
carnitine palmitoyltransferase II inhibitor
carnitine palmitoyltransferase II inhibitors
carnitine palmitoyltransferase inhibitor
carnitine palmitoyltransferase inhibitors
carnitine palmitoyltransferase-1 inhibitor
carnitine palmitoyltransferase-1 inhibitors
carnitine palmitoyltransferase-A inhibitor
carnitine palmitoyltransferase-A inhibitors
mitochondrial carnitine palmitoyltransferase-1 inhibitor
mitochondrial carnitine palmitoyltransferase-1 inhibitors
outer malonyl-CoA inhibitable carnitine palmitoyltransferase inhibitor
outer malonyl-CoA inhibitable carnitine palmitoyltransferase inhibitors
palmitoyl-CoA:L-carnitine O-palmitoyltransferase inhibitor
palmitoyl-CoA:L-carnitine O-palmitoyltransferase inhibitors
palmitoylcarnitine transferase inhibitor
palmitoylcarnitine transferase inhibitors
EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor
T-cell proliferation inhibitor
T-cell proliferation inhibitors
T-cell proliferation inhibitor
peptidomimetic
peptidomimetics
peptidomimetic
reducing agent
reducer
reducers
reducing agents
reductant
reductants
reducing agent
oxidising agent
oxidant
oxidants
oxidiser
oxidisers
oxidising agents
oxidizer
oxidizers
oxidizing agent
oxidizing agents
oxidising agent
sodium-dependent Pi-transporter inhibitor
NPC inhibitor
Na-Pi inhibitor
sodium-dependent inorganic phosphate cotransporter inhibitor
sodium-dependent inorganic phosphate transporter inhibitor
sodium-dependent Pi-transporter inhibitor
EC 3.1.3.1 (alkaline phosphatase) inhibitor
EC 3.1.3.1 (alkaline phosphatase) inhibitors
EC 3.1.3.1 inhibitor
EC 3.1.3.1 inhibitors
alkaline phenyl phosphatase inhibitor
alkaline phenyl phosphatase inhibitors
alkaline phosphatase (EC 3.1.3.1) inhibitor
alkaline phosphatase (EC 3.1.3.1) inhibitors
alkaline phosphatase inhibitor
alkaline phosphatase inhibitors
alkaline phosphohydrolase inhibitor
alkaline phosphohydrolase inhibitors
alkaline phosphomonoesterase inhibitor
alkaline phosphomonoesterase inhibitors
glycerophosphatase inhibitor
glycerophosphatase inhibitors
orthophosphoric-monoester phosphohydrolase (alkaline optimum) inhibitor
orthophosphoric-monoester phosphohydrolase (alkaline optimum) inhibitors
phosphate-monoester phosphohydrolase (alkaline optimum) inhibitor
phosphate-monoester phosphohydrolase (alkaline optimum) inhibitors
phosphomonoesterase inhibitor
phosphomonoesterase inhibitors
EC 3.1.3.1 (alkaline phosphatase) inhibitor
fibroblast growth factor receptor antagonist
FGFR inhibitor
FGFR inhibitors
fibroblast growth factor receptor antagonists
fibroblast growth factor receptor inhibitor
fibroblast growth factor receptor inhibitors
fibroblast growth factor receptor antagonist
explosive
explosive compound
explosive compounds
explosive material
explosives
explosives chemical
explosives chemicals
explosive
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitors
EC 3.6.3.9 inhibitor
EC 3.6.3.9 inhibitors
Na(+)/K(+)-ATPase inhibitor
Na(+)/K(+)-ATPase inhibitors
Na(+)/K(+)-pump inhibitor
Na(+)/K(+)-pump inhibitors
Na(+)/K(+)-transporting ATPase (EC 3.6.3.9) inhibitor
Na(+)/K(+)-transporting ATPase (EC 3.6.3.9) inhibitors
Na(+)/K(+)-transporting ATPase inhibitor
Na(+)/K(+)-transporting ATPase inhibitors
sodium pump inhibitor
sodium pump inhibitors
sodium-potassium adenosine triphosphatase inhibitor
sodium-potassium adenosine triphosphatase inhibitors
sodium-potassium pump inhibitor
sodium-potassium pump inhibitors
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
gonadotropin releasing hormone agonist
GnRH agonist
GnRH agonists
GnRH-A
gonadotrophin releasing hormone agonist
gonadotrophin releasing hormone agonists
gonadotropin releasing hormone agonists
gonadotropin releasing hormone agonist
glucocorticoid receptor agonist
glucocorticoid receptor agonists
glucocorticoid receptor agonist
chemokine receptor 5 antagonist
C-C chemokine receptor 5 antagonist
C-C chemokine receptor 5 antagonists
CCR-5 antagonist
CCR-5 antagonists
CCR5 antagonist
CCR5 antagonists
chemokine receptor 5 antagonists
chemokine receptor 5 antagonist
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
4-aminobutanoate:2-oxoglutarate aminotransferase inhibitor
4-aminobutanoate:2-oxoglutarate aminotransferase inhibitors
4-aminobutyrate aminotransferase inhibitor
4-aminobutyrate aminotransferase inhibitors
4-aminobutyrate transaminase inhibitor
4-aminobutyrate transaminase inhibitors
4-aminobutyrate--2-ketoglutarate aminotransferase inhibitor
4-aminobutyrate--2-ketoglutarate aminotransferase inhibitors
4-aminobutyrate--2-oxoglutarate aminotransferase inhibitor
4-aminobutyrate--2-oxoglutarate aminotransferase inhibitors
4-aminobutyrate--2-oxoglutarate transaminase (EC 2.6.1.19) inhibitor
4-aminobutyrate--2-oxoglutarate transaminase (EC 2.6.1.19) inhibitors
4-aminobutyrate--2-oxoglutarate transaminase inhibitor
4-aminobutyrate--2-oxoglutarate transaminase inhibitors
4-aminobutyrate-2-oxoglutarate transaminase inhibitor
4-aminobutyrate-2-oxoglutarate transaminase inhibitors
4-aminobutyric acid 2-ketoglutaric acid aminotransferase inhibitor
4-aminobutyric acid 2-ketoglutaric acid aminotransferase inhibitors
4-aminobutyric acid aminotransferase inhibitor
4-aminobutyric acid aminotransferase inhibitors
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitors
EC 2.6.1.19 inhibitor
EC 2.6.1.19 inhibitors
GABA aminotransferase inhibitor
GABA aminotransferase inhibitors
GABA transaminase inhibitor
GABA transaminase inhibitors
GABA transferase inhibitor
GABA transferase inhibitors
GABA--2-oxoglutarate aminotransferase inhibitor
GABA--2-oxoglutarate aminotransferase inhibitors
GABA--2-oxoglutarate transaminase inhibitor
GABA--2-oxoglutarate transaminase inhibitors
GABA--alpha-ketoglutarate aminotransferase inhibitors
GABA--alpha-ketoglutarate transaminase inhibitor
GABA--alpha-ketoglutarate transaminase inhibitors
GABA--alpha-ketoglutaric acid transaminase inhibitor
GABA--alpha-ketoglutaric acid transaminase inhibitors
GABA--alpha-oxoglutarate aminotransferase inhibitor
GABA--alpha-oxoglutarate aminotransferase inhibitors
GABA--oxoglutarate aminotransferase inhibitor
GABA--oxoglutarate aminotransferase inhibitors
GABA--oxoglutarate transaminase inhibitor
GABA--oxoglutarate transaminase inhibitors
GabT inhibitor
GabT inhibitors
aminobutyrate aminotransferase inhibitor
aminobutyrate aminotransferase inhibitors
aminobutyrate transaminase inhibitor
aminobutyrate transaminase inhibitors
beta-alanine aminotransferase inhibitor
beta-alanine aminotransferase inhibitors
beta-alanine--oxoglutarate aminotransferase inhibitor
beta-alanine--oxoglutarate aminotransferase inhibitors
beta-alanine--oxoglutarate transaminase inhibitor
beta-alanine--oxoglutarate transaminase inhibitors
gamma-amino-N-butyrate transaminase inhibitor
gamma-amino-N-butyrate transaminase inhibitors
gamma-aminobutyrate aminotransaminase inhibitor
gamma-aminobutyrate aminotransaminase inhibitors
gamma-aminobutyrate transaminase inhibitor
gamma-aminobutyrate transaminase inhibitors
gamma-aminobutyrate--alpha-ketoglutarate aminotransferase inhibitor
gamma-aminobutyrate--alpha-ketoglutarate aminotransferase inhibitors
gamma-aminobutyrate--alpha-ketoglutarate transaminase inhibitor
gamma-aminobutyrate--alpha-ketoglutarate transaminase inhibitors
gamma-aminobutyrate:alpha-oxoglutarate aminotransferase inhibitor
gamma-aminobutyrate:alpha-oxoglutarate aminotransferase inhibitors
gamma-aminobutyric acid aminotransferase inhibitor
gamma-aminobutyric acid aminotransferase inhibitors
gamma-aminobutyric acid pyruvate transaminase inhibitor
gamma-aminobutyric acid pyruvate transaminase inhibitors
gamma-aminobutyric acid transaminase inhibitor
gamma-aminobutyric acid transaminase inhibitors
gamma-aminobutyric acid--2-oxoglutarate transaminase inhibitor
gamma-aminobutyric acid--2-oxoglutarate transaminase inhibitors
gamma-aminobutyric acid--alpha-ketoglutarate transaminase inhibitor
gamma-aminobutyric acid--alpha-ketoglutarate transaminase inhibitors
gamma-aminobutyric acid--alpha-ketoglutaric acid aminotransferase inhibitor
gamma-aminobutyric acid--alpha-ketoglutaric acid aminotransferase inhibitors
gamma-aminobutyric transaminase inhibitor
gamma-aminobutyric transaminase inhibitors
glutamate--succinic semialdehyde transaminase inhibitor
glutamate--succinic semialdehyde transaminase inhibitors
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
EC 2.1.1.45 (thymidylate synthase) inhibitor
5,10-methylenetetrahydrofolate:dUMP C-methyltransferase inhibitor
5,10-methylenetetrahydrofolate:dUMP C-methyltransferase inhibitors
EC 2.1.1.45 (thymidylate synthase) inhibitors
EC 2.1.1.45 inhibitor
EC 2.1.1.45 inhibitors
TMP synthetase inhibitor
TMP synthetase inhibitors
dTMP synthase inhibitor
dTMP synthase inhibitors
methylenetetrahydrofolate:dUMP C-methyltransferase inhibitor
methylenetetrahydrofolate:dUMP C-methyltransferase inhibitors
thymidylate synthase inhibitor
thymidylate synthase inhibitors
thymidylate synthetase inhibitor
thymidylate synthetase inhibitors
EC 2.1.1.45 (thymidylate synthase) inhibitor
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor
10-formyltetrahydrofolate:5'-phosphoribosylglycinamide N-formyltransferase inhibitors
2-amino-N-ribosylacetamide 5'-phosphate transformylase inhibitor
5,10-methenyltetrahydrofolate:2-amino-N-ribosylacetamide ribonucleotide transformylase inhibitor
5,10-methenyltetrahydrofolate:2-amino-N-ribosylacetamide ribonucleotide transformylase inhibitors
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitors
EC 2.1.2.2 inhibitor
EC 2.1.2.2 inhibitors
GAR TFase inhibitor
GAR TFase inhibitors
GAR formyltransferase inhibitor
GAR formyltransferase inhibitors
GAR transformylase inhibitor
GAR transformylase inhibitors
glycinamide ribonucleotide formyltransferase inhibitor
glycinamide ribonucleotide formyltransferase inhibitors
glycinamide ribonucleotide transformylase inhibitor
glycinamide ribonucleotide transformylase inhibitors
phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) inhibitor
phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) inhibitors
phosphoribosylglycinamide formyltransferase inhibitor
phosphoribosylglycinamide formyltransferase inhibitors
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor
neuroprotective agent
neuroprotectant
neuroprotectants
neuroprotective agents
neuroprotective agent
retinoid X receptor agonist
retinoid X receptor agonists
retinoid X receptor agonist
film-forming compound
film-forming agent
film-forming agents
film-forming compounds
film-forming compound
sclerotherapy agent
sclerotherapy agents
sclerotherapy agent
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitors
EC 1.14.16.2 inhibitor
EC 1.14.16.2 inhibitors
L-tyrosine hydroxylase inhibitor
L-tyrosine hydroxylase inhibitors
L-tyrosine,tetrahydrobiopterin:oxygen oxidoreductase (3-hydroxylating) inhibitor
L-tyrosine,tetrahydrobiopterin:oxygen oxidoreductase (3-hydroxylating) inhibitors
tyrosine 3-hydroxylase inhibitor
tyrosine 3-hydroxylase inhibitors
tyrosine 3-monooxygenase (EC 1.14.16.2) inhibitor
tyrosine 3-monooxygenase (EC 1.14.16.2) inhibitors
tyrosine 3-monooxygenase inhibitor
tyrosine 3-monooxygenase inhibitors
tyrosine hydroxylase inhibitor
tyrosine hydroxylase inhibitors
EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor
alpha1B-adrenoceptor antagonist
alpha1B-adrenoceptor antagonists
alpha1B-adrenoceptor antagonist
estrogen receptor agonist
estrogen receptor agonists
estrogen receptor agonist
adenosine A1 receptor antagonist
adenosine A1 receptor antagonists
adenosine A1 receptor antagonist
cellulose synthesis inhibitor
cellulose biosynthesis inhibitor
cellulose biosynthesis inhibitors
cellulose synthesis inhibitors
cellulose synthesis inhibitor
Hsp90 inhibitor
Hsp90 inhibitors
heat shock protein 90 inhibitor
heat shock protein 90 inhibitors
Hsp90 inhibitor
metabotropic glutamate receptor antagonist
mGluR antagonist
mGluR antagonists
metabotropic glutamate receptor antagonists
metabotropic glutamate receptor antagonist
protein kinase C agonist
protein kinase C agonists
protein kinase C agonist
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitors
EC 3.5.1.99 inhibitor
EC 3.5.1.99 inhibitors
FAAH inhibitor
FAAH inhibitors
anandamide amidohydrolase inhibitor
anandamide amidohydrolase inhibitors
arachidonoylethanolamide amidohydrolase inhibitor
arachidonoylethanolamide amidohydrolase inhibitors
fatty acid amide hydrolase (EC 3.5.1.99) inhibitor
fatty acid amide hydrolase (EC 3.5.1.99) inhibitors
fatty acid amide hydrolase inhibitor
fatty acid amide hydrolase inhibitors
fatty acylamide amidohydrolase inhibitor
fatty acylamide amidohydrolase inhibitors
oleamide hydrolase inhibitor
oleamide hydrolase inhibitors
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor
food additive
food additives
food additive
food acidity regulator
acidity regulator
acidity regulators
food acidity regulators
pH control agent
pH control agents
food acidity regulator
delta-opioid receptor agonist
delta-opioid receptor agonist
incretin mimetic
incretin mimetics
incretin mimetic
AMPA receptor agonist
AMPA receptor agonists
AMPAR agonist
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor agonist
quisqualate receptor agonist
AMPA receptor agonist
protein kinase G agonist
protein kinase G agonists
protein kinase G agonist
protein kinase agonist
protein kinase agonists
protein kinase agonist
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
EC 2.5.1.58 (protein farnesyltransferase) inhibitors
EC 2.5.1.58 inhibitor
EC 2.5.1.58 inhibitors
FTase inhibitor
FTase inhibitors
farnesyl transferase inhibitor
farnesyl transferase inhibitors
farnesyl-diphosphate:protein-cysteine farnesyltransferase inhibitor
farnesyl-diphosphate:protein-cysteine farnesyltransferase inhibitors
farnesyltransferase inhibitor
farnesyltransferase inhibitors
protein farnesyltransferase (EC 2.5.1.58) inhibitor
protein farnesyltransferase (EC 2.5.1.58) inhibitors
protein farnesyltransferase inhibitor
protein farnesyltransferase inhibitors
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
cysteine protease inhibitor
cysteine protease inhibitors
cysteine proteinase inhibitor
cysteine proteinase inhibitors
cysteine protease inhibitor
H3-receptor agonist
H3-receptor agonists
histamine H3-receptor agonist
histamine H3-receptor agonists
H3-receptor agonist
H4-receptor agonist
H4-receptor agonists
H4-receptor agonist
H3-receptor antagonist
H3-receptor antagonists
histamine H3-receptor antagonist
histamine H3-receptor antagonists
H3-receptor antagonist
EC 2.7.8.15 (UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase) inhibitor
EC 2.7.8.15 (UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase) inhibitors
EC 2.7.8.15 inhibitor
EC 2.7.8.15 inhibitors
GlcNAc-1-P transferase inhibitor
GlcNAc-1-P transferase inhibitors
N-acetylglucosamine phosphotransferase inhibitor
N-acetylglucosamine transferase inhibitors
N-acetylglucosamine-1-phosphate transferase inhibitor
N-acetylglucosamine-1-phosphate transferase inhibitors
UDP-D-N-acetylglucosamine N-acetylglucosamine 1-phosphate transferase inhibitor
UDP-D-N-acetylglucosamine N-acetylglucosamine 1-phosphate transferase inhibitors
UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase inhibitor
UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate transferase inhibitors
UDP-N-acetyl-D-glucosamine:dolichol phosphate N-acetyl-D-glucosamine-1-phosphate transferase inhibitor
UDP-N-acetyl-D-glucosamine:dolichol phosphate N-acetyl-D-glucosamine-1-phosphate transferase inhibitors
UDP-N-acetyl-D-glucosamine:dolichyl-phosphate N-acetyl-D-glucosaminephosphotransferase inhibitor
UDP-N-acetyl-D-glucosamine:dolichyl-phosphate N-acetyl-D-glucosaminephosphotransferase inhibitors
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) inhibitor
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) inhibitors
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitor
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase inhibitors
UDP-acetylglucosamine--dolichol phosphate acetylglucosamine phosphotransferase inhibitor
UDP-acetylglucosamine--dolichol phosphate acetylglucosamine phosphotransferase inhibitors
UDP-acetylglucosamine--dolichol phosphate acetylglucosamine-1-phosphotransferase inhibitor
UDP-acetylglucosamine--dolichol phosphate acetylglucosamine-1-phosphotransferase inhibitors
chitobiosylpyrophosphoryldolichol synthase inhibitor
chitobiosylpyrophosphoryldolichol synthase inhibitors
dolichol phosphate N-acetylglucosamine-1-phosphotransferase inhibitor
dolichol phosphate N-acetylglucosamine-1-phosphotransferase inhibitors
uridine diphosphoacetylglucosamine--dolichyl phosphate acetylglucosamine-1-phosphotransferase inhibitor
uridine diphosphoacetylglucosamine--dolichyl phosphate acetylglucosamine-1-phosphotransferase inhibitors
EC 2.7.8.15 (UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase) inhibitor
reaction intermediate
chemical intermediate
reaction intermediate
K-ATP channel agonist
ATP-sensitive K(+) channel agonist
ATP-sensitive K(+) channel agonists
ATP-sensitive K+ channel agonist
ATP-sensitive K+ channel agonists
ATP-sensitive K+ channel opener
ATP-sensitive K+ channel openers
K(ATP) channel agonist
K(ATP) channel agonists
K-ATP channel agonists
K-ATP channel agonist
MALDI matrix material
'matrix-assisted laser desorption/ionization' matrix material
'matrix-assisted laser desorption/ionization' matrix materials
MALDI matrix materials
MALDI matrix solution
MALDI matrix solutions
MALDI matrix material
glutamate transporter activator
excitatory amino-acid transporter activator
excitatory amino-acid transporter activators
glutamate transporter activators
glutamate transporter activator
neurotransmitter transporter modulator
neurotransmitter transporter modulators
neurotransmitter transporter modulator
EC 3.4.22.38 (cathepsin K) inhibitor
EC 3.4.22.38 (cathepsin K) inhibitors
EC 3.4.22.38 inhibitor
EC 3.4.22.38 inhibitors
cathepsin K (EC 3.4.22.38) inhibitor
cathepsin K (EC 3.4.22.38) inhibitors
cathepsin K inhibitor
cathepsin K inhibitors
cathepsin O inhibitor
cathepsin O inhibitors
cathepsin O2 inhibitor
cathepsin O2 inhibitors
cathepsin X inhibitor
cathepsin X inhibitors
EC 3.4.22.38 (cathepsin K) inhibitor
EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitor
(2E,6E)-farnesyl-diphosphate:isopentenyl-diphosphate farnesyltranstransferase inhibitor
(2E,6E)-farnesyl-diphosphate:isopentenyl-diphosphate farnesyltranstransferase inhibitors
EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitors
EC 2.5.1.29 inhibitor
EC 2.5.1.29 inhibitors
GGPP synthase inhibitor
GGPP synthase inhibitors
farnesyltransferase inhibitor
farnesyltransferase inhibitors
geranylgeranyl diphosphate synthase (EC 2.5.1.29) inhibitor
geranylgeranyl diphosphate synthase (EC 2.5.1.29) inhibitors
geranylgeranyl diphosphate synthase inhibitor
geranylgeranyl diphosphate synthase inhibitors
geranylgeranyl pyrophosphate synthase inhibitor
geranylgeranyl pyrophosphate synthase inhibitors
geranylgeranyl pyrophosphate synthetase inhibitor
geranylgeranyl pyrophosphate synthetase inhibitors
geranylgeranyl-PP synthetase inhibitor
geranylgeranyl-PP synthetase inhibitors
EC 2.5.1.29 (geranylgeranyl diphosphate synthase) inhibitor
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor
EC 1.3.1.43 (arogenate dehydrogenase) inhibitors
EC 1.3.1.43 inhibitor
EC 1.3.1.43 inhibitors
L-arogenate:NAD(+) oxidoreductase (decarboxylating) inhibitor
L-arogenate:NAD(+) oxidoreductase (decarboxylating) inhibitors
L-arogenate:NAD+ oxidoreductase (decarboxylating) inhibitor
L-arogenate:NAD+ oxidoreductase (decarboxylating) inhibitors
L-arogenate:NAD+ oxidoreductase inhibitor
L-arogenate:NAD+ oxidoreductase inhibitors
TyrA(a) inhibitor
TyrA(a) inhibitors
arogenate dehydrogenase (EC 1.3.1.43) inhibitor
arogenate dehydrogenase (EC 1.3.1.43) inhibitors
arogenate dehydrogenase inhibitor
arogenate dehydrogenase inhibitors
cyclohexadienyl dehydrogenase inhibitor
cyclohexadienyl dehydrogenase inhibitors
EC 1.3.1.43 (arogenate dehydrogenase) inhibitor
monolignol
monolignols
monolignol
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor
5,10-methylenetetrahydrofolate:glycine hydroxymethyltransferase inhibitor
5,10-methylenetetrahydrofolate:glycine hydroxymethyltransferase inhibitors
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitors
EC 2.1.2.1 inhibitor
EC 2.1.2.1 inhibitors
L-serine hydroxymethyltransferase inhibitor
L-serine hydroxymethyltransferase inhibitors
L-threonine aldolase inhibitor
L-threonine aldolase inhibitors
allothreonine aldolase inhibitor
allothreonine aldolase inhibitors
glycine hydroxymethyltransferase (EC 2.1.2.1) inhibitor
glycine hydroxymethyltransferase (EC 2.1.2.1) inhibitors
glycine hydroxymethyltransferase inhibitor
glycine hydroxymethyltransferase inhibitors
serine aldolase inhibitor
serine aldolase inhibitors
serine hydroxymethylase inhibitor
serine hydroxymethylase inhibitors
serine hydroxymethyltransferase inhibitor
serine hydroxymethyltransferase inhibitors
serine transhydroxymethylase inhibitor
serine transhydroxymethylase inhibitors
threonine aldolase inhibitor
threonine aldolase inhibitors
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor
NMDA receptor agonist
N-methyl-D-aspartate receptor agonist
N-methyl-D-aspartate receptor agonists
NMDA receptor agonists
NMDAR agonist
NMDAR agonists
NMDA receptor agonist
flour treatment agent
dough improver
dough improvers
flour treatment agent
improving agent
improving agents
flour treatment agent
uremic toxin
uremic toxins
uremic toxin
glycine transporter 1 inhibitor
GlyT1 inhibitor
GlyT1 inhibitors
glycine transporter 1 inhibitors
glycine transporter 1 inhibitor
glycine receptor agonist
glycine receptor agonists
glycine receptor agonist
EC 1.8.1.9 (thioredoxin reductase) inhibitor
EC 1.8.1.9 (thioredoxin reductase) inhibitors
EC 1.8.1.9 inhibitor
EC 1.8.1.9 inhibitors
NADP-thioredoxin reductase inhibitor
NADP-thioredoxin reductase inhibitors
NADPH-thioredoxin reductase inhibitor
NADPH-thioredoxin reductase inhibitors
NADPH2:oxidized thioredoxin oxidoreductase inhibitor
NADPH2:oxidized thioredoxin oxidoreductase inhibitors
TrxR inhibitor
TrxR inhibitors
thioredoxin reductase (EC 1.8.1.9) inhibitor
thioredoxin reductase (EC 1.8.1.9) inhibitors
thioredoxin reductase (NADPH) inhibitor
thioredoxin reductase (NADPH) inhibitors
thioredoxin reductase inhibitor
thioredoxin reductase inhibitors
thioredoxin-disulfide reductase inhibitor
thioredoxin-disulfide reductase inhibitors
thioredoxin:NADP+ oxidoreductase inhibitor
thioredoxin:NADP+ oxidoreductase inhibitors
EC 1.8.1.9 (thioredoxin reductase) inhibitor
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
ACAT inhibitor
ACAT inhibitors
EC 2.3.1.26 (sterol O-acyltransferase) inhibitors
EC 2.3.1.26 inhibitor
EC 2.3.1.26 inhibitors
acyl coenzyme A-cholesterol-O-acyltransferase inhibitor
acyl coenzyme A-cholesterol-O-acyltransferase inhibitors
acyl-CoA:cholesterol O-acyltransferase inhibitor
acyl-CoA:cholesterol acyltransferase inhibitor
acyl-CoA:cholesterol acyltransferase inhibitors
acylcoenzyme A:cholesterol O-acyltransferase inhibitor
acylcoenzyme A:cholesterol O-acyltransferase inhibitors
cholesterol acyltransferase inhibitor
cholesterol acyltransferase inhibitors
cholesterol ester synthase inhibitor
cholesterol ester synthase inhibitors
cholesterol ester synthetase inhibitor
cholesterol ester synthetase inhibitors
cholesteryl ester synthetase inhibitor
cholesteryl ester synthetase inhibitors
sterol O-acyltransferase (EC 2.3.1.26) inhibitor
sterol O-acyltransferase (EC 2.3.1.26) inhibitors
sterol O-acyltransferase inhibitor
sterol O-acyltransferase inhibitors
sterol-ester synthase inhibitor
sterol-ester synthase inhibitors
sterol-ester synthetase inhibitor
sterol-ester synthetase inhibitors
EC 2.3.1.26 (sterol O-acyltransferase) inhibitor
acyl-CoA:cholesterol acyltransferase 2 inhibitor
ACAT-2 inhibitor
ACAT-2 inhibitors
acyl-CoA:cholesterol acyltransferase 2 inhibitors
acyl-CoA:cholesterol acyltransferase 2 inhibitor
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
1-phosphatidyl-1D-myo-inositol-4,5-bisphosphate inositoltrisphosphohydrolase inhibitor
1-phosphatidyl-1D-myo-inositol-4,5-bisphosphate inositoltrisphosphohydrolase inhibitors
1-phosphatidyl-D-myo-inositol-4,5-bisphosphate inositoltrisphosphohydrolase inhibitor
1-phosphatidyl-D-myo-inositol-4,5-bisphosphate inositoltrisphosphohydrolase inhibitors
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase inhibitor
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase inhibitors
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitors
EC 3.1.4.11 inhibitor
EC 3.1.4.11 inhibitors
PI-PLC inhibitor
PI-PLC inhibitors
monophosphatidylinositol phosphodiesterase inhibitor
monophosphatidylinositol phosphodiesterase inhibitors
phosphatidylinositol phospholipase C inhibitor
phosphatidylinositol phospholipase C inhibitors
phosphatidylinositol-specific phospholipase C inhibitor
phosphatidylinositol-specific phospholipase C inhibitors
phosphoinositidase C inhibitor
phosphoinositidase C inhibitors
phosphoinositide phospholipase C (EC 3.1.4.11) inhibitor
phosphoinositide phospholipase C (EC 3.1.4.11) inhibitors
phosphoinositide phospholipase C inhibitor
phosphoinositide phospholipase C inhibitors
triphosphoinositide phosphodiesterase inhibitor
triphosphoinositide phosphodiesterase inhibitors
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
cosmetic
cosmetic component
cosmetics
cosmetic
poison
poisonous agent
poisonous agents
poisonous substance
poisonous substances
poisons
toxic agent
toxic agents
toxic substance
toxic substances
poison
antimitotic
antimitotics
mitosis inhibitor
mitosis inhibitors
mitotic inhibitor
mitotic inhibitors
antimitotic
antimycobacterial drug
antimycobacterial agent
antimycobacterial agents
antimycobacterial drugs
antimycobacterials
antimycobacterium
antimycobacterial drug
antiplasmodial drug
antiplasmodial agent
antiplasmodial agents
antiplasmodial drugs
antiplasmodium agent
antiplasmodium agents
antiplasmodium drug
antiplasmodium drugs
antiplasmodial drug
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor
1,2-diacylglycerol acyltransferase inhibitor
1,2-diacylglycerol acyltransferase inhibitors
DGAT inhibitor
DGAT inhibitors
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitors
EC 2.3.1.20 inhibitor
EC 2.3.1.20 inhibitors
acyl-CoA:1,2-diacylglycerol O-acyltransferase inhibitor
acyl-CoA:1,2-diacylglycerol O-acyltransferase inhibitors
diacylglycerol O-acyltransferase (EC 2.3.1.20) inhibitor
diacylglycerol O-acyltransferase (EC 2.3.1.20) inhibitors
diacylglycerol O-acyltransferase inhibitor
diacylglycerol O-acyltransferase inhibitors
diacylglycerol acyltransferase inhibitor
diacylglycerol acyltransferase inhibitors
diglyceride O-acyltransferase inhibitor
diglyceride O-acyltransferase inhibitors
diglyceride acyltransferase inhibitor
diglyceride acyltransferase inhibitors
palmitoyl-CoA-sn-1,2-diacylglycerol acyltransferase inhibitor
palmitoyl-CoA-sn-1,2-diacylglycerol acyltransferase inhibitors
EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor
EC 6.5.1.1 [DNA ligase (ATP)] inhibitor
DNA joinase inhibitor
DNA joinase inhibitors
DNA ligase (ATP) (EC 6.5.1.1) inhibitor
DNA ligase (ATP) (EC 6.5.1.1) inhibitors
DNA ligase (ATP) inhibitor
DNA ligase inhibitor
DNA ligase inhibitors
DNA repair enzyme inhibitor
DNA repair enzyme inhibitors
DNA-joining enzyme inhibitor
DNA-joining enzyme inhibitors
EC 6.5.1.1 (DNA ligase (ATP)) inhibitor
EC 6.5.1.1 (DNA ligase (ATP)) inhibitors
EC 6.5.1.1 [DNA ligase (ATP)] inhibitors
EC 6.5.1.1 inhibitor
EC 6.5.1.1 inhibitors
deoxyribonucleate ligase inhibitor
deoxyribonucleate ligase inhibitors
deoxyribonucleic acid joinase inhibitor
deoxyribonucleic acid joinase inhibitors
deoxyribonucleic acid ligase inhibitor
deoxyribonucleic acid ligase inhibitors
deoxyribonucleic acid repair enzyme inhibitor
deoxyribonucleic acid repair enzyme inhibitors
deoxyribonucleic acid-joining enzyme inhibitor
deoxyribonucleic acid-joining enzyme inhibitors
deoxyribonucleic joinase inhibitor
deoxyribonucleic joinase inhibitors
deoxyribonucleic ligase inhibitor
deoxyribonucleic ligase inhibitors
deoxyribonucleic repair enzyme inhibitor
deoxyribonucleic repair enzyme inhibitors
deoxyribonucleic-joining enzyme inhibitor
deoxyribonucleic-joining enzyme inhibitors
polydeoxyribonucleotide synthase (ATP) inhibitor
sealase inhibitor
sealase inhibitors
EC 6.5.1.1 [DNA ligase (ATP)] inhibitor
EC 3.4.21.37 (leukocyte elastase) inhibitor
EC 3.4.21.37 (leukocyte elastase) inhibitors
EC 3.4.21.37 inhibitor
EC 3.4.21.37 inhibitors
elastase inhibitor
elastase inhibitors
elaszym inhibitor
elaszym inhibitors
granulocyte elastase inhibitor
granulocyte elastase inhibitors
leukocyte elastase (EC 3.4.21.37) inhibitor
leukocyte elastase (EC 3.4.21.37) inhibitors
leukocyte elastase inhibitor
lysosomal elastase inhibitor
lysosomal elastase inhibitors
neutrophil elastase inhibitor
neutrophil elastase inhibitors
polymorphonuclear leukocyte elastase inhibitor
polymorphonuclear leukocyte elastase inhibitors
serine elastase inhibitor
serine elastase inhibitors
EC 3.4.21.37 (leukocyte elastase) inhibitor
hepatitis C protease inhibitor
hepatitis C protease inhibitors
hepatitis C protease inhibitor
serine protease inhibitor
serine protease inhibitors
serine proteinase inhibitor
serine proteinase inhibitors
serine protease inhibitor
cathepsin B inhibitor
EC 3.4.22.1 inhibitor
EC 3.4.22.1 inhibitors
cathepsin B inhibitors
cathepsin B1 inhibitor
cathepsin B1 inhibitors
cathepsin II inhibitor
cathepsin II inhibitors
cathepsin B inhibitor
melanin synthesis inhibitor
melanin biosynthesis inhibitor
melanin biosynthesis inhibitors
melanin synthesis inhibitors
melanogenesis inhibitor
melanogenesis inhibitors
melanin synthesis inhibitor
EC 3.4.21.1 (chymotrypsin) inhibitor
EC 3.4.21.1 (chymotrypsin) inhibitors
EC 3.4.21.1 inhibitor
EC 3.4.21.1 inhibitors
alpha-chymar inhibitor
alpha-chymar inhibitors
alpha-chymar ophth inhibitor
alpha-chymar ophth inhibitors
alpha-chymotrypsin inhibitor
alpha-chymotrypsin inhibitors
avazyme inhibitor
avazyme inhibitors
chymar inhibitor
chymar inhibitors
chymotest inhibitor
chymotest inhibitors
chymotrypsin (EC 3.4.21.1) inhibitor
chymotrypsin (EC 3.4.21.1) inhibitors
chymotrypsin inhibitor
chymotrypsin inhibitors
chymotrypsins A and B inhibitor
chymotrypsins A and B inhibitors
chymotrypsins A inhibitor
chymotrypsins A inhibitors
chymotrypsins B inhibitor
chymotrypsins B inhibitors
enzeon inhibitor
enzeon inhibitors
quimar inhibitor
quimar inhibitors
quimotrase inhibitor
quimotrase inhibitors
EC 3.4.21.1 (chymotrypsin) inhibitor
anti-HIV agent
anti-AIDS agent
anti-AIDS agents
anti-HIV agents
anti-HIV agent
anti-HIV-1 agent
anti-HIV-1 agents
anti-HTLV-III agent
anti-HTLV-III agents
anti-LAV agent
anti-LAV agents
anti-HIV-1 agent
anti-HIV-2 agent
anti-HIV-2 agents
anti-HIV-2 agent
anti-HBV agent
anti-HBV agents
anti-hepatitis B virus agent
anti-hepatitis B virus agents
anti-HBV agent
anti-HSV agent
anti-HHV agent
anti-HHV agents
anti-HSV agents
anti-herpes simplex virus agent
anti-herpes simplex virus agents
anti-human herpes virus agent
anti-human herpes virus agents
anti-HSV agent
anti-HSV-1 agent
anti-HHV-1 agent
anti-HHV-1 agents
anti-HHV-I agent
anti-HHV-I agents
anti-HSV-1 agents
anti-HSV-I agent
anti-HSV-I agents
anti-human herpes virus-1 agent
anti-human herpes virus-1 agents
anti-human herpes virus-I agent
anti-human herpes virus-I agents
anti-HSV-1 agent
anti-HSV-2 agent
anti-HHV-2 agent
anti-HHV-2 agents
anti-HHV-II agent
anti-HHV-II agents
anti-HSV-2 agents
anti-HSV-II agent
anti-HSV-II agents
anti-human herpes virus-2 agent
anti-human herpes virus-2 agents
anti-human herpes virus-II agent
anti-human herpes virus-II agents
anti-HSV-2 agent
EC 3.2.1.166 (heparanase) inhibitor
C1A heparanase inhibitor
C1A heparanase inhibitors
EC 3.2.1.166 (heparanase) inhibitors
HPSE inhibitor
HPSE inhibitors
Hpa1 heparanase inhibitor
Hpa1 heparanase inhibitors
Hpa1 inhibitor
Hpa1 inhibitors
heparan sulfate N-sulfo-D-glucosamine endoglucanase inhibitor
heparan sulfate N-sulfo-D-glucosamine endoglucanase inhibitors
heparanase (EC 3.2.1.166) inhibitor
heparanase (EC 3.2.1.166) inhibitors
heparanase 1 inhibitor
heparanase 1 inhibitors
heparanase inhibitor
heparanase inhibitors
heparanase-1 inhibitor
heparanase-1 inhibitors
EC 3.2.1.166 (heparanase) inhibitor
EC 3.4.21.39 (chymase) inhibitor
EC 3.4.21.39 (chymase) inhibitors
EC 3.4.21.39 inhibitor
EC 3.4.21.39 inhibitors
SK protease inhibitor
SK protease inhibitors
chymase (EC 3.4.21.39) inhibitor
chymase (EC 3.4.21.39) inhibitors
chymase inhibitor
chymase inhibitors
mast cell protease I inhibitor
mast cell protease I inhibitors
skeletal muscle (SK) protease inhibitor
skeletal muscle (SK) protease inhibitors
skeletal muscle protease inhibitor
skeletal muscle protease inhibitors
skin chymotryptic proteinase inhibitor
skin chymotryptic proteinase inhibitors
EC 3.4.21.39 (chymase) inhibitor
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
5-LOX inhibitor
5-LOX inhibitors
5-lipoxygenase inhibitor
5-lipoxygenase inhibitors
5delta-lipoxygenase inhibitor
5delta-lipoxygenase inhibitors
C-5-lipoxygenase inhibitor
C-5-lipoxygenase inhibitors
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitors
EC 1.13.11.34 inhibitor
EC 1.13.11.34 inhibitors
LTA synthase inhibitor
LTA synthase inhibitors
arachidonate 5-lipoxygenase (EC 1.13.11.34) inhibitor
arachidonate 5-lipoxygenase (EC 1.13.11.34) inhibitors
arachidonate 5-lipoxygenase inhibitor
arachidonate 5-lipoxygenase inhibitors
arachidonic 5-lipoxygenase inhibitor
arachidonic 5-lipoxygenase inhibitors
arachidonic acid 5-lipoxygenase inhibitor
arachidonic acid 5-lipoxygenase inhibitors
delta(5)-lipoxygenase inhibitor
delta(5)-lipoxygenase inhibitors
leukotriene A4 synthase inhibitor
leukotriene A4 synthase inhibitors
leukotriene-A4 synthase inhibitor
leukotriene-A4 synthase inhibitors
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor
12-LOX inhibitor
12-LOX inhibitors
12-lipoxygenase inhibitor
12-lipoxygenase inhibitors
12S-lipoxygenase inhibitor
12S-lipoxygenase inhibitors
5delta-lipoxygenase inhibitor
5delta-lipoxygenase inhibitors
C-5-lipoxygenase inhibitor
C-5-lipoxygenase inhibitors
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitors
EC 1.13.11.31 inhibitor
EC 1.13.11.31 inhibitors
LTA4 synthase inhibitor
LTA4 synthase inhibitors
arachidonate 12-lipoxygenase (EC 1.13.11.31) inhibitor
arachidonate 12-lipoxygenase (EC 1.13.11.31) inhibitors
arachidonate 12-lipoxygenase inhibitor
arachidonate 12-lipoxygenase inhibitors
delta(12)-lipoxygenase inhibitor
delta(12)-lipoxygenase inhibitors
leukotriene A4 synthase inhibitor
leukotriene A4 synthase inhibitors
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor
15-LOX inhibitor
15-LOX inhibitors
15-lipoxygenase inhibitor
15-lipoxygenase inhibitors
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitors
EC 1.13.11.33 inhibitor
EC 1.13.11.33 inhibitors
arachidonate 15-lipoxygenase (EC 1.13.11.33) inhibitor
arachidonate 15-lipoxygenase (EC 1.13.11.33) inhibitors
arachidonate 15-lipoxygenase inhibitor
arachidonate 15-lipoxygenase inhibitors
arachidonate:oxygen 15-oxidoreductase inhibitor
arachidonate:oxygen 15-oxidoreductase inhibitors
linoleic acid omega(6)-lipoxygenase inhibitor
linoleic acid omega(6)-lipoxygenase inhibitors
omega(6) lipoxygenase inhibitor
omega(6) lipoxygenase inhibitors
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
EC 3.1.1.3 (triacylglycerol lipase) inhibitors
EC 3.1.1.3 inhibitor
EC 3.1.1.3 inhibitors
GEH inhibitor
GEH inhibitors
PPL inhibitor
PPL inhibitors
Tween hydrolase inhibitor
Tween hydrolase inhibitors
Tweenase inhibitor
Tweenase inhibitors
Tweenesterase inhibitor
Tweenesterase inhibitors
butyrinase inhibitor
butyrinase inhibitors
cacordase inhibitor
cacordase inhibitors
capalase L inhibitor
capalase L inhibitors
glycerol ester hydrolase inhibitor
glycerol ester hydrolase inhibitors
glycerol-ester hydrolase inhibitor
glycerol-ester hydrolase inhibitors
heparin releasable hepatic lipase inhibitor
heparin releasable hepatic lipase inhibitors
hepatic lipase inhibitor
hepatic lipase inhibitors
hepatic monoacylglycerol acyltransferase inhibitor
hepatic monoacylglycerol acyltransferase inhibitors
lipase inhibitor
lipase inhibitors
lipazin inhibitor
lipazin inhibitors
liver lipase inhibitor
liver lipase inhibitors
pancreatic lipase inhibitor
pancreatic lipase inhibitors
pancreatic triacylglycerol lipase inhibitor
pancreatic triacylglycerol lipase inhibitors
post-heparin plasma protamine-resistant lipase inhibitor
post-heparin plasma protamine-resistant lipase inhibitors
salt-resistant post-heparin lipase inhibitor
salt-resistant post-heparin lipase inhibitors
steapsin inhibitor
steapsin inhibitors
triacetinase inhibitor
triacetinase inhibitors
triacylglycerol ester hydrolase inhibitor
triacylglycerol ester hydrolase inhibitors
triacylglycerol lipase (EC 3.1.1.3) inhibitor
triacylglycerol lipase (EC 3.1.1.3) inhibitors
triacylglycerol lipase inhibitor
triacylglycerol lipase inhibitors
tributyrase inhibitor
tributyrase inhibitors
tributyrin esterase inhibitor
tributyrin esterase inhibitors
tributyrinase inhibitor
tributyrinase inhibitors
triglyceridase inhibitor
triglyceridase inhibitors
triglyceride hydrolase inhibitor
triglyceride hydrolase inhibitors
triglyceride lipase inhibitor
triglyceride lipase inhibitors
triolein hydrolase inhibitor
triolein hydrolase inhibitors
tween-hydrolysing esterase inhibitor
tween-hydrolyzing esterase inhibitors
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
anti-asthmatic agent
anti-asthmatic agents
antiasthmatic agent
antiasthmatic agents
anti-asthmatic agent
EC 4.1.1.19 (arginine decarboxylase) inhibitor
ADC inhibitor
ADC inhibitors
EC 4.1.1.19 (arginine decarboxylase) inhibitors
EC 4.1.1.19 inhibitor
EC 4.1.1.19 inhibitors
L-arginine carboxy-lyase (agmatine-forming) inhibitor
L-arginine carboxy-lyase (agmatine-forming) inhibitors
L-arginine carboxy-lyase inhibitor
L-arginine carboxy-lyase inhibitors
SpeA inhibitor
SpeA inhibitors
arginine decarboxylase (EC 4.1.1.19) inhibitor
arginine decarboxylase (EC 4.1.1.19) inhibitors
arginine decarboxylase inhibitor
arginine decarboxylase inhibitors
EC 4.1.1.19 (arginine decarboxylase) inhibitor
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor
D-fructose 1,6-diphosphatase inhibitor
D-fructose 1,6-diphosphatase inhibitors
D-fructose-1,6-bisphosphate 1-phosphohydrolase inhibitor
D-fructose-1,6-bisphosphate 1-phosphohydrolase inhibitors
D-fructose-1,6-bisphosphate phosphatase inhibitor
D-fructose-1,6-bisphosphate phosphatase inhibitors
EC 3.1.3.11 (fructose-bisphosphatase) inhibitors
EC 3.1.3.11 inhibitor
EC 3.1.3.11 inhibitors
FBPase inhibitor
FBPase inhibitors
fructose 1,6-bisphosphatase inhibitor
fructose 1,6-bisphosphatase inhibitors
fructose 1,6-bisphosphate 1-phosphatase inhibitor
fructose 1,6-bisphosphate 1-phosphatase inhibitors
fructose 1,6-bisphosphate phosphatase inhibitor
fructose 1,6-bisphosphate phosphatase inhibitors
fructose 1,6-diphosphatase inhibitor
fructose 1,6-diphosphatase inhibitors
fructose 1,6-diphosphate phosphatase inhibitor
fructose 1,6-diphosphate phosphatase inhibitors
fructose bisphosphate phosphatase inhibitor
fructose bisphosphate phosphatase inhibitors
fructose diphosphatase inhibitor
fructose diphosphatase inhibitors
fructose diphosphate phosphatase inhibitor
fructose diphosphate phosphatase inhibitors
fructose-bisphosphatase (EC 3.1.3.11) inhibitor
fructose-bisphosphatase (EC 3.1.3.11) inhibitors
fructose-bisphosphatase inhibitor
fructose-bisphosphatase inhibitors
hexose bisphosphatase inhibitor
hexose bisphosphatase inhibitors
hexose diphosphatase inhibitor
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor
adenosine A1 receptor agonist
adenosine A1 receptor agonists
adenosine A1 receptor agonist
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor
CFA synthase inhibitor
CFA synthase inhibitors
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitors
EC 2.1.1.79 inhibitor
EC 2.1.1.79 inhibitors
S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclising) inhibitor
S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclising) inhibitors
S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclizing) inhibitor
S-adenosyl-L-methionine:unsaturated-phospholipid methyltransferase (cyclizing) inhibitors
cyclopropane fatty acid synthase inhibitors
cyclopropane fatty acid synthetase inhibitor
cyclopropane fatty acid synthetase inhibitors
cyclopropane synthase inhibitor
cyclopropane synthase inhibitors
cyclopropane synthetase inhibitor
cyclopropane synthetase inhibitors
cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) inhibitor
cyclopropane-fatty-acyl-phospholipid synthase (EC 2.1.1.79) inhibitors
cyclopropane-fatty-acyl-phospholipid synthase inhibitor
cyclopropane-fatty-acyl-phospholipid synthase inhibitors
unsaturated-phospholipid methyltransferase inhibitor
unsaturated-phospholipid methyltransferase inhibitors
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor
DNA adenine methyltransferase inhibitor
DNA adenine methyltransferase inhibitors
Dam inhibitor
Dam inhibitors
EC 2.1.1.72 (site-specific DNA-methyltransferase (adenine-specific)) inhibitor
EC 2.1.1.72 (site-specific DNA-methyltransferase (adenine-specific)) inhibitors
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitors
EC 2.1.1.72 inhibitor
EC 2.1.1.72 inhibitors
modification methylase inhibitor
modification methylase inhibitors
restriction-modification system inhibitor
restriction-modification system inhibitors
site-specific DNA-methyltransferase (adenine-specific) (EC 2.1.1.72) inhibitor
site-specific DNA-methyltransferase (adenine-specific) (EC 2.1.1.72) inhibitors
site-specific DNA-methyltransferase (adenine-specific) inhibitor
site-specific DNA-methyltransferase (adenine-specific) inhibitors
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor
first generation antipsychotic
first generation antipsychotic agent
first generation antipsychotic agents
first generation antipsychotic drug
first generation antipsychotic drugs
first generation antipsychotics
typical antipsychotic
typical antipsychotic agent
typical antipsychotic agents
typical antipsychotic drug
typical antipsychotic drugs
typical antipsychotics
first generation antipsychotic
second generation antipsychotic
atypical antipsychotic
atypical antipsychotic agent
atypical antipsychotic agents
atypical antipsychotic drug
atypical antipsychotic drugs
atypical antipsychotics
second generation antipsychotic agent
second generation antipsychotic agents
second generation antipsychotic drug
second generation antipsychotic drugs
second generation antipsychotics
second generation antipsychotic
vascular endothelial growth factor receptor antagonist
VEGF receptor inhibitor
VEGF receptor inhibitors
VEGFR inhibitor
VEGFR inhibitors
vascular endothelial growth factor receptor antagonists
vascular endothelial growth factor receptor inhibitor
vascular endothelial growth factor receptor inhibitors
vascular endothelial growth factor receptor antagonist
EC 3.4.21.5 (thrombin) inhibitor
E thrombin inhibitor
E thrombin inhibitors
EC 3.4.21.5 (thrombin) inhibitors
EC 3.4.21.5 inhibitor
EC 3.4.21.5 inhibitors
activated blood-coagulation factor II inhibitor
activated blood-coagulation factor II inhibitors
beta-thrombin inhibitor
beta-thrombin inhibitors
blood-coagulation factor IIa inhibitor
blood-coagulation factor IIa inhibitors
factor IIa inhibitor
factor IIa inhibitors
fibrinogenase inhibitor
fibrinogenase inhibitors
gamma-thrombin inhibitor
gamma-thrombin inhibitors
thrombase inhibitor
thrombase inhibitors
thrombin (EC 3.4.21.5) inhibitor
thrombin (EC 3.4.21.5) inhibitors
thrombin inhibitor
thrombin inhibitors
thrombin-C inhibitor
thrombin-C inhibitors
thrombofort inhibitor
thrombofort inhibitors
tropostasin inhibitor
tropostasin inhibitors
EC 3.4.21.5 (thrombin) inhibitor
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
(1->3)-(1->6)-mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitor
(1->3)-(1->6)-mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitors
1,3(1,6)-alpha-D-mannosidase inhibitor
1,3(1,6)-alpha-D-mannosidase inhibitors
1,3-(1,6-)mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitor
1,3-(1,6-)mannosyl-oligosaccharide alpha-D-mannohydrolase inhibitors
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitors
EC 3.2.1.114 inhibitor
EC 3.2.1.114 inhibitors
GlcNAc transferase I-dependent alpha1,3[alpha1,6]mannosidase inhibitor
GlcNAc transferase I-dependent alpha1,3[alpha1,6]mannosidase inhibitors
Golgi alpha-mannosidase II inhibitor
Golgi alpha-mannosidase II inhibitors
ManII inhibitor
ManII inhibitors
alpha-D-mannosidase II inhibitor
alpha-D-mannosidase II inhibitors
alpha-mannosidase II inhibitor
alpha-mannosidase II inhibitors
alpha1-3,6-mannosidase inhibitor
alpha1-3,6-mannosidase inhibitors
exo-1,3-1,6-alpha-mannosidase inhibitor
exo-1,3-1,6-alpha-mannosidase inhibitors
golgi alpha-mannosidase II inhibitor
golgi alpha-mannosidase II inhibitors
mannosidase II inhibitor
mannosidase II inhibitors
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (EC 3.2.1.114) inhibitor
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase (EC 3.2.1.114) inhibitors
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase inhibitor
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase inhibitors
EC 3.2.1.114 (mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) inhibitor
LRH-1 agonist
LRH-1 agonists
NR5A2 agonist
NR5A2 agonists
liver receptor homologue-1 agonist
liver receptor homologue-1 agonists
nuclear receptor subfamily 5 group A member 2 agonist
nuclear receptor subfamily 5 group A member 2 agonists
LRH-1 agonist
food preservative
food preservatives
food preservative
antimicrobial food preservative
antimicrobial food preservatives
antimicrobial preservative
antimicrobial preservatives
antimicrobial food preservative
GABA antagonist
GABA antagonists
gamma-aminobutyric acid receptor antagonist
gamma-aminobutyric acid receptor antagonists
GABA antagonist
antacid
antacids
antacid
erythropeotin receptor agonist
erythropeotin receptor agonist
erythropoiesis-stimulating agent
erythropoiesis-stimulating agents
erythropeotin receptor agonist
prostaglandin receptor agonist
prostaglandin receptor agonists
prostaglandin receptor agonist
CFTR potentiator
CFTR potentiators
cystic fibrosis transmembrane conductance regulator potentiator
cystic fibrosis transmembrane conductance regulator potentiators
CFTR potentiator
SMO receptor antagonist
SMO receptor antagonists
smoothened antagonist
smoothened antagonists
smoothened receptor antagonist
smoothened receptor antagonists
SMO receptor antagonist
antidyskinesia agent
antidyskinesia agents
antidyskinesia drug
antidyskinesia drugs
antidyskinetic agent
antidyskinetic agents
antidyskinetic drug
antidyskinetic drugs
antidyskinesia agent
nootropic agent
cognitive enhancer
cognitive enhancers
intelligence enhancer
intelligence enhancers
memory enhancer
memory enhancers
neuro enhancer
neuro enhancers
nootropic
nootropic agents
nootropic drug
nootropic drugs
nootropics
smart drug
smart drugs
nootropic agent
ophthalmology drug
ophthalmic
ophthalmic agent
ophthalmic agents
ophthalmics
ophthalmological
ophthalmologicals
ophthalmology agent
ophthalmology agents
ophthalmology drugs
ophthalmology drug
radiation protective agent
radiation mitigation agent
radiation mitigation agents
radiation protective agents
radiation protective drug
radiation protective drugs
radioprotective agent
radioprotective agents
radioprotector
radioprotectors
radiation protective agent
sympatholytic agent
sympatholytic
sympatholytic agents
sympatholytic drug
sympatholytic drugs
sympatholytics
sympatholytic agent
tocolytic agent
anti-contraction drug
anti-contraction drugs
anti-contraction medication
anti-contraction medications
labour repressant
labour repressants
tocolytic
tocolytic agents
tocolytic drug
tocolytic drugs
tocolytics
tocolytic agent
cannabinoid receptor agonist
cannabinoid receptor agonists
cannabinoid receptor agonist
anti-inflammatory agent
anti-inflammatory agents
antiinflammatory agent
antiinflammatory agents
anti-inflammatory agent
insect sterilant
insect chemosterilant
insect chemosterilants
insect sterilants
insect sterilant
ryanodine receptor agonist
RyR activator
RyR activators
RyR agonist
RyR agonists
RyRs activator
RyRs agonist
ryanodine receptor activator
ryanodine receptor activators
ryanodine receptor agonist
colorimetric reagent
color reagent
color reagents
colorimetric reagents
colour reagent
colour reagents
colorimetric reagent
NMR shift reagent
NMR shift reagents
lanthanide shift reagent
lanthanide shift reagents
nuclear magnetic resonance shift reagent
nuclear magnetic resonance shift reagents
NMR shift reagent
EC 3.4.24.3 (microbial collagenase) inhibitor
Achromobacter iophagus collagenase inhibitor
Achromobacter iophagus collagenase inhibitors
Clostridium histolyticum collagenase inhibitor
Clostridium histolyticum collagenase inhibitors
Clostridium histolyticum proteinase A inhibitor
Clostridium histolyticum proteinase A inhibitors
EC 3.4.24.3 (microbial collagenase) inhibitors
EC 3.4.24.3 inhibitor
EC 3.4.24.3 inhibitors
MMP-1 inhibitor
MMP-1 inhibitors
MMP-8 inhibitor
MMP-8 inhibitors
aspergillopeptidase C inhibitor
aspergillopeptidase C inhibitors
azocollase inhibitor
azocollase inhibitors
clostridiopeptidase A inhibitor
clostridiopeptidase A inhibitors
clostridiopeptidase I inhibitor
clostridiopeptidase I inhibitors
clostridiopeptidase II inhibitor
clostridiopeptidase II inhibitors
collagen peptidase inhibitor
collagen peptidase inhibitors
collagen protease inhibitor
collagen protease inhibitors
collagenase A inhibitor
collagenase A inhibitors
collagenase I inhibitor
collagenase I inhibitors
collagenase MMP-1 inhibitor
collagenase MMP-1 inhibitors
collagenase inhibitor
collagenase inhibitors
interstitial collagenase inhibitor
interstitial collagenase inhibitors
kollaza inhibitor
kollaza inhibitors
matrix metalloproteinase-1 inhibitor
matrix metalloproteinase-1 inhibitors
matrix metalloproteinase-18 inhibitor
matrix metalloproteinase-18 inhibitors
matrix metalloproteinase-8 inhibitor
matrix metalloproteinase-8 inhibitors
metallocollagenase inhibitor
metallocollagenase inhibitors
metalloproteinase-1 inhibitor
metalloproteinase-1 inhibitors
microbial collagenase (EC 3.4.24.3) inhibitor
microbial collagenase (EC 3.4.24.3) inhibitors
microbial collagenase inhibitor
microbial collagenase inhibitors
nucleolysin inhibitor
nucleolysin inhibitors
soycollagestin inhibitor
soycollagestin inhibitors
EC 3.4.24.3 (microbial collagenase) inhibitor
gap junctional intercellular communication inhibitor
gap junctional intercellular communication inhibitors
gap junctional intercellular communication inhibitor
retinoic acid receptor agonist
retinoic acid receptor agonists
retinoic acid receptor agonist
AP-1 antagonist
AP-1 antagonists
activator protein-1 antagonist
activator protein-1 antagonists
AP-1 antagonist
provitamin A
provitamin As
provitamin A
EC 3.2.1.45 (glucosylceramidase) inhibitor
D-glucosyl-N-acylsphingosine glucohydrolase inhibitor
D-glucosyl-N-acylsphingosine glucohydrolase inhibitors
EC 3.2.1.45 (glucosylceramidase) inhibitors
EC 3.2.1.45 inhibitor
EC 3.2.1.45 inhibitors
GlcCer-beta-glucosidase inhibitor
GlcCer-beta-glucosidase inhibitors
acid beta-glucosidase inhibitor
acid beta-glucosidase inhibitors
acid-beta-glucosidase inhibitor
acid-beta-glucosidase inhibitors
beta-D-glucocerebrosidase inhibitor
beta-D-glucocerebrosidase inhibitors
beta-glucosylceramidase inhibitor
beta-glucosylceramidase inhibitors
ceramide glucosidase inhibitor
ceramide glucosidase inhibitors
glucocerebrosidase inhibitor
glucocerebrosidase inhibitors
glucosphingosine glucosylhydrolase inhibitor
glucosphingosine glucosylhydrolase inhibitors
glucosylceramidase (EC 3.2.1.45) inhibitor
glucosylceramidase (EC 3.2.1.45) inhibitors
glucosylceramidase inhibitor
glucosylceramidase inhibitors
glucosylcerebrosidase inhibitor
glucosylcerebrosidase inhibitors
glucosylsphingosine beta-D-glucosidase inhibitor
glucosylsphingosine beta-D-glucosidase inhibitors
glucosylsphingosine beta-glucosidase inhibitor
glucosylsphingosine beta-glucosidase inhibitors
psychosine hydrolase inhibitor
psychosine hydrolase inhibitors
EC 3.2.1.45 (glucosylceramidase) inhibitor
EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor
EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitors
EC 3.2.1.48 inhibitor
EC 3.2.1.48 inhibitors
intestinal sucrase inhibitor
intestinal sucrase inhibitors
sucrase (invertase) inhibitor
sucrase (invertase) inhibitors
sucrase inhibitor
sucrase inhibitors
sucrase-isomaltase inhibitor
sucrase-isomaltase inhibitors
sucrose alpha-glucohydrolase inhibitor
sucrose alpha-glucohydrolase inhibitors
sucrose alpha-glucosidase (EC 3.2.1.48) inhibitor
sucrose alpha-glucosidase (EC 3.2.1.48) inhibitors
sucrose alpha-glucosidase inhibitor
sucrose alpha-glucosidase inhibitors
sucrose-alpha-D-glucohydrolase inhibitor
sucrose-alpha-D-glucohydrolase inhibitors
EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitors
EC 3.2.1.10 inhibitor
EC 3.2.1.10 inhibitors
alpha-limit dextrinase inhibitor
alpha-limit dextrinase inhibitors
dextrin 6-glucanohydrolase inhibitor
dextrin 6-glucanohydrolase inhibitors
dextrin 6alpha-glucanohydrolase inhibitor
dextrin 6alpha-glucanohydrolase inhibitors
exo-oligo-1,6-glucosidase inhibitor
exo-oligo-1,6-glucosidase inhibitors
isomaltase inhibitor
isomaltase inhibitors
oligo-1,6-glucosidase (EC 3.2.1.10) inhibitor
oligo-1,6-glucosidase (EC 3.2.1.10) inhibitors
oligo-1,6-glucosidase inhibitor
oligo-1,6-glucosidase inhibitors
oligosaccharide alpha-1,6-glucohydrolase inhibitor
oligosaccharide alpha-1,6-glucohydrolase inhibitors
sucrase-isomaltase inhibitor
sucrase-isomaltase inhibitors
EC 3.2.1.10 (oligo-1,6-glucosidase) inhibitor
EC 3.2.1.20 (alpha-glucosidase) inhibitor
EC 3.2.1.20 (alpha-glucosidase) inhibitors
EC 3.2.1.20 inhibitor
EC 3.2.1.20 inhibitors
alpha-1,4-glucosidase inhibitor
alpha-1,4-glucosidase inhibitors
alpha-D-glucosidase inhibitor
alpha-D-glucosidase inhibitors
alpha-glucopyranosidase inhibitor
alpha-glucopyranosidase inhibitors
alpha-glucosidase (EC 3.2.1.20) inhibitor
alpha-glucosidase (EC 3.2.1.20) inhibitors
alpha-glucosidase inhibitor
alpha-glucosidase inhibitors
alpha-glucoside hydrolase inhibitor
alpha-glucoside hydrolase inhibitors
glucoinvertase inhibitor
glucoinvertase inhibitors
glucosidoinvertase inhibitor
glucosidoinvertase inhibitors
glucosidosucrase inhibitor
glucosidosucrase inhibitors
maltase inhibitor
maltase inhibitors
maltase-glucoamylase inhibitor
maltase-glucoamylase inhibitors
EC 3.2.1.20 (alpha-glucosidase) inhibitor
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitors
EC 2.5.1.59 inhibitor
EC 2.5.1.59 inhibitors
GGTase I inhibitor
GGTase I inhibitors
geranylgeranyl-diphosphate:protein-cysteine geranyltransferase inhibitor
geranylgeranyl-diphosphate:protein-cysteine geranyltransferase inhibitors
geranylgeranyltransferase type I inhibitor
geranylgeranyltransferase type I inhibitors
protein geranylgeranyltransferase type I (EC 2.5.1.59) inhibitor
protein geranylgeranyltransferase type I (EC 2.5.1.59) inhibitors
protein geranylgeranyltransferase type I inhibitor
protein geranylgeranyltransferase type I inhibitors
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor
HIV-1 integrase inhibitor
HIV-1 integrase inhibitor
metformin
1,1-dimethylbiguanide
LA 6023
LA-6023
N(1),N(1)-dimethylbiguanide
N,N-dimethylbiguanide
N,N-dimethyldiguanide
N,N-dimethylguanylguanidine
N,N-dimethylimidodicarbonimidic diamide
N,N-dimethyltriimidodicarbonic diamide
dimethylbiguanide
dimethyldiguanide
metformin
metformina
metformine
metforminum
metformin
mTOR inhibitor
mTOR inhibitors
mammalian target of rapamycin inhibitor
mammalian target of rapamycin inhibitors
mTOR inhibitor
apoptosis inhibitor
Type I cell-death inhibitor
Type I cell-death inhibitors
Type I programmed cell-death inhibitor
Type I programmed cell-death inhibitors
apoptosis inhibitors
apoptosis inhibitor
apoptosis inducer
Type I cell-death inducer
Type I cell-death inducers
Type I programmed cell-death inducer
Type I programmed cell-death inducers
apoptosis inducers
apoptosis inducer
glutathione depleting agent
glutathione depleting agents
glutathione depletion agent
glutathione depletion agents
glutathione depletor
glutathione depletors
glutathione depleting agent
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor
(S)-dihydroorotate:fumarate oxidoreductase inhibitor
(S)-dihydroorotate:fumarate oxidoreductase inhibitors
DHODH inhibitor
DHODH inhibitors
EC 1.3.3.1 inhibitor
EC 1.3.3.1 inhibitors
EC 1.3.98.1 (dihydroorotate oxidase (fumarate)) inhibitor
EC 1.3.98.1 (dihydroorotate oxidase (fumarate)) inhibitors
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitors
EC 1.3.98.1 inhibitor
EC 1.3.98.1 inhibitors
dihydroorotate dehydrogenase inhibitor
dihydroorotate dehydrogenase inhibitors
dihydroorotate oxidase (fumarate) (EC 1.3.98.1) inhibitor
dihydroorotate oxidase (fumarate) (EC 1.3.98.1) inhibitors
dihydroorotate oxidase (fumarate) inhibitor
dihydroorotate oxidase (fumarate) inhibitors
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor
pyrimidine synthesis inhibitor
pyrimidine synthesis inhibitors
pyrimidine synthesis inhibitor
guanylate cyclase 2C agonist
GC-C agonist
GC-C agonists
guanylate cyclase 2C agonists
guanylate cyclase 2C agonist
bradykinin receptor antagonist
bradykinin receptor antagonists
bradykinin receptor antagonist
P2Y12 receptor antagonist
ADP receptor subtype P2Y12 antagonist
ADP receptor subtype P2Y12 antagonists
P2Y12 receptor antagonists
purinergic receptor subtype P2Y12 antagonist
purinergic receptor subtype P2Y12 antagonists
P2Y12 receptor antagonist
EC 3.4.21.6 (coagulation factor Xa) inhibitor
EC 3.4.21.6 (coagulation factor Xa) inhibitors
EC 3.4.21.6 inhibitor
EC 3.4.21.6 inhibitors
Stuart factor inhibitor
Stuart factor inhibitors
activated Stuart-Prower factor inhibitor
activated Stuart-Prower factor inhibitors
activated blood-coagulation factor X inhibitor
activated blood-coagulation factor X inhibitors
activated factor X inhibitor
activated factor X inhibitors
autoprothrombin C inhibitor
autoprothrombin C inhibitors
coagulation factor Xa (EC 3.4.21.6) inhibitor
coagulation factor Xa (EC 3.4.21.6) inhibitors
coagulation factor Xa inhibitor
coagulation factor Xa inhibitors
factor Xa inhibitor
factor Xa inhibitors
plasma thromboplastin inhibitor
plasma thromboplastin inhibitors
prothrombase inhibitor
prothrombase inhibitors
prothrombinase inhibitor
prothrombinase inhibitors
thrombokinase inhibitor
thrombokinase inhibitors
thromboplastin inhibitor
thromboplastin inhibitors
EC 3.4.21.6 (coagulation factor Xa) inhibitor
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor
DPP IV/CD26 inhibitor
DPP IV/CD26 inhibitors
DPP-4 inhibitor
DPP-4 inhibitors
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitors
EC 3.4.14.5 inhibitor
EC 3.4.14.5 inhibitors
Gly-Pro naphthylamidase inhibitor
Gly-Pro naphthylamidase inhibitors
T cell triggering molecule Tp103 inhibitor
T cell triggering molecule Tp103 inhibitors
X-PDAP inhibitor
X-PDAP inhibitors
X-prolyl dipeptidyl aminopeptidase inhibitor
X-prolyl dipeptidyl aminopeptidase inhibitors
Xaa-Pro-dipeptidyl-aminopeptidase inhibitor
Xaa-Pro-dipeptidyl-aminopeptidase inhibitors
amino acyl-prolyl dipeptidyl aminopeptidase inhibitor
amino acyl-prolyl dipeptidyl aminopeptidase inhibitors
dipeptidyl aminopeptidase IV inhibitor
dipeptidyl aminopeptidase IV inhibitors
dipeptidyl peptidase IV inhibitor
dipeptidyl peptidase IV inhibitors
dipeptidyl peptidase-4 inhibitors
dipeptidyl-aminopeptidase IV inhibitor
dipeptidyl-aminopeptidase IV inhibitors
dipeptidyl-peptidase IV (EC 3.4.14.5) inhibitor
dipeptidyl-peptidase IV (EC 3.4.14.5) inhibitors
dipeptidyl-peptidase IV inhibitor
dipeptidyl-peptidase IV inhibitors
dipeptidyl-peptide hydrolase inhibitor
dipeptidyl-peptide hydrolase inhibitors
glycoprotein GP110 inhibitor
glycoprotein GP110 inhibitors
glycylproline aminopeptidase inhibitor
glycylproline aminopeptidase inhibitors
glycylprolyl aminopeptidase inhibitor
glycylprolyl aminopeptidase inhibitors
glycylprolyl dipeptidylaminopeptidase inhibitor
glycylprolyl dipeptidylaminopeptidase inhibitors
leukocyte antigen CD26 inhibitor
leukocyte antigen CD26 inhibitors
lymphocyte antigen CD26 inhibitor
lymphocyte antigen CD26 inhibitors
pep X inhibitor
pep X inhibitors
postproline dipeptidyl aminopeptidase IV inhibitor
postproline dipeptidyl aminopeptidase IV inhibitors
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
17-alpha-hydroxylase/C17,20-lyase inhibitor
17-alpha-hydroxylase/C17,20-lyase inhibitors
17alpha-hydroxylase-C17,20 lyase inhibitor
17alpha-hydroxylase-C17,20 lyase inhibitors
CYP17 inhibitor
CYP17 inhibitors
CYP17A1 inhibitor
CYP17A1 inhibitors
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitors
EC 1.14.99.9 inhibitor
EC 1.14.99.9 inhibitors
cytochrome P-45017alpha inhibitor
cytochrome P-45017alpha inhibitors
cytochrome P450 (P-45017alpha,lyase) inhibitor
cytochrome P450 (P-45017alpha,lyase) inhibitors
cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitor
cytochrome P450 17-alpha-hydroxylase/C17,20-lyase inhibitors
cytochrome p450 XVIIA1 inhibitor
cytochrome p450 XVIIA1 inhibitors
steroid 17alpha-hydroxylase inhibitor
steroid 17alpha-hydroxylase inhibitors
steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitor
steroid 17alpha-monooxygenase (EC 1.14.99.9) inhibitors
steroid 17alpha-monooxygenase inhibitor
steroid 17alpha-monooxygenase inhibitors
steroid 17alphahydroxylase/17,20 lyase inhibitor
steroid 17alphahydroxylase/17,20 lyase inhibitors
steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitor
steroid,NADPH--hemoprotein reductase:oxygen oxidoreductase (17alpha-hydroxylating) inhibitors
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
phosphodiesterase IV inhibitor
PDE4 inhibitor
PDE4 inhibitors
phosphodiesterase 4 inhibitor
phosphodiesterase 4 inhibitors
phosphodiesterase IV inhibitors
type 4 phosphodiesterase inhibitor
type 4 phosphodiesterase inhibitors
phosphodiesterase IV inhibitor
midazolam
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Buccolam
Dormicum
mezolam
midazolam
midazolamum
midazolam
progesterone receptor agonist
PR agonist
PR agonists
progesterone receptor agonists
progesterone receptor agonist
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor
ACC inhibitor
ACC inhibitors
ACCase inhibitor
ACCase inhibitors
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitors
EC 6.4.1.2 inhibitor
EC 6.4.1.2 inhibitors
acetyl coenzyme A carboxylase inhibitor
acetyl coenzyme A carboxylase inhibitors
acetyl-CoA carboxylase (EC 6.4.1.2) inhibitor
acetyl-CoA carboxylase (EC 6.4.1.2) inhibitors
acetyl-CoA carboxylase inhibitor
acetyl-CoA carboxylase inhibitors
acetyl-CoA:carbon-dioxide ligase (ADP-forming) inhibitor
acetyl-CoA:carbon-dioxide ligase (ADP-forming) inhibitors
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor
cell dedifferentiation agent
cell dedifferentiation agents
cell dedifferentiation agent
adenosine A3 receptor antagonist
adenosine A3 receptor antagonistS
adenosine A3 receptor antagonist
topoisomerase inhibitor
topoisomerase inhibitors
topoisomerase inhibitor
actin polymerisation inhibitor
actin polymerisation inhibitors
actin polymerization inhibitor
actin polymerization inhibitors
inhibitor of actin polymerization
inhibitors of actin polymerization
actin polymerisation inhibitor
Aurora kinase inhibitor
Aurora kinase inhibitors
Aurora kinase inhibitor
capsaicin receptor antagonist
TRPV1 antagonist
TRPV1 antagonists
TrpV1 antagonist
TrpV1 antagonists
capsaicin antagonist
capsaicin antagonists
capsaicin receptor antagonists
transient receptor potential cation channel subfamily V member 1 antagonist
transient receptor potential cation channel subfamily V member 1 antagonists
vanilloid receptor 1 antagonist
vanilloid receptor 1 antagonists
capsaicin receptor antagonist
PPAR modulator
PPAR modulators
peroxisome proliferator-activated receptor modulator
peroxisome proliferator-activated receptor modulators
PPAR modulator
PPARalpha agonist
PPAR-alpha agonist
PPAR-alpha agonists
PPARalpha agonist
PPARalpha agonists
peroxisome proliferator-activated receptor-alpha agonist
peroxisome proliferator-activated receptor-alpha agonists
PPARalpha agonist
EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitor
3-phosphoglyceraldehyde dehydrogenase inhibitor
3-phosphoglyceraldehyde dehydrogenase inhibitors
D-glyceraldehyde-3-phosphate:NAD(+) oxidoreductase (phosphorylating) inhibitor
D-glyceraldehyde-3-phosphate:NAD(+) oxidoreductase (phosphorylating) inhibitors
EC 1.2.1.12 (glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)) inhibitor
EC 1.2.1.12 (glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)) inhibitors
EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitors
EC 1.2.1.12 inhibitor
EC 1.2.1.12 inhibitors
GAPDH inhibitor
GAPDH inhibitors
NAD-dependent glyceraldehyde phosphate dehydrogenase inhibitor
NAD-dependent glyceraldehyde phosphate dehydrogenase inhibitors
NADH-glyceraldehyde phosphate dehydrogenase inhibitor
NADH-glyceraldehyde phosphate dehydrogenase inhibitors
dehydrogenase, glyceraldehyde phosphate inhibitor
dehydrogenase, glyceraldehyde phosphate inhibitors
glyceraldehyde phosphate dehydrogenase (NAD) inhibitor
glyceraldehyde phosphate dehydrogenase (NAD) inhibitors
glyceraldehyde-3-P-dehydrogenase inhibitor
glyceraldehyde-3-P-dehydrogenase inhibitors
glyceraldehyde-3-phosphate dehydrogenase (NAD) inhibitor
glyceraldehyde-3-phosphate dehydrogenase (NAD) inhibitors
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12) inhibitor
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) (EC 1.2.1.12) inhibitors
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) inhibitor
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) inhibitors
glyceraldehyde-3-phosphate dehydrogenase inhibitor
glyceraldehyde-3-phosphate dehydrogenase inhibitors
phosphoglyceraldehyde dehydrogenase inhibitor
phosphoglyceraldehyde dehydrogenase inhibitors
triosephosphate dehydrogenase inhibitor
triosephosphate dehydrogenase inhibitors
EC 1.2.1.12 [glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)] inhibitor
cathepsin L (EC 3.4.22.15) inhibitor
Aldrichina grahami cysteine proteinase inhibitor
Aldrichina grahami cysteine proteinase inhibitors
EC 3.4.22.15 inhibitor
EC 3.4.22.15 inhibitors
cathepsin L (EC 3.4.22.15) inhibitor
cathepsin L (EC 3.4.22.15) inhibitors
cathepsin L inhibitor
cathepsin L inhibitors
cathepsin L1 inhibitor
cathepsin L1 inhibitors
cathepsin L (EC 3.4.22.15) inhibitor
EC 3.4.22.2 (papain) inhibitor
EC 3.4.22.2 (papain) inhibitor
EC 3.4.22.2 inhibitor
EC 3.4.22.2 inhibitors
papain (EC 3.4.22.2) inhibitor
papain (EC 3.4.22.2) inhibitors
papain inhibitor
papain inhibitors
papaine inhibitor
papaine inhibitors
papaya peptidase I inhibitor
papaya peptidase I inhibitors
papayotin inhibitor
papayotin inhibitors
summetrin inhibitor
summetrin inhibitors
velardon inhibitor
velardon inhibitors
EC 3.4.22.2 (papain) inhibitor
antileishmanial agent
antileishmanial agents
antileishmanial drug
antileishmanial drugs
antileishmanial agent
reactive oxygen species generator
ROS generator
ROS generators
reactive oxygen species generators
reactive oxygen species generator
G-protein-coupled receptor agonist
G-protein-coupled receptor agonists
GPCR agonist
GPCR agonists
G-protein-coupled receptor agonist
AMPA receptor antagonist
AMPA receptor antagonists
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists
AMPA receptor antagonist
progesterone receptor modulator
progesterone receptor modulators
progesterone receptor modulator
orphan drug
orphan drugs
orphan drug
carbamylphosphate synthetase I activator
carbamylphosphate synthetase I activators
carbamylphosphate synthetase I activator
HIV-1 maturation inhibitor
HIV-1 maturation inhibitors
HIV-1 maturation inhibitor
H1-receptor agonist
H1-receptor agonists
histamine H1-receptor agonist
histamine H1-receptor agonists
H1-receptor agonist
EC 2.1.1.4 (acetylserotonin O-methyltransferase) inhibitor
ASMT inhibitor
ASMT inhibitors
EC 2.1.1.4 (acetylserotonin O-methyltransferase) inhibitors
EC 2.1.1.4 inhibitor
EC 2.1.1.4 inhibitors
N-acetylserotonin O-methyltransferase inhibitor
N-acetylserotonin O-methyltransferase inhibitors
N-acetylserotonin methyltransferase inhibitor
N-acetylserotonin methyltransferase inhibitors
S-adenosyl-L-methionine:N-acetylserotonin O-methyltransferase inhibitor
S-adenosyl-L-methionine:N-acetylserotonin O-methyltransferase inhibitors
acetylserotonin O-methyltransferase (EC 2.1.1.4) inhibitor
acetylserotonin O-methyltransferase (EC 2.1.1.4) inhibitors
acetylserotonin O-methyltransferase inhibitor
acetylserotonin O-methyltransferase inhibitors
acetylserotonin methyltransferase inhibitor
acetylserotonin methyltransferase inhibitors
hydroxyindole O-methyltransferase inhibitor
hydroxyindole O-methyltransferase inhibitors
hydroxyindole methyltransferase inhibitor
hydroxyindole methyltransferase inhibitors
EC 2.1.1.4 (acetylserotonin O-methyltransferase) inhibitor
Sir2 inhibitor
Sir2 inhibitors
Sir2 inhibitor
glucagon-like peptide-1 receptor agonist
GLP-1 receptor agonist
GLP-1 receptor agonists
glucagon-like peptide-1 receptor agonists
glucagon-like peptide-1 receptor agonist
prohormone
prohormones
prohormone
adenosine receptor antagonist
adenosine receptor antagonists
adenosine receptor antagonist
EC 2.* (transferase) inhibitor
EC 2 inhibitor
EC 2 inhibitors
EC 2.* (transferase) inhibitors
EC 2.* inhibitor
EC 2.* inhibitors
transferase inhibitor
transferase inhibitors
EC 2.* (transferase) inhibitor
autoinducer
autoinducers
autoinducer
EC 2.3.1.85 (fatty acid synthase) inhibitor
(FAS) inhibitors
EC 2.3.1.85 (fatty acid synthase) inhibitors
EC 2.3.1.85 inhibitor
EC 2.3.1.85 inhibitors
acyl-CoA:malonyl-CoA C-acyltransferase (decarboxylating, oxoacyl- and enoyl-reducing and thioester-hydrolysing) inhibitor
acyl-CoA:malonyl-CoA C-acyltransferase (decarboxylating, oxoacyl- and enoyl-reducing and thioester-hydrolysing) inhibitors
fatty acid synthase (EC 2.3.1.85) inhibitor
fatty acid synthase (EC 2.3.1.85) inhibitors
fatty acid synthase inhibitor
fatty acid synthase inhibitors
EC 2.3.1.85 (fatty acid synthase) inhibitor
EC 3.5.1.23 (ceramidase) inhibitor
AC inhibitor
AC inhibitors
EC 3.5.1.23 (ceramidase) inhibitors
EC 3.5.1.23 inhibitor
EC 3.5.1.23 inhibitors
N-acylsphingosine amidohydrolase inhibitor
N-acylsphingosine amidohydrolase inhibitors
acid ceramidase inhibitor
acid ceramidase inhibitors
acylsphingosine deacylase inhibitor
acylsphingosine deacylase inhibitors
ceramidase (EC 3.5.1.23) inhibitor
ceramidase (EC 3.5.1.23) inhibitors
ceramidase inhibitor
ceramidase inhibitors
glycosphingolipid ceramide deacylase inhibitor
glycosphingolipid ceramide deacylase inhibitors
EC 3.5.1.23 (ceramidase) inhibitor
PPARgamma agonist
PPAR-gamma agonist
PPAR-gamma agonists
PPARgamma agonist
PPARgamma agonists
peroxisome proliferator-activated receptor-gamma agonist
peroxisome proliferator-activated receptor-gamma agonists
PPARgamma agonist
insect repellent
insect repellents
insect repellent
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor
3',5'-cyclic-GMP 5'-nucleotidohydrolase inhibitor
3',5'-cyclic-GMP 5'-nucleotidohydrolase inhibitors
3',5'-cyclic-GMP phosphodiesterase (EC 3.1.4.35) inhibitor
3',5'-cyclic-GMP phosphodiesterase (EC 3.1.4.35) inhibitors
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitors
EC 3.1.4.35 inhibitor
EC 3.1.4.35 inhibitors
PDE5 inhibitor
PDE5 inhibitors
cGMP phosphodiesterase inhibitor
cGMP phosphodiesterase inhibitors
cGMP-PDE inhibitor
cGMP-PDE inhibitors
cyclic 3',5'-GMP phosphodiesterase inhibitor
cyclic 3',5'-GMP phosphodiesterase inhibitors
cyclic GMP phosphodiesterase inhibitor
cyclic GMP phosphodiesterase inhibitors
cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitor
cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
cyclic guanosine 3',5'-phosphate phosphodiesterase inhibitor
cyclic guanosine 3',5'-phosphate phosphodiesterase inhibitors
guanosine cyclic 3',5'-phosphate phosphodiesterase inhibitor
guanosine cyclic 3',5'-phosphate phosphodiesterase inhibitors
phosphodiesterase 5 inhibitor
phosphodiesterase 5 inhibitors
phosphodiesterase V inhibitor
phosphodiesterase V inhibitors
type 5 phosphodiesterase inhibitor
type 5 phosphodiesterase inhibitors
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor
EC 3.5.1.88 (peptide deformylase) inhibitor
EC 3.5.1.88 (peptide deformylase) inhibitors
EC 3.5.1.88 inhibitor
EC 3.5.1.88 inhibitors
PDF inhibitors
formyl-L-methionyl peptide amidohydrolase inhibitor
formyl-L-methionyl peptide amidohydrolase inhibitors
peptide deformylase (EC 3.5.1.88) inhibitor
peptide deformylase (EC 3.5.1.88) inhibitors
peptide deformylase inhibitor
peptide deformylase inhibitors
EC 3.5.1.88 (peptide deformylase) inhibitor
nerve growth factor stimulator
NGF stimulator
NGF stimulators
nerve growth factor stimulators
nerve growth factor stimulator
MTP inhibitor
MTP inhibitors
MTTP inhibitor
MTTP inhibitors
microsomal triglyceride transfer protein inhibitor
microsomal triglyceride transfer protein inhibitors
MTP inhibitor
glucagon-like peptide-2 receptor agonist
GLP-2 receptor agonist
GLP-2 receptor agonists
glucagon-like peptide-2 receptor agonists
glucagon-like peptide-2 receptor agonist
virulence factor
virulence factors
virulence factor
provitamin B1
provitamin B1s
provitamin B1
vesicular glutamate transport inhibitor
vesicular glutamate transport inhibitors
vesicular glutamate transporter 1 inhibitor
vesicular glutamate transporter 1 inhibitors
vesicular glutamate transport inhibitor
pro-angiogenic agent
angiogenesis inducing agent
angiogenesis inducing agents
pro-angiogenic agents
proangiogenic agent
proangiogenic agents
pro-angiogenic agent
alarm pheromone
alarm pheromones
alarm signal
alarm signals
alarm substance
alarm substances
alarm pheromone
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitors
EC 2.3.2.13 inhibitor
EC 2.3.2.13 inhibitors
Factor XIIIa inhibitor
R-glutaminyl-peptide:amine gamma-glutamyl transferase inhibitor
TG-2 inhibitor
TG-2 inhibitors
TG2 inhibitor
TG2 inhibitors
TGase inhibitor
TGase inhibitors
fibrin stabilizing factor inhibitor
fibrin stabilizing factor inhibitors
fibrinoligase inhibitor
fibrinoligase inhibitors
glutaminylpeptide gamma-glutamyltransferase inhibitor
glutaminylpeptide gamma-glutamyltransferase inhibitors
polyamine transglutaminase inhibitor
polyamine transglutaminase inhibitors
protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) inhibitor
protein-glutamine gamma-glutamyltransferase (EC 2.3.2.13) inhibitors
protein-glutamine gamma-glutamyltransferase inhibitor
protein-glutamine gamma-glutamyltransferase inhibitors
protein-glutamine:amine gamma-glutamyltransferase inhibitor
protein-glutamine:amine gamma-glutamyltransferase inhibitors
tissue transglutaminase inhibitor
tissue transglutaminase inhibitors
transglutaminase inhibitor
transglutaminase inhibitors
transglutaminase-2 inhibitor
transglutaminase-2 inhibitors
EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor
aryl hydrocarbon receptor agonist
AHR agonist
AHR agonists
AhR agonist
AhR agonists
aryl hydrocarbon receptor agonists
aryl hydrocarbon receptor agonist
breast cancer resistance protein inhibitor
ABCG2 inhibitor
ABCG2 inhibitors
breast cancer resistance protein inhibitors
breast cancer resistance protein inhibitor
carotogenesis inhibitor
carotogenesis inhibitors
carotogenesis inhibitor
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor
15-cis-phytoene:acceptor oxidoreductase (zeta-carotene-forming) inhibitor
15-cis-phytoene:acceptor oxidoreductase (zeta-carotene-forming) inhibitors
2-step phytoene desaturase inhibitor
2-step phytoene desaturase inhibitors
CrtIa inhibitor
CrtIa inhibitors
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitors
EC 1.3.99.29 inhibitor
EC 1.3.99.29 inhibitors
phytoene dehydrogenase inhibitor
phytoene dehydrogenase inhibitors
phytoene desaturase (zeta-carotene-forming) (EC 1.3.99.29) inhibitor
phytoene desaturase (zeta-carotene-forming) (EC 1.3.99.29) inhibitors
phytoene desaturase (zeta-carotene-forming) inhibitor
phytoene desaturase (zeta-carotene-forming) inhibitors
phytoene desaturase inhibitor
phytoene desaturase inhibitors
two-step phytoene desaturase inhibitor
two-step phytoene desaturase inhibitors
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor
D-tryptophan:oxygen 2,3-oxidoreductase (decyclizing) inhibitor
D-tryptophan:oxygen 2,3-oxidoreductase (decyclizing) inhibitors
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitors
EC 1.13.11.52 inhibitor
EC 1.13.11.52 inhibitors
IDO inhibitor
IDO inhibitors
indoleamine 2,3-dioxygenase (EC 1.13.11.52) inhibitor
indoleamine 2,3-dioxygenase (EC 1.13.11.52) inhibitors
indoleamine 2,3-dioxygenase inhibitor
indoleamine 2,3-dioxygenase inhibitors
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor
ALR3 inhibitor
ALR3 inhibitors
EC 1.1.1.184 (carbonyl reductase (NADPH)) inhibitor
EC 1.1.1.184 (carbonyl reductase (NADPH)) inhibitors
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitors
EC 1.1.1.184 inhibitor
EC 1.1.1.184 inhibitors
NADPH2-dependent carbonyl reductase inhibitor
NADPH2-dependent carbonyl reductase inhibitors
aldehyde reductase 1 inhibitor
aldehyde reductase 1 inhibitors
carbonyl reductase (NADPH) (EC 1.1.1.184) inhibitor
carbonyl reductase (NADPH) (EC 1.1.1.184) inhibitors
carbonyl reductase (NADPH) inhibitor
carbonyl reductase (NADPH) inhibitors
carbonyl reductase (NADPH2) inhibitor
carbonyl reductase (NADPH2) inhibitors
carbonyl reductase inhibitor
carbonyl reductase inhibitors
nonspecific NADPH-dependent carbonyl reductase inhibitor
nonspecific NADPH-dependent carbonyl reductase inhibitors
prostaglandin 9-ketoreductase inhibitor
prostaglandin 9-ketoreductase inhibitors
secondary-alcohol:NADP+ oxidoreductase inhibitor
secondary-alcohol:NADP+ oxidoreductase inhibitors
xenobiotic ketone reductase inhibitor
xenobiotic ketone reductase inhibitors
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitors
EC 1.11.1.11 inhibitor
EC 1.11.1.11 inhibitors
L-ascorbate peroxidase (EC 1.11.1.11) inhibitor
L-ascorbate peroxidase (EC 1.11.1.11) inhibitors
L-ascorbate peroxidase inhibitor
L-ascorbate peroxidase inhibitors
L-ascorbate:hydrogen-peroxide oxidoreductase inhibitor
L-ascorbate:hydrogen-peroxide oxidoreductase inhibitors
L-ascorbic acid peroxidase inhibitor
L-ascorbic acid peroxidase inhibitors
L-ascorbic acid-specific peroxidase inhibitor
L-ascorbic acid-specific peroxidase inhibitors
ascorbate peroxidase inhibitor
ascorbate peroxidase inhibitors
ascorbic acid peroxidase inhibitor
ascorbic acid peroxidase inhibitors
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor
plant activator
plant activators
plant activator
brassinosteroid biosynthesis inhibitor
brassinosteroid biosynthesis inhibitors
brassinosteroid biosynthesis inhibitor
antimutagen
antimutagenic agent
antimutagenic agents
antimutagens
antimutagen
abscisic acid receptor agonist
ABA agonist
ABA agonists
ABA receptor agonist
ABA receptor agonists
abscisic acid receptor agonists
abscisic acid receptor agonist
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitors
EC 1.3.3.4 inhibitor
EC 1.3.3.4 inhibitors
HemG inhibitor
HemG inhibitors
HemY inhibitor
HemY inhibitors
PPO inhibitor
PPO inhibitors
Protox inhibitor
Protox inhibitors
protoporphyrinogen IX oxidase inhibitor
protoporphyrinogen IX oxidase inhibitors
protoporphyrinogen oxidase (EC 1.3.3.4) inhibitor
protoporphyrinogen oxidase (EC 1.3.3.4) inhibitors
protoporphyrinogen oxidase inhibitor
protoporphyrinogen oxidase inhibitors
protoporphyrinogen-IX:oxygen oxidoreductase inhibitor
protoporphyrinogen-IX:oxygen oxidoreductase inhibitors
protoporphyrinogenase inhibitor
protoporphyrinogenase inhibitors
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor
gibberellin biosynthesis inhibitor
gibberellin biosynthesis inhibitors
gibberellin biosynthesis inhibitor
EC 4.4.1.11 (methionine gamma-lyase) inhibitor
EC 4.4.1.11 (methionine gamma-lyase) inhibitors
L-methioninase inhibitor
L-methioninase inhibitors
methioninase inhibitor
methioninase inhibitors
methionine gamma-lyase (EC 4.4.1.11) inhibitor
methionine gamma-lyase (EC 4.4.1.11) inhibitors
methionine gamma-lyase inhibitor
methionine gamma-lyase inhibitors
EC 4.4.1.11 (methionine gamma-lyase) inhibitor
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor
ATP phosphohydrolase (H(+)-transporting) inhibitor
ATP phosphohydrolase (H(+)-transporting) inhibitors
ATP synthase inhibitor
ATP synthase inhibitors
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitors
EC 3.6.3.14 inhibitor
EC 3.6.3.14 inhibitors
F1-ATPase inhibitor
F1-ATPase inhibitors
FoF1-ATPase inhibitor
FoF1-ATPase inhibitors
H(+)-transporting ATPase inhibitor
H(+)-transporting ATPase inhibitors
H(+)-transporting two-sector ATPase (EC 3.6.3.14) inhibitor
H(+)-transporting two-sector ATPase (EC 3.6.3.14) inhibitors
H(+)-transporting two-sector ATPase inhibitor
H(+)-transporting two-sector ATPase inhibitors
bacterial Ca(2+)/Mg(2+) ATPase inhibitor
bacterial Ca(2+)/Mg(2+) ATPase inhibitors
chloroplast ATPase inhibitor
chloroplast ATPase inhibitors
coupling factors (Fo, F1 and CF1) inhibitor
coupling factors (Fo, F1 and CF1) inhibitors
mitochondrial ATPase inhibitor
mitochondrial ATPase inhibitors
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor
EC 3.6.* (hydrolases acting on acid anhydrides) inhibitor
EC 3.6 inhibitor
EC 3.6 inhibitors
EC 3.6.* (hydrolases acting on acid anhydrides) inhibitors
EC 3.6.* inhibitor
EC 3.6.* inhibitors
EC 3.6.*.* inhibitor
EC 3.6.*.* inhibitors
acid anhydride hydrolase inhibitor
acid anhydride hydrolase inhibitors
inhibitor of hydrolase acting on acid anhydride (EC 3.6.*)
inhibitors of hydrolase acting on acid anhydride (EC 3.6.*)
EC 3.6.* (hydrolases acting on acid anhydrides) inhibitor
NF-kappaB inhibitor
NF-kappaB inhibitors
nuclear factor kappa-light-chain-enhancer of activated B cells inhibitor
nuclear factor kappa-light-chain-enhancer of activated B cells inhibitors
NF-kappaB inhibitor
cyclooxygenase 3 inhibitor
COX-3 inhibitor
COX-3 inhibitors
cyclo-oxygenase 3 inhibitor
cyclo-oxygenase 3 inhibitors
cyclooxygenase 3 inhibitors
cyclooxygenase-3 inhibitor
cyclooxygenase-3 inhibitors
cyclooxygenase 3 inhibitor
oxidative phosphorylation inhibitor
oxidative phosphorylation inhibitors
oxidative phosphorylation inhibitor
sodium-glucose transport protein subtype 2 inhibitor
SGLT2 inhibitor
SGLT2 inhibitors
sodium glucose co-transporter 2 inhibitor
sodium glucose co-transporter 2 inhibitors
sodium-glucose transport protein subtype 2 inhibitors
sodium-glucose transport protein subtype 2 inhibitor
cholecystokinin antagonist
CCK antagonist
CCK antagonists
cholecystokinin antagonists
cholecystokinin antagonist
adenosine A2A receptor agonist
A2A agonist
A2A agonists
A2A receptor agonist
A2A receptor agonists
adenosine A2A receptor agonists
adenosine A2A receptor agonist
adenosine receptor agonist
adenosine receptor agonist
adenosine receptor agonist
adenosine A3 receptor agonist
A3 agonist
A3 agonists
A3 receptor agonist
A3 receptor agonists
adenosine A3 receptor agonists
adenosine A3 receptor agonist
scabicide
scabicides
scabicide
thyroid hormone agonist
thyroid hormone agonists
thyromimetic
thyromimetics
thyroid hormone agonist
ultraviolet filter
UV filter
UV filters
ultraviolet filters
ultraviolet filter
vulnerary
vulneraries
wound-healing agent
wound-healing agents
wound-healing drug
wound-healing drugs
vulnerary
protein-sequencing agent
protein-sequencing agents
sequencing agent
sequencing agents
protein-sequencing agent
EC 2.7.3.2 (creatine kinase) inhibitor
CK inhibitor
CK inhibitors
CPK inhibitor
CPK inhibitors
EC 2.7.3.2 (creatine kinase) inhibitors
creatine kinase (EC 2.7.3.2) inhibitor
creatine kinase (EC 2.7.3.2) inhibitors
creatine kinase inhibitor
creatine kinase inhibitors
creatine phosphokinase inhibitor
creatine phosphokinase inhibitors
EC 2.7.3.2 (creatine kinase) inhibitor
EC 3.4.11.18 (methionyl aminopeptidase) inhibitor
EC 3.4.11.18 (methionyl aminopeptidase) inhibitors
EC 3.4.11.18 inhibitor
EC 3.4.11.18 inhibitors
L-methionine aminopeptidase inhibitor
L-methionine aminopeptidase inhibitors
MAP inhibitor
MAP inhibitors
methionine aminopeptidase inhibitor
methionine aminopeptidase inhibitors
methionyl aminopeptidase (EC 3.4.11.18) inhibitor
methionyl aminopeptidase (EC 3.4.11.18) inhibitors
methionyl aminopeptidase inhibitor
methionyl aminopeptidase inhibitors
peptidase M inhibitor
peptidase M inhibitors
EC 3.4.11.18 (methionyl aminopeptidase) inhibitor
methionine aminopeptidase 2 inhibitor
MAP2 inhibitor
MAP2 inhibitors
METAP2 inhibitor
METAP2 inhibitors
MetAP2 inhibitor
MetAP2 inhibitors
methionine aminopeptidase 2 inhibitors
methionine aminopeptidase-2 inhibitor
methionine aminopeptidase-2 inhibitors
methionine aminopeptidase 2 inhibitor
cannabinoid receptor antagonist
cannabinoid receptor antagonists
cannabinoid receptor antagonist
CB1 receptor antagonist
CB1 receptor antagonist
CB1 receptor antagonists
CB1R antagonist
CB1R antagonists
cannabinoid receptor 1 antagonist
cannabinoid receptor 1 antagonists
cannabinoid receptor type 1 antagonist
cannabinoid receptor type 1 antagonists
type 1 cannabinoid receptor antagonist
type 1 cannabinoid receptor antagonists
CB1 receptor antagonist
CB2 receptor antagonist
CB2 receptor antagonist
CB2 receptor antagonists
CB2R antagonist
CB2R antagonists
cannabinoid receptor 2 antagonist
cannabinoid receptor 2 antagonists
cannabinoid receptor type 2 antagonist
cannabinoid receptor type 2 antagonists
type 2 cannabinoid receptor antagonist
type 2 cannabinoid receptor antagonists
CB2 receptor antagonist
kynuramine
2',3-diaminopropiophenone
3-amino-1-(2-aminophenyl)-1-propanone
3-amino-1-(2-aminophenyl)propan-1-one
kynurenamine
kynuramine
spectrophotometric reagent
spectrophotometric reagents
spectrophotometric reagent
tolerogen
tolerogens
tolerogen
peptide coupling reagent
peptide coupling reagents
peptide coupling reagent
PPARbeta/delta agonist
NR1C2 agonist
NR1C2 agonists
PPAR(beta/delta) agonist
PPAR(beta/delta) agonists
PPAR-beta agonist
PPAR-beta agonists
PPAR-beta/delta agonist
PPAR-beta/delta agonists
PPAR-delta agonist
PPAR-delta agonists
PPARD agonist
PPARD agonists
PPARD receptor agonist
PPARD receptor agonists
PPARbeta agonist
PPARbeta agonists
PPARbeta/delta agonist
PPARbeta/delta agonists
PPARdelta agonist
PPARdelta agonists
nuclear receptor subfamily 1, group C, member 2 agonist
nuclear receptor subfamily 1, group C, member 2 agonists
peroxisome proliferator-activated receptor-beta agonist
peroxisome proliferator-activated receptor-beta agonists
peroxisome proliferator-activated receptor-delta agonist
peroxisome proliferator-activated receptor-delta agonists
PPARbeta/delta agonist
vibriostatic agent
vibriostatic
vibriostatics
vibriostatic agent
antifolate
antifolates
folic acid antagonist
folic acid antagonists
antifolate
nitric oxide synthase activator
NOS activator
NOS activators
nitric oxide synthase activators
nitric oxide synthase activator
lachrymator
lachrymators
lachrymator
mordant
mordant
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitor
2'-deoxyribonucleoside-diphosphate:thioredoxin-disulfide 2'-oxidoreductase inhibitors
ADP reductase inhibitor
ADP reductase inhibitors
CDP reductase inhibitor
CDP reductase inhibitors
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitors
EC 1.17.4.1 inhibitor
EC 1.17.4.1 inhibitors
RR inhibitor
RR inhibitors
UDP reductase inhibitor
UDP reductase inhibitors
nucleoside diphosphate reductase inhibitor
nucleoside diphosphate reductase inhibitors
ribonucleoside diphosphate reductase inhibitor
ribonucleoside diphosphate reductase inhibitors
ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitor
ribonucleoside-diphosphate reductase (EC 1.17.4.1) inhibitors
ribonucleoside-diphosphate reductase inhibitor
ribonucleoside-diphosphate reductase inhibitors
ribonucleotide diphosphate reductase inhibitor
ribonucleotide diphosphate reductase inhibitors
ribonucleotide reductase inhibitor
ribonucleotide reductase inhibitors
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor
7,8-dihydrobiopterin:NADP(+) oxidoreductase
7,8-dihydrobiopterin:NADP(+) oxidoreductases
EC 1.1.1.153 (sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)) inhibitor
EC 1.1.1.153 (sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)) inhibitors
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitors
L-erythro-7,8-dihydrobiopterin:NADP(+) oxidoreductase inhibitor
L-erythro-7,8-dihydrobiopterin:NADP(+) oxidoreductase inhibitors
sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) (EC 1.1.1.153) inhibitor
sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) (EC 1.1.1.153) inhibitors
sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) inhibitor
sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming) inhibitors
sepiapterin reductase inhibitor
sepiapterin reductase inhibitors
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor
polymerisation monomer
polymerization monomer
polymerisation monomer
quinol oxidation site inhibitor
QP site inhibitor
QP site inhibitors
quinol oxidation site inhibitors
quinol oxidation site inhibitor
epidermal growth factor receptor antagonist
EGFR antagonoist
EGFR antagonoists
EGFR inhibitor
EGFR inhibitors
epidermal growth factor receptor antagonists
epidermal growth factor receptor inhibitor
epidermal growth factor receptor inhibitors
epidermal growth factor receptor antagonist
anti-obesity agent
anti-obesity agents
anti-obestic agent
anti-obestic agents
anti-obesity agent
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
6-phospho-D-gluconate dehydrogenase inhibitor
6-phospho-D-gluconate dehydrogenase inhibitors
6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitor
6-phospho-D-gluconate:NADP+ 2-oxidoreductase (decarboxylating) inhibitors
6-phosphogluconate dehydrogenase (decarboxylating) inhibitor
6-phosphogluconate dehydrogenase (decarboxylating) inhibitors
6-phosphogluconic carboxylase inhibitor
6-phosphogluconic carboxylase inhibitors
6-phosphogluconic dehydrogenase inhibitor
6-phosphogluconic dehydrogenase inhibitors
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitors
EC 1.1.1.44 inhibitor
EC 1.1.1.44 inhibitors
NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitor
NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase (EC 1.1.1.44) inhibitors
NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitor
NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase inhibitors
phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitor
phosphogluconate dehydrogenase (NADP+ -dependent, decarboxylating) inhibitors
phosphogluconic acid dehydrogenase inhibitor
phosphogluconic acid dehydrogenase inhibitors
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor
antidote to paracetamol poisoning
Tylenol poisoning antidote
Tylenol poisoning antidotes
acetaminophen poisoning antidote
acetaminophen poisoning antidotes
antidote to Tylenol poisoning
antidote to acetaminophen poisoning
antidotes to Tylenol poisoning
antidotes to acetaminophen poisoning
antidotes to paracetamol poisoning
paracetamol poisoning antidote
paracetamol poisoning antidotes
antidote to paracetamol poisoning
antidote to curare poisoning
antidote to curare
antidote to tubocurarine
antidote to tubocurarine poisoning
antidotes to curare
antidotes to curare poisoning
antidotes to tubocurarine
antidotes to tubocurarine poisoning
curare antidote
curare antidotes
curare poisoning antidote
curare poisoning antidotes
tubocurarine antidote
tubocurarine antidotes
antidote to curare poisoning
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor
(5-L-glutamyl)-peptide:amino-acid 5-glutamyltransferase inhibitor
(5-L-glutamyl)-peptide:amino-acid 5-glutamyltransferase inhibitors
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitors
EC 2.3.2.2 inhibitor
EC 2.3.2.2 inhibitors
GGT inhibitor
GGT inhibitors
L-gamma-glutamyl transpeptidase inhibitor
L-gamma-glutamyl transpeptidase inhibitors
L-gamma-glutamyltransferase inhibitor
L-gamma-glutamyltransferase inhibitors
L-glutamyltransferase inhibitor
L-glutamyltransferase inhibitors
alpha-glutamyl transpeptidase inhibitor
alpha-glutamyl transpeptidase inhibitors
gamma-GPT inhibitor
gamma-GPT inhibitors
gamma-GT inhibitor
gamma-GT inhibitors
gamma-GTP inhibitor
gamma-GTP inhibitors
gamma-glutamyl peptidyltransferase inhibitor
gamma-glutamyl peptidyltransferase inhibitors
gamma-glutamyl transpeptidase inhibitor
gamma-glutamyl transpeptidase inhibitors
gamma-glutamyltransferase (EC 2.3.2.2) inhibitor
gamma-glutamyltransferase (EC 2.3.2.2) inhibitors
gamma-glutamyltransferase inhibitor
gamma-glutamyltransferase inhibitors
gamma-glutamyltranspeptidase inhibitor
gamma-glutamyltranspeptidase inhibitors
glutamyl transpeptidase inhibitor
glutamyl transpeptidase inhibitors
EC 2.3.2.2 (gamma-glutamyltransferase) inhibitor
astringent
adstringent
adstringents
astringents
astringent
neoglycolipid probe
neoglycolipid probe
microarray analysis reagent
microarray analysis reagents
microarray analysis reagent
EC 3.4.23.46 (memapsin 2) inhibitor
BACE1 inhibitor
BACE1 inhibitors
EC 3.4.23.46 (memapsin 2) inhibitors
EC 3.4.23.46 inhibitor
EC 3.4.23.46 inhibitors
Gamma-secretase inhibitor
Gamma-secretase inhibitors
beta-secretase inhibitor
beta-secretase inhibitors
beta-site APP-cleaving enzyme 1 inhibitor
beta-site APP-cleaving enzyme 1 inhibitors
beta-site Alzheimer's amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor
beta-site Alzheimer's amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors
beta-site Alzheimer's amyloid precursor protein cleaving enzyme 1 inhibitor
beta-site Alzheimer's amyloid precursor protein cleaving enzyme 1 inhibitors
gamma-secretase inhibitor
gamma-secretase inhibitors
memapsin 2 (EC 3.4.23.46) inhibitor
memapsin 2 (EC 3.4.23.46) inhibitors
memapsin 2 inhibitor
memapsin 2 inhibitors
membrane-associated aspartic protease 2 inhibitor
membrane-associated aspartic protease 2 inhibitors
EC 3.4.23.46 (memapsin 2) inhibitor
EC 3.1.27.3 (ribonuclease T1) inhibitor
Aspergillus oryzae ribonuclease inhibitor
Aspergillus oryzae ribonuclease inhibitors
EC 3.1.27.3 (ribonuclease T1) inhibitors
EC 3.1.27.3 inhibitor
EC 3.1.27.3 inhibitors
RNase F1 inhibitor
RNase F1 inhibitors
RNase G inhibitor
RNase G inhibitors
RNase N1 inhibitor
RNase N1 inhibitors
RNase N2 inhibitor
RNase N2 inhibitors
RNase Sa inhibitor
RNase Sa inhibitors
RNase T1 inhibitor
RNase T1 inhibitors
T1 inhibitor
T1 inhibitors
binase inhibitor
binase inhibitors
guanyl-specific RNase inhibitor
guanyl-specific RNase inhibitors
guanyloribonuclease inhibitor
guanyloribonuclease inhibitors
ribonuclease C2 inhibitor
ribonuclease C2 inhibitors
ribonuclease Ch inhibitor
ribonuclease Ch inhibitors
ribonuclease F1 inhibitor
ribonuclease F1 inhibitors
ribonuclease N1 inhibitor
ribonuclease N1 inhibitors
ribonuclease N3 inhibitor
ribonuclease N3 inhibitors
ribonuclease PP1 inhibitor
ribonuclease PP1 inhibitors
ribonuclease SA inhibitor
ribonuclease SA inhibitors
ribonuclease T1 (EC 3.1.27.3) inhibitor
ribonuclease T1 (EC 3.1.27.3) inhibitors
ribonuclease T1 inhibitor
ribonuclease T1 inhibitors
ribonuclease U1 inhibitor
ribonuclease U1 inhibitors
ribonuclease guaninenucleotido-2'-transferase (cyclising) inhibitor
ribonuclease guaninenucleotido-2'-transferase (cyclising) inhibitors
ribonuclease guaninenucleotido-2'-transferase (cyclizing) inhibitor
ribonuclease guaninenucleotido-2'-transferase (cyclizing) inhibitors
EC 3.1.27.3 (ribonuclease T1) inhibitor
B-Raf inhibitor
B-Raf inhibitors
BRAF inhibitor
BRAF inhibitors
human mutant serine/threonine kinase inhibitor
human mutant serine/threonine kinase inhibitors
B-Raf inhibitor
chromogenic compound
chromogen
chromogenic compounds
chromogens
chromogenic compound
EC 2.5.1.21 (squalene synthase) inhibitor
EC 2.5.1.21 (squalene synthase) inhibitors
EC 2.5.1.21 inhibitor
EC 2.5.1.21 inhibitors
SQS inhibitor
SQS inhibitors
farnesyl-diphosphate farnesyltransferase inhibitor
farnesyl-diphosphate farnesyltransferase inhibitors
farnesyl-diphosphate:farnesyl-diphosphate farnesyltransferase inhibitor
farnesyl-diphosphate:farnesyl-diphosphate farnesyltransferase inhibitors
farnesyltransferase inhibitor
farnesyltransferase inhibitors
presqualene synthase inhibitor
presqualene synthase inhibitors
presqualene-diphosphate synthase inhibitor
presqualene-diphosphate synthase inhibitors
squalene synthase (EC 2.5.1.21) inhibitor
squalene synthase (EC 2.5.1.21) inhibitors
squalene synthase inhibitor
squalene synthase inhibitors
squalene synthetase inhibitor
squalene synthetase inhibitors
EC 2.5.1.21 (squalene synthase) inhibitor
EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor
EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitors
EC 5.4.3.2 inhibitor
EC 5.4.3.2 inhibitors
L-lysine 2,3-aminomutase inhibitor
L-lysine 2,3-aminomutase inhibitors
lysine 2,3-aminomutase (EC 5.4.3.2) inhibitor
lysine 2,3-aminomutase (EC 5.4.3.2) inhibitors
lysine 2,3-aminomutase inhibitor
lysine 2,3-aminomutase inhibitors
EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor
insulin-like growth factor receptor 1 antagonist
IGF-1R antagonist
IGF-1R antagonists
insulin-like growth factor receptor 1 antagonists
insulin-like growth factor receptor 1 antagonist
ergosterol biosynthesis inhibitor
ergosterol biosynthesis inhibitors
ergosterol biosynthesis inhibitor
histamine releasing agent
histamine releasing agents
histamine releasing compound
histamine releasing compounds
histamine releasing substance
histamine releasing substances
histamine releasing agent
excipient
bulking agent
bulking agents
excipient
filler
fillers
excipient
cathartic
cathartics
cathartic
curing agent
curing agents
vulcanization agent
vulcanization agents
vulcanizing agent
vulcanizing agents
curing agent
EC 1.11.1.6 (catalase) inhibitor
CAT inhibitor
CAT inhibitors
EC 1.11.1.6 (catalase) inhibitors
EC 1.11.1.6 inhibitor
EC 1.11.1.6 inhibitors
caperase inhibitor
caperase inhibitors
catalase (EC 1.11.1.6) inhibitor
catalase (EC 1.11.1.6) inhibitors
catalase inhibitor
catalase inhibitors
catalase-peroxidase inhibitor
catalase-peroxidase inhibitors
equilase inhibitor
equilase inhibitors
hydrogen-peroxide:hydrogen-peroxide oxidoreductase inhibitor
hydrogen-peroxide:hydrogen-peroxide oxidoreductase inhibitors
optidase inhibitor
optidase inhibitors
EC 1.11.1.6 (catalase) inhibitor
EC 1.11.1.* (peroxidases) inhibitor
EC 1.11.1 inhibitor
EC 1.11.1 inhibitors
EC 1.11.1.* (peroxidase) inhibitor
EC 1.11.1.* (peroxidase) inhibitors
EC 1.11.1.* (peroxidases) inhibitors
EC 1.11.1.* inhibitor
EC 1.11.1.* inhibitors
inhibitor of peroxidases
inhibitors of peroxidases
peroxidases inhibitors
EC 1.11.1.* (peroxidases) inhibitor
platelet-activating factor receptor agonist
platelet-activating factor receptor agonists
platelet-activating factor receptor agonist
EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor
EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitors
EC 6.1.1.* inhibitor
EC 6.1.1.* inhibitors
aminoacyl tRNA synthetase inhibitor
aminoacyl tRNA synthetase inhibitors
ligases forming aminoacyl tRNA and related compounds (EC 6.1.1.*) inhibitor
ligases forming aminoacyl tRNA and related compounds (EC 6.1.1.*) inhibitors
tRNA synthetase inhibitor
tRNA synthetase inhibitors
EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor
EC 1.4.4.2 [glycine dehydrogenase (aminomethyl-transferring)] inhibitor
EC 1.4.4.2 (glycine dehydrogenase (aminomethyl-transferring)) inhibitor
EC 1.4.4.2 (glycine dehydrogenase (aminomethyl-transferring)) inhibitors
EC 1.4.4.2 [glycine dehydrogenase (aminomethyl-transferring)] inhibitors
EC 1.4.4.2 inhibitor
EC 1.4.4.2 inhibitors
P-protein inhibitor
P-protein inhibitors
glycine cleavage system P-protein inhibitor
glycine cleavage system P-protein inhibitors
glycine decarboxylase inhibitor
glycine decarboxylase inhibitors
glycine dehydrogenase (aminomethyl-transferring) (EC 1.4.4.2) inhibitor
glycine dehydrogenase (aminomethyl-transferring) (EC 1.4.4.2) inhibitors
glycine dehydrogenase (aminomethyl-transferring) inhibitor
glycine dehydrogenase (aminomethyl-transferring) inhibitors
glycine dehydrogenase (decarboxylating) inhibitor
glycine dehydrogenase (decarboxylating) inhibitors
glycine-cleavage complex P-protein inhibitor
glycine-cleavage complex P-protein inhibitors
glycine-cleavage complex inhibitor
glycine-cleavage complex inhibitors
glycine:H-protein-lipoyllysine oxidoreductase (decarboxylating, acceptor-amino-methylating)
glycine:H-protein-lipoyllysine oxidoreductase (decarboxylating, acceptor-amino-methylating) inhibitor
glycine:lipoylprotein oxidoreductase (decarboxylating and acceptor-aminomethylating) inhibitor
glycine:lipoylprotein oxidoreductase (decarboxylating and acceptor-aminomethylating) inhibitors
protein P1 inhibitor
protein P1 inhibitors
EC 1.4.4.2 [glycine dehydrogenase (aminomethyl-transferring)] inhibitor
EC 6.1.1.11 (serine--tRNA ligase) inhibitor
EC 6.1.1.11 (serine--tRNA ligase) inhibitor
EC 6.1.1.11 (serine--tRNA ligase) inhibitors
EC 6.1.1.11 inhibitor
EC 6.1.1.11 inhibitors
L-serine:tRNA(Ser) ligase (AMP-forming) inhibitor
L-serine:tRNA(Ser) ligase (AMP-forming) inhibitors
SerRS inhibitor
SerRS inhibitors
serine translase inhibitor
serine translase inhibitors
serine--tRNA ligase (EC 6.1.1.11) inhibitor
serine--tRNA ligase (EC 6.1.1.11) inhibitors
serine--tRNA ligase inhibitor
serine--tRNA ligase inhibitors
seryl-tRNA synthetase inhibitor
seryl-tRNA synthetase inhibitors
seryl-transfer RNA synthetase inhibitor
seryl-transfer RNA synthetase inhibitors
seryl-transfer ribonucleate synthetase inhibitor
seryl-transfer ribonucleate synthetase inhibitors
seryl-transfer ribonucleic acid synthetase inhibitor
seryl-transfer ribonucleic acid synthetase inhibitors
EC 6.1.1.11 (serine--tRNA ligase) inhibitor
EC 5.1.1.1 (alanine racemase) inhibitor
EC 5.1.1.1 (alanine racemase) inhibitors
EC 5.1.1.1 inhibitor
EC 5.1.1.1 inhibitors
L-alanine racemase inhibitor
L-alanine racemase inhibitors
alanine racemase (EC 5.1.1.1) inhibitor
alanine racemase (EC 5.1.1.1) inhibitors
alanine racemase inhibitor
alanine racemase inhibitors
EC 5.1.1.1 (alanine racemase) inhibitor
EC 5.* (isomerase) inhibitor
EC 5.* (isomerase) inhibitors
EC 5.* inhibitor
EC 5.* inhibitors
EC 5.*.*.* inhibitor
EC 5.*.*.* inhibitors
isomerase (EC 5.*) inhibitor
isomerase (EC 5.*) inhibitors
isomerase inhibitor
isomerase inhibitors
EC 5.* (isomerase) inhibitor
EC 6.3.2.4 (D-alanine--D-alanine ligase) inhibitor
D-alanine--D-alanine ligase (EC 6.3.2.4) inhibitor
D-alanine--D-alanine ligase (EC 6.3.2.4) inhibitors
D-alanine--D-alanine ligase inhibitor
D-alanine--D-alanine ligase inhibitors
D-alanine:D-alanine ligase (ADP-forming) inhibitor
D-alanine:D-alanine ligase (ADP-forming) inhibitors
EC 6.3.2.4 (D-alanine--D-alanine ligase) inhibitors
EC 6.3.2.4 inhibitor
EC 6.3.2.4 inhibitors
alanine:alanine ligase (ADP-forming) inhibitor
alanine:alanine ligase (ADP-forming) inhibitors
alanylalanine synthetase inhibitor
alanylalanine synthetase inhibitors
EC 6.3.2.4 (D-alanine--D-alanine ligase) inhibitor
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitors
EC 6.3.2.2 inhibitor
EC 6.3.2.2 inhibitors
gamma-glutamyl-L-cysteine synthetase inhibitor
gamma-glutamyl-L-cysteine synthetase inhibitors
gamma-glutamylcysteine synthetase inhibitor
gamma-glutamylcysteine synthetase inhibitors
gamma-glutamylcysteinyl synthetase inhibitor
gamma-glutamylcysteinyl synthetase inhibitors
glutamate--cysteine ligase (EC 6.3.2.2) inhibitor
glutamate--cysteine ligase (EC 6.3.2.2) inhibitors
glutamate--cysteine ligase inhibitor
glutamate--cysteine ligase inhibitors
EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor
EC 6.3.* (C-N bond-forming ligase) inhibitor
C--N bond-forming ligase inhibitor
C--N bond-forming ligase inhibitors
C-N bond-forming ligase (EC 6.3.*) inhibitor
C-N bond-forming ligase (EC 6.3.*) inhibitors
C-N bond-forming ligase inhibitor
C-N bond-forming ligase inhibitors
EC 6.3.* (C-N bond-forming ligase) inhibitorS
EC 6.3.* inhibitor
EC 6.3.* inhibitors
EC 6.3.*.* inhibitor
EC 6.3.*.* inhibitors
EC 6.3.* (C-N bond-forming ligase) inhibitor
EC 6.* (ligase) inhibitor
EC 6.* (ligase) inhibitors
EC 6.* inhibitor
EC 6.* inhibitors
EC 6.*.*.* inhibitor
EC 6.*.*.* inhibitors
ligase inhibitor
ligase inhibitors
EC 6.* (ligase) inhibitor
EC 6.4.* (C-C bond-forming ligase) inhibitor
C--C bond-forming ligase inhibitor
C--C bond-forming ligase inhibitors
C-C bond-forming ligase (EC 6.4.*) inhibitor
C-C bond-forming ligase (EC 6.4.*) inhibitorS
C-C bond-forming ligase inhibitor
C-C bond-forming ligase inhibitors
EC 6.4.* (C-C bond-forming ligase) inhibitorS
EC 6.4.* inhibitor
EC 6.4.* inhibitors
EC 6.4.*.* inhibitor
EC 6.4.*.* inhibitors
EC 6.4.* (C-C bond-forming ligase) inhibitor
EC 6.5.* (phosphoric ester bond-forming ligase) inhibitor
EC 6.5.* (phosphoric ester bond-forming ligase) inhibitors
EC 6.5.* inhibitor
EC 6.5.* inhibitors
EC 6.5.*.* inhibitor
EC 6.5.*.* inhibitors
phosphoric ester bond-forming ligase (EC 6.5.*) inhibitor
phosphoric ester bond-forming ligase (EC 6.5.*) inhibitors
phosphoric ester bond-forming ligase inhibitor
phosphoric ester bond-forming ligase inhibitors
EC 6.5.* (phosphoric ester bond-forming ligase) inhibitor
nifedipine
4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester
Adalat
Adapine
Coracten
Nifecard
Nifecor
Nifedipine
Nifedipres
Procardia
dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
nifedipine
nifedipino
nifedipinum
nifedipine
eukaryotic metabolite
eukaryotic metabolites
eukaryotic metabolite
animal metabolite
animal metabolites
animal metabolite
mammalian metabolite
mammalian metabolites
mammalian metabolite
mouse metabolite
Mus musculus metabolite
Mus musculus metabolites
mouse metabolites
mouse metabolite
Saccharomyces cerevisiae metabolite
S. cerevisiae metabolite
S. cerevisiae metabolites
S. cerevisiae secondary metabolite
S. cerevisiae secondary metabolites
Saccharomyces cerevisiae metabolites
Saccharomyces cerevisiae secondary metabolites
baker's yeast metabolite
baker's yeast metabolites
baker's yeast secondary metabolite
baker's yeast secondary metabolites
Saccharomyces cerevisiae metabolite
prokaryotic metabolite
prokaryotic metabolites
prokaryotic metabolite
anti-anaemic agent
anti-anaemic agents
anti-anaemic drug
anti-anaemic drugs
anti-anemia agent
anti-anemia agents
anti-anemia drug
anti-anemia drugs
anti-anemic agent
anti-anemic agents
anti-anemic drug
anti-anemic drugs
antianaemia agent
antianaemia agents
antianaemia drug
antianaemia drugs
antianaemic agent
antianaemic agents
antianaemic drug
antianaemic drugs
antianemia drug
antianemia drugs
anti-anaemic agent
EC 6.3.2.19 (ubiquitin--protein ligase) inhibitor
EC 6.3.2.19 (ubiquitin--protein ligase) inhibitors
EC 6.3.2.19 inhibitor
EC 6.3.2.19 inhibitors
S-phase kinase-associated protein 2 inhibitor
S-phase kinase-associated protein 2 inhibitors
Skp2 inhibitor
Skp2 inhibitors
ubiquitin--protein ligase inhibitor
ubiquitin--protein ligase inhibitors
ubiquitin-activating enzyme inhibitor
ubiquitin-activating enzyme inhibitors
ubiquitin:protein-lysine N-ligase (AMP-forming) inhibitor
ubiquitin:protein-lysine N-ligase (AMP-forming) inhibitors
EC 6.3.2.19 (ubiquitin--protein ligase) inhibitor
soluble guanylate cyclase activator
sGC activator
sGC activators
soluble guanylate cyclase activators
soluble guanylyl cyclase activator
soluble guanylyl cyclase activators
soluble guanylate cyclase activator
xenobiotic metabolite
xenobiotic metabolites
xenobiotic metabolite
fluorogen
fluorogen
EC 2.3.1.48 (histone acetyltransferase) inhibitor
EC 2.3.1.48 (histone acetyltransferase) inhibitors
EC 2.3.1.48 inhibitor
EC 2.3.1.48 inhibitors
HAT inhibitor
HAT inhibitors
acetyl-CoA:histone acetyltransferase inhibitor
acetyl-CoA:histone acetyltransferase inhibitors
histone acetokinase inhibitor
histone acetokinase inhibitors
histone acetylase inhibitor
histone acetylase inhibitors
histone acetyltransferase (EC 2.3.1.48) inhibitor
histone acetyltransferase (EC 2.3.1.48) inhibitors
histone acetyltransferase inhibitor
histone acetyltransferase inhibitors
histone transacetylase inhibitor
histone transacetylase inhibitors
nucleosome-histone acetyltransferase inhibitor
nucleosome-histone acetyltransferase inhibitors
EC 2.3.1.48 (histone acetyltransferase) inhibitor
greenhouse gas
greenhouse gases
greenhouse gas
propellant
propellants
propellant
coral metabolite
coral metabolites
coral metabolite
marine metabolite
marine metabolites
marine metabolite
odorant receptor antagonist
odorant receptor antagonists
odorant receptor blocker
odorant receptor blockers
odorant receptor antagonist
nephroprotective agent
nephroprotective agents
nephroprotective agent
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
ABL inhibitor
ABL inhibitors
ABL1 inhibitor
ABL1 inhibitors
ABL2 inhibitor
ABL2 inhibitors
ABLL inhibitor
ABLL inhibitors
ACK1 inhibitor
ACK1 inhibitors
ACK2 inhibitor
ACK2 inhibitors
AGMX1 inhibitor
AGMX1 inhibitors
ARG inhibitor
ARG inhibitors
ATK inhibitor
ATK inhibitors
ATP:[protein]-L-tyrosine O-phosphotransferase (non-specific) inhibitor
ATP:[protein]-L-tyrosine O-phosphotransferase (non-specific) inhibitors
BLK inhibitor
BLK inhibitors
BMX inhibitor
BMX inhibitors
BRK inhibitor
BRK inhibitors
BTK inhibitor
BTK inhibitors
BTKL inhibitor
BTKL inhibitors
Bmk inhibitor
Bmk inhibitors
Bruton's tyrosine kinase inhibitor
Bruton's tyrosine kinase inhibitors
Bsk inhibitor
Bsk inhibitors
CAKb inhibitor
CAKb inhibitors
CHK inhibitor
CHK inhibitors
CSK inhibitor
CSK inhibitors
CTK inhibitor
CTK inhibitors
CYL inhibitor
CYL inhibitors
Cdgip inhibitor
Cdgip inhibitors
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitors
EC 2.7.10.2 inhibitor
EC 2.7.10.2 inhibitors
EMT inhibitor
EMT inhibitors
ETK inhibitor
ETK inhibitors
FAK inhibitor
FAK inhibitors
FAK2 inhibitor
FAK2 inhibitors
FER inhibitor
FER inhibitors
FES inhibitor
FES inhibitors
FGR inhibitor
FGR inhibitors
FPS inhibitor
FPS inhibitors
FRK inhibitor
FRK inhibitors
FYN inhibitor
FYN inhibitors
Fadk inhibitor
Fadk inhibitors
Fert1/2 inhibitor
Fert1/2 inhibitors
HCK inhibitor
HCK inhibitors
HCTK inhibitor
HCTK inhibitors
HYL inhibitor
HYL inhibitors
IMD1 inhibitor
IMD1 inhibitors
ITK inhibitor
ITK inhibitors
IYK inhibitor
IYK inhibitors
JAK1 inhibitor
JAK1 inhibitors
JAK2 inhibitor
JAK2 inhibitors
JAK3 inhibitor
JAK3 inhibitors
JTK1 inhibitor
JTK1 inhibitors
JTK9 inhibitor
JTK9 inhibitors
Janus kinase 1 inhibitor
Janus kinase 1 inhibitors
Janus kinase 2 inhibitor
Janus kinase 2 inhibitors
Janus kinase 3 inhibitor
Janus kinase 3 inhibitors
Janus kinase inhibitor
L-JAK inhibitor
L-JAK inhibitors
LCK inhibitor
LCK inhibitors
LSK inhibitor
LSK inhibitors
LYN inhibitor
LYN inhibitors
MATK inhibitor
MATK inhibitors
Ntk inhibitor
Ntk inhibitors
PKB inhibitor
PKB inhibitors
PSCTK inhibitor
PSCTK inhibitors
PSCTK1 inhibitor
PSCTK1 inhibitors
PSCTK2 inhibitor
PSCTK2 inhibitors
PSCTK4 inhibitor
PSCTK4 inhibitors
PSCTK5 inhibitor
PSCTK5 inhibitors
PTK2 inhibitor
PTK2 inhibitors
PTK2B inhibitor
PTK2B inhibitors
PTK6 inhibitor
PTK6 inhibitors
PYK2 inhibitor
PYK2 inhibitors
RAFTK inhibitor
RAFTK inhibitors
RAK inhibitor
RAK inhibitors
Rlk inhibitor
Rlk inhibitors
SLK inhibitor
SLK inhibitors
SRC inhibitor
SRC inhibitors
SRC2 inhibitor
SRC2 inhibitors
SRK inhibitor
SRK inhibitors
SRM inhibitor
SRM inhibitors
SRMS inhibitor
SRMS inhibitors
STD inhibitor
STD inhibitors
SYK inhibitor
SYK inhibitors
SYN inhibitor
SYN inhibitors
Sik inhibitor
Sik inhibitors
TEC inhibitor
TEC inhibitors
TNK1 inhibitor
TNK1 inhibitors
TXK inhibitor
TXK inhibitors
TYK2 inhibitor
TYK2 inhibitors
TYK3 inhibitor
TYK3 inhibitors
Tck inhibitor
Tck inhibitors
Tsk inhibitor
Tsk inhibitors
YES1 inhibitor
YES1 inhibitors
YK2 inhibitor
YK2 inhibitors
ZAP70 inhibitor
ZAP70 inhibitors
cytoplasmic protein tyrosine kinase inhibitor
cytoplasmic protein tyrosine kinase inhibitors
focal adhesion kinase inhibitor
focal adhesion kinase inhibitors
non-specific protein-tyrosine kinase (EC 2.7.10.2) inhibitor
non-specific protein-tyrosine kinase (EC 2.7.10.2) inhibitors
p60c-src protein tyrosine kinase inhibitor
p60c-src protein tyrosine kinase inhibitors
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
fluorescence quencher
fluorescence quenchers
fluorescence quencher
EC 2.1.* (C1-transferase) inhibitor
C1-transferase (EC 2.1.*) inhibitor
C1-transferase (EC 2.1.*) inhibitors
C1-transferase inhibitor
C1-transferase inhibitors
EC 2.1.* (C1-transferase) inhibitors
EC 2.1.* inhibitor
EC 2.1.* inhibitors
one-carbon-containing group transferase inhibitor
one-carbon-containing group transferase inhibitors
EC 2.1.* (C1-transferase) inhibitor
EC 2.2.* (aldehyde or ketone transferase) inhibitor
EC 2.2.* (aldehyde or ketone transferase) inhibitors
EC 2.2.* inhibitor
EC 2.2.* inhibitors
aldehyde or ketone transferase inhibitor
aldehyde or ketone transferase inhibitors
aldehyde/ketone transferase (EC 2.2.*) inhibitor
aldehyde/ketone transferase (EC 2.2.*) inhibitors
aldehyde/ketone transferase inhibitor
aldehyde/ketone transferase inhibitors
EC 2.2.* (aldehyde or ketone transferase) inhibitor
EC 2.3.* (acyltransferase) inhibitor
EC 2.3.* (acyltransferase) inhibitors
EC 2.3.* inhibitor
EC 2.3.* inhibitors
acyltransferase inhibitor
acyltransferase inhibitors
EC 2.3.* (acyltransferase) inhibitor
EC 2.4.* (glycosyltransferase) inhibitor
EC 2.4.* (glycosyltransferase) inhibitors
EC 2.4.* inhibitor
EC 2.4.* inhibitors
glycosyltransferase (EC 2.4.*) inhibitor
glycosyltransferase (EC 2.4.*) inhibitors
glycosyltransferase inhibitor
glycosyltransferase inhibitors
EC 2.4.* (glycosyltransferase) inhibitor
EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor
EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitors
EC 2.5.1.* inhibitor
EC 2.5.1.* inhibitors
alkyl/aryl (non-methyl) transferase inhibitor
alkyl/aryl (non-methyl) transferase inhibitors
non-methyl alkyl/aryl transferase (EC 2.5.1.*) inhibitor
non-methyl alkyl/aryl transferase (EC 2.5.1.*) inhibitors
non-methyl alkyl/aryl transferase inhibitor
non-methyl alkyl/aryl transferase inhibitors
non-methyl-alkyl or aryl transferase inhibitor
non-methyl-alkyl or aryl transferase inhibitors
EC 2.5.1.* (non-methyl-alkyl or aryl transferase) inhibitor
EC 2.6.* (nitrogenous group transferase) inhibitor
EC 2.6.* inhibitor
EC 2.6.* inhibitors
nitrogenous group transferase (EC 2.6.*) inhibitor
nitrogenous group transferase (EC 2.6.*) inhibitors
nitrogenous group transferase inhibitor
nitrogenous group transferase inhibitors
EC 2.6.* (nitrogenous group transferase) inhibitor
EC 2.7.* (P-containing group transferase) inhibitor
EC 2.7.* (P-containing group transferase) inhibitors
EC 2.7.* (phosphorus-containing group transferase) inhibitor
EC 2.7.* (phosphorus-containing group transferase) inhibitors
EC 2.7.* inhibitor
EC 2.7.* inhibitors
phosphorus-containing group transferase (EC 2.7.*) inhibitor
phosphorus-containing group transferase (EC 2.7.*) inhibitors
phosphorus-containing group transferase inhibitor
phosphorus-containing group transferase inhibitors
EC 2.7.* (P-containing group transferase) inhibitor
EC 2.8.* (S-containing group transferase) inhibitor
EC 2.8.* (S-containing group transferase) inhibitor
EC 2.8.* (S-containing group transferase) inhibitors
EC 2.8.* inhibitor
EC 2.8.* inhibitors
S-containing group transferase inhibitor
S-containing group transferase inhibitors
sulfur-containing group transferase (EC 2.8.*) inhibitor
sulfur-containing group transferase (EC 2.8.*) inhibitors
sulfur-containing group transferase inhibitor
sulfur-containing group transferase inhibitors
EC 2.8.* (S-containing group transferase) inhibitor
EC 2.9.* (Se-containing group transferase) inhibitor
EC 2.9.* (Se-containing group transferase) inhibitors
EC 2.9.* inhibitor
EC 2.9.* inhibitors
Se-containing group transferase inhibitor
Se-containing group transferase inhibitors
selenium-containing group transferase (EC 2.9.*) inhibitor
selenium-containing group transferase (EC 2.9.*) inhibitors
selenium-containing group transferase inhibitor
selenium-containing group transferase inhibitors
EC 2.9.* (Se-containing group transferase) inhibitor
EC 2.10.* (Mo- or W-containing group transferase) inhibitor
EC 2.10.* (Mo- or W-containing group transferase) inhibitors
EC 2.10.* inhibitor
EC 2.10.* inhibitors
Mo- or W-containing group transferase (EC 2.10.*) inhibitor
Mo- or W-containing group transferase (EC 2.10.*) inhibitors
Mo- or W-containing group transferase inhibitor
Mo- or W-containing group transferase inhibitors
EC 2.10.* (Mo- or W-containing group transferase) inhibitor
EC 5.1.* (racemase/epimerase) inhibitor
EC 5.1.* (racemase/epimerase) inhibitors
EC 5.1.* inhibitor
EC 5.1.* inhibitors
racemase and epimerase (EC 5.1*) inhibitor
racemase and epimerase (EC 5.1*) inhibitors
racemase and epimerase inhibitor
racemase and epimerase inhibitors
racemase/epimerase inhibitor
racemase/epimerase inhibitors
EC 5.1.* (racemase/epimerase) inhibitor
EC 5.2.* (cis-trans-isomerase) inhibitor
EC 5.2.* (cis-trans-isomerase) inhibitors
EC 5.2.* inhibitor
EC 5.2.* inhibitors
cis-trans-isomerase (EC5.2.*) inhibitor
cis-trans-isomerase (EC5.2.*) inhibitors
cis-trans-isomerase inhibitor
cis-trans-isomerase inhibitors
EC 5.2.* (cis-trans-isomerase) inhibitor
EC 5.3.* (intramolecular oxidoreductase) inhibitor
EC 5.3.* (intramolecular oxidoreductase) inhibitors
intramolecular oxidoreductase (EC 5.3.*) inhibitor
intramolecular oxidoreductase (EC 5.3.*) inhibitors
intramolecular oxidoreductase inhibitor
intramolecular oxidoreductase inhibitors
EC 5.3.* (intramolecular oxidoreductase) inhibitor
EC 5.4.* (intramolecular transferase) inhibitor
EC 5.4.* (intramolecular transferase) inhibitors
intramolecular transferase (EC 5.4.*) inhibitor
intramolecular transferase (EC 5.4.*) inhibitors
intramolecular transferase inhibitor
intramolecular transferase inhibitors
EC 5.4.* (intramolecular transferase) inhibitor
EC 5.5.* (intramolecular lyase) inhibitor
EC 5.5.* (intramolecular lyase) inhibitors
EC 5.5.* inhibitor
EC 5.5.* inhibitors
intramolecular lyase inhibitor
intramolecular lyase inhibitors
EC 5.5.* (intramolecular lyase) inhibitor
EC 5.99.* (other isomerases) inhibitor
EC 5.99.* (miscellaneous isomerases) inhibitor
EC 5.99.* (miscellaneous isomerases) inhibitors
EC 5.99.* (other isomerase) inhibitor
EC 5.99.* (other isomerase) inhibitors
EC 5.99.* (other isomerases) inhibitors
EC 5.99.* inhibitor
EC 5.99.* inhibitors
EC 5.99.* (other isomerases) inhibitor
EC 6.1.* (C-O bond-forming ligase) inhibitor
C-O bond-forming ligase (EC 6.1.*) inhibitor
C-O bond-forming ligase (EC 6.1.*) inhibitors
C-O bond-forming ligase inhibitor
C-O bond-forming ligase inhibitors
EC 6.1.* (C-O bond-forming ligase) inhibitors
EC 6.1.* inhibitor
EC 6.1.* inhibitors
EC 6.1.* (C-O bond-forming ligase) inhibitor
EC 6.2.* (C-S bond-forming ligase) inhibitor
C-S bond-forming ligase (EC 6.2.*) inhibitor
C-S bond-forming ligase (EC 6.2.*) inhibitors
C-S bond-forming ligase inhibitor
C-S bond-forming ligase inhibitors
EC 6.2.* (C-S bond-forming ligase) inhibitors
EC 6.2.* inhibitor
EC 6.2.* inhibitors
EC 6.2.* (C-S bond-forming ligase) inhibitor
EC 6.6.* (N-metal bond-forming ligase) inhibitor
EC 6.6.* (N-metal bond-forming ligase) inhibitors
EC 6.6.* inhibitor
EC 6.6.* inhibitors
N-metal bond-forming ligase (EC 6.6.*) inhibitor
N-metal bond-forming ligase (EC 6.6.*) inhibitors
N-metal bond-forming ligase inhibitor
N-metal bond-forming ligase inhibitors
EC 6.6.* (N-metal bond-forming ligase) inhibitor
EC 4.* (lyase) inhibitor
EC 4.* (lyase) inhibitors
EC 4.* inhibitor
EC 4.* inhibitors
EC 4.*.*.* inhibitor
EC 4.*.*.* inhibitors
lyase (EC 4.*) inhibitor
lyase (EC 4.*) inhibitorS
lyase inhibitor
lyase inhibitors
EC 4.* (lyase) inhibitor
EC 4.1.* (C-C lyase) inhibitor
C-C lyase (EC 4.1.*) inhibitor
C-C lyase (EC 4.1.*) inhibitors
C-C lyase inhibitor
C-C lyase inhibitors
EC 4.1.* (C-C lyase) inhibitors
EC 4.1.* inhibitor
EC 4.1.* inhibitors
EC 4.1.* (C-C lyase) inhibitor
EC 4.2.* (C-O lyase) inhibitor
C-O lyase (EC 4.2.*) inhibitor
C-O lyase (EC 4.2.*) inhibitors
C-O lyase inhibitor
C-O lyase inhibitors
EC 4.2.* (C-O lyase) inhibitors
EC 4.2.* inhibitor
EC 4.2.* inhibitors
EC 4.2.* (C-O lyase) inhibitor
EC 4.3.* (C-N lyase) inhibitor
C-N lyase (EC 4.3.*) inhibitor
C-N lyase (EC 4.3.*) inhibitors
C-N lyase inhibitor
C-N lyase inhibitors
EC 4.3.* (C-N lyase) inhibitors
EC 4.3.* inhibitor
EC 4.3.* inhibitors
EC 4.3.* (C-N lyase) inhibitor
EC 4.4.* (C-S lyase) inhibitor
C-S lyase (EC 4.4.*) inhibitor
C-S lyase (EC 4.4.*) inhibitors
C-S lyase inhibitor
C-S lyase inhibitors
EC 4.4.* (C-S lyase) inhibitors
EC 4.4.* inhibitor
EC 4.4.* inhibitors
EC 4.4.* (C-S lyase) inhibitor
EC 4.5.* (C-halide lyase) inhibitor
C-halide lyase (EC 4.5.*) inhibitor
C-halide lyase (EC 4.5.*) inhibitors
C-halide lyase inhibitor
C-halide lyase inhibitors
EC 4.5.* (C-halide lyase) inhibitors
EC 4.5.* inhibitor
EC 4.5.* inhibitors
EC 4.5.* (C-halide lyase) inhibitor
EC 4.6.* (P-O lyase) inhibitor
EC 4.6.* (P-O lyase) inhibitors
EC 4.6.* inhibitor
EC 4.6.* inhibitors
P-O lyase (EC 4.6.*) inhibitor
P-O lyase (EC 4.6.*) inhibitors
P-O lyase inhibitor
P-O lyase inhibitors
EC 4.6.* (P-O lyase) inhibitor
EC 4.7.* (C-P lyase) inhibitor
C-P lyase (EC 4.7.*) inhibitor
C-P lyase (EC 4.7.*) inhibitors
C-P lyase inhibitor
C-P lyase inhibitors
EC 4.7.* (C-P lyase) inhibitors
EC 4.7.* inhibitor
EC 4.7.* inhibitors
EC 4.7.* (C-P lyase) inhibitor
EC 4.99.* (miscellaneous lyase) inhibitor
EC 4.99.* (miscellaneous lyase) inhibitors
EC 4.99.* (other lyase) inhibitor
EC 4.99.* (other lyase) inhibitors
EC 4.99.* inhibitor
EC 4.99.* inhibitors
miscellaneous lyase (EC 4.99.*) inhibitor
miscellaneous lyase (EC 4.99.*) inhibitors
miscellaneous lyase inhibitor
miscellaneous lyase inhibitors
other lyase (EC 4.99.*) inhibitor
other lyase (EC 4.99.*) inhibitors
EC 4.99.* (miscellaneous lyase) inhibitor
antisense oligonucleotide
antisense oligonucleotide
EC 1.* (oxidoreductase) inhibitor
EC 1.* (oxidoreductase) inhibitors
EC 1.* inhibitor
EC 1.* inhibitors
oxidoreductase (EC 1.*) inhibitor
oxidoreductase (EC 1.*) inhibitors
oxidoreductase inhibitor
oxidoreductase inhibitors
EC 1.* (oxidoreductase) inhibitor
EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor
EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitors
EC 1.1.* inhibitor
EC 1.1.* inhibitors
inhibitor of oxidoreductase acting on CH-OH group of donor
inhibitor of oxidoreductase acting on CH-OH group of donors
inhibitors of oxidoreductase acting on CH-OH group of donor
inhibitors of oxidoreductase acting on CH-OH group of donors
oxidoreductase acting on donor CH-OH group (EC 1.1.*) inhibitor
oxidoreductase acting on donor CH-OH group (EC 1.1.*) inhibitors
oxidoreductase acting on donor CH-OH group inhibitor
oxidoreductase acting on donor CH-OH group inhibitors
EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor
EC 1.2.* (oxidoreductase acting on donor aldehyde/oxo group) inhibitor
EC 1.2.* (oxidoreductase acting on donor aldehyde or oxo group) inhibitor
EC 1.2.* (oxidoreductase acting on donor aldehyde or oxo group) inhibitors
EC 1.2.* (oxidoreductase acting on donor aldehyde/oxo group) inhibitors
EC 1.2.* inhibitor
EC 1.2.* inhibitors
inhibitor of oxidoreductase acting on aldehyde or oxo group of donor
inhibitor of oxidoreductase acting on aldehyde or oxo group of donors
inhibitor of oxidoreductase acting on aldehyde/oxo group of donor
inhibitor of oxidoreductase acting on aldehyde/oxo group of donors
inhibitors of oxidoreductase acting on aldehyde or oxo group of donor
inhibitors of oxidoreductase acting on aldehyde or oxo group of donors
inhibitors of oxidoreductase acting on aldehyde/oxo group of donor
inhibitors of oxidoreductase acting on aldehyde/oxo group of donors
oxidoreductase acting on donor aldehyde or oxo group (EC 1.2.*) inhibitor
oxidoreductase acting on donor aldehyde or oxo group (EC 1.2.*) inhibitors
oxidoreductase acting on donor aldehyde or oxo group inhibitor
oxidoreductase acting on donor aldehyde or oxo group inhibitors
oxidoreductase acting on donor aldehyde/oxo group (EC 1.2.*) inhibitor
oxidoreductase acting on donor aldehyde/oxo group (EC 1.2.*) inhibitors
oxidoreductase acting on donor aldehyde/oxo group inhibitor
oxidoreductase acting on donor aldehyde/oxo group inhibitors
EC 1.2.* (oxidoreductase acting on donor aldehyde/oxo group) inhibitor
EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor
EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitors
EC 1.3.* inhibitor
EC 1.3.* inhibitors
inhibitor of oxidoreductase acting on CH-CH group of donor
inhibitor of oxidoreductase acting on CH-CH group of donors
inhibitors of oxidoreductase acting on CH-CH group of donor
inhibitors of oxidoreductase acting on CH-CH group of donors
oxidoreductase acting on donor CH-CH group (EC 1.3.*) inhibitor
oxidoreductase acting on donor CH-CH group (EC 1.3.*) inhibitors
oxidoreductase acting on donor CH-CH group inhibitor
oxidoreductase acting on donor CH-CH group inhibitors
EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor
EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor
EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor
EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitors
EC 1.4.* inhibitor
EC 1.4.* inhibitors
inhibitor of oxidoreductase acting on CH-NH2 group of donor
inhibitor of oxidoreductase acting on CH-NH2 group of donors
inhibitors of oxidoreductase acting on CH-NH2 group of donor
inhibitors of oxidoreductase acting on CH-NH2 group of donors
oxidoreductase acting on CH-NH2 group of donor inhibitor
oxidoreductase acting on CH-NH2 group of donor inhibitors
oxidoreductase acting on CH-NH2 group of donors (EC 1.4.*) inhibitor
oxidoreductase acting on CH-NH2 group of donors (EC 1.4.*) inhibitors
EC 1.4.* (oxidoreductase acting on donor CH-NH2 group) inhibitor
EC 1.5.* (oxidoreductase acting on donor CH-NH group) inhibitor
EC 1.5.* (oxidoreductase acting on donor CH-NH group) inhibitors
EC 1.5.* inhibitor
EC 1.5.* inhibitors
inhibitor of oxidoreductase acting on CH-NH group of donor
inhibitor of oxidoreductase acting on CH-NH group of donors
inhibitors of oxidoreductase acting on CH-NH group of donor
inhibitors of oxidoreductase acting on CH-NH group of donors
oxidoreductase acting on donor CH-NH group (EC 1.5.*) inhibitor
oxidoreductase acting on donor CH-NH group (EC 1.5.*) inhibitors
EC 1.5.* (oxidoreductase acting on donor CH-NH group) inhibitor
EC 1.6.* (oxidoreductase acting on NADH or NADPH) inhibitor
EC 1.6.* (oxidoreductase acting on NADH or NADPH) inhibitors
inhibitor of oxidoreductase acting on NADH or NADPH
inhibitor of oxidoreductase acting on NADH or NADPH (EC 1.6.*)
inhibitors of oxidoreductase acting on NADH or NADPH
inhibitors of oxidoreductase acting on NADH or NADPH (EC 1.6.*)
oxidoreductase acting on NADH or NADPH (EC 1.6.*) inhibitor
oxidoreductase acting on NADH or NADPH (EC 1.6.*) inhibitors
oxidoreductase acting on NADH or NADPH inhibitor
oxidoreductase acting on NADH or NADPH inhibitors
EC 1.6.* (oxidoreductase acting on NADH or NADPH) inhibitor
EC 1.7.* (oxidoreductase acting on other nitrogenous compounds as donors) inhibitor
EC 1.7.* (oxidoreductase acting on other nitrogenous compounds as donors) inhibitors
EC 1.7.* inhibitor
EC 1.7.* inhibitors
inhibitor of oxidoreductase acting on other nitrogenous compounds as donors
inhibitor of oxidoreductase acting on other nitrogenous compounds as donors (EC 1.7.*)
inhibitors of oxidoreductase acting on other nitrogenous compounds as donors
inhibitors of oxidoreductase acting on other nitrogenous compounds as donors (EC 1.7.*)
EC 1.7.* (oxidoreductase acting on other nitrogenous compounds as donors) inhibitor
EC 1.8.* (oxidoreductase acting on sulfur group of donors) inhibitor
EC 1.8.* (oxidoreductase acting on sulfur group of donors) inhibitors
EC 1.8.* inhibitor
EC 1.8.* inhibitors
oxidoreductase acting on a sulfur group of donors (EC 1.8.*) inhibitor
oxidoreductase acting on a sulfur group of donors (EC 1.8.*) inhibitors
EC 1.8.* (oxidoreductase acting on sulfur group of donors) inhibitor
EC 1.9.* (oxidoreductase acting on donor heme group) inhibitor
EC 1.9.* (oxidoreductase acting on a heme group of donors) inhibitor
EC 1.9.* (oxidoreductase acting on a heme group of donors) inhibitors
EC 1.9.* (oxidoreductase acting on donor heme group) inhibitors
EC 1.9.* inhibitor
EC 1.9.* inhibitors
oxidoreductase acting on a heme group of donors (EC 1.9.*) inhibitor
oxidoreductase acting on a heme group of donors (EC 1.9.*) inhibitors
EC 1.9.* (oxidoreductase acting on donor heme group) inhibitor
EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitor
EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitors
EC 1.10.* (oxidoreductases acting on diphenols and related substances as donors) inhibitor
EC 1.10.* (oxidoreductases acting on diphenols and related substances as donors) inhibitors
EC 1.10.* inhibitor
EC 1.10.* inhibitors
inhibitor of an oxidoreductase acting on diphenols and related substances as donor
inhibitor of an oxidoreductase acting on diphenols and related substances as donor (EC 1.10.*)
inhibitor of an oxidoreductase acting on diphenols and related substances as donors
inhibitors of an oxidoreductase acting on diphenols and related substances as donor
inhibitors of an oxidoreductase acting on diphenols and related substances as donor (EC 1.10.*)
inhibitors of an oxidoreductase acting on diphenols and related substances as donors
EC 1.10.* (oxidoreductase acting on diphenols and related substances as donors) inhibitor
EC 1.11.* (oxidoreductase acting on peroxide as donors) inhibitor
EC 1.11.* (oxidoreductase acting on peroxide as donors) inhibitors
EC 1.11.* (oxidoreductases acting on peroxide as donors) inhibitor
EC 1.11.* (oxidoreductases acting on peroxide as donors) inhibitors
EC 1.11.* inhibitor
EC 1.11.* inhibitors
oxidoreductase acting on peroxide as donors (EC 1.11.*) inhibitor
oxidoreductase acting on peroxide as donors (EC 1.11.*) inhibitors
oxidoreductases acting on peroxide as donors (EC 1.11.*) inhibitor
oxidoreductases acting on peroxide as donors (EC 1.11.*) inhibitors
EC 1.11.* (oxidoreductase acting on peroxide as donors) inhibitor
EC 1.12.* (oxidoreductase acting on hydrogen as donors) inhibitor
EC 1.12.* (oxidoreductase acting on hydrogen as donors) inhibitors
EC 1.12.* (oxidoreductases acting on hydrogen as donors) inhibitor
EC 1.12.* (oxidoreductases acting on hydrogen as donors) inhibitors
EC 1.12.* inhibitor
EC 1.12.* inhibitors
inhibitor of oxidoreductase acting on hydrogen as donors
inhibitor of oxidoreductase acting on hydrogen as donors (EC 1.12.*)
inhibitors of oxidoreductase acting on hydrogen as donors
inhibitors of oxidoreductase acting on hydrogen as donors (EC 1.12.*)
oxidoreductase acting on hydrogen as donors inhibitor
oxidoreductase acting on hydrogen as donors inhibitors
EC 1.12.* (oxidoreductase acting on hydrogen as donors) inhibitor
EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitor
EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitors
EC 1.13.* inhibitor
EC 1.13.* inhibitors
oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases) (EC 1.13.*) inhibitor
oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases) (EC 1.13.*) inhibitors
oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases) inhibitor
oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases) inhibitors
EC 1.13.* [oxidoreductase acting on single donors with incorporation of molecular oxygen (oxygenases)] inhibitor
EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitors
EC 1.14.* inhibitor
EC 1.14.* inhibitors
inhibitor of oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*)
inhibitor of oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*)
inhibitors of oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*)
inhibitors of oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*)
oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*) inhibitor
oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.*) inhibitors
oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen inhibitor
oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen inhibitors
EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
EC 1.15.* (oxidoreductase acting on superoxide as acceptor) inhibitor
EC 1.15.* (oxidoreductase acting on superoxide as acceptor) inhibitors
EC 1.15.* inhibitor
EC 1.15.* inhibitors
inhibitor of oxidoreductase acting on superoxide as acceptor
inhibitor of oxidoreductase acting on superoxide as acceptor (EC 1.15.*)
inhibitors of oxidoreductase acting on superoxide as acceptor
inhibitors of oxidoreductase acting on superoxide as acceptor (EC 1.15.*)
oxidoreductase acting on superoxide as acceptor (EC 1.15.*) inhibitor
oxidoreductase acting on superoxide as acceptor (EC 1.15.*) inhibitors
oxidoreductase acting on superoxide as acceptor inhibitor
oxidoreductase acting on superoxide as acceptor inhibitors
EC 1.15.* (oxidoreductase acting on superoxide as acceptor) inhibitor
EC 1.16.* (oxidoreductase oxidising metal ions) inhibitor
EC 1.16.* (oxidoreductase oxidising metal ions) inhibitors
EC 1.16.* (oxidoreductase oxidizing metal ions) inhibitor
EC 1.16.* (oxidoreductase oxidizing metal ions) inhibitors
EC 1.16.* inhibitor
EC 1.16.* inhibitors
oxidoreductase oxidising metal ions (EC 1.16.*) inhibitor
oxidoreductase oxidising metal ions (EC 1.16.*) inhibitors
oxidoreductase oxidising metal ions inhibitor
oxidoreductase oxidising metal ions inhibitors
oxidoreductase oxidizing metal ions (EC 1.16.*) inhibitor
oxidoreductase oxidizing metal ions (EC 1.16.*) inhibitors
oxidoreductase oxidizing metal ions inhibitor
oxidoreductase oxidizing metal ions inhibitors
EC 1.16.* (oxidoreductase oxidising metal ions) inhibitor
EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor
EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitors
EC 1.17.* inhibitor
EC 1.17.* inhibitors
oxidoreductase acting on CH or CH2 (EC 1.17.*) inhibitor
oxidoreductase acting on CH or CH2 (EC 1.17.*) inhibitors
oxidoreductase acting on CH or CH2 inhibitor
oxidoreductase acting on CH or CH2 inhibitors
EC 1.17.* (oxidoreductase acting on CH or CH2) inhibitor
EC 1.18.* (oxidoreductase acting on Fe-S proteins as donors) inhibitor
EC 1.18.* (oxidoreductase acting on Fe-S proteins as donors) inhibitors
EC 1.18.* (oxidoreductase acting on iron-sulfur proteins as donors) inhibitor
EC 1.18.* (oxidoreductase acting on iron-sulfur proteins as donors) inhibitors
EC 1.18.* inhibitor
EC 1.18.* inhibitors
inhibitor of oxidoreductase acting on Fe-S proteins as donors
inhibitor of oxidoreductase acting on iron-sulfur proteins as donors
inhibitors of oxidoreductase acting on Fe-S proteins as donors
inhibitors of oxidoreductase acting on iron-sulfur proteins as donors
inhibitors of oxidoreductases acting on iron-sulfur proteins as donors
oxidoreductase acting on Fe-S proteins as donors (EC 1.18.*) inhibitor
oxidoreductase acting on Fe-S proteins as donors (EC 1.18.*) inhibitors
oxidoreductase acting on iron-sulfur proteins as donors (EC 1.18.*) inhibitor
oxidoreductase acting on iron-sulfur proteins as donors (EC 1.18.*) inhibitors
EC 1.18.* (oxidoreductase acting on Fe-S proteins as donors) inhibitor
EC 1.19.* (oxidoreductase acting on reduced flavodoxin as donor) inhibitor
EC 1.19.* (oxidoreductase acting on reduced flavodoxin as donor) inhibitors
EC 1.19.* inhibitor
EC 1.19.* inhibitors
inhibitor of oxidoreductase acting on reduced flavodoxin as donor
inhibitor of oxidoreductase acting on reduced flavodoxin as donor (EC 1.19.*)
inhibitors of oxidoreductase acting on reduced flavodoxin as donor
inhibitors of oxidoreductase acting on reduced flavodoxin as donor (EC 1.19.*)
oxidoreductase acting on reduced flavodoxin as donor (EC 1.19.*) inhibitor
oxidoreductase acting on reduced flavodoxin as donor (EC 1.19.*) inhibitors
EC 1.19.* (oxidoreductase acting on reduced flavodoxin as donor) inhibitor
EC 1.20.* (oxidoreductase acting on P or As in donors) inhibitor
EC 1.20.* (oxidoreductase acting on P or As in donors) inhibitors
EC 1.20.* (oxidoreductase acting on phosphorus or arsenic in donors) inhibitor
EC 1.20.* (oxidoreductase acting on phosphorus or arsenic in donors) inhibitors
EC 1.20.* inhibitor
EC 1.20.* inhibitors
oxidoreductase acting on P or As in donors (EC 1.20.*) inhibitor
oxidoreductase acting on P or As in donors (EC 1.20.*) inhibitors
oxidoreductase acting on phosphorus or arsenic in donors (EC 1.20.*) inhibitor
oxidoreductase acting on phosphorus or arsenic in donors (EC 1.20.*) inhibitors
EC 1.20.* (oxidoreductase acting on P or As in donors) inhibitor
EC 1.21.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond) inhibitor
EC 1.21.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond) inhibitors
EC 1.21.* inhibitor
EC 1.21.* inhibitors
oxidoreductase acting on X-H and Y-H to form an X-Y bond (EC 1.21.*) inhibitor
oxidoreductase acting on X-H and Y-H to form an X-Y bond (EC 1.21.*) inhibitors
oxidoreductase acting on X-H and Y-H to form an X-Y bond inhibitor
oxidoreductase acting on X-H and Y-H to form an X-Y bond inhibitors
EC 1.21.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond) inhibitor
EC 1.22.* (oxidoreductase acting on halogen in donors) inhibitor
EC 1.22.* (oxidoreductase acting on halogen in donors) inhibitors
EC 1.22.* inhibitor
EC 1.22.* inhibitors
inhibitor of oxidoreductase acting on halogen in donors
inhibitor of oxidoreductase acting on halogen in donors (EC 1.22.*)
inhibitors of oxidoreductase acting on halogen in donors
inhibitors of oxidoreductase acting on halogen in donors (EC 1.22.*)
oxidoreductase acting on halogen in donors (EC 1.22.*) inhibitor
oxidoreductase acting on halogen in donors (EC 1.22.*) inhibitors
EC 1.22.* (oxidoreductase acting on halogen in donors) inhibitor
EC 1.23.* (oxidoreductase acting on C-O-C group as acceptor) inhibitor
EC 1.23.* (oxidoreductase acting on C-O-C group as acceptor) inhibitors
EC 1.23.* inhibitor
EC 1.23.* inhibitors
inhibitor of oxidoreductase acting on C-O-C group as acceptor
inhibitor of oxidoreductase acting on C-O-C group as acceptor (EC 1.23.*)
inhibitors of oxidoreductase acting on C-O-C group as acceptor
inhibitors of oxidoreductase acting on C-O-C group as acceptor (EC 1.23.*)
oxidoreductase acting on C-O-C group as acceptor (EC 1.23.*) inhibitor
oxidoreductase acting on C-O-C group as acceptor (EC 1.23.*) inhibitors
oxidoreductase acting on C-O-C group as acceptor inhibitor
oxidoreductase acting on C-O-C group as acceptor inhibitors
EC 1.23.* (oxidoreductase acting on C-O-C group as acceptor) inhibitor
EC 1.97.* (other oxidoreductase) inhibitor
EC 1.97.* (miscellaneous oxidoreductase) inhibitor
EC 1.97.* (miscellaneous oxidoreductase) inhibitors
EC 1.97.* (other oxidoreductase) inhibitors
EC 1.97.* inhibitor
EC 1.97.* inhibitors
inhibitor of 'other' oxidoreductase (EC 1.97.*)
inhibitor of miscellaneous oxidoreductase (EC 1.97.*)
inhibitors of 'other' oxidoreductase (EC 1.97.*)
inhibitors of miscellaneous oxidoreductase (EC 1.97.*)
EC 1.97.* (other oxidoreductase) inhibitor
EC 1.98.* (enzymes using H2 as reductant) inhibitor
EC 1.98.* (enzymes using H2 as reductant) inhibitors
EC 1.98.* inhibitor
EC 1.98.* inhibitors
inhibitor of enzymes using H2 as reductant (EC 1.98.*)
inhibitors of enzymes using H2 as reductant (EC 1.98.*)
EC 1.98.* (enzymes using H2 as reductant) inhibitor
EC 1.99.* (other oxidoreductases using O2 as oxidant) inhibitor
EC 1.99.* (other oxidoreductases using O2 as oxidant) inhibitors
EC 1.99.* inhibitor
EC 1.99.* inhibitors
EC 1.99.* (other oxidoreductases using O2 as oxidant) inhibitor
EC 3.* (hydrolase) inhibitor
EC 3.* (hydrolase) inhibitors
EC 3.* inhibitor
EC 3.* inhibitors
EC 3.*.*.* inhibitor
EC 3.*.*.* inhibitors
hydrolase (EC 3.*) inhibitor
hydrolase (EC 3.*) inhibitors
hydrolase inhibitor
hydrolase inhibitors
EC 3.* (hydrolase) inhibitor
EC 3.1.* (ester hydrolase) inhibitor
EC 3.1.* (ester hydrolase) inhibitors
EC 3.1.* inhibitor
EC 3.1.* inhibitors
ester hydrolase (EC 3.1.*) inhibitor
ester hydrolase (EC 3.1.*) inhibitors
ester hydrolase inhibitor
ester hydrolase inhibitors
EC 3.1.* (ester hydrolase) inhibitor
EC 3.2.* (glycosylase) inhibitor
EC 3.2.* (glycosylase) inhibitors
EC 3.2.* inhibitor
EC 3.2.* inhibitors
glycosylase (EC 3.2.*) inhibitor
glycosylase (EC 3.2.*) inhibitors
glycosylase inhibitor
glycosylase inhibitors
EC 3.2.* (glycosylase) inhibitor
EC 3.3.* (ether hydrolase) inhibitor
EC 3.3.* (ether hydrolase) inhibitors
EC 3.3.* (hydrolase acting on ether bond) inhibitor
EC 3.3.* (hydrolase acting on ether bond) inhibitors
EC 3.3.* inhibitor
EC 3.3.* inhibitors
ether hydrolase (EC 3.3.*) inhibitor
ether hydrolase (EC 3.3.*) inhibitors
ether hydrolase inhibitor
ether hydrolase inhibitors
EC 3.3.* (ether hydrolase) inhibitor
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor
EC 3.5.* (hydrolase acting on non-peptide C-N bond) inhibitor
EC 3.5.* (hydrolase acting on non-peptide C-N bond) inhibitors
EC 3.5.* (hydrolases acting on C-N bonds, other than peptide bonds) inhibitor
EC 3.5.* (hydrolases acting on C-N bonds, other than peptide bonds) inhibitors
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitors
EC 3.5.* inhibitor
EC 3.5.* inhibitors
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor
EC 3.7.* (hydrolases acting on C-C bonds) inhibitor
EC 3.7.* (hydrolases acting on C-C bonds) inhibitors
EC 3.7.* (hydrolases acting on carbon-carbon bonds) inhibitor
EC 3.7.* (hydrolases acting on carbon-carbon bonds) inhibitors
EC 3.7.* inhibitor
EC 3.7.* inhibitors
EC 3.7.* (hydrolases acting on C-C bonds) inhibitor
EC 3.8.* (hydrolases acting on halide bonds) inhibitor
EC 3.8.* (hydrolases acting on halide bonds) inhibitors
EC 3.8.* inhibitor
EC 3.8.* inhibitors
hydrolases acting on halide bonds (EC 3.8.*) inhibitor
hydrolases acting on halide bonds (EC 3.8.*) inhibitors
inhibitor of hydrolases acting on halide bonds (EC 3.8.*)
inhibitors of hydrolases acting on halide bonds (EC 3.8.*)
EC 3.8.* (hydrolases acting on halide bonds) inhibitor
EC 3.9.* (hydrolases acting on P-N bonds) inhibitor
EC 3.9.* (hydrolases acting on P-N bonds) inhibitors
EC 3.9.* (hydrolases acting on phosphorus-nitrogen bonds) inhibitor
EC 3.9.* (hydrolases acting on phosphorus-nitrogen bonds) inhibitors
EC 3.9.* inhibitor
EC 3.9.* inhibitors
hydrolases acting on P-N bonds (EC 3.9.*) inhibitor
hydrolases acting on P-N bonds (EC 3.9.*) inhibitors
hydrolases acting on phosphorus-nitrogen bonds (EC 3.9.*) inhibitor
hydrolases acting on phosphorus-nitrogen bonds (EC 3.9.*) inhibitors
inhibitor of hydrolases acting on P-N bonds
inhibitor of hydrolases acting on P-N bonds (EC 3.9.*)
inhibitor of hydrolases acting on phosphorus-nitrogen bonds
inhibitor of hydrolases acting on phosphorus-nitrogen bonds (EC 3.9.*)
inhibitors of hydrolases acting on P-N bonds
inhibitors of hydrolases acting on P-N bonds (EC 3.9.*)
inhibitors of hydrolases acting on phosphorus-nitrogen bonds
inhibitors of hydrolases acting on phosphorus-nitrogen bonds (EC 3.9.*)
EC 3.9.* (hydrolases acting on P-N bonds) inhibitor
EC 3.10.* (hydrolases acting on S-N bonds) inhibitor
EC 3.10.* (hydrolases acting on S-N bonds) inhibitors
EC 3.10.* (hydrolases acting on sulfur-nitrogen bonds) inhibitor
EC 3.10.* (hydrolases acting on sulfur-nitrogen bonds) inhibitors
EC 3.10.* inhibitor
EC 3.10.* inhibitors
hydrolases acting on S-N bonds (EC 3.10.*) inhibitor
hydrolases acting on S-N bonds (EC 3.10.*) inhibitors
hydrolases acting on sulfur-nitrogen bonds (EC 3.10.*) inhibitor
hydrolases acting on sulfur-nitrogen bonds (EC 3.10.*) inhibitors
inhibitor of hydrolases acting on S-N bonds
inhibitor of hydrolases acting on S-N bonds (EC 3.10.*)
inhibitor of hydrolases acting on sulfur-nitrogen bonds
inhibitor of hydrolases acting on sulfur-nitrogen bonds (EC 3.10.*)
inhibitors of hydrolases acting on S-N bonds
inhibitors of hydrolases acting on S-N bonds (EC 3.10.*)
inhibitors of hydrolases acting on sulfur-nitrogen bonds
inhibitors of hydrolases acting on sulfur-nitrogen bonds (EC 3.10.*)
EC 3.10.* (hydrolases acting on S-N bonds) inhibitor
EC 3.11.* (hydrolases acting on C-P bonds) inhibitor
EC 3.11.* (hydrolases acting on C-P bonds) inhibitors
EC 3.11.* (hydrolases acting on carbon-phosphorus bonds) inhibitor
EC 3.11.* (hydrolases acting on carbon-phosphorus bonds) inhibitors
EC 3.11.* inhibitor
EC 3.11.* inhibitors
hydrolases acting on C-P bonds (EC 3.11.*) inhibitor
hydrolases acting on C-P bonds (EC 3.11.*) inhibitors
hydrolases acting on carbon-phosphorus bonds (EC 3.11.*) inhibitor
hydrolases acting on carbon-phosphorus bonds (EC 3.11.*) inhibitors
inhibitor of hydrolases acting on C-P bonds
inhibitor of hydrolases acting on C-P bonds (EC 3.11.*)
inhibitor of hydrolases acting on carbon-phosphorus bonds
inhibitor of hydrolases acting on carbon-phosphorus bonds (EC 3.11.*)
inhibitors of hydrolases acting on C-P bonds
inhibitors of hydrolases acting on C-P bonds (EC 3.11.*)
inhibitors of hydrolases acting on carbon-phosphorus bonds
inhibitors of hydrolases acting on carbon-phosphorus bonds (EC 3.11.*)
EC 3.11.* (hydrolases acting on C-P bonds) inhibitor
EC 3.12.* (hydrolases acting on S-S bonds) inhibitor
EC 3.12.* (hydrolases acting on S-S bonds) inhibitors
EC 3.12.* (hydrolases acting on sulfur-sulfur bonds) inhibitor
EC 3.12.* (hydrolases acting on sulfur-sulfur bonds) inhibitors
EC 3.12.* inhibitor
EC 3.12.* inhibitors
hydrolases acting on S-S bonds (EC 3.12.*) inhibitor
hydrolases acting on S-S bonds (EC 3.12.*) inhibitors
hydrolases acting on S-S bonds inhibitor
hydrolases acting on S-S bonds inhibitors
hydrolases acting on sulfur-sulfur bonds (EC 3.12.*) inhibitor
hydrolases acting on sulfur-sulfur bonds (EC 3.12.*) inhibitors
hydrolases acting on sulfur-sulfur bonds inhibitor
hydrolases acting on sulfur-sulfur bonds inhibitors
EC 3.12.* (hydrolases acting on S-S bonds) inhibitor
EC 3.13.* (hydrolases acting on C-S bonds) inhibitor
EC 3.13.* (hydrolases acting on C-S bonds) inhibitors
EC 3.13.* (hydrolases acting on carbon-sulfur bonds) inhibitor
EC 3.13.* (hydrolases acting on carbon-sulfur bonds) inhibitors
EC 3.13.* inhibitor
EC 3.13.* inhibitors
hydrolases acting on C-S bonds (EC 3.13.*) inhibitor
hydrolases acting on C-S bonds (EC 3.13.*) inhibitors
hydrolases acting on C-S bonds inhibitor
hydrolases acting on C-S bonds inhibitors
hydrolases acting on carbon-sulfur bonds (EC 3.13.*) inhibitor
hydrolases acting on carbon-sulfur bonds (EC 3.13.*) inhibitors
hydrolases acting on carbon-sulfur bonds inhibitor
hydrolases acting on carbon-sulfur bonds inhibitors
EC 3.13.* (hydrolases acting on C-S bonds) inhibitor
EC 3.1.1.* (carboxylic ester hydrolase) inhibitor
EC 3.1.1.* (carboxylic ester hydrolase) inhibitors
EC 3.1.1.* inhibitor
EC 3.1.1.* inhibitors
carboxylic ester hydrolase (EC 3.1.1.*) inhibitor
carboxylic ester hydrolase (EC 3.1.1.*) inhibitors
EC 3.1.1.* (carboxylic ester hydrolase) inhibitor
EC 3.1.3.* (phosphoric monoester hydrolase) inhibitor
EC 3.1.3.* (phosphoric monoester hydrolase) inhibitors
EC 3.1.3.* inhibitor
EC 3.1.3.* inhibitors
inhibitor of phosphoric monoester hydrolase
inhibitor of phosphoric monoester hydrolase (EC 3.1.3.*)
inhibitors of phosphoric monoester hydrolase
inhibitors of phosphoric monoester hydrolase (EC 3.1.3.*)
phosphoric monoester hydrolase (EC 3.1.3.*) inhibitor
phosphoric monoester hydrolase (EC 3.1.3.*) inhibitors
phosphoric monoester hydrolase inhibitor
phosphoric monoester hydrolase inhibitors
EC 3.1.3.* (phosphoric monoester hydrolase) inhibitor
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
EC 3.4.21.26 (prolyl oligopeptidase) inhibitors
EC 3.4.21.26 inhibitor
EC 3.4.21.26 inhibitors
endoprolylpeptidase inhibitor
endoprolylpeptidase inhibitors
post-proline cleaving enzyme inhibitor
post-proline cleaving enzyme inhibitors
post-proline endopeptidase inhibitor
post-proline endopeptidase inhibitors
proline endopeptidase inhibitor
proline endopeptidase inhibitors
proline-specific endopeptidase inhibitor
proline-specific endopeptidase inhibitors
prolyl endopeptidase inhibitor
prolyl endopeptidase inhibitors
prolyl oligopeptidase (EC 3.4.21.26) inhibitor
prolyl oligopeptidase (EC 3.4.21.26) inhibitors
prolyl oligopeptidase inhibitor
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
EC 3.4.15.* (peptidyl-dipeptidase) inhibitor
EC 3.4.15.* (peptidyl-dipeptidase) inhibitors
EC 3.4.15.* inhibitor
EC 3.4.15.* inhibitors
inhibitor of peptidyl-dipeptidases
inhibitor of peptidyl-dipeptidases (EC 3.4.15.*)
inhibitors of peptidyl-dipeptidases
inhibitors of peptidyl-dipeptidases (EC 3.4.15.*)
peptidyl-dipeptidase (EC 3.4.15.*) inhibitor
peptidyl-dipeptidase (EC 3.4.15.*) inhibitors
peptidyl-dipeptidase inhibitor
peptidyl-dipeptidase inhibitors
EC 3.4.15.* (peptidyl-dipeptidase) inhibitor
EC 3.1.26.* (endoribonucleases producing 5'-phosphomonoesters) inhibitor
EC 3.1.26.* (endoribonucleases producing 5'-phosphomonoesters) inhibitors
EC 3.1.26.* inhibitor
EC 3.1.26.* inhibitors
endoribonuclease producing 5'-phosphomonoesters (EC 3.1.26.*) inhibitor
endoribonuclease producing 5'-phosphomonoesters (EC 3.1.26.*) inhibitors
endoribonuclease producing 5'-phosphomonoesters inhibitor
endoribonuclease producing 5'-phosphomonoesters inhibitors
EC 3.1.26.* (endoribonucleases producing 5'-phosphomonoesters) inhibitor
EC 3.4.11.* (aminopeptidase) inhibitor
EC 3.4.11.* (aminopeptidase) inhibitors
EC 3.4.11.* inhibitor
EC 3.4.11.* inhibitors
aminopeptidase (EC 3.4.11.*) inhibitor
aminopeptidase (EC 3.4.11.*) inhibitors
EC 3.4.11.* (aminopeptidase) inhibitor
EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor
EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitors
EC 3.4.14.* inhibitor
EC 3.4.14.* inhibitors
EC 3.4.14.*(dipeptidyl-peptidases and tripeptidyl-peptidases) inhibitor
EC 3.4.14.*(dipeptidyl-peptidases and tripeptidyl-peptidases) inhibitors
dipeptidyl- and tripeptidyl-peptidase (EC 3.4.14.*) inhibitor
dipeptidyl- and tripeptidyl-peptidase (EC 3.4.14.*) inhibitors
dipeptidyl- and tripeptidyl-peptidase inhibitor
dipeptidyl- and tripeptidyl-peptidase inhibitors
dipeptidyl- and tripeptidyl-peptidases (EC 3.4.14.*) inhibitor
dipeptidyl- and tripeptidyl-peptidases (EC 3.4.14.*) inhibitors
dipeptidyl- and tripeptidyl-peptidases inhibitor
dipeptidyl- and tripeptidyl-peptidases inhibitors
dipeptidyl-peptidases and tripeptidyl-peptidases (EC 3.4.14.*) inhibitor
dipeptidyl-peptidases and tripeptidyl-peptidases (EC 3.4.14.*) inhibitors
EC 3.4.14.* (dipeptidyl- and tripeptidyl-peptidases) inhibitor
EC 2.4.1.* (hexosyltransferase) inhibitor
EC 2.4.1.* (hexosyltransferase) inhibitors
EC 2.4.1.* inhibitor
EC 2.4.1.* inhibitors
hexosyltransferase (EC 2.4.1.*) inhibitor
hexosyltransferase (EC 2.4.1.*) inhibitors
hexosyltransferase inhibitor
hexosyltransferase inhibitors
EC 2.4.1.* (hexosyltransferase) inhibitor
EC 2.4.2.* (pentosyltransferase) inhibitor
EC 2.4.2.* (pentosyltransferase) inhibitors
EC 2.4.2.* inhibitor
EC 2.4.2.* inhibitors
pentosyltransferase (EC 2.4.2.*) inhibitor
pentosyltransferase (EC 2.4.2.*) inhibitors
pentosyltransferase inhibitor
pentosyltransferase inhibitors
EC 2.4.2.* (pentosyltransferase) inhibitor
EC 3.1.27.* (endoribonucleases producing other than 5'-phosphomonoesters) inhibitor
EC 3.1.27.* (endoribonucleases producing other than 5'-phosphomonoesters) inhibitors
EC 3.1.27.* inhibitor
EC 3.1.27.* inhibitors
inhibitor of endoribonucleases producing other than 5'-phosphomonoesters
inhibitor of endoribonucleases producing other than 5'-phosphomonoesters (EC 3.1.27.*)
inhibitors of endoribonucleases producing other than 5'-phosphomonoesters
inhibitors of endoribonucleases producing other than 5'-phosphomonoesters (EC 3.1.27.*)
EC 3.1.27.* (endoribonucleases producing other than 5'-phosphomonoesters) inhibitor
EC 3.4.22.36 (caspase-1) inhibitor
EC 3.4.22.36 (caspase-1) inhibitors
EC 3.4.22.36 inhibitor
EC 3.4.22.36 inhibitors
ICE inhibitor
ICE inhibitors
caspase-1 (EC 3.4.22.36) inhibitor
caspase-1 (EC 3.4.22.36) inhibitors
caspase-1 inhibitor
caspase-1 inhibitors
interleukin 1 converting enzyme inhibitor
interleukin 1 converting enzyme inhibitors
interleukin 1beta converting enzyme inhibitor
interleukin 1beta converting enzyme inhibitors
interleukin 1beta precursor proteinase inhibitor
interleukin 1beta precursor proteinase inhibitors
interleukin 1beta-converting endopeptidase inhibitor
interleukin 1beta-converting endopeptidase inhibitors
interleukin 1beta-converting enzyme inhibitor
interleukin 1beta-converting enzyme inhibitors
interleukin-1 beta convertase precursor inhibitor
interleukin-1 beta convertase precursor inhibitors
interleukin-1beta convertase inhibitor
interleukin-1beta convertase inhibitors
interleukin-1beta converting enzyme inhibitor
interleukin-1beta converting enzyme inhibitors
interleukin-1beta precursor proteinase inhibitor
interleukin-1beta precursor proteinase inhibitors
precursor interleukin-1beta converting enzyme inhibitor
precursor interleukin-1beta converting enzyme inhibitors
pro-interleukin 1beta proteinase inhibitor
pro-interleukin 1beta proteinase inhibitors
prointerleukin 1beta protease inhibitor
prointerleukin 1beta protease inhibitors
protease A inhibitor
protease A inhibitors
protease VII inhibitor
protease VII inhibitors
EC 3.4.22.36 (caspase-1) inhibitor
EC 3.4.22.* (cysteine endopeptidase) inhibitor
EC 3.4.22.* (cysteine endopeptidase) inhibitors
EC 3.4.22.* inhibitor
EC 3.4.22.* inhibitors
cysteine endopeptidase (EC 3.4.22.*) inhibitor
cysteine endopeptidase (EC 3.4.22.*) inhibitors
cysteine endopeptidase inhibitor
cysteine endopeptidase inhibitors
EC 3.4.22.* (cysteine endopeptidase) inhibitor
EC 2.5.1.18 (glutathione transferase) inhibitor
EC 2.5.1.18 (glutathione transferase) inhibitors
EC 2.5.1.18 inhibitor
EC 2.5.1.18 inhibitors
RX:glutathione R-transferase inhibitor
RX:glutathione R-transferase inhibitors
S-(hydroxyalkyl)glutathione lyase inhibitor
S-(hydroxyalkyl)glutathione lyase inhibitors
glutathione S-alkyl transferase inhibitor
glutathione S-alkyl transferase inhibitors
glutathione S-alkyltransferase inhibitor
glutathione S-alkyltransferase inhibitors
glutathione S-aralkyltransferase inhibitor
glutathione S-aralkyltransferase inhibitors
glutathione S-aryltransferase inhibitor
glutathione S-aryltransferase inhibitors
glutathione S-transferase inhibitor
glutathione S-transferase inhibitors
glutathione transferase (EC 2.5.1.18) inhibitor
glutathione transferase (EC 2.5.1.18) inhibitors
glutathione transferase inhibitor
glutathione transferase inhibitors
EC 2.5.1.18 (glutathione transferase) inhibitor
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitors
EC 1.14.15.4 inhibitor
EC 1.14.15.4 inhibitors
cytochrome p450 XIB1 inhibitor
cytochrome p450 XIB1 inhibitors
steroid 11beta-hydroxylase inhibitor
steroid 11beta-hydroxylase inhibitors
steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor
steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitors
steroid 11beta-monooxygenase inhibitors
steroid 11beta/18-hydroxylase inhibitor
steroid 11beta/18-hydroxylase inhibitors
steroid,reduced-adrenodoxin:oxygen oxidoreductase (11beta-hydroxylating) inhibitor
steroid,reduced-adrenodoxin:oxygen oxidoreductase (11beta-hydroxylating) inhibitors
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitors
EC 3.5.1.* inhibitor
EC 3.5.1.* inhibitors
non-peptide linear amide C-N hydrolase (EC 3.5.1.*) inhibitor
non-peptide linear amide C-N hydrolase (EC 3.5.1.*) inhibitors
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor
EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor
EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitors
EC 3.5.2.* inhibitor
EC 3.5.2.* inhibitors
non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*) inhibitor
non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*) inhibitors
non-peptide cyclic amide C-N hydrolase inhibitor
non-peptide cyclic amide C-N hydrolase inhibitors
EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor
EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor
EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitors
non-peptide cyclic amidine C-N hydrolase (EC 3.5.4.*) inhibitor
non-peptide cyclic amidine C-N hydrolase (EC 3.5.4.*) inhibitors
non-peptide cyclic amidine C-N hydrolase inhibitor
non-peptide cyclic amidine C-N hydrolase inhibitors
EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitors
EC 3.1.4.12 inhibitor
EC 3.1.4.12 inhibitors
SMase inhibitor
SMase inhibitors
acid sphingomyelinase inhibitor
acid sphingomyelinase inhibitors
neutral sphingomyelinase inhibitor
neutral sphingomyelinase inhibitors
sphingomyelin cholinephosphohydrolase inhibitor
sphingomyelin cholinephosphohydrolase inhibitors
sphingomyelin phosphodiesterase (EC 3.1.4.12) inhibitor
sphingomyelin phosphodiesterase (EC 3.1.4.12) inhibitors
sphingomyelin phosphodiesterase inhibitor
sphingomyelin phosphodiesterase inhibitors
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor
EC 2.7.11.* (protein-serine/threonine kinase) inhibitor
EC 2.7.11.* (protein-serine/threonine kinase) inhibitors
EC 2.7.11.* inhibitor
EC 2.7.11.* inhibitors
protein-serine/threonine kinase (EC 2.7.11.*) inhibitor
protein-serine/threonine kinase (EC 2.7.11.*) inhibitors
protein-serine/threonine kinase inhibitor
protein-serine/threonine kinase inhibitors
EC 2.7.11.* (protein-serine/threonine kinase) inhibitor
EC 2.7.7.* (nucleotidyltransferase) inhibitor
EC 2.7.7.* (nucleotidyltransferase) inhibitors
inhibitor of nucleotidyltransferases
inhibitor of nucleotidyltransferases (EC 2.7.7.*)
inhibitors of nucleotidyltransferases
inhibitors of nucleotidyltransferases (EC 2.7.7.*)
nucleotidyltransferase (EC 2.7.7.*) inhibitor
nucleotidyltransferase (EC 2.7.7.*) inhibitors
nucleotidyltransferase inhibitor
nucleotidyltransferase inhibitors
EC 2.7.7.* (nucleotidyltransferase) inhibitor
EC 2.7.8.* (transferases for other substituted phosphate groups) inhibitor
EC 2.7.8.* (transferases for other substituted phosphate groups) inhibitors
EC 2.7.8.* inhibitor
EC 2.7.8.* inhibitors
EC 2.7.8.* (transferases for other substituted phosphate groups) inhibitor
EC 2.7.10.* (protein-tyrosine kinase) inhibitor
EC 2.7.10.* (protein-tyrosine kinase) inhibitors
EC 2.7.10.* inhibitor
EC 2.7.10.* inhibitors
protein-tyrosine kinase (EC 2.7.10.*) inhibitor
protein-tyrosine kinase (EC 2.7.10.*) inhibitors
protein-tyrosine kinase inhibitor
protein-tyrosine kinase inhibitors
EC 2.7.10.* (protein-tyrosine kinase) inhibitor
EC 2.7.3.* (phosphotransferases with a nitrogenous group as acceptor) inhibitor
EC 2.7.3.* (phosphotransferases with a nitrogenous group as acceptor) inhibitors
EC 2.7.3.* inhibitor
EC 2.7.3.* inhibitors
phosphotransferases with a nitrogenous group as acceptor (EC 2.7.3.*) inhibitor
phosphotransferases with a nitrogenous group as acceptor (EC 2.7.3.*) inhibitors
EC 2.7.3.* (phosphotransferases with a nitrogenous group as acceptor) inhibitor
EC 3.2.1.31 (beta-glucuronidase) inhibitor
EC 3.2.1.31 (beta-glucuronidase) inhibitors
EC 3.2.1.31 inhibitor
EC 3.2.1.31 inhibitors
beta-D-glucuronoside glucuronosohydrolase inhibitor
beta-D-glucuronoside glucuronosohydrolase inhibitors
beta-glucuronidase (EC 3.2.1.31) inhibitor
beta-glucuronidase (EC 3.2.1.31) inhibitors
beta-glucuronidase inhibitor
beta-glucuronidase inhibitors
beta-glucuronide glucuronohydrolase inhibitor
beta-glucuronide glucuronohydrolase inhibitors
exo-beta-D-glucuronidase inhibitor
exo-beta-D-glucuronidase inhibitors
glucuronidase inhibitor
glucuronidase inhibitors
ketodase inhibitor
ketodase inhibitors
EC 3.2.1.31 (beta-glucuronidase) inhibitor
EC 6.3.1.* (acid-ammonia/amine ligase) inhibitor
EC 6.3.1.* (acid-ammonia/amine ligase) inhibitors
EC 6.3.1.* inhibitor
EC 6.3.1.* inhibitors
acid-ammonia (or amine) ligase inhibitor
acid-ammonia (or amine) ligase inhibitors
EC 6.3.1.* (acid-ammonia/amine ligase) inhibitor
EC 6.4.1.* (carboxylase) inhibitor
EC 6.4.1.* (C-C bond forming ligase) inhibitor
EC 6.4.1.* (C-C bond forming ligase) inhibitors
EC 6.4.1.* (C-C bond-forming ligase) inhibitors
EC 6.4.1.* (carboxylase) inhibitors
EC 6.4.1.* inhibitor
EC 6.4.1.* inhibitors
inhibitor of ligases forming C-C bonds
inhibitor of ligases forming C-C bonds (EC 6.4.1.*)
inhibitors of ligases forming C-C bonds
inhibitors of ligases forming C-C bonds (EC 6.4.1.*)
EC 6.4.1.* (carboxylase) inhibitor
EC 6.5.1.* (DNA/RNA repair enzymes) inhibitor
EC 6.5.1.* (DNA/RNA repair enzymes) inhibitors
EC 6.5.1.* inhibitor
EC 6.5.1.* inhibitors
EC 6.5.1.* (DNA/RNA repair enzymes) inhibitor
EC 5.1.1.* (racemases acting on amino acids and derivatives) inhibitor
EC 5.1.1.* (racemases acting on amino acids and derivatives) inhibitors
EC 5.1.1.* inhibitor
EC 5.1.1.* inhibitors
inhibitor of racemases acting on amino acids and derivatives
inhibitor of racemases acting on amino acids and derivatives (EC 5.1.1.*)
inhibitors of racemases acting on amino acids and derivatives
inhibitors of racemases acting on amino acids and derivatives (EC 5.1.1.*)
EC 5.1.1.* (racemases acting on amino acids and derivatives) inhibitor
EC 5.4.3.* (intramolecular transferase transferring amino groups) inhibitor
EC 5.4.3.* (intramolecular transferase transferring amino groups) inhibitors
EC 5.4.3.* inhibitor
EC 5.4.3.* inhibitors
inhibitor of intramolecular transferase transferring amino groups
inhibitor of intramolecular transferase transferring amino groups (EC 5.4.3.*)
inhibitors of intramolecular transferase transferring amino groups
inhibitors of intramolecular transferase transferring amino groups (EC 5.4.3.*)
EC 5.4.3.* (intramolecular transferase transferring amino groups) inhibitor
EC 5.99.1.* (miscellaneous isomerase) inhibitor
EC 5.99.1.* (miscellaneous isomerase) inhibitors
EC 5.99.1.* inhibitor
EC 5.99.1.* inhibitors
EC 5.99.1.* (miscellaneous isomerase) inhibitor
EC 4.4.1.* (C-S lyase) inhibitor
C-S lyase (EC 4.4.1.*) inhibitor
C-S lyase (EC 4.4.1.*) inhibitors
EC 4.4.1.* (C-S lyase) inhibitors
EC 4.4.1.* inhibitor
EC 4.4.1.* inhibitors
EC 4.4.1.* (C-S lyase) inhibitor
EC 4.3.1.* (ammonia-lyase) inhibitor
EC 4.3.1.* (ammonia-lyase) inhibitors
EC 4.3.1.* (ammonia-lyases) inhibitor
EC 4.3.1.* (ammonia-lyases) inhibitors
EC 4.3.1.* inhibitor
EC 4.3.1.* inhibitors
ammonia-lyase (EC 4.3.1.*) inhibitor
ammonia-lyase (EC 4.3.1.*) inhibitors
ammonia-lyase inhibitor
ammonia-lyase inhibitors
EC 4.3.1.* (ammonia-lyase) inhibitor
EC 2.5.* (non-methyl-alkyl or aryl transferase) inhibitor
EC 2.5.* (non-methyl-alkyl or aryl transferase) inhibitors
EC 2.5.* inhibitor
EC 2.5.* inhibitors
non-methyl-alkyl or aryl transferase (EC 2.5.*) inhibitor
non-methyl-alkyl or aryl transferase (EC 2.5.*) inhibitors
EC 2.5.* (non-methyl-alkyl or aryl transferase) inhibitor
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+)acceptor) inhibitors
EC 1.1.1.* inhibitor
EC 1.1.1.* inhibitors
oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor (EC 1.1.1.*) inhibitor
oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor (EC 1.1.1.*) inhibitors
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
EC 1.1.3.* (oxidoreductase acting on donor CH-OH group, oxygen as acceptor) inhibitor
EC 1.1.3.* (oxidoreductase acting on donor CH-OH group, oxygen as acceptor) inhibitors
EC 1.1.3.* inhibitor
EC 1.1.3.* inhibitors
oxidoreductase acting on donor CH-OH group, oxygen as acceptor (EC 1.1.3.*) inhibitor
oxidoreductase acting on donor CH-OH group, oxygen as acceptor (EC 1.1.3.*) inhibitors
EC 1.1.3.* (oxidoreductase acting on donor CH-OH group, oxygen as acceptor) inhibitor
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 O atoms) inhibitor
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 O atoms) inhibitors
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 atoms of oxygen) inhibitor
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 atoms of oxygen) inhibitors
EC 1.13.11.* inhibitor
EC 1.13.11.* inhibitors
oxidoreductase acting on single donors and incorporating 2 atoms of oxygen (EC 1.13.11.*) inhibitor
oxidoreductase acting on single donors and incorporating 2 atoms of oxygen (EC 1.13.11.*) inhibitors
EC 1.13.11.* (oxidoreductase acting on single donors and incorporating 2 O atoms) inhibitor
EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor
EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors
EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor
EC 1.14.14.* (oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitors
EC 1.14.14.* inhibitor
EC 1.14.14.* inhibitors
oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor (EC 1.14.14.*) inhibitor
oxidoreductase acting on paired donors, with incorporation of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor (EC 1.14.14.*) inhibitors
EC 1.14.14.* (oxidoreductase acting on paired donors, incorporating of 1 atom of oxygen, with reduced flavin or flavoprotein as one donor) inhibitor
EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitors
EC 1.14.99.* inhibitor
EC 1.14.99.* inhibitors
miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.99.*) inhibitor
miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen (EC 1.14.99.*) inhibitors
EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor
EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitors
EC 1.14.13.* inhibitor
EC 1.14.13.* inhibitors
oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor (EC 1.14.13.*) inhibitor
oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor (EC 1.14.13.*) inhibitors
EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced Fe-S protein as one donor, incorporating 1 O atom) inhibitor
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced Fe-S protein as one donor, incorporating 1 O atom) inhibitors
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced iron-sulfur protein as one donor, incorporating 1 atom of oxygen) inhibitor
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced iron-sulfur protein as one donor, incorporating 1 atom of oxygen) inhibitors
EC 1.14.15.* inhibitor
EC 1.14.15.* inhibitors
oxidoreductase acting on paired donors, with reduced iron-sulfur protein as one donor, incorporating 1 atom of oxygen (EC 1.14.15.*) inhibitor
oxidoreductase acting on paired donors, with reduced iron-sulfur protein as one donor, incorporating 1 atom of oxygen (EC 1.14.15.*) inhibitors
EC 1.14.15.* (oxidoreductase acting on paired donors, with reduced Fe-S protein as one donor, incorporating 1 O atom) inhibitor
EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitor
EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitors
EC 1.14.18.* inhibitor
EC 1.14.18.* inhibitors
oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen (EC 1.14.18.*) inhibitor
oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen (EC 1.14.18.*) inhibitors
EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitor
EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitor
EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitors
EC 1.14.16.* inhibitor
EC 1.14.16.* inhibitors
oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen (EC 1.14.16.*) inhibitor
oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen (EC 1.14.16.*) inhibitors
EC 1.14.16.* (oxidoreductase acting on paired donors, reduced pteridine as one donor, incorporating 1 atom of oxygen) inhibitor
EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor
EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitors
EC 1.17.4.* inhibitor
EC 1.17.4.* inhibitors
oxidoreductase acting on CH or CH2 with a disulfide as acceptor (EC 1.17.4.*) inhibitor
oxidoreductase acting on CH or CH2 with a disulfide as acceptor (EC 1.17.4.*) inhibitors
EC 1.17.4.* (oxidoreductase acting on CH or CH2 with a disulfide as acceptor) inhibitor
EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitor
EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitors
EC 1.17.3.* inhibitor
EC 1.17.3.* inhibitors
oxidoreductase acting on CH or CH2 with oxygen as acceptor (EC 1.17.3.*) inhibitor
oxidoreductase acting on CH or CH2 with oxygen as acceptor (EC 1.17.3.*) inhibitors
EC 1.17.3.* (oxidoreductase acting on CH or CH2 with oxygen as acceptor) inhibitor
EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.2.1.* inhibitor
EC 1.2.1.* inhibitors
oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor (EC 1.2.1.*) inhibitor
oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor (EC 1.2.1.*) inhibitors
EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.2.3.* (oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor) inhibitor
EC 1.2.3.* (oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor) inhibitors
EC 1.2.3.* inhibitor
EC 1.2.3.* inhibitors
oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor (EC 1.2.3.*) inhibitor
oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor (EC 1.2.3.*) inhibitors
EC 1.2.3.* (oxidoreductase acting on donor aldehyde/oxo group with oxygen as acceptor) inhibitor
EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor, NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.3.1.* inhibitor
EC 1.3.1.* inhibitors
oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor (EC 1.3.1.*) inhibitor
oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor (EC 1.3.1.*) inhibitors
EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.3.98.* (oxidoreductase acting on donor CH-CH group, with other, known, acceptors) inhibitor
EC 1.3.98.* (oxidoreductase acting on CH-CH group of donors, with other, known, acceptors) inhibitor
EC 1.3.98.* (oxidoreductase acting on CH-CH group of donors, with other, known, acceptors) inhibitors
EC 1.3.98.* (oxidoreductase acting on donor CH-CH group, with other, known, acceptors) inhibitors
EC 1.3.98.* inhibitor
EC 1.3.98.* inhibitors
oxidoreductase acting on CH-CH group of donors, with other, known, acceptors (EC 1.3.98.*) inhibitor
oxidoreductase acting on CH-CH group of donors, with other, known, acceptors (EC 1.3.98.*) inhibitors
EC 1.3.98.* (oxidoreductase acting on donor CH-CH group, with other, known, acceptors) inhibitor
EC 1.3.99.* (oxidoreductase acting on donor CH-CH group, with other acceptors) inhibitor
EC 1.3.99.* (oxidoreductase acting on donor CH-CH group with other acceptors) inhibitors
EC 1.3.99.* (oxidoreductase acting on donor CH-CH group, with other acceptors) inhibitors
EC 1.3.99.* inhibitor
EC 1.3.99.* inhibitors
oxidoreductase acting on donor CH-CH group with other acceptors (EC 1.3.99.*) inhibitor
oxidoreductase acting on donor CH-CH group with other acceptors (EC 1.3.99.*) inhibitors
EC 1.3.99.* (oxidoreductase acting on donor CH-CH group, with other acceptors) inhibitor
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group, oxygen as acceptor) inhibitor
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group with oxygen as acceptor) inhibitor
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group with oxygen as acceptor) inhibitors
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group, oxygen as acceptor) inhibitors
EC 1.3.3.* inhibitor
EC 1.3.3.* inhibitors
oxidoreductase acting on donor CH-CH group with oxygen as acceptor (EC 1.3.3.*) inhibitor
oxidoreductase acting on donor CH-CH group with oxygen as acceptor (EC 1.3.3.*) inhibitors
EC 1.3.3.* (oxidoreductase acting on donor CH-CH group, oxygen as acceptor) inhibitor
EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor
EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitors
EC 1.4.3.* inhibitor
EC 1.4.3.* inhibitors
oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor (EC 1.4.3.*) inhibitor
oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor (EC 1.4.3.*) inhibitors
EC 1.4.3.* (oxidoreductase acting on donor CH-NH2 group, oxygen as acceptor) inhibitor
EC 1.4.4.* (oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor) inhibitor
EC 1.4.4.* (oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor) inhibitors
EC 1.4.4.* inhibitor
EC 1.4.4.* inhibitors
oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor (EC 1.4.4.*) inhibitor
oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor (EC 1.4.4.*) inhibitors
EC 1.4.4.* (oxidoreductase acting on donor CH-NH2 group, a disulfide as acceptor) inhibitor
EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.5.1.* inhibitor
EC 1.5.1.* inhibitors
oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor (EC 1.5.1.*) inhibitor
oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor (EC 1.5.1.*) inhibitors
EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitor
EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitors
EC 1.6.5.* inhibitor
EC 1.6.5.* inhibitors
oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor (EC 1.6.5.*) inhibitor
oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor (EC 1.6.5.*) inhibitors
EC 1.6.5.* (oxidoreductase acting on NADH or NADPH with a quinone or similar as acceptor) inhibitor
EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitor
EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitors
EC 1.6.3.* inhibitor
EC 1.6.3.* inhibitors
oxidoreductase acting on NADH or NADPH with oxygen as acceptor (EC 1.6.3.*) inhibitor
oxidoreductase acting on NADH or NADPH with oxygen as acceptor (EC 1.6.3.*) inhibitors
EC 1.6.3.* (oxidoreductase acting on NADH or NADPH with oxygen as acceptor) inhibitor
EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.8.1.* inhibitor
EC 1.8.1.* inhibitors
oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor (EC 1.8.1.*) inhibitor
oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor (EC 1.8.1.*) inhibitors
EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor
EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitors
EC 1.9.3.* inhibitor
EC 1.9.3.* inhibitors
oxidoreductase acting on donor heme group, oxygen as acceptor (EC 1.9.3.*) inhibitor
oxidoreductase acting on donor heme group, oxygen as acceptor (EC 1.9.3.*) inhibitors
EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor
EC 2.1.1.* (methyltransferases) inhibitor
EC 2.1.1.* (methyltransferase) inhibitor
EC 2.1.1.* (methyltransferase) inhibitors
EC 2.1.1.* (methyltransferases) inhibitors
EC 2.1.1.* inhibitor
EC 2.1.1.* inhibitors
methyltransferase (EC 2.1.1.*) inhibitor
methyltransferase (EC 2.1.1.*) inhibitors
EC 2.1.1.* (methyltransferases) inhibitor
EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitor
EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitors
EC 2.1.2.* inhibitor
EC 2.1.2.* inhibitors
hydroxymethyl-, formyl- and related transferases (EC 2.1.2.*) inhibitor
hydroxymethyl-, formyl- and related transferases (EC 2.1.2.*) inhibitors
EC 2.1.2.* (hydroxymethyl-, formyl- and related transferases) inhibitor
EC 2.2.1.* (transketolase/transaldolase) inhibitor
EC 2.2.1.* (transketolase/transaldolase) inhibitors
EC 2.2.1.* (transketolases and transaldolases) inhibitor
EC 2.2.1.* (transketolases and transaldolases) inhibitors
EC 2.2.1.* inhibitor
EC 2.2.1.* inhibitors
transketolase/transaldolase (EC 2.2.1.*) inhibitor
transketolase/transaldolase (EC 2.2.1.*) inhibitors
EC 2.2.1.* (transketolase/transaldolase) inhibitor
EC 2.3.2.* (aminoacyltransferase) inhibitor
EC 2.3.2.* (aminoacyltransferase) inhibitors
EC 2.3.2.* inhibitor
EC 2.3.2.* inhibitors
aminoacyltransferase (EC 2.3.2.*) inhibitor
aminoacyltransferase (EC 2.3.2.*) inhibitors
EC 2.3.2.* (aminoacyltransferase) inhibitor
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitors
EC 2.3.1.* inhibitor
EC 2.3.1.* inhibitors
acyltransferase transferring other than amino-acyl group EC 2.3.1.* inhibitor
acyltransferase transferring other than amino-acyl group EC 2.3.1.* inhibitors
EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor
EC 2.6.1.* (transaminase) inhibitor
EC 2.6.1.* (transaminase) inhibitors
EC 2.6.1.* inhibitor
EC 2.6.1.* inhibitors
transaminase (EC 2.6.1.*) inhibitor
transaminase (EC 2.6.1.*) inhibitors
EC 2.6.1.* (transaminase) inhibitor
EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor
EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitors
EC 2.7.1.* inhibitor
EC 2.7.1.* inhibitors
phosphotransferases with an alcohol group as acceptor (EC 2.7.1.*) inhibitor
phosphotransferases with an alcohol group as acceptor (EC 2.7.1.*) inhibitors
EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor
EC 2.4.99.* (glycosyltransferases transferring other glycosyl groups) inhibitor
EC 2.4.99.* (glycosyltransferases transferring other glycosyl groups) inhibitors
EC 2.4.99.* inhibitor
EC 2.4.99.* inhibitors
glycosyltransferases transferring other glycosyl groups (EC 2.4.99.*) inhibitor
glycosyltransferases transferring other glycosyl groups (EC 2.4.99.*) inhibitors
EC 2.4.99.* (glycosyltransferases transferring other glycosyl groups) inhibitor
EC 3.11.1.* (hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate) inhibitor
EC 3.11.1.* (hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate) inhibitors
EC 3.11.1.* inhibitor
EC 3.11.1.* inhibitors
hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate (EC 3.11.1.*) inhibitor
hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate (EC 3.11.1.*) inhibitors
EC 3.11.1.* (hydrolases acting on C-P bonds of phosphono-acetaldehyde, -acetate, or -pyruvate) inhibitor
EC 3.4.23.* (aspartic endopeptidase) inhibitor
EC 3.4.23.* (aspartic endopeptidase) inhibitors
EC 3.4.23.* (aspartic endopeptidases) inhibitor
EC 3.4.23.* (aspartic endopeptidases) inhibitors
EC 3.4.23.* inhibitor
EC 3.4.23.* inhibitors
aspartic endopeptidase (EC 3.4.23.*) inhibitor
aspartic endopeptidase (EC 3.4.23.*) inhibitors
aspartic endopeptidases (EC 3.4.23.*) inhibitor
aspartic endopeptidases (EC 3.4.23.*) inhibitors
EC 3.4.23.* (aspartic endopeptidase) inhibitor
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitors
EC 3.4.11.14 inhibitor
EC 3.4.11.14 inhibitors
alanine aminopeptidase inhibitor
alanine aminopeptidase inhibitors
aminopolypeptidase inhibitor
aminopolypeptidase inhibitors
arylamidase inhibitor
arylamidase inhibitors
cytosol alanyl aminopeptidase (EC 3.4.11.14) inhibitor
cytosol alanyl aminopeptidase (EC 3.4.11.14) inhibitors
cytosol alanyl aminopeptidase inhibitor
cytosol alanyl aminopeptidase inhibitors
cytosol aminopeptidase III inhibitor
cytosol aminopeptidase III inhibitors
human liver aminopeptidase inhibitor
human liver aminopeptidase inhibitors
puromycin-sensitive aminopeptidase inhibitor
puromycin-sensitive aminopeptidase inhibitors
soluble alanyl aminopeptidase inhibitor
soluble alanyl aminopeptidase inhibitors
thiol-activated aminopeptidase inhibitor
thiol-activated aminopeptidase inhibitors
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor
DAP II inhibitor
DAP II inhibitors
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitors
EC 3.4.14.2 inhibitor
EC 3.4.14.2 inhibitors
carboxytripeptidase inhibitor
carboxytripeptidase inhibitors
dipeptidyl aminopeptidase II inhibitor
dipeptidyl aminopeptidase II inhibitors
dipeptidyl arylamidase II inhibitor
dipeptidyl arylamidase II inhibitors
dipeptidyl peptidase II inhibitor
dipeptidyl peptidase II inhibitors
dipeptidyl(amino)peptidase II inhibitor
dipeptidyl(amino)peptidase II inhibitors
dipeptidyl-peptidase II (EC 3.4.14.2) inhibitor
dipeptidyl-peptidase II (EC 3.4.14.2) inhibitors
dipeptidyl-peptidase II inhibitor
dipeptidyl-peptidase II inhibitors
dipeptidylarylamidase inhibitor
dipeptidylarylamidase inhibitors
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor
EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor
EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitors
EC 3.6.3.* inhibitor
EC 3.6.3.* inhibitors
acid anhydride hydrolase catalysing transmembrane movement of substances (EC 3.6.3.*) inhibitor
acid anhydride hydrolase catalysing transmembrane movement of substances (EC 3.6.3.*) inhibitors
EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor
EC 1.14.14.1 (unspecific monooxygenase) inhibitor
EC 1.14.14.1 (unspecific monooxygenase) inhibitors
EC 1.14.14.1 inhibitor
EC 1.14.14.1 inhibitors
aryl hydrocarbon hydroxylase inhibitor
aryl hydrocarbon hydroxylase inhibitors
aryl-4-monooxygenase inhibitor
aryl-4-monooxygenase inhibitors
flavoprotein monooxygenase inhibitor
flavoprotein monooxygenase inhibitors
flavoprotein-linked monooxygenase inhibitor
flavoprotein-linked monooxygenase inhibitors
microsomal P-450 inhibitor
microsomal P-450 inhibitors
microsomal monooxygenase inhibitor
microsomal monooxygenase inhibitors
substrate,reduced-flavoprotein:oxygen oxidoreductase (RH-hydroxylating or -epoxidising) inhibitor
substrate,reduced-flavoprotein:oxygen oxidoreductase (RH-hydroxylating or -epoxidising) inhibitors
unspecific monooxygenase (EC 1.14.14.1) inhibitor
unspecific monooxygenase (EC 1.14.14.1) inhibitors
unspecific monooxygenase inhibitor
unspecific monooxygenase inhibitors
xenobiotic monooxygenase inhibitor
xenobiotic monooxygenase inhibitors
EC 1.14.14.1 (unspecific monooxygenase) inhibitor
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitors
EC 1.14.11.* (oxidoreductase acting on paired donors, with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors) inhibitor
EC 1.14.11.* (oxidoreductase acting on paired donors, with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors) inhibitors
EC 1.14.11.* inhibitor
EC 1.14.11.* inhibitors
oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors (EC 1.14.11.*) inhibitor
oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors (EC 1.14.11.*) inhibitors
oxidoreductase acting on paired donors, with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (EC 1.14.11.*) inhibitor
oxidoreductase acting on paired donors, with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (EC 1.14.11.*) inhibitors
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor
EC 4.1.1.* (carboxy-lyase) inhibitor
EC 4.1.1.* (carboxy-lyase) inhibitors
EC 4.1.1.* inhibitor
EC 4.1.1.* inhibitors
carboxy-lyase (EC 4.1.1.*) inhibitor
carboxy-lyase (EC 4.1.1.*) inhibitors
carboxy-lyases (EC 4.1.1.*) inhibitor
carboxy-lyases (EC 4.1.1.*) inhibitors
EC 4.1.1.* (carboxy-lyase) inhibitor
EC 4.2.1.* (hydro-lyases) inhibitor
EC 4.2.1.* (hydro-lyase) inhibitor
EC 4.2.1.* (hydro-lyase) inhibitors
EC 4.2.1.* (hydro-lyases) inhibitors
EC 4.2.1.* inhibitor
EC 4.2.1.* inhibitors
hydro-lyase (EC 4.2.1.*) inhibitor
hydro-lyase (EC 4.2.1.*) inhibitors
EC 4.2.1.* (hydro-lyases) inhibitor
hyperglycemic agent
diabetes inducer
hyperglycemic agents
hyperglycemic agent
EC 1.1.3.9 (galactose oxidase) inhibitor
D-galactose oxidase inhibitor
D-galactose oxidase inhibitors
D-galactose:oxygen 6-oxidoreductase inhibitor
D-galactose:oxygen 6-oxidoreductase inhibitors
EC 1.1.3.9 (galactose oxidase) inhibitors
EC 1.1.3.9 inhibitor
EC 1.1.3.9 inhibitors
beta-galactose oxidase inhibitor
beta-galactose oxidase inhibitors
galactose oxidase inhibitor
galactose oxidase inhibitors
EC 1.1.3.9 (galactose oxidase) inhibitor
plant metabolite
plant metabolites
plant secondary metabolites
plant metabolite
EC 3.4.13.19 (membrane dipeptidase) inhibitor
DPH I inhibitors
EC 3.4.13.19 (membrane dipeptidase) inhibitors
EC 3.4.13.19 inhibitor
EC 3.4.13.19 inhibitors
MDP inhibitors
aminodipeptidase inhibitors
dehydropeptidase I (DPH I) inhibitors
dehydropeptidase I inhibitors
dipeptidase inhibitors
dipeptide hydrolase inhibitors
dipeptidyl hydrolase inhibitors
glycosyl-phosphatidylinositol-anchored renal dipeptidase inhibitors
membrane dipeptidase (EC 3.4.13.19) inhibitor
membrane dipeptidase (EC 3.4.13.19) inhibitors
membrane dipeptidase inhibitor
membrane dipeptidase inhibitors
microsomal dipeptidase inhibitors
nonspecific dipeptidase inhibitors
renal dipeptidase inhibitors
EC 3.4.13.19 (membrane dipeptidase) inhibitor
pathway inhibitor
metabolic pathway inhibitor
metabolic pathway inhibitors
pathway inhibitors
pathway inhibitor
EC 3.6.4.* (hydrolases acting on ATP; involved in cellular and subcellular movement) inhibitor
EC 3.6.4.* (hydrolase acting on ATP; involved in cellular and subcellular movement) inhibitor
EC 3.6.4.* (hydrolase acting on ATP; involved in cellular and subcellular movement) inhibitors
EC 3.6.4.* (hydrolases acting on ATP; involved in cellular and subcellular movement) inhibitors
EC 3.6.4.* inhibitor
EC 3.6.4.* inhibitors
hydrolases acting on ATP; involved in cellular and subcellular movement (EC 3.6.4.*) inhibitor
hydrolases acting on ATP; involved in cellular and subcellular movement (EC 3.6.4.*) inhibitors
EC 3.6.4.* (hydrolases acting on ATP; involved in cellular and subcellular movement) inhibitor
EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor
ATP phosphohydrolase (polypeptide-polymerising) inhibitor
ATP phosphohydrolase (polypeptide-polymerising) inhibitors
ATP phosphohydrolase (polypeptide-polymerizing) inhibitor
ATP phosphohydrolase (polypeptide-polymerizing) inhibitors
EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitors
EC 3.6.4.10 inhibitor
EC 3.6.4.10 inhibitors
molecular chaperone Hsc70 ATPase inhibitor
molecular chaperone Hsc70 ATPase inhibitors
non-chaperonin molecular chaperone ATPase (EC 3.6.4.10) inhibitor
non-chaperonin molecular chaperone ATPase (EC 3.6.4.10) inhibitors
EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor
EC 3.4.21.4 (trypsin) inhibitor
EC 3.4.21.4 (trypsin) inhibitors
EC 3.4.21.4 inhibitor
EC 3.4.21.4 inhibitors
alpha-trypsin inhibitor
alpha-trypsin inhibitors
beta-trypsin inhibitor
beta-trypsin inhibitors
cocoonase inhibitor
cocoonase inhibitors
parenzyme inhibitor
parenzyme inhibitors
parenzymol inhibitor
parenzymol inhibitors
pseudotrypsin inhibitor
pseudotrypsin inhibitors
sperm receptor hydrolase inhibitor
sperm receptor hydrolase inhibitors
tripcellim inhibitor
tripcellim inhibitors
trypsin (EC 3.4.21.4) inhibitor
trypsin (EC 3.4.21.4) inhibitors
trypsin inhibitor
trypsin inhibitors
tryptar inhibitor
tryptar inhibitors
tryptase inhibitor
tryptase inhibitors
trypure inhibitor
trypure inhibitors
EC 3.4.21.4 (trypsin) inhibitor
fungal metabolite
fungal metabolites
fungal metabolite
Aspergillus metabolite
Aspergillus metabolites
Aspergillus metabolite
Chaetomium metabolite
Chaetomium metabolites
Chaetomium metabolite
Penicillium metabolite
Penicillium metabolites
Penicillium metabolite
human xenobiotic metabolite
human xenobiotic metabolites
human xenobiotic metabolite
fungal xenobiotic metabolite
fungal xenobiotic metabolites
fungal xenobiotic metabolite
bacterial metabolite
bacterial metabolite
Escherichia coli metabolite
E.coli metabolite
E.coli metabolites
Escherichia coli metabolites
Escherichia coli metabolite
Streptococcus pneumoniae metabolite
S. pneumoniae metabolite
S. pneumoniae metabolites
S. pneumoniae secondary metabolite
S. pneumoniae secondary metabolites
Streptococcus pneumoniae metabolites
Streptococcus pneumoniae secondary metabolites
Streptococcus pneumoniae metabolite
bacterial xenobiotic metabolite
bacterial xenobiotic metabolites
bacterial xenobiotic metabolite
corticotropin-releasing factor receptor antagonist
CRF antagonist
CRF antagonists
corticotropin-releasing factor receptor antagonists
corticotropin-releasing factor receptor antagonist
xenoestrogen
xenoestrogens
xenoestrogen
phytoestrogen
phytoestrogens
phytoestrogen
mycoestrogen
mycoestrogens
mycoestrogen
aryl hydrocarbon receptor antagonist
AhR antagonist
AhR antagonists
AhR receptor antagonist
AhR receptor antagonists
aryl hydrocarbon receptor antagonists
aryl hydrocarbon receptor antagonist
EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor
EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitors
EC 1.10.99.* inhibitor
EC 1.10.99.* inhibitors
oxidoreductases acting on diphenols and related substances as donors, other acceptors (EC 1.10.99.*) inhibitor
oxidoreductases acting on diphenols and related substances as donors, other acceptors (EC 1.10.99.*) inhibitors
EC 1.10.99.* (oxidoreductases acting on diphenols and related substances as donors, other acceptors) inhibitor
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor
1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide:quinone oxidoreductase inhibitor
1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide:quinone oxidoreductase inhibitors
EC 1.10.99.2 (ribosyldihydronicotinamide dehydrogenase (quinone)) inhibitor
EC 1.10.99.2 (ribosyldihydronicotinamide dehydrogenase (quinone)) inhibitors
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitors
EC 1.10.99.2 inhibitor
EC 1.10.99.2 inhibitors
N-ribosyldihydronicotinamide dehydrogenase (quinone) inhibitor
N-ribosyldihydronicotinamide dehydrogenase (quinone) inhibitors
NAD(P)H:quinone oxidoreductase-2 inhibitor
NAD(P)H:quinone oxidoreductase-2 inhibitors
NAD(P)H:quinone oxidoreductase2 inhibitor
NAD(P)H:quinone oxidoreductase2 inhibitors
NQO2 inhibitor
NQO2 inhibitors
NRH:quinone oxidoreductase 2 inhibitor
NRH:quinone oxidoreductase 2 inhibitors
QR2 inhibitor
QR2 inhibitors
quinone reductase 2 inhibitor
quinone reductase 2 inhibitors
ribosyldihydronicotinamide dehydrogenase (quinone) (EC 1.10.99.2) inhibitor
ribosyldihydronicotinamide dehydrogenase (quinone) (EC 1.10.99.2) inhibitors
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor
EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor
EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitors
EC 2.3.3.* inhibitor
EC 2.3.3.* inhibitors
acyltransferase converting acyl to alkyl group on transfer (EC 2.3.3.*) inhibitor
acyltransferase converting acyl to alkyl group on transfer (EC 2.3.3.*) inhibitors
EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor
(R)-citrate synthase inhibitor
(R)-citrate synthase inhibitors
EC 2.3.3.1 (citrate (Si)-synthase) inhibitor
EC 2.3.3.1 (citrate (Si)-synthase) inhibitors
EC 2.3.3.1 [citrate (Si)-synthase] inhibitors
EC 2.3.3.1 inhibitor
EC 2.3.3.1 inhibitors
acetyl-CoA:oxaloacetate C-acetyltransferase [thioester-hydrolysing, (pro-S)-carboxymethyl forming] inhibitor
acetyl-CoA:oxaloacetate C-acetyltransferase [thioester-hydrolysing, (pro-S)-carboxymethyl forming] inhibitors
citrate (Si)-synthase (EC 2.3.3.1) inhibitor
citrate (Si)-synthase (EC 2.3.3.1) inhibitors
citrate condensing enzyme inhibitor
citrate condensing enzyme inhibitors
citrate oxaloacetate-lyase [(pro-3S)-CH2COO->acetyl-CoA] inhibitor
citrate oxaloacetate-lyase [(pro-3S)-CH2COO->acetyl-CoA] inhibitors
citrate oxaloacetate-lyase, CoA-acetylating inhibitor
citrate oxaloacetate-lyase, CoA-acetylating inhibitors
citrate synthase inhibitor
citrate synthase inhibitors
citrate synthetase inhibitor
citrate synthetase inhibitors
citric synthase inhibitor
citric synthase inhibitors
citric-condensing enzyme inhibitor
citric-condensing enzyme inhibitors
citrogenase inhibitor
citrogenase inhibitors
condensing enzyme inhibitor
condensing enzyme inhibitors
oxalacetic transacetase inhibitor
oxalacetic transacetase inhibitors
oxaloacetate transacetase inhibitor
oxaloacetate transacetase inhibitors
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor
4-nitrophenylphosphatase (EC 3.1.3.41) inhibitor
4-nitrophenylphosphatase (EC 3.1.3.41) inhibitors
4-nitrophenylphosphate phosphohydrolase inhibitor
4-nitrophenylphosphate phosphohydrolase inhibitors
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitors
EC 3.1.3.41 inhibitor
EC 3.1.3.41 inhibitors
Ecto-p-nitrophenyl phosphatase inhibitor
Ecto-p-nitrophenyl phosphatase inhibitors
K-pNPPase inhibitor
K-pNPPase inhibitors
NPPase inhibitor
NPPase inhibitors
PNPPase inhibitor
PNPPase inhibitors
nitrophenyl phosphatase inhibitor
nitrophenyl phosphatase inhibitors
p-nitrophenylphosphatase inhibitor
p-nitrophenylphosphatase inhibitors
p-nitrophenylphosphate phosphohydrolase inhibitor
p-nitrophenylphosphate phosphohydrolase inhibitors
para-nitrophenyl phosphatase inhibitor
para-nitrophenyl phosphatase inhibitors
xK-pNPPase inhibitors
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor
mucolytic
mucolytics
mucolytic
expectorant
expectorants
expectorant
EC 1.4.7.* (oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor) inhibitor
EC 1.4.7.* (oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor) inhibitors
EC 1.4.7.* inhibitor
EC 1.4.7.* inhibitors
inhibitor of oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor
inhibitors of oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor
oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor (EC 1.4.7.*) inhibitor
oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor (EC 1.4.7.*) inhibitors
EC 1.4.7.* (oxidoreductase acting on donor CH-NH2 group, Fe-S protein as acceptor) inhibitor
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitors
EC 2.5.1.49 inhibitor
EC 2.5.1.49 inhibitors
O-acetyl-L-homoserine acetate-lyase (adding methanethiol) inhibitor
O-acetyl-L-homoserine acetate-lyase (adding methanethiol) inhibitors
O-acetyl-L-homoserine sulfhydrolase inhibitor
O-acetyl-L-homoserine sulfhydrolase inhibitors
O-acetyl-L-homoserine:methanethiol 3-amino-3-carboxypropyltransferase inhibitor
O-acetyl-L-homoserine:methanethiol 3-amino-3-carboxypropyltransferase inhibitors
O-acetylhomoserine (thiol)-lyase inhibitor
O-acetylhomoserine (thiol)-lyase inhibitors
O-acetylhomoserine aminocarboxypropyltransferase (EC 2.5.1.49) inhibitor
O-acetylhomoserine aminocarboxypropyltransferase (EC 2.5.1.49) inhibitors
O-acetylhomoserine aminocarboxypropyltransferase inhibitor
O-acetylhomoserine aminocarboxypropyltransferase inhibitors
O-acetylhomoserine sulfhydrolase inhibitor
O-acetylhomoserine sulfhydrolase inhibitors
methionine synthase inhibitor
methionine synthase inhibitors
EC 2.5.1.49 (O-acetylhomoserine aminocarboxypropyltransferase) inhibitor
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
(L-SOS)lyase inhibitor
(L-SOS)lyase inhibitors
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitors
EC 4.3.1.10 inhibitor
EC 4.3.1.10 inhibitors
L-serine-O-sulfate ammonia-lyase (pyruvate-forming) inhibitor
L-serine-O-sulfate ammonia-lyase (pyruvate-forming) inhibitors
serine-sulfate ammonia-lyase (EC 4.3.1.10) inhibitor
serine-sulfate ammonia-lyase (EC 4.3.1.10) inhibitors
serine-sulfate ammonia-lyase inhibitor
serine-sulfate ammonia-lyase inhibitors
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor
EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitors
EC 1.3.5.* inhibitor
EC 1.3.5.* inhibitors
inhibitor of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor
inhibitor of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*)
inhibitors of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor
inhibitors of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*)
oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*) inhibitor
oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*) inhibitors
EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor
(S)-dihydroorotate:(acceptor) oxidoreductase inhibitor
(S)-dihydroorotate:(acceptor) oxidoreductase inhibitors
(S)-dihydroorotate:acceptor oxidoreductase inhibitor
(S)-dihydroorotate:acceptor oxidoreductase inhibitors
(S)-dihydroorotate:quinone oxidoreductase inhibitor
(S)-dihydroorotate:quinone oxidoreductase inhibitors
DHOD inhibitor
DHOD inhibitors
DHODH inhibitor
DHODH inhibitors
DHOdehase inhibitor
DHOdehase inhibitors
EC 1.3.5.2 (dihydroorotate dehydrogenase (quinone)) inhibitor
EC 1.3.5.2 (dihydroorotate dehydrogenase (quinone)) inhibitors
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitors
EC 1.3.5.2 inhibitor
EC 1.3.5.2 inhibitors
dihydroorotate:ubiquinone oxidoreductase inhibitor
dihydroorotate:ubiquinone oxidoreductase inhibitors
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor
EC 1.10.2.* (oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor) inhibitor
EC 1.10.2.* (oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor) inhibitors
EC 1.10.2.* inhibitor
EC 1.10.2.* inhibitors
inhibitor of an oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor (EC 1.10.2.*)
inhibitors of an oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor (EC 1.10.2.*)
oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor (EC 1.10.2.*) inhibitor
oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor (EC 1.10.2.*) inhibitors
EC 1.10.2.* (oxidoreductase acting on diphenols and related substances as donors with a cytochrome as acceptor) inhibitor
EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor
EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitors
EC 1.10.2.2 inhibitor
EC 1.10.2.2 inhibitors
inhibitor of quinol--cytochrome-c reductase (EC 1.10.2.2)
inhibitors of quinol--cytochrome-c reductase (EC 1.10.2.2)
quinol--cytochrome-c reductase (EC 1.10.2.2) inhibitor
quinol--cytochrome-c reductase (EC 1.10.2.2) inhibitors
EC 1.10.2.2 (quinol--cytochrome-c reductase) inhibitor
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
15-OH-PGDH inhibitor
15-OH-PGDH inhibitors
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors
15-hydroxyprostaglandin dehydrogenase inhibitor
15-hydroxyprostaglandin dehydrogenase inhibitors
15-hydroxyprostanoic dehydrogenase inhibitor
15-hydroxyprostanoic dehydrogenase inhibitors
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors
EC 1.1.1.141 inhibitor
EC 1.1.1.141 inhibitors
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors
PGDH inhibitor
PGDH inhibitors
prostaglandin dehydrogenase inhibitor
prostaglandin dehydrogenase inhibitors
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor
EC 1.21.3.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor) inhibitor
EC 1.21.3.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor) inhibitors
EC 1.21.3.* inhibitor
EC 1.21.3.* inhibitors
inhibitor of oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor
inhibitor of oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor (EC 1.21.3.*)
inhibitors of oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor
inhibitors of oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor (EC 1.21.3.*)
oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor (EC 1.21.3.*) inhibitor
oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor (EC 1.21.3.*) inhibitors
EC 1.21.3.* (oxidoreductase acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor) inhibitor
EC 1.21.3.3 (reticuline oxidase) inhibitor
(S)-reticuline:oxygen oxidoreductase (methylene-bridge-forming) inhibitor
(S)-reticuline:oxygen oxidoreductase (methylene-bridge-forming) inhibitors
BBE inhibitor
BBE inhibitors
EC 1.21.3.3 (reticuline oxidase) inhibitors
EC 1.21.3.3 inhibitor
EC 1.21.3.3 inhibitors
EC 1.5.3.9 inhibitor
EC 1.5.3.9 inhibitors
berberine bridge enzyme inhibitor
berberine bridge enzyme inhibitors
berberine-bridge-forming enzyme inhibitor
berberine-bridge-forming enzyme inhibitors
reticuline oxidase (EC 1.21.3.3) inhibitor
reticuline oxidase (EC 1.21.3.3) inhibitors
reticuline oxidase inhibitor
reticuline oxidase inhibitors
tetrahydroprotoberberine synthase inhibitor
tetrahydroprotoberberine synthase inhibitors
EC 1.21.3.3 (reticuline oxidase) inhibitor
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase (EC 2.1.1.116) inhibitor
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase (EC 2.1.1.116) inhibitors
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitors
EC 2.1.1.116 inhibitor
EC 2.1.1.116 inhibitors
S-adenosyl-L-methionine:3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase inhibitor
S-adenosyl-L-methionine:3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase inhibitors
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor
EC 2.7.11.10 (IkappaB kinase) inhibitor
ATP:[IkappaB protein] phosphotransferase
ATP:[IkappaB protein] phosphotransferase inhibitor
CHUK inhibitor
CHUK inhibitors
EC 2.7.11.10 (IkappaB kinase) inhibitors
EC 2.7.11.10 inhibitor
EC 2.7.11.10 inhibitors
IKBKA inhibitor
IKBKA inhibitors
IKBKB inhibitor
IKBKB inhibitors
IKK inhibitor
IKK inhibitors
IKK-1 inhibitor
IKK-1 inhibitors
IKK-2 inhibitor
IKK-2 inhibitors
IkappaB kinase (EC 2.7.11.10) inhibitor
IkappaB kinase (EC 2.7.11.10) inhibitors
IkappaB kinase inhibitor
IkappaB kinase inhibitors
STK12 inhibitor
STK12 inhibitors
TANK-binding kinase 1 inhibitor
TANK-binding kinase 1 inhibitors
TBK1 inhibitor
TBK1 inhibitors
EC 2.7.11.10 (IkappaB kinase) inhibitor
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor
(S)-tetrahydroprotoberberine N-methyltransferase (EC 2.1.1.122) inhibitor
(S)-tetrahydroprotoberberine N-methyltransferase (EC 2.1.1.122) inhibitors
(S)-tetrahydroprotoberberine N-methyltransferase inhibitor
(S)-tetrahydroprotoberberine N-methyltransferase inhibitors
EC 2.1.1.122 ((S)-tetrahydroprotoberberine N-methyltransferase) inhibitor
EC 2.1.1.122 ((S)-tetrahydroprotoberberine N-methyltransferase) inhibitors
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitors
EC 2.1.1.122 inhibitor
EC 2.1.1.122 inhibitors
S-adenosyl-L-methionine:(S)-7,8,13,14-tetrahydroprotoberberine cis-N-methyltransferase inhibitor
S-adenosyl-L-methionine:(S)-7,8,13,14-tetrahydroprotoberberine cis-N-methyltransferase inhibitors
tetrahydroprotoberberine cis-N-methyltransferase inhibitor
tetrahydroprotoberberine cis-N-methyltransferase inhibitors
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor
EC 3.5.5.* (hydrolase acting on C-N bonds in nitriles) inhibitor
EC 3.5.5.* (hydrolase acting on C-N bonds in nitriles) inhibitors
EC 3.5.5.* inhibitor
EC 3.5.5.* inhibitors
hydrolase acting on C-N bonds in nitriles (EC 3.5.5.*) inhibitor
hydrolase acting on C-N bonds in nitriles (EC 3.5.5.*) inhibitors
inhibitor of hydrolases acting on C-N bonds in nitriles
inhibitors of hydrolases acting on C-N bonds in nitriles
EC 3.5.5.* (hydrolase acting on C-N bonds in nitriles) inhibitor
EC 3.5.5.1 (nitrilase) inhibitor
EC 3.5.5.1 (nitrilase) inhibitors
EC 3.5.5.1 inhibitor
EC 3.5.5.1 inhibitors
acetonitrilase inhibitor
acetonitrilase inhibitors
benzonitrilase inhibitor
benzonitrilase inhibitors
nitrilase (EC 3.5.5.1) inhibitor
nitrilase (EC 3.5.5.1) inhibitors
nitrile aminohydrolase inhibitor
nitrile aminohydrolase inhibitors
EC 3.5.5.1 (nitrilase) inhibitor
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitors
9-keto-prostaglandin E2 reductase inhibitor
9-keto-prostaglandin E2 reductase inhibitors
9-ketoprostaglandin reductase inhibitor
9-ketoprostaglandin reductase inhibitors
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitors
EC 1.1.1.189 inhibitor
EC 1.1.1.189 inhibitors
PGE-9-ketoreductase inhibitor
PGE-9-ketoreductase inhibitors
PGE2 9-oxoreductase inhibitor
PGE2 9-oxoreductase inhibitors
PGE2-9-OR inhibitor
PGE2-9-OR inhibitors
PGE2-9-ketoreductase inhibitor
PGE2-9-ketoreductase inhibitors
prostaglandin 9-ketoreductase inhibitor
prostaglandin 9-ketoreductase inhibitors
prostaglandin E 9-ketoreductase inhibitor
prostaglandin E 9-ketoreductase inhibitors
prostaglandin E2-9-oxoreductase inhibitor
prostaglandin E2-9-oxoreductase inhibitors
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitor
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitors
reductase, 15-hydroxy-9-oxoprostaglandin inhibitor
reductase, 15-hydroxy-9-oxoprostaglandin inhibitors
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor
Toll-like receptor 2 agonist
TLR 2 agonist
TLR 2 agonists
TLR-2 agonist
TLR-2 agonists
Toll-like receptor 2 agonists
Toll-like receptor-2 agonist
Toll-like receptor-2 agonists
Toll-like receptor 2 agonist
histological dye
biological stain
biological stains
histological dyes
histological stain
histological stains
histological dye
food colouring
food coloring
food colorings
food colourings
food colouring
EC 2.7.1.33 (pantothenate kinase) inhibitor
ATP:(R)-pantothenate 4'-phosphotransferase inhibitor
ATP:(R)-pantothenate 4'-phosphotransferase inhibitors
ATP:pantothenate 4'-phosphotransferase inhibitor
ATP:pantothenate 4'-phosphotransferase inhibitors
D-pantothenate kinase inhibitor
D-pantothenate kinase inhibitors
EC 2.7.1.33 (pantothenate kinase) inhibitors
EC 2.7.1.33 inhibitor
EC 2.7.1.33 inhibitors
pantothenate kinase (EC 2.7.1.33) inhibitor
pantothenate kinase (EC 2.7.1.33) inhibitors
pantothenate kinase (phosphorylating) inhibitor
pantothenate kinase (phosphorylating) inhibitors
pantothenic acid kinase inhibitor
pantothenic acid kinase inhibitors
EC 2.7.1.33 (pantothenate kinase) inhibitor
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitors
EC 3.4.24.83 inhibitor
EC 3.4.24.83 inhibitors
anthrax lethal factor endopeptidase (EC 3.4.24.83) inhibitor
anthrax lethal factor endopeptidase (EC 3.4.24.83) inhibitors
lethal toxin inhibitor
lethal toxin inhibitors
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor
cardioprotective agent
cardioprotective agents
cardioprotective agent
pregnane X receptor agonist
PXR agonist
PXR agonists
pregnane X receptor agonists
pregnane X receptor agonist
UDP-glucuronosyltransferase activator
UDP-glucuronosyltransferase activators
UDP-glucuronosyltransferase activator
androstane receptor agonist
CAR agonist
CAR agonists
androstane receptor agonists
constitutive androstane receptor agonist
constitutive androstane receptor agonists
androstane receptor agonist
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitors
EC 1.8.1.12 inhibitor
EC 1.8.1.12 inhibitors
N(1),N(8)-bis(glutathionyl)spermidine reductase inhibitor
N(1),N(8)-bis(glutathionyl)spermidine reductase inhibitors
NADPH2:trypanothione oxidoreductase inhibitor
NADPH2:trypanothione oxidoreductase inhibitors
NADPH:trypanothione oxidoreductase inhibitor
NADPH:trypanothione oxidoreductase inhibitors
trypanothione reductase inhibitor
trypanothione reductase inhibitors
trypanothione-disulfide reductase (EC 1.8.1.12) inhibitor
trypanothione-disulfide reductase (EC 1.8.1.12) inhibitors
trypanothione:NADP(+) oxidoreductase inhibitor
trypanothione:NADP(+) oxidoreductase inhibitors
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 11-oxidoreductase inhibitors
EC 1.1.1.188 (prostaglandin-F synthase) inhibitors
EC 1.1.1.188 inhibitor
EC 1.1.1.188 inhibitors
NADPH-dependent prostaglandin D2 11-keto reductase inhibitor
NADPH-dependent prostaglandin D2 11-keto reductase inhibitors
PGD2 11-ketoreductase inhibitor
PGD2 11-ketoreductase inhibitors
PGF synthetase inhibitor
PGF synthetase inhibitors
PGF2alpha synthetase inhibitor
PGF2alpha synthetase inhibitors
prostaglandin 11-keto reductase inhibitor
prostaglandin 11-keto reductase inhibitors
prostaglandin 11-ketoreductase inhibitor
prostaglandin 11-ketoreductase inhibitors
prostaglandin D2-ketoreductase inhibitor
prostaglandin D2-ketoreductase inhibitors
prostaglandin F synthase inhibitor
prostaglandin F synthase inhibitors
prostaglandin F synthetase inhibitor
prostaglandin F synthetase inhibitors
prostaglandin-D2 11-reductase inhibitor
prostaglandin-D2 11-reductase inhibitors
reductase, 15-hydroxy-11-oxoprostaglandin inhibitor
reductase, 15-hydroxy-11-oxoprostaglandin inhibitors
synthetase, prostaglandin F2alpha inhibitor
synthetase, prostaglandin F2alpha inhibitors
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor
5-dehydroshikimate reductase inhibitor
5-dehydroshikimate reductase inhibitors
5-dehydroshikimic reductase inhibitor
5-dehydroshikimic reductase inhibitors
AroE inhibitor
AroE inhibitors
DHS reductase inhibitor
DHS reductase inhibitors
EC 1.1.1.25 (shikimate dehydrogenase) inhibitors
EC 1.1.1.25 inhibitor
EC 1.1.1.25 inhibitors
dehydroshikimic reductase inhibitor
dehydroshikimic reductase inhibitors
shikimate 5-dehydrogenase inhibitor
shikimate 5-dehydrogenase inhibitors
shikimate dehydrogenase (EC 1.1.1.25) inhibitor
shikimate dehydrogenase (EC 1.1.1.25) inhibitors
shikimate dehydrogenase inhibitor
shikimate dehydrogenase inhibitors
shikimate oxidoreductase inhibitor
shikimate oxidoreductase inhibitors
shikimate:NADP(+) 3-oxidoreductase inhibitor
shikimate:NADP(+) 3-oxidoreductase inhibitors
shikimate:NADP(+) 5-oxidoreductase inhibitor
shikimate:NADP(+) 5-oxidoreductase inhibitors
shikimate:NADP(+) oxidoreductase inhibitor
shikimate:NADP(+) oxidoreductase inhibitors
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor
bradykinin receptor agonist
bradykinin receptor agonists
bradykinin receptor agonist
bradykinin receptor B2 agonist
B2 receptor agonist
B2 receptor agonists
B2R agonist
B2R agonists
bradykinin receptor B2 agonists
bradykinin receptor B2 agonist
thermal degradation product
thermal artefact
thermal artefacts
thermal degradation products
thermal degradation product
Maillard reaction product
Maillard product
Maillard products
maillard reaction products
Maillard reaction product
eugeroic
eugeroics
vigilance promoting agent
vigilance promoting agents
vigilance promoting drug
vigilance promoting drugs
vigilance-promoting agent
vigilance-promoting agents
vigilance-promoting drug
vigilance-promoting drugs
wake-promoting agent
wake-promoting agents
wake-promoting drug
wake-promoting drugs
wakefulness-promoting agent
wakefulness-promoting agents
wakefulness-promoting drug
wakefulness-promoting drugs
eugeroic
loop diuretic
loop diuretics
loop diuretic
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor
1-deoxy-D-xylulose-5-phosphate isomeroreductase inhibitor
1-deoxy-D-xylulose-5-phosphate isomeroreductase inhibitors
1-deoxy-D-xylulose-5-phosphate reductoisomerase (EC 1.1.1.267) inhibitor
1-deoxy-D-xylulose-5-phosphate reductoisomerase (EC 1.1.1.267) inhibitors
1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors
1-deoxyxylulose-5-phosphate reductoisomerase inhibitor
1-deoxyxylulose-5-phosphate reductoisomerase inhibitors
2-C-methyl-D-erythritol-4-phosphate:NADP(+) oxidoreductase (isomerising) inhibitor
2-C-methyl-D-erythritol-4-phosphate:NADP(+) oxidoreductase (isomerising) inhibitors
2-C-methyl-D-erythritol-4-phosphate:NADP(+) oxidoreductase (isomerizing) inhibitor
2-C-methyl-D-erythritol-4-phosphate:NADP(+) oxidoreductase (isomerizing) inhibitors
2C-methyl-D-erythritol-4-phosphate (MEP) synthase inhibitor
2C-methyl-D-erythritol-4-phosphate (MEP) synthase inhibitors
DXP-reductoisomerase inhibitor
DXP-reductoisomerase inhibitors
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitors
EC 1.1.1.267 inhibitor
EC 1.1.1.267 inhibitors
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor
EC 4.3.1.3 (histidine ammonia-lyase) inhibitor
EC 4.3.1.3 (histidine ammonia-lyase) inhibitors
EC 4.3.1.3 inhibitor
EC 4.3.1.3 inhibitors
L-histidine ammonia-lyase (urocanate-forming) inhibitor
L-histidine ammonia-lyase (urocanate-forming) inhibitors
L-histidine ammonia-lyase inhibitor
L-histidine ammonia-lyase inhibitors
histidase inhibitor
histidase inhibitors
histidinase inhibitor
histidinase inhibitors
histidine alpha-deaminase inhibitor
histidine alpha-deaminase inhibitors
histidine ammonia-lyase (EC 4.3.1.3) inhibitor
histidine ammonia-lyase (EC 4.3.1.3) inhibitors
histidine ammonia-lyase inhibitor
histidine ammonia-lyase inhibitors
EC 4.3.1.3 (histidine ammonia-lyase) inhibitor
EC 3.4.19.* (omega-peptidase) inhibitor
EC 3.4.19.* (omega-peptidase) inhibitors
EC 3.4.19.* inhibitor
EC 3.4.19.* inhibitors
omega-peptidase (EC 3.4.19.*) inhibitor
omega-peptidase (EC 3.4.19.*) inhibitors
omega-peptidase inhibitor
omega-peptidase inhibitors
EC 3.4.19.* (omega-peptidase) inhibitor
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
5-oxoprolyl-peptidase inhibitors
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitors
EC 3.4.19.3 inhibitor
EC 3.4.19.3 inhibitors
L-pyroglutamyl peptide hydrolase inhibitor
L-pyroglutamyl peptide hydrolase inhibitors
L-pyrrolidonecarboxylate peptidase inhibitor
L-pyrrolidonecarboxylate peptidase inhibitors
pyrase inhibitor
pyrase inhibitors
pyroglutamate aminopeptidase inhibitor
pyroglutamate aminopeptidase inhibitors
pyroglutamidase inhibitor
pyroglutamidase inhibitors
pyroglutamyl aminopeptidase inhibitor
pyroglutamyl aminopeptidase inhibitors
pyroglutamyl-peptidase I (EC 3.4.19.3) inhibitor
pyroglutamyl-peptidase I (EC 3.4.19.3) inhibitors
pyroglutamyl-peptidase I inhibitor
pyroglutamyl-peptidase I inhibitors
pyrrolidone-carboxyl peptidase inhibitor
pyrrolidone-carboxyl peptidase inhibitors
pyrrolidonecarboxylyl peptidase inhibitor
pyrrolidonecarboxylyl peptidase inhibitors
pyrrolidonyl peptidase inhibitor
pyrrolidonyl peptidase inhibitors5-oxoprolyl-peptidase inhibitor
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
nasal decongestant
decongestant
decongestants
nasal decongestants
nasal decongestant
p53 activator
cellular tumor antigen p53 activator
cellular tumor antigen p53 activators
p53 activators
phosphoprotein p53 activator
phosphoprotein p53 activators
tumor protein p53 activator
tumor protein p53 activators
tumour protein p53 activator
tumour protein p53 activators
tumour suppressor p53 activator
tumour suppressor p53 activators
p53 activator
EC 3.4.24.18 (meprin A) inhibitor
EC 3.4.24.18 (meprin A) inhibitors
EC 3.4.24.18 inhibitor
EC 3.4.24.18 inhibitors
N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase inhibitor
N-benzoyl-L-tyrosyl-p-aminobenzoic acid hydrolase inhibitors
PABA-peptide hydrolase inhibitor
PABA-peptide hydrolase inhibitors
PPH inhibitor
PPH inhibitors
endopeptidase-2 inhibitor
endopeptidase-2 inhibitors
meprin A (EC 3.4.24.18) inhibitor
meprin A (EC 3.4.24.18) inhibitors
meprin A inhibitor
meprin A inhibitors
meprin inhibitor
meprin inhibitors
meprin-a inhibitor
meprin-a inhibitors
EC 3.4.24.18 (meprin A) inhibitor
human metabolite
H. sapiens metabolite
H. sapiens metabolites
Homo sapiens metabolite
Homo sapiens metabolites
human metabolite
EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitor
ATP phosphohydrolase (phospholipid-flipping) inhibitor
ATP phosphohydrolase (phospholipid-flipping) inhibitors
EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitors
EC 3.6.3.1 inhibitor
EC 3.6.3.1 inhibitors
Mg(2)(+)-ATPase inhibitor
Mg(2)(+)-ATPase inhibitors
aminophospholipid-transporting ATPase inhibitor
aminophospholipid-transporting ATPase inhibitors
flippase inhibitor
flippase inhibitors
magnesium-ATPase inhibitor
magnesium-ATPase inhibitors
phospholipid-translocating ATPase (EC 3.6.3.1) inhibitor
phospholipid-translocating ATPase (EC 3.6.3.1) inhibitors
phospholipid-translocating ATPase inhibitor
phospholipid-translocating ATPase inhibitors
phospholipid-transporting ATPase inhibitor
phospholipid-transporting ATPase inhibitors
EC 3.6.3.1 (phospholipid-translocating ATPase) inhibitor
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor
ATP phosphohydrolase (steroid-exporting) inhibitor
ATP phosphohydrolase (steroid-exporting) inhibitors
ATP phosphohydrolase (xenobiotic-exporting) inhibitor
ATP phosphohydrolase (xenobiotic-exporting) inhibitors
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitors
EC 3.6.3.44 inhibitor
EC 3.6.3.44 inhibitors
MDR protein inhibitor
MDR protein inhibitors
P-glycoprotein inhibitor
P-glycoprotein inhibitors
PDR protein inhibitor
PDR protein inhibitors
multidrug-resistance protein inhibitor
multidrug-resistance protein inhibitors
pleiotropic-drug-resistance protein inhibitor
pleiotropic-drug-resistance protein inhibitors
steroid-transporting ATPase inhibitor
steroid-transporting ATPase inhibitors
xenobiotic-transporting ATPase (EC 3.6.3.44) inhibitor
xenobiotic-transporting ATPase (EC 3.6.3.44) inhibitors
xenobiotic-transporting ATPase inhibitor
xenobiotic-transporting ATPase inhibitors
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor
ATP/ADP translocase inhibitor
ATP-ADP translocase inhibitor
ATP-ADP translocase inhibitors
ATP/ADP translocase inhibitors
ATP/ADP translocase inhibitor
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor
3',5'-cyclic-AMP 5'-nucleotidohydrolase inhibitor
3',5'-cyclic-AMP 5'-nucleotidohydrolase inhibitors
3',5'-cyclic-AMP phosphodiesterase (EC 3.1.4.53) inhibitor
3',5'-cyclic-AMP phosphodiesterase (EC 3.1.4.53) inhibitors
3',5'-cyclic-AMP phosphodiesterase inhibitor
3',5'-cyclic-AMP phosphodiesterase inhibitors
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitors
EC 3.1.4.53 inhibitor
EC 3.1.4.53 inhibitors
cAMP-specific PDE inhibitor
cAMP-specific PDE inhibitors
cAMP-specific phosphodiesterase inhibitor
cAMP-specific phosphodiesterase inhibitors
EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
1-pyrroline dehydrogenase inhibitor
1-pyrroline dehydrogenase inhibitors
1-pyrroline-5-carboxylate dehydrogenase inhibitor
1-pyrroline-5-carboxylate dehydrogenase inhibitors
1-pyrroline-5-carboxylate:NAD(+) oxidoreductase inhibitor
1-pyrroline-5-carboxylate:NAD(+) oxidoreductase inhibitors
Delta(1)-pyrroline-5-carboxylate dehydrogenase inhibitor
Delta(1)-pyrroline-5-carboxylate dehydrogenase inhibitors
Delta(1)-pyrroline-5-carboxylic acid dehydrogenase inhibitor
Delta(1)-pyrroline-5-carboxylic acid dehydrogenase inhibitors
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitors
EC 1.2.1.88 inhibitor
EC 1.2.1.88 inhibitors
L-glutamate gamma-semialdehyde dehydrogenase (EC 1.2.1.88) inhibitor
L-glutamate gamma-semialdehyde dehydrogenase (EC 1.2.1.88) inhibitors
L-glutamate gamma-semialdehyde dehydrogenase inhibitor
L-glutamate gamma-semialdehyde dehydrogenase inhibitors
L-glutamate gamma-semialdehyde:NAD(+) oxidoreductase inhibitor
L-glutamate gamma-semialdehyde:NAD(+) oxidoreductase inhibitors
L-pyrroline-5-carboxylate-NAD(+) oxidoreductase inhibitor
L-pyrroline-5-carboxylate-NAD(+) oxidoreductase inhibitors
pyrroline-5-carboxylate dehydrogenase inhibitor
pyrroline-5-carboxylate dehydrogenase inhibitors
pyrroline-5-carboxylic acid dehydrogenase inhibitor
pyrroline-5-carboxylic acid dehydrogenase inhibitors
EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
sulfaphenazole
1-phenyl-5-sulfanilamidopyrazole
3-(p-aminobenzenesulfonamido)-2-phenylpyrazole
4-amino-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
5-sulfanilamido-1-phenylpyrazole
N'-(1-phenylpyrazol-5-yl)sulfanilamide
N(1)-(1-phenylpyrazol-5-yl)sulfanilamide
Sulfabid
sulfafenazol
sulfaphenazol
sulfaphenazole
sulfaphenazolum
sulphaphenazole
sulfaphenazole
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor
13-deoxydaunorubicin hydroxylase (EC 1.14.13.181) inhibitor
13-deoxydaunorubicin hydroxylase (EC 1.14.13.181) inhibitors
13-deoxydaunorubicin hydroxylase inhibitor
13-deoxydaunorubicin hydroxylase inhibitors
13-deoxydaunorubicin,NADPH:oxygen oxidoreductase (13-hydroxylating) inhibitor
13-deoxydaunorubicin,NADPH:oxygen oxidoreductase (13-hydroxylating) inhibitors
DoxA inhibitor
DoxA inhibitors
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitors
EC 1.14.13.181 inhibitor
EC 1.14.13.181 inhibitors
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitors
EC 1.14.13.67 inhibitor
EC 1.14.13.67 inhibitors
quinine 3-hydroxylase inhibitor
quinine 3-hydroxylase inhibitors
quinine 3-monooxygenase (EC 1.14.13.67) inhibitor
quinine 3-monooxygenase (EC 1.14.13.67) inhibitors
quinine 3-monooxygenase inhibitor
quinine 3-monooxygenase inhibitors
quinine,NADPH:oxygen oxidoreductase inhibitor
quinine,NADPH:oxygen oxidoreductase inhibitors
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor
persistent organic pollutant
POP
POPs
persistent organic pollutants
persistent organic pollutant
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor
2,3-diaminopropanoate ammonia-lyase (adding H2O; pyruvate-forming) inhibitor
2,3-diaminopropanoate ammonia-lyase (adding H2O; pyruvate-forming) inhibitors
2,3-diaminopropanoate ammonia-lyase (adding water; pyruvate-forming) inhibitor
2,3-diaminopropanoate ammonia-lyase (adding water; pyruvate-forming) inhibitors
2,3-diaminopropanoate ammonia-lyase inhibitor
2,3-diaminopropanoate ammonia-lyase inhibitors
2,3-diaminopropionate ammonia-lyase inhibitor
2,3-diaminopropionate ammonia-lyase inhibitors
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitors
EC 4.3.1.15 inhibitor
EC 4.3.1.15 inhibitors
alpha,beta-diaminopropionate ammonia-lyase inhibitor
alpha,beta-diaminopropionate ammonia-lyase inhibitors
diaminopropionatase inhibitor
diaminopropionatase inhibitors
diaminopropionate ammonia-lyase (EC 4.3.1.15) inhibitor
diaminopropionate ammonia-lyase (EC 4.3.1.15) inhibitors
diaminopropionate ammonia-lyase inhibitor
diaminopropionate ammonia-lyase inhibitors
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitors
EC 1.14.13.70 inhibitor
EC 1.14.13.70 inhibitors
cytochrome P450 51 inhibitor
cytochrome P450 51 inhibitors
lanosterol 14-demethylase inhibitor
lanosterol 14-demethylase inhibitors
lanosterol 14alpha-demethylase inhibitor
lanosterol 14alpha-demethylase inhibitors
obtusufoliol 14-demethylase inhibitor
obtusufoliol 14-demethylase inhibitors
sterol 14-demethylase inhibitor
sterol 14-demethylase inhibitors
sterol 14alpha-demethylase inhibitor
sterol 14alpha-demethylase inhibitors
sterol,NADPH:oxygen oxidoreductase (14-methyl cleaving) inhibitor
sterol,NADPH:oxygen oxidoreductase (14-methyl cleaving) inhibitors
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
EC 3.5.1.4 (amidase) inhibitor
EC 3.5.1.4 (amidase) inhibitors
EC 3.5.1.4 inhibitor
EC 3.5.1.4 inhibitors
N-acetylaminohydrolase inhibitor
N-acetylaminohydrolase inhibitors
acylamidase inhibitor
acylamidase inhibitors
acylamide amidohydrolase inhibitor
acylamide amidohydrolase inhibitors
amidase (EC 3.5.1.4) inhibitor
amidase (EC 3.5.1.4) inhibitors
amidase inhibitor
amidase inhibitors
amidohydrolase inhibitor
amidohydrolase inhibitors
deaminase inhibitor
deaminase inhibitors
fatty acylamidase inhibitor
fatty acylamidase inhibitors
EC 3.5.1.4 (amidase) inhibitor
EC 6.1.1.4 (leucine--tRNA ligase) inhibitor
EC 6.1.1.4 (leucine--tRNA ligase) inhibitors
EC 6.1.1.4 inhibitor
EC 6.1.1.4 inhibitors
L-leucine:tRNA(Leu) ligase (AMP-forming) inhibitor
L-leucine:tRNA(Leu) ligase (AMP-forming) inhibitors
leucine translase inhibitor
leucine translase inhibitors
leucine--tRNA ligase inhibitor
leucine--tRNA ligase inhibitors
leucine--tRNA synthetase inhibitor
leucine--tRNA synthetase inhibitors
leucyl--tRNA synthetase inhibitor
leucyl--tRNA synthetase inhibitors
leucyl-transfer RNA synthetase inhibitor
leucyl-transfer RNA synthetase inhibitors
leucyl-transfer ribonucleate synthetase inhibitor
leucyl-transfer ribonucleate synthetase inhibitors
leucyl-transfer ribonucleic acid synthetase inhibitor
leucyl-transfer ribonucleic acid synthetase inhibitors
EC 6.1.1.4 (leucine--tRNA ligase) inhibitor
food firming agent
firming agent
firming agents
food firming agents
food firming agent
food antioxidant
food antioxidants
food antioxidant
sequestrant
sequestrants
sequestrant
anticaking agent
anti-caking agent
anti-caking agents
anticaking agents
anticaking agent
food anticaking agent
food anti-caking agent
food anti-caking agents
food anticaking agent
food anticaking agent
food stabiliser
food stabilisers
food stabilizer
food stabilizers
stabiliser
stabilisers
stabilizer
stabilizers
food stabiliser
humectant
humectants
humectant
food humectant
food humectants
food humectant
food thickening agent
food thickening agents
thickening agent
thickening agents
food thickening agent
raising agent
food raising agent
food raising agents
leavening agent
leavening agents
raising agents
raising agent
food glazing agent
food glazing agents
glazing agent
glazing agents
food glazing agent
antifoaming agent
antifoaming agents
defoamer
defoamers
antifoaming agent
food packaging gas
food packaging gases
food packaging gas
food bleaching agent
food bleaching agents
food bleaching agent
food bulking agent
filler
fillers
food bulking agents
food bulking agent
food colour retention agent
color retention agent
color retention agents
colour retention agent
colour retention agents
food color retention agent
food color retention agents
food colour retention agents
food colour retention agent
foaming agent
foaming agents
foaming agent
Wiskott-Aldrich syndrome protein inhibitor
N-WASP inhibitor
N-WASP inhibitors
WASP inhibitor
WASP inhibitors
Wiskott-Aldrich syndrome protein inhibitors
Wiskott-Aldrich syndrome protein inhibitor
food gelling agent
food gelling agents
food gelling agent
food propellant
food propellants
food propellant
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitor
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitors
EC 4.1.1.50 inhibitor
EC 4.1.1.50 inhibitors
S-adenosyl-L-methionine carboxy-lyase [(5-deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium-salt-forming] inhibitor
S-adenosyl-L-methionine carboxy-lyase [(5-deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium-salt-forming] inhibitors
S-adenosyl-L-methionine carboxy-lyase [S-adenosyl 3-(methylthio)propylamine-forming] inhibitor
S-adenosyl-L-methionine carboxy-lyase [S-adenosyl 3-(methylthio)propylamine-forming] inhibitors
S-adenosyl-L-methionine carboxy-lyase inhibitor
S-adenosyl-L-methionine carboxy-lyase inhibitors
S-adenosyl-L-methionine decarboxylase inhibitor
S-adenosyl-L-methionine decarboxylase inhibitors
S-adenosylmethionine decarboxylase inhibitor
S-adenosylmethionine decarboxylase inhibitors
EC 4.1.1.50 (adenosylmethionine decarboxylase) inhibitor
Wnt signalling inhibitor
Wnt signaling inhibitor
Wnt signaling inhibitors
Wnt signalling inhibitors
Wnt-signaling inhibitor
Wnt-signaling inhibitors
Wnt-signalling inhibitor
Wnt-signalling inhibitors
Wnt signalling inhibitor
food antifoaming agent
food antifoaming agents
food defoamer
food defoamers
food antifoaming agent
food additive carrier
carrier
carriers
food additive carriers
food additive carrier
enzyme mimic
enzyme mimetic
enzyme mimetics
enzyme mimics
enzyme mimic
oxazepam
(+-)-Oxazepam
(RS)-Oxazepam
7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Oxazepam
Serax
Tazepam
oxazepam
vitamin B1 antagonist
vitamin B1 antagonists
vitamin B1 antagonist
food component
dietary component
dietary components
food components
food component
environmental contaminant
environmental contaminants
environmental contaminant
environmental food contaminant
environmental food contaminants
environmental food contaminant
lichen metabolite
lichen metabolites
lichen metabolite
EC 2.7.1.1 (hexokinase) inhibitor
ATP-dependent hexokinase inhibitor
ATP-dependent hexokinase inhibitors
ATP:D-hexose 6-phosphotransferase inhibitor
ATP:D-hexose 6-phosphotransferase inhibitors
EC 2.7.1.1 (hexokinase) inhibitors
EC 2.7.1.1 inhibitor
EC 2.7.1.1 inhibitors
glucose ATP phosphotransferase inhibitor
glucose ATP phosphotransferase inhibitors
hexokinase (phosphorylating) inhibitor
hexokinase (phosphorylating) inhibitors
hexokinase D inhibitor
hexokinase D inhibitors
hexokinase inhibitor
hexokinase inhibitors
hexokinase type I inhibitor
hexokinase type I inhibitors
hexokinase type II inhibitor
hexokinase type II inhibitors
hexokinase type III inhibitor
hexokinase type III inhibitors
hexokinase type IV glucokinase inhibitor
hexokinase type IV glucokinase inhibitors
hexokinase type IV inhibitor
hexokinase type IV inhibitors
EC 2.7.1.1 (hexokinase) inhibitor
EC 3.1.1.5 (lysophospholipase) inhibitor
2-lysophosphatidylcholine acylhydrolase inhibitor
2-lysophosphatidylcholine acylhydrolase inhibitors
EC 3.1.1.5 (lysophospholipase) inhibitors
EC 3.1.1.5 inhibitor
EC 3.1.1.5 inhibitors
NTE inhibitor
NTE inhibitors
NTE-LysoPLA inhibitor
NTE-LysoPLA inhibitors
NTE-lysophospholipase inhibitor
NTE-lysophospholipase inhibitors
lecithinase B inhibitor
lecithinase B inhibitors
lecitholipase inhibitor
lecitholipase inhibitors
lysolecithinase inhibitor
lysolecithinase inhibitors
lysophopholipase L2 inhibitor
lysophopholipase L2 inhibitors
lysophosphatidase inhibitor
lysophosphatidase inhibitors
lysophosphatidylcholine hydrolase inhibitor
lysophosphatidylcholine hydrolase inhibitors
lysophospholipase (EC 3.1.1.5) inhibitor
lysophospholipase (EC 3.1.1.5) inhibitors
lysophospholipase A1 inhibitor
lysophospholipase A1 inhibitors
lysophospholipase inhibitor
lysophospholipase inhibitors
lysophospholipase transacylase inhibitor
lysophospholipase transacylase inhibitors
neuropathy target esterase inhibitor
neuropathy target esterase inhibitors
phosphatidase B inhibitor
phosphatidase B inhibitors
phospholipase B inhibitor
phospholipase B inhibitors
EC 3.1.1.5 (lysophospholipase) inhibitor
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor
2-enoyl-CoA reductase inhibitor
2-enoyl-CoA reductase inhibitors
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitors
EC 1.3.1.8 inhibitor
EC 1.3.1.8 inhibitors
acyl-CoA dehydrogenase (NADP(+)) (EC 1.3.1.8) inhibitor
acyl-CoA dehydrogenase (NADP(+)) (EC 1.3.1.8) inhibitors
acyl-CoA dehydrogenase (NADP(+)) inhibitor
acyl-CoA dehydrogenase (NADP(+)) inhibitors
acyl-CoA:NADP(+) 2-oxidoreductase inhibitor
acyl-CoA:NADP(+) 2-oxidoreductase inhibitors
crotonyl coenzyme A reductase inhibitor
crotonyl coenzyme A reductase inhibitors
crotonyl-CoA reductase inhibitor
crotonyl-CoA reductase inhibitors
dehydrogenase, acyl coenzyme A (nicotinamide adenine dinucleotide phosphate) inhibitor
dehydrogenase, acyl coenzyme A (nicotinamide adenine dinucleotide phosphate) inhibitors
enoyl coenzyme A reductase inhibitor
enoyl coenzyme A reductase inhibitors
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitors
EC 2.5.1.7 inhibitor
EC 2.5.1.7 inhibitors
MurA transferase inhibitor
MurA transferase inhibitors
UDP-N-acetylglucosamine 1-carboxyvinyl-transferase inhibitor
UDP-N-acetylglucosamine 1-carboxyvinyl-transferase inhibitors
UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 2.5.1.7) inhibitor
UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 2.5.1.7) inhibitors
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitors
UDP-N-acetylglucosamine enoylpyruvyltransferase inhibitor
UDP-N-acetylglucosamine enoylpyruvyltransferase inhibitors
enoylpyruvate transferase inhibitor
enoylpyruvate transferase inhibitors
phosphoenolpyruvate-UDP-acetylglucosamine-3-enolpyruvyltransferase inhibitor
phosphoenolpyruvate-UDP-acetylglucosamine-3-enolpyruvyltransferase inhibitors
phosphoenolpyruvate:UDP-2-acetamido-2-deoxy-D-glucose 2-enoyl-1-carboxyethyltransferase inhibitor
phosphoenolpyruvate:UDP-2-acetamido-2-deoxy-D-glucose 2-enoyl-1-carboxyethyltransferase inhibitors
phosphoenolpyruvate:UDP-N-acetyl-D-glucosamine 1-carboxyvinyltransferase inhibitor
phosphoenolpyruvate:UDP-N-acetyl-D-glucosamine 1-carboxyvinyltransferase inhibitors
phosphoenolpyruvate:UDP-N-acetyl-alpha-D-glucosamine 1-carboxyvinyltransferase inhibitor
phosphoenolpyruvate:UDP-N-acetyl-alpha-D-glucosamine 1-carboxyvinyltransferase inhibitors
phosphoenolpyruvate:uridine diphosphate N-acetylglucosamine enolpyruvyltransferase inhibitor
phosphoenolpyruvate:uridine diphosphate N-acetylglucosamine enolpyruvyltransferase inhibitors
phosphoenolpyruvate:uridine-5'-diphospho-N-acetyl-2-amino-2-deoxyglucose 3-enolpyruvyltransferase inhibitor
phosphoenolpyruvate:uridine-5'-diphospho-N-acetyl-2-amino-2-deoxyglucose 3-enolpyruvyltransferase inhibitors
phosphopyruvate-uridine diphosphoacetylglucosamine pyruvatetransferase inhibitor
phosphopyruvate-uridine diphosphoacetylglucosamine pyruvatetransferase inhibitors
pyruvate-UDP-acetylglucosamine transferase inhibitor
pyruvate-UDP-acetylglucosamine transferase inhibitors
pyruvate-uridine diphospho-N-acetyl-glucosamine transferase inhibitor
pyruvate-uridine diphospho-N-acetyl-glucosamine transferase inhibitors
pyruvate-uridine diphospho-N-acetylglucosamine transferase inhibitor
pyruvate-uridine diphospho-N-acetylglucosamine transferase inhibitors
pyruvic-uridine diphospho-N-acetylglucosaminyltransferase inhibitor
pyruvic-uridine diphospho-N-acetylglucosaminyltransferase inhibitors
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor
EC 3.5.4.1 (cytosine deaminase) inhibitor
EC 3.5.4.1 (cytosine deaminase) inhibitors
EC 3.5.4.1 inhibitor
EC 3.5.4.1 inhibitors
cytosine aminohydrolase inhibitor
cytosine aminohydrolase inhibitors
cytosine deaminase (EC 3.5.4.1) inhibitor
cytosine deaminase (EC 3.5.4.1) inhibitors
cytosine deaminase inhibitor
cytosine deaminase inhibitors
isocytosine deaminase inhibitor
isocytosine deaminase inhibitors
EC 3.5.4.1 (cytosine deaminase) inhibitor
EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitor
EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitors
EC 5.1.2.* inhibitor
EC 5.1.2.* inhibitors
inhibitor of racemases acting on hydroxy acids and derivatives
inhibitor of racemases acting on hydroxy acids and derivatives (EC 5.1.2.*)
inhibitors of racemases acting on hydroxy acids and derivatives
inhibitors of racemases acting on hydroxy acids and derivatives (EC 5.1.2.*)
EC 5.1.2.* (racemases acting on hydroxy acids and derivatives) inhibitor
EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitor
EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitors
EC 5.1.3.* inhibitor
EC 5.1.3.* inhibitors
inhibitor of racemases acting on carbohydrates and derivatives
inhibitor of racemases acting on carbohydrates and derivatives (EC 5.1.3.*)
inhibitors of racemases acting on carbohydrates and derivatives
inhibitors of racemases acting on carbohydrates and derivatives (EC 5.1.3.*)
EC 5.1.3.* (racemases acting on carbohydrates and derivatives) inhibitor
EC 5.1.99.* (racemases acting on other compounds) inhibitor
EC 5.1.99.* (racemases acting on other compounds) inhibitors
EC 5.1.99.* inhibitor
EC 5.1.99.* inhibitors
inhibitor of racemases acting on other compounds (EC 5.1.99.*)
inhibitors of racemases acting on other compounds (EC 5.1.99.*)
EC 5.1.99.* (racemases acting on other compounds) inhibitor
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor
4-epimerase inhibitor
4-epimerase inhibitors
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitors
EC 5.1.3.2 inhibitor
EC 5.1.3.2 inhibitors
UDP-D-galactose 4-epimerase inhibitor
UDP-D-galactose 4-epimerase inhibitors
UDP-alpha-D-glucose 4-epimerase inhibitor
UDP-alpha-D-glucose 4-epimerase inhibitors
UDP-galactose 4-epimerase inhibitor
UDP-galactose 4-epimerase inhibitors
UDP-glucose 4-epimerase (EC 5.1.3.2) inhibitor
UDP-glucose 4-epimerase (EC 5.1.3.2) inhibitors
UDP-glucose 4-epimerase inhibitor
UDP-glucose 4-epimerase inhibitors
UDP-glucose epimerase inhibitor
UDP-glucose epimerase inhibitors
UDPG-4-epimerase inhibitor
UDPG-4-epimerase inhibitors
UDPgalactose 4-epimerase inhibitor
UDPgalactose 4-epimerase inhibitors
UDPglucose 4-epimerase inhibitor
UDPglucose 4-epimerase inhibitors
galactowaldenase inhibitor
galactowaldenase inhibitors
uridine diphosphate galactose 4-epimerase inhibitor
uridine diphosphate galactose 4-epimerase inhibitors
uridine diphosphate glucose 4-epimerase inhibitor
uridine diphosphate glucose 4-epimerase inhibitors
uridine diphospho-galactose-4-epimerase inhibitor
uridine diphospho-galactose-4-epimerase inhibitors
uridine diphosphoglucose 4-epimerase inhibitor
uridine diphosphoglucose 4-epimerase inhibitors
uridine diphosphoglucose epimerase inhibitor
uridine diphosphoglucose epimerase inhibitors
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor
refrigerant
refrigerants
refrigerant
EC 3.1.1.1 (carboxylesterase) inhibitor
Alpha-carboxylesterase inhibitor
Alpha-carboxylesterase inhibitors
Beta-esterase inhibitor
Beta-esterase inhibitors
EC 3.1.1.1 (carboxylesterase) inhibitors
ali-esterase inhibitor
ali-esterase inhibitors
butyrate esterase inhibitor
butyrate esterase inhibitors
butyryl esterase inhibitor
butyryl esterase inhibitors
carboxyl ester hydrolase inhibitor
carboxyl ester hydrolase inhibitors
carboxylate esterase inhibitor
carboxylate esterase inhibitors
carboxylesterase inhibitor
carboxylesterase inhibitors
carboxylic acid esterase inhibitor
carboxylic acid esterase inhibitors
carboxylic esterase inhibitor
carboxylic esterase inhibitors
carboxylic-ester hydrolase inhibitor
carboxylic-ester hydrolase inhibitors
cocaine esterase inhibitor
cocaine esterase inhibitors
esterase A inhibitor
esterase A inhibitors
esterase B inhibitor
esterase B inhibitors
esterase D inhibitor
esterase D inhibitors
methylbutyrase inhibitor
methylbutyrase inhibitors
methylbutyrate esterase inhibitor
methylbutyrate esterase inhibitors
monobutyrase inhibitor
monobutyrase inhibitors
nonspecific carboxylesterase inhibitor
nonspecific carboxylesterase inhibitors
procaine esterase inhibitor
procaine esterase inhibitors
propionyl esterase inhibitor
propionyl esterase inhibitors
serine esterase inhibitor
serine esterase inhibitors
triacetin esterase inhibitor
triacetin esterase inhibitors
vitamin A esterase inhibitor
vitamin A esterase inhibitors
EC 3.1.1.1 (carboxylesterase) inhibitor
venom
venoms
venom
protein kinase A agonist
protein kinase A agonists
protein kinase A agonist
adenylate cyclase agonist
adenylate cyclase agonists
adenylyl cyclase agonist
adenylyl cyclase agonists
adenylate cyclase agonist
vesicant
blister agent
blister agents
vesicants
vesicant
Hsp70 inducer
Hsp70 activator
Hsp70 activators
Hsp70 inducers
heat shock protein 70 activator
heat shock protein 70 activators
heat shock protein 70 inducer
heat shock protein 70 inducers
Hsp70 inducer
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
3-hydroxy-3-methylglutaryl coenzyme A reductase kinase inhibitor
3-hydroxy-3-methylglutaryl coenzyme A reductase kinase inhibitors
3-hydroxy-3-methylglutaryl-CoA reductase kinase inhibitor
3-hydroxy-3-methylglutaryl-CoA reductase kinase inhibitors
AMP-activated protein kinase inhibitor
AMP-activated protein kinase inhibitors
AMPK inhibitor
AMPK inhibitors
ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase inhibitor
ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase inhibitors
EC 2.7.11.31 ([hydroxymethylglutaryl-CoA reductase (NADPH)] kinase) inhibitor
EC 2.7.11.31 ([hydroxymethylglutaryl-CoA reductase (NADPH)] kinase) inhibitors
EC 2.7.11.31 inhibitor
EC 2.7.11.31 inhibitors
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitors
HMG-CoA reductase kinase inhibitor
HMG-CoA reductase kinase inhibitors
STK29 inhibitor
STK29 inhibitors
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitor
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase inhibitors
[hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase inhibitor
[hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase inhibitors
beta-hydroxy-beta-methylglutaryl-CoA reductase kinase inhibitor
beta-hydroxy-beta-methylglutaryl-CoA reductase kinase inhibitors
hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) inhibitor
hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) inhibitors
hydroxymethylglutaryl coenzyme A reductase kinase inhibitor
hydroxymethylglutaryl coenzyme A reductase kinase inhibitors
hydroxymethylglutaryl-CoA reductase kinase inhibitor
hydroxymethylglutaryl-CoA reductase kinase inhibitors
reductase kinase inhibitor
reductase kinase inhibitors
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
bone morphogenetic protein receptor antagonist
BMP antagonist
BMP antagonists
BMP receptor inhibitor
BMP receptor inhibitors
bone morphogenetic protein antagonists
bone morphogenetic protein inhibitor
bone morphogenetic protein receptor inhibitors
bone morphogenetic protein receptor antagonist
fundamental metabolite
essential metabolite
essential metabolites
fundamental metabolites
fundamental metabolite
EC 4.6.1.2 (guanylate cyclase) inhibitor
EC 4.6.1.2 (guanylate cyclase) inhibitors
EC 4.6.1.2 inhibitor
EC 4.6.1.2 inhibitors
GTP diphosphate-lyase (cyclizing) inhibitor
GTP diphosphate-lyase (cyclizing) inhibitors
GTP diphosphate-lyase (cyclizing; 3',5'-cyclic-GMP-forming) inhibitor
GTP diphosphate-lyase (cyclizing; 3',5'-cyclic-GMP-forming) inhibitors
guanyl cyclase inhibitor
guanyl cyclase inhibitors
guanylyl cyclase inhibitor
guanylyl cyclase inhibitors
EC 4.6.1.2 (guanylate cyclase) inhibitor
tropomyosin-related kinase B receptor antagonist
TrkB receptor antagonist
TrkB receptor antagonists
tropomyosin-related kinase B receptor antagonists
tropomyosin-related kinase B receptor antagonist
EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor
EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitors
myristoyl-CoA-protein N-myristoyltransferase inhibitor
myristoyl-CoA-protein N-myristoyltransferase inhibitors
myristoyl-coenzyme A:protein N-myristoyl transferase inhibitor
myristoyl-coenzyme A:protein N-myristoyl transferase inhibitors
peptide N-myristoyltransferase inhibitor
peptide N-myristoyltransferase inhibitors
protein N-myristoyltransferase inhibitor
protein N-myristoyltransferase inhibitors
tetradecanoyl-CoA:glycylpeptide N-tetradecanoyltransferase inhibitor
tetradecanoyl-CoA:glycylpeptide N-tetradecanoyltransferase inhibitors
EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor
Delta(24)-sterol reductase (EC 1.3.1.72) inhibitor
Delta(24)-sterol reductase (EC 1.3.1.72) inhibitors
Delta(24)-sterol reductase inhibitor
Delta(24)-sterol reductase inhibitors
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitors
EC 1.3.1.72 inhibitor
EC 1.3.1.72 inhibitors
lanosterol Delta (24)-reductase
sterol:NADP(+) Delta(24)-oxidoreductase
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor
EC 2.5.1.6 (methionine adenosyltransferase) inhibitor
ATP-methionine adenosyltransferase inhibitor
ATP-methionine adenosyltransferase inhibitors
ATP:L-methionine S-adenosyltransferase inhibitor
ATP:L-methionine S-adenosyltransferase inhibitors
AdoMet synthetase inhibitor
AdoMet synthetase inhibitors
EC 2.5.1.6 (methionine adenosyltransferase) inhibitors
EC 2.5.1.6 inhibitor
EC 2.5.1.6 inhibitors
S-adenosyl-L-methionine synthetase inhibitor
S-adenosyl-L-methionine synthetase inhibitors
S-adenosylmethionine synthase inhibitor
S-adenosylmethionine synthase inhibitors
S-adenosylmethionine synthetase inhibitor
S-adenosylmethionine synthetase inhibitors
adenosylmethionine synthetase inhibitor
adenosylmethionine synthetase inhibitors
methionine S-adenosyltransferase inhibitor
methionine S-adenosyltransferase inhibitors
methionine-activating enzyme inhibitor
methionine-activating enzyme inhibitors
EC 2.5.1.6 (methionine adenosyltransferase) inhibitor
EC 2.7.1.91 (sphingosine kinase) inhibitor
ATP:sphinganine 1-phosphotransferase inhibitor
ATP:sphinganine 1-phosphotransferase inhibitors
EC 2.7.1.91 (sphinganine kinase) inhibitor
EC 2.7.1.91 (sphinganine kinase) inhibitors
EC 2.7.1.91 (sphingosine kinase) inhibitors
EC 2.7.1.91 inhibitor
EC 2.7.1.91 inhibitors
SGK inhibitor
SGK inhibitors
SK inhibitor
SK inhibitors
dihydrosphingosine kinase (phosphorylating) inhibitor
dihydrosphingosine kinase (phosphorylating) inhibitors
dihydrosphingosine kinase inhibitor
dihydrosphingosine kinase inhibitors
sphinganine kinase inhibitor
sphinganine kinase inhibitors
sphingoid base kinase inhibitor
sphingoid base kinase inhibitors
sphingosine kinase (phosphorylating) inhibitor
sphingosine kinase (phosphorylating) inhibitors
EC 2.7.1.91 (sphingosine kinase) inhibitor
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
ATP:[myosin-light-chain] O-phosphotransferase inhibitor
ATP:[myosin-light-chain] O-phosphotransferase inhibitors
ATP:myosin-light-chain O-phosphotransferase inhibitor
ATP:myosin-light-chain O-phosphotransferase inhibitors
EC 2.7.11.18 (myosin-light-chain kinase) inhibitors
EC 2.7.11.18 inhibitor
EC 2.7.11.18 inhibitors
MLCK inhibitor
MLCK inhibitors
MLCkase inhibitor
MLCkase inhibitors
[myosin-light-chain] kinase inhibitor
[myosin-light-chain] kinase inhibitors
calcium/calmodulin-dependent myosin light chain kinase inhibitor
calcium/calmodulin-dependent myosin light chain kinase inhibitors
myosin kinase inhibitor
myosin kinase inhibitors
myosin light chain kinase inhibitor
myosin light chain kinase inhibitors
myosin light chain protein kinase inhibitor
myosin light chain protein kinase inhibitors
myosin light-chain kinase (phosphorylating) inhibitor
myosin light-chain kinase (phosphorylating) inhibitors
myosin light-chain kinase inhibitor
myosin light-chain kinase inhibitors
myosin-light-chain kinase (EC 2.7.11.18) inhibitor
myosin-light-chain kinase (EC 2.7.11.18) inhibitors
myosin-light-chain kinase inhibitor
myosin-light-chain kinase inhibitors
smooth-muscle-myosin-light-chain kinase inhibitor
smooth-muscle-myosin-light-chain kinase inhibitors
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
nematode metabolite
nematode metabolites
nematode metabolite
Caenorhabditis elegans metabolite
C. elegans metabolite
C. elegans metabolites
Caenorhabditis elegans metabolites
Caenorhabditis elegans metabolite
survivin dimerisation modulator
survivin dimerisation modulators
survivin modulator
survivin modulators
survivin dimerisation modulator
EC 3.6.1.* (hydrolases acting on acid anhydrides in P-containing anhydrides) inhibitor
EC 3.6.1.* (hydrolases acting on acid anhydrides in P-containing anhydrides) inhibitors
EC 3.6.1.* (hydrolases acting on acid anhydrides in phosphorus-containing anhydrides) inhibitor
EC 3.6.1.* (hydrolases acting on acid anhydrides in phosphorus-containing anhydrides) inhibitors
EC 3.6.1.* inhibitor
EC 3.6.1.* inhibitors
hydrolases acting on acid anhydrides in P-containing anhydrides (EC 3.6.1.*) inhibitor
hydrolases acting on acid anhydrides in P-containing anhydrides (EC 3.6.1.*) inhibitors
hydrolases acting on acid anhydrides in phosphorus-containing anhydrides (EC 3.6.1.*) inhibitor
hydrolases acting on acid anhydrides in phosphorus-containing anhydrides (EC 3.6.1.*) inhibitors
EC 3.6.1.* (hydrolases acting on acid anhydrides in P-containing anhydrides) inhibitor
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor
(Ca(2+) + Mg(2+))-ATPase inhibitor
(Ca(2+) + Mg(2+))-ATPase inhibitors
ATP hydrolase inhibitor
ATP hydrolase inhibitors
ATP monophosphatase inhibitor
ATP monophosphatase inhibitors
ATP phosphohydrolase inhibitor
ATP phosphohydrolase inhibitors
ATPase inhibitor
ATPase inhibitors
EC 3.6.1.3 (adenosinetriphosphatase) inhibitors
EC 3.6.1.3 inhibitor
EC 3.6.1.3 inhibitors
HCO3(-)-ATPase inhibitor
HCO3(-)-ATPase inhibitors
SV40 T-antigen inhibitor
SV40 T-antigen inhibitors
adenosine 5'-triphosphatase inhibitor
adenosine 5'-triphosphatase inhibitors
adenosine triphosphatase inhibitor
adenosine triphosphatase inhibitors
adenosinetriphosphatase (EC 3.6.1.3) inhibitor
adenosinetriphosphatase (EC 3.6.1.3) inhibitors
adenosinetriphosphatase inhibitor
adenosinetriphosphatase inhibitors
adenylpyrophosphatase inhibitor
adenylpyrophosphatase inhibitors
complex V (mitochondrial electron transport) inhibitor
complex V (mitochondrial electron transport) inhibitors
triphosphatase inhibitor
triphosphatase inhibitors
EC 3.6.1.3 (adenosinetriphosphatase) inhibitor
archaeal metabolite
archaeal metabolites
archaeal metabolite
melatonin receptor agonist
melatonin receptor agonists
melatonin receptor agonist
EC 3.4.22.52 (calpain-1) inhibitor
EC 3.4.22.52 (calpain-1) inhibitors
EC 3.4.22.52 inhibitor
EC 3.4.22.52 inhibitors
calcium-activated neutral protease I inhibitor
calcium-activated neutral protease I inhibitors
calpain-1 (EC 3.4.22.52) inhibitor
calpain-1 (EC 3.4.22.52) inhibitors
calpain-1 inhibitor
calpain-1 inhibitors
mu-calpain inhibitor
mu-calpain inhibitors
EC 3.4.22.52 (calpain-1) inhibitor
plasticiser
plasticisers
plasticizer
plasticizers
plasticiser
potassium channel opener
potassium channel activator
potassium channel activators
potassium channel agonist
potassium channel agonists
potassium channel openers
potassium channel opener
EC 3.4.24.35 (gelatinase B) inhibitor
92-kDa gelatinase inhibitor
92-kDa gelatinase inhibitors
92-kDa type IV collagenase inhibitor
92-kDa type IV collagenase inhibitors
95 kDa type IV collagenase/gelatinase inhibitor
95 kDa type IV collagenase/gelatinase inhibitors
EC 3.4.24.35 (gelatinase B) inhibitors
EC 3.4.24.35 inhibitor
EC 3.4.24.35 inhibitors
MMP 9 inhibitor
MMP 9 inhibitors
collagenase IV inhibitor
collagenase IV inhibitors
collagenase type IV inhibitor
collagenase type IV inhibitors
gelatinase B (EC 3.4.24.35) inhibitor
gelatinase B (EC 3.4.24.35) inhibitors
gelatinase B inhibitor
gelatinase B inhibitors
gelatinase MMP 9 inhibitor
gelatinase MMP 9 inhibitors
macrophage gelatinase inhibitor
macrophage gelatinase inhibitors
matrix metalloproteinase 9 inhibitor
matrix metalloproteinase 9 inhibitors
type IV collagen metalloproteinase inhibitor
type IV collagen metalloproteinase inhibitors
type V collagenase inhibitor
type V collagenase inhibitors
EC 3.4.24.35 (gelatinase B) inhibitor
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
ATP:protein phosphotransferase (MAPKK-activated) inhibitor
ATP:protein phosphotransferase (MAPKK-activated) inhibitors
Dp38 inhibitor
Dp38 inhibitors
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitors
EC 2.7.11.24 inhibitor
EC 2.7.11.24 inhibitors
ERK inhibitor
ERK inhibitors
ERK1 inhibitor
ERK1 inhibitors
ERK2 inhibitor
ERK2 inhibitors
JNK inhibitor
JNK inhibitors
JNK3alpha1 inhibitor
JNK3alpha1 inhibitors
LeMPK3 inhibitor
LeMPK3 inhibitors
MAP kinase inhibitor
MAP kinase inhibitors
MAP-2 kinase inhibitor
MAP-2 kinase inhibitors
MAPK inhibitor
MAPK inhibitors
MBP kinase I inhibitor
MBP kinase I inhibitors
MBP kinase II inhibitor
MBP kinase II inhibitors
MEK inhibitor
MEK inhibitors
PMK-1 inhibitor
PMK-1 inhibitors
PMK-2 inhibitor
PMK-2 inhibitors
PMK-3 inhibitor
PMK-3 inhibitors
SAPK inhibitor
SAPK inhibitors
STK26 inhibitor
STK26 inhibitors
c-Jun N-terminal kinase inhibitor
c-Jun N-terminal kinase inhibitors
extracellular signal-regulated kinase inhibitor
extracellular signal-regulated kinase inhibitors
microtubule-associated protein 2 kinase inhibitor
microtubule-associated protein 2 kinase inhibitors
microtubule-associated protein kinase inhibitor
microtubule-associated protein kinase inhibitors
mitogen-activated protein kinase (EC 2.7.11.24) inhibitor
mitogen-activated protein kinase (EC 2.7.11.24) inhibitors
mitogen-activated protein kinase inhibitor
mitogen-activated protein kinase inhibitors
myelin basic protein kinase inhibitor
myelin basic protein kinase inhibitors
p38-2 inhibitor
p38-2 inhibitors
p38delta inhibitor
p38delta inhibitors
p42 mitogen-activated protein kinase inhibitor
p42 mitogen-activated protein kinase inhibitors
p42(mapk) inhibitor
p42(mapk) inhibitors
p44mpk inhibitor
p44mpk inhibitors
pp42 inhibitor
pp42 inhibitors
pp44(mapk) inhibitor
pp44(mapk) inhibitors
stress-activated protein kinase inhibitor
stress-activated protein kinase inhibitors
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
EC 1.11.2.* (oxidoreductase with H2O2 as acceptor, incorporating 1 O atom into product) inhibitor
EC 1.11.2.* (oxidoreductase with H2O2 as acceptor, incorporating 1 O atom into product) inhibitors
EC 1.11.2.* inhibitor
EC 1.11.2.* inhibitors
EC 1.11.2.* (oxidoreductase with H2O2 as acceptor, incorporating 1 O atom into product) inhibitor
EC 1.11.2.2 (myeloperoxidase) inhibitor
EC 1.11.2.2 (myeloperoxidase) inhibitors
EC 1.11.2.2 inhibitor
EC 1.11.2.2 inhibitors
MPO inhibitor
MPO inhibitors
chloride:hydrogen-peroxide oxidoreductase (hypochlorite-forming) inhibitor
chloride:hydrogen-peroxide oxidoreductase (hypochlorite-forming) inhibitors
myeloperoxidase (EC 1.11.2.2) inhibitor
myeloperoxidase (EC 1.11.2.2) inhibitors
myeloperoxidase inhibitor
myeloperoxidase inhibitors
verdoperoxidase inhibitor
verdoperoxidase inhibitors
EC 1.11.2.2 (myeloperoxidase) inhibitor
flame retardant
flame retardants
flame retardant
paroxetine
(-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
Paroxetine
paroxetina
paroxetinum
paroxetine
glycerophosphoinositol synthesis inhibitor
GPI synthesis inhibitor
GPI synthesis inhibitors
glycerophosphoinositol synthesis inhibitors
glycerophosphoinositol synthesis inhibitor
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitors
EC 6.1.1.2 inhibitor
EC 6.1.1.2 inhibitors
L-tryptophan-tRNA(Trp) ligase (AMP-forming) inhibitor
L-tryptophan-tRNA(Trp) ligase (AMP-forming) inhibitors
L-tryptophan:tRNA(Trp) ligase (AMP-forming) inhibitor
L-tryptophan:tRNA(Trp) ligase (AMP-forming) inhibitors
TrpRS inhibitor
TrpRS inhibitors
tryptophan translase inhibitor
tryptophan translase inhibitors
tryptophan--tRNA ligase (EC 6.1.1.2) inhibitor
tryptophan--tRNA ligase (EC 6.1.1.2) inhibitors
tryptophanyl ribonucleic synthetase inhibitor
tryptophanyl ribonucleic synthetase inhibitors
tryptophanyl-tRNA synthase inhibitor
tryptophanyl-tRNA synthase inhibitors
tryptophanyl-tRNA synthetase inhibitor
tryptophanyl-tRNA synthetase inhibitors
tryptophanyl-transfer RNA synthetase inhibitor
tryptophanyl-transfer RNA synthetase inhibitors
tryptophanyl-transfer ribonucleate synthetase inhibitor
tryptophanyl-transfer ribonucleate synthetase inhibitors
tryptophanyl-transfer ribonucleic acid synthetase inhibitor
tryptophanyl-transfer ribonucleic acid synthetase inhibitors
tryptophanyl-transfer ribonucleic synthetase inhibitor
tryptophanyl-transfer ribonucleic synthetase inhibitors
EC 6.1.1.2 (tryptophan--tRNA ligase) inhibitor
phenacetin
1-Acetamido-4-ethoxybenzene
4-Ethoxyacetanilide
Acetophenetidin
Acetophenetidine
Acetophenetin
Acetphenetidin
Achrocidin
Codempiral
Commotional
Contradol
Contradouleur
Fenacetina
N-(4-ethoxyphenyl)acetamide
Phenacetin
Phenacetine
Phenacetinum
phenacetin
phenacetin
phytochrome chromophore
phytochrome chromophores
phytochrome chromophore
animal growth promotant
animal growth promotants
animal growth promoter
animal growth promoters
animal growth promotant
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
ATP:cyclin phosphotransferase inhibitor
ATP:cyclin phosphotransferase inhibitors
Bur1 Cdk inhibitor
Bur1 Cdk inhibitors
Bur1 inhibitor
Bur1 inhibitors
CDK inhibitor
CDK inhibitors
Cak1 inhibitor
Cak1 inhibitors
Cak1p inhibitor
Cak1p inhibitors
Cdc28p inhibitor
Cdc28p inhibitors
Cdk-activating protein kinase inhibitors
Cdk1 inhibitor
Cdk1 inhibitors
Cdk19 inhibitor
Cdk19 inhibitors
Cdk2 inhibitor
Cdk2 inhibitors
Cdk3 inhibitor
Cdk3 inhibitors
Cdk4 inhibitor
Cdk4 inhibitors
Cdk5 inhibitor
Cdk5 inhibitors
Cdk6 inhibitor
Cdk6 inhibitors
Cdk7 inhibitor
Cdk7 inhibitors
Cdk8 inhibitor
Cdk8 inhibitors
Cdk9 inhibitor
Cdk9 inhibitors
D-type cyclin kinase inhibitor
D-type cyclin kinase inhibitors
EC 2.7.11.22 (cyclin-dependent kinase) inhibitors
EC 2.7.11.22 inhibitor
EC 2.7.11.22 inhibitors
PCTAIRE-1 inhibitor
PCTAIRE-1 inhibitors
STK25 inhibitor
STK25 inhibitors
cdc2 inhibitor
cdc2 inhibitors
cdc2 kinase inhibitor
cdc2 kinase inhibitors
cdk-activating kinase inhibitor
cdk-activating kinase inhibitors
cyclin A-activated cdc2 inhibitor
cyclin A-activated cdc2 inhibitors
cyclin A-activated cdk2 inhibitor
cyclin A-activated cdk2 inhibitors
cyclin D-cdk6 kinase inhibitor
cyclin D-cdk6 kinase inhibitors
cyclin D-dependent kinase inhibitor
cyclin D-dependent kinase inhibitors
cyclin E kinase inhibitor
cyclin E kinase inhibitors
cyclin-A associated kinase inhibitor
cyclin-A associated kinase inhibitors
cyclin-dependent kinase 6 inhibitor
cyclin-dependent kinase 6 inhibitors
cyclin-dependent kinase inhibitor
cyclin-dependent kinase inhibitors
cyclin-dependent kinase-2 inhibitor
cyclin-dependent kinase-2 inhibitors
cyclin-dependent kinase-4 inhibitor
cyclin-dependent kinase-4 inhibitors
cyclin-dependent protein kinase activating kinase inhibitor
cyclin-dependent protein kinase activating kinase inhibitors
cyk inhibitor
cyk inhibitors
ndk inhibitor
ndk inhibitors
neuronal cdc2-like kinase inhibitor
neuronal cdc2-like kinase inhibitors
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
EC 6.1.1.12 (aspartate--tRNA ligase) inhibitor
EC 6.1.1.12 (aspartate--tRNA ligase) inhibitors
EC 6.1.1.12 inhibitor
EC 6.1.1.12 inhibitors
L-aspartate:tRNA(Asp) ligase (AMP-forming) inhibitor
L-aspartate:tRNA(Asp) ligase (AMP-forming) inhibitors
aspartic acid translase inhibitor
aspartic acid translase inhibitors
aspartyl ribonucleate synthetase inhibitor
aspartyl ribonucleate synthetase inhibitors
aspartyl ribonucleic synthetase inhibitor
aspartyl ribonucleic synthetase inhibitors
aspartyl-tRNA synthetase inhibitors
aspartyl-transfer RNA synthetase inhibitor
aspartyl-transfer RNA synthetase inhibitors
aspartyl-transfer ribonucleic acid synthetase inhibitor
aspartyl-transfer ribonucleic acid synthetase inhibitors
EC 6.1.1.12 (aspartate--tRNA ligase) inhibitor
EC 3.4.22.53 (calpain-2) inhibitor
EC 3.4.22.53 (calpain-2) inhibitors
EC 3.4.22.53 inhibitor
EC 3.4.22.53 inhibitors
calcium-activated neutral protease II inhibitor
calcium-activated neutral protease II inhibitors
calpain-2 (EC 3.4.22.53) inhibitor
calpain-2 (EC 3.4.22.53) inhibitors
m-calpain inhibitor
m-calpain inhibitors
milli-calpain inhibitor
milli-calpain inhibitors
EC 3.4.22.53 (calpain-2) inhibitor
EC 3.4.22.54 (calpain-3) inhibitor
CANP 3 inhibitor
CANP 3 inhibitors
CAPN3 inhibitor
CAPN3 inhibitors
EC 3.4.22.54 (calpain-3) inhibitors
EC 3.4.22.54 inhibitor
EC 3.4.22.54 inhibitors
calcium-activated neutral proteinase 3 inhibitor
calcium-activated neutral proteinase 3 inhibitors
calpain 3 inhibitor
calpain 3 inhibitors
calpain L3 inhibitor
calpain L3 inhibitors
calpain p94 inhibitor
calpain p94 inhibitors
calpain-3 (EC 3.4.22.54) inhibitor
calpain-3 (EC 3.4.22.54) inhibitors
muscle calpain inhibitor
muscle calpain inhibitors
muscle-specific calcium-activated neutral protease 3 inhibitor
muscle-specific calcium-activated neutral protease 3 inhibitors
p94 inhibitor
p94 inhibitors
EC 3.4.22.54 (calpain-3) inhibitor
calpain inhibitor
calpain inhibitors
calpain inhibitor
glucocorticoid receptor antagonist
glucocorticoid receptor antagonists
glucocorticoid receptor antagonist
gut flora metabolite
gut flora metabolites
gut flora metabolite
EC 3.4.24.11 (neprilysin) inhibitor
CALLA (common acute lymphoblastic leukemia-associated) antigens inhibitor
CALLA (common acute lymphoblastic leukemia-associated) antigens inhibitors
CALLA antigen inhibitor
CALLA antigen inhibitors
CALLA glycoprotein inhibitor
CALLA glycoprotein inhibitors
CALLA glycoproteins inhibitor
CALLA glycoproteins inhibitors
CALLA inhibitor
CALLA inhibitors
CD10 inhibitor
CD10 inhibitors
EC 3.4.24.11 (neprilysin) inhibitors
EC 3.4.24.11 inhibitor
EC 3.4.24.11 inhibitors
NEP inhibitor
NEP inhibitors
acute lymphoblastic leukemia antigen inhibitor
acute lymphoblastic leukemia antigen inhibitors
common acute lymphoblastic leukemia antigen inhibitor
common acute lymphoblastic leukemia antigen inhibitors
common acute lymphoblastic leukemia-associated antigens inhibitor
common acute lymphoblastic leukemia-associated antigens inhibitors
endopeptidase 24.11 inhibitor
endopeptidase 24.11 inhibitors
endopeptidase inhibitor
endopeptidase inhibitors
endopeptidase-2 inhibitor
endopeptidase-2 inhibitors
enkephalinase inhibitor
enkephalinase inhibitors
kidney-brush-border neutral endopeptidase inhibitor
kidney-brush-border neutral endopeptidase inhibitors
kidney-brush-border neutral peptidase inhibitor
kidney-brush-border neutral peptidase inhibitors
kidney-brush-border neutral proteinase inhibitor
kidney-brush-border neutral proteinase inhibitors
membrane metalloendopeptidase inhibitor
membrane metalloendopeptidase inhibitors
neprilysin (EC 3.4.24.11) inhibitor
neprilysin (EC 3.4.24.11) inhibitors
neprilysin inhibitor
neprilysin inhibitors
neutral endopeptidase 24.11 inhibitor
neutral endopeptidase 24.11 inhibitors
neutral endopeptidase inhibitor
neutral endopeptidase inhibitors
neutral metallendopeptidase inhibitor
neutral metallendopeptidase inhibitors
EC 3.4.24.11 (neprilysin) inhibitor
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitors
EC 3.4.24.71 inhibitor
EC 3.4.24.71 inhibitors
ECE-1 inhibitor
ECE-1 inhibitors
endothelin-converting enzyme 1 (EC 3.4.24.71) inhibitor
endothelin-converting enzyme 1 (EC 3.4.24.71) inhibitors
endothelin-converting enzyme 1 inhibitor
endothelin-converting enzyme 1 inhibitors
endothelin-converting enzyme inhibitor
endothelin-converting enzyme inhibitors
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
EC 4.1.2.27 (sphinganine-1-phosphate aldolase) inhibitor
EC 4.1.2.27 (sphinganine-1-phosphate aldolase) inhibitors
EC 4.1.2.27 inhibitor
EC 4.1.2.27 inhibitors
S1P lyase inhibitor
S1P lyase inhibitors
dihydrosphingosine 1-phosphate aldolase inhibitor
dihydrosphingosine 1-phosphate aldolase inhibitors
sphinganine-1-phosphate alkanal-lyase inhibitor
sphinganine-1-phosphate alkanal-lyase inhibitors
sphinganine-1-phosphate lyase inhibitor
sphinganine-1-phosphate lyase inhibitors
sphinganine-1-phosphate palmitaldehyde-lyase (phosphoethanolamine-forming) inhibitor
sphinganine-1-phosphate palmitaldehyde-lyase (phosphoethanolamine-forming) inhibitors
sphinganine-1-phosphate palmitaldehyde-lyase inhibitor
sphinganine-1-phosphate palmitaldehyde-lyase inhibitors
sphingosine-1-phosphate aldolase inhibitor
sphingosine-1-phosphate aldolase inhibitors
sphingosine-1-phosphate lyase inhibitor
sphingosine-1-phosphate lyase inhibitors
EC 4.1.2.27 (sphinganine-1-phosphate aldolase) inhibitor
EC 4.1.2.* (aldehyde-lyase) inhibitor
EC 4.1.2.* (aldehyde-lyase) inhibitors
EC 4.1.2.* (aldehyde-lyases) inhibitor
EC 4.1.2.* (aldehyde-lyases) inhibitors
EC 4.1.2.* inhibitor
EC 4.1.2.* inhibitors
EC 4.1.2.* (aldehyde-lyase) inhibitor
Daphnia galeata metabolite
Daphnia galeata metabolites
Daphnia galeata metabolite
crustacean metabolite
crustacean metabolites
crustacean metabolite
Daphnia magna metabolite
Daphnia magna metabolites
Daphnia magna metabolite
Daphnia metabolite
Daphnia metabolites
Daphnia metabolite
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitors
EC 1.3.5.1 inhibitor
EC 1.3.5.1 inhibitors
SDH inhibitor
SDH inhibitors
complex II inhibitor
complex II inhibitors
succinate dehydrogenase (ubiquinone) inhibitor
succinate dehydrogenase (ubiquinone) inhibitors
succinate dehydrogenase complex inhibitor
succinate dehydrogenase complex inhibitors
succinate dehydrogenase inhibitor
succinate dehydrogenase inhibitors
succinate:quinone oxidoreductase inhibitor
succinate:quinone oxidoreductase inhibitors
succinate:ubiquinone oxidoreductase inhibitor
succinate:ubiquinone oxidoreductase inhibitors
succinic dehydrogenase inhibitor
succinic dehydrogenase inhibitors
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
kairomone
kairomones
kairomone
Daphnia pulex metabolite
Daphnia pulex metabolites
Daphnia pulex metabolite
Daphnia tenebrosa metabolite
Daphnia tenebrosa metabolites
Daphnia tenebrosa metabolite
EC 6.2.1.* (acid-thiol ligase) inhibitor
EC 6.2.1.* (acid-thiol ligase) inhibitors
EC 6.2.1.* (acid-thiol ligases) inhibitor
EC 6.2.1.* (acid-thiol ligases) inhibitors
EC 6.2.1.* inhibitor
EC 6.2.1.* inhibitors
EC 6.2.1.* (acid-thiol ligase) inhibitor
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor
ACS3 inhibitor
ACS3 inhibitors
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitors
EC 6.2.1.3 inhibitor
EC 6.2.1.3 inhibitors
FAA1 inhibitor
FAA1 inhibitors
LCFA synthetase inhibitor
LCFA synthetase inhibitors
acyl coenzyme A synthetase inhibitor
acyl coenzyme A synthetase inhibitors
acyl-CoA ligase inhibitor
acyl-CoA ligase inhibitors
acyl-CoA synthetase inhibitor
acyl-CoA synthetase inhibitors
acyl-activating enzyme inhibitor
acyl-activating enzyme inhibitors
acyl-coenzyme A ligase inhibitor
acyl-coenzyme A ligase inhibitors
arachidonyl-CoA synthetase inhibitor
arachidonyl-CoA synthetase inhibitors
fatty acid CoA ligase inhibitor
fatty acid CoA ligase inhibitors
fatty acid elongase inhibitor
fatty acid elongase inhibitors
fatty acid thiokinase (long chain) inhibitor
fatty acid thiokinase (long chain) inhibitors
fatty acyl-coenzyme A synthetase inhibitor
fatty acyl-coenzyme A synthetase inhibitors
lignoceroyl-CoA synthase inhibitor
lignoceroyl-CoA synthase inhibitors
long chain fatty acyl-CoA synthetase inhibitor
long chain fatty acyl-CoA synthetase inhibitors
long-chain acyl CoA synthetase inhibitor
long-chain acyl CoA synthetase inhibitors
long-chain acyl-CoA synthetase I inhibitor
long-chain acyl-CoA synthetase I inhibitors
long-chain acyl-CoA synthetase II inhibitor
long-chain acyl-CoA synthetase II inhibitors
long-chain acyl-coenzyme A synthetase inhibitor
long-chain acyl-coenzyme A synthetase inhibitors
long-chain fatty acid:CoA ligase (AMP-forming) inhibitor
long-chain fatty acid:CoA ligase (AMP-forming) inhibitors
long-chain fatty acyl coenzyme A synthetase inhibitor
long-chain fatty acyl coenzyme A synthetase inhibitors
oleoyl-CoA synthetase inhibitor
oleoyl-CoA synthetase inhibitors
palmitoyl coenzyme A synthetase inhibitor
palmitoyl coenzyme A synthetase inhibitors
palmitoyl-CoA ligase inhibitor
palmitoyl-CoA ligase inhibitors
palmitoyl-CoA synthase inhibitor
palmitoyl-CoA synthase inhibitors
pristanoyl-CoA synthetase inhibitor
pristanoyl-CoA synthetase inhibitors
stearoyl-CoA synthetase inhibitor
stearoyl-CoA synthetase inhibitors
thiokinase inhibitor
thiokinase inhibitors
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor
orexin receptor antagonist
orexin receptor antagonists
orexin receptor antagonist
protease-activated receptor-1 antagonist
PAR-1 antagonist
PAR-1 antagonists
PAR-1 receptor antagonist
PAR-1 receptor antagonists
PAR1 antagonist
PAR1 antagonists
coagulation factor II (thrombin) receptor antagonist
coagulation factor II (thrombin) receptor antagonists
coagulation factor II receptor antagonist
coagulation factor II receptor antagonists
coagulation factor II thrombin receptor antagonist
coagulation factor II thrombin receptor antagonists
protease activated receptor 1 antagonist
protease activated receptor 1 antagonists
protease-activated receptor 1 antagonist
protease-activated receptor 1 antagonists
protease-activated receptor-1 antagonists
proteinase-activated receptor 1 antagonist
proteinase-activated receptor 1 antagonists
protease-activated receptor-1 antagonist
EC 1.14.13.72 (methylsterol monooxygenase) inhibitor
4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,NAD(P)H:oxygen oxidoreductase (hydroxylating) inhibitor
4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,NAD(P)H:oxygen oxidoreductase (hydroxylating) inhibitors
4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,hydrogen-donor:oxygen oxidoreductase (hydroxylating) inhibitor
4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,hydrogen-donor:oxygen oxidoreductase (hydroxylating) inhibitors
4-methylsterol oxidase inhibitor
4-methylsterol oxidase inhibitors
EC 1.14.13.72 (ethylsterol monooxygenase) inhibitors
EC 1.14.13.72 inhibitor
EC 1.14.13.72 inhibitors
methylsterol hydroxylase inhibitor
methylsterol hydroxylase inhibitors
methylsterol monooxygenase (EC 1.14.13.72) inhibitor
methylsterol monooxygenase (EC 1.14.13.72) inhibitors
methylsterol monooxygenase inhibitor
methylsterol monooxygenase inhibitors
EC 1.14.13.72 (methylsterol monooxygenase) inhibitor
sterol biosynthesis inhibitor
sterol biosynthesis inhibitors
sterol biosynthesis inhibitor
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor
4,4-dimethyl-5alpha-cholesta-8,24-dien-3beta-ol:NADP(+) Delta(14)-oxidoreductase inhibitor
4,4-dimethyl-5alpha-cholesta-8,24-dien-3beta-ol:NADP(+) Delta(14)-oxidoreductase inhibitors
C-14 sterol reductase inhibitor
C-14 sterol reductase inhibitors
Delta(14)-sterol reductase (EC 1.3.1.70) inhibitor
Delta(14)-sterol reductase (EC 1.3.1.70) inhibitors
Delta(14)-sterol reductase inhibitor
Delta(14)-sterol reductase inhibitors
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitors
EC 1.3.1.70 inhibitor
EC 1.3.1.70 inhibitors
sterol C14-reductase inhibitor
sterol C14-reductase inhibitors
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor
marine xenobiotic metabolite
marine xenobiotic metabolites
marine xenobiotic metabolite
steatosis inducing agent
steatosis inducing agents
steatosis inducing drug
steatosis inducing drugs
steatosis inducing agent
hepatic steatosis inducing agent
hepatic steatosis inducing agents
hepatic steatosis inducing drug
hepatic steatosis inducing drugs
hepatic steatosis inducing agent
sterol demethylation inhibitor
sterol demethylation inhibitors
sterol demethylation inhibitor
phospholipid biosynthesis inhibitor
phospholipid biosynthesis inhibitors
phospholipid biosynthesis inhibitor
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitors
EC 2.4.1.231 inhibitor
EC 2.4.1.231 inhibitors
alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231) inhibitor
alpha,alpha-trehalose phosphorylase (configuration-retaining) (EC 2.4.1.231) inhibitors
alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitor
alpha,alpha-trehalose phosphorylase (configuration-retaining) inhibitors
alpha,alpha-trehalose:phosphate alpha-D-glucosyltransferase inhibitor
alpha,alpha-trehalose:phosphate alpha-D-glucosyltransferase inhibitors
trehalose phosphorylase inhibitor
trehalose phosphorylase inhibitors
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitors
EC 2.4.1.64 inhibitor
EC 2.4.1.64 inhibitors
alpha,alpha-trehalose phosphorylase (EC 2.4.1.64) inhibitor
alpha,alpha-trehalose phosphorylase (EC 2.4.1.64) inhibitors
alpha,alpha-trehalose phosphorylase inhibitor
alpha,alpha-trehalose phosphorylase inhibitors
alpha,alpha-trehalose:phosphate beta-D-glucosyltransferase inhibitor
alpha,alpha-trehalose:phosphate beta-D-glucosyltransferase inhibitors
trehalose phosphorylase inhibitor
trehalose phosphorylase inhibitors
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitors
EC 3.2.1.28 inhibitor
EC 3.2.1.28 inhibitors
alpha,alpha-trehalase (EC 3.2.1.28) inhibitor
alpha,alpha-trehalase (EC 3.2.1.28) inhibitors
alpha,alpha-trehalase inhibitor
alpha,alpha-trehalase inhibitors
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor
nonstructural protein 5A inhibitor
HCV non-structural protein 5A inhibitor
HCV non-structural protein 5A inhibitors
NS5A inhibitor
NS5A inhibitors
NS5A replication complex inhibitor
NS5A replication complex inhibitors
nonstructural protein 5A inhibitors
nonstructural protein 5A inhibitor
EC 4.2.1.94 (scytalone dehydratase) inhibitor
EC 4.2.1.94 (scytalone dehydratase) inhibitors
EC 4.2.1.94 inhibitor
EC 4.2.1.94 inhibitors
scytalone 7,8-hydro-lyase (1,3,8-trihydroxynaphthalene-forming) inhibitor
scytalone 7,8-hydro-lyase (1,3,8-trihydroxynaphthalene-forming) inhibitors
scytalone 7,8-hydro-lyase inhibitor
scytalone 7,8-hydro-lyase inhibitors
EC 4.2.1.94 (scytalone dehydratase) inhibitor
EC 3.4.24.24 (gelatinase A) inhibitor
72 kDa gelatinase inhibitor
72 kDa gelatinase inhibitors
72 kDa gelatinase type A inhibitor
72 kDa gelatinase type A inhibitors
EC 3.4.24.35 (gelatinase B) inhibitors
EC 3.4.24.35 inhibitor
EC 3.4.24.35 inhibitors
MMP 2 inhibitor
MMP 2 inhibitors
collagenase IV inhibitor
collagenase IV inhibitors
collagenase type IV inhibitor
collagenase type IV inhibitors
matrix metalloproteinase 2 inhibitor
matrix metalloproteinase 2 inhibitors
type IV collagen metalloproteinase inhibitor
type IV collagen metalloproteinase inhibitors
type IV collagenase inhibitor
type IV collagenase inhibitors
type IV collagenase/gelatinase inhibitor
type IV collagenase/gelatinase inhibitors
EC 3.4.24.24 (gelatinase A) inhibitor
human urinary metabolite
human urinary metabolites
human urinary metabolite
EC 3.5.1.19 (nicotinamidase) inhibitor
EC 3.5.1.19 (nicotinamidase) inhibitors
EC 3.5.1.19 inhibitor
EC 3.5.1.19 inhibitors
YNDase inhibitor
YNDase inhibitors
nicotinamidase (EC 3.5.1.19) inhibitor
nicotinamidase (EC 3.5.1.19) inhibitors
nicotinamidase inhibitor
nicotinamidase inhibitors
nicotinamide amidase inhibitor
nicotinamide amidase inhibitors
nicotinamide amidohydrolase inhibitor
nicotinamide amidohydrolase inhibitors
nicotinamide deaminase inhibitor
nicotinamide deaminase inhibitors
EC 3.5.1.19 (nicotinamidase) inhibitor
EC 3.4.21.64 (peptidase K) inhibitor
EC 3.4.21.64 (peptidase K) inhibitors
EC 3.4.21.64 inhibitor
EC 3.4.21.64 inhibitors
Tritirachium album proteinase K inhibitor
Tritirachium album proteinase K inhibitors
Tritirachium album serine proteinase inhibitor
Tritirachium album serine proteinase inhibitors
endopeptidase K inhibitor
endopeptidase K inhibitors
peptidase K inhibitor
peptidase K inhibitors
proteinase K inhibitor
proteinase K inhibitors
EC 3.4.21.64 (peptidase K) inhibitor
algal metabolite
algal metabolites
algal metabolite
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor
2-naphthylamine N-acetyltransferase inhibitor
2-naphthylamine N-acetyltransferase inhibitors
4-aminobiphenyl N-acetyltransferase inhibitor
4-aminobiphenyl N-acetyltransferase inhibitors
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitors
EC 2.3.1.5 inhibitor
EC 2.3.1.5 inhibitora
N-acetyltransferase inhibitor
N-acetyltransferase inhibitors
acetyl CoA-arylamine N-acetyltransferase inhibitor
acetyl CoA-arylamine N-acetyltransferase inhibitors
acetyl-CoA:arylamine N-acetyltransferase inhibitor
acetyl-CoA:arylamine N-acetyltransferase inhibitors
arylamine N-acetyltransferase (EC 2.3.1.5) inhibitor
arylamine N-acetyltransferase (EC 2.3.1.5) inhibitors
arylamine N-acetyltransferase inhibitor
arylamine N-acetyltransferase inhibitors
arylamine acetylase inhibitor
arylamine acetylase inhibitors
arylamine acetyltransferase inhibitor
arylamine acetyltransferase inhibitors
beta-naphthylamine N-acetyltransferase inhibitor
beta-naphthylamine N-acetyltransferase inhibitors
indoleamine N-acetyltransferase inhibitor
indoleamine N-acetyltransferase inhibitors
p-aminosalicylate N-acetyltransferase inhibitor
p-aminosalicylate N-acetyltransferase inhibitors
serotonin N-acetyltransferase inhibitor
serotonin N-acetyltransferase inhibitors
serotonin acetyltransferase inhibitor
serotonin acetyltransferase inhibitors
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor
EC 2.4.1.1 (glycogen phosphorylase) inhibitor
(1->4)-alpha-D-glucan:phosphate alpha-D-glucosyltransferase inhibitor
(1->4)-alpha-D-glucan:phosphate alpha-D-glucosyltransferase inhibitors
1,4-alpha-D-glucan:phosphate alpha-D-glucosyltransferase inhibitor
1,4-alpha-D-glucan:phosphate alpha-D-glucosyltransferase inhibitors
1,4-alpha-glucan phosphorylase inhibitor
1,4-alpha-glucan phosphorylase inhibitors
EC 2.4.1.1 (glycogen phosphorylase) inhibitors
EC 2.4.1.1 inhibitor
EC 2.4.1.1 inhibitors
alpha-glucan phosphorylase inhibitor
alpha-glucan phosphorylase inhibitors
amylopectin phosphorylase inhibitor
amylopectin phosphorylase inhibitors
amylophosphorylase inhibitor
amylophosphorylase inhibitors
glucan phosphorylase inhibitor
glucan phosphorylase inhibitors
glucosan phosphorylase inhibitor
glucosan phosphorylase inhibitors
glycogen phosphorylase (EC 2.4.1.1) inhibitor
glycogen phosphorylase (EC 2.4.1.1) inhibitors
glycogen phosphorylase inhibitor
glycogen phosphorylase inhibitors
granulose phosphorylase inhibitor
granulose phosphorylase inhibitors
maltodextrin phosphorylase inhibitor
maltodextrin phosphorylase inhibitors
muscle phosphorylase a and b inhibitor
muscle phosphorylase a and b inhibitors
muscle phosphorylase inhibitor
muscle phosphorylase inhibitors
myophosphorylase inhibitor
myophosphorylase inhibitors
phosphorylase inhibitor
phosphorylase inhibitors
polyphosphorylase inhibitor
polyphosphorylase inhibitors
potato phosphorylase inhibitor
potato phosphorylase inhibitors
starch phosphorylase inhibitor
starch phosphorylase inhibitors
EC 2.4.1.1 (glycogen phosphorylase) inhibitor
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor
1D-myo-inositol-trisphosphate 3-kinase inhibitor
1D-myo-inositol-trisphosphate 3-kinase inhibitors
ATP:1D-myo-inositol-1,4,5-trisphosphate 3-phosphotransferase inhibitor
ATP:1D-myo-inositol-1,4,5-trisphosphate 3-phosphotransferase inhibitors
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitors
EC 2.7.1.127 inhibitor
EC 2.7.1.127 inhibitors
IP3 3-kinase inhibitor
IP3 3-kinase inhibitors
IP3K inhibitor
IP3K inhibitors
Ins(1,4,5)P3 3-kinase inhibitor
Ins(1,4,5)P3 3-kinase inhibitors
inositol 1,4,5-trisphosphate 3-kinase inhibitor
inositol 1,4,5-trisphosphate 3-kinase inhibitors
inositol-trisphosphate 3-kinase (EC 2.7.1.127) inhibitor
inositol-trisphosphate 3-kinase (EC 2.7.1.127) inhibitors
inositol-trisphosphate 3-kinase inhibitor
inositol-trisphosphate 3-kinase inhibitors
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor
ATP:1D-myo-inositol-1,4,5-trisphosphate 6-phosphotransferase inhibitor
ATP:1D-myo-inositol-1,4,5-trisphosphate 6-phosphotransferase inhibitors
ArgRIII inhibitor
ArgRIII inhibitors
AtIpk2alpha inhibitor
AtIpk2alpha inhibitors
AtIpk2beta inhibitor
AtIpk2beta inhibitors
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitors
EC 2.7.1.151 inhibitor
EC 2.7.1.151 inhibitors
IP3/IP4 6-/3-kinase inhibitor
IP3/IP4 6-/3-kinase inhibitors
IP3/IP4 dual-specificity 6-/3-kinase inhibitor
IP3/IP4 dual-specificity 6-/3-kinase inhibitors
IpK2 inhibitor
IpK2 inhibitors
IpmK inhibitor
IpmK inhibitors
inositol polyphosphate 6-/3-/5-kinase inhibitor
inositol polyphosphate 6-/3-/5-kinase inhibitors
inositol-polyphosphate multikinase (EC 2.7.1.151) inhibitor
inositol-polyphosphate multikinase (EC 2.7.1.151) inhibitors
inositol-polyphosphate multikinase inhibitor
inositol-polyphosphate multikinase inhibitors
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor
EC 2.7.4.* (phosphotransferases with a phosphate group as acceptor) inhibitor
EC 2.7.4.* (phosphotransferases with a phosphate group as acceptor) inhibitors
EC 2.7.4.* inhibitor
EC 2.7.4.* inhibitors
phosphotransferases with a phosphate group as acceptor (EC 2.7.4.*) inhibitor
phosphotransferases with a phosphate group as acceptor (EC 2.7.4.*) inhibitors
EC 2.7.4.* (phosphotransferases with a phosphate group as acceptor) inhibitor
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor
ATP:nucleoside-diphosphate phosphotransferase inhibitor
ATP:nucleoside-diphosphate phosphotransferase inhibitors
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitors
EC 2.7.4.6 inhibitor
EC 2.7.4.6 inhibitors
UDP kinase inhibitor
UDP kinase inhibitors
nucleoside 5'-diphosphate kinase inhibitor
nucleoside 5'-diphosphate kinase inhibitors
nucleoside diphosphate (UDP) kinase inhibitor
nucleoside diphosphate (UDP) kinase inhibitors
nucleoside diphosphokinase inhibitor
nucleoside diphosphokinase inhibitors
nucleoside-diphosphate kinase (EC 2.7.4.6) inhibitor
nucleoside-diphosphate kinase (EC 2.7.4.6) inhibitors
nucleoside-diphosphate kinase inhibitor
nucleoside-diphosphate kinase inhibitors
nucleotide phosphate kinase inhibitor
nucleotide phosphate kinase inhibitors
uridine diphosphate kinase inhibitor
uridine diphosphate kinase inhibitors
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor
EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitor
D-fructose-6-phosphate amidotransferase inhibitor
D-fructose-6-phosphate amidotransferase inhibitors
EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitors
EC 2.6.1.16 inhibitor
EC 2.6.1.16 inhibitors
GlcN6P synthase inhibitor
GlcN6P synthase inhibitors
L-glutamine-D-fructose-6-phosphate amidotransferase inhibitor
L-glutamine-D-fructose-6-phosphate amidotransferase inhibitors
L-glutamine:D-fructose-6-phosphate isomerase (deaminating) inhibitor
L-glutamine:D-fructose-6-phosphate isomerase (deaminating) inhibitors
glucosamine 6-phosphate synthase inhibitor
glucosamine 6-phosphate synthase inhibitors
glucosamine-6-phosphate isomerase (glutamine-forming) inhibitor
glucosamine-6-phosphate isomerase (glutamine-forming) inhibitors
glucosamine-6-phosphate synthase inhibitor
glucosamine-6-phosphate synthase inhibitors
glucosaminephosphate isomerase inhibitor
glucosaminephosphate isomerase inhibitors
hexosephosphate aminotransferase inhibitor
hexosephosphate aminotransferase inhibitors
EC 2.6.1.16 (glutamine--fructose-6-phosphate transaminase (isomerizing)) inhibitor
thrombopoietin receptor agonist
TPO receptor agonist
TPO receptor agonists
thrombopoietin receptor agonists
thrombopoietin receptor agonist
skin lightening agent
melanogenesis inhibitor
melanogenesis inhibitors
skin bleaching agent
skin bleaching agents
skin depigmenting agent
skin depigmenting agents
skin lightening agents
skin whitening agent
skin whitening agents
skin lightening agent
EC 1.10.3.* (oxidoreductase acting on diphenols and related substances as donors with oxygen as acceptor) inhibitor
EC 1.10.3.* (oxidoreductase acting on diphenols and related substances as donors with oxygen as acceptor) inhibitors
EC 1.10.3.* inhibitor
EC 1.10.3.* inhibitors
EC 1.10.3.* (oxidoreductase acting on diphenols and related substances as donors with oxygen as acceptor) inhibitor
EC 1.10.3.1 (catechol oxidase) inhibitor
1,2-benzenediol:oxygen oxidoreductase inhibitor
1,2-benzenediol:oxygen oxidoreductase inhibitors
Dopa oxidase inhibitor
Dopa oxidase inhibitors
EC 1.10.3.1 (catechol oxidase) inhibitors
EC 1.10.3.1 inhibitor
EC 1.10.3.1 inhibitors
catechol oxidase (EC 1.10.3.1) inhibitor
catechol oxidase (EC 1.10.3.1) inhibitors
catechol oxidase inhibitor
catechol oxidase inhibitors
catecholase inhibitor
catecholase inhibitors
diphenol oxidase inhibitor
diphenol oxidase inhibitors
o-diphenol oxidoreductase inhibitor
o-diphenol oxidoreductase inhibitors
o-diphenol:oxygen oxidoreductase inhibitor
o-diphenol:oxygen oxidoreductase inhibitors
o-diphenolase inhibitor
o-diphenolase inhibitors
phenolase inhibitor
phenolase inhibitors
polyphenol oxidase inhibitor
polyphenol oxidase inhibitors
pyrocatechol oxidase inhibitor
pyrocatechol oxidase inhibitors
tyrosinase inhibitor
tyrosinase inhibitors
EC 1.10.3.1 (catechol oxidase) inhibitor
EC 1.10.3.2 (laccase) inhibitor
EC 1.10.3.2 (laccase) inhibitors
EC 1.10.3.2 inhibitor
EC 1.10.3.2 inhibitors
benzenediol:oxygen oxidoreductase inhibitor
benzenediol:oxygen oxidoreductase inhibitors
laccase (EC 1.10.3.2) inhibitor
laccase (EC 1.10.3.2) inhibitors
laccase inhibitor
laccase inhibitors
p-diphenol oxidase inhibitor
p-diphenol oxidase inhibitors
urishiol oxidase inhibitor
urishiol oxidase inhibitors
urushiol oxidase inhibitor
urushiol oxidase inhibitors
EC 1.10.3.2 (laccase) inhibitor
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitors
EC 1.13.11.24 inhibitor
EC 1.13.11.24 inhibitors
flavonol 2,4-oxygenase inhibitor
flavonol 2,4-oxygenase inhibitors
quercetin 2,3-dioxygenase (EC 1.13.11.24) inhibitor
quercetin 2,3-dioxygenase (EC 1.13.11.24) inhibitors
quercetin 2,3-dioxygenase inhibitor
quercetin 2,3-dioxygenase inhibitors
quercetin:oxygen 2,3-oxidoreductase (decyclising) inhibitor
quercetin:oxygen 2,3-oxidoreductase (decyclising) inhibitors
quercetin:oxygen 2,3-oxidoreductase (decyclizing) inhibitor
quercetin:oxygen 2,3-oxidoreductase (decyclizing) inhibitors
quercetin:oxygen 2,3-oxidoreductase (ring-opening) inhibitor
quercetin:oxygen 2,3-oxidoreductase (ring-opening) inhibitors
quercetinase inhibitor
quercetinase inhibitors
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor
D-amino-acid oxidase (EC 1.4.3.3) inhibitor
D-amino-acid oxidase (EC 1.4.3.3) inhibitors
D-amino-acid oxidase inhibitor
D-amino-acid oxidase inhibitors
D-amino-acid:oxygen oxidoreductase (deaminating) inhibitor
D-amino-acid:oxygen oxidoreductase (deaminating) inhibitors
EC 1.4.3.3 (D-amino-acid oxidase) inhibitors
EC 1.4.3.3 inhibitor
EC 1.4.3.3 inhibitors
L-amino acid:O2 oxidoreductase inhibitor
L-amino acid:O2 oxidoreductase inhibitors
new yellow enzyme inhibitor
new yellow enzyme inhibitors
ophio-amino-acid oxidase inhibitor
ophio-amino-acid oxidase inhibitors
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} activator
3-hydroxy-3-methylglutaryl coenzyme A reductase kinase activator
3-hydroxy-3-methylglutaryl coenzyme A reductase kinase activators
3-hydroxy-3-methylglutaryl-CoA reductase kinase activator
3-hydroxy-3-methylglutaryl-CoA reductase kinase activators
AMP-activated protein kinase activator
AMP-activated protein kinase activators
AMPK activator
AMPK activators
ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase activator
ATP:[hydroxymethylglutaryl-CoA reductase (NADPH)] phosphotransferase activators
EC 2.7.11.31 ([hydroxymethylglutaryl-CoA reductase (NADPH)] kinase) activator
EC 2.7.11.31 ([hydroxymethylglutaryl-CoA reductase (NADPH)] kinase) activators
EC 2.7.11.31 activator
EC 2.7.11.31 activators
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} activators
HMG-CoA reductase kinase activator
HMG-CoA reductase kinase activators
STK29 activator
STK29 activators
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activator
[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activators
[hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase activator
[hydroxymethylglutaryl-CoA reductase (NADPH2)] kinase activators
beta-hydroxy-beta-methylglutaryl-CoA reductase kinase activator
beta-hydroxy-beta-methylglutaryl-CoA reductase kinase activators
hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) activator
hydroxymethylglutaryl coenzyme A reductase kinase (phosphorylating) activators
hydroxymethylglutaryl coenzyme A reductase kinase activator
hydroxymethylglutaryl coenzyme A reductase kinase activators
hydroxymethylglutaryl-CoA reductase kinase activator
hydroxymethylglutaryl-CoA reductase kinase activators
reductase kinase activator
reductase kinase activators
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} activator
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
ATP:protein phosphotransferase (cAMP-dependent) inhibitor
ATP:protein phosphotransferase (cAMP-dependent) inhibitors
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitors
EC 2.7.11.11 inhibitor
EC 2.7.11.11 inhibitors
PKA C inhibitor
PKA C inhibitors
PKA inhibitor
PKA inhibitors
STK22 inhibitor inhibitor
STK22 inhibitors inhibitors
cAMP-dependent protein kinase (EC 2.7.11.11) inhibitor
cAMP-dependent protein kinase (EC 2.7.11.11) inhibitors
cAMP-dependent protein kinase inhibitor
cAMP-dependent protein kinase inhibitors
protein kinase A inhibitor
protein kinase A inhibitors
EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor
3':5'-cyclic GMP-dependent protein kinase inhibitor
3':5'-cyclic GMP-dependent protein kinase inhibitors
ATP:protein phosphotransferase (cGMP-dependent) inhibitor
ATP:protein phosphotransferase (cGMP-dependent) inhibitors
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitors
EC 2.7.11.12 inhibitor
EC 2.7.11.12 inhibitors
PKG 1alpha inhibitor
PKG 1alpha inhibitors
PKG 1beta inhibitor
PKG 1beta inhibitors
PKG II inhibitor
PKG II inhibitors
PKG inhibitor
PKG inhibitors
STK23 inhibitor
STK23 inhibitors
cGMP-dependent protein kinase (EC 2.7.11.12) inhibitor
cGMP-dependent protein kinase (EC 2.7.11.12) inhibitors
cGMP-dependent protein kinase Ibeta inhibitor
cGMP-dependent protein kinase Ibeta inhibitors
cGMP-dependent protein kinase inhibitor
cGMP-dependent protein kinase inhibitors
guanosine 3':5'-cyclic monophosphate-dependent protein kinase inhibitor
guanosine 3':5'-cyclic monophosphate-dependent protein kinase inhibitors
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor
nonnucleoside hepatitis C virus polymerase inhibitor
NS5B inhibitor
NS5B inhibitors
nonnucleoside hepatitis C virus polymerase inhibitors
nonstructural protein 5B inhibitor
nonstructural protein 5B inhibitors
nonnucleoside hepatitis C virus polymerase inhibitor
hepatitis C virus nonstructural protein 5A inhibitor
NS5A inhibitor
NS5A inhibitors
hepatitis C virus nonstructural protein 5A inhibitors
nonstructural protein 5A inhibitor
nonstructural protein 5A inhibitors
hepatitis C virus nonstructural protein 5A inhibitor
human blood serum metabolite
human blood serum metabolites
human blood serum metabolite
GABA reuptake inhibitor
GABA re-uptake inhibitor
GABA re-uptake inhibitors
GABA reuptake inhibitors
gamma-aminobutyric acid re-uptake inhibitor
gamma-aminobutyric acid re-uptake inhibitors
gamma-aminobutyric acid reuptake inhibitor
gamma-aminobutyric acid reuptake inhibitors
GABA reuptake inhibitor
glycine transporter 2 inhibitor
GlyT2 inhibitor
GlyT2 inhibitors
glycine transporter 2 inhibitors
glycine transporter 2 inhibitor
glycine transporter inhibitor
glycine transporter inhibitors
glycine transporter inhibitor
thromboxane A2 antagonist
TXA2/PGH2 antagonist
TXA2/PGH2 antagonists
TXA2/PGH2 receptor antagonist
TXA2/PGH2 receptor antagonists
thromboxane A2 antagonists
thromboxane A2 receptor antagonist
thromboxane A2 receptor antagonists
thromboxane A2 antagonist
EC 2.5.1.31 {ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific]} inhibitor
(2E,6E)-farnesyl-diphosphate:isopentenyl-diphosphate cistransferase (adding 8 isopentenyl units) inhibitor
(2E,6E)-farnesyl-diphosphate:isopentenyl-diphosphate cistransferase (adding 8 isopentenyl units) inhibitors
EC 2.5.1.31 inhibitor
EC 2.5.1.31 inhibitors
EC 2.5.1.31 {ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific]} inhibitors
UPP synthetase inhibitor
UPP synthetase inhibitors
bactoprenyl-diphosphate synthase inhibitor
bactoprenyl-diphosphate synthase inhibitors
ditrans,polycis-undecaprenyl-diphosphate synthase inhibitor
ditrans,polycis-undecaprenyl-diphosphate synthase inhibitors
ditrans,polycis-undecaprenylcistransferase inhibitor
ditrans,polycis-undecaprenylcistransferase inhibitors
undecaprenyl diphosphate synthetase inhibitor
undecaprenyl diphosphate synthetase inhibitors
undecaprenyl pyrophosphate synthase inhibitor
undecaprenyl pyrophosphate synthase inhibitors
undecaprenyl pyrophosphate synthetase inhibitor
undecaprenyl pyrophosphate synthetase inhibitors
undecaprenyl-diphosphate synthase inhibitor
undecaprenyl-diphosphate synthase inhibitors
EC 2.5.1.31 {ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific]} inhibitor
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group; NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group with NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group with NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group; NAD(+) or NADP(+) as acceptor) inhibitors
EC 1.4.1.* inhibitor
EC 1.4.1.* inhibitors
EC 1.4.1.* (oxidoreductase acting on donor CH-NH2 group; NAD(+) or NADP(+) as acceptor) inhibitor
EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitor
EC 1.4.1.3 inhibitor
EC 1.4.1.3 inhibitors
EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitors
L-glutamate:NAD(P)(+) oxidoreductase (deaminating) inhibitor
L-glutamate:NAD(P)(+) oxidoreductase (deaminating) inhibitors
glutamate dehydrogenase [NAD(P)(+)] (EC 1.4.1.3) inhibitor
glutamate dehydrogenase [NAD(P)(+)] (EC 1.4.1.3) inhibitors
glutamate dehydrogenase [NAD(P)(+)] inhibitor
glutamate dehydrogenase [NAD(P)(+)] inhibitors
glutamic dehydrogenase inhibitor
glutamic dehydrogenase inhibitors
EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitor
liver X receptor agonist
LXR agonist
LXR agonists
liver X receptor agonists
liver X receptor agonist
rat metabolite
Rattus norvegicus metabolite
Rattus norvegicus metabolites
rat metabolites
rat metabolite
antifungal drug
anti-fungal drug
anti-fungal drugs
anti-fungal medication
anti-fungal medications
antifungal drugs
antifungal medication
antifungal medications
pharmaceutical fungicide
pharmaceutical fungicides
antifungal drug
antifungal agrochemical
agrichemical fungicide
agrichemical fungicides
agrochemical fungicide
agrochemical fungicides
anti-fungal agrichemical
anti-fungal agrichemicals
anti-fungal agrochemical
anti-fungal agrochemicals
antifungal agrichemical
antifungal agrichemicals
antifungal agrochemicals
antifungal agrochemical
EC 5.3.3.* (intramolecular oxidase transposing C=C bonds) inhibitor
EC 5.3.3.* (intramolecular oxidase transposing C=C bonds) inhibitors
EC 5.3.3.* inhibitor
EC 5.3.3.* inhibitors
intramolecular oxidase transposing C=C bonds inhibitor (EC 5.3.3.*) inhibitor
intramolecular oxidase transposing C=C bonds inhibitor (EC 5.3.3.*) inhibitors
EC 5.3.3.* (intramolecular oxidase transposing C=C bonds) inhibitor
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
Delta(7)-cholestenol Delta(7)-Delta(8)-isomerase inhibitor
Delta(7)-cholestenol Delta(7)-Delta(8)-isomerase inhibitors
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitors
EC 5.3.3.5 inhibitor
EC 5.3.3.5 inhibitors
cholestenol Delta-isomerase (EC 5.3.3.5) inhibitor
cholestenol Delta-isomerase (EC 5.3.3.5) inhibitors
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
EC 1.14.13.78 (ent-kaurene oxidase) inhibitor
EC 1.14.13.78 (ent-kaurene oxidase) inhibitors
EC 1.14.13.78 inhibitor
EC 1.14.13.78 inhibitors
ent-kaurene oxidase (EC 1.14.13.78) inhibitor
ent-kaurene oxidase (EC 1.14.13.78) inhibitors
EC 1.14.13.78 (ent-kaurene oxidase) inhibitor
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor
CYP3A4 inhibitor
CYP3A4 inhibitors
CYP4A21 inhibitor
CYP4A21 inhibitors
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitors
EC 1.14.13.97 inhibitor
EC 1.14.13.97 inhibitors
cytochrome P450 3A4 inhibitor
cytochrome P450 3A4 inhibitors
taurochenodeoxycholate 6alpha-hydroxylase inhibitor
taurochenodeoxycholate 6alpha-hydroxylase inhibitors
taurochenodeoxycholate 6alpha-monooxygenase inhibitor
taurochenodeoxycholate 6alpha-monooxygenase inhibitors
taurochenodeoxycholate,NADPH:oxygen oxidoreductase (6alpha-hydroxylating) inhibitor
taurochenodeoxycholate,NADPH:oxygen oxidoreductase (6alpha-hydroxylating) inhibitors
EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor
EC 3.4.21.92 (endopeptidase Clp) inhibitor
ATP-dependent Clp protease inhibitor
ATP-dependent Clp protease inhibitors
Clp protease inhibitor
Clp protease inhibitors
ClpP inhibitor
ClpP inhibitors
EC 3.4.21.92 (endopeptidase Clp) inhibitors
EC 3.4.21.92 inhibitor
EC 3.4.21.92 inhibitors
caseinolytic protease inhibitor
caseinolytic protease inhibitors
endopeptidase Ti inhibitor
endopeptidase Ti inhibitors
protease Ti inhibitor
protease Ti inhibitors
EC 3.4.21.92 (endopeptidase Clp) inhibitor
STAT3 inhibitor
STAT3 inhibitors
signal transducer and activator of transcription 3 inhibitor
signal transducer and activator of transcription 3 inhibitors
STAT3 inhibitor
Smad3 inhibitor
Mothers against decapentaplegic homolog 3 inhibitors
Mothers against decapentaplegic homologue 3 inhibitor
Mothers against decapentaplegic homologue 3 inhibitors
SMAD family member 3 inhibitor
SMAD family member 3 inhibitors
SMAD3 inhibitors
Smad3 inhibitor
Smad3 inhibitors
mothers against decapentaplegic homolog 3 inhibitor
Smad3 inhibitor
signal transducer and activator of transcription 5 protein inhibitor
STAT5 inhibitor
STAT5 inhibitors
signal transducer and activator of transcription 5 protein inhibitors
signal transducer and activator of transcription 5 protein inhibitor
cyanotoxin
cyanotoxins
cyanotoxin
drug allergen
allergenic drug
drug allergen
potassium ionophore
potassium ionophores
potassium ionophore
autophagy inhibitor
autophagocytosis inhibitor
autophagocytosis inhibitors
autophagy inhibitors
autophagy inhibitor
EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor
EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitors
EC 2.7.12.* inhibitor
EC 2.7.12.* inhibitors
inhibitor of dual-specificity kinases (those acting on Ser/Thr and Tyr residues) (EC 2.7.12.*)
inhibitors of dual-specificity kinases (those acting on Ser/Thr and Tyr residues) (EC 2.7.12.*)
EC 2.7.12.* [dual-specificity kinases (those acting on Ser/Thr and Tyr residues)] inhibitor
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
ATP:protein phosphotransferase (MAPKKK-activated) inhibitor
ATP:protein phosphotransferase (MAPKKK-activated) inhibitors
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitors
EC 2.7.12.2 inhibitor
EC 2.7.12.2 inhibitors
MAP kinase kinase 4 inhibitor
MAP kinase kinase 4 inhibitors
MAP kinase kinase 7 inhibitor
MAP kinase kinase 7 inhibitors
MAP kinase kinase inhibitor
MAP kinase kinase inhibitors
MAP kinase or ERK kinase inhibitor
MAP kinase or ERK kinase inhibitors
MAP2K inhibitor
MAP2K inhibitors
MAPKK inhibitor
MAPKK inhibitors
MAPKK1 inhibitor
MAPKK1 inhibitors
MEK inhibitor
MEK inhibitors
MEK1 inhibitor
MEK1 inhibitors
MEK2 inhibitor
MEK2 inhibitors
MKK inhibitor
MKK inhibitors
MKK2 inhibitor
MKK2 inhibitors
MKK4 inhibitor
MKK4 inhibitors
MKK6 inhibitor
MKK6 inhibitors
MKK7 inhibitor
MKK7 inhibitors
STK27 inhibitor
STK27 inhibitors
mitogen-activated protein kinase kinase (EC 2.7.12.2) inhibitor
mitogen-activated protein kinase kinase (EC 2.7.12.2) inhibitors
mitogen-activated protein kinase kinase inhibitor
mitogen-activated protein kinase kinase inhibitors
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
G-protein-coupled receptor antagonist
G-protein-coupled receptor antagonists
GPCR antagonist
GPCR antagonists
G-protein-coupled receptor antagonist
retinoic acid receptor gamma agonist
NR1B3 agonist
NR1B3 agonists
RARgamma agonist
RARgamma agonists
nuclear receptor subfamily 1, group B, member 3 agonist
nuclear receptor subfamily 1, group B, member 3 agonists
retinoic acid receptor gamma agonists
retinoic acid receptor gamma agonist
alpha-secretase activator
alpha-secretase activators
alpha-secretase activator
EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor
3beta-hydroxy-4alpha-methylcholestenecarboxylate 3-dehydrogenase (decarboxylating) inhibitor
3beta-hydroxy-4alpha-methylcholestenecarboxylate 3-dehydrogenase (decarboxylating) inhibitors
3beta-hydroxy-4beta-methylcholestenecarboxylate 3-dehydrogenase (decarboxylating) inhibitor
3beta-hydroxy-4beta-methylcholestenecarboxylate 3-dehydrogenase (decarboxylating) inhibitors
3beta-hydroxy-4beta-methylcholestenoate dehydrogenase inhibitor
3beta-hydroxy-4beta-methylcholestenoate dehydrogenase inhibitors
3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating) (EC 1.1.1.170) inhibitor
3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating) (EC 1.1.1.170) inhibitors
3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating) inhibitor
3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating) inhibitors
3beta-hydroxysteroid-4alpha-carboxylate:NAD(P)(+) 3-oxidoreductase (decarboxylating) inhibitor
3beta-hydroxysteroid-4alpha-carboxylate:NAD(P)(+) 3-oxidoreductase (decarboxylating) inhibitors
EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitors
EC 1.1.1.170 inhibitor
EC 1.1.1.170 inhibitors
sterol 4alpha-carboxylic decarboxylase inhibitor
sterol 4alpha-carboxylic decarboxylase inhibitors
sterol-4alpha-carboxylate 3-dehydrogenase (decarboxylating) inhibitor
sterol-4alpha-carboxylate 3-dehydrogenase (decarboxylating) inhibitors
EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor
c-Jun N-terminal kinase inhibitor
JNK inhibitor
JNK inhibitors
c-Jun N-terminal kinase inhibitors
c-Jun N-terminal kinase inhibitor
EC 2.1.1.37 [DNA (cytosine-5-)-methyltransferase] inhibitor
DNA 5-cytosine methylase inhibitor
DNA 5-cytosine methylase inhibitors
DNA cytosine c(5) methylase inhibitor
DNA cytosine c(5) methylase inhibitors
DNA cytosine methylase inhibitor
DNA cytosine methylase inhibitors
DNA methylase inhibitor
DNA methylase inhibitors
DNA methyltransferase inhibitor
DNA methyltransferase inhibitors
DNA transmethylase inhibitor
DNA transmethylase inhibitors
DNA-cytosine 5-methylase inhibitor
DNA-cytosine 5-methylase inhibitors
DNA-cytosine methyltransferase inhibitor
DNA-cytosine methyltransferase inhibitors
EC 2.1.1.37 [DNA (cytosine-5-)-methyltransferase] inhibitors
EC 2.1.1.37 inhibitor
EC 2.1.1.37 inhibitors
EcoRI methylase inhibitor
EcoRI methylase inhibitors
HpaII methylase inhibitor
HpaII methylase inhibitors
HpaII' methylase inhibitor
HpaII' methylase inhibitors
M.BsuRIa inhibitor
M.BsuRIa inhibitors
M.BsuRIb inhibitor
M.BsuRIb inhibitors
S-adenosyl-L-methionine:DNA (cytosine-5-)-methyltransferase inhibitor
S-adenosyl-L-methionine:DNA (cytosine-5-)-methyltransferase inhibitors
Typ II DNA methylase inhibitor
Typ II DNA methylase inhibitors
cytosine 5-methyltransferase inhibitor
cytosine 5-methyltransferase inhibitors
cytosine DNA methylase inhibitors
cytosine DNA methyltransferase inhibitor
cytosine DNA methyltransferase inhibitors
cytosine-specific DNA methyltransferase inhibitor
cytosine-specific DNA methyltransferase inhibitors
deoxyribonucleate methylase inhibitor
deoxyribonucleate methylase inhibitors
deoxyribonucleate methyltransferase inhibitor
deoxyribonucleate methyltransferase inhibitors
deoxyribonucleic (cytosine-5-)-methyltransferase inhibitor
deoxyribonucleic (cytosine-5-)-methyltransferase inhibitors
deoxyribonucleic acid (cytosine-5-)-methyltransferase inhibitor
deoxyribonucleic acid (cytosine-5-)-methyltransferase inhibitors
deoxyribonucleic acid methylase inhibitor
deoxyribonucleic acid methylase inhibitors
deoxyribonucleic acid methyltransferase inhibitor
deoxyribonucleic acid methyltransferase inhibitors
deoxyribonucleic acid modification methylase inhibitor
deoxyribonucleic acid modification methylase inhibitors
deoxyribonucleic methylase inhibitor
deoxyribonucleic methylase inhibitors
methylphosphotriester-DNA methyltransferase inhibitor
methylphosphotriester-DNA methyltransferase inhibitors
modification methylase inhibitor
modification methylase inhibitors
restriction-modification system inhibitor
restriction-modification system inhibitors
site-specific DNA-methyltransferase (cytosine-specific) inhibitor
site-specific DNA-methyltransferase (cytosine-specific) inhibitors
EC 2.1.1.37 [DNA (cytosine-5-)-methyltransferase] inhibitor
c-Met tyrosine kinase inhibitor
MET inhibitor
MET inhibitors
MET proto-oncogene, receptor tyrosine kinase inhibitor
MET proto-oncogene, receptor tyrosine kinase inhibitors
c-Met inhibitor
c-Met inhibitors
c-Met tyrosine kinase inhibitors
c-Met tyrosine kinase inhibitor
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitors
EC 4.1.1.23 inhibitor
EC 4.1.1.23 inhibitors
ODCase inhibitor
ODCase inhibitors
OMP decarboxylase inhibitor
OMP decarboxylase inhibitors
OMP-DC inhibitor
OMP-DC inhibitors
OMPdcase inhibitor
OMPdcase inhibitors
UMP synthase inhibitor
UMP synthase inhibitors
orotate decarboxylase inhibitor
orotate decarboxylase inhibitors
orotate monophosphate decarboxylase inhibitor
orotate monophosphate decarboxylase inhibitors
orotic decarboxylase inhibitor
orotic decarboxylase inhibitors
orotidine 5'-phosphate decarboxylase inhibitor
orotidine 5'-phosphate decarboxylase inhibitors
orotidine monophosphate decarboxylase inhibitor
orotidine monophosphate decarboxylase inhibitors
orotidine phosphate decarboxylase inhibitor
orotidine phosphate decarboxylase inhibitors
orotidine-5'-monophosphate decarboxylase inhibitor
orotidine-5'-monophosphate decarboxylase inhibitors
orotidine-5'-phosphate carboxy-lyase (UMP-forming) inhibitor
orotidine-5'-phosphate carboxy-lyase (UMP-forming) inhibitors
orotidine-5'-phosphate carboxy-lyase inhibitor
orotidine-5'-phosphate carboxy-lyase inhibitors
orotidine-5'-phosphate decarboxylase (EC 4.1.1.23) inhibitor
orotidine-5'-phosphate decarboxylase (EC 4.1.1.23) inhibitors
orotidylic acid decarboxylase inhibitor
orotidylic acid decarboxylase inhibitors
orotidylic decarboxylase inhibitor
orotidylic decarboxylase inhibitors
orotodylate decarboxylase inhibitor
orotodylate decarboxylase inhibitors
uridine 5'-monophosphate synthase inhibitor
uridine 5'-monophosphate synthase inhibitors
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
EC 6.4.1.1 (pyruvate carboxylase) inhibitor
EC 6.4.1.1 (pyruvate carboxylase) inhibitors
EC 6.4.1.1 inhibitor
EC 6.4.1.1 inhibitors
pyruvate carboxylase (EC 6.4.1.1) inhibitor
pyruvate carboxylase (EC 6.4.1.1) inhibitors
pyruvate carboxylase inhibitor
pyruvate carboxylase inhibitors
pyruvate:carbon-dioxide ligase (ADP-forming) inhibitor
pyruvate:carbon-dioxide ligase (ADP-forming) inhibitors
pyruvic carboxylase inhibitor
pyruvic carboxylase inhibitors
EC 6.4.1.1 (pyruvate carboxylase) inhibitor
EC 4.6.1.1 (adenylate cyclase) inhibitor
3',5'-cyclic AMP synthetase inhibitor
3',5'-cyclic AMP synthetase inhibitors
ATP diphosphate-lyase (cyclising) inhibitor
ATP diphosphate-lyase (cyclising) inhibitors
ATP diphosphate-lyase (cyclising; 3',5'-cyclic-AMP-forming) inhibitor
ATP diphosphate-lyase (cyclising; 3',5'-cyclic-AMP-forming) inhibitors
ATP diphosphate-lyase (cyclizing) inhibitor
ATP diphosphate-lyase (cyclizing) inhibitors
ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming) inhibitor
ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming) inhibitors
ATP pyrophosphate-lyase inhibitor
ATP pyrophosphate-lyase inhibitors
EC 4.6.1.1 (adenylate cyclase) inhibitors
EC 4.6.1.1 inhibitor
EC 4.6.1.1 inhibitors
adenyl cyclase inhibitor
adenylate cyclase (EC 4.6.1.1) inhibitor
adenylate cyclase (EC 4.6.1.1) inhibitors
adenylate cyclase inhibitor
adenylate cyclase inhibitors
adenylyl cyclase inhibitor
adenylyl cyclase inhibitors
adenylylcyclase inhibitor
adenylylcyclase inhibitors
EC 4.6.1.1 (adenylate cyclase) inhibitor
histone acetyltransferase activator
HAT activator
HAT activators
histone acetyltransferase activators
histone acetyltransferase activator
Sir1 inhibitor
SIRT1 inhibitor
SIRT1 inhibitors
Sir1 inhibitors
sirtuin 1 inhibitor
sirtuin 1 inhibitors
Sir1 inhibitor
secretagogue
secretagogues
secretagogue
insulin secretagogue
insulin secretagogues
insulin secretagogue
EC 5.3.1.* (intramolecular oxidoreductase interconverting aldoses and ketoses) inhibitor
EC 5.3.1.* (intramolecular oxidoreductase interconverting aldoses and ketoses) inhibitor
EC 5.3.1.1 (triose-phosphate isomerase) inhibitor
D-glyceraldehyde-3-phosphate ketol-isomerase inhibitor
D-glyceraldehyde-3-phosphate ketol-isomerase inhibitors
EC 5.3.1.1 (triose-phosphate isomerase) inhibitors
EC 5.3.1.1 inhibitor
EC 5.3.1.1 inhibitors
phosphotriose isomerase inhibitor
phosphotriose isomerase inhibitors
triose phosphate mutase inhibitor
triose phosphate mutase inhibitors
triose phosphoisomerase inhibitor
triose phosphoisomerase inhibitors
triose-phosphate isomerase (EC 5.3.1.1) inhibitor
triose-phosphate isomerase (EC 5.3.1.1) inhibitors
triose-phosphate isomerase inhibitor
triose-phosphate isomerase inhibitors
triosephosphate isomerase inhibitor
triosephosphate isomerase inhibitors
triosephosphate mutase inhibitor
triosephosphate mutase inhibitors
EC 5.3.1.1 (triose-phosphate isomerase) inhibitor
retinoic acid receptor modulator
retinoic acid receptor modulators
retinoic acid receptor modulator
nuclear receptor modulator
nuclear receptor modulators
nuclear receptor modulator
receptor modulator
receptor modulators
receptor modulator
retinoic acid receptor alpha antagonist
RAR alpha antagonist
RAR alpha antagonists
RARalpha antagonist
RARalpha antagonists
retinoic acid receptor alpha antagonists
retinoic acid receptor alpha antagonist
retinoic acid receptor antagonist
RAR antagonist
RAR antagonists
retinoic acid receptor antagonists
retinoic acid receptor antagonist
retinoic acid receptor beta agonist
RAR beta agonist
RAR beta agonists
RARbeta agonist
RARbeta agonists
retinoic acid receptor beta agonists
retinoic acid receptor beta agonist
retinoic acid receptor gamma antagonist
RAR gamma antagonist
RAR gamma antagonists
RARgamma antagonist
RARgamma antagonists
retinoic acid receptor gamma antagonists
retinoic acid receptor gamma antagonist
antidote to cyanide poisoning
antidote to cyanide poisoning
antidote to organophosphate poisoning
antidote to acetylcholinesterase inhibitor poisoning
antidote to nerve agents
antidote to organophosphate poisoning
antidote to opioid poisoning
antidote to opioid overdose
antidote to opioid poisoning
antidote to benzodiazepine poisoning
antidote to benzodiazepine overdose
antidote to benzodiazepine poisoning
eukaryotic translation elongation factor 1alpha 1 inhibitor
EEF1A1 inhibitor
EEF1A1 inhibitors
eEF1A inhibitor
eEF1A inhibitors
eukaryotic translation elongation factor 1alpha 1 inhibitors
eukaryotic translation elongation factor 1alpha 1 inhibitor
AKT1 kinase inhibitor
AKT1 kinase inhibitors
RAC-alpha serine/threonine-protein kinase inhibitor
RAC-alpha serine/threonine-protein kinase inhibitors
AKT1 kinase inhibitor
prostacyclin receptor agonist
IP receptor agonist
IP receptor agonists
IP1 agonist
IP1 agonists
prostacyclin receptor I2 agonist
prostacyclin receptor I2 agonists
prostacyclin receptor agonists
prostacyclin receptor agonist
liver X receptor inverse agonist
LXR inverse agonist
LXR inverse agonists
liver X receptor inverse agonists
liver X receptor inverse agonist
inverse agonist
inverse agonists
inverse agonist
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
EC 2.4.2.4 (thymidine phosphorylase) inhibitors
EC 2.4.2.4 inhibitor
EC 2.4.2.4 inhibitors
deoxythymidine phosphorylase inhibitor
deoxythymidine phosphorylase inhibitors
pyrimidine deoxynucleoside phosphorylase inhibitor
pyrimidine deoxynucleoside phosphorylase inhibitors
pyrimidine phosphorylase inhibitor
pyrimidine phosphorylase inhibitors
thymidine phosphorylase inhibitor
thymidine phosphorylase inhibitors
thymidine-orthophosphate deoxyribosyltransferase inhibitor
thymidine-orthophosphate deoxyribosyltransferase inhibitors
thymidine:phosphate deoxy-D-ribosyltransferase inhibitor
thymidine:phosphate deoxy-D-ribosyltransferase inhibitors
thymidine:phosphate deoxy-alpha-D-ribosyltransferase inhibitor
thymidine:phosphate deoxy-alpha-D-ribosyltransferase inhibitors
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
EC 1.8.5.* (oxidoreductase acting on sulfur group donors, quinone or similar as acceptor) inhibitor
EC 1.8.5.* (oxidoreductase acting on sulfur group donors, quinone or similar as acceptor) inhibitors
EC 1.8.5.* inhibitor
EC 1.8.5.* inhibitors
oxidoreductase acting on sulfur group donors, quinone or similar as acceptor (EC 1.8.5.*) inhibitor
oxidoreductase acting on sulfur group donors, quinone or similar as acceptor (EC 1.8.5.*) inhibitors
EC 1.8.5.* (oxidoreductase acting on sulfur group donors, quinone or similar as acceptor) inhibitor
EC 1.8.5.4 (sulfide:quinone reductase) inhibitor
EC 1.8.5.4 (sulfide:quinone reductase) inhibitors
EC 1.8.5.4 inhibitor
EC 1.8.5.4 inhibitors
sulfide:quinone oxidoreductase inhibitor
sulfide:quinone oxidoreductase inhibitors
sulfide:quinone reductase (EC 1.8.5.4) inhibitor
sulfide:quinone reductase (EC 1.8.5.4) inhibitors
sulfide:quinone reductase inhibitor
sulfide:quinone reductase inhibitors
EC 1.8.5.4 (sulfide:quinone reductase) inhibitor
ERK dimerisation inhibitor
ERK dimerisation inhibitors
extracellular signal-regulated kinase dimerisation inhibitor
extracellular signal-regulated kinase dimerisation inhibitors
ERK dimerisation inhibitor
steroid receptor coactivator stimulator
SRC stimulator
SRC stimulators
steroid receptor coactivator small molecule stimulator
steroid receptor coactivator small molecule stimulators
steroid receptor coactivator stimulators
steroid receptor coactivator stimulator
corrosion inhibitor
corrosion inhibitors
corrosion inhibitor
GABAA receptor agonist
GABAA receptor agonists
GABAA receptor agonist
erythropoietin inhibitor
EPO inhibitor
EPO inhibitors
erythropoietin inhibitors
erythropoietin inhibitor
purinergic receptor P2 antagonist
P2 antagonist
P2 antagonists
non-selective P2 purinergic antagonist
non-selective P2 purinergic antagonists
purinergic receptor P2 antagonists
purinergic receptor P2 antagonist
purinergic receptor P2X antagonist
P2X antagonist
P2X antagonists
purinergic receptor P2X antagonists
purinergic receptor P2X antagonist
collagen cross-linking inhibitor
collagen cross-linking inhibitors
collagen cross-linking inhibitor
EC 2.7.11.26 (tau-protein kinase) inhibitor
ATP:[tau-protein] O-phosphotransferase inhibitor
ATP:[tau-protein] O-phosphotransferase inhibitors
ATP:tau-protein O-phosphotransferase inhibitor
ATP:tau-protein O-phosphotransferase inhibitors
CDK5/p23 inhibitor
CDK5/p23 inhibitors
EC 2.7.11.26 (tau-protein kinase) inhibitors
EC 2.7.11.26 inhibitor
EC 2.7.11.26 inhibitors
GSK inhibitor
GSK inhibitors
GSK-3 inhibitor
GSK-3 inhibitors
STK31 inhibitor
STK31 inhibitors
TPK I inhibitor
TPK I inhibitors
TPK II inhibitor
TPK II inhibitors
TPK inhibitor
TPK inhibitors
TTK inhibitor
TTK inhibitors
[tau-protein] kinase inhibitor
[tau-protein] kinase inhibitors
brain protein kinase PK40erk inhibitor
brain protein kinase PK40erk inhibitors
cdk5/p20 inhibitor
cdk5/p20 inhibitors
glycogen synthase kinase-3beta inhibitor
glycogen synthase kinase-3beta inhibitors
protein tau kinase inhibitor
protein tau kinase inhibitors
tau kinase inhibitor
tau kinase inhibitors
tau-protein kinase I inhibitor
tau-protein kinase I inhibitors
tau-protein kinase II inhibitor
tau-protein kinase II inhibitors
tau-tubulin inhibitor
tau-tubulin inhibitors
EC 2.7.11.26 (tau-protein kinase) inhibitor
elastin-laminin receptor agonist
ELR agonist
ELR agonists
elastin-laminin receptor agonists
elastin-laminin receptor agonist
EC 1.1.5.3 (glycerol-3-phosphate dehydrogenase) inhibitor
EC 1.1.5.3 (glycerol-3-phosphate dehydrogenase) inhibitors
EC 1.1.5.3 inhibitor
EC 1.1.5.3 inhibitors
glycerol-3-phosphate dehydrogenase inhibitor
glycerol-3-phosphate dehydrogenase inhibitors
EC 1.1.5.3 (glycerol-3-phosphate dehydrogenase) inhibitor
EC 1.1.5.* (oxidoreductase acting on donor CH-OH group, quinone or similar compound as acceptor) inhibitor
EC 1.1.5.* (oxidoreductase acting on donor CH-OH group, quinone or simliar compound as acceptor) inhibitors
EC 1.1.5.* inhibitor
EC 1.1.5.* inhibitors
oxidoreductase acting on donor CH-OH group, quinone or simliar compound as acceptor (EC 1.1.5.*) inhibitor
oxidoreductase acting on donor CH-OH group, quinone or simliar compound as acceptor (EC 1.1.5.*) inhibitors
EC 1.1.5.* (oxidoreductase acting on donor CH-OH group, quinone or similar compound as acceptor) inhibitor
VEGF activator
VEGF activators
VEGF inducer
VEGF inducers
vascular endothelial growth factor activator
vascular endothelial growth factor activators
vascular endothelial growth factor inducer
vascular endothelial growth factor inducers
VEGF activator
lysophosphatidic acid receptor antagonist
LPA receptor antagonist
LPA receptor antagonists
LPAR antagonist
LPAR antagonists
lysophosphatidic acid receptor antagonists
lysophosphatidic acid receptor antagonist
TGFbeta receptor antagonist
TGFR antagonist
TGFR antagonists
TGFbeta receptor antagonists
transforming growth factor receptor antagonist
transforming growth factor receptor antagonists
TGFbeta receptor antagonist
macrophage migration inhibitory factor inhibitor
MIF inhibitor
MIF inhibitors
macrophage migration inhibitory factor inhibitors
macrophage migration inhibitory factor inhibitor
tienilic acid
(2,3-Dichloro-4-(2-thenoyl)phenoxy)acetic acid
(2,3-Dichloro-4-(2-thiophenecarbonyl)phenoxy)acetic acid
4-(2-Theonyl)-2,3-dichlorphenoxyessigsaeure
4-(2-Thienylketo)-2,3-dichlorophenoxyacetic acid
Thienylic acid
Ticrynafen
[2,3-dichloro-4-(2-thienylcarbonyl)phenoxy]acetic acid
acide tienilique
acido tienilico
acidum tienilicum
tienilic acid
tienilic acid
cell line cell
A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
Yongqun He, Matthew Brush, Sirarat Sarntivijai, Alexander Diehl, Jie Zheng, Yu Lin, Bjoern Peters
A 'cell line cell' is a part of a cell line established through the passaging/selection of a primary cultured cells or the experimental modification of an existing cell line. New types of cell line cells are established after sufficient passaging of a primary culture to establish a stable and homogenous population that qualifies as a line (typically 1-20 passages), or following some spontaneous or experimental modification that confers novel characteristics to an existing line. A cell line cell typically has mutations of five or more genes compared to the original cell that derives the cell line cell. Some gene mutations may turn on some oncogenes. Cell line cells can be in active culture, stored in a quiescent state for future use (e.g. frozen in liquid nitrogen), or applied in experimental procedures.
cell line cell
immortal cell line cell
A cell line cell that is expected to be capable of an unlimited number of divisions, and is thus able to support indefinite propagation in vitro as part of an immortal cell line.
Yongqun He, Matthew Brush, Allen Xiang, Asiyah Yu Lin, Sirarat Sarntivijai, James Malone, Jie Zheng, Tomasz Adamusiak
continuous cell line cell
permanent cell line cell
immortal cell line cell
cell line
He, Tong-Chuan, et al., Identification of c-MYC as a target of the APC pathway. Science 281.5382 (1998): 1509-1512.: "To evaluate the transcriptional effects of APC, we studied a human colorectal cancer cell line (HT29-APC) containing a zinc-inducible APC gene and a control cell line (HT29–β-Gal) containing an analogous inducible lacZ gene".
Note that common usage in the literature is often of the form "a human colorectal cancer cell line", as seen above. But such references to studies in "a line" refer to the fact that discrete populations of cells that are input into culturing or experiments, not an entire lineage of cells. It is these discrete populations that we refer to as 'cell lines'.
A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
In the spring of 2013, a working group comprised of domain experts and representatives from CLO, OBI, CL, and ReO worked to establish a consensus model and definitions of cultured cells across these efforts. This included a careful characterization of how the term 'cell line' should be defined and applied. Notes about this work and its outcomes can be found on the CLO wiki here:
http://code.google.com/p/clo-ontology/wiki/Cell_Lines
MB, SS, JZ, MAH, BP, CS, YH
The term 'line' is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells (see 'establishing cell line'). This will require one or more passages, but may involve additional selection processes. Through such passaging and/or selection processes, the resulting 'line' attains some level of genetic stability and compositional homogeneity which is typically absent in primary cultures. Because of their relative homogeneity, ‘lines’ are capable of being characterized and stably propagated over a period of time. A new *type* of cell line can be established not only through the passaging/selection of a primary culture, but also through experimental modifications of existing lines (e.g. immortalization, stable genetic modifications, drug selection for a resistant subset, etc.).
The definition provided here establishes the 'scale' of cell populations that qualify as cell lines - specifically those with a shared propagation history in culture. In this way, the 'cell line' class demarcates populations that represent what researchers actually use in the practice of science - e.g. as inputs to culturing, experimentation, and sharing. The definition is such that cell lines will exhibit important attributes. For example, they will have a relatively homogenous cell type composition as they have experienced similar selective pressures due to their continuous co-propagation. In addition, these populations can also be characterized by a passage number, again owing to their common passaging history. As defined here, 'cell line' can refer to a population of cells in active culture, applied experimentally, or stored in a quiescent state for future use.
cell line
LCL-1042
697
697 cell
CHEMBL: CHEMBL3308147
CVCL: CVCL_0079
HyperCLDB: cl117
Sanger: COSMIC ID:906800
293
293 HEK
HEK 293
HEK-293
Human Embryonic Kidney 293
293 cell
WEB: http://hek293.com/
WEB: http://web.expasy.org/cellosaurus/CVCL_0045
WEB: https://www.atcc.org/Products/All/CRL-1573.aspx
HEK293
ATCC: CRL-1573
BTO: BTO_0000007
EFO: EFO_0001182)
RRID: CVCL_0045
293T/17
WEB: https://www.atcc.org/Products/All/CRL-11268.aspx
293T/17 cell
ATCC: CRL-11268
LCL-1601
A549
A549 cell
ATCC: CCL-185
CHEMBL: CHEMBL3307651
CVCL: CVCL_0023
EFO: EFO_0001086
HyperCLDB: cl207
LCL-1756
ACHN
ACHN cell
ATCC: CRL-1611
CHEMBL: CHEMBL3307633
CVCL: CVCL_1067
EFO: EFO_0002108
AML12
AML12 cell
ATCC: CRL-2254
BA/F3
BA/F3 cell
HyperCLDB: cl5028
LCL-1310
BT-549
disease: ductal carcinoma
BT-549 cell
ATCC: HTB-122
CHEMBL: CHEMBL3308490
CVCL: CVCL_1092
EFO: EFO_0001096
LCL-1300
C-33 A
C-33 A cell
ATCC: HTB-31
LCL-1170
Caco-2
disease: colorectal adenocarcinoma
Caco-2 cell
ATCC: HTB-37
CHEMBL: CHEMBL3307519
CVCL: CVCL_0025
EFO: EFO_0001099
HyperCLDB: cl618
MeSH: D018938
CAKI-1
CAKI-1 cell
HyperCLDB: cl623
LCL-1774
Caki-1
disease: clear cell carcinoma (kidney primary)
Caki-1 cell
ATCC: HTB-46
CHEMBL: CHEMBL3307522
CVCL: CVCL_0234
EFO: EFO_0002149
LCL-1580
ZN
Calu-1
disease: epidermoid carcinoma (lung primary)
Calu-1 cell
ATCC: HTB-54
CHEMBL: CHEMBL3308031
CVCL: CVCL_0608
EFO: EFO_0002151
HyperCLDB: cl631
HyperCLDB: cl632
LCL-1012
CCRF-CEM
CCRF-CEM cell
ATCC: CCL-119
CHEMBL: CHEMBL3307641
CVCL: CVCL_0207
EFO: EFO_0002128
CHL-1
CHL-1 cell
ATCC: CRL-9446
CHO
Chinese Hamster Ovary cell
CHO cell
HyperCLDB: cl721
MeSH: D016466
CHO-K1
CHO-K1 cell
ATCC: CCL-61
LCL-1173
COLO 205
disease: colorectal adenocarcinoma (colon primary)
COLO 205 cell
ATCC: CCL-222
CHEMBL: CHEMBL3308348
CVCL: CVCL_0218
ECACC: 87061208
EFO: EFO_0003082
COS-7
COS-7 cell
ATCC: CRL-1651
MeSH: D019556
LCL-1175
DLD-1
disease: colorectal adenocarcinoma
DLD-1 cell
ATCC: CCL-221
CHEMBL: CHEMBL3307580
CVCL: CVCL_0248
LCL-1146
DU 145
disease: carcinoma (prostate primary)
DU 145 cell
ATCC: HTB-81
H-4-II-E
disease: hepatoma
H-4-II-E cell
ATCC: CRL-1548
H69AR
disease: carcinoma; small cell lung cancer; multidrug resistant
H69AR cell
ATCC: CRL-11351
LCL-1161
immortal human epithelial cell line cell that was derived from some colon epithelial cell from a human patient with the disease colon carcinoma
HCT 116
HCT-116
HCT116
WEB: http://web.expasy.org/cellosaurus/CVCL_0291
WEB: https://www.atcc.org/products/all/CCL-247.aspx
disease: colorectal carcinoma
HCT 116 cell
ATCC: CCL-247
ECACC: 91091005
HyperCLDB: cl1575
MeSH: D045325
RRID:CVCL_0291
LCL-1053
HEL
HEL cell
CHEMBL: CHEMBL3308090
CVCL: CVCL_0001
DSMZ: ACC 11
HyperCLDB: cl1585
LCL-1512
an immortal human uterine cervix-derived epithelial cell line that was derived from cervical adenocarcinoma cancer cells taken on February 8, 1951 from Henrietta Lacks, a patient who died of her cancer on October 4, 1951.
HeLa
WEB: http://en.wikipedia.org/wiki/HeLa
WEB: http://www.atcc.org/products/all/CCL-2.aspx
WEB: https://www.ncbi.nlm.nih.gov/pubmed/12001993
HeLa cell
ATCC: CCL-2
CHEMBL: CHEMBL3308376
EFO: EFO_0001185
HyperCLDB: cl1601
MeSH: D006367
RRID:CVCL_0030
LCL-1925
HEP G2
HEP-G2
HEPG2
Hep G2
HepG2
WEB: http://web.expasy.org/cellosaurus/CVCL_0027
WEB: https://en.wikipedia.org/wiki/Hep_G2
WEB: https://www.atcc.org/products/all/HB-8065.aspx
Hep G2 cell
ATCC: HB-8065
HyperCLDB: cl1644
RRID:CVCL_0027
LCL-1054
HL-60
disease: promyeloblast; acute promyelocytic leukemia
HL-60 cell
ATCC: CCL-240
CHEMBL: CHEMBL3307654
CVCL: CVCL_0002
EFO: EFO_0002793
HyperCLDB: cl1684
HyperCLDB: cl1689
MeSH: D018922
LCL-1315
HS578T
Hs 578T
disease: ductal carcinoma
Hs 578T cell
ATCC: HTB-126
HT-1080
disease: fibrosarcoma
HT-1080 cell
ATCC: CCL-121
LCL-1180
HT-29
HT29
disease: colorectal adenocarcinoma
HT-29 cell
ATCC: HTB-38
CHEMBL: CHEMBL3307768
CVCL: CVCL_0320
EFO: EFO_0001193
HyperCLDB: cl1752
MeSH: D019073
HUV-EC-C
HUVEC
WEB: https://www.atcc.org/Products/All/CRL-1730.aspx
HUV-EC-C cell
ATCC: CRL-1730
IEC-6
disease: epithelium
IEC-6 cell
ATCC: CRL-1592
HyperCLDB: cl1802
an immortalized human T lymphocyte cell that was derived in the late 1970s from the peripheral blood of a 14-year-old boy with T cell leukemia
JURKAT
WEB: https://en.wikipedia.org/wiki/Jurkat_cells
disease: leukemia, T cell
JURKAT cell
HyperCLDB: cl5296
MeSH: D019169
RRID: CVCL_0065
L6
L6 cell
ATCC: CRL-1458
LCL-1460
an immortal breast cancer cell line cell isolated in 1970 from a 69-year-old Caucasian woman.
ZN
MCF 7 cell
MCF-7 cell
MCF7
WEB: http://web.expasy.org/cellosaurus/CVCL_0031
WEB: https://en.wikipedia.org/wiki/MCF-7
disease: adenocarcinoma (mammary gland primary)
MCF7 cell
ATCC: HTB-22
CHEMBL: CHEMBL3308403
EFO: EFO_0002082
HyperCLDB: cl3366
HyperCLDB: cl3372
RRID: CVCL_0031
LCL-1461
an immortal breast cancer cell line cell derived from a human patient with breast adenocarcinoma
ZN, YH
MDA-MB-231
MDA-MB-231 cell
ATCC: HTB-26
CHEMBL: CHEMBL3307960
EFO: EFO_0001209
RRID: CVCL_0062
MDCK
MDCK cell
HyperCLDB: cl5078
LCL-1305
ME-180
disease: epidermoid carcinoma (cervix primary)
ME-180 cell
ATCC: HTB-33
CHEMBL: CHEMBL3308114
CVCL: CVCL_1401
MRC-5
MRC-5 cell
ATCC: CCL-171
HyperCLDB: cl3564
Mv 1 Lu
Mv 1 Lu cell
HyperCLDB: cl3604
HyperCLDB: cl3608
HyperCLDB: cl3609
NIH-3T3
NIH-3T3 cell
ATCC: CRL-1658
HyperCLDB: cl3710
HyperCLDB: cl3711
MeSH: D041681
LCL-2000
SH-SY5Y
SHSY5Y
https://www.atcc.org/en/Products/Cells_and_Microorganisms/By_Tissue/Bone_Marrow/CRL-2266.aspx
SH-SY5Y cell
ATCC: CRL-2266
LCL-1282
A melanoma cell line cell. This cell line was established in 1974 from a metastatic site (axillary lymph node) in a 24-year-old Caucasian female with malignant melanoma, expresses mutant B-Raf (V600E) and wildtype N-Ras.
SK-MEL-5
WEB: http://web.expasy.org/cellosaurus/CVCL_1706
WEB: http://www.ncbi.nlm.nih.gov/pubmed/3121170
WEB: https://strap.nci.nih.gov/celline_detail.php?sample_id=56
SK-MEL-5 cell
ATCC: HTB-70
CHEMBL: CHEMBL3307744
CVCL: CVCL_0527
EFO: EFO_0002080
PubChem AID: 488899
Sanger: COSMIC ID:905956
LCL-1971
SK-N-SH
SK-N-SH cell
ATCC: HTB-11
CHEMBL: CHEMBL3307745
CVCL: CVCL_0531
EFO: EFO_0003072
LCL-1195
SW403
SW403 cell
ATCC: CCL-230
PubChem AID: 504653
RRID: CVCL_0545
Sanger: COSMIC ID:910908
LCL-1072
THP-1
THP1
THP-1 cell
ATCC: TIB-202
CHEMBL: CHEMBL3307574
CVCL: CVCL_0006
EFO: EFO_0001253
HyperCLDB: cl4514
LCL-1431
U-2 OS
U2OS
WEB: https://www.atcc.org/Products/All/HTB-96.aspx
U-2 OS cell
ATCC: HTB-96
CHEMBL: CHEMBL3307757
CVCL: CVCL_0042
EFO: EFO_0002869
U87 MG
There is a CLO term for the cell line already: http://purl.obolibrary.org/obo/CLO_0009464
obsolete: U87 MG cell
HyperCLDB: cl5280
Vero
Vero cell
ATCC: CCL-81
HyperCLDB: cl4644
MeSH: D014709
VERO 76
VERO 76 cell
ATCC: CRL-1587
HyperCLDB: cl4655
VERO C1008
VERO C1008 cell
ATCC: CRL-1586
HyperCLDB: cl4656
HyperCLDB: cl4657
LCL-1346
A human glioblastoma cell line cell. The cell line is part of the NCI-60 screening panel.
Oliver He, Jiangan Xie
SNB-75
SNB75
WEB: http://web.expasy.org/cellosaurus/CVCL_1706
WEB: http://www.ncbi.nlm.nih.gov/pubmed/3121170
WEB: https://strap.nci.nih.gov/celline_detail.php?sample_id=56
SNB75 cell
PubChem AID: 652144
Sanger: COSMIC ID:905982
LCL-1134
Oliver He, Jiangan Xie
SU-DHL-10
SU-DHL-10 cell
DSMZ: ACC 576
LCL-1138
Oliver He, Jiangan Xie
SU-DHL-6
SU-DHL-6 cell
DSMZ: ACC 572
BJeLR cell is BJ fibroblast cell line cell transformed with hTERT, genomic SV40 LT and ST oncoproteins, and oncogenic HRASV12.
YH, JX
BJeLR
PubChem probe report: http://www.ncbi.nlm.nih.gov/books/NBK98919/
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18355723
BJeLR cell
PubChem AID: 2635
BJeH=BJ derivative transformed only with hTERT (BJ fibroblasts were derived from primary human cells by transformation with hTERT, genomic SV40 Large T (LT) and Ssmall T (ST))
YH, JX
BJeLR
PubChem probe report: http://www.ncbi.nlm.nih.gov/books/NBK98919/
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18355723
BJeH cell
PUbChem AID: 493051
A human follicular lymphoms cell line
Oliver He, Jiangan Xie
RS11846
WEB: http://cellfinder.org/ontology?id=CELDA_00012667
RS-11846 cell
PubChem AID: 743410
RRID: CVCL_E048
A derivative of the CHO cell line that is adapted to high-density, serum-free suspension culture
YH, JX
WEB: https://www.thermofisher.com/order/catalog/product/R80007
CHO-S cell
PubChem AID: 624379
DRD=BJ fibroblasts expressing hTERT, SV40 small T oncoprotein, dominant negative p53, cyclin D1, a mutant form of CDK4, along with the oncogene HRASV12
JX, YH
WEB: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683762/
DRD cell
PubChem AID: 2633
HL2/3 is a derivative of HeLa cells and contains a stably integrated copies of the HIV-1 molecular clone HXB2/3gpt.
JX, YH
WEB: https://www.aidsreagent.org/reagentdetail.cfm?t=cell_lines&id=83
WEB: https://www.ncbi.nlm.nih.gov/pubmed/?term=2078409
HL2/3
PubChem AID: 504574
HeLa-MAGI-CCR5 cells are derived from HeLa cells and express human CD4, CXCR4 and CCR5, and an integrated gene encoding the b-galactosidase gene expressed from the HIV long terminal repeat.
JX, YH
WEB: http://web.expasy.org/cellosaurus/CVCL_D260
MAGI-CCR5 cells; HeLa-R5-16, engineered to express the Envelope protein (Env) from the CCR5-tropic HIV-1 clinical isolate 92US715, and also to express the Tat protein from HIV-1 NL4 3
HeLa-MAGI-CCR5
PubChem AID: 504341
RRID: CVCL_D260
HeLa-R5-16 (gift from Roche Palo Alto, LLC) is a derivative of HeLa cells, engineered to express the Envelope protein (Env) from the CCR5-tropic HIV-1 clinical isolate 92US715, and also to express the Tat protein from HIV-1 NL43
JX, YH
WEB: http://www.ncbi.nlm.nih.gov/pubmed/?term=16314403
HeLa-R5-16
PubChem AID: 504341
RD-HGA16 is derivative of CHO cells stably transfected with the promiscuous G-protein Gα16 gene and hygromycin-resistant. RD-HGA16 is from FLIPR LiveWare Cells (Molecular Devices, Sunnyvale CA), a series of cells and expression vectors successfully used in drug discovery, based on G-protein chimeras developed by Bruce Conklin and colleagues at the Gladstone Institute, UCSF.
YH, JX
WEB: http://go.pardot.com/l/83942/2015-06-17/njr/83942/4464/Data_Sheet__FLIPR_LiveWare_G_protein_Cells_and_Plasmids.pdf
RD-HGA16
PubChem AID: 624467
Sufu-KO-LIGHT cells were derived from Sufu knockout mouse embryonic fibroblasts according to the method of Chen et al. [Genes Dev. 2009;23(16): 1910-28.] The cells were co-transfected with the zeocin resistance vector (pVgRXR, Invitrogen) and a firefly luciferase reporter driven by eight Gli binding sites and a γ-crystallin basal promoter (8XGHBS-FL). Sufu-KO-LIGHT lacks Sufu and exhibits constitutive Hh target gene expression in response to endogenous Gli activators.
JX, YH
WEB: https://www.google.com/patents/WO2013192301A1?cl=en
Sufu-KO-LIGHT cell
PubChem AID: 588413
A Hela-derived cell line cell that expresses ubiquitinated GFP (Green Fluroescent Protein)
JX, YH
Ub-G76V-GFP/HeLa
PubChem AID: 463185
602478
The GripTite™ 293 MSR Cell Line is a genetically engineered Human Embryonic Kidney (HEK 293) cell line that expresses the human macrophage scavenger receptor and strongly adheres to standard tissue culture plates for dependable results.
BAO, YH
GripTite™ 293 MSR
https://pubchem.ncbi.nlm.nih.gov/bioassay/602478
https://www.thermofisher.com/order/catalog/product/R79507
GripTite 293 MSR cell
BAO: BAO_0030043
ThermoFisher: R79507
493062
A mouse T-cell hybridoma cell line cell that is derived from the murine hybridoma cell line 2B4, stably transfected to overexpress the human protein BCL-2.
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/16697956
https://www.google.com/patents/WO2007123791A2?cl=en
https://www.ncbi.nlm.nih.gov/books/NBK143557
2B4/BCL-2 cell
BAO: BAO_0030042
493059
A mouse T-cell hybridoma cell line cell that is derived from the murine hybridoma cell line 2B4, stably transfected to overexpress the human protein MCL-1.
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/16697956
https://www.google.com/patents/WO2007123791A2?cl=en
https://www.ncbi.nlm.nih.gov/books/NBK143557
2B4/MCL-1 cell
BAO: BAO_0030044
463235
AVA5 cells are derived from the Huh-7 human hepatoma cell line, stably-expressing the HCV replicon (sub-genomic [CON1], genotype 1b); http://www.apath.com/index.html. See also PMID: 27013634, 1110665, 10390360
BAO, YH
https://www.ncbi.nlm.nih.gov/pubmed/10390360
https://www.ncbi.nlm.nih.gov/pubmed/1110665
https://www.ncbi.nlm.nih.gov/pubmed/27013634
AVA5 cell
BAO: BAO_0030045
624396
A murine leukemia cell line driven by the overexpression of Myc and BCL-2.
BAO, YH
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919900/
BCL-2 1863 cell
BAO: BAO_0030052
1353
An immortalised mouse neural progenitor cell line cell that is capable of differentiation in vitro and is established by retorviral-mediated transduction of the avian myc oncogene into mitotic progenitor cells of neonatal mouse cerrebellum. Mouse strain CD1 x C57BL/6.
BAO, YH
http://web.expasy.org/cellosaurus/CVCL_4511
http://www.sigmaaldrich.com/catalog/product/sigma/07062902
C17.2 cell
BAO: BAO_0030046
651610
CEM21 (aka CEM#21 or CEM-R5Luc1#21) is derived from CEM.NKR-CCR5 by stable transfecttion of a Tet-activator responsive Luciferase reporter
Oliver He
CEM#21
CEM-R5Luc1#21
https://www.ncbi.nlm.nih.gov/pubmed/10516002
CEM21 cell
BAO: BAO_0030049
434939
DPX2 (aka DPX-2) is a HepG2-derived cell line stably integrated with a PXR (pregnane X receptor) expression vector plus a luciferase reporter, used to detect PXR activation/ CYP3A induction
BAO, YH
DPX-2
http://www.ncbi.nlm.nih.gov/pubmed/15548381
http://www.ncbi.nlm.nih.gov/pubmed/22912432
DPX2 cell
BAO: BAO_0030035
623928
FA2N-4 is a human hepatocyte cell line. Reference: http://web.expasy.org/cellosaurus/CVCL_0267
BAO, YH
http://cellfinder.org/ontology?id=CF_194407
http://purl.bioontology.org/ontology/MCCL/MCC_0000158
http://web.expasy.org/cellosaurus/CVCL_0267
FA2N-4 cell
BAO: BAO_0030036
651646
HBL-1 (aka human is an EBV-negative B-cell lymphoma cell line established from the pleural effusion of a patient with malignant lymphoma, diffuse, large cell.
BAO, YH
http://purl.obolibrary.org/obo/BTO_0002522
http://web.expasy.org/cellosaurus/CVCL_4213
HBL-1 cell
BAO: BAO_0030037
BTO: BTO_0002522
RRID:CVCL_4213
449755
HMC-1-8 is a human breast cancer cell line
BAO, YH
http://portals.broadinstitute.org/ccle/cell%20lines/HMC18_BREAST
http://web.expasy.org/cellosaurus/CVCL_2949
HMC-1-8 cell
BAO: BAO_0030037
RRID:CVCL_2949
2717
HMLE_sh_ECAD is a stable cell line mimicking a cancer stem cell (CSC), derived by knocking down E-Cadherin (via shRNA) in human breast epithelial cells to induce epithelial to mesenchymal transition (EMT)
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/19682730
http://www.ncbi.nlm.nih.gov/pubmed/22941295
HMLE_sh_ECAD cell
BAO: BAO_0030038
463074
HMLE_sh_eGFP is a human breast epithelial cell line containing shRNA to GFP (green fluorescent reporter); used as an isogenic control line for HMLE_sh_ECAD
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/19682730
http://www.ncbi.nlm.nih.gov/pubmed/22941295
HMLE_sh_eGFP cell
BAO: BAO_0030039
588703
HMLE_sh_TWIST is a stable cell line mimicking a cancer stem cell (CSC), derived by knocking down TWIST (via shRNA) in human breast epithelial cells to induce epithelial to mesenchymal transition (EMT); isogenic with another CSC line, HMLE_sh_ECAD
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/19682730
http://www.ncbi.nlm.nih.gov/pubmed/22941295
HMLE_sh_TWIST cell
BAO: BAO_0030040
651570
An engineered 3T3 mouse fibroblast cell line, which expresses the firefly luciferase reporter gene under the control of Wnt-responsive promoters (TCF/LEF).
http://www.enzolifesciences.com/ENZ-61001/leading-light-wnt-reporter-assay-starter-kit/
LEADING LIGHT Wnt Reporter cell line cell
BAO: BAO_0030031
624396
MCL-1 1780 is a murine leukemia cell line driven by the overexpression of Myc and MCL-1.
BAO, YH
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919900/
Source: Anthony Letai (Dana Farber)
MCL-1 1780 cell
BAO: BAO_0030053
652260
MG213 is a subline of the BRG1/BRM-deficient cell line SW13 (http://purl.obolibrary.org/obo/CLO_0009185) that contains a stably integrated glucocorticoid-responsive MMTV-luciferase reporter.
BAO, YH
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615482/
MG213 cell
BAO: BAO_0030048
624495
A PathHunter Beta-Arrestin GPCR cell line (DiscoverX), engineered to co-express the ProLink (PK) tagged GPCR (DRD2L, long form of human DRD2) and the Enzyme Acceptor (EA) tagged Beta-Arrestin. Activation of DRD2L-PK induces Beta-Arrestin-EA recruitment, forcing complementation of the two Beta-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
BAO, YH
https://www.discoverx.com/products/cell-line/cho-k1-drd2l-beta-arrestin-cell-line-93-0579c2
PathHunter CHO-K1 DRD2L Beta-Arrestin cell
BAO: BAO_0030056
624500
A PathHunter Beta-Arrestin GPCR cell line (DiscoverX), engineered to co-express the ProLink (PK) tagged GPCR (human DRD3) and the Enzyme Acceptor (EA) tagged Beta-Arrestin. Activation of DRD3-PK induces Beta-Arrestin-EA recruitment, forcing complementation of the two Beta-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
BAO, YH
https://www.discoverx.com/products/cell-line/cho-k1-drd3-beta-arrestin-cell-line-93-0591c2
PathHunter CHO-K1 DRD3 Beta-Arrestin cell
BAO: BAO_0030057
652166
RAW-Blue cells are derived from the murine RAW 264.7 macrophages with chromosomal integration of a secreted embryonic alkaline phosphatase (SEAP) reporter construct inducible by NF-κB and AP-1.
BAO, YH
http://web.expasy.org/cellosaurus/CVCL_X594
http://www.invivogen.com/raw-blue
RAW-Blue cell
BAO: BAO_0030060
RRID:CVCL_X594
624032
A rat immortilized Schwann cell line.
S-16 cell
http://purl.obolibrary.org/obo/BTO_0002937
http://web.expasy.org/cellosaurus/CVCL_B072
S16 cell
BAO: BAO_0030061
BTO: BTO_0002937
RRID:CVCL_B072
1355
A mouse melanoma cell line (which harbors N-Ras mutation), isolated from a small amelanotic lung metastasis in a mouse
with a s.c. K-1735 tumor.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158838/
http://www.ncbi.nlm.nih.gov/pubmed/2832058/
SW1 cell
BAO: BAO_0030062
485366
'Tango cell' refers to one of many stable cell lines, all based on the parental line HEK293T, designed to work in a 'Tango beta-arrestin' recruitiment assay to measure receptor activation for more than 300 GPCRs. See PMID25895059 and https://pdspdb.unc.edu/prestotango/
BAO, YH
http://www.ncbi.nlm.nih.gov/pubmed/25895059
https://pdspdb.unc.edu/prestotango/
https://www.ncbi.nlm.nih.gov/pubmed/18165312
Tango cell
BTO: BAO_0030063
651712
Human diffuse large B cell lymphoma cell line derived from a 62-year-old male patient
BAO, YH
http://web.expasy.org/cellosaurus/CVCL_A442
TMD8 cell
BAO: BAO_0030064
RRID:CVCL_A442
504935
U87-EGFRvIII (aka U87/vIII) is a stable cell line derived from U87MG (a human glioblastoma) to overexpress the most common mutation of epidermal growth factor receptor (EGFR) found in human glioblastomas--an in-frame deletion of an 801-bp sequence in the extracellular domain of EGFR termed EGFRvIII. (descr. in PMID 15548697).
BAO, YH
U87/vIII
http://www.ncbi.nlm.nih.gov/pubmed/15548697/
U87-EGFRvIII cell
BAO: BAO_0030059
A disease that involving errors in metabolic processes of building or degradation of molecules.
ICD10CM:E88.9
ICD9CM:277.9
MESH:D008659
NCI:C3235
SNOMEDCT_US_2020_03_01:75934005
UMLS_CUI:C0025517
metabolic disease
disease_ontology
DOID:0014667
disease of metabolism
A viral infectious disease that results_in infection located_in joint, has_material_basis_in Chikungunya virus, which is transmitted_by Aedes mosquito bite. The infection has_symptom fever, has_symptom arthralgia, and has_symptom maculopapular rash.
GARD:6038
Chikungunya fever
disease_ontology
DOID:0050012
chikungunya
An acquired metabolic disease that is characterized by abnormal carbohydrate metabolism.
disease_ontology
DOID:0050013
carbohydrate metabolism disease
An ehrlichiosis that results in infection located in granular leukocyte, has_material_basis_in Anaplasma phagocytophilum, which is transmitted by lone start tick (Amblyomma americanum ). The infection has symptom headache, has symptom muscle aches, has symptom fatigue, has symptom fever and has symptom rash.
DOID:0050021
DOID:0050022
human granulocytic ehrlichiosis
disease_ontology
HGE
DOID:0050025
human granulocytic anaplasmosis
An ehrlichiosis that results in infection located in monocyte or located in macrophage, has_material_basis_in Ehrlichia chaffeensis, which is transmitted by black-legged tick (Ixodes scapularis), transmitted by western black-legged tick (Ixodes pacificus) or transmitted by castor bean tick (Ixodes ricinus). The infection has symptom headache, has symptom muscle aches, has symptom fatigue, has symptom fever and has symptom rash.
DOID:14091
GARD:72
disease_ontology
Ehrlichiosis chafeensis
DOID:0050026
human monocytic ehrlichiosis
An acquired metabolic disease that is characterized by abnormal mineral metabolism.
disease_ontology
DOID:0050032
mineral metabolism disease
A spotted fever that has_material_basis_in Rickettsia africae, which is transmitted_by ticks (Amblyomma hebraeum and Amblyomma variegatum). The infection has_symptom fever, has_symptom eschar and has_symptom maculopapular rash.
DOID:0050034
DOID:0050036
Rickettsia africae spotted fever
south african tick-bite fever
disease_ontology
DOID:0050035
African tick-bite fever
A spotted fever that has_material_basis_in Rickettsia heilongjiangensis, which is transmitted_by ticks (Haemaphysalis concinna). The infection has_symptom fever, has_symptom eschar, has_symptom maculopapular rash, and has_symptom regional adenopathy.
Rickettsia heilongjiangensis spotted fever
disease_ontology
DOID:0050046
Far Eastern spotted fever
A spotted fever that has_material_basis_in Rickettsia japonica, which is transmitted_by ticks (Dermacentor taiwanensis and Haemaphysalis flava). The infection has_symptom fever, has_symptom eschars, has_symptom regional adenopathy, and has_symptom rash on extremities.
DOID:0050049
Rickettsia japonica spotted fever
oriental spotted fever
disease_ontology
DOID:0050050
Japanese spotted fever
A primary bacterial infectious disease that results_in infection located_in skin, has_material_basis_in Erysipelothrix rhusiopathiae, which is transmitted_by contact with infected animals. The infection has_symptom redness of skin, has_symptom tenderness of skin and has_symptom warmth of skin.
MESH:D004887
disease_ontology
DOID:0050061
erysipeloid
A primary systemic mycosis that is a fungal infection located_in lungs, or located_in skin, which results_in disseminated granulomatous pulmonary process and cutaneous infection in rodents, small wild mammals and humans, has_material_basis_in Chrysosporium parvum or Emmonsia crescens.
disease_ontology
DOID:0050072
adiaspiromycosis
An aspergillosis that is a serious fungal infection of the lung with pneumonia caused by Aspergillus, which spreads to other parts of the body through bloodstream in patients with acute leukemia and recipients of tissue transplants. Clinical symptoms include pulmonary nodules and hemorrhage.
disease_ontology
DOID:0050073
invasive aspergillosis
A nutritional deficiency that is disease characterized by a cardiomyopathy secondary to selenium deficiency.
GARD:8761
disease_ontology
DOID:0050083
Keshan disease
A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions.
infectious disease
DOID:10115
DOID:11078
DOID:1304
DOID:1321
DOID:2040
DOID:2288
DOID:3099
DOID:4120
DOID:4620
DOID:5256
DOID:945
DOID:95
DOID:9532
DOID:9696
ICD9CM:079.0
UMLS_CUI:C0001485
infectious disease
disease_ontology
DOID:0050117
DO:wk
disease by infectious agent
A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in La Crosse virus, which is transmitted_by treehole mosquito, Ochlerotatus triseriatus. The infection has_symptom seizures, has_symptom headache, has_symptom fever, has_symptom coma, and has_symptom paralysis.
DOID:10840
ICD10CM:A83.5
ICD9CM:062.5
MESH:D004670
SNOMEDCT_US_2020_03_01:69627004
UMLS_CUI:C0014053
California Encephalitis
California virus encephalitis
Neuroinvasive California encephalitis virus infection
disease_ontology
DOID:0050118
La Crosse encephalitis
A lymphatic system disease that is characterized by an expansion of the monocyte-macrophage population and intense hemophagocytosis. It can occur de novo, but more often occurs in the setting of another disorder, usually an infection or a malignancy. A clinical picture of fever, hepatosplenomegaly, lymphadenopathy and peripheral pancytopenia. The morphologic hallmark of this syndrome is the phagocytosis of hematopoietic elements by morphologically normal macrophages.
DOID:6453
GARD:6589
ICD10CM:D76.1
MESH:D051359
NCI:C34792
OMIM:PS267700
ORDO:540
SNOMEDCT_US_2020_03_01:190958003
UMLS_CUI:C0024291
haemophagocytic syndrome
disease_ontology
DOID:0050120
Xref MGI.
MESH:C537250 added from NeuroDevNet [WAK].
hemophagocytic lymphohistiocytosis
A paranasal sinus disease involving inflammation of the paranasal sinuses resulting from bacterial, fungal, viral infection, allergic or autoimmune issues. Symptoms can include fever, weakness, fatigue, cough and congestion. There may also be mucus drainage in the back of the throat, called postnasal drip.
DOID:2052
DOID:9564
ICD10CM:J01
ICD9CM:461
NCI:C128411
SNOMEDCT_US_2020_03_01:195649005
UMLS_CUI:C0149512
disease_ontology
DOID:0050127
sinusitis
Secretory diarrhea is a diarrhea where there is an increase in the active secretion, or there is an inhibition of absorption causing little to no structural damage. The most common cause of this type of diarrhea is a cholera toxin that stimulates the secretion of anions, especially chloride ions.
disease_ontology
DOID:0050129
secretory diarrhea
A fungal infectious disease that results_in infection of the outermost layer located_in skin or located_in hair shaft, has_material_basis_in Fungi. No living tissue is invaded and there is no cellular response from the host.
DOID:13370
ICD10CM:B36.9
MESH:D010854
SNOMEDCT_US_2020_03_01:266218008
SNOMEDCT_US_2020_03_01:47382004
UMLS_CUI:C0031898
UMLS_CUI:C2980104
Steroid-modified tinea infection
piedra
disease_ontology
DOID:0050133
Adding a UMLS CUI for piedra C2980104.
superficial mycosis
A fungal infectious disease that results_in infection of the keratinized layers located_in skin, located_in hair or located_in nail, which extends deeper into the epidermis, has_material_basis_in Fungi and results_in_formation_of skin lesions.
disease_ontology
DOID:0050134
cutaneous mycosis
A fungal infectious disease that results_in infection located_in skin or located_in subcutaneous tissue, has_material_basis_in Fungi, which penetrate the dermis or even deeper during or after a skin trauma.
disease_ontology
DOID:0050135
subcutaneous mycosis
A fungal infectious disease that results_in infection of internal organs and tissues located_in human body, has_material_basis_in Fungi, which enter the body via the respiratory tract, through the gut, paranasal sinuses or skin and spread through the bloodstream to multiple organs.
disease_ontology
DOID:0050136
systemic mycosis
A diarrhea that is of rapid onset and course characterized by frequent loose or liquid bowel movements. Acute diarrhea is a common cause of death in developing countries and the second most common cause of infant deaths worldwide.
disease_ontology
DOID:0050140
acute diarrhea
A botulism that involves intoxication caused by botulinum neurotoxins (BoNTA, B, E and F) in adults, has_material_basis_in Clostridium botulinum A, has_material_basis_in Clostridium botulinum B, has_material_basis_in Clostridium botulinum E and has_material_basis_in Clostridium botulinum F, which are transmitted by ingestion of bacterial spores, which then grow in the intestine and release toxins.
disease_ontology
DOID:0050141
intestinal botulism
An upper respiratory tract disease which involves inflammation, pain, and swelling of the adenoid tissue due to the infection by bacteria and viruses. It occurs primarily in children and may be secondary to an allergy, infection of nose or throat and an obstruction of the eustachian tube. The infection has symptom pain, has symptom redness, has symptom swelling, and has symptom difficulty swallowing.
DOID:13750
ICD10CM:J35.02
ICD9CM:474.01
SNOMEDCT_US_2020_03_01:195794009
UMLS_CUI:C0396023
chronic adenoiditis
disease_ontology
DOID:0050145
adenoiditis
An otitis externa which is a disease of the ear produced by the growth of fungi in the external auditory canal. It is characterized by inflammation, pruritus, scaling and severe discomfort. The most common fungi are Aspergillus niger and Candida albicans.
MESH:D059249
Singapore ear
disease_ontology
DOID:0050147
otomycosis
An upper respiratory tract disease involving inflammation of both larynx and trachea often caused by viral infection. The infection can close off the windpipe.
DOID:11795
DOID:9390
ICD10CM:J04
ICD10CM:J37.1
ICD9CM:464
ICD9CM:476.1
SNOMEDCT_US_2020_03_01:276443001
SNOMEDCT_US_2020_03_01:83271005
UMLS_CUI:C0155811
UMLS_CUI:C0155837
disease_ontology
DOID:0050148
laryngotracheitis
A legionellosis that involves a milder respiratory illness without pneumonia. Symptoms include fever, headache and muscle aches which last for 2 to 5 days.
disease_ontology
DOID:0050150
Pontiac fever
A bacterial pneumonia which is an acute pulmonary inflammatory response that develops after the inhalation of colonized oropharyngeal material containing bacteria. It is seen in individuals with dysphagia and gastric dysmotility. The disease has_symptom tachypnea and has_symptom cough.
ICD10CM:J69.0
MESH:D011015
SNOMEDCT_US_2020_03_01:47839005
UMLS_CUI:C0032290
disease_ontology
DOID:0050152
aspiration pneumonia
An aspergillosis that presents as a clump of tangled mass of Aspergillus fungus fibres, blood clots, and white blood cells, which exists in the cavities of the lungs that develop in an area of previous lung disease or lung scarring.
disease_ontology
DOID:0050153
pulmonary aspergilloma
A nervous system disease which is located in a part of the nervous system responsible for processing sensory information that consists of sensory receptors, neural pathways, and parts of the brain involved in sensory perception. Commonly recognized sensory systems are those for vision, hearing, somatic sensation (touch), taste and olfaction (smell).
disease_ontology
DOID:0050155
sensory system disease
A pulmonary fibrosis that is characterized by scarring of the lung.
EFO:0000768
GARD:8609
ICD10CM:J84.112
ICD9CM:516.31
MESH:D054990
NCI:C35716
OMIM:178500
SNOMEDCT_US_2020_03_01:28168000
UMLS_CUI:C1800706
FIBROCYSTIC PULMONARY DYSPLASIA
IDIOPATHIC PULMONARY FIBROSIS, FAMILIAL
cryptogenic fibrosing alveolitis
disease_ontology
DOID:0050156
OMIM mapping confirmed by DO. [SN].
idiopathic pulmonary fibrosis
An idiopathic interstitial pneumonia characterized by lung inflammation and scarring that obstructs the small airways and air sacs of the lungs (alveoli). A flu-like illness, with a cough, fever, a feeling of illness (malaise), fatigue, and weight loss, heralds the onset in about 50% of people. Frequent presence of crackling sounds (called Velcro crackles) when the doctor listens with a stethoscope.
DOID:2798
GARD:1620
ICD10CM:J84.116
ICD9CM:516.36
MESH:D018549
NCI:C62586
SNOMEDCT_US_2020_03_01:129458007
UMLS_CUI:C0242770
BOOP
Cryptogenic organising pneumonitis
Cryptogenic organizing pneumonitis
bronchiolitis obliterans organising pneumonia
bronchiolitis obliterans organizing pneumonia
cryptogenic organising pneumonia
idiopathic bronchiolitis obliterans with organising pneumonia
idiopathic bronchiolitis obliterans with organizing pneumonia
disease_ontology
DOID:0050157
cryptogenic organizing pneumonia
An anthrax disease that results in infection located in lung lymph nodes brought on by breathing in the spores of the bacteria Bacillus anthracis. The first symptoms of inhalation anthrax are like cold or flu symptoms and can include a sore throat, mild fever and muscle aches. Later symptoms include cough, chest discomfort, shortness of breath, tiredness and muscle aches.
pulmonary anthrax
respiratory anthrax
wool-sorters' disease
woolsorters' disease
disease_ontology
DOID:0050160
inhalation anthrax
A respiratory system disease which involves the lower respiratory tract.
ICD9CM:478.19
SNOMEDCT_US_2020_03_01:195823002
UMLS_CUI:C0029581
disease_ontology
DOID:0050161
lower respiratory tract disease
An autoimmune polyendocrine syndrome that is inherited in an autosomal recessive fashion, which is characterized by abnormal functioning of the immune system that causes auto-reactivity against endocrine organs.
GARD:8466
OMIM:240300
Autoimmune Polyglandular Syndrome I
Whitaker syndrome
autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
disease_ontology
DOID:0050167
autoimmune polyendocrine syndrome type 1
An autoimmune polyendocrine syndrome that is characterized by abnormal functioning of the immune system that causes auto-reactivity against endocrine organs. It is more heterogeneous and has not been linked to one gene.
GARD:7611
OMIM:269200
Schmidt syndrome
disease_ontology
DOID:0050168
autoimmune polyendocrine syndrome type 2
A lupus erythematosus that causes skin lesions on parts of the body that are exposed to sunlight.
GARD:6225
disease_ontology
DOID:0050169
cutaneous lupus erythematosus
A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in Tick-borne encephalitis virus, which is transmitted_by Ixodes ticks. The infection has_symptom drowsiness, has_symptom confusion, has_symptom sensory disturbances, and has_symptom paralysis.
DOID:0050176
DOID:10251
DOID:10252
GARD:5216
ICD10CM:A84.1
ICD9CM:063.2
MESH:D004675
SNOMEDCT_US_2020_03_01:16901001
UMLS_CUI:C0014054
Central European encephalitis
Far Eastern TBE
Russian spring-summer encephalitis
Siberian tick-borne encephalitis
Taiga encephalitis
Western European tick-borne encephalitis
west-Siberian encephalitis
disease_ontology
DOID:0050175
tick-borne encephalitis
A genetic disease that is the result of one or more abnormal alleles and may be dominant, semi-dominant, or recessive.
disease_ontology
DOID:0050177
monogenic disease
A skin disease that is a type of allergic reaction located_in skin, which occurs in response to medications, infections, or illness.
GARD:6372
MESH:D004892
disease_ontology
DOID:0050185
erythema multiforme
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Junin virus, which is transmitted_by rodent, Calomys musculinus. The infection has_symptom fever, has_symptom fatigue, has_symptom malaise, has_symptom leukopenia, has_symptom thrombocytopenia, and has_symptom hemorrhagic manifestations.
disease_ontology
DOID:0050194
Argentine hemorrhagic fever
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Guanarito virus, which is transmitted_by cotton rat, Sigmodon alstoni and transmitted_by cane mouse, Zygodontomys brevicauda. The infection has_symptom fever, has_symptom headache, has_symptom myalgia, has_symptom sore throat, has_symptom weakness, has_symptom anorexia, has_symptom nausea, has_symptom vomiting, has_symptom convulsions, has_symptom epistaxis, has_symptom bleeding gums, has_symptom hematemesis, has_symptom melena, and has_symptom menorrhagia.
disease_ontology
DOID:0050196
Venezuelan hemorrhagic fever
A hemorrhagic fever with renal syndrome that results_in infection located_in kidney, has_material_basis_in Hantaan virus, which is transmitted_by the eurasian field mouse, Apodemus agrarius, or has_material_basis_in Seoul virus, which is transmitted_by norwegian rat, Rattus norvegicus. The infection has_symptom headache, has_symptom back pain, has_symptom abdominal pain, has_symptom fever, has_symptom chills, has_symptom nausea, has_symptom blurred vision, has_symptom flushing of the face, has_symptom redness of the eyes, has_symptom rash, has_symptom low blood pressure, has_symptom acute shock, has_symptom vascular leakage, and has_symptom acute kidney failure, which can cause severe fluid overload.
disease_ontology
DOID:0050200
Korean hemorrhagic fever
A neuromuscular junction disease that is characterized by an abnormality of acetylcholine (ACh) release at the neuromuscular junction which results from an autoimmune attack against voltage-gated calcium channels (VGCC) on the presynaptic motor nerve terminal.
ICD10CM:G70.80
ICD9CM:358.3
MESH:D015624
NCI:C3155
SNOMEDCT_US_2020_03_01:230688006
UMLS_CUI:C0022972
Eaton-Lambert syndrome
LEMS
Lambert-Eaton syndrome
disease_ontology
DOID:0050214
Lambert-Eaton myasthenic syndrome
A parasitic protozoa infectious disease that involves infection of the central nervous system caused by Naegleria fowleri. The symptoms include headache, nausea, rigidity of the neck muscles, vomiting, delirium, seizures and coma.
GARD:9554
Naegleria fowleri infection
disease_ontology
DOID:0050242
primary amebic meningoencephalitis
A parasitic protozoa infectious disease that results in infection of the brain caused by Acanthamoeba or Balamuthia mandrillaris. The symptoms include headaches, altered mental status, and focal neurologic deficit, which progresses over several weeks to death.
GARD:12651
Acanthamoeba encephalitis
Acanthamoeba granulomatous encephalitis
Granulomatous Amebic Encephalitis due to Acanthamoeba
granulomatous amoebic encephalitis
disease_ontology
DOID:0050246
granulomatous amebic encephalitis
A parasitic helminthiasis infectious disease that involves parasitic infection of the intestine, central nervous system and eyes by Angiostrongylus cantonensis or Angiostrongylus costaricensis.
GARD:683
disease_ontology
DOID:0050256
angiostrongyliasis
A parasitic ectoparasitic infectious disease that is an inflammatory skin disease caused by the parasitic infestation of the female chigoe flea, Tunga penetrans in animals and humans. The symptoms include skin inflammation, severe pain, itching, and a lesion at the site of infection that is characterized by a black dot at the center of a swollen red lesion, surrounded a white halo.
GARD:393
MESH:D058285
disease_ontology
DOID:0050266
tungiasis
A myiasis that involves parasitic infestation of Oestrus ovis larvae in the eye causing severe irritation, edema, and pain.
disease_ontology
DOID:0050268
ophthalmomyiasis
An subcutaneous mycosis that is a chronic inflammatory or granulomatous fungal infection caused by Conidiobolus species, which is restricted to the nasal submucosa and characterized by polyps or palpable restricted subcutaneous masses. Symptoms include nasal obstruction, drainage and sinus pain. Subcutaneous nodules develop in the nasal and perinasal regions.
disease_ontology
DOID:0050279
conidiobolomycosis
An opportunistic mycosis that involves localized or hematogenously disseminated fungal infection by Fusarium solani or Fusarium oxysporum. Skin lesions are seen in neutropenic patients, and indolent cellulitis or soft-tissue necrosis occur in immunocompromised patients at the site of trauma.
MESH:D060585
disease_ontology
DOID:0050289
fusariosis
An opportunistic mycosis that results_in disseminated infection, has_material_basis_in Trichosporon and results_in_formation_of nontender erythematous nodules anywhere on the body.
MESH:D060586
disease_ontology
DOID:0050290
trichosporonosis
A systemic mycosis that results_in infection located_in human body, has_material_basis_in Fungi, which can overcome the physiological and cellular defences of the normal human host. The primary deep pathogens usually gain access to the host via the respiratory tract.
disease_ontology
DOID:0050292
primary systemic mycosis
A refractive error that is characterized by the significant difference in perceived sizes of an object between the two eyes.
MESH:D000839
disease_ontology
DOID:0050304
aniseikonia
A hypothyroidism that is present at birth.
DOID:11631
DOID:11632
GARD:1487
ICD10CM:E00.1
ICD10CM:E03.1
ICD9CM:243
MESH:D003409
NCI:C26734
NCI:C98921
OMIM:PS275200
SNOMEDCT_US_2020_03_01:217710005
SNOMEDCT_US_2020_03_01:75065003
UMLS_CUI:C0010308
UMLS_CUI:C0342200
disease_ontology
DOID:0050328
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital hypothyroidism
A syndrome that is characterized by autosomal dominant inheritance of abnormalities affecting the lacrimal and salivary glands and ducts, ears, teeth and fingers and toes.
OMIM:149730
LEVY-HOLLISTER SYNDROME
lacrimoauriculodentodigital syndrome
disease_ontology
DOID:0050331
OMIM mapping confirmed by DO. [SN].
LADD syndrome
A vestibular disease that is characterized by progressive hearing loss resulting from congenital enlargement of the vestibular aqueducts.
GARD:8651
disease_ontology
DOID:0050332
OMIM mapping confirmed by DO. [SN].
enlarged vestibular aqueduct
A phosphorus metabolism disease that is characterized by hypophosphatemia and the symptoms of osteomalacia including bone pain, skeletal deformities and osteoarthritis.
MESH:D017674
disease_ontology
DOID:0050336
hypophosphatemia
A bacterial infectious disease that results_in infection by bacteria as a result of their presence or activity within the normal, healthy host, and their intrinsic virulence is, in part, a necessary consequence of their need to reproduce and spread.
disease_ontology
DOID:0050338
primary bacterial infectious disease
A bacterial infectious disease that results_in infection by bacteria which are part of the normal human flora when one or more of the defense mechanisms designed to restrict them from the usually sterile internal tissues are breached by accident, by intent (surgery), or by an underlying metabolic or an infectious disorder.
disease_ontology
DOID:0050339
commensal bacterial infectious disease
A bacterial infectious disease that results_in infection by bacteria in individuals whose host defense mechanisms have been compromised.
disease_ontology
DOID:0050340
opportunistic bacterial infectious disease
A botulism that involves intoxication caused by botulinum neurotoxins (BoNTA, B, E and F), which are transmitted by ingestion of food contaminated with preformed toxins, has_material_basis_in Clostridium botulinum A, has_material_basis_in Clostridium botulinum B, has_material_basis_in Clostridium botulinum E and has_material_basis_in Clostridium botulinum F. The infection has symptom blurred vision, has symptom diplopia, has symptom dysarthria, has symptom dysphonia, has symptom dysphagia and has symptom descending muscle paralysis.
disease_ontology
DOID:0050352
foodborne botulism
A botulism that involves intoxication caused by botulinum neurotoxins (BoNTA, B, E and F), has_material_basis_in Clostridium botulinum A, has_material_basis_in Clostridium botulinum B, has_material_basis_in Clostridium botulinum E and has_material_basis_in Clostridium botulinum F, which are transmitted by contact of spores with the open wounds, which then reproduce in an anaerobic environment to produce toxins.
disease_ontology
DOID:0050353
wound botulism
A botulism that involves intoxication caused by botulinum neurotoxins (BoNTA or B) in infants, has_material_basis_in Clostridium botulinum A or has_material_basis_in Clostridium botulinum B, which are transmitted_by ingestion of bacterial spores, which then grow in the intestine and release toxins. The infection has_symptom constipation, has_symptom lethargy, has_symptom difficulty feeding, has_symptom swallowing, has_symptom ptosis, has_symptom loss of head control, and has_symptom muscle weakness.
disease_ontology
DOID:0050354
infant botulism
A bartonellosis that results_in infection located_in endothelial cells or located_in red blood cells, has_material_basis_in Bartonella bacilliformis, which is transmitted_by sandflies of genus Lutzomyia. The infection has acute and chronic phases. The acute phase is characterized by severe hemolytic anemia and transient immunosuppression. The chronic phase is characterized by verruga peruana lesions which may ulcerate and bleed.
Carrion disease
Oroya fever
disease_ontology
DOID:0050398
Carrion's disease
An intestinal disease that has_material_basis_in mutations in the APC gene and involves formation of numerous polyps in the epithelium of the large intestine which are initially benign and later transform into colon cancer.
GARD:6408
MESH:D011125
NCI:C3339
OMIM:PS175100
ORDO:733
SNOMEDCT_US_2020_03_01:72900001
UMLS_CUI:C0032580
adenomatous polyposis of the colon
disease_ontology
DOID:0050424
OMIM mapping confirmed by DO. [SN].
familial adenomatous polyposis
A skin disease that is characterized by ulceration of less than 10 percent of the surface area of the body. The disease is often precipitated by the use of medications, such as antibiotics or antiepileptics, or onset of infection.
EFO:0004276
GARD:7700
ICD10CM:L51.1
ICD9CM:695.13
NCI:C79484
NCI:C79777
SNOMEDCT_US_2020_03_01:73442001
UMLS_CUI:C0038325
disease_ontology
DOID:0050426
Stevens-Johnson syndrome
MESH:D013262
A syndrome that is characterized by a deficiency in the ability to repair ultraviolet damage that has_material_basis_in autosomal recessive inheritance of DNA repair.
GARD:7910
ICD10CM:Q82.1
MESH:D014983
NCI:C3452
ORDO:910
SNOMEDCT_US_2020_03_01:44600005
UMLS_CUI:C0043346
disease_ontology
DOID:0050427
OMIM mapping confirmed by DO. [SN].
xeroderma pigmentosum
A palmoplantar keratosis characterized by a well-demarcated, symmetric keratoderma located_in palms and located_in soles.
MESH:D015776
NCI:C3147
OMIM:600962
OMIM:613000
OMIM:615735
ORDO:2337
SNOMEDCT_US_2020_03_01:81206005
UMLS_CUI:C0022584
UMLS_CUI:C3489771
Thost-Unna Syndrome
Unna-Thost Syndrome
diffuse nonepidermolytic palmomplantar keratoderma
tylosis
disease_ontology
DOID:0050428
Xref MGI.
OMIM mapping confirmed by DO. [SN].
nonepidermolytic palmoplantar keratoderma
A pemphigus that is characterized by recurring blistering most commonly occurring in the folds of the skin and has_material_basis_in mutations in the ATP2C1 gene that result in loss of adhesion within the skin.
GARD:6559
ICD10CM:Q82.8
MESH:D016506
NCI:C82865
OMIM:169600
SNOMEDCT_US_2020_03_01:79468000
UMLS_CUI:C0085106
BENIGN CHRONIC PEMPHIGUS
Pemphigus, Benign Familial
disease_ontology
DOID:0050429
OMIM mapping confirmed by DO. [SN].
Hailey-Hailey disease
A multiple endocrine neoplasia characterized by medullary carcinoma of the thyroid, pheochromocytoma, hyperparathyroidism, and occasionally cutaneous lichen amyloidosis.
ICD10CM:E31.22
ICD9CM:258.02
MESH:D018813
NCI:C3226
OMIM:171400
ORDO:247698
SNOMEDCT_US_2020_03_01:721188000
UMLS_CUI:C0025268
MEN2A
Sipple syndrome
multiple endocrine neoplasia II
disease_ontology
DOID:0050430
OMIM mapping confirmed by DO. [SN].
multiple endocrine neoplasia type 2A
An intrinsic cardiomyopathy that is characterized by hypokinetic areas involving the free wall of the right ventricle, with fibrofatty replacement of the right ventricular myocardium, with associated arrhythmias originating in the right ventricle.
MESH:D019571
NCI:C84571
OMIM:PS107970
ORDO:217656
ORDO:247
SNOMEDCT_US_2020_03_01:281170005
UMLS_CUI:C0349788
ARVC
ARVC cardiomyopathy
ARVD
arrhythmogenic right ventricular dysplasia
arrhythmogenic right ventricular dysplasia/cardiomyopathy
disease_ontology
DOID:0050431
Xref MGI.
OMIM mapping confirmed by DO. [SN].
arrhythmogenic right ventricular cardiomyopathy
An autism spectrum disorder that is characterized by significant difficulties in social interaction, along with restricted and repetitive patterns of behavior and interests. It differs from other autism spectrum disorders by its relative preservation of linguistic and cognitive development.
GARD:5855
ICD10CM:F84.5
MESH:D020817
NCI:C97159
OMIM:608631
OMIM:608638
OMIM:608781
OMIM:609954
ORDO:1162
SNOMEDCT_US_2020_03_01:154879004
UMLS_CUI:C0236792
disease_ontology
DOID:0050432
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Asperger syndrome
A prion disease that is characterized by insomnia, hallucinations, dementia and death, located_in the brain.
GARD:6429
ICD10CM:A81.83
ICD9CM:046.72
MESH:D034062
NCI:C84711
OMIM:600072
SNOMEDCT_US_2020_03_01:83157008
UMLS_CUI:C0206042
disease_ontology
DOID:0050433
OMIM mapping confirmed by DO. [SN].
fatal familial insomnia
A syndrome that is characterized by global growth retardation of the muscle, liver, brain and eyes as well as constrictive pericarditis and has_material_basis_in mutations in the TRIM37 gene.
GARD:95
MESH:D050336
NCI:C84906
OMIM:253250
ORDO:2576
SNOMEDCT_US_2020_03_01:81604003
UMLS_CUI:C0524582
MUL
Mulibrey growth disorder
Muscle-Liver-Brain-Eye Nanism
PERICARDIAL CONSTRICTION AND GROWTH FAILURE
Perheentupa Syndrome
disease_ontology
DOID:0050436
OMIM mapping confirmed by DO. [SN].
mulibrey nanism
A lysosomal storage disease that is characterized by cardiomyopathy, skeletal myopathy and intellectual disability and has_material_basis_in mutations in the LAMP2 gene.
GARD:9730
MESH:D052120
NCI:C84735
OMIM:300257
SNOMEDCT_US_2020_03_01:419097006
UMLS_CUI:C0878677
ANTOPOL DISEASE
PSEUDOGLYCOGENOSIS II
disease_ontology
DOID:0050437
OMIM mapping confirmed by DO. [SN].
Danon disease
A syndrome that is characterized by gonadal dysgenesis, streak gonads, progressive focal segmental glomerulonephropathy and the development of urogenital cancers that is the result of mutation in the WT1 gene.
GARD:2375
MESH:D052159
NCI:C122805
OMIM:136680
SNOMEDCT_US_2020_03_01:445431000
UMLS_CUI:C0950122
disease_ontology
DOID:0050438
OMIM mapping confirmed by DO. [SN].
Frasier syndrome
A syndrome characterized by a combination of hearing loss and visual impairment.
GARD:7843
MESH:D052245
NCI:C85217
OMIM:PS276900
ORDO:886
SNOMEDCT_US_2020_03_01:57838006
UMLS_CUI:C0271097
disease_ontology
DOID:0050439
Xref MGI.
OMIM mapping confirmed by DO. [LS].
Usher syndrome
A sphingolipidosis that is characterized by leukodystrophy, ichthyosis, skeletal abnormalities and shortened life expectancy and has_material_basis_in mutation in the SUMF1 gene that results in deficiency in multiple sulfatase enzymes.
ICD10CM:E75.26
MESH:D052517
NCI:C84908
OMIM:272200
SNOMEDCT_US_2020_03_01:254076009
SNOMEDCT_US_2020_03_01:54898003
UMLS_CUI:C0268263
UMLS_CUI:C1720864
Sulfatidosis, Juvenile, Austin Type
multiple sulfatase deficiency disease
disease_ontology
DOID:0050441
OMIM mapping confirmed by DO. [SN].
mucosulfatidosis
A peroxisomal disease that is characterized by neurological impairment, intellectual disability, hepatosplenomegaly and ichthyosis and results from the accumulation of very long chain fatty acids and phytanic acid, secondary to mutation in the PEX genes.
ICD10CM:G60.1
MESH:D052919
NCI:C84789
OMIM:266510
SNOMEDCT_US_2020_03_01:238062008
UMLS_CUI:C0282527
infantile phytanic acid storage disease
disease_ontology
DOID:0050444
OMIM mapping confirmed by DO. [SN].
infantile Refsum disease
A rickets has_material_basis in X-linked mutations in the PHEX gene that lead to increased circulating levels of FGF-23, a phosphate-regulating hormone (phosphatonin), that leads to reduced renal phosphate reabsorption and consequently abnormal bone mineralization.
MESH:D053098
NCI:C123265
NCI:C85234
OMIM:307800
UMLS_CUI:C0733682
UMLS_CUI:C1845168
UMLS_CUI:C3540852
Hypophosphatemia, Vitamin D-Resistant Rickets
Vitamin D-Resistant Rickets, X-Linked
X-linked hypophosphatemia
hypophosphatemic rickets X-linked dominant
disease_ontology
DOID:0050445
OMIM mapping confirmed by DO. [SN].
X-linked dominant hypophosphatemic rickets
A skin disease characterized by a defect in the normal process of keratinization of the mucosa.
MESH:D053529
NCI:C84760
OMIM:193900
OMIM:615785
ORDO:171723
SNOMEDCT_US_2020_03_01:85388002
UMLS_CUI:C1721005
white sponge nevus
white sponge nevus of Cannon
disease_ontology
DOID:0050448
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hereditary mucosal leukokeratosis
A syndrome that is characterized by hypertrophic nails and hyperkeratosis of the hands and feet and has_material_basis in gene mutations that result in changes in keratin.
GARD:10753
MESH:D053549
NCI:C84986
OMIM:PS167200
ORDO:2309
SNOMEDCT_US_2020_03_01:39427000
UMLS_CUI:C0265334
UMLS_CUI:C1706595
UMLS_CUI:C1721007
Jackson-Lawler Type Pachyonychia Congenita
Jadassohn-Lewandowsky Syndrome
PACHYONYCHIA CONGENITA, JADASSOHN-LEWANDOWSKY TYPE
Pachyonychia Congenita Type 1
disease_ontology
DOID:0050449
OMIM mapping confirmed by DO. [SN].
pachyonychia congenita
A renal tubular transport disease that is has_material_basis_in mutations in genes that produce proteins involved in the kidneys' reabsorption of salt (sodium chloride or NaCl) from urine back into the bloodstream, thus impairing the kidneys' ability to reabsorb salt, leading to the loss of excess salt in the urine (salt wasting).
GARD:8547
MESH:D053579
NCI:C84730
OMIM:263800
SNOMEDCT_US_2020_03_01:3188003
UMLS_CUI:C0268450
HYPOMAGNESEMIA-HYPOKALEMIA, PRIMARY RENOTUBULAR, WITH HYPOCALCIURIA
disease_ontology
DOID:0050450
OMIM mapping confirmed by DO. [SN].
Gitelman syndrome
A heart conduction disease that is characterized by abnormal electrocardiogram (ECG) findings and an increased risk of sudden cardiac death.
GARD:1030
ICD10CM:I49.8
MESH:D053840
NCI:C142891
OMIM:PS601144
ORDO:130
SNOMEDCT_US_2020_03_01:418818005
UMLS_CUI:C1142166
UMLS_CUI:C1721096
Bangungut
Brugada type idiopathic ventricular fibrillation
Dream disease
Pokkuri death syndrome
SUNDS
sudden unexplained nocturnal death syndrome
disease_ontology
DOID:0050451
OMIM mapping confirmed by DO. [SN].
Brugada syndrome
A peroxisomal disease that is characterized by cortical atrophy, microcephaly, dysmorphic facies, muscular hypotonia and intellectual disability and has_material_basis_in mutation in the MVK gene that results in deficiency of mevalonate kinase and impaired cholesterol. biosynthesis.
GARD:3588
ICD10CM:M04.1
MESH:D054078
NCI:C84890
OMIM:610377
ORDO:29
SNOMEDCT_US_2020_03_01:124327008
SNOMEDCT_US_2020_03_01:234538002
UMLS_CUI:C0342731
UMLS_CUI:C0398691
UMLS_CUI:C1959626
Mevalonate Kinase Deficiency
disease_ontology
DOID:0050452
OMIM mapping confirmed by DO. [SN].
mevalonic aciduria
A congenital nervous system abnormality characterized by the absence of folds in the cerebral cortex and caused_by defective neuronal migration during the 12th to 24th weeks of gestation.
GARD:12291
ICD10CM:Q04.3
MESH:D054082
NCI:C103921
OMIM:300067
OMIM:300215
OMIM:607432
OMIM:611603
OMIM:614019
OMIM:615191
ORDO:102009
SNOMEDCT_US_2020_03_01:204036008
SNOMEDCT_US_2020_03_01:23024003
UMLS_CUI:C0266463
UMLS_CUI:C0266483
disease_ontology
DOID:0050453
Xref MGI.
OMIM mapping confirmed by DO. [SN].
lissencephaly
A congenital nervous system abnormality characterized by non proper migration of neurons during the early development of the fetal brain.
MESH:D054091
OMIM:300049
OMIM:608097
OMIM:608098
OMIM:612881
OMIM:615544
ORDO:98892
SNOMEDCT_US_2020_03_01:448227009
SNOMEDCT_US_2020_03_01:816068000
UMLS_CUI:C1848213
UMLS_CUI:C1868720
periventricular heterotopia
disease_ontology
DOID:0050454
Xref MGI.
OMIM mapping confirmed by DO. [SN].
periventricular nodular heterotopia
A primary bacterial infectious disease that results_in infection located_in skin or located_in subcutaneous tissue, has_material_basis_in Mycobacterium ulcerans, which could be transmitted_by insects. The bacterium produces a toxin, named mycolactone, which causes subcutaneous fat necrosis and inhibits an immune response. The infection has_symptom nodule, which is a painless, mobile swelling in the skin.
GARD:9520
ICD10CM:A31.1
MESH:D054312
NCI:C84604
SNOMEDCT_US_2020_03_01:186343005
UMLS_CUI:C0085568
Bairnsdale ulcer
Daintree ulcer
Mossman ulcer
Searl ulcer
Searle's ulcer
disease_ontology
DOID:0050456
Buruli ulcer disease
A male infertility disease characterized by male sterility, has_material_basis_in azospermia without abnormal sexual development.
GARD:8406
MESH:D054331
SNOMEDCT_US_2020_03_01:73465006
UMLS_CUI:C1384583
DEL CASTILLO SYNDROME
Germinal Cell Aplasia
disease_ontology
DOID:0050457
OMIM mapping confirmed by DO. [SN].
Sertoli cell-only syndrome
A myelodysplastic/myeloproliferative neoplasm that is characterized by the uncontrolled growth of monocytes.
GARD:9884
ICD10CM:C93.3
MESH:D054429
NCI:C9233
OMIM:607785
SNOMEDCT_US_2020_03_01:445227008
UMLS_CUI:C0349639
disease_ontology
DOID:0050458
OMIM mapping confirmed by DO. [SN].
juvenile myelomonocytic leukemia
A phosphorus metabolism disease characterized by hyperphosphatemia and abnormal deposits of phosphate and calcium in joints and soft tissues, results from abnomral phosphorus metabolism and has_material_basis_in mutations in the FGF23, GALNT3 or KL gene.
MESH:D054559
NCI:C113750
SNOMEDCT_US_2020_03_01:20165001
UMLS_CUI:C0085681
disease_ontology
DOID:0050459
hyperphosphatemia
A chromosomal deletion syndrome that is characterized by distinct craniofacial features, hypotonia and intellectual disability and has_material_basis_in a microdeletion of the short arm of chromosome 4.
DOID:6684
GARD:7896
ICD10CM:Q93.3
MESH:D054877
NCI:C35528
OMIM:194190
ORDO:280
SNOMEDCT_US_2020_03_01:17122004
UMLS_CUI:C0796117
UMLS_CUI:C1956097
4p deletion syndrome
PITT SYNDROME
Pitt-Rogers-Danks Syndrome
chromosome 4p16.3 deletion syndrome
disease_ontology
DOID:0050460
OMIM mapping confirmed by DO. [LS].
Wolf-Hirschhorn syndrome
A lysosomal storage disease that is characterized by delayed speech at 2-3 years of age, has_material_basis_in mutations in the AGA gene that result in the absence or shortage of the aspartylglucosaminidase enzyme in lysosomes, preventing the normal breakdown of glycoproteins.
GARD:5854
ICD10CM:E77.1
MESH:D054880
NCI:C61273
OMIM:208400
SNOMEDCT_US_2020_03_01:54954004
UMLS_CUI:C0268225
aspartylglucosaminidase deficiency
aspartylglycosaminuria
glycosylasparaginase deficiency
disease_ontology
DOID:0050461
OMIM mapping confirmed by DO. [SN].
aspartylglucosaminuria
MESH:D054880
A syndrome that is characterized at birth or prenatally by malformations and deformities affecting the majority of the skeleton and other areas of the body with autosomal recessive inheritance of the FGFR2 gene.
OMIM:201750
OMIM:207410
SNOMEDCT_US_2020_03_01:62964007
trapezoidocephaly-synostosis syndrome
disease_ontology
DOID:0050462
OMIM mapping confirmed by DO. [SN].
Antley-Bixler syndrome
MESH:D054882
An osteochondrodysplasia that has_material_basis_in a mutation in chromosome 17 which results_in bowing in the located_in tibia or located_in femur.
GARD:10027
MESH:D055036
NCI:C120205
NCI:C84609
OMIM:114290
ORDO:140
SNOMEDCT_US_2020_03_01:74928006
UMLS_CUI:C1861922
UMLS_CUI:C1861923
Acampomelic Campomelic Dysplasia
disease_ontology
DOID:0050463
OMIM mapping confirmed by DO. [SN].
campomelic dysplasia
A lipid storage disease that is characterized by abnormalities in swallowing, cognition, joint function, and central nervous system due to a deficiency in the enzyme ceramidase that results in sphingolipids deposition.
GARD:6426
MESH:D055577
NCI:C84710
OMIM:228000
SNOMEDCT_US_2020_03_01:79935000
UMLS_CUI:C0268255
Farber disease
N-laurylsphingosine deacylase deficiency
acid ceramidase deficiency
disease_ontology
DOID:0050464
OMIM mapping confirmed by DO. [SN].
Farber lipogranulomatosis
A Lynch syndrome that is characterized by a propensity to develop cancers of the gastrointestinal tract, genitourinary tract, and skin that has_material_basis_in mutations in DNA mismatch repair genes.
GARD:6821
MESH:D055653
NCI:C84905
OMIM:158320
SNOMEDCT_US_2020_03_01:403824007
UMLS_CUI:C1321489
disease_ontology
DOID:0050465
OMIM mapping confirmed by DO. [SN].
Muir-Torre syndrome
A syndrome that is characterized by increased risk of aortic aneurysm and dissection, elongated limbs, hypertelorism, bifid uvula and easy skin bruising due to mutations in TGFB3 that results in connective tissue defects.
GARD:10788
MESH:D055947
NCI:C75006
ORDO:60030
SNOMEDCT_US_2020_03_01:446263001
UMLS_CUI:C1836635
UMLS_CUI:C2697932
disease_ontology
DOID:0050466
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Loeys-Dietz syndrome
A skin disease that is characterized by areas of sharply demarcated, brown hyperkeratosis and has_material_basis_in mutations in genes encoding for connexin channels proteins in the epidermis.
MESH:D056266
NCI:C84696
OMIM:PS133200
ORDO:317
SNOMEDCT_US_2020_03_01:70041004
UMLS_CUI:C0265961
UMLS_CUI:C1851480
Erythrokeratodermia Figurata Variabilis
Greither Disease
disease_ontology
DOID:0050467
OMIM mapping confirmed by DO. [SN].
erythrokeratodermia variabilis
MESH:D056266
A syndrome that is characterized by an accumulation of protein-rich fluid (lymph) in the soft layers of tissue under the skin resulting in pleural effusions, lymphedema (due to lymphatic hypoplasia) and yellow dystrophic nails hat lack a cuticle, grow slowly, and are loose or detached.
GARD:184
ICD10CM:L60.5
MESH:D056684
NCI:C85238
OMIM:153300
SNOMEDCT_US_2020_03_01:400211001
UMLS_CUI:C0221348
disease_ontology
DOID:0050468
OMIM mapping confirmed by DO. [SN].
yellow nail syndrome
A RASopathy characterized by craniofacial dysmorphology, cardiac defects, mild mental retardation, and high birth weight followed by a failure to thrive and developmental delays.
GARD:1550
MESH:D056685
NCI:C84652
OMIM:218040
SNOMEDCT_US_2020_03_01:205803001
UMLS_CUI:C0587248
FCS SYNDROME
Faciocutaneoskeletal Syndrome
disease_ontology
DOID:0050469
OMIM mapping confirmed by DO. [SN].
Costello syndrome
A syndrome that is characterized by protuberant and low-set ears, flaring nostrils, thick lips, enlarged secondary sex organs and overwhelming insulin resistance and has_material_basis_in mutation within the INSR gene causing abnormalities in the insulin receptor.
MESH:D056731
NCI:C131000
NCI:C84676
OMIM:246200
ORDO:508
SNOMEDCT_US_2020_03_01:111307005
SNOMEDCT_US_2020_03_01:33559001
UMLS_CUI:C0265344
UMLS_CUI:C0271695
Leprechaunism
disease_ontology
DOID:0050470
OMIM mapping confirmed by DO. [SN].
Donohue syndrome
A syndrome characterized by myxomas, spotty pigmentation of the skin and endocrine overactivity.
GARD:1119
MESH:D056733
NCI:C4705
OMIM:160980
OMIM:605244
OMIM:608837
ORDO:1359
SNOMEDCT_US_2020_03_01:733491005
UMLS_CUI:C0406810
UMLS_CUI:C1854540
UMLS_CUI:C2607929
Carney Complex, Type 1
Carney Complex, Type 2
Carney Syndrome
Carney complex variant
LAMB Syndrome
NAME Syndrome
disease_ontology
DOID:0050471
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Carney complex
A hair disease that is characterized by short, easily broken hair that results in alopecia and has_material_basis_in mutations in genes for type II hair cortex keratins.
GARD:93
ICD10CM:Q84.1
MESH:D056734
NCI:C84894
OMIM:158000
SNOMEDCT_US_2020_03_01:69488000
UMLS_CUI:C0546966
disease_ontology
DOID:0050472
OMIM mapping confirmed by DO. [SN].
monilethrix
A syndrome that is characterized by multiorgan dysfunction. The key features are childhood obesity, blindness due to congenital retinal dystrophy, and sensorineural hearing loss with autosomal recessive inheritance and has_material_basis_in mutations in the ALMS1 gene.
MESH:D056769
NCI:C84549
OMIM:203800
SNOMEDCT_US_2020_03_01:63702009
UMLS_CUI:C0268425
disease_ontology
DOID:0050473
OMIM mapping confirmed by DO. [SN].
Alstrom syndrome
MESH:D056769
A skin disease that is characterized by chronic skin inflammation, trichorrhexis invaginata, atopic dermatitis and has_material_basis_in mutations in the SPINK5 gene resulting in reduced capacity to inhibit serine proteases expressed in the skin.
GARD:7182
MESH:D056770
NCI:C84922
OMIM:256500
ORDO:634
SNOMEDCT_US_2020_03_01:312514006
UMLS_CUI:C0265962
disease_ontology
DOID:0050474
OMIM mapping confirmed by DO. [SN].
Netherton syndrome
A syndrome characterized by short stature, bachycephaly and other facial abnormalities, brachydactyly, joint stiffness and distinctive ocular abnormalities.
GARD:4936
MESH:D056846
NCI:C85226
OMIM:277600
OMIM:608328
OMIM:613195
OMIM:614819
ORDO:3449
SNOMEDCT_US_2020_03_01:205801004
UMLS_CUI:C0265313
UMLS_CUI:C1869114
UMLS_CUI:C1869115
GEMSS syndrome
Marchesani-Weill Syndrome
Mesodermal Dysmorphodystrophy, Congenital
Spherophakia Brachymorphia Syndrome
congenital mesodermal dystrophy
disease_ontology
DOID:0050475
Xref MGI.
OMIM mapping confirmed by DO. [LS].
Weill-Marchesani syndrome
A lipid metabolism disorder that has_material_basis_in X-linked inheritance of the tafazzin gene and is characterized by decreased production of an enzyme required to produce cardiolipin.
GARD:5890
ICD10CM:E78.71
MESH:D056889
NCI:C84585
OMIM:302060
SNOMEDCT_US_2020_03_01:297231002
UMLS_CUI:C0574083
3-methylglutaconicaciduria type 2
3-methylglutaconicaciduria type II
MGA Type 2
MGA type II
disease_ontology
DOID:0050476
OMIM mapping confirmed by DO. [SN].
Barth syndrome
MESH:D056889
A renal tubular transport disease that is characterized by hypertension and hypokalemia caused by dysregulation of epithelial sodium channels causing over expression of the channel.
GARD:7381
MESH:D056929
NCI:C84827
OMIM:177200
SNOMEDCT_US_2020_03_01:707749005
UMLS_CUI:C0221043
Liddle's syndrome
Pseudoaldosteronism
disease_ontology
DOID:0050477
OMIM mapping confirmed by DO. [SN].
Liddle syndrome
A typhus that has_material_basis_in Rickettsia typhi or has_material_basis_in Rickettsia felis, which are transmitted by fleas (Xenopsylla cheopis). The infection has symptom headache, has symptom fever, has symptom chills, has symptom myalgia, has symptom nausea, has symptom vomiting, has symptom cough and has symptom rash.
DOID:0050028
DOID:0050029
DOID:0050030
DOID:0050057
DOID:0050058
Rat-Flea Typhus
Rickettsia felis spotted fever
Urban Typhus of Malaya
cat flea rickettsiosis
fleaborne typhus
murine typhus
toulon typhus
urban typhus
disease_ontology
Shop typhus
DOID:0050481
endemic typhus
A primary bacterial infectious disease that results_in infection, has_material_basis_in Neorickettsia sennetsu, which is transmitted_by ingestion of raw or under-cooked gray mullet fish infected with the trematodes. The infection has_symptom fever, has_symptom malaise, has_symptom anorexia, has_symptom lymphadenopathy, has_symptom hepatosplenomegaly, has_symptom fatigue, has_symptom chills, has_symptom headache, has_symptom backache and has_symptom myalgia.
GARD:120
Sennetsu ehrlichiosis
disease_ontology
DOID:0050485
sennetsu fever
A skin disease that is characterized by a rash that results from a variety of causes including bacteria, viruses, toxins, drugs and autoimmune disorders.
ICD10CM:R21
ICD9CM:782.1
MESH:D005076
NCI:C111884
SNOMEDCT_US_2020_03_01:112625008
UMLS_CUI:C0015230
Rash
exanthema
disease_ontology
DOID:0050486
exanthem
A viral infectious disease that results_in infection in infants and children, located_in skin, has_material_basis_in Human herpesvirus 6 or has_material_basis_in Human herpesvirus 7 and has_symptom sudden high fever, and has_symptom red rash that occurs first on the trunk then spreading to legs and neck.
ICD10CM:B08.2
ICD9CM:058.1
MESH:D005077
SNOMEDCT_US_2020_03_01:54385001
UMLS_CUI:C0015231
Roseola Infantum
Sixth Disease
disease_ontology
DOID:0050495
exanthema subitum
A T-cell leukemia that results_in abnormal increase of lymphocytes, derives_from T-cells, has_material_basis_in Human T-lymphotropic virus 1, which is transmitted_by sexual contact, transmitted_by contaminated needles used by intravenous-drug users, and transmitted_by breast feeding. The infection results_in_formation_of skin lesions.
GARD:13103
ICD10CM:C91.5
MESH:D015459
NCI:C3184
SNOMEDCT_US_2020_03_01:77430005
UMLS_CUI:C0023493
Adult T-cell leukemia/lymphoma
disease_ontology
DOID:0050523
adult T-cell leukemia
A diabetes mellitus that has_material_basis_in autosomal dominant inheritance of mutations in the MODY genes impacting beta-cell function, typically occurring before 25 years of age and caused by primary insulin secretion defects.
GARD:3697
ICD10CM:E11.8
KEGG:04950
OMIM:606391
ORDO:552
MODY
Mason-type diabetes
disease_ontology
DOID:0050524
Xref MGI.
OMIM mapping confirmed by DO. [SN].
maturity-onset diabetes of the young
A syndrome that is characterized by brittle hair, short stature, decreased fertility and cognitive impairment without photosensitivity has_material_basis_in mutations in the TTDN1 gene.
OMIM:234050
AMISH BRITTLE HAIR BRAIN SYNDROME
BIDS syndrome
HAIR-BRAIN SYNDROME
TTD4
disease_ontology
DOID:0050528
OMIM mapping confirmed by DO. [SN].
nonphotosensitive trichothiodystrophy 4
A spinal muscular atrophy that is characterized by progressive muscular weakness and motor disability that typically presents in the third decade of life and has_material_basis_in mutations in the SMN1 or SMN2 genes that are required for the survival of motor neurons.
ICD10CM:G12.1
MESH:C563948
OMIM:271150
ORDO:83420
UMLS_CUI:C1838230
SMA4
SPINAL MUSCULAR ATROPHY, ADULT FORM
SPINAL MUSCULAR ATROPHY, TYPE IV
spinal muscular atrophy 4
disease_ontology
DOID:0050529
OMIM mapping confirmed by DO. [SN].
adult spinal muscular atrophy
A hereditary night blindness that is characterized by hemeralopia with a moderate loss of visual acuity and caused by defective photoreceptor-to-bipolar cell signaling with common ERG findings of reduced or absent b-waves and generally normal a-waves.
ICD10CM:H53.63
ICD9CM:368.61
MESH:C537743
OMIM:PS310500
ORDO:215
SNOMEDCT_US_2020_03_01:193687000
UMLS_CUI:C1306122
congenital essential nyctalopia
disease_ontology
DOID:0050534
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital stationary night blindness
A retinal vascular disease characterized by the prevention of blood vessel formation at the edges of the retina and the hemorrhage of the blood vessels in the retina.
GARD:1613
ICD10CM:H35.00
ICD9CM:362.10
OMIM:PS133780
ORDO:891
SNOMEDCT_US_2020_03_01:193355009
UMLS_CUI:C0004608
FEVR
familial exudative vitreoretinopathy
disease_ontology
DOID:0050535
Xref MGI.
OMIM mapping confirmed by DO. [SN].
exudative vitreoretinopathy
A cataract that is characterized by a distinctive discoid lens opacity situated posteriorly and adjacent to the posterior capsule.
CATARACT, POSTERIOR POLAR
disease_ontology
DOID:0050537
OMIM mapping confirmed by DO. [SN].
posterior polar cataract
A Charcot-Marie-Tooth disease characterized by demyelination of the peripheral nerve axons.
GARD:12433
hereditary motor and sensory neuropathy type 1
disease_ontology
DOID:0050538
OMIM mapping confirmed by DO. [SN].
Charcot-Marie-Tooth disease type 1
A Charcot-Marie-Tooth disease that is characterized by motor and sensory peripheral neuropathies caused by demyelination.
OMIM:145900
DEJERINE-SOTTAS NEUROPATHY
DEJERINE-SOTTAS SYNDROME
disease_ontology
DOID:0050540
OMIM mapping confirmed by DO. [SN].
Charcot-Marie-Tooth disease type 3
An amino acid metabolic disorder that involves an excess of the amino acid methionine, in the blood. This condition can occur when methionine is not broken down properly in the body.
disease_ontology
DOID:0050544
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hypermethioninemia
A physical disorder characterized by the abnormal distribution of the major visceral organs within the chest and abdomen.
GARD:10875
OMIM:306955
OMIM:605376
OMIM:606325
OMIM:613751
OMIM:614779
ORDO:450
heterotaxia
situs ambiguus
disease_ontology
DOID:0050545
Xref MGI.
OMIM mapping confirmed by DO. [SN].
visceral heterotaxy
An adrenal gland disease that is characterized by cortisol deficiency, hypoaldosteronism and excessive or insufficient sex hormones, has_material_basis_in the mutation in the gene for 21-hydroxylase, 11beta-hydroxylase, 3beta-hydroxysteroid, 17alpha-hydroxylase or 20,22-desmolase.
OMIM:613743
ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE
P450scc DEFICIENCY
disease_ontology
DOID:0050546
OMIM mapping confirmed by DO. [SN].
congenital adrenal insufficiency
A thyroid gland medullary carcinoma that has_material_basis_in autosomal dominant inheritance.
OMIM:155240
THYROID CARCINOMA, FAMILIAL MEDULLARY
disease_ontology
DOID:0050547
OMIM mapping confirmed by DO. [SN].
familial medullary thyroid carcinoma
A neuropathy characterized by congenital insensitivity to pain resulting in ulceration to the fingers, tongue, lips, and other distal appendages.
OMIM:PS162400
familial dysautonomia, type II
hereditary sensory and autonomic neuropathy
disease_ontology
DOID:0050548
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hereditary sensory neuropathy
A syndrome that is characterized by childhood onset of joint stiffness and severe contractures of the hands and feet, erythematous skin lesions with subsequent development of severe lipodystrophy that has_material_basis_in homozygous or compound heterozygous mutation in PSMB8 on chromosome 6p21.32.
GARD:10988
OMIM:256040
ORDO:324999
JOINT CONTRACTURES, MUSCULAR ATROPHY, MICROCYTIC ANEMIA, AND PANNICULITIS-INDUCED LIPODYSTROPHY
disease_ontology
DOID:0050553
JMP syndrome
A sideroblastic anemia that is characterized by decreased production of hemoglobin and ataxia and has_material_basis_in the mutation in the ABCB7 gene.
DOID:0060064
OMIM:301310
Anemia sideroblastic and spinocerebellar ataxia
X-linked sideroblastic anaemia and ataxia
X-linked sideroblastic anaemia with ataxia
X-linked sideroblastic anemia and ataxia
disease_ontology
DOID:0050554
OMIM mapping confirmed by DO. [SN].
X-linked sideroblastic anemia with ataxia
A muscular dystrophy that is characterized by diminished muscle tone (hypotonia), progressive muscle weakness and degeneration (atrophy), abnormally fixed joints, spinal rigidity, and delays in reaching motor milestones such as sitting or standing unassisted.
GARD:9138
ICD9CM:359.0
OMIM:254100
ORDO:97242
SNOMEDCT_US_2020_03_01:193221009
UMLS_CUI:C2937300
disease_ontology
DOID:0050557
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital muscular dystrophy
A congenital muscular dystrophy that is characterized by muscle weakness and respiratory depression and has_material_basis_in mutation in the COL6A1, COL6A2 and COL6A3 that produce components of type VI collagen.
GARD:4769
OMIM:254090
ULLRICH DISEASE
Ullrich scleroatonic muscular dystrophy
disease_ontology
DOID:0050558
OMIM mapping confirmed by DO. [SN].
Ullrich congenital muscular dystrophy
A congenital muscular dystrophy-dystroglycanopathy type A that is characterized by muscle weakness, failure to thrive, severe intellectual and developmental disability, impaired vision and cardiac abnormalities and has_material_basis_in mutation in the FKTN gene that produces the fukutin protein.
GARD:6475
OMIM:253800
ORDO:272
disease_ontology
DOID:0050559
OMIM mapping confirmed by DO. [SN].
Fukuyama congenital muscular dystrophy
A congenital muscular dystrophy that is characterized by hypotonia, seizures, severe intellectual and developmental disability, eye abnormalities and early death and has_material_basis_in mutations in multiple genes including POMT1, POMT2, ISPD, FKTN, FKRP, and LARGE1.
GARD:2599
MESH:D058494
HARD syndrome
cerebroocular dysplasia-muscular dystrophy syndrome
disease_ontology
DOID:0050560
OMIM mapping confirmed by DO. [SN].
Walker-Warburg syndrome
A childhood electroclinical syndrome that is characterized by frequent seizures and intellectual disability that present in early childhood.
GARD:9912
OMIM:606369
ORDO:2382
Lennox syndrome
disease_ontology
DOID:0050561
Lennox-Gastaut syndrome
An auditory system disease that is associated with permanent hearing loss caused by damage to structures in the inner ear and/or the middle ear, which is not associated with other signs and symptoms.
nonsyndromic hearing loss
nonsyndromic hereditary hearing loss
disease_ontology
DOID:0050563
nonsyndromic deafness
A nonsyndromic deafness characterized by an X-linked inheritance mode.
ICD10CM:H90.3
OMIM:PS304500
ORDO:90625
X-linked deafness
disease_ontology
DOID:0050566
OMIM mapping confirmed by DO. [SN].
X-linked nonsyndromic deafness
A physical disorder that is characterized by cleft lip and/or cleft palate that result in feeding, speech and hearing problems caused by failures during development.
OMIM:PS119530
disease_ontology
DOID:0050567
Xref MGI.
OMIM mapping confirmed by DO. [SN].
orofacial cleft
A dysostosis that results_in abnormal development located_in vertebrae or located_in ribs. The bones of the spine do not develop properly, which causes them to be misshapen and abnormally joined together.
GARD:12174
GARD:6798
OMIM:122600
OMIM:277300
OMIM:608681
OMIM:609813
OMIM:613686
ORDO:1797
ORDO:2311
Jarcho-Levin syndrome
spondylocostal dysostosis, autosomal recessive 3
spondylothoracic dysostosis
spondylothoracic dysplasia
disease_ontology
DOID:0050568
Xref MGI.
OMIM mapping confirmed by DO. [SN].
spondylocostal dysostosis
A syndrome characterized by intrauterine growth retardation and postnatal dwarfism with microcephaly and intellectual disability.
GARD:8562
ICD10CM:Q87.1
OMIM:PS210600
ORDO:808
Harper's syndrome
Virchow-Seckel dwarfism
bird-headed dwarfism
microcephalic primordial dwarfism
disease_ontology
DOID:0050569
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Seckel syndrome
A retinal degeneration that characterized by progressive deterioration of the cone and rod photoreceptor cells.
GARD:10790
ICD10CM:H35.5
ORDO:1872
cone-rod retinal dystrophy
disease_ontology
DOID:0050572
Xref MGI.
OMIM mapping confirmed by DO. [SN].
cone-rod dystrophy
An amino acid metabolic disorder that is an autosomal recessive neurometabolic disorder characterized by the significant elevation of urinary levels of hydroxyglutaric acid causing progressive brain damage.
GARD:10761
disease_ontology
DOID:0050573
2-hydroxyglutaric aciduria
An 2-hydroxyglutaric aciduria that involves damage to cerebellum affecting movement coordination resulting in problems with balance and muscle coordination (ataxia).
GARD:10472
OMIM:236792
ORDO:79314
L-2-HYDROXYGLUTARIC ACIDEMIA
disease_ontology
DOID:0050574
L-2-hydroxyglutaric aciduria
An 2-hydroxyglutaric aciduria that involves developmental delay, seizures, weak muscle tone (hypotonia), and abnormalities in the largest part of the brain (the cerebrum), which controls many important functions such as muscle movement, speech, vision, thinking, emotion, and memory.
GARD:5661
OMIM:PS600721
disease_ontology
DOID:0050575
D-2-hydroxyglutaric aciduria
A syndrome that is characterized by characterized by sagittal craniosynostosis and facial, ectodermal, and skeletal anomalies.
OMIM:PS218330
Levin syndrome
Sensenbrenner syndrome
disease_ontology
DOID:0050577
OMIM mapping confirmed by DO. [SN].
cranioectodermal dysplasia
A macular degeneration that is characterized by a central cone dysfunction leading to a loss of vision with a normal fundus and normal fluorescein angiography findings.
OMIM:613587
disease_ontology
DOID:0050578
OMIM mapping confirmed by DO. [SN].
occult macular dystrophy
A dysostosis characterized by short fingers and toes.
GARD:11913
ORDO:294937
disease_ontology
DOID:0050581
Xref MGI.
OMIM mapping confirmed by DO. [SN].
brachydactyly
MESH:D059327
An impulse control disorder that involves the uncontrollable plucking of ones hair.
GARD:7803
MESH:D014256
OMIM:613229
disease_ontology
DOID:0050587
OMIM mapping confirmed by DO. [SN].
trichotillomania
A congenital muscular dystrophy characterized by muscle weakness, cognitive impairment and brain abnormalities and has_material_basis_in mutation to the POMT1 gene that encodes O-mannosyltransferase.
ICD10CM:G71.2
OMIM:613151
OMIM:613152
OMIM:613155
OMIM:613156
OMIM:615351
OMIM:616094
OMIM:PS613155
ORDO:370953
CMD due to dystroglycanopathy
disease_ontology
DOID:0050588
Xref MGI.
muscular dystrophy-dystroglycanopathy
An intestinal disease characterized by inflammation located in all parts of digestive tract.
EFO:0003767
KEGG:05321
MESH:D015212
NCI:C3138
OMIM:PS266600
SNOMEDCT_US_2020_03_01:155759008
UMLS_CUI:C0021390
disease_ontology
DOID:0050589
Xref MGI.
OMIM mapping confirmed by DO. [SN].
inflammatory bowel disease
A neutropenia characterized by a maturation arrest of granulopoiesis at the level or promyelocytes and early onset of severe bacterial infections.
GARD:13592
ICD10CM:D70
OMIM:PS202700
ORDO:42738
disease_ontology
DOID:0050590
Xref MGI.
OMIM mapping confirmed by DO. [SN].
severe congenital neutropenia
A tooth disease characterized by failure to develop on or more missing teeth.
ICD10CM:K00.0
ICD9CM:520.0
MESH:D000848
OMIM:106600
OMIM:150400
OMIM:313500
OMIM:602639
OMIM:604625
OMIM:610926
ORDO:2227
ORDO:99798
SNOMEDCT_US_2020_03_01:234951001
UMLS_CUI:C0399352
familial tooth agenesis
hypodontia
oligodontia
selective tooth agenesis
disease_ontology
DOID:0050591
Xref MGI.
tooth agenesis
A bone development disease characterized by skeletal abnormalities and resulting in difficulty in breathing caused by mutations that result in ciliopathy.
ICD10CM:Q77.2
OMIM:PS208500
ORDO:474
Jeune syndrome
short-rib thoracic dysplasia with or without polydactyly
thoracic pelvic phalangeal dystrophy
disease_ontology
DOID:0050592
OMIM mapping confirmed by DO. [SN].
asphyxiating thoracic dystrophy
A parasitic helminthiasis infectious disease that has_material_basis_in Taenia solium or has_material_basis_in Taenia saginata, which are transmitted by ingestion of undercooked contaminated meat.
DOID:10076
ICD10CM:B68.1
ICD9CM:123.2
SNOMEDCT_US_2020_03_01:69163003
UMLS_CUI:C0152073
disease_ontology
Beef tapeworm infection
Infection by Taeniarhynchus saginatus
Taenia saginata infectious disease
DOID:0050596
taeniasis
A schistosomiasis that involves parasitic infection of the intestine caused by Schistosoma mansoni, Schistosoma intercalatum or Schistosomiasis japonicum. The symptoms include fever, cough, abdominal pain, diarrhea, hepatosplenomegaly, colonic polyposis with bloody diarrhea and eosinophilia.
DOID:13692
DOID:13721
DOID:3468
ICD10CM:B65.1
ICD10CM:B65.2
ICD9CM:120.1
ICD9CM:120.2
MESH:D012554
MESH:D012555
NCI:C35001
NCI:C35002
NCI:C35364
OMIM:181460
ORDO:1247
SNOMEDCT_US_2020_03_01:187114003
SNOMEDCT_US_2020_03_01:52179003
SNOMEDCT_US_2020_03_01:750009
UMLS_CUI:C0036329
UMLS_CUI:C0036330
UMLS_CUI:C0276932
Katayama fever
Schistosoma japonicum infection
Schistosoma mansoni infectious disease
schistosomiasis japonica
disease_ontology
DOID:0050597
Xref MGI.
intestinal schistosomiasis
A tuberculosis that occurs at body sites other than the lung.
disease_ontology
DOID:0050598
extrapulmonary tuberculosis
An extrapulmonary tuberculosis that is located_in gastrointestinal tract, located_in peritoneum, located_in omentum, located_in mesentery, located_in liver, located_in spleen or located_in pancreas.
disease_ontology
DOID:0050599
abdominal tuberculosis
A syndrome that is characterized by albinism, black lock, cell migration disorder of the neurocytes of the gut and sensorineural deafness and has_material_basis_in a mutation in the endothelin B receptor gene (EDNRB).
OMIM:600501
ABCDS
albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness
disease_ontology
DOID:0050600
OMIM mapping confirmed by DO. [SN].
ABCD syndrome
A syndrome that is characterized by light pigmentation with excessive freckling, sparse hair involving the scalp and axilla, lacrimal duct stenosis or atresia, onychodysplasia, hypodontia or early loss of permanent teeth, athelia or hypoplastic nipples, and breast hypoplasia, has_material_basis_in a mutation in TP63.
GARD:384
OMIM:103285
acro-dermato-ungual-lacrimal-tooth syndrome
disease_ontology
DOID:0050601
OMIM mapping confirmed by DO. [SN].
ADULT syndrome
A syndrome characterized by achalasia, adrenal insufficiency and alacrima and has_material_basis_in mutations in the AAAS gene that encodes ALADIN within the nuclear envelope and results in dysfunction of the autonomic nervous system.
GARD:457
OMIM:231550
AAAS
Achalasia-Addisonianism-Alacrimia syndrome
Allgrove Syndrome
disease_ontology
DOID:0050602
OMIM mapping confirmed by DO. [SN].
triple-A syndrome
An osteochondrodysplasia characterized by a lack of formation of the distal extremities has_material_basis_in mutation in the LMBR1 gene.
GARD:376
OMIM:200500
Acheiropodia
Horn-Kolb Syndrome
disease_ontology
DOID:0050603
OMIM mapping confirmed by DO. [SN].
acheiropody
A metal metabolism disorder characterized by dermatitis around bodily openings and the tips of fingers and toes, alopecia and diarrhea and has_material_basis_in mutation in the SLC39A4 gene that encodes a zinc uptake protein and results in zinc deficiency.
GARD:5723
OMIM:201100
disease_ontology
DOID:0050605
acrodermatitis enteropathica
A keratosis that has_material_basis_in mutations in the ATP2A2 gene.
OMIM:101900
Acrokeratosis verruciformis of Hopf
Hopf disease
disease_ontology
DOID:0050606
OMIM mapping confirmed by DO. [SN].
acrokeratosis verruciformis
An organ system cancer located_in the respiratory system that is characterized by uncontrolled cellular proliferation in the respiratory tract.
disease_ontology
DOID:0050615
respiratory system cancer
A respiratory system cancer that is located_in the paranasal sinuses.
DOID:1354
DOID:2442
DOID:2765
DOID:2767
DOID:4689
MESH:D010255
NCI:C6014
NCI:C6017
NCI:C6018
NCI:C6019
NCI:C8193
UMLS_CUI:C0280334
UMLS_CUI:C0854995
UMLS_CUI:C1335336
UMLS_CUI:C1335337
UMLS_CUI:C1335340
Epidermoid carcinoma of the paranasal sinus
Mucoepidermoid carcinoma of Accessory sinus
adenoid cystic carcinoma of Accessory sinus
paranasal sinus adenocarcinoma
paranasal sinus adenoid cystic carcinoma
paranasal sinus mucoepidermoid carcinoma
paranasal sinus squamous cell carcinoma
disease_ontology
adenoid cystic carcinoma of paranasal sinus
squamous cell carcinoma of paranasal sinus
DOID:0050619
paranasal sinus cancer
An organ system benign neoplasm that is located in the respiratory system which extends from the nasal sinuses to the diaphragm.
disease_ontology
DOID:0050621
respiratory system benign neoplasm
An organ system benign neoplasm that is located_in reproductive system organs.
disease_ontology
DOID:0050622
reproductive organ benign neoplasm
A urinary system benign neoplasm located_in the bladder including papillomas, leiomyomas, fibromas, hemangiomas, neurofibromas and lipomas.
disease_ontology
DOID:0050623
bladder benign neoplasm
An organ system benign neoplasm located_in gastrointestinal tract organs.
disease_ontology
DOID:0050624
gastrointestinal system benign neoplasm
A hepatobiliary benign neoplasm located_in the biliary tract.
DOID:4609
NCI:C4441
SNOMEDCT_US_2020_03_01:126855001
UMLS_CUI:C0345913
extrahepatic bile duct neoplasm
neoplasm of extrahepatic bile ducts
tumor of the extrahepatic bile duct
disease_ontology
DOID:0050625
biliary tract benign neoplasm
A syndrome that is a genetically heterogeneous encephalopathy characterized in its most severe form by cerebral atrophy, leukodystrophy, intracranial calcifications, chronic cerebrospinal fluid lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infections.
GARD:575
ICD10CM:G31.8
OMIM:225750
OMIM:610181
OMIM:610329
OMIM:610333
OMIM:612952
OMIM:615010
OMIM:615846
ORDO:51
Cree encephalitis
disease_ontology
DOID:0050629
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Aicardi-Goutieres syndrome
An eye disease characterized by fundus hypopigmentation, decreased visual acuity, nystagmus, astigmatism, myopia and defective darkness adaptation and has_material_basis_in mutation in the CACNA1F gene.
GARD:10574
MESH:C562664
OMIM:300600
FORSIUS-ERIKSSON TYPE OCULAR ALBINISM
Forsius-Eriksson syndrome
disease_ontology
DOID:0050630
Aland Island eye disease
A syndrome that has_material_basis_in mutation at is in the gene encoding the monocarboxylate transporter-8 which alters the structure and function of the SLC16A2 protein which is then unable to transport the thyroid triiodothyronine (T3) hormone into nerve cells of the developing brain affecting normal brain development resulting in intellectual disability and problems with movement.
GARD:5617
MESH:C537047
OMIM:300523
ORDO:59
AHDS
ALLAN-HERNDON SYNDROME
disease_ontology
DOID:0050631
OMIM mapping confirmed by DO. [SN].
Allan-Herndon-Dudley syndrome
A syndrome characterized by abnormal pigmentation of the skin, hair and eyes.
GARD:10958
ICD10CM:E70.3
MESH:D016115
OMIM:PS203100
ORDO:55
disease_ontology
DOID:0050632
Xref MGI.
OMIM mapping confirmed by DO. [SN].
oculocutaneous albinism
An eye disease that is characterized by reduced pigmentation of the iris and the resulting impairment of visual acuity without significantly affecting the color of skin or hair and has_material_basis in mutation in the GPR143 gene that encodes segments of the melanosomes that stores melanin.
MESH:D016117
OMIM:300500
disease_ontology
DOID:0050633
ocular albinism
An amyloidosis characterized by pruritus, skin scratching and by deposits of amyloid in the dermis.
GARD:132
OMIM:105250
OMIM:613955
ORDO:137807
PCA
familial primary localized cutaneous amyloidosis
disease_ontology
DOID:0050639
Xref MGI.
OMIM mapping confirmed by DO. [SN].
primary cutaneous amyloidosis
A vascular disease that is characterized by generalized calcification of the arterial internal elastic lamina, leading to rupture of the lamina and occlusive changes in the tunica intima with stenosis and decreased elasticity of the vessel wall.
GARD:8380
MESH:C537440
OMIM:208000
OMIM:614473
ORDO:51608
generalized arterial calcification of infancy
idiopathic infantile arterial calcification
infantile arteriosclerosis
disease_ontology
DOID:0050644
Xref MGI.
OMIM mapping confirmed by DO. [SN].
arterial calcification of infancy
A connective tissue disease that is characterized by elongation and generalized tortuosity of the major arteries including the aorta.
GARD:774
MESH:C565942
OMIM:208050
disease_ontology
DOID:0050645
OMIM mapping confirmed by DO. [SN].
arterial tortuosity syndrome
A muscle tissue disease characterized by congenital joint contractures of hand and feet.
GARD:786
OMIM:108120
OMIM:108145
OMIM:108200
OMIM:114300
OMIM:121050
OMIM:121070
OMIM:158300
OMIM:187370
OMIM:193700
OMIM:601680
OMIM:609128
OMIM:614335
OMIM:615065
ORDO:1147
ORDO:97120
Arthrogryposis Multiplex Congenita
Freeman-Sheldon syndrome
disease_ontology
DOID:0050646
Xref MGI.
OMIM mapping confirmed by DO. [SN].
distal arthrogryposis
An X-linked disease that is characterized by profound congenital sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk of infection and has_material_basis_in mutations of the PRPS1 gene.
GARD:8756
MESH:C535388
OMIM:301835
ORDO:1187
SNOMEDCT_US_2020_03_01:702441001
UMLS_CUI:C0796028
ARTS
Lethal ataxia with deafness and optic atrophy
MRXS18
MRXSARTS
fatal X-linked ataxia with deafness and loss of vision
syndromic X-linked mental retardation 18
syndromic X-linked mental retardation Arts type
disease_ontology
DOID:0050647
OMIM mapping confirmed by DO. [SN].
Arts syndrome
An osteochondrodysplasia that is characterized by specific patterns of aplasia/hypoplasia of humeri, femora, spine in newborns.
OMIM:108720
OMIM:108721
OMIM:256050
disease_ontology
DOID:0050648
OMIM mapping confirmed by DO. [SN].
atelosteogenesis
A metal metabolism disorder that is characterized by transferrin deficiency, microcytic anemia, and iron loading, and has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the structural gene for transferrin on chromosome 3q22.
GARD:9595
NCI:C125693
OMIM:209300
ORDO:1195
familial hypotransferrinemia
disease_ontology
DOID:0050649
OMIM mapping confirmed by DO. [SN].
atransferrinemia
An atrial fibrillation that has_material_basis_in autosomal dominant inheritance of the familial atrial fibrillation (ATFB) genes.
GARD:9740
OMIM:607554
OMIM:608583
OMIM:608988
OMIM:611493
OMIM:611494
OMIM:612201
OMIM:612240
OMIM:613055
OMIM:613980
OMIM:614022
OMIM:614049
OMIM:614050
OMIM:615377
OMIM:615378
OMIM:615770
OMIM:PS608583
ORDO:334
ATFB
disease_ontology
DOID:0050650
Xref MGI.
familial atrial fibrillation
A congenital heart septal defect characterized by an abnormal or inadequate fusion of the superior and inferior endocardial cushions with the mid portion of the atrial septum and the muscular portion of the ventricular septum, thus allowing extra blood to circulate the lungs.
GARD:802
ICD10CM:Q21.2
ICD9CM:745.6
MESH:D004694
OMIM:600309
OMIM:606215
OMIM:614430
OMIM:614474
ORDO:98722
SNOMEDCT_US_2020_03_01:204322008
UMLS_CUI:C0014116
AVCD
AVSD
ECD
atrioventricular canal defect
endocardial cushion defect
disease_ontology
DOID:0050651
Xref MGI.
OMIM mapping confirmed by DO. [SN].
atrioventricular septal defect
A synostosis characterized by coronal craniosynostosis, short stature, and aplasia or hypoplasia of the radial bone.
GARD:1602
MESH:C536788
OMIM:218600
ORDO:1223
SNOMEDCT_US_2020_03_01:77608001
UMLS_CUI:C0265308
disease_ontology
DOID:0050654
OMIM mapping confirmed by DO. [SN].
Baller-Gerold syndrome
A hypothyroidism that is characterized by thyroid dysgenesis, cleft palate, spiky hair and bifid epiglottis, has_material_basis_in homozygous mutation in the FKHL15 gene on chromosome 9q22.
OMIM:241850
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
disease_ontology
DOID:0050655
OMIM mapping confirmed by DO. [SN].
Bamforth-Lazarus syndrome
A syndrome that is characterized by congenital microcephaly, intracranial calcifications, severe developmental delay, simplified gyration and polymicrogyria that has_material_basis_in homozygous or compound heterozygous mutation in OCLN on chromosome 5q13.2.
GARD:12426
OMIM:251290
ORDO:1229
BLC-PMG
BLCPMG
Baraitser-Brett-Piesowicz syndrome
Baraitser-Reardon syndrome
PTORCH1
band-like calcification with simplified gyration and polymicrogyria
bilateral band-like calcification with polymicrogyria
microcephaly-intracranial calcification-intellectual disability syndrome
disease_ontology
DOID:0050656
pseudo-TORCH syndrome 1
A syndrome that is characterized by macrocephaly, multiple noncancerous tumors and hamartomas, and dark freckles on the penis, and has_material_basis_in heterozygous germline mutation in the PTEN gene on chromosome 10q23.
GARD:5887
ICD10CM:Q87.89
MESH:D006223
NCI:C3939
OMIM:158350
ORDO:109
Bannayan-Zonana syndrome
Riley-Smith syndrome
Ruvalcaba-Myhre-Smith syndrome
disease_ontology
DOID:0050657
OMIM mapping confirmed by DO. [SN].
Bannayan-Riley-Ruvalcaba syndrome
A syndrome that is characterized by leukonychia, wart-like skin growths, palmoplantar keratoderma and hearing loss, has_material_basis_in heterozygous mutation in the GJB2 gene on chromosome 13q12.
OMIM:149200
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS
disease_ontology
DOID:0050658
OMIM mapping confirmed by DO. [SN].
Bart-Pumphrey syndrome
A basal ganglia disease that is characterized by recurrent subacute encephalopathy, has_symptom confusion, has_symptom seizure, has_symptom ataxia, has_symptom dystonia, has_symptom supranuclear facial palsy, has_symptom external ophthalmoplegia, and has_symptom dysphagia.
MESH:C537658
OMIM:607483
disease_ontology
DOID:0050659
OMIM mapping confirmed by DO. [SN].
biotin-responsive basal ganglia disease
A syndrome that is characterized by cutis gyrata, acanthosis nigricans and craniosynostosis, has_material_basis_in heterozygous mutation in the FGFR2 gene on chromosome 10q26.
GARD:332
OMIM:123790
disease_ontology
DOID:0050660
OMIM mapping confirmed by DO. [SN].
Beare-Stevenson cutis gyrata syndrome
A macular degeneration that it is characterized by the disruption of cells in a small area near the center of the retina, the macula and may cause progressive vision loss.
GARD:10120
GARD:182
ICD10CM:H35.5
MESH:D057826
OMIM:153700
OMIM:153840
OMIM:608161
OMIM:616151
OMIM:616152
ORDO:1243
ORDO:99000
Best disease
Best macular dystrophy
juvenile-onset vitelliform macular dystrophy
disease_ontology
DOID:0050661
Xref MGI.
OMIM mapping confirmed by DO. [SN].
vitelliform macular dystrophy
A macular degeneration that is characterized by central vision loss, an absent electrooculogram light rise and a reduced electroretinogram, has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the BEST1 gene on chromosome 11q12.
MESH:C567518
OMIM:611809
autosomal recessive bestrophinopathy
disease_ontology
DOID:0050662
OMIM mapping confirmed by DO. [SN].
bestrophinopathy
A congenital muscular dystrophy that is characterized by myopathy and joint contractures that progresses slowly, has_material_basis_in autosomal dominant inheritance of heterozygous mutation in the COL6A1 gene, the COL6A2 gene, or the COL6A3 gene.
GARD:873
OMIM:158810
benign congenital muscular dystrophy
disease_ontology
DOID:0050663
OMIM mapping confirmed by DO. [SN].
Bethlem myopathy
A fetal alcohol spectrum disorder that results in severe mental and physical defects which can develop in a child when the mother drinks alcohol during pregnancy. The presenting features include craniofacial dysmorphology (microcephaly, smooth philtrum, thin upper lip, small eye openings), pre- and postnatal growth deficiency, and central nervous system dysfunction.
disease_ontology
DOID:0050665
fetal alcohol syndrome
A fetal alcohol spectrum disorder that results in most, but not all, of the growth deficiency and/or craniofacial features of fetal alcohol syndrome including central nervous system dysfunction due to prenatal alcohol exposure.
disease_ontology
DOID:0050666
partial fetal alcohol syndrome
A fetal alcohol spectrum disorder that results in central nervous system dysfunction and behavioral and/or cognitive deficits due to prenatal alcohol exposure.
ARND
static encephalopathy
disease_ontology
DOID:0050667
alcohol-related neurodevelopmental disorder
A cerebral palsy that is caused by damage in the outer layer of the brain, the cerebral cortex, which results in increased tone, or tension, in a muscle causing abnormal movements.
disease_ontology
DOID:0050669
spastic cerebral palsy
A cerebral palsy that is caused by damage to the cerebellum, which affects muscle coordination, particularly in the limb. Some individuals suffer from hypotonia, tremors, difficulty with visual and/or auditory processing.
GARD:10451
OMIM:605388
hypotonic cerebral palsy
disease_ontology
DOID:0050670
ataxic cerebral palsy
A steroid inherited metabolic disorder characterized by abnormal conversion of cholesterol into bile acids which occurs predominantly in the liver.
ICD10CM:K76.8
3-beta-hydroxy-delta-5-C27-steroid oxidoreductase deficiency
CBA
cholestasis with delta(4)-3-oxosteroid-5-beta-reductase deficiency
disease_ontology
DOID:0050674
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital bile acid synthesis defect
A syndrome that is characterized by intellectual disability, hypotonia, hyperactivity and facies, has_material_basis_in heterozygous mutation in the KCNK9 gene on chromosome 8q24.
GARD:10358
MESH:C567357
OMIM:612292
Birk-Barel mental retardation dysmorphism syndrome
disease_ontology
DOID:0050675
OMIM mapping confirmed by DO. [SN].
Birk-Barel syndrome
A skin disease that is characterized by the development of skin papules on the head, face and upper torso, has_material_basis_in heterozygous mutation in the gene encoding folliculin on chromosome 17p11.
GARD:2322
MESH:D058249
OMIM:135150
disease_ontology
DOID:0050676
OMIM mapping confirmed by DO. [SN].
Birt-Hogg-Dube syndrome
A syndrome characterized by familial granulomatous arthritis, uveitis and skin granulomas. It has_material_basis_in heterozygous mutations in the NOD2 gene.
GARD:304
NCI:C116794
OMIM:186580
ARTHROCUTANEOUVEAL GRANULOMATOSIS
BLAUS
Jabs syndrome
disease_ontology
DOID:0050678
OMIM mapping confirmed by DO. [SN].
Blau syndrome
An achromatopsia that is characterized by severely impaired color discrimination, low visual acuity, nystagmus, photophobia due to the absence of functional long wavelength-sensitive and medium wavelength-sensitive cones in the retina and has_material_basis_in recessive X-linked inheritance.
GARD:917
OMIM:303700
disease_ontology
DOID:0050679
OMIM mapping confirmed by DO. [SN].
blue cone monochromacy
An osteochondrodysplasia that is characterized by severe dwarfism, dislocated joints, club feet, distinctive facies and dysplastic tubular bones with boomerang-like bowing, has_material_basis_in heterozygous mutation in the FLNB gene on chromosome 3p14.
GARD:933
OMIM:112310
disease_ontology
DOID:0050680
OMIM mapping confirmed by DO. [SN].
Boomerang dysplasia
An X-linked disease that is characterized by intellectual disability, truncal obesity, seizures, hypogonadism, developmental delay, distinctive facial features, tapered fingers and short toes and has_material_basis_in X-linked recessive inheritance of mutations in the PHF6 gene.
GARD:936
MESH:C536575
NCI:C157122
OMIM:301900
ORDO:127
SNOMEDCT_US_2020_03_01:21634003
UMLS_CUI:C0265339
BFLS
BORJ
Borjeson syndrome
MRXSBFL
intellectual deficiency-epilepsy-endocrine disorders syndrome
mental retardation, epilepsy, and endocrine disorder
syndromic X-linked mental retardation Borjeson-Forssman-Lehmann type
disease_ontology
DOID:0050681
OMIM mapping confirmed by DO. [SN].
Borjeson-Forssman-Lehmann syndrome
A syndrome that is characterized by growth delays, failure to thrive and malformations of the head and face that results in infantile death, has_material_basis_in homozygous mutation in the EMG1 gene on chromosome 12p13.
GARD:5950
MESH:C537081
OMIM:211180
ORDO:1270
SNOMEDCT_US_2020_03_01:711153001
UMLS_CUI:C1859405
BWCNS
Bowen Hutterite syndrome
Bowen-Conradi Hutterite syndrome
disease_ontology
DOID:0050684
OMIM mapping confirmed by DO. [SN].
Bowen-Conradi syndrome
A carcinoma that is an undifferentiated neoplasm composed of primitive-appearing cells.
snadendla
2011-06-13T01:25:14Z
DOID:7137
NCI:C4099
SNOMEDCT_US_2020_03_01:5958006
UMLS_CUI:C0334239
Small cell carcinoma - intermediate cell
Small cell carcinoma, intermediate cell
intermediate cell small cell carcinoma
disease_ontology
DOID:0050685
small cell carcinoma
A cancer that is classified based on the organ it starts in.
snadendla
2011-06-13T03:28:33Z
MESH:D009371
disease_ontology
DOID:0050686
organ system cancer
A cancer that is classified by the type of cell from which it is derived.
snadendla
2011-06-13T03:28:50Z
disease_ontology
DOID:0050687
cell type cancer
A large intestine cancer that is located_in the terminal part of the large intestine.
snadendla
2011-06-14T01:34:36Z
disease_ontology
DOID:0050688
anal canal cancer
A syndrome that is characterized by brachydactyly and syndactyly, has_material_basis_in heterozygous mutation in the HOXD13 gene on chromosome 2q31.
snadendla
2011-06-17T03:55:47Z
MESH:C565193
OMIM:610713
disease_ontology
DOID:0050689
OMIM mapping confirmed by DO. [SN].
brachydactyly-syndactyly syndrome
An osteochondrodysplasia characterized by generalized platyspondyly without significant long bone abnormalities and short stature.
snadendla
2011-06-17T04:00:27Z
GARD:10903
OMIM:113500
OMIM:271530
OMIM:271630
OMIM:613678
ORDO:1293
brachyrachia
disease_ontology
DOID:0050690
Xref MGI.
OMIM mapping confirmed by DO. [SN].
brachyolmia
A syndrome that is characterized by low birth weight and growth retardation, bilateral branchial clefts.
snadendla
2011-06-17T04:10:18Z
GARD:3212
OMIM:113620
disease_ontology
DOID:0050691
OMIM mapping confirmed by DO. [SN].
branchiooculofacial syndrome
A skin disease that is characterized by the development of several types of tumors from the skin, has_material_basis_in heterozygous mutation in the CYLD gene on chromosome 16q12.
snadendla
2011-06-17T04:34:10Z
GARD:10179
OMIM:605041
ORDO:79493
SNOMEDCT_US_2020_03_01:703531009
UMLS_CUI:C1857941
BRSS
BSS
CYLD cutaneous syndrome
SBS
Spiegler-Brooke Syndrome
disease_ontology
DOID:0050693
OMIM mapping confirmed by DO. [SN].
Brooke-Spiegler syndrome
A syndrome that is characterized by sensorineural hearing loss and a variety of cranial nerve palsies, usually involving the motor components of the seventh and ninth to twelfth cranial nerves.
snadendla
2011-06-17T04:38:07Z
MESH:C537111
OMIM:PS211530
disease_ontology
DOID:0050694
OMIM mapping confirmed by DO. [SN].
Brown-Vialetto-Van Laere syndrome
MESH:C537111
A specific developmental disorder and physical disorder that is characterized by physical, behavioral and learning birth defects resulting from maternal ingestion of alcohol during pregnancy.
lschriml
2011-12-01T01:01:25Z
disease_ontology
DOID:0050696
fetal alcohol spectrum disorder
A placenta disease that is an inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection.
lschriml
2012-01-03T01:13:08Z
MESH:D002821
disease_ontology
DOID:0050697
chorioamnionitis
A connective tissue disease that is an inflammation of the connective tissue of the umbilical cord.
lschriml
2012-01-03T01:18:35Z
disease_ontology
DOID:0050698
funisitis
A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.
lschriml
2012-01-03T02:54:11Z
ICD10CM:I42
ICD9CM:425
ICD9CM:425.9
MESH:D009202
NCI:C34830
NCI:C53654
SNOMEDCT_US_2020_03_01:266301006
SNOMEDCT_US_2020_03_01:89461002
SNOMEDCT_US_2020_03_01:89600009
UMLS_CUI:C0033141
UMLS_CUI:C0036529
UMLS_CUI:C0878544
Cardiomyopathies
disease_ontology
DOID:0050700
MESH:D009202 added from NeuroDevNet [WAK].
cardiomyopathy
An epilepsy syndrome that is a group of clinical entities showing a cluster of electro-clinical characteristics, classified according to age at onset, cognitive and developmental antecedents and consequences, motor and sensory examinations, EEG features, provoking or triggering factors, and patterns of seizure occurrence with respect to sleep.
lschriml
2012-04-11T11:42:46Z
electro-clinical syndrome
disease_ontology
DOID:0050701
electroclinical syndrome
An electroclinical syndrome with onset in the neonatal period less than 44 weeks of gestational age.
lschriml
2012-04-11T11:48:18Z
disease_ontology
DOID:0050702
JA:Epilepsy Genetics Kiel
neonatal period electroclinical syndrome
An electroclinical syndrome with onset in infancy occurring between birth and one year of age.
lschriml
2012-04-11T11:48:18Z
disease_ontology
DOID:0050703
JA:Epilepsy Genetics Kiel
infancy electroclinical syndrome
An electroclinical syndrome with onset in childhood between one and 12 years of age.
lschriml
2012-04-11T11:48:18Z
disease_ontology
DOID:0050704
JA:Epilepsy Genetics Kiel
childhood electroclinical syndrome
An electroclinical syndrome with onset in adolescence and adulthood.
lschriml
2012-04-11T11:48:18Z
disease_ontology
DOID:0050705
adolescence-adult electroclinical syndrome
An electroclinial syndrome that is characterized by development of seizures later in life with a variable age of onset and duration.
lschriml
2012-04-11T11:48:18Z
disease_ontology
DOID:0050706
variable age at onset electroclinical syndrome
A childhood electroclinical syndrome characterized by the occurrence of typical absence seizures starting between the age of four and ten years.
lschriml
2012-04-11T02:29:04Z
disease_ontology
DOID:0050708
JA:Epilepsy Genetics Kiel
early onset absence epilepsy
A neonatal period electroclinical syndrome that is characterized by tonic spasms and partial seizures.
lschriml
2012-05-10T10:02:58Z
DOID:2481
GARD:9255
OMIM:PS308350
ORDO:1934
Early Infantile Epileptic Encephalopathy with Burst-Suppression
disease_ontology
DOID:0050709
early infantile epileptic encephalopathy
An amino acid metabolic disorder that is classified by inadequate levels of the enzyme 3-methylcrotonyl-CoA carboxylase that helps break down proteins containing the amino acid leucine. This disease has_symptom muscular hypotonia (weak muscle tone), has_symptom muscular atrophy, has_symptom feeding difficulties, has_symptom recurrent episodes of vomiting and diarrhea, and has_symptom lethargy.
lschriml
2012-05-22T10:32:44Z
GARD:10954
OMIM:PS210200
ORDO:6
3-Methylcrotonylglycinuria
3MCC deficiency
BMCC deficiency
disease_ontology
DOID:0050710
3-Methylcrotonyl-CoA carboxylase deficiency
An iron metabolism disease that has_material_basis_in a mutation in the ceruloplasmin gene characterized by progressive neurodegeneration of the retina and basal ganglia and diabetes mellitus.
lschriml
2012-05-22T11:47:25Z
GARD:9499
OMIM:604290
disease_ontology
DOID:0050711
aceruloplasminemia
An amino acid metabolic disorder that has_material_basis_in a mutation in the GATM gene resulting in deficiency of arginine:glycine amidinotransferase which then limits creatine synthesis.
lschriml
2012-05-22T11:53:57Z
OMIM:612718
CEREBRAL CREATINE DEFICIENCY SYNDROME 3
arginine:glycine amidinotransferase deficiency
disease_ontology
DOID:0050712
AGAT deficiency
An inherited metabolic disorder resulting from a deficiency in vitamin or vitamin cofactor transport or metabolism.
lschriml
2012-06-11T02:44:53Z
disease_ontology
DOID:0050718
vitamin metabolic disorder
An amino acid metabolic disorder that has_material_basis in deficiency of ornithine translocase resulting in the accumulation of ammonia in the blood.
lschriml
2012-06-13T03:09:31Z
OMIM:238970
HHH syndrome
Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) syndrome
disease_ontology
DOID:0050720
ornithine translocase deficiency
An amino acid metabolic disorder that has_material_basis_in defects in the biosynthesis of the amino acid L-serine.
lschriml
2012-06-13T03:09:31Z
disease_ontology
DOID:0050721
serine deficiency
A tyrosinemia that has_material_basis_in deficiency of 4-hydroxyphenylpyruvate dioxygenase disrupting the break down of tyrosine.
lschriml
2012-07-06T02:55:45Z
OMIM:276710
disease_ontology
DOID:0050727
tyrosinemia type III
A carbohydrate metabolism disorder that is characterized by abnormal accumulation or depletion of liver glycogen.
lschriml
2012-07-13T10:42:54Z
disease_ontology
DOID:0050728
glycogen metabolism disorder
A lipid storage disease that is characterized by accumulation of triglycerides in the cytoplasm of leukocytes, muscle, liver, fibroblasts, and other tissues.
lschriml
2012-07-17T12:31:48Z
OMIM:275630
Chanarin-Dorfman syndrome
disease_ontology
DOID:0050729
neutral lipid storage disease
A mitochondrial metabolism disease that is characterized by a deficiency of CoQ10 resulting from reduced biosynthesis.
lschriml
2012-07-17T12:58:37Z
GARD:10423
OMIM:PS607426
COENZYME Q10 DEFICIENCY, PRIMARY
disease_ontology
DOID:0050730
coenzyme Q10 deficiency disease
A vitamin metabolic disorder that results from low blood levels of vitamin B12.
lschriml
2012-07-17T01:01:29Z
cobalamin deficiency
hypocobalaminemia
disease_ontology
DOID:0050731
vitamin B12 deficiency
A monogenic disease that has_material_basis_in muations in genes on the X chromosome.
lschriml
2012-07-24T12:47:31Z
disease_ontology
DOID:0050735
X-linked monogenic disease
An autosomal genetic disease that is characterized by the presence of one disease-associated mutation of a gene which is sufficient to cause the disease.
lschriml
2012-07-24T12:51:47Z
disease_ontology
DOID:0050736
autosomal dominant disease
An autosomal genetic disease that is characterized by the presence of two mutated copies of the gene, both of which must be present in order for the disease or trait to develop.
lschriml
2012-07-24T12:51:47Z
disease_ontology
DOID:0050737
autosomal recessive disease
A monogenic disease that has_material_basis_in a mutation in a single gene on one of the non-sex chromosomes.
lschriml
2012-07-24T04:45:53Z
disease_ontology
DOID:0050739
autosomal genetic disease
A substance dependence that is characterized by tolerance, withdrawal symptoms, increasing use, persistent desire to decrease consumption, time spent obtaining or recovering from alcohol caused by a physical and psychological dependence on alcohol.
lschriml
2012-09-05T11:48:42Z
EFO:0003829
KEGG:05034
OMIM:103780
SNOMEDCT_US_2020_03_01:66590003
alcoholism
disease_ontology
DOID:0050741
alcohol dependence
A substance dependence that is characterized by a physical dependence on nicotine.
lschriml
2012-09-05T11:48:42Z
EFO:0003768
ICD10CM:F17
MESH:D014029
NCI:C54203
SNOMEDCT_US_2020_03_01:56294008
UMLS_CUI:C0028043
tobacco use disorder
disease_ontology
DOID:0050742
nicotine dependence
A non-Hodgkin lymphoma that has_material_basis_in mature T lymphocytes and natural killer cells.
lschriml
2012-09-18T01:56:52Z
NK-T cell lymphoma
mature T-cell and natural killer cell lymphoma
disease_ontology
DOID:0050743
mature T-cell and NK-cell lymphoma
A non-Hodgkin lymphoma involving aberrant T-cells.
lschriml
2012-09-18T01:57:40Z
disease_ontology
DOID:0050744
anaplastic large cell lymphoma
A B-cell lymphoma that is a cancer of B cells presenting as an aggressive tumour which can arise in virtually any part of the body.
lschriml
2012-09-18T01:58:25Z
GARD:3178
disease_ontology
DOID:0050745
diffuse large B-cell lymphoma
A B-cell lymphocytic neoplasm due to CD5 positive antigen-naive pregerminal center B-cell within the mantle zone that surrounds normal germinal center follicles.
lschriml
2012-09-18T02:00:45Z
GARD:6969
MESH:D020522
disease_ontology
DOID:0050746
mantle cell lymphoma
A B-cell lymphoma that is characterized by initial formation in the marginal zones of lymph tissue.
lschriml
2012-09-18T02:00:45Z
marginal zone lymphoma
disease_ontology
DOID:0050748
marginal zone B-cell lymphoma
A mature T-cell and NK-cell lymphoma includes a group of T-cell lymphomas that develop away from the thymus.
lschriml
2012-09-18T02:01:49Z
GARD:7368
disease_ontology
DOID:0050749
peripheral T-cell lymphoma
A marginal zone B-cell lymphocyte located_in the spleen comprised of B-cells in place of white pulp.
lschriml
2012-09-18T02:03:06Z
disease_ontology
DOID:0050750
splenic marginal zone lymphoma
A hereditary ataxia that is characterized by ataxia originating in the cerebellum.
lschriml
2013-01-16T01:07:02Z
MESH:D002524
disease_ontology
DOID:0050753
cerebellar ataxia
An autosomal recessive cerebellar ataxia that is characterized by the onset of ataxia between age three and thirty including axonal sensorimotor neuropathy, oculomotor apraxia, cerebellar atrophy and elevated alpha-fetoprotein, has_material_basis_in homozygous or compound heterozygous mutation in the SETX gene on chromosome 9q34.
lschriml
2013-01-16T01:07:02Z
OMIM:606002
disease_ontology
DOID:0050755
ataxia with oculomotor apraxia type 2
A mitochondrial metabolism disease that is characterized by hearing loss that begins early in life, problems with movement, impaired vision, and behavior problems, and has_material_basis_in mutations in the TIMM8A gene resulting in abnormal protein transport within the mitochondria.
lschriml
2013-01-16T01:20:50Z
DOID:0050867
MESH:C535808
OMIM:304700
ORDO:3213
Deafness Dystonia Optic Atrophy Syndrome
Deafness Dystonia Optic Neuronopathy Syndrome
Dystonia Deafness Syndrome
Jensen syndrome
Mohr-Tranebjaerg Syndrome
Mohr-Tranebjaerg syndrome
deafness dystonia syndrome
disease_ontology
DOID:0050757
deafness-dystonia-optic neuronopathy syndrome
An acquired metabolic disease that characterized by excessive production of acid.
lschriml
2013-01-16T01:23:37Z
disease_ontology
DOID:0050758
metabolic acidosis
A myotonic disease that is characterized by myotonia and progressive, proximal muscle wasting and weakness affecting the skeletal and smooth muscles of the neck, shoulders, elbows and hips and has_material_basis_in the autosomal dominant inheritance of the CNBP (ZNF9) gene containing an expansion of a CCTG repeat in intron one.
lschriml
2013-01-16T01:27:31Z
GARD:9728
ICD10CM:G71.1
ICD10CM:G71.19
ICD9CM:359.2
MESH:D020967
NCI:C122789
NCI:C122790
NCI:C84913
OMIM:602668
SNOMEDCT_US_2020_03_01:155096007
SNOMEDCT_US_2020_03_01:41574007
SNOMEDCT_US_2020_03_01:715788001
UMLS_CUI:C0221055
UMLS_CUI:C0553604
UMLS_CUI:C0752355
proximal myotonic myopathy
disease_ontology
DOID:0050759
myotonic dystrophy type 2
MESH:C535686
A syndrome that is characterized by congenital joint contractures, renal tubular dysfunction, cholestasis, severe failure to thrive, ichthyosis and a defect in platelet alpha-granule biogenesis and that has_material_basis_in homozygous or compound heterozygous mutation in the VPS33B gene or homozygous or compound heterozygous mutation in the VIPAR gene on chromosome 14q24.3.
lschriml
2013-01-17T12:46:38Z
OMIM:PS208085
ORDO:2697
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS
Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome
Arthrogryposis-renal dysfunction-cholestasis
disease_ontology
DOID:0050763
ARC syndrome
A neurodegenerative disease that is characterized by characterized by misshapen, spiny red blood cells (acanthocytosis) and neurological abnormalities, especially movement disorders.
lschriml
2013-01-17T12:54:19Z
GARD:10902
MESH:D054546
ORDO:263440
disease_ontology
DOID:0050765
neuroacanthocytosis
A neuroacanthocytosis characterized by progressive neurodegeneration and red cell acanthocytosis, with onset in the third to fifth decade of life and has_material_basis_in homozygous or compound heterozygous mutation in the VPS13A gene, which encodes chorein, on chromosome 9q21.
lschriml
2013-01-17T12:54:19Z
GARD:3956
MESH:D054546
NCI:C84926
OMIM:200150
ORDO:2388
SNOMEDCT_US_2020_03_01:26848004
UMLS_CUI:C0393576
Levine-Critchley syndrome
choreo-acanthocytosis
disease_ontology
DOID:0050766
choreaacanthocytosis
A syndrome that is characterized by intellectual disability, deafness, ocular abnormalities, T-cell leukemia, cryptorchidism, hypospadias and spasticity.
lschriml
2013-02-21T11:32:26Z
GARD:3902
OMIM:310465
ORDO:2608
NSX
disease_ontology
DOID:0050769
N syndrome
A liver disease that is characterized by the presence of multiple cysts located_in the liver.
lschriml
2013-02-21T11:36:13Z
DOID:1173
GARD:9457
OMIM:174050
congenital cystic liver disease
congenital hepatic cyst
fibrocystic liver disease
disease_ontology
DOID:0050770
polycystic liver disease
An endocrine organ benign neoplasm that arises within the adrenal medulla, releasing epinephrines and norepinephrines hormones that cause either episodic or persistent high blood pressure.
lschriml
2013-02-21T11:40:58Z
GARD:7385
MESH:D010673
OMIM:171300
phaeochromocytoma
disease_ontology
DOID:0050771
pheochromocytoma
A pheochromocytoma that arises in extraadrenal sympathetic ganglia.
lschriml
2013-02-21T11:51:57Z
MESH:D010235
NCI:C3308
OMIM:115310
OMIM:168000
OMIM:601650
OMIM:605373
OMIM:614165
OMIM:PS168000
SNOMEDCT_US_2020_03_01:302833002
UMLS_CUI:C0030421
chemodectoma
glomus body tumor
disease_ontology
DOID:0050773
Xref MGI.
paraganglioma
A syndrome that is characterized by radial ray defect, patellae hypoplasia, cleft palate, diarrhea, dislocated joints, limb malformations, long nose and normal intelligence, has_material_basis_in homozygous or compound heterozygous mutation in the DNA helicase gene RECQL4 on chromosome 8q24.
lschriml
2013-02-21T11:56:15Z
GARD:4637
MESH:C535288
OMIM:266280
ORDO:3021
SNOMEDCT_US_2020_03_01:702413000
UMLS_CUI:C1849453
disease_ontology
DOID:0050774
rapadilino syndrome
An osteochondrodysplasia that is characterized by hypoplastic iliac bones, hypoplastic vertebral bodies, short ribs and broad long bones, prenatally lethal, has_material_basis_in homozygous or compound heterozygous mutation in the SLC35D1 gene on chromosome 1p31.
lschriml
2013-02-21T12:00:39Z
GARD:169
MESH:C536637
OMIM:269250
disease_ontology
DOID:0050775
schneckenbecken dysplasia
A non-syndromic intellectual disability characterized by a X-linked inheritance pattern.
lschriml
2013-02-21T12:06:40Z
OMIM:300716
OMIM:PS309530
ORDO:777
non-specific X-linked mental retardation
disease_ontology
DOID:0050776
Xref MGI.
non-syndromic X-linked intellectual disability
An amino acid metabolic disorder that is characterized by mental retardation, severe speech delay, behavioral abnormalities and seizures, has_material_basis_in mutation in the creatine transporter gene on chromosome Xq28.
lschriml
2013-11-21T12:10:58Z
disease_ontology
DOID:0050798
cerebral creatine deficiency syndrome
A heart conduction disease that is characterized by the impairment of the conduction between the atria and ventricles of the heart.
lschriml
2014-02-12T01:35:05Z
ICD10CM:I44.3
ICD9CM:426.10
MESH:D054537
NCI:C26703
SNOMEDCT_US_2020_03_01:58547007
UMLS_CUI:C0004245
AV block
disease_ontology
DOID:0050820
atrioventricular block
MESH:D054537
A heart conduction disease that is characterized by dysfunction of the impulse-generating (pacemaker) tissue located in the right atrium of the heart which generates normal sinus rhythm.
lschriml
2014-02-12T01:47:54Z
SA node
sinuatrial node
disease_ontology
DOID:0050824
sinoatrial node disease
A heart disease that is located_in the innermost layer of tissue that lines the chambers of the heart.
lschriml
2014-02-12T01:53:42Z
disease_ontology
DOID:0050825
endocardium disease
A heart valve disease that is characterized by valvular insufficiency or valvular stenosis, located_in tricuspid valve between the right atrium and right ventricle.
lschriml
2014-02-12T02:55:24Z
DOID:13834
ICD10CM:I07
ICD9CM:397.0
SNOMEDCT_US_2020_03_01:49699002
UMLS_CUI:C0264776
RH. tricuspid valve disease
Rheumatic disease of tricuspid valve
Rheumatic tricuspid valve disease
Tricuspid disease
disease of tricuspid valve
rheumatic tricuspid valve disease
disease_ontology
DOID:0050826
tricuspid valve disease
A vascular disease that is located_in an artery.
lschriml
2014-02-12T03:08:35Z
disease_ontology
DOID:0050828
artery disease
A cardiovascular system disease that is located_in the fibrous sac surrounding the heart.
lschriml
2014-02-18T12:20:15Z
disease_ontology
DOID:0050829
pericardium disease
A dystonia that is localized to a specific part of the body.
lschriml
2014-03-18T01:13:36Z
GARD:6458
disease_ontology
DOID:0050836
focal dystonia
A focal dystonia that is characterized as dystonia that affects the muscles of the head, face, and neck.
lschriml
2014-03-18T01:33:33Z
disease_ontology
DOID:0050845
cranio-facial dystonia
A sleep disorder characterized by repeated cessation and commencing of breathing that repeatedly disrupts sleep.
lschriml
2014-03-20T03:57:22Z
ICD10CM:G47.3
ICD9CM:780.57
MESH:D012891
NCI:C26884
SNOMEDCT_US_2020_03_01:206750008
UMLS_CUI:C0037315
disease_ontology
DOID:0050847
sleep apnea
A glomerulonephritis that is characterized by hardening of the glomerulus in the kidney.
lschriml
2014-04-15T03:40:31Z
disease_ontology
DOID:0050851
glomerulosclerosis
An intellectual disability that is characterized by the presence of associated medical and behavioral sign and symptoms.
lschriml
2014-08-14T10:55:32Z
disease_ontology
DOID:0050888
syndromic intellectual disability
An intellectual disability that is characterized by the absence of associated medical and behavioral signs and symptoms.
lschriml
2014-08-14T10:57:36Z
OMIM:613192
OMIM:614202
disease_ontology
DOID:0050889
non-syndromic intellectual disability
A neurodegenerative disease that is characterized by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibres or glial cells.
lschriml
2014-08-14T03:29:17Z
Synucleinopathies
alpha Synucleinopathies
disease_ontology
DOID:0050890
synucleinopathy
An infratentorial cancer that is located_in the lower part of the brain and is a type of primitive neuroectodermal tumor.
lschriml
2014-10-06T14:36:37Z
DOID:0060105
DOID:168
DOID:3858
DOID:4981
GARD:7005
MESH:D008527
MESH:D018242
NCI:C27294
NCI:C3222
NCI:C3716
OMIM:155255
SNOMEDCT_US_2020_03_01:189925001
SNOMEDCT_US_2020_03_01:443333004
UMLS_CUI:C0025149
UMLS_CUI:C0206663
UMLS_CUI:C1334410
CNS PNET
CPNET
brain medulloblastoma
infratentorial primitive neuroectodermal tumor
localized primitive neuroectodermal tumor
disease_ontology
DOID:0050902
OMIM mapping confirmed by DO. [SN].
medulloblastoma
A salivary gland cancer that has_material_basis_in epithelial cells.
lschriml
2014-10-08T16:52:58Z
disease_ontology
DOID:0050904
salivary gland carcinoma
A breast carcinoma that derives_from breast lobules (milk glands).
lschriml
2014-10-22T13:05:34Z
disease_ontology
DOID:0050938
breast lobular carcinoma
A cerebellar ataxia that has_material_basis_in autosomal recessive inheritance.
lschriml
2015-10-05T14:21:08Z
OMIM:PS213200
ORDO:1172
disease_ontology
DOID:0050950
autosomal recessive cerebellar ataxia
A neurodegenerative disease that is characterized by slowly progressive incoordination of gait and often associated with poor coordination of hands, speech, and eye movements.
lschriml
2015-10-05T14:38:17Z
GARD:6614
disease_ontology
DOID:0050951
hereditary ataxia
An endocarditis that is characterized by inflammation of the endocardium caused by infectious agents.
GARD:6337
disease_ontology
DOID:0060000
infective endocarditis
A substance-related disorder that occurs upon the abrupt discontinuation/separation or a decrease in dosage of the intake of medications, recreational drugs, and alcohol.
disease_ontology
DOID:0060001
withdrawal disorder
A complement deficiency that is a functional deficiency in the complement component C1 inhibitor leading to hereditary angioedema (HAE) involving swelling due to leakage of fluid from blood vessels into connective tissue.
Quincke edema
disease_ontology
DOID:0060002
C1 inhibitor deficiency
An autoimmune hypersensitivity disease located_in the central nervous system.
disease_ontology
DOID:0060004
autoimmune disease of central nervous system
An autoimmune disease that is the abnormal functioning of the immune system resulting in production of antibodies or T cells against cells and/or tissues in the endocrine system.
disease_ontology
DOID:0060005
autoimmune disease of endocrine system
A severe combined immunodeficiency that is characterized by recurrent bacterial, viral, and fungal infections, especially of the lung, and sterile necrotizing granulomas of the skin, develops_from deficiency or decreased surface expression of MHC Class I, has_material_basis_in autosomal recessive inheritance of mutation affecting MHC Class I production or expression and frequently involves TAP1 and TAP2 subunits, and is typically asymptomatic in infancy.
OMIM:604571
BLS, TYPE I
BLSI
HLA CLASS I DEFICIENCY
bare lymphocyte syndrome type I
disease_ontology
DOID:0060009
OMIM mapping confirmed by DO. [SN].
MHC class I deficiency
A severe combined immunodeficiency that has_material_basis in the RAG1 and RAG2 genes on chromosome 11p and the Artemis gene on chromosome 10p. It is characterized by erythroderma, desquamation, alopecia, chronic diarrhea, failure to thrive, lymphadenopathy, and hepatosplenomegaly.
GARD:8198
ICD10CM:D81.8
OMIM:603554
combined immunodeficiency with hypereosinophilia
disease_ontology
DOID:0060010
Omenn syndrome
A severe combined immunodeficiency that is a X-linked SCID that has_material_basis_in mutations in genes encoding common gamma chain proteins shared by the interleukin (IL-2,4,7,9,16 and21) receptors resulting in a non-functional gamma chain, defective interleukin signalling, minimal or ascent T- and NK cells and non-functional B-cells.
DOID:5811
GARD:5618
MESH:D053632
NCI:C4682
OMIM:300400
SNOMEDCT_US_2020_03_01:203592006
UMLS_CUI:C1279481
SCID-X1
X-Linked Severe Combined Immunodeficiency
XSCID
gamma chain deficiency
thymic epithelial hypoplasia
disease_ontology
DOID:0060013
OMIM mapping confirmed by DO. [LS].
X-linked severe combined immunodeficiency
A severe combined immunodeficiency that is an actin regulator when mutated results in SCID through inhibition of thymic egress of mature thymocytes into peripheral lymphoid organs.
OMIM:615401
disease_ontology
DOID:0060019
coronin-1A deficiency
A severe combined immunodeficiency that is the most severe form of SCID and has_material_basis_in mutations in the gene encoding mitochondrial adenylate kinase 2. It is characterized by congenital agranulocytosis, lymphopenia, and lymphoid and thymic hypoplasia with absent cellular and humoral immunity functions.
DOID:1226
GARD:8625
MESH:C538361
NCI:C27070
OMIM:267500
SNOMEDCT_US_2020_03_01:111584000
UMLS_CUI:C0272167
De Vaal disease
disease_ontology
aleukocytosis
DOID:0060020
OMIM mapping confirmed by DO. [SN].
reticular dysgenesis
A combined T cell and B cell immunodeficiency that has_material_basis_in a mutation in the LIG4 gene, a DNA ligase, encoding a protein essential for V(D)J recombination and DNA double-strand break (DSB) repair through nonhomologous end joining (NHEJ). Patients present with immunodeficiency and developmental and growth delay.
OMIM:606593
LIG4 Syndrome
disease_ontology
DOID:0060021
OMIM mapping confirmed by DO. [SN].
DNA ligase IV deficiency
A combined T cell and B cell immunodeficiency that is a X-linked immunodeficiency with hyperimmunoglobulin M (XHIM) affecting isotype switching and is caused by the absence of CD40 ligand which is normally expressed on activated CD4+ T cells. Individuals with this mutation are unable to switch from IgM to IgG, IgA and IgE.
OMIM:308230
HIGMX-1
X-linked hyper-IgM syndrome
disease_ontology
DOID:0060022
CD40 ligand deficiency
A B cell deficiency that is an autosomal recessive disorder that has_material_basis_in mutation in the IgA (CD79 alpha) antigen receptor.
GARD:10197
MESH:D017098
OMIM:137100
OMIM:269650
OMIM:609529
ORDO:69127
SNOMEDCT_US_2020_03_01:29260007
UMLS_CUI:C0162538
IgA deficiency
gamma-A-globulin deficiency
disease_ontology
DOID:0060025
Xref MGI.
immunoglobulin alpha deficiency
A combined T cell and B cell immunodeficiency that is a condition where there is co-occurrence of deficient cell-mediated immunity and benign thymoma.
thymoma with hypogammaglobulinemia
disease_ontology
DOID:0060028
Good syndrome
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the exocrine system.
disease_ontology
DOID:0060029
autoimmune disease of exocrine system
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the gastrointestinal tract.
disease_ontology
DOID:0060031
autoimmune disease of gastrointestinal tract
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the musculoskeletal system.
disease_ontology
DOID:0060032
autoimmune disease of musculoskeletal system
An autoimmune disease of the nervous system that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the peripheral nervous system.
disease_ontology
DOID:0060033
autoimmune disease of peripheral nervous system
A cardiomyopathy that is characterized as weakness in the muscle of the heart that is not due to an identifiable external cause.
disease_ontology
DOID:0060036
intrinsic cardiomyopathy
A disease of mental health that occur during a child's developmental period between birth and age 18 resulting in retarding of the child's psychological or physical development.
disease_ontology
DOID:0060037
developmental disorder of mental health
A developmental disorder of mental health that categorizes specific learning disabilities and developmental disorders affecting coordination.
disease_ontology
DOID:0060038
specific developmental disorder
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the skin and connective tissue.
disease_ontology
DOID:0060039
autoimmune disease of skin and connective tissue
A developmental disorder of mental health that refers to a group of five disorders characterized by impairments in socialization and communication, as well as restricted interests and repetitive behaviors.
DOID:1208
ICD9CM:299.80
UMLS_CUI:C0154451
pervasive development disorder
disease_ontology
DOID:0060040
pervasive developmental disorder
A pervasive developmental disorder that is a spectrum of psychological conditions. The disease has_symptom widespread abnormalities of social interactions and communication, has_symptom severely restricted interests and has_symptom highly repetitive behavior.
GARD:10248
MESH:D000067877
disease_ontology
DOID:0060041
autism spectrum disorder
An autism spectrum disorder that involves some autistic symptoms occuring after age 3 with an abscence of all the traits necessary for a diagnosis of autism.
PDD
disease_ontology
DOID:0060042
atypical autism
A disease of mental health that involves the impairment in normal sexual functioning.
disease_ontology
DOID:0060043
sexual disorder
A sexual disorder that is characterized recurrent, intense sexually arousing fantasies, sexual urges or behaviors generally involving nonhuman objects.
disease_ontology
DOID:0060044
paraphilia disorder
A language disorder that involves an acquired impairment of any laguage modality such as producting or comprehending spoken or written language.
disease_ontology
DOID:0060046
aphasia
MESH:D001037
A learning disability that involves impaired written language ability such as impairments in handwriting, spelling, organization of ideas, and composition.
disease_ontology
DOID:0060047
writing disorder
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the urogenital tract.
disease_ontology
DOID:0060049
autoimmune disease of urogenital tract
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the blood.
disease_ontology
DOID:0060050
autoimmune disease of blood
An autoimmune disease that is the abnormal functioning of the immune system that causes your immune system to produce antibodies or T cells against cells and/or tissues in the cardiovascular system.
disease_ontology
DOID:0060051
autoimmune disease of cardiovascular system
An immune system disease that has_material_basis_in abnormal immune responses.
disease_ontology
DOID:0060056
hypersensitivity reaction disease
A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs.
DOID:1033
DOID:353
ICD10CM:C85.9
MESH:D008223
NCI:C3208
NCI:C7065
SNOMEDCT_US_2020_03_01:118600007
SNOMEDCT_US_2020_03_01:414628006
UMLS_CUI:C0024299
UMLS_CUI:C0598798
lymphoid cancer
disease_ontology
DOID:0060058
lymphoma
A lymphoma that is characterized as any kind of lymphoma except Hodgkin's lymphoma.
MESH:D008228
OMIM:605027
ORDO:547
disease_ontology
DOID:0060060
OMIM mapping confirmed by DO. [LS].
non-Hodgkin lymphoma
A non-Hodgkin's lymphoma that has_material_basis_in a mutation of T cells.
GARD:6226
MESH:D016410
cutaneous T-cell lymphoma
disease_ontology
DOID:0060061
cutaneous T cell lymphoma
A kidney disease that is characterized by hyperuricemia with renal uric acid under-excretion, gout and chronic kidney disease.
OMIM:162000
OMIM:613092
OMIM:614227
ORDO:209886
ORDO:217330
disease_ontology
DOID:0060062
Xref MGI.
OMIM mapping confirmed by DO. [LS].
familial juvenile hyperuricemic nephropathy
A sideoblastic anemia that is characterized by the presence of microcytic hypochromic anemia and iron overload, and has_material_basis_in X-linked inheritance.
OMIM:206000
disease_ontology
DOID:0060066
OMIM mapping confirmed by DO. [LS].
pyridoxine-responsive sideroblastic anemia
A mitochondrial metabolism disease that is characterized by sideroblastic anemia and exocrine pancreas dysfunction.
GARD:7343
OMIM:557000
Pearson Marrow-Pancreas Syndrome
disease_ontology
DOID:0060067
OMIM mapping confirmed by DO. [LS].
Pearson syndrome
A disease of cellular proliferation that results in abnormal growths in the body, which do not invade or destroy the surrounding tissue but, given enough time, will transform into a cancer.
lschriml
2011-05-11T12:18:41Z
disease_ontology
DOID:0060071
pre-malignant neoplasm
A disease of cellular proliferation that results in abnormal growths in the body which lack the ability to metastasize.
lschriml
2011-05-11T12:18:41Z
disease_ontology
DOID:0060072
benign neoplasm
An immune system cancer that is located_in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue.
lschriml
2011-05-11T01:05:14Z
disease_ontology
DOID:0060073
lymphatic system cancer
A breast carcinoma in situ that is characterized by being non-invasive, not having spread outside of the duct into the surrounding breast tissue, has_material_basis_in abnormally proliferating cells, derives_from epithelial cells.
lschriml
2011-06-08T12:19:28Z
disease_ontology
DOID:0060074
ductal carcinoma in situ
A breast cancer that is characterized by the presence of estrogen receptors.
lschriml
2011-06-08T12:23:02Z
disease_ontology
DOID:0060075
estrogen-receptor positive breast cancer
A thoracic benign neoplasm that is characterized by lack of malignancy.
lschriml
2011-06-08T01:02:29Z
disease_ontology
DOID:0060082
breast benign neoplasm
An organ system cancer located_in the immune system that is characterized by uncontrolled cellular proliferation in organs of the immune system.
lschriml
2011-06-08T01:11:18Z
disease_ontology
DOID:0060083
immune system cancer
A benign neoplasm that is classified by the type of cell or tissue from which it is derived.
lschriml
2011-07-14T11:59:48Z
disease_ontology
DOID:0060084
cell type benign neoplasm
A benign neoplasm that is classified by the organ system from which it is arising from.
lschriml
2011-07-14T12:12:23Z
disease_ontology
DOID:0060085
organ system benign neoplasm
A reproductive organ benign neoplasm that is characterized by a lack of malignancy located_in the female reproductive system.
lschriml
2011-07-14T12:20:52Z
disease_ontology
DOID:0060086
female reproductive organ benign neoplasm
A reproductive organ benign neoplasm that is characterized by a lack of malignancy located_in the male reproductive system.
lschriml
2011-07-14T12:20:52Z
disease_ontology
DOID:0060087
male reproductive organ benign neoplasm
An organ system benign neoplasm that is located_in endocrine glands which secretes a type of hormone directly into the bloodstream to regulate the body.
lschriml
2011-07-14T01:45:15Z
disease_ontology
DOID:0060089
endocrine organ benign neoplasm
A nervous system benign neoplasm that is characterized by lack of malignancy.
lschriml
2011-07-14T01:45:15Z
disease_ontology
DOID:0060090
central nervous system benign neoplasm
An organ system benign neoplasm disease located_in the blood, heart, blood vessels or the lymphatic system.
lschriml
2011-07-14T01:45:15Z
disease_ontology
DOID:0060091
cardiovascular organ benign neoplasm
A connective tissue benign neoplasm that is located_in bone.
lschriml
2011-07-15T01:34:59Z
disease_ontology
DOID:0060094
bone benign neoplasm
A female reproductive organ benign neoplasm that is located_in the uterus.
lschriml
2011-07-15T01:42:11Z
DOID:0060113
disease_ontology
DOID:0060095
uterine benign neoplasm
A nervous system benign neoplasm that is located_in a sensory organ.
lschriml
2011-07-15T01:45:26Z
disease_ontology
DOID:0060096
sensory organ benign neoplasm
An organ system benign neoplam that is located_in the thoracic cavity.
lschriml
2011-07-15T01:55:57Z
disease_ontology
DOID:0060097
thoracic benign neoplasm
A bone benign neoplasm of the bone that is characterized by clinical and histological similarity to osteoid osteomas.
lschriml
2011-07-15T02:14:40Z
MESH:D018215
disease_ontology
DOID:0060098
osteoblastoma
An organ system benign neoplasm that is located_in the muscular and skeletal organs.
lschriml
2011-07-15T02:28:52Z
disease_ontology
DOID:0060099
musculoskeletal system benign neoplasm
An organ system cancer located_in the muscular and skeletal organs and characterized by uncontrolled cellular proliferation of the musculoskeletal organs.
lschriml
2011-07-15T02:30:51Z
DOID:0060124
skeletal system cancer
disease_ontology
DOID:0060100
musculoskeletal system cancer
A cell type benign neoplasm that has_material_basis_in glial cells.
lschriml
2011-07-19T01:27:04Z
disease_ontology
DOID:0060101
benign glioma
A central nervous system cancer of children and young adults that develops from neural crest cells located_in cerebrum, has_material_basis_in abnormally proliferating cells derives_from neuroectoderm.
lschriml
2011-07-21T02:24:10Z
disease_ontology
DOID:0060103
central nervous system primitive neuroectodermal neoplasm
A brain cancer that has_material_basis_in glial cells.
lschriml
2011-07-22T12:42:50Z
lower grade glioma
disease_ontology
DOID:0060108
brain glioma
A female reproductive organ benign neoplasm that is located_in the vulva.
lschriml
2011-07-25T11:50:50Z
disease_ontology
DOID:0060109
vulvar benign neoplasm
A female reproductive organ benign neoplasm that is located_in the ovary.
lschriml
2011-07-25T11:50:50Z
disease_ontology
DOID:0060112
ovarian benign neoplasm
An organ system benign neoplasm that is located_in the central nervous system or located_in the peripheral nervous system.
lschriml
2011-07-25T12:47:43Z
disease_ontology
DOID:0060115
nervous system benign neoplasm
A nervous system cancer that is located in the sensory system.
lschriml
2011-07-25T01:51:56Z
disease_ontology
DOID:0060116
sensory system cancer
A disease of anatomical entity that is located_in the thoracic cavity.
lschriml
2011-07-25T02:23:47Z
disease_ontology
DOID:0060118
thoracic disease
A gastrointestinal system cancer that is located_in the pharynx.
lschriml
2011-07-27T01:26:34Z
MESH:D010610
NCI:C3325
SNOMEDCT_US_2020_03_01:126685009
UMLS_CUI:C0031347
pharyngeal neoplasm
pharynx neoplasm
disease_ontology
pharyngeal cancer
DOID:0060119
pharynx cancer
An organ system benign neoplasm located_in the integumentary system organs.
lschriml
2011-07-27T01:49:44Z
disease_ontology
DOID:0060121
integumentary system benign neoplasm
An organ system cancer that is located_in the skin, hair and nails.
lschriml
2011-07-27T02:31:34Z
disease_ontology
DOID:0060122
integumentary system cancer
A musculoskeletal system benign neoplasm that is located_in connective tissue.
lschriml
2011-07-27T02:35:57Z
DOID:177
MESH:D012983
NCI:C3377
SNOMEDCT_US_2020_03_01:126600002
UMLS_CUI:C0037579
neoplasm of soft tissue
neoplasm of soft tissues
soft tissue benign neoplasm
tumor of the soft tissue
disease_ontology
DOID:0060123
connective tissue benign neoplasm
A hypersensitivity reaction type IV disease that results from a proliferation of cells producing immunoglobulin heavy chains.
lschriml
2011-08-22T11:23:09Z
ICD10CM:C88.2
MESH:D006362
NCI:C3082
NCI:C3083
NCI:C3892
SNOMEDCT_US_2020_03_01:61493004
SNOMEDCT_US_2020_03_01:6381009
SNOMEDCT_US_2020_03_01:68979007
UMLS_CUI:C0018852
UMLS_CUI:C0018854
UMLS_CUI:C0242310
disease_ontology
DOID:0060125
heavy chain disease
MESH:D006362
A heavy chain disease that results from an overproduction of alpha antibodies (IgA).
lschriml
2011-08-22T11:23:09Z
Seligmann's disease
disease_ontology
DOID:0060126
alpha chain disease
A heavy chain disease that results from an overproduction of gamma antibody (IgG).
lschriml
2011-08-22T11:23:09Z
GARD:10346
Franklin's disease
disease_ontology
DOID:0060127
gamma heavy chain disease
A heavy chain disease that results from an overproduction of mu antibody (IgM).
lschriml
2011-08-22T11:23:09Z
disease_ontology
DOID:0060128
mu chain disease
An agnosia that is a deficiency in understanding, processing, or describing emotions.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060131
alexithymia
An agnosia that is a loss of the ability to recognize musical notes, rhythms, and intervals.
lschriml
2011-08-22T12:04:56Z
receptive amusia
disease_ontology
DOID:0060132
amusia
An agnosia that is a loss of the ability to gain feedback about one's own condition or impairments.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060133
anosognosia
An agnosia that is a loss of the ability to distinguish visual shapes.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060134
apperceptive agnosia
An agnosia that is a loss of the ability to map out physical actions in order to repeat them in functional activities.
lschriml
2011-08-22T12:04:56Z
GARD:5838
ICD10CM:R48.2
SNOMEDCT_US_2019_09_01:68345001
disease_ontology
DOID:0060135
apraxia
MESH:D001072
An agnosia that is a loss of the ability to recognize visual scenes or classes of objects but retain the abilty to describe them.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060136
associative agnosia
An agnosia that is a loss of the ability to distinguishing environmental and non-verbal auditory cues including difficulty distinguishing speech from non-speech sounds even though hearing is usually normal.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060137
auditory agnosia
An agnosia that is a loss of the ability to perceive any auditory information but whose hearing is intact.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060140
cortical deafness
An agnosia that is a loss of the ability to distinguish the fingers on the hand.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060141
finger agnosia
An agnosia that is a loss of the ability to perceive a whole object while perceiving only parts of details.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060142
form agnosia
An agnosia that is a loss of the ability to perceive and process pain.
lschriml
2011-08-22T12:04:56Z
analgesia
disease_ontology
DOID:0060145
pain agnosia
An agnosia that is a loss of the ability to recgonize a whole image or scene while retianing the ability to recognize objects or details in their visual field one at a time.
lschriml
2011-08-22T12:04:56Z
GARD:11943
disease_ontology
DOID:0060148
simultanagnosia
An agnosia that is the loss of the ability to recognize objects by touch based on its texture, size and weight.
lschriml
2011-08-22T12:04:56Z
somatosensory agnosia
disease_ontology
DOID:0060150
astereognosia
An agnosia that is a loss of the ability to recognize or identify objects by touch alone.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060151
tactile agnosia
An agnosia that is a loss of the ability to recognising spoken words as semantically meaningful.
lschriml
2011-08-22T12:04:56Z
disease_ontology
DOID:0060154
verbal auditory agnosia
An agnosia that is a loss of the ability to visually recognize objects.
lschriml
2011-08-22T12:04:56Z
MESH:C531604
UMLS_CUI:C2930796
disease_ontology
DOID:0060155
visual agnosia
A disease of metabolism that has _material_basis_in enzyme deficiency or accumulation of enzymes or toxins which interfere with normal function due to an endocrine organ disease, organ malfunction, inadequate intake, dietary deficiency, or malabsorption.
lschriml
2011-08-24T02:53:03Z
disease_ontology
DOID:0060158
acquired metabolic disease
An amino acid metabolic disorder that disrupts normal amino acid metabolism causing a building up of branched-chain amino acids.
lschriml
2011-08-26T11:17:14Z
GARD:9433
organic acid metabolism disorder
organic aciduria
disease_ontology
DOID:0060159
organic acidemia
A spinal muscular atrophy that is associated with the survival of motor neuron protein in childhood.
lschriml
2011-08-29T01:15:14Z
GARD:7674
MESH:D014897
NCI:C85076
ORDO:70
UMLS_CUI:C0700595
spinal muscular atrophies of childhood
survival motor neuron spinal muscular atrophy
disease_ontology
DOID:0060160
childhood spinal muscular atrophy
A spinal muscular dystrophy that has_material_basis_in an X-linked recessive expansion of CAG triplet repeats (glutamine) in exon 1 of AR gene encoding the androgen receptor.
lschriml
2011-08-29T01:31:03Z
GARD:6818
MESH:D055534
NCI:C85233
OMIM:313200
SNOMEDCT_US_2020_03_01:230253001
UMLS_CUI:C1839259
Kennedy disease
SBMA
Spinobulbar Muscular Atrophy
X-Linked Bulbo-Spinal Atrophy
X-linked Spinal and Bulbar Muscular Atrophy
spinal bulbar muscular atrophy
disease_ontology
DOID:0060161
Kennedy's disease
An autosomal dominant cerebellar ataxia that has_material_basis_in expansion of CAG triplet repeats (glutamine) encoding a polyglutamine tract in the atrophin-1 protein.
lschriml
2011-08-29T01:41:48Z
GARD:5643
MESH:D020191
NCI:C122653
OMIM:125370
SNOMEDCT_US_2020_03_01:702422004
UMLS_CUI:C0751781
DRPLA
Haw River Syndrome
Naito-Oyanagi disease
disease_ontology
DOID:0060162
dentatorubral-pallidoluysian atrophy
MESH:D020191
NCI:C122653
UMLS_CUI:C0751781
A somatoform disorder that involves an excessive concern about and preoccupation with a perceived defect in his or her physical features (body image).
lschriml
2011-09-07T01:38:34Z
body dysmorphia
dysmorphic syndrome
dysmorphophobia
disease_ontology
DOID:0060163
body dysmorphic disorder
A somatoform disorder that involves chronic pain in one or more areas, and is thought to be caused by psychological stress.
lschriml
2011-09-07T01:42:46Z
disease_ontology
DOID:0060164
pain disorder
A recurrent hypersomnia that is characterized by recurring periods of excessive amounts of sleep and altered behavior.
lschriml
2011-09-07T02:46:02Z
MESH:D017593
OMIM:148840
disease_ontology
DOID:0060165
Kleine-Levin syndrome
A histidine metabolism disease characterized by a deficiency of the enzyme histidase.
lschriml
2011-09-20T12:47:05Z
GARD:6661
MESH:C538320
OMIM:235800
histidinuria
disease_ontology
DOID:0060168
histidinemia
An infancy electroclinical syndrome that is characterized by convulsions, with onset at age 3 to 12 months.
lschriml
2011-10-28T02:55:02Z
GARD:1518
GARD:857
OMIM:601764
OMIM:605751
OMIM:607745
OMIM:612627
ORDO:306
BFIC
BFIE
benign familial infantile convulsion
benign familial infantile seizures
disease_ontology
DOID:0060169
Xref MGI.
benign familial infantile epilepsy
An adolescence-adult electroclinical syndrome statring between the age of ten to 17 years characterized by the occurrence of typical absence seizures.
lschriml
2011-11-08T10:42:18Z
disease_ontology
DOID:0060172
JA:Epilepsy Genetics Kiel
juvenile absence epilepsy
A syndrome that is characterized by cardiac, hand/foot, facial, and neurodevelopmental features. The two forms are type 1 (classic) and type 2, a rare form that has_material_basis_in mutations in a transcript variant of CACNA1C on chromosome 12p13.33.
lschriml
2011-11-08T12:52:33Z
DOID:0110649
ICD10CM:G72.3
MESH:C536962
OMIM:601005
ORDO:65283
ORDO:768
disease_ontology
DOID:0060173
Timothy syndrome
A gamma-amino butyric acid metabolism disorder that is characterized by a deficiency of succinic semialdehyde dehydrogenase resulting in elevated levels of gamma-hydroxybutyric acid.
lschriml
2011-11-08T02:02:12Z
MESH:C535803
OMIM:271980
4-hydroxybutyric aciduria
SSADH
gamma-hydroxybutyric aciduria
disease_ontology
DOID:0060175
succinic semialdehyde dehydrogenase deficiency
An amino acid metabolic disorder characterized by impairment of the GABA catabolic pathway.
lschriml
2011-11-08T02:02:12Z
disease_ontology
DOID:0060176
gamma-amino butyric acid metabolism disorder
A gamma-amino butyric acid metabolism disorder that is characterized by an excess of homocarnosine in the brain and has_material_basis_in a deficiency of serum carnosinase in its ability to hydrolyze homocarnosine.
lschriml
2011-11-08T02:02:12Z
GARD:2730
MESH:C535328
disease_ontology
DOID:0060177
homocarnosinosis
An inflammatory bowel disease that involves inflammation located_in colon.
emitraka
2014-09-12T14:31:45Z
EFO:0003872
ICD10CM:K52.9
MESH:D003092
NCI:C26723
SNOMEDCT_US_2020_03_01:64226004
UMLS_CUI:C0009319
disease_ontology
DOID:0060180
colitis
An urticaria induced by external physical influences.
emitraka
2014-11-21T15:51:38Z
disease_ontology
DOID:0060220
WD correction.
physical urticaria
A heart conduction disease that is characterized by uncoordinated electrical activity in the heart's upper chambers (the atria), which causes the heartbeat to become fast and irregular and has symptoms palpitations, weakness, fatigue, lightheadedness, dizziness, confusion, shortness of breath and chest pain.
emitraka
2015-01-16T14:55:21Z
ICD9CM:427.31
MESH:D001281
NCI:C50466
SNOMEDCT_US_2020_03_01:266306001
UMLS_CUI:C0004238
A-fib
disease_ontology
DOID:0060224
atrial fibrillation
MESH:D001281
A gastrointestinal system disease that is located_in the gallbladder.
emitraka
2015-02-02T15:48:08Z
DOID:0000000
ICD10CM:K82.9
ICD9CM:575.9
MESH:D005705
NCI:C34631
OMIM:609918
OMIM:609919
OMIM:611465
SNOMEDCT_US_2020_03_01:155807008
UMLS_CUI:C0016977
disease_ontology
DOID:0060262
Xref MGI.
gallbladder disease
A non-syndromic intellectual disability characterized by an autosomal dominant inheritance pattern.
emitraka
2015-02-10T16:47:55Z
GARD:12107
OMIM:PS156200
ORDO:178469
autosomal dominant mental retardation
autosomal dominant non-syndromic mental retardation
disease_ontology
DOID:0060307
NT MGI.
autosomal dominant non-syndromic intellectual disability
A syndromic intellectual characterized by an X-linked inheritance pattern.
emitraka
2015-02-11T16:14:46Z
OMIM:PS309510
syndromic X-linked mental retardation
disease_ontology
DOID:0060309
NT MGI.
syndromic X-linked intellectual disability
A syndrome associated with mutations encoding defective proteins, which result in either abnormal function formation or function of cilia.
emitraka
2015-05-21T10:41:29Z
disease_ontology
DOID:0060340
ciliopathy
A chromosomal disease that has_material_basis_in partial deletion of chromosomes.
elvira
2015-09-28T15:48:41Z
disease_ontology
DOID:0060388
chromosomal deletion syndrome
A chromosomal disease that has_material_basis_in extra copies of a chromosomal region.
elvira
2015-10-02T15:19:23Z
disease_ontology
DOID:0060429
chromosomal duplication syndrome
A corneal dystrophy that is characterized by abnormal deposition of proteins in the cornea and is caused by mutations in TGFBI gene of chromosome 5q.
elvira
2015-10-16T16:39:25Z
disease_ontology
DOID:0060441
epithelial-stromal TGFBI dystrophy
A corneal dystrophy that affects the corneal stroma.
elvira
2015-10-16T16:39:25Z
disease_ontology
DOID:0060442
stromal dystrophy
A corneal dystrophy that affects the corneal endothelium and/or the descemet membrane.
elvira
2015-10-16T16:39:25Z
endothelial dystrophy
disease_ontology
DOID:0060443
corneal endothelial dystrophy
An allergic disease that is located_in the respiratory tract.
airway allergy
disease_ontology
DOID:0060496
respiratory allergy
An allergic disease that is located_in the gastrointestinal tract.
disease_ontology
DOID:0060502
gastrointestinal allergy
A food allergy triggered by a plant fruit product.
disease_ontology
DOID:0060503
fruit allergy
A bone disease that is located_in the spine.
disease_ontology
DOID:0060564
spinal disease
A syndrome that is characterized by abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease.
GARD:9226
OMIM:PS605552
disease_ontology
DOID:0060611
abdominal obesity-metabolic syndrome
An ichthyosis that is characterized by autosomal recessive inheritance and abnormal skin scaling over the whole body due to a defect in keratinization.
DOID:1699
ICD10CM:Q80.2
MESH:D017490
NCI:C84805
OMIM:PS242300
ORDO:281097
SNOMEDCT_US_2020_03_01:12215009
UMLS_CUI:C0079154
ARCI
lamellar ichthyosis
non bullous congenital ichthyosiform erythroderma
disease_ontology
DOID:0060655
autosomal recessive congenital ichthyosis
A congenital nervous system abnormality characterized by failure of the anterior neuropore to close resulting in partial or complete absence of the cranial vault accompanied by absence of overlying tissues, including the brain and cerebral hemispheres, skull and scalp.
GARD:5808
ICD10CM:Q00.0
OMIM:206500
ORDO:1048
disease_ontology
DOID:0060668
anencephaly
MESH:D000757
A leukodystrophy characterized by T2 hyperintensity and T1 iso- or hyperintensity of affected white matter in the central nervous system.
OMIM:PS312080
HLD
disease_ontology
DOID:0060786
hypomyelinating leukodystrophy
A syndrome that has_material_basis_in homozygous deletion on chromosome 2p21 that disrupts the SLC3A1 and PREPL genes. The deletion ranges in size from 23.8 to 75.5 kb. Itis characterized_by neonatal and infantile hypotonia and failure to thrive, cystinuria type 1 and nephrolithiasis, growth retardation due to growth hormone deficiency, and minor facial dysmorphism.
ICD10CM:E72.0
OMIM:606407
ORDO:163690
cystinuria with mitochondrial disease
disease_ontology
DOID:0060858
hypotonia-cystinuria syndrome
A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.
ICD10CM:A02.0
ICD9CM:003.0
Salmonella infection
disease_ontology
DOID:0060859
salmonellosis
A vascular disease caused by the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system.
MESH:D013927
disease_ontology
DOID:0060903
thrombosis
A fruit allergy triggered by Fabaceae (legume) plant fruit or seed food product.
Fabaceae allergy
disease_ontology
DOID:0060904
legume allergy
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from precursor cells called blast cells.
disease_ontology
DOID:0070003
blastoma
A bone marrow cancer that is formed of any one of the bone marrow cells belonging to the granulocytic (neutrophil, eosinophil, basophil), monocytic/macrophage, erythroid, megakaryocytic and mast cell lineages.
myeloma
disease_ontology
DOID:0070004
myeloid neoplasm
An electroclinical syndrome characterized by the occurrence of generalized onset seizures that cause lapses in awareness, begin and end abruptly, typically last only a few seconds and are associated with abnormal spike-wave discharges as seen by electroencephalogram.
MESH:D004832
disease_ontology
DOID:0070309
absence epilepsy
A nutritional deficiency disease that is characterized by low levels of thiamine.
NCI:C34418
SNOMEDCT_US_2020_03_01:399357009
disease_ontology
DOID:0070313
thiamine deficiency disease
A mitochondrial metabolism disease that is characterized by significant reduction in mitochondrial DNA in affected tissues, resulting in impaired mtDNA-encoded protein synthesis and energy production in the affected tissues and organs.
GARD:13643
OMIM:PS603041
ORDO:35698
mtDNA depletion syndrome
disease_ontology
DOID:0070329
mitochondrial DNA depletion syndrome
A musculoskeletal system disease that affects the muscles.
disease_ontology
DOID:0080000
muscular disease
A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function.
DOID:1290
ICD10CM:M89.9
MESH:D001847
SNOMEDCT_US_2020_03_01:76069003
UMLS_CUI:C0005940
disease_ontology
skeletal disease
DOID:0080001
bone disease
A bone disease that results_in formation or resorption abnormalities located_in bone.
disease_ontology
DOID:0080005
bone remodeling disease
A bone disease that results_in abnormal growth and development located_in bone or located_in cartilage.
disease_ontology
DOID:0080006
bone development disease
A bone structure disease that results_in change or damage of structure located_in bone.
disease_ontology
DOID:0080007
bone deterioration disease
A bone disease that results_in an interruption of blood supply located_in bone.
disease_ontology
DOID:0080008
ischemic bone disease
A X-linked monogenic disease that has_material_basis_in dominant inheritance.
disease_ontology
DOID:0080009
X-linked dominant disease
A bone disease that has_material_basis_in an abnormality in the location or function of the skeletal structure.
disease_ontology
DOID:0080010
bone structure disease
A bone remodeling disease that results in an abnormal decrease of bone density or mass.
MESH:D001862
disease_ontology
DOID:0080011
bone resorption disease
A X-linked monogenic disease that has_material_basis_in recessive inheritance.
disease_ontology
DOID:0080012
X-linked recessive disease
A genetic disease that has_material_basis_in extra, missing, or re-arranged chromosomes.
disease_ontology
DOID:0080014
chromosomal disease
A disease that has_material_basis_in a genetic abnormality, error with embryonic development, infection or compromised intrauterine environment.
congenital disorder
disease_ontology
DOID:0080015
physical disorder
A neural tube defect that is characterized by incomplete closing of the spine and membranes around the spinal cord during early development.
GARD:7673
ICD10CM:Q05
ICD9CM:741
MESH:D016135
NCI:C101214
SNOMEDCT_US_2020_03_01:156888006
UMLS_CUI:C0080178
disease_ontology
DOID:0080016
spina bifida
MESH:D016135
NCI:C101214
An osteochondrodysplasia that is characterized by abnormally broad ends of the arm and leg long bones resembling a boat oar or paddle due to enlargement of the spongy inner layer of bone.
OMIM:215050
Bakwin-Krida syndrome
Pyle's disease
Pyle-Cohn syndrome
disease_ontology
DOID:0080019
metaphyseal dysplasia
An osteochondrodysplasia that results_in abnormalities of bone growth located_in vertebral column, located_in epiphysis, located_in metaphysis.
disease_ontology
DOID:0080027
spondyloepimetaphyseal dysplasia
A bone remodeling disease that results_in the destruction of normal bone and replacing it with fibrous bone tissue.
GARD:6444
disease_ontology
DOID:0080031
fibrous dysplasia
An osteosclerosis that is characterized by hyperostosis and sclerosis of the craniofacial bones associated with abnormal modeling of the metaphyses.
OMIM:PS123000
ORDO:1522
disease_ontology
DOID:0080033
Xref MGI.
craniometaphyseal dysplasia
A hyperostosis that has_material_basis_in a mutation in the SOST gene which results_in overgrowth of endosteal bone producing dense and wide bones throughout the body especially located_in skull.
DOID:0080035
OMIM:239100
ORDO:3152
van Buchem disease
disease_ontology
DOID:0080036
SOST-related sclerosing bone dysplasia
An osteochondrodysplasia that has_material_basis_in a mutation in the CTSK gene which results_in dwarfism, brittle bones, osteopetrosis, shortening of the distal phalanges.
GARD:4611
MESH:D058631
OMIM:265800
ORDO:763
disease_ontology
DOID:0080038
pycnodysostosis
An osteochondrodysplasia that has_material_basis_in mutation in the FGFR3 gene which affects ossification of cartilage and results_in short limb dwarfism.
GARD:6724
ICD10CM:Q77.4
MESH:C562937
NCI:C118697
OMIM:146000
ORDO:429
SNOMEDCT_US_2020_03_01:205468002
UMLS_CUI:C0410529
disease_ontology
DOID:0080041
hypochondroplasia
An osteochondrodysplasia that has_material_basis_in deficient endochondral ossification which results_in dwarfism, short-trunk, short-limbed, anascara, disaprportionately large cranium, and a narrow chest which leads to death in utero or during early neonatal period.
GARD:2882
OMIM:PS200600
disease_ontology
DOID:0080043
achondrogenesis
An osteochondrodysplasia that has_material_basis_in a mutation in the COL2A1 gene which results_in dwarfism with a short trunk and limbs as well as vision and hearing problems. The disease has_symptom large joints, has_symptom wide set eyes, has_symptom round flat face.
GARD:6841
MESH:C537207
OMIM:156550
disease_ontology
DOID:0080045
Kniest dysplasia
A syndrome that is characterized by a distinctive facial appearance, eye abnormalities, hearing loss, and joint problems.
GARD:10782
OMIM:PS108300
ORDO:828
disease_ontology
DOID:0080046
OMIM mapping confirmed by DO. [SN].
Stickler syndrome
An osteochondrodysplasia that has_material_basis_in mutations in the COMP gene which results_in short limb dwarfism.
DOID:14800
GARD:4540
MESH:C535819
OMIM:177170
PSEUDOACHONDROPLASIA
SPONDYLOEPIPHYSEAL DYSPLASIA, PSEUDOACHONDROPLASTIC
pseudoachondroplastic dysplasia
disease_ontology
DOID:0080047
OMIM mapping confirmed by DO. [SN].
pseudoachondroplasia
An osteochondrodysplasia that has_material_basis_in mesomelia and acromelia, which results_in short limb dwarfism.
GARD:6
ORDO:93437
disease_ontology
DOID:0080049
acromesomelic dysplasia
A colonic disease that is characterized by bowel obstruction resulting from impairment of the muscle contractions that move food through the digestive tract.
lschriml
2015-10-19T14:28:30Z
DOID:3878
GARD:12744
GARD:6789
MESH:D007418
NCI:C34733
ORDO:2978
SNOMEDCT_US_2020_03_01:715201005
UMLS_CUI:C0021847
Chronic intestinal pseudo-obstruction
neuronal intestinal dysplasia
disease_ontology
DOID:0080072
intestinal pseudo-obstruction
A physical disorder characterized by incomplete closure of the neural tube.
lschriml
2015-10-19T14:41:42Z
GARD:4016
OMIM:301410
OMIM:601634
disease_ontology
DOID:0080074
neural tube defect
A mitochondrial DNA depletion syndrome that is characterized by a clinical triad of psychomotor retardation, intractable epilepsy, and liver failure in infants and young children, and has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the nuclear gene encoding mitochondrial DNA polymerase gamma on chromosome 15q26.
DOID:1442
GARD:5783
ICD10CM:G31.81
MESH:D002549
NCI:C35257
OMIM:203700
ORDO:726
SNOMEDCT_US_2020_03_01:20415001
UMLS_CUI:C0205710
Alper's syndrome
Alpers disease
Alpers progressive infantile poliodystrophy
Alpers syndrome
Alpers' disease or gray-matter degeneration
Diffuse Cerebral Sclerosis of Schilder
mitochondrial DNA depletion syndrome 4a
progressive sclerosing poliodystrophy
disease_ontology
DOID:0080122
Alpers-Huttenlocher syndrome
MESH:D002549
A mitochondrial DNA depletion syndrome that is characterized by progressive ataxia, hypotonia, hyporeflexia, athetosis and sensory impairment and has_material_basis_in autosomal recessive homozygous or compound heterozygous mutation in the C10ORF2 gene, which encodes the twinkle and twinky proteins, on chromosome 10q24.
DOID:0050556
GARD:4062
MESH:C535523
OMIM:271245
OHAHA SYNDROME
infantile onset spinocerebellar ataxia
disease_ontology
DOID:0080126
mitochondrial DNA depletion syndrome 7
A lipid storage disease characterized by lysosomal and lipase deficiency.
OMIM:278000
disease_ontology
DOID:0080217
lysosomal and lipase deficiency
A central nervous system benign neoplasm the is located_in the peripheral nervous system.
disease_ontology
DOID:0080320
peripheral nervous system benign neoplasm
A peripheral nervous system benign neoplasm that is located_in the autonomic nervous system.
disease_ontology
DOID:0080321
autonomic nervous system benign neoplasm
A cystic kidney disease that is characterized by the growth of fluid-filled cysts in the kidneys that reduces kidney function and may lead to kidney failure.
OMIM:PS173900
disease_ontology
DOID:0080322
polycystic kidney disease
A gastrointestinal system cancer that is located_in the hepatobiliary system.
disease_ontology
DOID:0080355
hepatobiliary system cancer
A cell type cancer that is composed_of epithelial tissue in which tumor cells form glands or glandlike structures, representing an early form of colorectal cancer.
disease_ontology
DOID:0080364
malignant adenoma
A male reproductive system disease that is located_in the epididymis.
disease_ontology
DOID:0080373
epididymis disease
A peroxisomal biogenesis disorder that has_material_basis_in defects in PEX genes.
DOID:0080378
OMIM:PS214100
disease_ontology
DOID:0080377
peroxisomal biogenesis disorder
An early infantile epileptic encephalopathy that has_material_basis_in heterozygous mutation in the SCN1A gene on chromosome 2q24.
DOID:0060171
GARD:10430
OMIM:607208
ORDO:33069
early infantile epileptic encephalopathy 6
disease_ontology
DOID:0080422
Dravet syndrome
A lipid storage disease that is characterized by increased storage of carbohydrates and lipids.
disease_ontology
DOID:0080488
mucolipidosis
A thyroid gland carcinoma that derives_from epithelial cells of glandular origin.
NCI:C27380
disease_ontology
DOID:0080524
thyroid gland adenocarcinoma
A thyroid gland adenocarcinoma characterized by extensive evidence of follicular cell differentiation.
NCI:C7153
disease_ontology
DOID:0080525
differentiated thyroid gland carcinoma
A hyperimmunoglobin syndrome that is characterized by an immune system that fails to produce normal levels of the antibodies IgA, IgG and IgE but can produce normal or elevated levels of IgM.
NCI:C3990
OMIM:PS308230
immunodeficiency with hyper-IgM
disease_ontology
DOID:0080544
hyper IgM syndrome
A hyperimmunoglobulin syndrome that is characterized by eczema, distinct facial features, a tendency to experience bone fractures and recurrent bacterial infections of the skin and lungs.
GARD:10956
OMIM:PS147060
hyper immunoglobulin E syndrome
disease_ontology
DOID:0080545
hyper IgE syndrome
A viral infectious disease that has_material_basis_in Coronavirus.
disease_ontology
DOID:0080599
Coronavirus infectious disease
A benign neoplasm that derives_from germ cells.
disease_ontology
DOID:0080601
germ cell benign neoplasm
A germ cell benign neoplasm that derives_from mature tissue elements or a limited amount of immature tissue elements.
NCI:C67107
disease_ontology
DOID:0080602
benign teratoma
A kidney benign neoplasm that is located_in the kidney cortex.
benign nephroma
disease_ontology
DOID:0080615
nephroma
A kidney disease that is located_in the kidney cortex.
disease_ontology
DOID:0080616
kidney cortex disease
A sensory system benign neoplasm that is located in the auditory system.
NCI:C8417
disease_ontology
DOID:0080619
auditory system benign neoplasm
A B-cell acute lymphoblastic leukemia that is characterized by the presence of too many B-cell lymphoblasts in the blood and bone marrow.
DOID:7061
NCI:C8936
UMLS_CUI:C0862030
B-ALL
precursor B lymphoblastic lymphoma/leukemia
disease_ontology
DOID:0080630
B-lymphoblastic leukemia/lymphoma
An acute lymphocytic leukemia characterized by too many B-cell lymphoblasts (immature white blood cells) in the bone marrow and blood.
NCI:C8644
B acute lymphoblastic leukemia
B-cell acute lymphocytic leukemia
disease_ontology
DOID:0080638
B-cell acute lymphoblastic leukemia
A bone cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.
disease_ontology
DOID:0080639
bone sarcoma
A syndrome that has_material_basis_in mutations in genes that alter the Ras subfamily and mitogen-activated protein kinases that control signal transduction.
RAS/mitogen-activated protein kinase syndrome
disease_ontology
DOID:0080690
RASopathy
An asthma that is characterized by severe and sudden onset of increasing wheezing, airways closing, smooth muscle contraction, mucus plugging and lower airway edema that may be reversible upon treatment.
disease_ontology
DOID:0080810
acute asthma
A malignant glioma that originate from two types of glial cells, astrocytes and oligodendrocytes.
NCI:C132067
disease_ontology
DOID:0080829
low-grade glioma
A low-grade glioma that occurs in children and encompasses tumors of astrocytic, oligodendroglial, and mixed glial-neuronal histology.
disease_ontology
DOID:0080830
pediatric low-grade glioma
A hypogonadism characterized by a impaired signalling by gonadotrpin relasing hormone.
DOID:7455
ICD10CM:E23.0
OMIM:PS147950
ORDO:432
ORDO:478
congenital idiopathic hypogonadotropic hypogonadism
hypogonadotropism
isolated congenital gonadotropin deficiency
disease_ontology
DOID:0090070
hypogonadotropic hypogonadism
A neuronal ceroid lipofuscinosis that is characterized by juvenile-onset of progressive dementia, seizures, and progressive visual failure and an ultrastructural pattern of lipopigment with a 'fingerprint' profile and has_material_basis_in homozygous or compound heterozygous mutation in the CLN3 gene on chromosome 16p11.
DOID:0050756
GARD:5897
ICD10CM:E75.4
OMIM:204200
ORDO:228346
Batten disease
CLN3
juvenile neuronal ceroid lipofuscinosis
disease_ontology
DOID:0110731
neuronal ceroid lipofuscinosis 3
A neurodegenerative disease characterized by progressive iron accumulation in the basal ganglia and other regions of the brain, resulting in extrapyramidal movements, such as parkinsonism and dystonia.
GARD:11899
MESH:C538421
OMIM:PS234200
ORDO:385
UMLS_CUI:C2931845
NBIA
disease_ontology
DOID:0110734
neurodegeneration with brain iron accumulation
A congenital muscular dystrophy-dystroglycanopathy type A characterized by cobblestone lissencephaly, muscle weakness, and brain and eye anomalies that has_material_basis_in autosomal recessive inheritance a defect in alpha-dystroglycan post-translational processing.
OMIM:PS236670
ORDO:352687
MDDGA
congenital muscular alpha-dystroglycanopathy with brain and eye anomalies
klissencephaly type 2 with muscular and ocular involvement
disease_ontology
DOID:0111229
congenital muscular dystrophy-dystroglycanopathy type A
A familial hyperlipidemia characterized by hypertriglyceridemia and fasting chylomicronemia.
ORDO:444490
disease_ontology
DOID:0111417
familial chylomicronemia syndrome
A syndrome characterized by facial, limbs and genital anomalies, and a disproportionate acromelic short stature.
ORDO:915
Aarskog-Scott syndrome
faciodigitogenital syndrome
faciogenital dysplasia
disease_ontology
DOID:0111824
Aarskog syndrome
A syndrome characterized by sparse, brittle, sulfur-deficient hair that is easily broken and in more severe cases delayed development, significant intellectual disability, and recurrent infections.
MESH:D054463
NCI:C4924
ORDO:33364
SNOMEDCT_US_2020_03_01:723551003
UMLS_CUI:C1955934
TTD
disease_ontology
DOID:0111866
trichothiodystrophy
A trichothiodystrophy characterized by absence of extreme sensitivity to UV radiation.
disease_ontology
DOID:0111867
nonphotosensitive trichothiodystrophy
A primary immunodeficiency disease that involves multiple components of the immune system.
disease_ontology
DOID:0111962
combined immunodeficiency
An intestinal disease that involves intestinal infection that has_material_basis_in viruses, bacteria, fungi and parasites.
DOID:10960
DOID:12509
DOID:5270
ICD10CM:A00-A09
ICD9CM:001-009.99
SNOMEDCT_US_2020_03_01:187266003
UMLS_CUI:C0178238
bacterial enteritis
disease_ontology
DOID:100
Updating outdated UMLS CUI.
intestinal infectious disease
DOID:11053
DOID:12112
DOID:12114
ICD9CM:389.1
MESH:D006319
NCI:C26739
SNOMEDCT_US_2020_03_01:60700002
UMLS_CUI:C0018784
High Frequency Hearing Loss
High frequency deafness
Perceptive deafness
Perceptive hearing loss
Perceptive hearing loss or deafness
Sensorineural Deafness
Sensory hearing loss
central hearing loss
high-frequency hearing loss
disease_ontology
DOID:10003
sensorineural hearing loss
MESH:D006319
NCI:C5265
UMLS_CUI:C1336753
disease_ontology
DOID:10011
thyroid lymphoma
A multiple endocrine neoplasia that has_material_basis_in a mutation in the MEN1 tumor suppressor gene and is characterized by over active endocrine glands frequently involving tumors of the parathyroid glands, the pituitary gland, and the pancreas.
GARD:3829
ICD10CM:E31.21
ICD9CM:258.01
MESH:D018761
NCI:C3225
OMIM:131100
ORDO:652
SNOMEDCT_US_2020_03_01:30664006
UMLS_CUI:C0025267
MEN type I
Wermer syndrome
Wermer's syndrome
disease_ontology
DOID:10017
OMIM mapping confirmed by DO. [SN].
multiple endocrine neoplasia type 1
An endometrial disease that is characterized by inflammation of the endometrium.
MESH:D004716
NCI:C26764
SNOMEDCT_US_2020_03_01:155975003
UMLS_CUI:C0014179
disease_ontology
DOID:1002
endometritis
ICD10CM:C24.1
ICD9CM:156.2
NCI:C3536
SNOMEDCT_US_2020_03_01:93668007
UMLS_CUI:C0153454
malignant tumour of ampulla of vater
disease_ontology
DOID:10020
ampulla of Vater cancer
A small intestine cancer that is located_in the beginning section of the small intestine.
DOID:6072
ICD10CM:C17.0
ICD9CM:152.0
MESH:D004379
NCI:C4803
NCI:C9328
SNOMEDCT_US_2020_03_01:254570009
SNOMEDCT_US_2020_03_01:363403002
UMLS_CUI:C0153426
UMLS_CUI:C0541912
Duodenal cancer
cancer of duodenum
duodenal neoplasm
disease_ontology
DOID:10021
duodenum cancer
A migraine characterized by migraine headache which is preceded or accompanied by a transient focal neurological phenomenon.
DOID:10025
ICD10CM:G43.1
ICD9CM:346.0
MESH:D020325
NCI:C117005
OMIM:609179
OMIM:609670
SNOMEDCT_US_2020_03_01:155047002
UMLS_CUI:C0154723
classic migraine
disease_ontology
DOID:10024
Xref MGI.
migraine with aura
A tertiary neurosyphilis that results in slow degeneration of the nerve cells and nerve fibers that carry sensory information to the brain. The infection has symptom intense, stabbing pain in the back and legs that recurs irregularly, has symptom gait ataxia, has symptom hyperesthesia, has symptom paresthesia, has symptom loss of bladder sensation leading to urine retention, has symptom erectile dysfunction.
GARD:8730
ICD10CM:A52.11
ICD9CM:094.0
MESH:D013606
NCI:C35057
SNOMEDCT_US_2020_03_01:266134000
UMLS_CUI:C0039223
Posterior spinal sclerosis
Tabes dorsalis - neurosyphilis
disease_ontology
DOID:10027
tabes dorsalis
A female reproductive system disease that is characterized by an infection of the female reproductive organs.
ICD10CM:N73.9
ICD9CM:614.9
MESH:D000292
NCI:C3889
SNOMEDCT_US_2020_03_01:266648001
UMLS_CUI:C0242172
PID
disease_ontology
DOID:1003
pelvic inflammatory disease
ICD10CM:H52.52
ICD9CM:367.51
SNOMEDCT_US_2020_03_01:68158006
UMLS_CUI:C0235238
Ciliary muscle paresis
Cycloplegic paralysis of accommodation
Paresis of accommodation
disease_ontology
DOID:10033
cycloplegia
An eye disease that is characterized by decreased ability to change the optical power of the eye to maintain a clear image.
ICD10CM:H52.5
ICD9CM:367.5
SNOMEDCT_US_2020_03_01:155137002
UMLS_CUI:C0152198
disease_ontology
DOID:10034
eye accommodation disease
MESH:D004416
UMLS_CUI:C0205747
FAMM syndrome
familial atypical multiple mole-melanoma
disease_ontology
DOID:10041
OMIM mapping confirmed by DO. [SN].
dysplastic nevus syndrome
A melanoma that is characterized as highly aggressive and manifests as a uniform blue-black, blue-red, or amelanotic nodule.
GARD:9961
NCI:C4225
SNOMEDCT_US_2020_03_01:2142002
UMLS_CUI:C0334424
nodular melanoma
disease_ontology
DOID:10047
nodular malignant melanoma
A uterine disease that is located_in the endometrium.
NCI:C3504
SNOMEDCT_US_2020_03_01:418632009
UMLS_CUI:C0151622
disease_ontology
DOID:1005
endometrial disease
NCI:C4426
SNOMEDCT_US_2020_03_01:126696001
UMLS_CUI:C0345746
Subglottic tumor
disease_ontology
DOID:10069
subglottis neoplasm
A parasitic helminthiasis infectious disease that involves infection of the bowel by Hymenolepis nana or Hymenolepis diminuta. The symptoms include diarrhea, gastrointestinal discomfort, itchy anus, poor appetite and weakness.
GARD:2787
ICD10CM:B71.0
ICD9CM:123.6
MESH:D006925
NCI:C84768
SNOMEDCT_US_2020_03_01:187153007
UMLS_CUI:C0020413
Hymenolepis infectious disease
dwarf tapeworm infection
disease_ontology
DOID:10074
hymenolepiasis
A parasitic helminthiasis infectious disease that involves parasitic infection caused by Diphyllobothrium latum through the consumption of raw or undercooked fish. The symptoms include abdominal discomfort, diarrhea, vomiting, weight loss and vitamin B12 deficiency with pernicious anemia.
GARD:942
ICD10CM:B70.0
ICD9CM:123.4
MESH:D004169
NCI:C128391
SNOMEDCT_US_2020_03_01:187151009
UMLS_CUI:C0012561
DiphylloboInOwlthrium infection
fish tapeworm
disease_ontology
DOID:10075
diphyllobothriasis
MESH:D004169
A taeniasis that results from ingestion of eggs or larvae of the Taenia solium tapeworm in undercooked pork or fecally contaminated food or water, which subsequently infect the central nervous system, heart, muscles, subcutaneous tissues, and eyes. Neurocysticercosis causes seizures, mental disturbances, focal neurologic deficits and intracerebral lesions.
DOID:10078
DOID:14424
GARD:8194
ICD10CM:B69
ICD9CM:123.1
MESH:D003551
NCI:C34520
SNOMEDCT_US_2020_03_01:59051007
UMLS_CUI:C0010678
Pork tapeworm infection
Tapeworm infection: intestinal taenia solum
Tapeworm infection: pork
intestinal taenia solium infection
neurocysticercosis
tenia solium infectious disease
disease_ontology
DOID:10079
cysticercosis
A parasitic helminthiasis infectious disease that involves parasitic infection by the genus Spirometra. A painful nodule develops after the plerocercoid larvae migrate to the brain causing cerebral sparganosis. Subcutaneous tissue, breast, orbit, urinary tract, pleural cavity, lungs, abdominal viscera and inner ear can be infected.
ICD10CM:B70.1
ICD9CM:123.5
MESH:D013031
NCI:C35030
SNOMEDCT_US_2020_03_01:187152002
UMLS_CUI:C0037753
Infection by Sparganum
Sparganosis
disease_ontology
DOID:10080
sparganosis
MESH:D013031
A central nervous system disease that is located_in the skull and is characterized by a collection of pus (infected material) inside the skull.
ICD9CM:324.0
NCI:C34734
SNOMEDCT_US_2020_03_01:192738001
UMLS_CUI:C0021874
disease_ontology
DOID:10095
intracranial abscess
A trypanosomiasis that results from infection by Trypanosoma brucei and gambiense, which is transmitted by the bite of an infected tsetse fly (Glossina spp). The symptoms include fever, headache, joint pain, itching, confusion, sensory disturbances, poor coordination and sleep disturbances.
ICD10CM:B56
ICD9CM:086.5
KEGG:05143
MESH:D014353
NCI:C84541
SNOMEDCT_US_2020_03_01:27031003
UMLS_CUI:C0041228
African sleeping sickness
African trypanosomiasis
disease_ontology
DOID:10112
sleeping sickness
A parasitic protozoa infectious disease that involves infection caused by parasitic protozoan of the genus Trypanosoma in animals and humans.
ICD10CM:B57.2
ICD9CM:086
MESH:D014352
SNOMEDCT_US_2020_03_01:266205000
UMLS_CUI:C0041227
disease_ontology
DOID:10113
trypanosomiasis
A skin disease that is characterized by discoloration of the skin.
ICD9CM:709.09
UMLS_CUI:C0375489
disease_ontology
DOID:10123
pigmentation disease
An eye disease that affects the cornea, which is the transparent surface of the eye that assists in light refraction.
DOID:2284
ICD10CM:H18.9
ICD9CM:371.9
MESH:D003316
NCI:C26731
SNOMEDCT_US_2020_03_01:15250008
UMLS_CUI:C0010034
disease_ontology
DOID:10124
corneal disease
A corneal disease characterized by structural changes within the cornea causing it to thin and change, leading to a protruding conical shape.
GARD:6824
ICD10CM:H18.6
ICD9CM:371.6
MESH:D007640
NCI:C26806
OMIM:148300
OMIM:608586
OMIM:608932
OMIM:609271
OMIM:614622
OMIM:614623
OMIM:614628
OMIM:614629
ORDO:156071
SNOMEDCT_US_2020_03_01:267733008
UMLS_CUI:C0022578
conical cornea
disease_ontology
DOID:10126
Xref MGI.
keratoconus
A vein disease that is characterized by impaired flow of blood through the veins.
ICD9CM:459.81
MESH:D014689
NCI:C127822
SNOMEDCT_US_2020_03_01:20696009
UMLS_CUI:C0042485
peripheral venous insufficiency
disease_ontology
DOID:10128
venous insufficiency
ICD9CM:302.79
UMLS_CUI:C0033951
disease_ontology
DOID:10132
psychosexual disorder
ICD10CM:E50.7
ICD9CM:375.15
MESH:D014985
NCI:C34503
SNOMEDCT_US_2020_03_01:193887002
UMLS_CUI:C0043349
Conjunctival xerosis
disease_ontology
DOID:10138
xerophthalmia
ICD10CM:H11.10
ICD9CM:372.50
SNOMEDCT_US_2020_03_01:40787005
UMLS_CUI:C0155160
disease_ontology
DOID:10139
conjunctival degeneration
A lacrimal apparatus disease that is characterized by persistent irritation or burning of the coreneal surface.
ICD10CM:H04.12
MESH:D015352
NCI:C34553
SNOMEDCT_US_2020_03_01:193980001
UMLS_CUI:C0013238
Tear film insufficiency
dry eye disease
disease_ontology
DOID:10140
dry eye syndrome
MESH:D015352
An intestinal cancer that is located_in the small intestine.
GARD:9385
ICD10CM:C17
ICD9CM:152.9
NCI:C7523
SNOMEDCT_US_2020_03_01:363509000
UMLS_CUI:C0153425
disease_ontology
DOID:10154
small intestine cancer
A gastrointestinal system cancer that is located_in the intestine.
ICD10CM:C26.0
ICD9CM:159.0
MESH:D007414
NCI:C4572
SNOMEDCT_US_2020_03_01:93838000
UMLS_CUI:C0346627
malignant intestinal tumors
malignant neoplasm of intestine
disease_ontology
DOID:10155
intestinal cancer
An ischemic bone disease that results_in necrosis located_in bone.
DOID:10160
DOID:10161
DOID:10162
DOID:10163
DOID:10164
DOID:4128
DOID:8380
DOID:86
ICD10CM:M87
ICD10CM:M87.9
ICD9CM:732.3
ICD9CM:733.41
ICD9CM:733.42
ICD9CM:733.43
ICD9CM:733.44
MESH:D010020
NCI:C34404
NCI:C34841
NCI:C34880
NCI:C35226
NCI:C35517
SNOMEDCT_US_2020_03_01:156837008
SNOMEDCT_US_2020_03_01:17926002
SNOMEDCT_US_2020_03_01:240196003
SNOMEDCT_US_2020_03_01:29281007
SNOMEDCT_US_2020_03_01:43453000
SNOMEDCT_US_2020_03_01:62100001
SNOMEDCT_US_2020_03_01:83453001
UMLS_CUI:C0003977
UMLS_CUI:C0027543
UMLS_CUI:C0029445
UMLS_CUI:C0158442
UMLS_CUI:C0158449
UMLS_CUI:C0158450
UMLS_CUI:C0158451
UMLS_CUI:C0745048
Avascular necrosis of bone
aseptic necrosis
bone necrosis
disease_ontology
DOID:10159
osteonecrosis
A skin benign neoplasm that derives_from fat cells.
DOID:10198
DOID:3943
ICD9CM:214.0
NCI:C4616
NCI:C5566
SNOMEDCT_US_2020_03_01:255187008
SNOMEDCT_US_2020_03_01:93159009
UMLS_CUI:C0153968
UMLS_CUI:C0347394
UMLS_CUI:C1333174
Cutaneous Lipoma
Lipoma of skin
cutaneous lipomatous tumor
lipoma of face
disease_ontology
DOID:10188
skin lipoma
A bone inflammation disease that has_material_basis_in infection located_in bone or located_in bone marrow.
DOID:1018
DOID:1020
DOID:10281
DOID:10282
DOID:10692
DOID:10860
DOID:1164
DOID:11788
DOID:11959
DOID:12011
DOID:13673
DOID:13674
DOID:13675
DOID:13678
DOID:13684
DOID:13737
DOID:14003
DOID:14100
DOID:14166
DOID:2249
DOID:2250
DOID:5858
DOID:9456
GARD:7286
ICD9CM:730.1
SNOMEDCT_US_2020_03_01:203181001
UMLS_CUI:C0008707
disease_ontology
DOID:1019
osteomyelitis
A breast benign neoplasm that is composed of lipocytes.
NCI:C4647
SNOMEDCT_US_2020_03_01:276891009
UMLS_CUI:C0349565
Lipoma of breast
disease_ontology
DOID:10199
breast lipoma
EFO:0004799
ICD9CM:574.5
SNOMEDCT_US_2020_03_01:197397004
UMLS_CUI:C0006739
disease_ontology
DOID:10211
cholelithiasis
A myositis that results_in inflammation located_in muscle or located_in skin where a skin rash is often seen prior to the onset of muscle weakness. The disease may result from either a viral infection or an autoimmune reaction.
GARD:6263
ICD10CM:M33
ICD9CM:710.3
MESH:D003882
NCI:C26744
SNOMEDCT_US_2020_03_01:38826005
UMLS_CUI:C0011633
Polymyositis with skin involvement
dermatopolymyositis
disease_ontology
Amyopathic dermatomyositis
Amyopathic dermatomyositis
DOID:10223
MESH:C538250 added from NeuroDevNet [WAK].
dermatomyositis
ICD10CM:I70.0
ICD9CM:440.0
SNOMEDCT_US_2020_03_01:81817003
UMLS_CUI:C0155733
Aortic atherosclerosis
Atherosclerosis of aorta
disease_ontology
DOID:10230
aortic atherosclerosis
ICD10CM:F65.2
ICD9CM:302.4
MESH:D005084
NCI:C94352
SNOMEDCT_US_2020_03_01:192514003
UMLS_CUI:C0015269
disease_ontology
DOID:10236
exhibitionism
A primary bacterial infectious disease that results_in infection located_in superficial peripheral nerves, located_in skin, located_in mucous membranes of the upper respiratory tract, located_in anterior chamber of the eyes, or located_in testes, has_material_basis_in Mycobacterium leprae, which is transmitted_by aerosol spread from infected nasal secretions to exposed nasal and oral mucosa. The infection has_symptom skin lesions, has_symptom sensory loss, has_symptom motor loss and has_symptom eye damage.
EFO:0001054
GARD:6886
ICD10CM:A30
ICD9CM:030
MESH:D007918
NCI:C84824
OMIM:607572
OMIM:609888
OMIM:613407
ORDO:548
SNOMEDCT_US_2020_03_01:154298007
UMLS_CUI:C0023343
disease_ontology
DOID:1024
Xref MGI.
leprosy
A hemolytic anemia characterized by decreased synthesis of one or more hemoglobin polypeptide chains.
DOID:12242
DOID:12243
GARD:7756
ICD10CM:D56
ICD9CM:282.4
MESH:D013789
NCI:C35069
SNOMEDCT_US_2020_03_01:191192008
UMLS_CUI:C0039730
Sickle-cell thalassemia with crisis
Sickle-cell thalassemia without crisis
thalassemia Hb-S disease with crisis
thalassemia Hb-S disease without crisis
disease_ontology
DOID:10241
OMIM mapping confirmed by DO. [LS].
thalassemia
A primary bacterial infectious disease that results in infection located_in leukocyte, has_material_basis_in Ehrlichia chaffeensis or Anaplasma phagocytophilum, which are transmitted_by lone start stick and transmitted_by black-legged tick respectively. The infection has_symptom headache, has_symptom muscle aches, has_symptom fatigue and has_symptom rash.
DOID:0050023
GARD:2092
ICD10CM:A77.4
ICD9CM:082.4
MESH:D016873
SNOMEDCT_US_2020_03_01:77361002
UMLS_CUI:C0085399
human ehrlichiosis
disease_ontology
DOID:10242
ehrlichiosis
MESH:D016873
A pleural disease that is characterized by inflammation of the pleura, the lining of the pleural cavity surrounding the lungs.
ICD9CM:511.8
UMLS_CUI:C0029799
disease_ontology
DOID:10247
pleurisy
A viral infectious disease that results in infection in sheep and rarely humans, has_material_basis_in Louping ill virus, which is transmitted by sheep tick, Ixodes ricinus. The infection has symptom lethargy, has symptom muscle pains, has symptom fever, and has symptom focal neurological signs.
ICD10CM:A84.8
ICD9CM:063.1
MESH:D008146
SNOMEDCT_US_2020_03_01:59350003
UMLS_CUI:C0024025
Louping ill
disease_ontology
DOID:10250
louping ill
A viral infectious disease that results in inflammation located in salivary gland, has_material_basis_in Mumps rubulavirus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.
GARD:7116
ICD10CM:B26
ICD9CM:072
MESH:D009107
NCI:C29888
SNOMEDCT_US_2020_03_01:154352008
UMLS_CUI:C0026780
disease_ontology
DOID:10264
mumps
A cardiovascular system disease that involves the heart's electrical conduction system.
ICD9CM:426.6
SNOMEDCT_US_2020_03_01:195053008
UMLS_CUI:C0029630
heart rhythm disease
disease_ontology
DOID:10273
heart conduction disease
A male reproductive organ cancer that is located_in the prostate.
DOID:514
ICD10CM:C61
ICD9CM:185
KEGG:05215
MESH:D011471
NCI:C3343
NCI:C7378
OMIM:176807
OMIM:300147
OMIM:300704
OMIM:601518
OMIM:602759
OMIM:608656
OMIM:608658
OMIM:609299
OMIM:609558
OMIM:610321
OMIM:610997
OMIM:611100
OMIM:611868
OMIM:611928
OMIM:611955
OMIM:611958
OMIM:611959
ORDO:1331
SNOMEDCT_US_2020_03_01:126906006
SNOMEDCT_US_2020_03_01:93974005
UMLS_CUI:C0033578
UMLS_CUI:C0376358
NGP - new growth of prostate
hereditary prostate cancer
malignant tumor of the prostate
prostate cancer, familial
prostate neoplasm
prostatic cancer
prostatic neoplasm
tumor of the prostate
disease_ontology
DOID:10283
Xref MGI.
OMIM mapping confirmed by DO. [SN].
prostate cancer
GARD:6422
ICD10CM:G72.3
MESH:D010245
NCI:C84709
SNOMEDCT_US_2020_03_01:193241004
UMLS_CUI:C0030443
disease_ontology
DOID:1029
familial periodic paralysis
ICD10CM:I73.0
MESH:D011928
OMIM:179600
SNOMEDCT_US_2020_03_01:195295006
UMLS_CUI:C0034734
Raynaud's disease
Raynaud's syndrome
disease_ontology
DOID:10300
OMIM mapping confirmed by DO. [SN].
Raynaud disease
MESH:D011928
A parotid disease characterized by the inflammation of one or both parotid glands.
ICD10CM:K11.2
MESH:D010309
NCI:C114281
SNOMEDCT_US_2020_03_01:196481002
UMLS_CUI:C0030583
disease_ontology
DOID:10301
parotitis
MESH:D010309
MESH:D010305
UMLS_CUI:C0030579
disease_ontology
DOID:10302
parotid disease
GARD:7638
ICD10CM:K11.2
ICD9CM:527.2
MESH:D012793
NCI:C26882
SNOMEDCT_US_2020_03_01:42982001
UMLS_CUI:C0037023
Sialoadenitis
disease_ontology
DOID:10303
sialadenitis
A endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves.
DOID:14058
ICD10CM:I33.9
ICD9CM:421.9
MESH:D004696
NCI:C34582
NCI:C35432
SNOMEDCT_US_2020_03_01:56819008
SNOMEDCT_US_2020_03_01:91357005
UMLS_CUI:C0014118
UMLS_CUI:C0375268
disease_ontology
DOID:10314
endocarditis
An interstitial lung disease that is caused by the inhalation of dust.
ICD10CM:J64
ICD9CM:505
MESH:D011009
NCI:C26861
SNOMEDCT_US_2020_03_01:196004000
UMLS_CUI:C0032273
disease_ontology
DOID:10316
pneumoconiosis
A pneumoconiosis caused by inhalation and retention of asbestos fibers.
GARD:5852
ICD10CM:J61
ICD9CM:501
MESH:D001195
NCI:C84573
SNOMEDCT_US_2020_03_01:266400008
UMLS_CUI:C0003949
disease_ontology
DOID:10320
asbestosis
GARD:5976
ICD10CM:J66.0
MESH:D002095
NCI:C84605
SNOMEDCT_US_2020_03_01:155589004
UMLS_CUI:C0006542
Flax-dressers' disease
Stripper's asthma
cotton mill fever
disease_ontology
DOID:10323
byssinosis
A pneumoconiosis that is an inflammation and scarring of the uper lobes of the lungs causing nodular lesions resulting from inhalation of silica, quartz or slate particles.
DOID:14007
GARD:7647
ICD10CM:J62.8
ICD9CM:502
MESH:D012829
NCI:C3369
SNOMEDCT_US_2020_03_01:155590008
UMLS_CUI:C0037116
Pneumoconiosis due to silicates
Silica pneumoconiosis
Silicotic fibrosis of lung
silicotuberculosis
disease_ontology
DOID:10325
silicosis
ICD10CM:J60
ICD9CM:500
MESH:D055008
NCI:C34390
SNOMEDCT_US_2020_03_01:29422001
UMLS_CUI:C0003165
Coal Miner's Pneumoconiosis
Coal workers' lung
Coal workers' pneumoconiosis
Melanoedema
black lung
disease_ontology
DOID:10327
anthracosis
GARD:7645
ICD10CM:J63.4
MESH:D012806
SNOMEDCT_US_2020_03_01:155591007
UMLS_CUI:C0037061
pulmonary siderosis
disease_ontology
DOID:10328
siderosis
GARD:5932
ICD10CM:H02.52
ICD9CM:374.46
MESH:D016569
UMLS_CUI:C0005744
disease_ontology
DOID:10348
blepharophimosis
MESH:D016569
A breast benign neoplasm that is characterized by a fluid-filled sac.
ICD10CM:N60.0
MESH:D047688
NCI:C5315
SNOMEDCT_US_2020_03_01:56726003
UMLS_CUI:C0006144
Cyst of the breast
disease_ontology
DOID:10350
breast cyst
A leukemia that has_material_basis_in a B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood.
DOID:10747
ICD10CM:C91
ICD9CM:204
MESH:D007945
NCI:C7539
SNOMEDCT_US_2020_03_01:93170002
UMLS_CUI:C0023448
lymphoblastic leukaemia
lymphoblastic leukemia
lymphocytic leukaemia
lymphoid leukemia
disease_ontology
DOID:1037
lymphoid leukemia
A primary bacterial infectious disease that results in infection located in skin, located in joint or located in bone, has_material_basis_in Treponema pallidum subsp pertenue, which is transmitted by direct skin contact with an infected person. The infection has symptom skin lesions.
GARD:7913
ICD10CM:A66
ICD9CM:102
MESH:D015001
NCI:C41353
SNOMEDCT_US_2020_03_01:266213004
UMLS_CUI:C0043388
Bouba
frambesia
frambesia tropica
frambosie
polypapilloma tropicum
thymosis
disease_ontology
DOID:10371
yaws
ICD10CM:H53.03
ICD9CM:368.01
MESH:D000550
SNOMEDCT_US_2020_03_01:35600002
UMLS_CUI:C0750903
Strabismic amblyopia
disease_ontology
DOID:10375
suppression amblyopia
An eye disease that is characterized by poor vision in one eye resulting from the brain failing to process inputs from one eye and over time favors the other eye.
ICD10CM:H53.00
ICD9CM:368.00
MESH:D000550
NCI:C118764
SNOMEDCT_US_2020_03_01:155145007
UMLS_CUI:C0002418
disease_ontology
DOID:10376
amblyopia
MESH:D000550
ICD10CM:H53.01
ICD9CM:368.02
SNOMEDCT_US_2020_03_01:193638002
UMLS_CUI:C0152189
Deprivation amblyopia
disease_ontology
DOID:10378
disuse amblyopia
MESH:D015463
NCI:C3181
SNOMEDCT_US_2020_03_01:110006004
UMLS_CUI:C0023486
disease_ontology
DOID:1039
prolymphocytic leukemia
ICD10CM:M89.4
ICD9CM:731.2
MESH:D010005
SNOMEDCT_US_2020_03_01:46922002
UMLS_CUI:C0029412
Bamberger-Marie disease
HPOA - hypertrophic pulmonary osteoarthropathy
Marie Bamberger disease
hypertrophic pulmonary osteoarthropathy
disease_ontology
DOID:10393
secondary hypertrophic osteoarthropathy
A plague that results_in infection located_in lung, which results from direct inhalation of the bacillus and has_symptom fever, has_symptom chills, has_symptom cough and has_symptom difficulty breathing.
DOID:10401
DOID:10402
ICD10CM:A20.2
ICD9CM:020.3
ICD9CM:020.4
ICD9CM:020.5
MESH:D010930
SNOMEDCT_US_2020_03_01:35339003
SNOMEDCT_US_2020_03_01:38976008
SNOMEDCT_US_2020_03_01:67525007
UMLS_CUI:C0152937
UMLS_CUI:C0152938
UMLS_CUI:C0524688
primary pneumonic plague
secondary pneumonic plague
disease_ontology
DOID:10398
pneumonic plague
A disease by infectious agent that results_in infection, has_material_basis_in Bacteria.
ICD10CM:A49.9
MESH:D001424
NCI:C2890
SNOMEDCT_US_2020_03_01:87628006
UMLS_CUI:C0004623
disease_ontology
DOID:104
bacterial infectious disease
A lymphocytic leukemia characterized by over production of B-cells and their accumulation in bone marrow and blood.
EFO:0000095
GARD:6104
ICD10CM:C91.10
ICD9CM:204.1
MESH:D015451
NCI:C3163
OMIM:109543
OMIM:151400
OMIM:609630
OMIM:612557
OMIM:612558
OMIM:612559
ORDO:67038
SNOMEDCT_US_2020_03_01:51092000
UMLS_CUI:C0023434
B-cell chronic lymphocytic leukaemia
B-cell chronic lymphocytic leukemia
CLL
chronic lymphatic leukaemia
chronic lymphatic leukemia
chronic lymphocytic leukaemia
lymphoplasmacytic leukaemia
lymphoplasmacytic leukemia
disease_ontology
B-cell chronic lymphoid leukemia
DOID:1040
Xref MGI.
chronic lymphocytic leukemia
A physical disorder that is characterized by abnormal segmentation of the vertebra during fetal development which results in fusion located in cervical vertebra.
DOID:14747
GARD:10280
ICD10CM:Q76.1
ICD9CM:756.16
MESH:D007714
NCI:C98967
OMIM:PS118100
ORDO:2345
SNOMEDCT_US_2020_03_01:268349005
UMLS_CUI:C0022738
Klippel-Feil and Turner syndrome
Klippel-Feil deformity, deafness and facial asymmetry
autosomal dominant Klippel-Feil syndrome
congenital dystrophia brevicollis
congenital synostosis of cervical vertebrae
disease_ontology
DOID:10426
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Klippel-Feil syndrome
A corneal ulcer that is characterized by painful peripheral corneal ulceration, sterile limbal inflammation, and episcleral and conjunctival edema.
ICD10CM:H16.05
ICD9CM:370.07
SNOMEDCT_US_2020_03_01:22440001
UMLS_CUI:C0155072
Mooren ulcer
disease_ontology
DOID:10439
Mooren's ulcer
An upper respiratory tract disease which is characterized by inflammation of the tonsils resulting from bacterial (Group A streptococcus) and viral (Epstein-Barr virus, adenovirus) infections. Symptoms include a severe sore throat, painful or difficult swallowing, coughing, headache, myalgia, fever and chills.
DOID:10454
DOID:13751
ICD10CM:J35.01
ICD9CM:474.00
MESH:D014069
NCI:C116006
SNOMEDCT_US_2020_03_01:195665006
SNOMEDCT_US_2020_03_01:195794009
UMLS_CUI:C0040425
UMLS_CUI:C0149517
Throat infection - tonsillitis
chronic tonsillitis
disease_ontology
DOID:10456
tonsillitis
A legionellosis that is characterized by severe form of infection producing pneumonia. Symptoms include fever, chills, and cough.
ICD10CM:A48.1
ICD9CM:482.84
MESH:D007877
NCI:C128339
SNOMEDCT_US_2020_03_01:195889001
UMLS_CUI:C0023241
Infection by Legionella pneumophilia
Legionella
Legionella pneumonia
Legionnaire's disease
disease_ontology
DOID:10457
Legionnaires' disease
A primary bacterial infectious disease that results_in infection located_in respiratory tract, has_material_basis_in Legionella pneumophila, which is transmitted_by inhalation of droplets containing bacteria. The symptoms include dry cough, fever, headache and diarrhea.
MESH:D007876
NCI:C128334
SNOMEDCT_US_2020_03_01:26726000
UMLS_CUI:C0023240
Legionella infection
disease_ontology
DOID:10458
legionellosis
An upper respiratory tract disease which involves inflammation of the mucous membranes of the nose, throat, eyes, and eustachian tubes with watery then purulent discharge. This is an acute contagious disease caused by rhinoviruses, human parainfluenza viruses, human respiratory syncytial virus, influenza viruses, adenoviruses, enteroviruses, or metapneumovirus.
ICD10CM:J00
ICD9CM:460
MESH:D003139
NCI:C34500
SNOMEDCT_US_2020_03_01:195648002
UMLS_CUI:C0009443
Acute viral rhinopharyngitis
Nasopharyngitis - acute
Nasopharyngitis, acute
acute Nasopharyngitis
acute coryza
acute nasopharyngitis
acute rhinitis
rhino-sinusitis
disease_ontology
DOID:10459
common cold
A nasopharyngeal disease which involves inflammation of the nasal passages and upper part of the pharynx.
DOID:11587
ICD10CM:J00
ICD10CM:J31.1
ICD9CM:472.2
MESH:D009304
NCI:C34837
SNOMEDCT_US_2020_03_01:155524006
SNOMEDCT_US_2020_03_01:51476001
UMLS_CUI:C0027441
UMLS_CUI:C0155826
chronic nasopharyngitis
disease_ontology
DOID:10460
nasopharyngitis
ICD10CM:K02
ICD9CM:521.02
SNOMEDCT_US_2020_03_01:442551007
UMLS_CUI:C0266846
Compound dental caries
Dental caries extending into dentine
Dentin caries
disease_ontology
DOID:10461
dentin caries
ICD10CM:M76.5
ICD9CM:726.64
SNOMEDCT_US_2020_03_01:156662006
UMLS_CUI:C0158317
Patellar tendonitis
disease_ontology
DOID:10471
patellar tendinitis
ICD10CM:Q79.1
MESH:D003965
NCI:C98912
SNOMEDCT_US_2020_03_01:34168003
UMLS_CUI:C0011981
disease_ontology
DOID:10480
diaphragmatic eventration
A muscular disease that is located_in the diaphragm.
ICD10CM:J98.6
ICD9CM:519.4
SNOMEDCT_US_2020_03_01:48475001
UMLS_CUI:C0152097
disease_ontology
DOID:10481
diaphragm disease
GARD:6381
ICD10CM:Q39.0
MESH:D004933
NCI:C87072
SNOMEDCT_US_2020_03_01:156947007
UMLS_CUI:C0014850
Congenital atresia of esophagus
Congenital imperforate esophagus
Imperforate esophagus
Oesophageal atresia
disease_ontology
DOID:10485
esophageal atresia
ICD10CM:Q41.1
MESH:D007409
NCI:C84790
UMLS_CUI:C0021828
disease_ontology
DOID:10486
intestinal atresia
A megacolon that is characterized by a blockage of the large intestine due to improper muscle movement in the bowel.
GARD:6660
ICD10CM:Q43.1
MESH:D006627
NCI:C34700
OMIM:600156
OMIM:606874
OMIM:606875
OMIM:608462
OMIM:611644
ORDO:388
SNOMEDCT_US_2020_03_01:204739008
UMLS_CUI:C0019569
Hirschsprung disease
aganglionic megacolon
congenital megacolon
macrocolon
pelvirectal achalasia
total intestinal aganglionosis
disease_ontology
DOID:10487
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Hirschsprung's disease
GARD:6769
ICD10CM:Q42.3
MESH:D001006
NCI:C84784
OMIM:207500
OMIM:301800
SNOMEDCT_US_2020_03_01:156956004
UMLS_CUI:C0003466
Congenital atresia of anus
Congenital or infantile occlusion of anus
Imperforate anus
anal atresia
disease_ontology
DOID:10488
OMIM mapping confirmed by DO. [SN].
imperforate anus
ICD9CM:255.4
NCI:C26691
SNOMEDCT_US_2020_03_01:68588005
UMLS_CUI:C0405580
Adrenal Cortical Insufficiency
Corticoadrenal insufficiency
disease_ontology
DOID:10493
adrenal cortical hypofunction
A pneumonia described as an inflammatory illness of the lung commonly caused by viruses such as influenza virus, parainfluenza, adenovirus, rhinovirus, herpes simplex virus, respiratory syncytial virus, hantavirus, and cytomegalovirus.
DOID:13167
ICD10CM:J12.9
ICD9CM:480
MESH:D011024
SNOMEDCT_US_2020_03_01:195880002
UMLS_CUI:C0032310
disease_ontology
DOID:10533
viral pneumonia
A gastrointestinal system cancer that is located_in the stomach.
DOID:10539
DOID:10542
DOID:10543
DOID:4713
GARD:7704
ICD10CM:C16
ICD10CM:C16.2
ICD10CM:C16.5
ICD10CM:C16.6
ICD9CM:151
ICD9CM:151.4
ICD9CM:151.5
ICD9CM:151.6
MESH:D013274
NCI:C3387
NCI:C9331
OMIM:613659
SNOMEDCT_US_2020_03_01:126824007
SNOMEDCT_US_2020_03_01:269459004
SNOMEDCT_US_2020_03_01:269460009
SNOMEDCT_US_2020_03_01:93717002
SNOMEDCT_US_2020_03_01:94074003
UMLS_CUI:C0024623
UMLS_CUI:C0038356
UMLS_CUI:C0153421
UMLS_CUI:C0153422
UMLS_CUI:C0153423
gastric cancer
gastric neoplasm
disease_ontology
DOID:10534
OMIM mapping confirmed by DO. [SN].
stomach cancer
GARD:6485
NCI:C4636
SNOMEDCT_US_2020_03_01:276811008
UMLS_CUI:C0349532
Lymphoma of the stomach
disease_ontology
DOID:10540
gastric lymphoma
ICD10CM:C16.0
ICD9CM:151.0
SNOMEDCT_US_2020_03_01:93738008
UMLS_CUI:C0153417
Ca cardia - stomach
malignant neoplasm of cardia of stomach
disease_ontology
DOID:10548
cardia cancer
A central nervous system disease that involves encephalitis which occurs along with meningitis.
ICD10CM:A69.22
MESH:D008590
NCI:C34813
SNOMEDCT_US_2020_03_01:7125002
UMLS_CUI:C0025309
Meningoencephalitis
disease_ontology
DOID:10554
meningoencephalitis
A syndrome that has_material_basis_in mutation in the OCRL gene on chromosome Xq26 and that is characterized by hydrophthalmia, cataract, mental retardation, vitamin D-resistant rickets, amino aciduria, and reduced ammonia production by the kidney.
GARD:3295
ICD10CM:E72.03
MEDDRA:10051707
MESH:D009800
NCI:C84940
OMIM:309000
ORDO:534
SNOMEDCT_US_2020_03_01:79385002
UMLS_CUI:C0028860
Lowe syndrome
lowe oculocerebrorenal syndrome
oculocerebrorenal syndrome of Lowe
disease_ontology
DOID:1056
OMIM mapping confirmed by DO. [SN].
oculocerebrorenal syndrome
A bone remodeling disease that has_material_basis_in a vitamin D deficiency which results_in softening located_in bone.
GARD:7285
ICD9CM:268.2
NCI:C26838
SNOMEDCT_US_2020_03_01:190639009
UMLS_CUI:C0029442
disease_ontology
DOID:10573
osteomalacia
MESH:D010018
ICD10CM:E83.5
ICD9CM:275.4
MESH:D002128
SNOMEDCT_US_2020_03_01:267442002
UMLS_CUI:C0006705
disease_ontology
DOID:10575
calcium metabolism disease
A cerebral degeneration characterized by dysfunction of the white matter of the brain.
GARD:6895
ICD9CM:330.0
NCI:C61253
SNOMEDCT_US_2020_03_01:5101009
UMLS_CUI:C0023520
disease_ontology
DOID:10579
leukodystrophy
A sphingolipidosis characterized by the accumulation of sulfatides in cells, especially the myelin producing cells of the nervous system.
GARD:3230
ICD10CM:E75.25
MESH:D007966
NCI:C61251
OMIM:249900
OMIM:250100
ORDO:512
SNOMEDCT_US_2020_03_01:3621006
UMLS_CUI:C0023522
MLD
Scholz cerebral sclerosis
arylsulfatase A deficiency
deficiency of cerebroside-sulfatase
sulfatide lipoidosis
disease_ontology
DOID:10581
Xref MGI.
OMIM mapping confirmed by DO. [SN].
metachromatic leukodystrophy
GARD:5691
ICD10CM:G60.1
ICD9CM:356.3
MESH:D012035
NCI:C85043
OMIM:266500
OMIM:266510
SNOMEDCT_US_2020_03_01:25362006
UMLS_CUI:C0034960
HMSN type IV
HSMN IV
Heredopathia atactica polyneuritiformis
Refsum's disease
disease_ontology
DOID:10582
OMIM mapping confirmed by DO. [SN].
Refsum disease
A retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss.
DOID:14742
GARD:5694
ICD10CM:H35.52
MESH:C538365
MESH:D012174
NCI:C85045
OMIM:PS268000
ORDO:791
SNOMEDCT_US_2020_03_01:155113002
UMLS_CUI:C0035334
UMLS_CUI:C0220701
pericentral pigmentary retinopathy
disease_ontology
DOID:10584
Xref MGI.
OMIM mapping confirmed by DO. [LS].
retinitis pigmentosa
GARD:6844
ICD10CM:E75.23
MESH:D007965
NCI:C61254
OMIM:245200
SNOMEDCT_US_2020_03_01:192782005
UMLS_CUI:C0023521
Diffuse globoInOwlid body sclerosis
GLOBOID CELL LEUKOENCEPHALOPATHY
Galactosylceramide beta-galactosidase deficiency
Krabbe's disease
Krabbe's leukodystrophy
beta galactocerebrosidase deficiency
globoInOwlid cell leukodystrophy
disease_ontology
DOID:10587
OMIM mapping confirmed by DO. [SN].
Krabbe disease
A leukodystrophy that disrupts the breakdown of very-long-chain fatty acids resulting in progressive brain damage, failure of the adrenal glands and eventually death.
DOID:13451
ICD10CM:E71.52
MESH:D000326
NCI:C61252
OMIM:300100
SNOMEDCT_US_2020_03_01:65389002
UMLS_CUI:C0162309
ALD
Bronze Schilder disease
Encephalitis periaxialis concentrica
Encephalitis periaxialis, Schilder's
Siemerling-Creutzfeldt Disease
X-linked adrenoleukodystrophy
diffuse sclerosis
sudanophilic cerebral sclerosis
disease_ontology
DOID:10588
MESH:D000326w added from NeuroDevNet [WAK].
adrenoleukodystrophy
MESH:D000326
A specific developmental disorder that involves significant limitations both in mental functioning and in adaptive behavior such as communicating, taking care of him or herself, and social skills.
NCI:C84392
SNOMEDCT_US_2020_03_01:1855002
UMLS_CUI:C0025362
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15
disease_ontology
mental retardation
DOID:1059
OMIM mapping submitted by NeuroDevNet. [LS].
intellectual disability
A hypertension occurring during pregnancy characterized by large amounts of protein in the urine (proteinuria) and edema, usually by the last trimester of pregnancy.
DOID:12684
ICD10CM:O14
MESH:D011225
NCI:C85021
OMIM:189800
OMIM:609402
OMIM:609403
OMIM:609404
OMIM:614592
ORDO:275555
SNOMEDCT_US_2020_03_01:6758009
UMLS_CUI:C0032914
gestational hypertension
hypertension induced by pregnancy
pre-eclamptic toxaemia
preeclampsia
preeclampsia/eclampsia
pregnancy associated hypertension
pregnancy toxemia
proteinuric hypertension of pregnancy
toxaemia of pregnancy
disease_ontology
DOID:10591
Xref MGI.
OMIM mapping confirmed by DO. [SN].
pre-eclampsia
A neuromuscular disease that is characterized by a slowly progressive degeneration of the muscles of the foot, lower leg, hand and forearm.
GARD:6034
ICD10CM:G60.0
ICD9CM:356.1
MESH:D002607
NCI:C75467
OMIM:PS118220
SNOMEDCT_US_2020_03_01:193158000
UMLS_CUI:C0007959
CMT - Charcot-Marie-Tooth disease
disease_ontology
DOID:10595
Charcot-Marie-Tooth disease
An amino acid metabolic disorder that is caused by abnormalities of the renal tubules and is characterized especially by aminoaciduria involving only monocarboxylic monoamines, a dry red scaly rash, and episodic muscular incoordination due to the effects of the disease on the cerebellum.
GARD:6569
ICD10CM:E72.02
MESH:D006250
NCI:C84748
OMIM:234500
SNOMEDCT_US_2020_03_01:80902009
UMLS_CUI:C0018609
Neutral 1 amino acid transport defect
deficiency of tryptophan oxygenase
neutral amino acid transport defect
disease_ontology
DOID:1060
OMIM mapping confirmed by DO. [SN].
Hartnup disease
A tic disorder that is characterized by single or multiple motor or phonic tics, but not both, which are present for more than a year.
ICD10CM:F95.1
ICD9CM:307.22
MESH:D013981
NCI:C116768
SNOMEDCT_US_2020_03_01:192623005
UMLS_CUI:C0008701
chronic motor or vocal tic disorder
disease_ontology
DOID:10600
chronic tic disorder
ICD10CM:R73.03
MESH:D018149
NCI:C34646
SNOMEDCT_US_2020_03_01:267426009
UMLS_CUI:C0271650
Glucose: intolerance
Glucose: malabsorption
Malabsorption of glucose
disease_ontology
DOID:10603
glucose intolerance
ICD10CM:E73
MESH:D007787
NCI:C3154
OMIM:223100
SNOMEDCT_US_2020_03_01:267497007
UMLS_CUI:C0022951
LM - Lactose malabsorption
disease_ontology
DOID:10604
OMIM mapping confirmed by DO. [SN].
lactose intolerance
MESH:D007787
An intestinal disease that is characterized by a reduced ability to absorb nutrients due to the physical loss or the loss of function of a portion of the small and/or large intestine.
MESH:D012778
NCI:C99059
SNOMEDCT_US_2020_03_01:204768009
UMLS_CUI:C0036992
acquired short bowel syndrome
short gut syndrome
disease_ontology
DOID:10605
short bowel syndrome
An intestinal disease characterized by a dysbalance of the bacterial flora of the small intestine, causing derangement to the normal physiological processes of digestion and absorption.
ICD10CM:K90.2
ICD9CM:579.2
MESH:D001765
NCI:C34431
SNOMEDCT_US_2020_03_01:77225009
UMLS_CUI:C0005750
Bacterial overgrowth syndrome
Blind loop syndrome
disease_ontology
DOID:10606
blind loop syndrome
GARD:7824
ICD10CM:K90.1
ICD9CM:579.1
MESH:D013182
NCI:C45428
SNOMEDCT_US_2020_03_01:155846005
UMLS_CUI:C0038054
Sprue - tropical
Tropical steatorrhea
disease_ontology
DOID:10607
tropical sprue
An autoimmune disease of gastrointestinal tract that is caused by a reaction located_in small intestine to gliadin, a prolamin (gluten protein) found in wheat, and similar proteins found in the crops of the tribe Triticeae. The disease is associated with HLA-DQ gene. It has_symptom abdominal pain, has_symptom constipation, has_symptom diarrhea, has_symptom nausea and vomiting, and has_symptom loss of appetite.
EFO:0001060
GARD:11998
ICD10CM:K90.0
ICD9CM:579.0
MESH:D002446
NCI:C26714
OMIM:607202
OMIM:609754
OMIM:611598
OMIM:612005
OMIM:612006
OMIM:612007
OMIM:612008
OMIM:612009
OMIM:612011
ORDO:555
SNOMEDCT_US_2020_03_01:197477005
UMLS_CUI:C0007570
celiac sprue
coeliac disease
idiopathic steatorrhea
disease_ontology
DOID:10608
Xref MGI.
OMIM mapping confirmed by DO. [SN].
celiac disease
A bone remodeling disease that has_material_basis_in impaired mineralization or calcification of bones before epiphyseal closure due to deficiency or impaired metabolism of vitamin D, phosphorus or calcium which results_in softening and deformity located_in bone.
DOID:11672
GARD:5700
ICD10CM:E55.0
ICD9CM:268.0
MESH:D012279
NCI:C26878
OMIM:264700
OMIM:277440
OMIM:600081
OMIM:600785
ORDO:289157
SNOMEDCT_US_2020_03_01:190639009
SNOMEDCT_US_2020_03_01:68295002
UMLS_CUI:C0035579
UMLS_CUI:C0221468
active rickets
vitamin D hydroxylation-deficient rickets
vitamin D-dependent rickets
disease_ontology
DOID:10609
Xref MGI.
rickets
MESH:D012279
ICD10CM:K90.3
ICD9CM:579.4
SNOMEDCT_US_2020_03_01:155845009
UMLS_CUI:C0152166
pancreatic steatorrhoea
disease_ontology
DOID:10610
pancreatic steatorrhea
MESH:D011504
OMIM:226300
SNOMEDCT_US_2020_03_01:66972006
UMLS_CUI:C0033680
Enteropathy, exudative
Exudative enteropathy
Protein-losing enteropathy
disease_ontology
DOID:10611
OMIM mapping confirmed by DO. [SN].
protein-losing enteropathy
An urticaria that is characterized by erythematous papules and plaques, has_symptom pruritis, and has_material_basis_in allergic reaction.
ICD10CM:L50.0
ICD9CM:708.0
SNOMEDCT_US_2020_03_01:201260002
UMLS_CUI:C0149526
Allergic urticaria
disease_ontology
DOID:10612
allergic urticaria
A renal tubular transport disease of the proximal renal tubes characterized by glucosuria, phosphaturia, generalized aminoaciduria and HCO3 wasting.
DOID:5956
GARD:9118
MESH:D005198
NCI:C3034
NCI:C4377
OMIM:PS134600
ORDO:3337
SNOMEDCT_US_2020_03_01:236468006
SNOMEDCT_US_2020_03_01:40488004
UMLS_CUI:C0015624
UMLS_CUI:C0341703
Congenital Fanconi syndrome
De Toni-Fanconi syndrome
Fanconi-de Toni syndrome
Fanconi-de-Toni syndrome
Infantile nephropathic cystinosis
Lignac-Fanconi syndrome
adult Fanconi Anemia
adult Fanconi syndrome
deToni Fanconi syndrome
disease_ontology
DOID:1062
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Fanconi syndrome
MESH:D005198
An eye disease where one or both eyeballs are abnormally small.
DOID:10650
GARD:12085
ICD10CM:Q11.2
ICD9CM:743.1
MESH:D008850
NCI:C98989
SNOMEDCT_US_2020_03_01:156902006
UMLS_CUI:C0026010
microphthalmos
simple microphthalmos
disease_ontology
DOID:10629
Xref MGI.
OMIM mapping confirmed by DO. [SN].
microphthalmia
ICD10CM:N12
MESH:D009395
NCI:C26834
SNOMEDCT_US_2020_03_01:28689008
UMLS_CUI:C0027707
renal tubulo-interstitial disease
disease_ontology
DOID:1063
interstitial nephritis
A syndrome that is characterized by diabetes mellitus, optic atrophy, and deafness.
GARD:7898
MESH:D014929
NCI:C35133
ORDO:3463
SNOMEDCT_US_2020_03_01:70694009
UMLS_CUI:C0043207
disease_ontology
DOID:10632
OMIM mapping confirmed by DO. [LS].
Wolfram syndrome
A lysosomal storage disease characterized by the abnormal accumulation of cystine in the lysosomes. It follows an autosomal recessive inheritance pattern and that has_material_basis_in mutations in the CTNS gene, located on chromosome 17.
GARD:6236
MESH:D003554
NCI:C129932
OMIM:219750
OMIM:219800
OMIM:219900
ORDO:213
SNOMEDCT_US_2020_03_01:62332007
UMLS_CUI:C2931187
cystine storage disease
disease_ontology
DOID:1064
cystinosis
A personality disorder that involves a need for social isolation, anxiety in social situations, odd behavior and thinking, and often unconventional beliefs.
ICD10CM:F21
ICD9CM:301.22
MESH:D012569
NCI:C92632
SNOMEDCT_US_2020_03_01:231486008
UMLS_CUI:C0036363
disease_ontology
DOID:10646
schizotypal personality disorder
A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.
EFO:0000249
GARD:10254
ICD10CM:G30
ICD9CM:331.0
KEGG:05010
MESH:D000544
NCI:C2866
SNOMEDCT_US_2020_03_01:73768007
UMLS_CUI:C0002395
Alzheimer disease
Alzheimers dementia
disease_ontology
DOID:10652
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Alzheimer's disease
NCI:C5493
UMLS_CUI:C0940607
Colonic Lipoma
disease_ontology
DOID:10655
lipoma of colon
A glaucoma characterized by optic nerve damage resulting in progressive loss of visual field and increased pressure in the eye due to trabecular blockage.
EFO:0004190
ICD10CM:H40.1
ICD9CM:365.1
MESH:D005902
NCI:C34641
OMIM:137750
OMIM:177700
OMIM:602429
OMIM:603383
OMIM:606689
OMIM:608695
OMIM:608696
OMIM:609745
OMIM:609887
OMIM:610535
OMIM:611274
OMIM:611276
OMIM:613100
SNOMEDCT_US_2020_03_01:84494001
UMLS_CUI:C0017612
Wide-angle glaucoma
glaucoma simplex
open angle glaucoma
pigmentary glaucoma
disease_ontology
DOID:1067
Xref MGI.
open-angle glaucoma
A breast disease characterized by painful infection of the breast tissue.
MESH:D008413
NCI:C53662
SNOMEDCT_US_2020_03_01:155952005
UMLS_CUI:C0024894
Inflammatory breast disease
Inflammatory disease of breast
breast inflammation
disease_ontology
DOID:10690
mastitis
ICD9CM:360.03
SNOMEDCT_US_2020_03_01:193269007
UMLS_CUI:C0154774
disease_ontology
DOID:10697
chronic endophthalmitis
A parasitic helminthiasis infectious disease that involves parasitic infection by flukes of the genus Paragonimus. In the acute phase, the symptoms are diarrhea, abdominal pain, fever, cough, urticaria, hepatosplenomegaly, pulmonary abnormalities, and eosinophilia. Pulmonary manifestations include cough, expectoration of discolored sputum, hemoptysis, and chest radiographic abnormalities. Various organs like brain, spleen and liver can be infected.
GARD:9815
ICD10CM:B66.4
ICD9CM:121.2
MESH:D010237
NCI:C84995
SNOMEDCT_US_2020_03_01:30369007
UMLS_CUI:C0030424
Infection by Paragonimus
lung fluke disease
lung fluke infection
pulmonary paragonimiasis
disease_ontology
DOID:10699
paragonimiasis
An open-angle glaucoma that is characterized by the absence of any apparent obstruction of aqueous outflow through the trabecular meshwork with gonioscopy, but often with elevated intraocular pressure.
ICD10CM:H40.11
ICD9CM:365.11
MESH:D005902
NCI:C35394
OMIM:137760
SNOMEDCT_US_2020_03_01:77075001
UMLS_CUI:C0339573
chronic simple glaucoma
disease_ontology
DOID:1070
OMIM mapping confirmed by DO. [SN].
primary open angle glaucoma
A parasitic protozoa infectious disease that involves infection of the small intestine by a single-celled enteric protozoan parasite Giardia intestinalis. The symptoms include greasy and malodorous stools, diarrhea, abdominal pain, bloating, nausea, and vomiting.
ICD10CM:A07.1
ICD9CM:007.1
MESH:D005873
SNOMEDCT_US_2020_03_01:266176008
UMLS_CUI:C0017536
Infection by Giardia lamblia
beaver feaver
disease_ontology
DOID:10718
giardiasis
GARD:6549
ICD9CM:242.00
UMLS_CUI:C0154138
disease_ontology
DOID:10719
toxic diffuse goiter
A kidney disease characterized by the failure of the kidneys to adequately filter waste products from the blood.
ICD10CM:N19
ICD9CM:586
MESH:D051437
NCI:C4376
SNOMEDCT_US_2020_03_01:42399005
UMLS_CUI:C0035078
renal failure
disease_ontology
DOID:1074
PRISM.
kidney failure
ICD9CM:330.1
SNOMEDCT_US_2020_03_01:16517004
UMLS_CUI:C0007788
disease_ontology
DOID:10742
cerebral lipidosis
A otitis which involves inflammation of the middle ear.
ICD10CM:H66.9
ICD9CM:382.9
MESH:D010033
NCI:C34885
SNOMEDCT_US_2020_03_01:65363002
UMLS_CUI:C0029882
disease_ontology
DOID:10754
otitis media
ICD10CM:N11
ICD9CM:590.0
NCI:C123216
SNOMEDCT_US_2020_03_01:123293005
UMLS_CUI:C0085697
disease_ontology
DOID:1076
chronic pyelonephritis
GARD:8229
ICD10CM:K76.6
ICD9CM:572.3
MESH:D006975
NCI:C3119
SNOMEDCT_US_2020_03_01:155821005
UMLS_CUI:C0020541
disease_ontology
DOID:10762
portal hypertension
An artery disease characterized by chronic elevated blood pressure in the arteries.
EFO:0000537
ICD10CM:I10
ICD9CM:401-405.99
MESH:D006973
NCI:C3117
SNOMEDCT_US_2020_03_01:38341003
UMLS_CUI:C0020538
HTN
High blood pressure
hyperpiesia
vascular hypertensive disorder
disease_ontology
hypertensive disease
DOID:10763
hypertension
GARD:9430
ICD10CM:M31.1
MESH:D011697
NCI:C78797
OMIM:274150
SNOMEDCT_US_2020_03_01:360402008
UMLS_CUI:C0034155
Moschcowitz's syndrome
disease_ontology
DOID:10772
thrombotic thrombocytopenic purpura
ICD10CM:I40.1
ICD9CM:422.91
SNOMEDCT_US_2020_03_01:194954007
UMLS_CUI:C0155689
Idiopathic myocarditis
Isolated (Fiedler's) myocarditis
fiedler myocarditis
disease_ontology
DOID:10778
fiedler's myocarditis
ICD10CM:D74
ICD9CM:289.7
MESH:D008708
NCI:C34817
SNOMEDCT_US_2020_03_01:191386007
UMLS_CUI:C0025637
disease_ontology
DOID:10783
methemoglobinemia
A spotted fever that has_material_basis_in Rickettsia australis, which is transmitted_by ticks (Ixodes holocyclus). The infection has_symptom fever, has_symptom headache, has_symptom myalgia, has_symptom maculopapular rash, and has_symptom lymphadenopathy.
DOID:0050038
Australian tick typhus
Rickettsia australis spotted fever
disease_ontology
North Queensland tick typhus
DOID:10784
Queensland tick typhus
A sinusitis which involves infection of the frontal sinuses over the eyes in the brow area. This causes pain or pressure in the frontal sinus cavity and headache over the forehead.
ICD10CM:J32.1
MESH:D015522
NCI:C34626
SNOMEDCT_US_2020_03_01:275485006
UMLS_CUI:C0016735
disease_ontology
DOID:10791
frontal sinusitis
A maxillary sinusitis which lasts for 12 weeks or more.
ICD10CM:J32.0
ICD9CM:473.0
NCI:C34477
SNOMEDCT_US_2020_03_01:195785003
UMLS_CUI:C0008698
chronic antritis
disease_ontology
DOID:10792
chronic maxillary sinusitis
A sinusitis which involves infection of sphenoid sinuses that causes pain or pressure behind the eyes, but often refers to the vertex of the head.
ICD10CM:J32.3
MESH:D015524
NCI:C35031
SNOMEDCT_US_2020_03_01:13266007
UMLS_CUI:C0037886
Sphenoidal sinusitis
disease_ontology
DOID:10794
sphenoid sinusitis
A parasitic helminthiasis infectious disease that involves parasitic infection of the lymphatics and subcutaneous tissue by nematodes of the superfamily Filarioidea.
ICD10CM:B74
ICD9CM:125.9
MESH:D005368
NCI:C34611
SNOMEDCT_US_2020_03_01:50342004
UMLS_CUI:C0016085
disease due to superfamily Filarioidea
disease_ontology
DOID:1080
filariasis
MESH:D005368
A respiratory system cancer that is located_in the nasal cavity.
ICD10CM:C30.0
ICD9CM:160.0
NCI:C4918
SNOMEDCT_US_2020_03_01:93917007
UMLS_CUI:C0728864
malignant neoplasm of nasal cavities
malignant tumor of the nasal cavity
disease_ontology
DOID:10811
nasal cavity cancer
NCI:C6074
UMLS_CUI:C1334921
Lymphoma of the nasal cavity
lymphoma of nasal cavity
disease_ontology
DOID:10813
nasal cavity lymphoma
A duodenum cancer that derives_from epithelial cells of glandular origin.
NCI:C7889
SNOMEDCT_US_2020_03_01:408644002
UMLS_CUI:C0278804
Duodenal adenocarcinoma
disease_ontology
DOID:10816
duodenum adenocarcinoma
A filariasis that is a zoonotic infection caused by nematodes Dirofilaria immitis or Dirofilaria repens, which are transmitted to humans from dogs, cats, wolves and coyotes by infected mosquitoes. The disease manifests as either subcutaneous nodules or pulmonary lesions.
GARD:11908
ICD10CM:B74.8
MESH:D004184
SNOMEDCT_US_2020_03_01:73328005
UMLS_CUI:C0012602
Dirofilaria infectious disease
Infection by Dirofilaria
disease_ontology
DOID:1082
dirofilariasis
ICD10CM:F65.3
ICD9CM:302.82
MESH:D014843
NCI:C94360
SNOMEDCT_US_2020_03_01:192515002
UMLS_CUI:C0042979
disease_ontology
DOID:10834
voyeurism
A viral infectious disease that results in inflammation located in brain of horses and humans, has_material_basis_in Eastern equine encephalitis virus, which is transmitted by Aedes, transmitted by Coquillettidia, and transmitted by Culex species of mosquitoes. The infection has symptom sudden onset of headache, has symptom high fever, has symptom chills, has symptom vomiting, has symptom disorientation, has symptom seizures, and has symptom coma.
GARD:10821
ICD10CM:A83.2
ICD9CM:062.2
MESH:D020242
SNOMEDCT_US_2020_03_01:40177004
UMLS_CUI:C0153065
Neuroinvasive Eastern equine encephalitis virus infection
disease_ontology
EEE
DOID:10841
Eastern equine encephalitis
A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in Murray Valley encephalitis virus, which is transmitted_by Culex annulirostris mosquitoes. The infection has_symptom fever, has_symptom headache, has_symptom nausea, has_symptom vomiting, has_symptom drowsiness, has_symptom confusion, has_symptom fitting, and has_symptom weakness.
ICD10CM:A83.4
ICD9CM:062.4
SNOMEDCT_US_2020_03_01:66454007
UMLS_CUI:C0153066
Australian X disease
Australian encephalitis
disease_ontology
DOID:10842
Murray Valley encephalitis
A viral infectious disease that results_in inflammation located_in brain of horses and humans, has_material_basis_in Western equine encephalomyelitis virus, which is transmitted_by Culex and transmitted_by Aedes species of mosquitoes. The infection has_symptom fever, has_symptom headache, has_symptom nausea, has_symptom vomiting, has_symptom anorexia, has_symptom malaise, has_symptom altered mental status, and has_symptom weakness.
GARD:7888
ICD10CM:A83.1
ICD9CM:062.1
MESH:D020241
NCI:C85227
SNOMEDCT_US_2020_03_01:47523006
UMLS_CUI:C0153064
disease_ontology
WEE
DOID:10843
Western equine encephalitis
A viral infectious disease that results_in infection located_in brain, has_material_basis_in Japanese encephalitis virus, which is transmitted_by Culex tritaeniorhynchus mosquito bite. The infection has_symptom headache, has_symptom high fever, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, and has_symptom spastic paralysis.
GARD:6797
ICD10CM:A83.0
ICD9CM:062.0
MESH:D004672
NCI:C34577
SNOMEDCT_US_2020_03_01:266194002
UMLS_CUI:C0014057
Japanese B encephalitis
disease_ontology
DOID:10844
Japanese encephalitis
A viral infectious disease that results_in inflammation located_in brain, has_material_basis_in St. Louis encephalitis virus, which is transmitted_by Culex mosquitoes. The infection has_symptom headache, has_symptom high fever, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions and has_symptom spastic paralysis.
ICD10CM:A83.3
ICD9CM:062.3
MESH:D004674
SNOMEDCT_US_2020_03_01:10429004
UMLS_CUI:C0014060
Neuroinvasive St. Louis encephalitis virus infection
disease_ontology
DOID:10845
St. Louis encephalitis
A chromosomal duplciation syndrome that is characterized by slow growth before birth and a low birth weight and that has_material_basis_in three copies of chromosome 18.
ICD9CM:758.2
MESH:D000073842
NCI:C101362
SNOMEDCT_US_2020_03_01:51500006
UMLS_CUI:C0152096
Complete trisomy 18 syndrome
E3 Trisomy
trisomy 18
disease_ontology
DOID:1085
OMIM mapping confirmed by DO. [LS].
Edwards syndrome
A mouth disease located_in the salivary gland.
DOID:12898
ICD9CM:527.8
UMLS_CUI:C0029773
Non-neoplastic Salivary gland disease
Salivary gland disease
disease_ontology
DOID:10854
salivary gland disease
ICD10CM:H49
ICD9CM:378.5
SNOMEDCT_US_2020_03_01:12942001
UMLS_CUI:C0152221
Incomitant dissociation
Paralytic strabismus
disease_ontology
DOID:10863
paralytic squint
A degeneration of macula and posterior pole that is characterized by a loss of vision in the center of the visual field (the macula) resulting from damage to the retina and resulting in blurring of the sharp central vision.
EFO:0001365
ICD10CM:H35.30
ICD9CM:362.50
MESH:D008268
NCI:C84391
OMIM:PS603075
SNOMEDCT_US_2020_03_01:18222007
UMLS_CUI:C0242383
Age Related Maculopathies
Age Related Maculopathy
Senile macular degeneration
Senile macular retinal degeneration
age-related macular degeneration
disease_ontology
DOID:10871
OMIM mapping confirmed by DO. [SN].
age related macular degeneration
ICD10CM:H35.32
ICD9CM:362.52
SNOMEDCT_US_2020_03_01:11290001
UMLS_CUI:C0271084
Exudative senile macular degeneration of retina
Neovascular age-related macular degeneration
Senile macular degeneration, wet
Wet senile macular retinal degeneration
disease_ontology
DOID:10873
Kuhnt-Junius degeneration
A spina bifida that is characterized by herniation of the meninges between the vertebrae.
SNOMEDCT_US_2020_03_01:268308005
UMLS_CUI:C0025299
disease_ontology
DOID:1088
meningocele
MESH:D008588
A viral infectious disease that results_in infection located_in skin, has_material_basis_in Human coxsackievirus A16 or has_material_basis_in Human enterovirus 71, which are transmitted_by contaminated fomites, and transmitted_by contact with nose and throat secretions, saliva, blister fluid and stool of infected persons. The infection has_symptom fever, has_symptom poor appetite, has_symptom malaise, has_symptom sore throat, has_symptom painful sores in the mouth, and has_symptom skin rash on the palms of the hands and soles of the feet.
ICD10CM:B08.4
ICD9CM:074.3
MESH:D006232
NCI:C128439
SNOMEDCT_US_2020_03_01:175497008
UMLS_CUI:C0018572
Vesicular stomatitis and exanthem
disease_ontology
DOID:10881
hand, foot and mouth disease
A viral infectious disease that results in necrosis located in intercostal muscle, has_material_basis_in Human enterovirus B. The infection has symptom severe chest pain, has symptom fever, has symptom malaise, has symptom pleuritis, and has symptom headache.
ICD10CM:B33.0
ICD9CM:074.1
MESH:D011000
SNOMEDCT_US_2020_03_01:83264000
UMLS_CUI:C0032238
Bamble disease
Bornholm disease
Epidemic pleurisy
Epidemic, myositis
devil's grip
epidemic myalgia
disease_ontology
DOID:10882
epidemic pleurodynia
A viral infectious disease that results in infection located in mouth, has_material_basis_in Human coxsackievirus A16, has_material_basis_in Human enterovirus 71, has_material_basis_in group B coxsackievirus, or has_material_basis_in echoviruses, which are transmitted by ingestion of food contaminated with feces, transmitted by contact with pharyngeal secretions, or transmitted by droplet spread of oronasal secretions. The infection has symptom fever, has symptom sore throat, and has symptom lesions in the back area of the mouth, particularly the soft palate or tonsillar pillars.
ICD10CM:B08.5
ICD9CM:074.0
MESH:D006557
SNOMEDCT_US_2020_03_01:154358007
UMLS_CUI:C0019338
Vesicular pharyngitis
disease_ontology
DOID:10883
herpangina
GARD:4018
SNOMEDCT_US_2020_03_01:282784007
UMLS_CUI:C0560648
spinal dysraphism
disease_ontology
DOID:1089
OMIM mapping confirmed by DO. [LS].
tethered spinal cord syndrome
NCI:C99080
A physical disorder characterized by an abnormally placed urethral opening on the underside of the penis or on the perineum.
ICD10CM:Q54
MESH:D007021
NCI:C40341
OMIM:146450
OMIM:300633
OMIM:300758
OMIM:300856
ORDO:440
SNOMEDCT_US_2020_03_01:156968008
UMLS_CUI:C0848558
familial hypospadias
disease_ontology
DOID:10892
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hypospadias
A congenital nervous system abnormality that is characterized by a significantly smaller than normal head in infants.
GARD:3603
GARD:7038
ICD10CM:Q02
ICD9CM:742.1
MESH:D008831
NCI:C85874
SNOMEDCT_US_2020_03_01:156893009
UMLS_CUI:C0025958
Microcephalus
microencephaly
disease_ontology
DOID:10907
OMIM mapping confirmed by DO. [SN].
microcephaly
MESH:D008831
A cerebral degeneration characterized by an abnormal accumulation of cerebrospinal fluid in the ventricles of the brain, leading to progressive enlargement of the head.
GARD:6682
ICD10CM:G91
MESH:D006849
NCI:C3111
OMIM:123155
OMIM:236600
OMIM:236635
OMIM:307000
OMIM:615219
ORDO:2182
ORDO:2185
SNOMEDCT_US_2020_03_01:267687006
UMLS_CUI:C0020255
hydrocephalus, X-linked
hydrocephalus, nonsyndromic, autosomal recessive
disease_ontology
DOID:10908
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hydrocephalus
A mouth disease located_in the teeth.
MESH:D014076
SNOMEDCT_US_2020_03_01:72722003
UMLS_CUI:C0040435
teeth disease
disease_ontology
DOID:1091
tooth disease
A cognitive disorder where the memory is disturbed or lost and involves the loss of memories previously established, loss of the ability to create new memories, or loss of the ability to learn new information.
DOID:4544
ICD10CM:R41.3
ICD9CM:294.0
MESH:D000647
NCI:C2867
SNOMEDCT_US_2020_03_01:247606008
SNOMEDCT_US_2020_03_01:3298001
UMLS_CUI:C0002622
UMLS_CUI:C0002625
Amnestic syndrome
Korsakoff's psychosis or syndrome
amnesia
disease_ontology
DOID:10914
amnestic disorder
A nutritional deficiency disease that is characterized by ophthalmoplegia, ataxia, change in mental status and acute onset of severe memory impairment without any dysfunction in intellectual abilities, and has_material_basis_in thiamine deficiency.
MESH:D020915
NCI:C35764
OMIM:277730
SNOMEDCT_US_2020_03_01:69482004
UMLS_CUI:C0349464
Korsakoff Syndrome
Korsakoff's psychosis
Korsakoff's syndrome
Korsakov psychosis
Korsakov's psychosis
disease_ontology
DOID:10915
OMIM mapping confirmed by DO. [LS].
Wernicke-Korsakoff syndrome
A gender identity disorder that is characterized by an individual's identification with a gender inconsistent or not culturally associated with their biological sex.
ICD9CM:302.50
SNOMEDCT_US_2020_03_01:191782007
UMLS_CUI:C0040630
disease_ontology
DOID:10919
transsexualism
A blood protein disease that is characterized by low number of red blood cells, repeated infections, and periodic episodes of pain, resulting from atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.
DOID:12924
DOID:13024
GARD:8614
ICD10CM:D57.1
ICD10CM:D57.2
ICD9CM:282.6
ICD9CM:282.63
MESH:D000755
MESH:D006450
NCI:C34383
NCI:C34676
OMIM:603903
ORDO:232
SNOMEDCT_US_2020_03_01:154798006
SNOMEDCT_US_2020_03_01:35434009
UMLS_CUI:C0002895
UMLS_CUI:C0019034
Hb SC disease
Hb-S/Hb-C disease
Hb-SS disease without crisis
Hemoglobin S disease without crisis
Sickle-cell/Hb-C disease without crisis
drepanocytosis
haemoglobin SC disease
hemoglobin SC disease
sickle cell anaemia
disease_ontology
DOID:10923
OMIM mapping confirmed by DO. [LS].
sickle cell anemia
A personality disorder that involves a prolonged disturbance of personality function characterized by depth and variability of moods.
ICD10CM:F60.3
ICD9CM:301.83
MESH:D001883
NCI:C92633
SNOMEDCT_US_2020_03_01:20010003
UMLS_CUI:C0006012
disease_ontology
DOID:10930
borderline personality disorder
A personality disorder that is characterized by a pervasive psychological dependence on other people.
ICD10CM:F60.7
ICD9CM:301.6
MESH:D003859
NCI:C92637
SNOMEDCT_US_2020_03_01:192492003
UMLS_CUI:C0011548
disease_ontology
DOID:10931
dependent personality disorder
A personality disorder that is characterized by a pervasive pattern of preoccupation with orderliness, perfectionism, and mental and interpersonal control at the expense of flexibility, openness, and efficiency.
ICD10CM:F60.5
ICD9CM:301.4
MESH:D003193
NCI:C92638
SNOMEDCT_US_2020_03_01:191761001
UMLS_CUI:C0009595
OCPD
disease_ontology
Anankastic personality disorder
DOID:10932
obsessive-compulsive personality disorder
A dissociative disorder that involves the simultaneous display of multiple distinct identities or personalities.
ICD10CM:F44.81
ICD9CM:300.14
MESH:D009105
NCI:C94330
SNOMEDCT_US_2020_03_01:31611000
UMLS_CUI:C0026773
Dissociative identity disorder
disease_ontology
DOID:10934
multiple personality disorder
A disease of mental health in which the normally well-integrated functions of memory, identity, perception, or consciousness are separated (dissociated).
DOID:4963
ICD10CM:F44.9
ICD10CM:F48.9
ICD9CM:300.15
ICD9CM:300.9
MESH:D004213
NCI:C92197
SNOMEDCT_US_2020_03_01:154883004
UMLS_CUI:C0012746
UMLS_CUI:C0041857
dissociative disease
dissociative reaction
disease_ontology
DOID:10935
dissociative disorder
A personality disorder that is characterized by a lack of interest in social relationships, a tendency towards a solitary lifestyle, secretiveness, emotional coldness and sometimes sexual apathy, with a simultaneous rich, elaborate and exclusively internal fantasy world.
ICD10CM:F60.1
ICD9CM:301.2
MESH:D012557
NCI:C92631
SNOMEDCT_US_2020_03_01:192486009
UMLS_CUI:C0036339
disease_ontology
DOID:10936
schizoid personality disorder
A disease of mental health that involves a failure to resist an impulsive act or behaviour that may be harmful to self or others.
ICD10CM:F63.9
ICD9CM:312.30
MESH:D007174
NCI:C34723
SNOMEDCT_US_2020_03_01:192098008
UMLS_CUI:C0021122
disease_ontology
DOID:10937
impulse control disorder
A personality disorder that is characterized by paranoia and a pervasive, long-standing suspiciousness and generalized mistrust of others.
ICD10CM:F60.0
ICD9CM:301.0
MESH:D010260
NCI:C92630
SNOMEDCT_US_2020_03_01:270529002
UMLS_CUI:C0030477
disease_ontology
DOID:10938
paranoid personality disorder
A personality disorder that involves a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood.
ICD10CM:F60.2
ICD9CM:301.7
MESH:D000987
NCI:C88413
SNOMEDCT_US_2020_03_01:191769004
UMLS_CUI:C0003431
Asocial personality
Dissocial personality disorder
Psychopath.personality
Psychopathic personality
Psychopathic personality disorder
sociopathic personality
disease_ontology
DOID:10939
antisocial personality disorder
A specific developmental disorder that is characterized by co-existence of attentional problems and hyperactivity, with each behavior occurring infrequently alone and symptoms starting before seven years of age.
DOID:1093
EFO:0003888
MESH:D001289
NCI:C35092
OMIM:143465
OMIM:608903
OMIM:608904
OMIM:608905
OMIM:608906
OMIM:612311
OMIM:612312
SNOMEDCT_US_2020_03_01:229713001
UMLS_CUI:C0041671
ADHD
attention deficit disorder
hyperkinetic disorder
disease_ontology
DOID:1094
Xref MGI.
attention deficit hyperactivity disorder
EFO:0003870
MESH:D002532
NCI:C34458
SNOMEDCT_US_2020_03_01:128609009
UMLS_CUI:C0007766
brain aneurysm
disease_ontology
DOID:10941
intracranial aneurysm
A mouth disease located_in the tongue.
ICD10CM:K14
ICD9CM:529.9
MESH:D014060
SNOMEDCT_US_2020_03_01:69244009
UMLS_CUI:C0040409
disease_ontology
DOID:10944
tongue disease
A kidney disease that is characterized by an inflammation of the kidneys.
ICD10CM:N08
MESH:D009393
NCI:C26833
SNOMEDCT_US_2020_03_01:52845002
UMLS_CUI:C0027697
disease_ontology
DOID:10952
nephritis
A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode Strongyloides stercoralis.
DOID:0050008
GARD:8195
ICD10CM:B78
ICD9CM:127.2
MESH:D013322
NCI:C128398
SNOMEDCT_US_2020_03_01:1214006
UMLS_CUI:C0038463
Infection by Strongyloides
disseminated strongyloidiasis
disease_ontology
DOID:10955
strongyloidiasis
A spastic cerebral palsy that affects lower extremities resulting in tight leg and hip muscles. The legs cross at the knees, making it difficult to walk.
DOID:3778
ICD10CM:G80.1
ICD9CM:343.0
MESH:D002547
NCI:C34781
SNOMEDCT_US_2020_03_01:1178005
SNOMEDCT_US_2020_03_01:275469001
UMLS_CUI:C0023882
UMLS_CUI:C0154695
Diplegic infantile cerebral palsy
Infantile spastic cerebral palsy
Little's disease
Littles disease
cerebral spastic infantile paralysis
infantile diplegic cerebral palsy
disease_ontology
DOID:10965
spastic diplegia
A spastic cerebral palsy that affects one side of the body resulting in stiff arm, hand and leg. On the affected side,the arm and leg may not develop normally.
GARD:10448
ICD9CM:343.1
SNOMEDCT_US_2020_03_01:258714003
UMLS_CUI:C0270805
Congenital hemiplegia
Hemiplegic cerebral palsy
Hemiplegic infantile cerebral palsy
hemiplegic cerebral palsy
spastic hemiplegic cerebral palsy
disease_ontology
DOID:10967
spastic hemiplegia
A central nervous system disease that is characterized by the complete paralysis of half of the body.
GARD:6583
ICD9CM:343.4
MESH:D006429
SNOMEDCT_US_2020_03_01:155024003
UMLS_CUI:C0392550
Infantile hemiplegia
Postnatal infantile hemiplegia
disease_ontology
DOID:10969
hemiplegia
A spastic cerebral palsy that affects all four limbs. The individuals have difficulty with walking and talking.
ICD9CM:343.2
MESH:D002547
OMIM:603513
OMIM:612900
ORDO:210141
SNOMEDCT_US_2020_03_01:192953000
UMLS_CUI:C0154697
quadriplegic infantile cerebral palsy
spastic quadriplegic cerebral palsy
tetraplegic infantile cerebral palsy
disease_ontology
DOID:10970
Xref MGI.
spastic quadriplegia
ICD10CM:N70
ICD9CM:614.2
SNOMEDCT_US_2020_03_01:46536000
UMLS_CUI:C0036133
Salpingitis/oophoritis
Tubo-ovarian inflammatory disease
disease_ontology
DOID:10972
salpingo-oophoritis
ICD10CM:N70.01
NCI:C40120
SNOMEDCT_US_2020_03_01:8912009
UMLS_CUI:C0269038
disease_ontology
DOID:10973
acute salpingitis
An ovarian disease that is characterized by inflammation of the ovary.
ICD10CM:N70.92
MESH:D009869
SNOMEDCT_US_2020_03_01:266648001
UMLS_CUI:C0029051
disease_ontology
DOID:10974
oophoritis
EFO:0004254
ICD10CM:N03.2
MESH:D015433
NCI:C34645
SNOMEDCT_US_2020_03_01:197710000
UMLS_CUI:C0017665
membranous nephropathy
disease_ontology
DOID:10976
membranous glomerulonephritis
A syndrome disease that is characterized by glomerulonephritis, endstage kidney disease, and hearing loss.
GARD:5785
MESH:D009394
ORDO:63
SNOMEDCT_US_2020_03_01:57333009
UMLS_CUI:C0027706
Hereditary Nephritis
disease_ontology
DOID:10983
OMIM mapping confirmed by DO. [SN].
Alport syndrome
Alpha thalassemia is a thalassemia involving the genes HBA1and HBA2 hemoglobin genes.
GARD:621
ICD10CM:D56.0
ICD9CM:282.43
MESH:D017085
NCI:C34368
OMIM:604131
SNOMEDCT_US_2020_03_01:191186002
UMLS_CUI:C0002312
Alpha thalassaemia
alpha-Thalassemia
disease_ontology
DOID:1099
OMIM mapping confirmed by DO. [SN].
alpha thalassemia
A very rare form of acute disseminated encephalomyelitis, characterized by a brief but intense attack of inflammation and necrotizing vasculitis of venules and hemorrhage, and edema.
GARD:8629
MESH:D004684
NCI:C84535
OMIM:606752
SNOMEDCT_US_2020_03_01:72986009
UMLS_CUI:C0014077
AHL
Weston-Hurst syndrome
acute haemorrhagic leucoencephalitis of Weston Hurst
acute hemorrhagic encephalomyelitis
acute necrotizing hemorrhagic leukoencephalitis
disease_ontology
DOID:10992
OMIM mapping confirmed by DO. [SN].
acute hemorrhagic leukoencephalitis
An eye disease that affects the lens of the eye, which is the transparent disc that focuses light to the photosensors in the back of the eye.
ICD10CM:H27.9
MESH:D007905
NCI:C26812
SNOMEDCT_US_2020_03_01:194613002
UMLS_CUI:C0023308
disease_ontology
DOID:110
lens disease
A female reproductive system disease that is located_in the ovary.
MESH:D010049
NCI:C26841
SNOMEDCT_US_2020_03_01:5552004
UMLS_CUI:C0029928
disease_ontology
DOID:1100
ovarian disease
ICD9CM:372.52
SNOMEDCT_US_2020_03_01:66139007
UMLS_CUI:C0155161
disease_ontology
DOID:11028
pseudopterygium
ICD10CM:H11.15
ICD9CM:372.51
MESH:D059407
NCI:C129468
SNOMEDCT_US_2020_03_01:267735001
UMLS_CUI:C0152255
disease_ontology
DOID:11029
pinguecula
ICD10CM:H18.20
ICD9CM:371.2
MESH:D015715
NCI:C50508
SNOMEDCT_US_2020_03_01:193811006
UMLS_CUI:C0010037
Corneal oedema
disease_ontology
DOID:11030
corneal edema
ICD10CM:H18.1
ICD9CM:371.23
NCI:C26970
SNOMEDCT_US_2020_03_01:193815002
UMLS_CUI:C0155111
disease_ontology
DOID:11031
bullous keratopathy
ICD10CM:H18.22
ICD9CM:371.21
SNOMEDCT_US_2020_03_01:193813009
UMLS_CUI:C0155109
disease_ontology
DOID:11033
idiopathic corneal edema
A dissociative disorder where he continuity of the patient's memory is disrupted. Patients with dissociative amnesia have recurrent episodes in which they forget important personal information or events, usually connected with trauma or severe stress.
ICD10CM:F44.0
ICD9CM:300.12
MESH:D000647
NCI:C94328
SNOMEDCT_US_2020_03_01:192420000
UMLS_CUI:C0236795
psychogenic amnesia
disease_ontology
DOID:11037
dissociative amnesia
A dissociative disorder in which the sufferer is affected by persistent or recurrent feelings of depersonalization and/or derealization.
GARD:6260
ICD9CM:300.6
MESH:D003861
NCI:C94331
SNOMEDCT_US_2020_03_01:70764005
UMLS_CUI:C0683416
Neurotic derealization
disease_ontology
DOID:11038
depersonalization disorder
A syndrome that results_in rheumatoid arthritis, splenomegaly and neutropenia.
GARD:8234
ICD10CM:M05.0
ICD9CM:714.1
MESH:D005258
NCI:C84712
OMIM:134750
SNOMEDCT_US_2020_03_01:57160007
UMLS_CUI:C0015773
Felty syndrome
Rheumatoid arthritis with splenoadenomegaly and leukopenia
disease_ontology
DOID:11042
OMIM mapping confirmed by DO. [SN].
Felty's syndrome
GARD:8661
ICD10CM:Q79.3
ICD9CM:756.73
MESH:D020139
NCI:C84725
OMIM:230750
SNOMEDCT_US_2020_03_01:72951007
UMLS_CUI:C0265706
disease_ontology
DOID:11044
OMIM mapping confirmed by DO. [SN].
gastroschisis
A lung disease that is characterized by a newborn breathing in a mixture of meconium and amniotic fluid into the lungs around the time of delivery.
GARD:10494
ICD10CM:P24.01
MESH:D008471
NCI:C87093
SNOMEDCT_US_2020_03_01:85779008
UMLS_CUI:C0025048
Neonatal aspiration of meconium
meconium aspiration
disease_ontology
DOID:11049
meconium aspiration syndrome
An urinary system cancer that results_in malignant growth located_in the urinary bladder.
DOID:5428
GARD:12210
ICD10CM:C67
ICD9CM:188
KEGG:05219
MESH:D001749
NCI:C2901
NCI:C9334
OMIM:109800
SNOMEDCT_US_2020_03_01:126885006
SNOMEDCT_US_2020_03_01:363455001
UMLS_CUI:C0005684
UMLS_CUI:C0005695
bladder cancer
tumor of the bladder
disease_ontology
DOID:11054
OMIM mapping confirmed by DO. [SN].
urinary bladder cancer
A primary bacterial infectious disease that results_in systemic infection, has_material_basis_in Pasteurella multocida, which is transmitted_by animal bite, scratch, or lick. The infection has_symptom joint pain has_symptom fever, has_symptom rigors, has_symptom pneumonia, has_symptom meningeal irritation, and has_symptom tachycardia.
ICD10CM:A28.0
ICD9CM:027.2
MESH:D010326
SNOMEDCT_US_2020_03_01:276199008
UMLS_CUI:C0030636
Pasteurella infection
Pasteurella infectious disease
disease_ontology
DOID:11055
pasteurellosis
A placenta disease that is characterized by placenta attachment to the uterine wall close to or covering the cervix.
ICD10CM:O44
MESH:D010923
NCI:C26858
SNOMEDCT_US_2020_03_01:157059004
UMLS_CUI:C0032046
disease_ontology
DOID:11060
placenta praevia
A esophageal cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
EFO:0002916
NCI:C3513
SNOMEDCT_US_2020_03_01:255079005
UMLS_CUI:C0152018
cancer of esophagus
cancer of oesophagus
carcinoma OF ESOPHAGUS
carcinoma of esophagus
carcinoma of oesophagus
disease_ontology
DOID:1107
esophageal carcinoma
A primary bacterial infectious disease that is caused by the bacteria of the genus Brucella, when humans come in contact with contaminated animals or animal products or ingestion of infected food products. The disease has_symptom fever, has_symptom sweat, has_symptom headache, has_symptom back pain, has_symptom physical weakness, has_symptom joint pain and has_symptom fatigue.
DOID:0050060
GARD:5966
ICD10CM:A23
ICD9CM:023
MESH:D002006
NCI:C84602
SNOMEDCT_US_2020_03_01:154296006
UMLS_CUI:C0006309
Maltese fever
undulant fever
disease_ontology
Bang's disease
Gibraltar fever
Malta fever
Mediterranean fever
DOID:11077
brucellosis
A parasitic ectoparasitic infectious disease that is caused by parasitic dipterous fly larvae (maggots) feeding on the host's necrotic or living tissue.
ICD10CM:B87
ICD9CM:134.0
MESH:D009198
NCI:C128400
SNOMEDCT_US_2020_03_01:266225001
UMLS_CUI:C0027030
Infestation by fly larvae
Infestation by maggots
Maggot infestation
disease_ontology
DOID:11080
myiasis
ICD10CM:H31.0
ICD9CM:363.3
SNOMEDCT_US_2020_03_01:53854005
UMLS_CUI:C0008512
disease_ontology
DOID:11086
chorioretinal scar
A respiratory system disease that is characterized by deprivation of oxygen to a newborn infant that lasts long enough during the birth process to cause physical harm, usually to the brain.
GARD:5857
ICD10CM:P84
ICD9CM:768.9
MESH:D001238
SNOMEDCT_US_2020_03_01:413654009
UMLS_CUI:C0004045
Asphyxia - birth
Asphyxia, in liveborn infant
Birth asphyxia
postnatal asphyxia
disease_ontology
DOID:11088
asphyxia neonatorum
MESH:D001238
A primary bacterial infectious disease that is a zoonotic infectious disease affecting multiple organs, has_material_basis_in Coxiella burnetii, which is transmitted_by inhalation of air contaminated by barnyard dust containing dried placental material, birth fluids, or excreta of infected herd animals, transmitted_by ingestion of contaminated milk, transmitted_by tick bites and transmitted_by contact with infected person. The infection has_symptom fever, has_symptom headache, has_symptom cough, has_symptom pleuritic chest pain, has_symptom myalgia and has_symptom arthralgia.
GARD:7515
ICD10CM:A78
ICD9CM:083.0
MESH:D011778
NCI:C34970
SNOMEDCT_US_2020_03_01:266205000
UMLS_CUI:C0034362
Infection due to Coxiella burnetii
disease_ontology
DOID:11100
Q fever
A primary bacterial infectious disease that results in systemic infection, has_material_basis_in Bartonella quintana, which is transmitted by body lice (Pediculus humanus corporis). The infection has symptom relapsing fever, has symptom headache, has symptom shin pain, and has symptom soreness of the muscles of the legs and back.
ICD10CM:A79.0
ICD9CM:083.1
MESH:D014205
SNOMEDCT_US_2020_03_01:82214002
UMLS_CUI:C0040830
His-Werner disease
Quintan fever
Wolhynian fever
shin bone fever
tibialgic fever
disease_ontology
DOID:11101
trench fever
MESH:D014205
A primary bacterial infectious disease that is caused by the bacteria of the genus Bartonella.
ICD10CM:A44
ICD9CM:088.0
MESH:D001474
NCI:C84586
SNOMEDCT_US_2020_03_01:17116008
UMLS_CUI:C0004771
Bartonella infectious disease
Rochalimaea infection
bartonelliasis
disease_ontology
DOID:11102
bartonellosis
A primary bacterial infectious disease that results in infection, located in endothelial cell of artery or located in endothelial cell of vein, has_material_basis_in Rickettsia, which is transmitted by ticks and mites. The infection has symptom fever, has symptom headache, has symptom fatigue, has symptom muscle aches, and has symptom maculopapular or petechial rash. A distinctive eschar (blackened or crusted skin) may develop at the site of a tick bite.
GARD:4998
ICD10CM:A77.9
ICD9CM:082.0
MESH:D000073605
SNOMEDCT_US_2020_03_01:186771002
UMLS_CUI:C0038041
Spotted fever group rickettsial disease
disease_ontology
DOID:11104
spotted fever
A fundus dystrophy that is characterized by discrete uniform white dots over the entire fundus with greatest density in the midperiphery and no macular involvement.
MESH:C562733
OMIM:136880
SNOMEDCT_US_2020_03_01:68222009
UMLS_CUI:C0311338
Pigmentary retinal dystrophy
retinitis punctata albescens
disease_ontology
DOID:11105
OMIM mapping confirmed by DO. [SN].
fundus albipunctatus
ICD10CM:N13.30
ICD9CM:591
MESH:D006869
NCI:C26796
SNOMEDCT_US_2020_03_01:155866001
UMLS_CUI:C0020295
disease_ontology
DOID:11111
hydronephrosis
A tic disorder that is characterized by multiple physical (motor) tics and at least one vocal (phonic) tic present for more than a year.
EFO:0004895
GARD:7783
ICD10CM:F95.2
ICD9CM:307.23
MESH:D005879
NCI:C35078
OMIM:137580
SNOMEDCT_US_2020_03_01:5158005
UMLS_CUI:C0040517
Guinon's disease
Psychogenic tics
Tourette syndrome
motor-verbal tic disorder
disease_ontology
DOID:11119
OMIM mapping confirmed by DO. [SN].
Gilles de la Tourette syndrome
ICD10CM:K04.0
ICD9CM:522.0
MESH:D011671
NCI:C52595
SNOMEDCT_US_2020_03_01:155638006
UMLS_CUI:C0034103
disease_ontology
DOID:11121
pulpitis
A hypersensitivity vasculitis that is characterized by purpura (purplish plaques), arthralgia, gastrointestinal upset, and/or glomerulonephritis, and may be related to increased immune response following an infection.
GARD:8204
ICD10CM:D69.0
ICD9CM:287.0
MESH:D011695
NCI:C34963
SNOMEDCT_US_2020_03_01:191306005
UMLS_CUI:C0034152
Allergic purpura
Autoimmune purpura
Henoch-Sch?nlein purpura
Henoch-Sch@nlein purpura
Henoch-Scholein purpura
Henoch-Schonlein Purpura
Purpura, autoimmune
disease_ontology
DOID:11123
Henoch-Schoenlein purpura
disease_ontology
DOID:11132
prostatic hypertrophy
A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.
DOID:3936
ICD10CM:C49
ICD9CM:171.9
SNOMEDCT_US_2020_03_01:93765001
UMLS_CUI:C0153519
connective and soft tissue neoplasm
tumor of soft tissue and skeleton
disease_ontology
DOID:1115
sarcoma
MESH:D041761
NCI:C34443
SNOMEDCT_US_2020_03_01:235919008
UMLS_CUI:C0947622
disease_ontology
DOID:11151
cholecystolithiasis
A miliaria that is characterized by erythematous papules resulting in leakage of sweat into the deeper, subcorneal layers of the epidermis provoking a local inflammatory reaction.
ICD10CM:L74.0
ICD9CM:705.1
MESH:D008883
SNOMEDCT_US_2020_03_01:44279002
UMLS_CUI:C0162423
prickly heat
disease_ontology
DOID:11153
miliaria rubra
A sweat gland disease that is characterized by reduced ability to sweat, has_symptom hyperthermia and dry skin of affected areas, and has_material_basis_in trauma to the sweat glands.
ICD10CM:L74.4
MESH:D007007
NCI:C34718
SNOMEDCT_US_2020_03_01:201189007
UMLS_CUI:C0020620
Hypohidrosis
Oligohidrosis
disease_ontology
DOID:11155
hypohidrosis
MESH:D007007
A hypohidrosis that is characterized by the inability to sweat and has_symptom hyperthermia and dry skin.
ICD10CM:L74.4
ICD9CM:705.0
MESH:D007007
NCI:C34385
OMIM:206600
SNOMEDCT_US_2020_03_01:201189007
UMLS_CUI:C0003028
Adiaphoresis
absence of sweating
disease_ontology
DOID:11156
OMIM mapping confirmed by DO. [SN].
anhidrosis
A commensal bacterial infectious disease that results_in inflammation located_in respiratory tract, has_material_basis_in Bordetella pertussis, or has_material_basis_in Bordetella parapertussis, which produce toxins that paralyze the cilia of the respiratory epithelial cells. The infection is characterized by a prolonged, high-pitched, deeply indrawn breath (whoop).
DOID:11333
DOID:11751
KEGG:05133
MESH:D001885
SNOMEDCT_US_2020_03_01:26484003
UMLS_CUI:C0006015
WC - Whooping cough
bordetella infection
whooping cough
disease_ontology
DOID:1116
pertussis
A lung disease characterized by inadequate gas exchange by the respiratory system.
DOID:11391
DOID:11392
DOID:11393
ICD10CM:J96.0
ICD9CM:518.81
NCI:C27043
SNOMEDCT_US_2020_03_01:65710008
UMLS_CUI:C0264490
acute and chronic respiratory failure
acute respiratory Failure
acute-on-chronic respiratory failure
chronic respiratory failure
respiratory insufficiency/failure
disease_ontology
DOID:11162
respiratory failure
ICD10CM:H18.42
ICD9CM:371.43
MESH:C562399
NCI:C118765
OMIM:217500
SNOMEDCT_US_2020_03_01:35055000
UMLS_CUI:C0155120
Band-shaped keratopathy
disease_ontology
DOID:11164
OMIM mapping confirmed by DO. [SN].
band keratopathy
A viral infectious disease that results_in infection located_in skin, has_material_basis_in human papillomavirus (types 2 and 4). This infection has_symptom raised wart with roughened surface, most common on hands, but can grow anywhere on the body.
ICD10CM:B07.8
ICD9CM:078.1
NCI:C27087
SNOMEDCT_US_2020_03_01:57019003
UMLS_CUI:C0043037
disease_ontology
DOID:11165
common wart
A viral infectious disease that results_in infection located_in skin of vagina, cervix, uterus, anus, penis, scrotum, mouth, and throat, has_material_basis_in human papillomaviruses (types 6 and 11), which are transmitted_by direct contact with the skin during oral, genital, or anal sex with an infected partner. The infection has_symptom anogenital warts.
DOID:7877
ICD10CM:A63.0
ICD9CM:078.11
MESH:D003218
NCI:C2960
NCI:C4820
SNOMEDCT_US_2020_03_01:240542006
SNOMEDCT_US_2020_03_01:302812006
UMLS_CUI:C0009663
UMLS_CUI:C0554632
Anogenital Human papilloma Virus Infectious Disease
Anogenital warts
Genital warts
genital wart virus infectious disease
venereal wart
disease_ontology
Condyloma acuminatum
DOID:11168
anogenital venereal wart
ICD10CM:H05.4
ICD9CM:376.5
MESH:D015841
NCI:C79552
SNOMEDCT_US_2020_03_01:267746003
UMLS_CUI:C0014306
disease_ontology
DOID:11175
enophthalmos
A otitis media which involves transudation of fluid in the middle ear without pus formation.
ICD10CM:H65
ICD9CM:381.4
SNOMEDCT_US_2020_03_01:275481002
UMLS_CUI:C0271446
Nonsuppurative otitis media
disease_ontology
DOID:11180
non-suppurative otitis media
ICD10CM:H10.02
ICD9CM:372.03
UMLS_CUI:C0029668
disease_ontology
DOID:11184
acute conjunctivitis
A synostosis that results_in the fusion of two or more digits.
GARD:13181
ICD10CM:Q70
ICD9CM:755.1
MESH:D013576
NCI:C87125
ORDO:295012
ORDO:90025
ORDO:93403
SNOMEDCT_US_2020_03_01:156989004
UMLS_CUI:C0039075
chromosome 2q35 duplication syndrome
symphalangism
symphalangy
webbing of digits
disease_ontology
DOID:11193
Xref MGI.
syndactyly
MESH:D013576
A syndrome that has_material_basis_in a large deletion of the chromosome 22q11.2 region which includes the DGS gene needed for development of the thymus and related glands with subsequent lack of T-cell production.
GARD:10299
ICD10CM:D82.1
ICD9CM:279.11
MESH:D004062
NCI:C2989
OMIM:188400
SNOMEDCT_US_2020_03_01:77128003
UMLS_CUI:C0012236
22q11.2 deletion syndrome
DiGeorge sequence
DiGeorge's syndrome
Pharyngeal pouch syndrome
disease_ontology
DOID:11198
OMIM mapping confirmed by DO. [SN].
DiGeorge syndrome
A parathyroid gland disease characterized by decreased function of parathyroid glands with underproduction of parathyroid hormone (PTH), leading to abnormally low ionized calcium levels in the blood.
GARD:6733
ICD10CM:E20
ICD9CM:252.1
MESH:D007011
NCI:C78350
OMIM:146200
OMIM:307700
ORDO:2238
SNOMEDCT_US_2020_03_01:154697005
UMLS_CUI:C0020626
disease_ontology
DOID:11199
Xref MGI.
hypoparathyroidism
MESH:D007011
DOID:111
DOID:13536
DOID:14031
GARD:6384
ICD10CM:I85.01
ICD9CM:456.0
ICD9CM:456.2
ICD9CM:456.20
NCI:C78282
SNOMEDCT_US_2020_03_01:195475003
SNOMEDCT_US_2020_03_01:195643006
SNOMEDCT_US_2020_03_01:236067006
UMLS_CUI:C0155789
UMLS_CUI:C0155791
UMLS_CUI:C0155792
Bleeding esophageal varices
Bleeding oesophageal varices
esophageal varices
esophageal varices in disease classified elsewhere, with bleeding
esophageal varices with bleeding
esophageal varices with bleeding in disease EC
esophageal varices without bleeding
esophageal varices without mention of bleeding
disease_ontology
DOID:112
esophageal varix
A primary immunodeficiency disease that is characterized by decreased numbers of circulating or functioning T cells.
DOID:613
NCI:C27145
NCI:C27872
SNOMEDCT_US_2020_03_01:402792003
UMLS_CUI:C1274233
UMLS_CUI:C1333147
T cell immunodeficiency
T lymphocyte deficiency
T lymphocyte immunodeficiency
disease_ontology
DOID:11200
T cell deficiency
An endocrine system disease that is located_in the parathyroid gland.
ICD10CM:E21.5
ICD9CM:252.9
MESH:D010279
NCI:C26844
SNOMEDCT_US_2020_03_01:73132005
UMLS_CUI:C0030517
disease of parathyroid glands
disease_ontology
DOID:11201
parathyroid gland disease
A chronic conjunctivitis that is an inflammation of the conjunctiva involing red, itchy, and watery eyes a resulting from an exposure to an allergen or an irritant.
MESH:D003233
NCI:C34506
SNOMEDCT_US_2020_03_01:231854006
UMLS_CUI:C0009766
disease_ontology
DOID:11204
allergic conjunctivitis
A substance abuse that involves the recurring use of opioid drugs despite negative consequences.
ICD10CM:F11.1
ICD9CM:305.5
MESH:D009293
SNOMEDCT_US_2020_03_01:5602001
UMLS_CUI:C0029095
disease_ontology
DOID:11206
opioid abuse
A viral infectious disease that results in inflammation located in conjunctiva, has_material_basis_in Human coxsackievirus A24 or has_material_basis_in Human enterovirus 70, which are transmitted by contaminated fomites or transmitted by contact with contaminated hands. The infection has symptom vascular dilation, has symptom eyelid edema, has symptom photophobia, has symptom redness of the eyes, has symptom watering of the eye, has symptom conjunctival congestion, and has symptom superficial punctate epithelial keratitis.
ICD9CM:077.4
MESH:D003232
NCI:C34505
SNOMEDCT_US_2020_03_01:186677009
UMLS_CUI:C0009765
Apollo disease
Epidemic hemorrhagic conjunctivitis
disease_ontology
viral conjunctivitis
DOID:11227
acute hemorrhagic conjunctivitis
ICD10CM:H05.0
ICD9CM:376.0
SNOMEDCT_US_2020_03_01:20551005
UMLS_CUI:C0155256
acute inflammation of orbit
disease_ontology
DOID:11230
acute orbital inflammation
An acute orbital inflammation that is characterized by painful orbital mass and has_symptom eyelid edema, has_symptom erythema, has_symptom chemiosis, has_symptom proptosis, has_symptom blurred vision, has_symptom headache, has_symptom fever and has_symptom double vision.
ICD10CM:H05.01
ICD9CM:376.01
MESH:D054517
NCI:C99000
SNOMEDCT_US_2020_03_01:194005002
UMLS_CUI:C0149507
disease_ontology
DOID:11234
orbital cellulitis
A intestinal cancer that is located_in the appendix.
ICD10CM:C18.1
ICD9CM:153.5
MESH:D001063
NCI:C9333
SNOMEDCT_US_2020_03_01:93679002
UMLS_CUI:C0496779
cancer of the appendix
malignant neoplasm of appendix vermiformis
malignant tumor of appendix
malignant tumor of the appendix
disease_ontology
DOID:11239
appendix cancer
MESH:D001063
NCI:C4434
SNOMEDCT_US_2020_03_01:126846004
UMLS_CUI:C0003614
appendix neoplasm
neoplasm of appendix
disease_ontology
DOID:11240
appendiceal neoplasm
MESH:D000751
SNOMEDCT_US_2020_03_01:111468003
UMLS_CUI:C0002891
anaemia neonatal
anemia neonatal
neonatal anaemia
disease_ontology
DOID:11244
neonatal anemia
ICD10CM:D65
ICD9CM:286.6
MESH:D004211
NCI:C2992
SNOMEDCT_US_2020_03_01:67406007
UMLS_CUI:C0012739
DIC
Defibrination syndrome
Diffuse or disseminated intravascular coagulation
disease_ontology
DOID:11247
disseminated intravascular coagulation
A nutritional deficiency disease that is characterized by easy bleeding due to an inability to form blood clots caused by vitamin K deficiency, occurs most commonly in newborns, and has_material_basis_in deficiency of vitamin K secondary to liver prematurity, lack of vitamin K in a breastmillk diet, largely sterile gut, malabsorption, diarrhea, chronic illness, menorrhagia, chronic kidney disease, and some medications.
ICD10CM:E56.1
ICD9CM:269.0
MESH:D014813
NCI:C99108
SNOMEDCT_US_2020_03_01:52675005
UMLS_CUI:C0042880
deficiency of vitamin K
vitamin K deficiency
vitamin K deficiency hemorrhagic disease
disease_ontology
DOID:11249
vitamin K deficiency bleeding
A primary bacterial infectious disease that refers to a group of diseases, located in endothelial cells of the small venous, arterial, and capillary vessels, has_material_basis_in Rickettsia bacteria, which are transmitted by lice, transmitted by fleas, and transmitted by mites.
DOID:11255
DOID:12353
GARD:7833
ICD10CM:A75.0
ICD10CM:A75.2
ICD10CM:A75.9
ICD9CM:080
ICD9CM:081.0
ICD9CM:081.9
MESH:D014437
MESH:D014438
NCI:C84688
NCI:C84689
SNOMEDCT_US_2020_03_01:154375001
SNOMEDCT_US_2020_03_01:25668000
SNOMEDCT_US_2020_03_01:39111003
UMLS_CUI:C0041471
UMLS_CUI:C0041472
UMLS_CUI:C0041473
Endemic Typhus fever
Exanthematic Typhus fever
Flea typhus
Louse-borne [epidemic] typhus
Moscow typhus
Murine [endemic] typhus
Typhus fever
endemic flea-borne typhus
epidemic louse-borne typhus
disease_ontology
Classical typhus
Epidemic (louse-borne) typhus
Epidemic louse-borne typhus fever due to Rickettsia prowazekii
European typhus
Exanthematous typhus
Famine fever
Flea-borne rickettsiosis
Flea-borne typhus
Hospital fever
Jail fever
Louse-borne rickettsiosis
Louse-borne typhus
Mexican typhus
Murine typhus
Petechial fever
Prison fever
Rat flea typhus
Ship fever
Shop typhus
Typhus exanthematique
Urban typhus
DOID:11256
typhus
A bartonellosis that results_in infection located_in lymph node, has_material_basis_in Bartonella henselae or has_material_basis_in Bartonella clarridgeiae, which are transmitted_by scratch or bite of a kitten, or transmitted_by contact of animal's saliva with an eye or through broken skin. The infection has_symptom regional lymphadenopathy, has_symptom headache, has_symptom chills, has_symptom backache, and has_symptom abdominal pain.
ICD10CM:A28.1
ICD9CM:078.3
MESH:D002372
NCI:C84620
SNOMEDCT_US_2020_03_01:123319006
UMLS_CUI:C0007361
Debre's Syndrome
Debre-Mollaret Syndrome
Foshay-Mollaret Cat Scratch Fever
benign lymphoreticulosis
cat scratch fever
disease_ontology
DOID:11258
cat-scratch disease
A viral infectious disease that results in inflammation located in brain or located in spinal cord, has_material_basis_in Rabies virus, which is transmitted by bite of an infected animal, or transmitted by contact of mucous membranes with saliva of an infected animal. The infection has symptom fever, has symptom headache, has symptom prickling or itching sensation at the site of bite, has symptom anxiety, has symptom confusion, has symptom agitation, has symptom delirium, has symptom difficulty swallowing, has symptom hydrophobia, and has symptom paralysis.
GARD:7516
ICD10CM:A82
ICD9CM:071
MESH:D011818
NCI:C28182
SNOMEDCT_US_2020_03_01:14168008
UMLS_CUI:C0034494
Lyssa
disease_ontology
DOID:11260
rabies
A primary bacterial infectious disease that results_in systemic infection, has_material_basis_in Chlamydia psittaci, which is transmitted_by inhaling aerosolized dried droppings or transmitted_by contact with infected birds. The infection has_symptom fever, has_symptom headache, has_symptom rash, has_symptom chills, and has_symptom pneumonia.
ICD10CM:A70
ICD9CM:073
MESH:D009956
NCI:C34873
SNOMEDCT_US_2020_03_01:154369005
UMLS_CUI:C0029291
psittacosis
disease_ontology
DOID:11262
ornithosis
A commensal bacterial infectious disease that results_in infection located_in eye, has_material_basis_in Chlamydia trachomatis (A, B, Ba and C serovars), which is transmitted_by contact with eye discharge from the infected person and transmitted_by congenital method. The infection causes eyelid to turn inward which makes eyelashes to scratch the cornea.
DOID:13013
DOID:13264
GARD:10374
ICD10CM:A71
ICD10CM:A71.0
ICD10CM:A71.1
ICD9CM:076
ICD9CM:076.0
ICD9CM:076.1
MESH:D014141
SNOMEDCT_US_2020_03_01:154367007
SNOMEDCT_US_2020_03_01:29976007
SNOMEDCT_US_2020_03_01:52812002
UMLS_CUI:C0040592
UMLS_CUI:C0153107
UMLS_CUI:C0153108
active stage trachoma
trachoma dubium
disease_ontology
DOID:11265
trachoma
A viral infectious disease that is a hemorrhagic fever, located in kidney, has_material_basis_in Hantaan virus, has_material_basis_in Dobrava-Belgrade orthohantavirus has_material_basis_in Seoul virus, or has_material_basis_in Puumala virus, which are carried and transmitted by rodents. The infection has symptom headache, has symptom fever, has symptom muscle pains, has symptom facial flush, has symptom petechiae, has symptom hemorrhagic features, has symptom proteinuria, and has symptom renal failure.
ICD10CM:A98.5
ICD9CM:078.6
MESH:D006480
NCI:C84753
SNOMEDCT_US_2020_03_01:186701001
UMLS_CUI:C0019101
HFRS
Hemorrhagic fever, Russian
Hemorrhagic nephrosonephritis
Puumala virus nephropathy
disease_ontology
DOID:11266
Hantavirus hemorrhagic fever with renal syndrome
GARD:6825
ICD10CM:H18.44
ICD9CM:371.45
MESH:C536156
SNOMEDCT_US_2020_03_01:85149007
UMLS_CUI:C0152455
disease_ontology
DOID:11267
keratomalacia
ICD10CM:K04.5
ICD9CM:522.6
SNOMEDCT_US_2020_03_01:718052004
UMLS_CUI:C0392492
disease_ontology
DOID:11269
chronic apical periodontitis
ICD10CM:E05.2
ICD9CM:242.3
NCI:C35171
SNOMEDCT_US_2020_03_01:57777000
UMLS_CUI:C0342127
Plummer disease
Toxic nodular Goiter
Toxic nodular goiter
disease_ontology
DOID:11277
Plummer's disease
MESH:D010899
NCI:C26853
SNOMEDCT_US_2020_03_01:237701005
UMLS_CUI:C0032001
Pituitary apoplexy
disease_ontology
DOID:1129
pituitary apoplexy
A hemangioma that is characterized by a configuration of blood vessels that shunts arterial blood directly into veins by bypassing the capillary system.
ICD10CM:I77.0
NCI:C2882
SNOMEDCT_US_2020_03_01:403966009
UMLS_CUI:C0334533
Arteriovenous hemangioma
Cirsoid aneurysm
Racemose Angioma
Racemose aneurysm
Racemose hemangioma
disease_ontology
DOID:11294
arteriovenous malformation
NCI:C27117
SNOMEDCT_US_2020_03_01:95830009
UMLS_CUI:C0342405
Pituitary infarction
disease_ontology
DOID:1130
pituitary infarct
A schistosomiasis that is a short-term, cutaneous inflammatory response associated with penetration of the skin by cercariae of bird schistosome, Austrobilharzia variglandis. The disease has symptom skin reddening, has symptom skin itching, in the water or immediately after emerging and has symptom itchy, raised papules, occur within hours of infection.
GARD:9747
ICD10CM:B65.3
ICD9CM:120.3
NCI:C34457
SNOMEDCT_US_2020_03_01:187115002
UMLS_CUI:C0546996
Cutaneous schistosomiasis
Sea bather's eruption
disease_ontology
DOID:11302
cercarial dermatitis
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Kyasanur forest disease virus, which is transmitted by Haemaphysalis spinigera tick bite. The infection has symptom fever, has symptom headache, has symptom stiffness of the neck, has symptom severe muscle pain, has symptom cough, has symptom dehydration, and has symptom bleeding problems.
GARD:8257
ICD10CM:A98.2
ICD9CM:065.2
MESH:D007733
SNOMEDCT_US_2020_03_01:23097003
UMLS_CUI:C0022810
disease_ontology
DOID:11320
Kyasanur forest disease
GARD:6370
ICD10CM:A46
ICD9CM:035
MESH:D004886
SNOMEDCT_US_2020_03_01:266005008
UMLS_CUI:C0014733
disease_ontology
DOID:11330
erysipelas
A hypersensitivity reaction type IV disease characterized by the growth of collections of inflammatory cells (granulomas) in multiple organs.
GARD:7607
ICD10CM:D86
ICD9CM:135
MESH:D012507
NCI:C34995
ORDO:797
SNOMEDCT_US_2020_03_01:154425004
UMLS_CUI:C0036202
Boeck sarcoid
lymphogranulomatosis
disease_ontology
DOID:11335
sarcoidosis
MESH:D012507
A primary bacterial infectious disease that involves the inflammation of mucosa lining the nasal cavity, pharynx, larynx, trachea and bronchi that is characterized by the formation of granulomas, dense induration of the tissues and nodular deformity caused by Klebsiella rhinoscleromatis.
ICD9CM:040.1
MESH:D012226
SNOMEDCT_US_2020_03_01:72409005
UMLS_CUI:C0035468
disease_ontology
DOID:11336
rhinoscleroma
A primary bacterial infectious disease that results in prolonged contraction of skeletal muscle fibers, has_material_basis_in Clostridium tetani, which produces tetanospasmin, a neurotoxin, which is carried to the brain and spinal cord, where it binds irreversibly to receptors inhibiting neurotransmission. Damaged upper motor neurons cannot control reflex responses to afferent sensory stimuli.
GARD:5144
ICD10CM:A35
ICD9CM:037
MESH:D013742
NCI:C85185
SNOMEDCT_US_2020_03_01:154312006
UMLS_CUI:C0039614
Infection due to Clostridium tetani
clostridial tetanus
disease_ontology
DOID:11338
tetanus
An opportunistic mycosis that is located in lungs, but can also occur in eyes, ears, skin, thyroid, pituitary, palate, parathyroid, esophagus, pleura, heart, liver, spleen, small intestine, adrenals, kidneys, bone marrow, and lymph nodes, has_material_basis_in Pneumocystis jirovecii that effects interstitial and alveolar tissues and has symptom nonproductive cough, has symptom shortness of breath, and has symptom fever.
GARD:4386
ICD10CM:B59
ICD9CM:136.3
MESH:D011020
NCI:C3334
SNOMEDCT_US_2020_03_01:57541005
UMLS_CUI:C1535939
Pneumocystis carinii pneumonia
Pneumocystis jirovecii pneumonia
Pneumocystis pneumonia
Pneumocystosis
Pneumocystosis pneumonia
pulmonary pneumocystosis
disease_ontology
DOID:11339
pneumocystosis
DOID:1133
DOID:13280
DOID:13901
DOID:2405
ICD10CM:K06.0
ICD10CM:K06.01
ICD9CM:523.2
ICD9CM:523.24
MESH:D005889
NCI:C82068
SNOMEDCT_US_2020_03_01:155645006
SNOMEDCT_US_2020_03_01:59898000
UMLS_CUI:C0017572
UMLS_CUI:C0266916
Gingival recession
Gingival recession, localized
localized gingival recession
minimal gingival recession
moderate gingival recession
severe gingival recession
disease_ontology
DOID:1134
gingival recession
An eye disease that affects the sclera, which is the white fibrous outer layer of the eyeball.
ICD10CM:H15
MESH:D015422
NCI:C79717
SNOMEDCT_US_2020_03_01:33064008
UMLS_CUI:C0036412
disease_ontology
DOID:11343
scleral disease
ICD10CM:N32.3
ICD9CM:596.3
MESH:C562406
NCI:C160155
OMIM:109820
SNOMEDCT_US_2020_03_01:268335001
UMLS_CUI:C0156273
Diverticulum - bladder
Diverticulum of bladder
disease_ontology
DOID:11353
OMIM mapping confirmed by DO. [SN].
bladder diverticulum
A viral infectious disease that results in infection, has_material_basis_in Sandfly fever Naples virus, or has_material_basis_in Sandfly fever sicilian virus, which are transmitted by Phlebotomus papatasi sandfly. The infection has symptom fever, has symptom severe frontal headaches, has symptom muscle ache, has symptom joint aches, has symptom flushing of the face, and has symptom tachycardia.
ICD10CM:A93.1
ICD9CM:066.0
MESH:D010217
SNOMEDCT_US_2020_03_01:33670001
UMLS_CUI:C0030372
Sandfly fever
Sandfly-borne arboviral fever
Sandfly-borne bunyavirus fever
Sandfly-borne phleboviral disease
pappataci fever
disease_ontology
DOID:11360
Phlebotomus fever
ICD10CM:H27.11
ICD9CM:379.32
MESH:D007906
NCI:C34772
SNOMEDCT_US_2020_03_01:155203002
UMLS_CUI:C0023316
Subluxation of lens
disease_ontology
DOID:11364
lens subluxation
MESH:D007906
ICD10CM:Q12.3
ICD9CM:743.35
NCI:C35172
OMIM:610256
SNOMEDCT_US_2020_03_01:35387008
UMLS_CUI:C0152422
APHAKIA, CONGENITAL PRIMARY
Congenital absence of lens
disease_ontology
DOID:11367
OMIM mapping confirmed by DO. [SN].
congenital aphakia
A colonic disease that is characterized by an abnormal dilation of the colon.
DOID:1771
ICD10CM:K59.39
MESH:D008531
NCI:C34810
SNOMEDCT_US_2020_03_01:33995003
UMLS_CUI:C0025160
Dilatation of colon
disease_ontology
DOID:11372
megacolon
A parasitic helminthiasis infectious disease that involves parasitic infection due to migrating immature worms of Gnathostoma spinigerum or Gnathostoma hispidum, which occurs by eating undercooked fish or poultry containing third-stage larvae, or by drinking water containing infective second-stage larvae in Cyclops. Migration in the subcutaneous tissues causes intermittent, migratory, painful, pruritic swellings (cutaneous larva migrans). Migration to other tissues (visceral larva migrans), result in cough, hematuria, and ocular involvement, with the most serious manifestations eosinophilic meningitis with myeloencephalitis.
GARD:9286
ICD10CM:B83.1
ICD9CM:128.1
MESH:D058429
NCI:C128395
SNOMEDCT_US_2020_03_01:44086001
UMLS_CUI:C0018013
Gnathostomiasis
Infectious Disease by Gnathostoma
disease_ontology
DOID:11379
gnathomiasis
GARD:10264
MESH:D008579
NCI:C6935
SNOMEDCT_US_2020_03_01:189167009
UMLS_CUI:C0347515
Spinal Cord meningioma
Spinal meningioma
disease_ontology
DOID:1138
spinal meningioma
ICD10CM:Q53.9
ICD9CM:752.51
MESH:D003456
NCI:C12326
OMIM:219050
SNOMEDCT_US_2020_03_01:204879009
UMLS_CUI:C0010417
Cryptorchism
Undescended testicle
Undescended testis
undescended testicles
disease_ontology
DOID:11383
OMIM mapping confirmed by DO. [SN].
cryptorchidism
A language disorder that involves difficulties with verbal and written expression characterized by an ability to use expressive spoken language that is markedly below the appropriate level for the mental age, but with a language comprehension that is within normal limits.
ICD10CM:F80.1
ICD9CM:315.31
NCI:C92562
SNOMEDCT_US_2020_03_01:80360005
UMLS_CUI:C0236826
Developmental expressive language disorder
disease_ontology
DOID:11385
expressive language disorder
A central nervous system disease that is characterized by a collection of pus (infected material) between the outer covering of the brain and spinal cord and the bones of the skull or spine and is caused by infection in the area between the bones of the skull or spine, and the membranes covering the brain and spinal cord (meninges).
MESH:D020802
SNOMEDCT_US_2020_03_01:310671007
UMLS_CUI:C0270629
abscess epidural
disease_ontology
DOID:11387
epidural abscess
ICD9CM:437.4
SNOMEDCT_US_2020_03_01:28366008
UMLS_CUI:C0007773
Cerebral arteritis
disease_ontology
DOID:11390
cerebral arteritis
A respiratory failure that results from diffuse injury to the endothelium of the lung (as in sepsis, chest trauma, massive blood transfusion, aspiration of the gastric contents, or pneumonia) and is characterized by pulmonary edema with an abnormally high amount of protein in the edematous fluid and by difficult rapid breathing and hypoxemia.
GARD:5698
ICD10CM:J80
MESH:D012128
NCI:C3353
SNOMEDCT_US_2020_03_01:155627006
UMLS_CUI:C0035222
ARDS
Non-cardiogenic pulmonary edema
Shock lung
acute respiratory distress syndrome
adult RDS
disease_ontology
DOID:11394
PRISM.
adult respiratory distress syndrome
A cardiovascular system disease that involves the heart.
ICD10CM:I51.9
ICD9CM:429.9
MESH:D006331
NCI:C3079
SNOMEDCT_US_2020_03_01:194707003
UMLS_CUI:C0018799
disease_ontology
DOID:114
heart disease
NCI:C5134
UMLS_CUI:C1334264
disease_ontology
DOID:1140
spinal canal and spinal cord meningioma
ICD10CM:N16
ICD9CM:590.80
MESH:D011704
NCI:C34965
SNOMEDCT_US_2020_03_01:45816000
UMLS_CUI:C0034186
disease_ontology
DOID:11400
pyelonephritis
MESH:D011705
NCI:C123038
SNOMEDCT_US_2020_03_01:197777006
UMLS_CUI:C0034188
Xanthogranulomatous pyelonephritis
disease_ontology
DOID:11401
xanthogranulomatous pyelonephritis
A primary bacterial infectious disease that is characterized by sore throat, low fever, and an adherent membrane (a pseudomembrane) on the tonsils, pharynx, and/or nasal cavity. A milder form of diphtheria can be restricted to the skin. It is caused by Corynebacterium diphtheriae, an aerobic Gram-positive bacterium. Diphtheria toxin spreads through the bloodstream and can lead to potentially life-threatening complications that affect other organs of the body, such as the heart and kidneys.
DOID:4132
GARD:1875
MESH:D003354
SNOMEDCT_US_2020_03_01:397434007
UMLS_CUI:C0010153
corynebacterium infection
disease_ontology
DOID:11405
diphtheria
A female reproductive system disease characterized by the growth of fallopian tube-like epithelium outside the fallopian tube.
NCI:C40121
SNOMEDCT_US_2020_03_01:55850004
UMLS_CUI:C0269106
disease_ontology
DOID:11427
endosalpingiosis
ICD10CM:H50.1
ICD9CM:378.1
MESH:D005099
NCI:C34601
SNOMEDCT_US_2020_03_01:155194007
UMLS_CUI:C0015310
Divergent Strabismus
Divergent concomitant strabismus
disease_ontology
DOID:1143
exotropia
A brain disease that is characterized by pressure on the intracranial tissues by an effusion of blood or cerebrospinal fluid, an abscess, a neoplasm, a depressed fracture of the skull, or edema of the brain.
ICD10CM:G93.5
ICD9CM:348.4
SNOMEDCT_US_2020_03_01:46963008
UMLS_CUI:C0009592
disease_ontology
DOID:11457
brain compression
GARD:4561
ICD10CM:G93.2
ICD9CM:348.2
MESH:D011559
NCI:C85035
OMIM:243200
SNOMEDCT_US_2020_03_01:68267002
UMLS_CUI:C0033845
Pseudotumor cerebri
benign intracran. hypt.
benign intracranial hypertension
idiopathic intracranial hypertension
disease_ontology
DOID:11459
OMIM mapping confirmed by DO. [SN].
pseudotumor cerebri
ICD9CM:337.1
UMLS_CUI:C0154691
autonomic nervous system disorder
disease_ontology
DOID:11465
autonomic nervous system disease
A bone resorption disease characterized by decreased density of normally mineralized bone which results_in the thinning of bone tissue and decreased mechanical strength.
EFO:0003882
ICD10CM:M81.0
ICD9CM:733.0
MESH:D010024
NCI:C3298
OMIM:166710
SNOMEDCT_US_2020_03_01:156825006
UMLS_CUI:C0029456
disease_ontology
DOID:11476
Xref MGI.
osteoporosis
A physical disorder that is characterized by the presence of more than five fingers per hand or five toes per foot.
DOID:14779
GARD:4410
ICD10CM:Q69
ICD9CM:755.0
MESH:C562429
MESH:D017689
NCI:C87110
OMIM:174200
OMIM:174500
OMIM:174700
OMIM:603596
SNOMEDCT_US_2020_03_01:205119005
UMLS_CUI:C0152427
UMLS_CUI:C0220697
postaxial polydactyly
disease_ontology
Supernumerary digit
DOID:1148
polydactyly
ICD9CM:423.2
MESH:D010494
NCI:C78246
SNOMEDCT_US_2020_03_01:155340008
UMLS_CUI:C0031048
Constrictive pericarditis
disease_ontology
DOID:11481
constrictive pericarditis
A pericardial effusion that results from blood in the pericardial sac.
ICD9CM:423.0
MESH:D010490
NCI:C111644
SNOMEDCT_US_2020_03_01:155339006
UMLS_CUI:C0019064
Haemopericardium
disease_ontology
DOID:11482
hemopericardium
GARD:6670
ICD10CM:G90.2
MESH:D006732
NCI:C28155
OMIM:143000
SNOMEDCT_US_2020_03_01:192922002
UMLS_CUI:C0019937
Bernard Horner syndrome
Horner syndrome
cervical sympathetic paralysis
disease_ontology
DOID:11486
Horner's syndrome
A pericardial effusion in which fluid accumulates in the pericardium (the sac in which the heart is enclosed) and the pericardial spaces fills up faster than the pericardial sac can stretch.
ICD10CM:I31.4
ICD9CM:423.3
MESH:D002305
NCI:C50481
SNOMEDCT_US_2020_03_01:266295005
UMLS_CUI:C0007177
Rose's tamponade
pericardial tamponade
disease_ontology
DOID:115
cardiac tamponade
DOID:11737
DOID:13947
ICD10CM:Q23.3
ICD9CM:396.3
ICD9CM:746.6
MESH:D008944
NCI:C50888
SNOMEDCT_US_2020_03_01:194736003
SNOMEDCT_US_2020_03_01:194977007
SNOMEDCT_US_2020_03_01:29928006
UMLS_CUI:C0026266
UMLS_CUI:C0158619
UMLS_CUI:C0264774
Congenital insufficiency of mitral valve
Mitral valve incompetence
congenital mitral insufficiency
congenital mitral regurgitation
mitral regurgitation
disease_ontology
DOID:11502
mitral valve insufficiency
NCI:C27033
SNOMEDCT_US_2020_03_01:277879009
UMLS_CUI:C0259749
disease_ontology
DOID:11504
autonomic neuropathy
A otitis media which involves inflammation of the middle ear with infected effusion containing pus.
ICD10CM:H66.4
ICD9CM:382.4
MESH:D010035
SNOMEDCT_US_2020_03_01:267758003
UMLS_CUI:C0029888
Otitis media with effusion - purulent
Purulent otitis media
disease_ontology
DOID:11506
suppurative otitis media
ICD10CM:I82.0
MESH:D006502
OMIM:600880
SNOMEDCT_US_2020_03_01:195436007
UMLS_CUI:C0019154
hepatic vein thrombosis
disease_ontology
DOID:11512
Budd-Chiari syndrome
ICD10CM:K14.5
ICD9CM:529.5
MESH:D014063
OMIM:137400
SNOMEDCT_US_2020_03_01:52368004
UMLS_CUI:C0040412
Congenital fissure of tongue
Congenital plicated tongue
Fissure of tongue
Fissure of tongue, congenital
Furrowed tongue
Plicated tongue
Tongue, Fissured
geographic tongue and fissured tongue
lingua plicata
scrotal tongue
disease_ontology
DOID:11514
OMIM mapping confirmed by DO. [SN].
fissured tongue
A heart disease that is caused by high blood pressure.
ICD10CM:I11
ICD9CM:402
NCI:C157879
SNOMEDCT_US_2020_03_01:155297007
UMLS_CUI:C0152105
disease_ontology
DOID:11516
hypertensive heart disease
ICD10CM:J38.6
ICD9CM:478.74
MESH:D007829
NCI:C79608
SNOMEDCT_US_2020_03_01:195864007
UMLS_CUI:C0023075
Stenosis of larynx
disease_ontology
DOID:11527
laryngostenosis
ICD10CM:H18.83
ICD9CM:371.42
SNOMEDCT_US_2020_03_01:2055003
UMLS_CUI:C0155119
recurrent erosion of cornea
recurrent erosion syndrome
disease_ontology
DOID:11541
recurrent corneal erosion
ICD10CM:H16.31
ICD9CM:370.55
NCI:C26969
SNOMEDCT_US_2020_03_01:64366002
UMLS_CUI:C0155091
disease_ontology
DOID:11543
corneal abscess
A corneal dystrophy characterized by accumulation of focal outgrowths (guttae) and thickening of Descemet's membrane, leading to corneal edema and loss of vision.
EFO:0003946
GARD:10018
ICD10CM:H18.51
MESH:D005642
NCI:C84721
OMIM:136800
OMIM:610158
OMIM:613267
OMIM:613268
OMIM:613269
OMIM:613270
OMIM:613271
OMIM:615523
ORDO:98974
SNOMEDCT_US_2020_03_01:16949007
UMLS_CUI:C0016781
FCED
Fuchs' corneal dystrophy
Fuchs' endothelial corneal dystrophy
disease_ontology
DOID:11555
Xref MGI.
Fuchs' endothelial dystrophy
An arthritis that has_material_basis_in the accumulation of salt crystals located_in joint.
DOID:11303
DOID:1155
DOID:12090
DOID:12102
DOID:12945
DOID:13298
DOID:13299
DOID:13301
DOID:13302
DOID:13303
DOID:13304
DOID:14143
DOID:14220
DOID:14513
DOID:1834
DOID:1945
DOID:2486
ICD9CM:712.1
NCI:C34955
OMIM:118600
OMIM:118610
OMIM:600668
ORDO:1416
SNOMEDCT_US_2020_03_01:201624004
SNOMEDCT_US_2020_03_01:201625003
UMLS_CUI:C0033802
UMLS_CUI:C0157852
calcium pyrophosphate deposition disease
pseudogout
disease_ontology
DOID:1156
Xref MGI.
chondrocalcinosis
ICD10CM:H35.03
ICD9CM:362.11
MESH:D058437
NCI:C3514
SNOMEDCT_US_2020_03_01:422001004
UMLS_CUI:C0152132
disease_ontology
DOID:11561
hypertensive retinopathy
A somatoform disorder that involves heart disease symptoms without any identifiable physiological abnormatlities.
ICD9CM:306.2
MESH:D009449
SNOMEDCT_US_2020_03_01:46219009
UMLS_CUI:C0027821
Cardiovascular malfunction arising from mental factors
Cardiovascular neurosis
Da Costa's syndrome
Krishaber's disease
disease_ontology
DOID:11569
neurocirculatory asthenia
A primary bacterial infectious disease that results_in infection, has_material_basis_in Listeria monocytogenes, which is transmitted_by ingestion of contaminated food or raw milk or transmitted_by congenital method. Ingestion of Listeria by pregnant women has_symptom nausea, has_symptom vomiting, has_symptom diarrhea, has_symptom fever, has_symptom malaise, has_symptom back pain, and has_symptom headache. Maternal infection with Listeria can result in chorioamnionitis, premature labor, spontaneous abortion, or stillbirth.
ICD10CM:A32
ICD9CM:027.0
MESH:D008088
NCI:C82994
SNOMEDCT_US_2020_03_01:186315001
UMLS_CUI:C0023860
Infection by Listeria monocytogenes
Listeria infection
disease_ontology
DOID:11573
listeriosis
A peripheral nervous system disease that involves an acute loss of function of the lumbar plexus, neurologic elements (nerve roots) of the spinal canal below the termination (conus) of the spinal cord.
GARD:10987
ICD10CM:G83.4
ICD9CM:344.6
MESH:D000077684
NCI:C35436
SNOMEDCT_US_2020_03_01:89356000
UMLS_CUI:C0392548
disease_ontology
DOID:11577
Cauda equina syndrome
ICD10CM:H16.25
ICD9CM:370.31
SNOMEDCT_US_2020_03_01:193773009
UMLS_CUI:C0155080
Phlyctenular keratoconjunctivitis
Strumous ophthalmia
disease_ontology
DOID:11581
phlyctenulosis
ICD10CM:G90.1
MESH:D004402
NCI:C84706
OMIM:223900
SNOMEDCT_US_2020_03_01:204087006
UMLS_CUI:C0013364
HSAN III
familial autonomic nervous dysfunction
familial dysautonomia
disease_ontology
DOID:11589
OMIM mapping confirmed by DO. [SN].
Riley-Day syndrome
ICD9CM:536.8
UMLS_CUI:C0013396
disease_ontology
DOID:1159
functional gastric disease
ICD10CM:H15.84
ICD9CM:379.11
SNOMEDCT_US_2020_03_01:111534007
UMLS_CUI:C0155359
Scleral ectasia
disease_ontology
DOID:11595
scleral staphyloma
GARD:6467
MESH:D013547
OMIM:144100
SNOMEDCT_US_2020_03_01:56046002
UMLS_CUI:C0038994
Baillarger syndrome
gustatory hyperhidrosis
gustatory sweating
disease_ontology
DOID:11599
OMIM mapping confirmed by DO. [SN].
Frey syndrome
DOID:5780
ICD10CM:C38.0
NCI:C4567
NCI:C4651
SNOMEDCT_US_2020_03_01:126734005
SNOMEDCT_US_2020_03_01:93957005
UMLS_CUI:C0346609
UMLS_CUI:C0349574
Pericardial tumor
malignant neoplasm of pericardium
malignant tumor of Pericardium
disease_ontology
DOID:116
pericardium cancer
A meningitis that has_material_basis_in a fungal infection.
MESH:D016921
SNOMEDCT_US_2020_03_01:24321005
UMLS_CUI:C0085438
disease_ontology
DOID:11608
fungal meningitis
An ovarian dysfunction that is characterized by hyperandrogenism, polycystic ovaries, hirsutism, oligomenorrhea or amenorrhea, anovulation and excessive body weight.
EFO:0000660
ICD10CM:E28.2
ICD9CM:256.4
MESH:D011085
NCI:C26862
OMIM:184700
SNOMEDCT_US_2020_03_01:69878008
UMLS_CUI:C0032460
Multicystic ovaries
PCOS
Polycystic Ovarian disease
Polycystic ovaries
Polycystic ovary syndrome
Stein-Leventhal synd.
Stein-Leventhal syndrome
polycystic ovary
disease_ontology
DOID:11612
OMIM mapping confirmed by DO. [SN].
polycystic ovary syndrome
MESH:D017588
SNOMEDCT_US_2020_03_01:237793004
UMLS_CUI:C0206081
hyperandrogenization syndrome
disease_ontology
DOID:11613
hyperandrogenism
DOID:11614
ICD10CM:C60
ICD10CM:C60.2
ICD9CM:187.3
ICD9CM:187.4
MESH:D010412
NCI:C7547
SNOMEDCT_US_2020_03_01:93716006
SNOMEDCT_US_2020_03_01:93954003
UMLS_CUI:C0153600
UMLS_CUI:C0153601
Ca penis
Penile Ca
malignant Penile tumor
malignant neoplasm of body of penis
penile neoplasm
disease_ontology
DOID:11615
penile cancer
ICD10CM:K04.1
ICD9CM:522.1
MESH:D003790
SNOMEDCT_US_2020_03_01:196332000
UMLS_CUI:C0011407
necrosis of the pulp
necrotic pulp
pulp necrosis
disease_ontology
DOID:11623
dental pulp necrosis
MESH:D010412
NCI:C3317
SNOMEDCT_US_2020_03_01:126896003
UMLS_CUI:C0030849
Penile tumor
neoplasm of penis
disease_ontology
DOID:11624
penile benign neoplasm
MESH:D018382
NCI:C85191
OMIM:188570
OMIM:274300
SNOMEDCT_US_2020_03_01:50375007
UMLS_CUI:C2940786
Generalized thyroid hormone resistance
Refetoff syndrome
Thyroid hormone resistance syndrome
Thyroid hormone responsiveness defect
thyroid hormone resistance
disease_ontology
DOID:11633
OMIM mapping confirmed by DO. [LS].
thyroid hormone resistance syndrome
ICD10CM:H52.4
ICD9CM:367.4
MESH:D011305
SNOMEDCT_US_2020_03_01:155135005
UMLS_CUI:C0033075
disease_ontology
DOID:11638
presbyopia
A bullous skin disease characterized by skin lesions and scaring and located_in mucous membranes and located_in skin.
DOID:11655
GARD:5913
ICD10CM:L12.1
ICD9CM:694.6
ICD9CM:694.61
MESH:D010390
NCI:C34907
OMIM:164185
SNOMEDCT_US_2020_03_01:34250006
SNOMEDCT_US_2020_03_01:76092003
UMLS_CUI:C0030804
UMLS_CUI:C0157721
Cicatricial pemphigoid with ocular involvement
Ocular pemphigoid
benign mucous membrane pemphigoid
benign mucous membrane pemphigoid with ocular involvement
ocular pemphigus
disease_ontology
DOID:11656
cicatricial pemphigoid
An arthritis that involves sudden and rapidly developing attacks of arthritis with a remission period that results_in no joint damage or symptoms.
DOID:1165
DOID:1177
DOID:1178
DOID:1179
DOID:12951
DOID:13354
DOID:13355
DOID:13771
GARD:7304
ICD10CM:M12.3
ICD9CM:719.3
ICD9CM:719.31
MESH:C538103
SNOMEDCT_US_2020_03_01:202455001
SNOMEDCT_US_2020_03_01:202457009
UMLS_CUI:C0085574
UMLS_CUI:C0158178
Hench's syndrome
Hench-Rosenberg syndrome
disease_ontology
DOID:1166
palindromic rheumatism
A color blindness that is characterised by a selective deficiency of blue vision, has_material_basis_in autosomal dominant inheritance of a mutation in the OPN1SW gene and is associated with a deficiency or absence of blue-sensitive cone photoreceptor function.
ICD10CM:H53.55
ICD9CM:368.53
MESH:D003117
OMIM:190900
SNOMEDCT_US_2020_03_01:51886007
UMLS_CUI:C0155017
Tritan defect
Tritanopia
disease_ontology
DOID:11661
OMIM mapping confirmed by DO. [SN].
blue color blindness
ICD10CM:Q91.7
ICD9CM:758.1
MESH:D000073839
NCI:C101223
SNOMEDCT_US_2020_03_01:21111006
UMLS_CUI:C0152095
D1 Trisomy
trisomy 13
disease_ontology
Patau's syndrome
DOID:11665
OMIM mapping confirmed by DO. [LS].
Patau syndrome
A filariasis that involves parasitic infection caused by the nematode Onchocerca volvulus, which is transmitted to humans through the bite of a blackfly of the genus Simulium. The worms spread throughout the body and, when they die, cause intense itching and a strong immune system response that can destroy nearby tissue. The symptoms include pruritus, dermatitis, blindness, onchocercomata (subcutaneous nodules), and lymphadenopathy.
GARD:7252
ICD10CM:B73
ICD9CM:125.3
MESH:D009855
NCI:C34861
SNOMEDCT_US_2020_03_01:38539003
UMLS_CUI:C0029001
Infection by Onchocerca volvulus
Onchocerca volvulus infection
volvulosis
disease_ontology
DOID:11678
onchocerciasis
DOID:3147
ICD10CM:E78.5
MESH:D006949
MESH:D006951
NCI:C34707
NCI:C34709
SNOMEDCT_US_2020_03_01:154739000
SNOMEDCT_US_2020_03_01:3744001
UMLS_CUI:C0020473
UMLS_CUI:C0020476
familial hyperlipoproteinemia
hyperlipemia
disease_ontology
hyperlipidaemia
DOID:1168
familial hyperlipidemia
NCI:C27548
SNOMEDCT_US_2020_03_01:201096007
UMLS_CUI:C1321683
disease_ontology
DOID:11684
melanoacanthoma
ICD10CM:K04.4
ICD9CM:522.4
SNOMEDCT_US_2020_03_01:88071000
UMLS_CUI:C0155934
acute apical periodontitis of pulpal origin
disease_ontology
DOID:11693
acute apical periodontitis
A hepatic vascular disease that is characterized by a blood clot that forms within the hepatic portal vein.
ICD10CM:I81
ICD9CM:452
NCI:C78565
SNOMEDCT_US_2020_03_01:155455003
UMLS_CUI:C0155773
disease_ontology
DOID:11695
portal vein thrombosis
A cardiovascular cancer located_in the heart.
DOID:9918
GARD:2619
ICD10CM:C38.0
ICD9CM:164.1
MESH:D006338
NCI:C3081
NCI:C3548
SNOMEDCT_US_2020_03_01:126730001
SNOMEDCT_US_2020_03_01:93825008
UMLS_CUI:C0018809
UMLS_CUI:C0153500
Cardiac tumor
Tumour of heart
malignant Cardiac tumor
malignant neoplasm of heart
disease_ontology
DOID:117
heart cancer
A selective immunoglobulin deficiency disease that is caused by a reduction in some types of gamma globulins.
MESH:D004406
SNOMEDCT_US_2020_03_01:127389001
UMLS_CUI:C0013374
Dysgammaglobulinemia
disease_ontology
DOID:11702
dysgammaglobulinemia
MESH:D004406
A peripheral vascular disease that is characterized by narrowing of the arteries as a complication arising from chronic diabetes.
DOID:10182
ICD9CM:250.7
MESH:D003925
NCI:C35610
SNOMEDCT_US_2020_03_01:127014009
UMLS_CUI:C0011871
UMLS_CUI:C0011875
Diabetic vascular disorder
diabetic peripheral angiopathy
disease_ontology
DOID:11713
diabetic angiopathy
A diabetes mellitus that manifests during pregnancy.
EFO:0004593
ICD10CM:O24.4
MESH:D016640
NCI:C34942
SNOMEDCT_US_2020_03_01:11687002
UMLS_CUI:C0085207
GDM
Gestational diabetes mellitus
Maternal gestational diabetes mellitus
disease_ontology
DOID:11714
gestational diabetes
A glucose metabolism disease that is characterized by blood glucose levels are high, but not high enough to be classified as type 2 diabetes.
ICD10CM:R73.03
MESH:D011236
NCI:C122685
SNOMEDCT_US_2020_03_01:15777000
UMLS_CUI:C0362046
Prediabetes
impaired glucose tolerance
prediabetic state
disease_ontology
DOID:11716
prediabetes syndrome
A diabetes mellitus that is characterized by hyperglycemia occuring within the first 6 months of life.
ICD10CM:P70.2
ICD9CM:775.1
NCI:C99248
SNOMEDCT_US_2020_03_01:49817004
UMLS_CUI:C0158981
diabetes mellitus syndrome in newborn infant
neonatal diabetes mellitus
disease_ontology
DOID:11717
neonatal diabetes
DOID:0050527
ICD10CM:E78.1
ICD9CM:272.1
MESH:D006953
NCI:C34711
OMIM:144600
OMIM:145750
SNOMEDCT_US_2020_03_01:154741004
UMLS_CUI:C0020480
Endogenous hyperlipidaemia
Fredrickson type IV Lipidemia
Fredrickson type IV hyperlipoproteinemia
Fredrickson type IV lipidaemia
VLDL hyperlipoproteinemia
familial hypertriglyceridemia
disease_ontology
DOID:1172
OMIM mapping confirmed by DO. [SN].
hyperlipoproteinemia type IV
A muscular dystrophy that is characterized by predominant weakness and atrophy beginning in the feet and/or hands.
ICD10CM:G71.09
MESH:D049310
NCI:C84675
ORDO:399096
ORDO:5448
ORDO:59135
SNOMEDCT_US_2020_03_01:58795000
UMLS_CUI:C0751336
Miyoshi muscular dystrophy
distal muscular dystrophy
disease_ontology
DOID:11720
Xref MGI.
OMIM mapping confirmed by DO. [SN].
distal myopathy
A myotonic disease that is characterized by progressive muscle wasting and weakness affecting the distal skeletal and smooth muscles of lower legs, hands, neck, and face along with myotonia and cataracts and has_material_basis_in the autosomal dominant inheritance of the DMPK gene containing an expansion of a CTG trinucleotide repeat in the non-coding region.
GARD:8310
ICD10CM:G71.11
ICD9CM:359.21
MESH:D009223
NCI:C84914
OMIM:160900
SNOMEDCT_US_2020_03_01:77956009
UMLS_CUI:C0027126
Dystrophia myotonica
Steinert disease
congenital myotonic dystrophy
myotonic dystrophy of Steinert
disease_ontology
DOID:11722
OMIM mapping confirmed by DO. [SN].
myotonic dystrophy type 1
MESH:C535686
A muscular dystrophy that has_material_basis_in X-linked mutations in the DMD gene found on the X chromosome. It is characterized by rapidly progressing muscle weakness and muscle atrophy initially involving the lower extremities and eventually affecting the whole body. It affects males whereas females can be carriers. The symptoms start before the age of six and may appear at infancy.
GARD:6291
MESH:D020388
NCI:C75482
OMIM:310200
SNOMEDCT_US_2020_03_01:155095006
UMLS_CUI:C0013264
Muscular dystrophy, Duchenne
disease_ontology
DOID:11723
OMIM mapping confirmed by DO. [SN].
Duchenne muscular dystrophy
A muscular dystrophy that is characterized by weakening of the muscles of the hip and shoulders which comprise the limb girdle muscles.
GARD:6907
ICD10CM:G71.09
MESH:D049288
NCI:C84828
ORDO:263
SNOMEDCT_US_2020_03_01:56096001
UMLS_CUI:C0686353
Erb's muscular dystrophy
Leyden-Mbius muscular dystrophy
limb girdle muscular dystrophy
disease_ontology
DOID:11724
Xref MGI.
OMIM mapping confirmed by DO. [SN].
limb-girdle muscular dystrophy
A syndrome that is characterized by slow growth before and after birth, intellectual disability that is usually severe to profound, skeletal abnormalities involving the arms and hands, and distinctive facial features.
GARD:10109
ICD10CM:Q87.19
MESH:D003635
NCI:C75016
OMIM:PS122470
ORDO:199
SNOMEDCT_US_2020_03_01:40354009
UMLS_CUI:C0270972
Brachmann de Lange syndrome
De Lange syndrome
disease_ontology
DOID:11725
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Cornelia de Lange syndrome
A muscular dystrophy that chiefly affects muscles used for movement (skeletal) and heart (cardiac) muscle.
GARD:6329
MESH:D020389
NCI:C84685
OMIM:PS310300
ORDO:261
SNOMEDCT_US_2020_03_01:129620000
UMLS_CUI:C0410189
EDMD
disease_ontology
DOID:11726
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Emery-Dreifuss muscular dystrophy
GARD:9941
ICD10CM:G71.02
MESH:D020391
NCI:C84704
SNOMEDCT_US_2020_03_01:56096001
UMLS_CUI:C0238288
Landouzy Dejerine muscular dystrophy
Landouzy-Dejerine muscular dystrophy
Muscular dystrophy, Landouzy-Dejerine
disease_ontology
DOID:11727
OMIM mapping confirmed by DO. [SN].
facioscapulohumeral muscular dystrophy
A primary bacterial infectious disease that results_in infection, has_material_basis_in Borrelia burgdorferi, which is transmitted_by blacklegged tick (Ixodes scapularis) or transmitted_by western blacklegged tick (Ixodes pacificus). The infection has_symptom fever, has_symptom headache, has_symptom fatigue, and has_symptom skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system.
DOID:12233
GARD:12073
ICD10CM:A69.2
ICD9CM:088.81
MESH:D008193
MESH:D020852
NCI:C45161
SNOMEDCT_US_2020_03_01:154376000
SNOMEDCT_US_2020_03_01:715507005
UMLS_CUI:C0024198
UMLS_CUI:C0752235
Bannwarth syndrome
Bannworth's syndrome
Lyme borreliosis
Neurological Lyme disease
lyme neuroboInOwlrreliosis
neuroboInOwlrreliosis
disease_ontology
DOID:11729
Lyme disease
MESH:D042883
SNOMEDCT_US_2020_03_01:197397004
UMLS_CUI:C0701818
disease_ontology
DOID:11755
choledocholithiasis
ICD10CM:D50
MESH:D000747
NCI:C34380
SNOMEDCT_US_2020_03_01:44452003
UMLS_CUI:C0002884
ANEMIA HYPOCHROMIC
disease_ontology
DOID:11759
hypochromic anemia
A lower respiratory tract disease that affects the airways leading into the lungs, which is caused due to inflammation of the bronchi and bronchioles, infection, or blockage.
DOID:1175
DOID:12322
MESH:D001982
SNOMEDCT_US_2020_03_01:41427001
UMLS_CUI:C0006261
Bronchospasm
disease_ontology
DOID:1176
bronchial disease
ICD10CM:H55.03
ICD9CM:379.53
MESH:D009759
SNOMEDCT_US_2020_03_01:39771000
UMLS_CUI:C0271384
Ocular nystagmus
Searching eye movements
visual deprivation nystagmus
disease_ontology
DOID:11771
spontaneous ocular nystagmus
ICD10CM:H44.53
ICD9CM:360.44
SNOMEDCT_US_2020_03_01:193288000
UMLS_CUI:C0152458
Leucocoria
disease_ontology
DOID:11772
leukocoria
ICD10CM:H52.22
ICD9CM:367.21
SNOMEDCT_US_2020_03_01:68905002
UMLS_CUI:C0152193
disease_ontology
DOID:11781
regular astigmatism
A refractive error characterized by the optics of the eye to focus a point object into a sharp focused image on the retina, has_symptom blurred vision.
EFO:0004222
ICD10CM:H52.2
ICD9CM:367.2
MESH:D001251
OMIM:603047
SNOMEDCT_US_2020_03_01:155134009
UMLS_CUI:C0004106
disease_ontology
DOID:11782
OMIM mapping confirmed by DO. [SN].
astigmatism
ICD9CM:289.52
UMLS_CUI:C1260402
disease_ontology
DOID:11786
splenic sequestration
A pericardium disease that is characterized by an abnormal accumulation of fluid in the pericardial cavity.
MESH:D010490
NCI:C3319
SNOMEDCT_US_2020_03_01:70370001
UMLS_CUI:C0031039
disease_ontology
DOID:118
pericardial effusion
A nutritional deficiency disease that is characterized by inadequate dietary protein and calories, which can have profound systemic effects including decreased metabolism, altered tissue distribution, compromised immunity, and impaired growth, and has_material_basis_in dietary deprivation.
ICD10CM:E46
ICD9CM:263.9
MESH:D011502
NCI:C34952
SNOMEDCT_US_2020_03_01:72608005
UMLS_CUI:C0033677
disease_ontology
DOID:11801
protein-energy malnutrition
ICD10CM:H43.81
ICD9CM:379.21
SNOMEDCT_US_2020_03_01:60189009
UMLS_CUI:C0155366
Vitreous degeneration
disease_ontology
DOID:11816
vitreous syneresis
A urinary system cancer that is located_in the ureter.
ICD10CM:C66
ICD9CM:189.2
MESH:D014516
NCI:C7543
OMIM:191600
SNOMEDCT_US_2020_03_01:94121005
UMLS_CUI:C0153619
malignant tumour of ureter
malignant ureteral tumor
disease_ontology
DOID:11819
OMIM mapping confirmed by DO. [SN].
ureter cancer
A syndrome that is characterized by papulonodular skin lesions containing a proliferation of true macrophages associated with arthritis.
GARD:7103
ICD10CM:E78.81
NCI:C27896
ORDO:139436
SNOMEDCT_US_2020_03_01:84241008
UMLS_CUI:C0311284
Lipoid dermatoarthritis
Multicentric reticulohistiocytosis
disease_ontology
DOID:11824
multicentric reticulohistiocytosis
A refractive error characterized by the inability to see farther objects clearly.
EFO:0003927
ICD10CM:H52.1
ICD9CM:367.1
MESH:D009216
NCI:C102533
OMIM:160700
OMIM:255500
OMIM:300613
OMIM:310460
OMIM:603221
OMIM:608367
OMIM:608474
OMIM:608908
OMIM:609256
OMIM:609257
OMIM:609258
OMIM:609259
OMIM:609994
OMIM:609995
OMIM:610320
OMIM:612554
OMIM:612717
OMIM:613959
OMIM:613969
OMIM:614166
OMIM:614167
OMIM:615420
OMIM:615431
OMIM:615946
SNOMEDCT_US_2020_03_01:155133003
UMLS_CUI:C0027092
near vision
near-sightedness
short-sightedness
disease_ontology
DOID:11830
Xref MGI.
myopia
MESH:D009216
ICD10CM:H47.61
ICD9CM:377.75
MESH:D019575
NCI:C118707
SNOMEDCT_US_2020_03_01:68574006
UMLS_CUI:C0155320
disease_ontology
DOID:11831
cortical blindness
MESH:D012640
NCI:C3980
SNOMEDCT_US_2020_03_01:39194005
UMLS_CUI:C0270824
epilepsy, visual
disease_ontology
DOID:11832
visual epilepsy
A bone development disease where one or both are inclined inwards, axially rotated outwards, and pointing downwards with concomitant soft tissue abnormalities.
DOID:0001874
ICD10CM:Q66.89
ICD9CM:754.51
MESH:D003025
NCI:C84641
OMIM:119800
SNOMEDCT_US_2020_03_01:33163000
UMLS_CUI:C0009081
Congenital equinovarus
Equinovarus deformity of foot
congenital clubfoot
congenital talipes equinovarus
disease_ontology
DOID:11836
OMIM mapping confirmed by DO. [SN].
clubfoot
A nephrosis characterized by marked increase in glomerular protein permeability resulting in marked elevation of urine protein levels, hypoalbuminemia, hyperlipidemia, and hypercoagulability.
ICD10CM:N04
ICD9CM:581
MESH:D009404
NCI:C34845
SNOMEDCT_US_2020_03_01:155851004
UMLS_CUI:C0027726
disease_ontology
DOID:1184
Xref MGI.
nephrotic syndrome
MESH:D003329
NCI:C34515
SNOMEDCT_US_2020_03_01:23687008
UMLS_CUI:C0010073
Coronary Vasospasm
Coronary artery spasm
disease_ontology
DOID:11840
coronary artery vasospasm
MESH:D020429
SNOMEDCT_US_2020_03_01:359842002
UMLS_CUI:C0751932
Posterior tibial neuropathy
Tibial neuropathy
disease_ontology
DOID:1187
tibial neuropathy
GARD:7392
ICD10CM:G31.01
ICD9CM:331.11
MESH:D020774
NCI:C85008
OMIM:172700
SNOMEDCT_US_2020_03_01:154998003
UMLS_CUI:C0236642
Dementia in Pick's disease
LOBAR ATROPHY OF BRAIN
PICK DISEASE OF BRAIN
Pick disease
disease_ontology
DOID:11870
OMIM mapping confirmed by DO. [SN].
Pick's disease
MESH:D020774
ICD10CM:K12.1
MESH:D013282
SNOMEDCT_US_2020_03_01:196576008
UMLS_CUI:C0038364
Denture sore mouth
disease_ontology
DOID:11875
denture stomatitis
A neuropathy that is characterized by damage to a single nerve, which results in loss of movement, sensation, or other function of that nerve.
ICD10CM:G58.9
MESH:D020422
SNOMEDCT_US_2020_03_01:304595001
UMLS_CUI:C0494491
disease_ontology
DOID:1188
mononeuropathy
MESH:D014516
NCI:C3427
SNOMEDCT_US_2020_03_01:126882009
UMLS_CUI:C0041955
neoplasm of ureter
ureteral tumor
disease_ontology
DOID:11885
ureteral benign neoplasm
A female reproductive system cancer that is located_in the vagina.
DOID:1902
GARD:9348
ICD10CM:C52
ICD9CM:184.0
MESH:D014625
NCI:C3437
NCI:C7410
SNOMEDCT_US_2020_03_01:126921000
SNOMEDCT_US_2020_03_01:188210000
UMLS_CUI:C0042237
UMLS_CUI:C0042258
malignant neoplasm of vagina
malignant tumor of vagina
malignant vaginal tumor
neoplasm of vagina
vagina neoplasm
vaginal tumor
disease_ontology
DOID:119
vaginal cancer
ICD10CM:K31.84
ICD9CM:536.3
MESH:D018589
NCI:C80512
SNOMEDCT_US_2020_03_01:235675006
UMLS_CUI:C0152020
Gastroparalysis
Gastroparesis syndrome
gastric atonia
disease_ontology
DOID:11914
gastroparesis
A dermatophytosis that results_in fungal skin infection located_in groin, located_in perineum, or located_in perianal region, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes and has_symptom itching in groin, thigh skin folds, or anus and results_in_formation_of rash which appears as raised red plaques (platelike areas) and scaly patches with sharply defined borders that may blister and ooze.
ICD9CM:110.3
NCI:C34535
SNOMEDCT_US_2020_03_01:59089002
UMLS_CUI:C0011638
Dermatophytosis of Groin and Perianal Area
Dermatophytosis of groin & perianal area
Dermatophytosis of groin and perianal area
Dhobie itch
disease_ontology
DOID:11917
tinea cruris
A nervous system cancer that is located in the peripheral nervous system.
DOID:3194
MESH:D010524
MESH:D018317
NCI:C3321
NCI:C4972
SNOMEDCT_US_2020_03_01:126980002
SNOMEDCT_US_2020_03_01:189946005
UMLS_CUI:C0031118
UMLS_CUI:C0206727
neoplasm of peripheral nerve
nerve sheath neoplasm
tumor of PNS
disease_ontology
DOID:1192
peripheral nervous system neoplasm
A respiratory system cancer that is located_in the trachea.
ICD10CM:C33
ICD9CM:162.0
NCI:C9346
SNOMEDCT_US_2020_03_01:187855003
UMLS_CUI:C0153489
disease_ontology
DOID:11920
tracheal cancer
An organ system cancer that arises in the head or neck region. This region includes the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx.
GARD:12425
MESH:D006258
NCI:C3077
SNOMEDCT_US_2020_03_01:255055008
UMLS_CUI:C0018671
head and neck neoplasm
head and neck tumours
head/neck neoplasm
tumor of head and neck
disease_ontology
DOID:11934
head and neck cancer
EFO:0004226
GARD:6956
ICD10CM:A81.0
ICD9CM:046.1
MESH:D007562
NCI:C26802
OMIM:123400
SNOMEDCT_US_2020_03_01:155061007
UMLS_CUI:C0022336
CJD
Creutzfeldt Jacob syndrome
Creutzfeldt Jakob disease
Creutzfeldt-Jacob disease
Jakob-Creutzfeldt disease
Subacute spongiform encephalopathy
Transmissible virus dementia
disease_ontology
DOID:11949
OMIM mapping confirmed by DO. [SN].
Creutzfeldt-Jakob disease
NCI:C27025
SNOMEDCT_US_2020_03_01:129611009
UMLS_CUI:C0238309
Ischemic peripheral neuropathy
disease_ontology
DOID:1195
ischemic neuropathy
DOID:11962
ICD10CM:K20
ICD9CM:530.1
MESH:D004941
NCI:C9224
SNOMEDCT_US_2020_03_01:155673008
UMLS_CUI:C0014868
acute esophagitis
disease_ontology
DOID:11963
esophagitis
A dysostosis that results_in abnormal fusing of adjacent bones.
MESH:D013580
UMLS_CUI:C0039093
disease_ontology
DOID:11971
synostosis
A primary bacterial infectious disease that involves intoxication caused by botulinum neurotoxins (BoNTA, B, E and F) located in neuromuscular junction resulting in descending muscle paralysis, has_material_basis_in Clostridium botulinum A, has_material_basis_in Clostridium botulinum B, has_material_basis_in Clostridium botulinum E and has_material_basis_in Clostridium botulinum F.
GARD:943
ICD10CM:A05.1
MESH:D001906
NCI:C84599
SNOMEDCT_US_2020_03_01:154276003
UMLS_CUI:C0006057
Botulism poisoning
Food poisoning due to Clostridium botulinum
Foodborne botulism
Infection due to clostridium botulinum
Intoxication with Clostridium botulinum toxin
disease_ontology
DOID:11976
botulism
ICD9CM:278.01
MESH:D009767
NCI:C34858
SNOMEDCT_US_2020_03_01:389986000
UMLS_CUI:C0028756
Severe obesity
disease_ontology
DOID:11981
morbid obesity
A chromosomal disease that is characterized by weak muscle tone, feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating and obesity.
GARD:5575
ICD10CM:Q87.11
ICD9CM:759.81
MESH:D011218
NCI:C75463
OMIM:176270
ORDO:739
SNOMEDCT_US_2020_03_01:205794007
UMLS_CUI:C0032897
Prader Willi syndrome
disease_ontology
DOID:11983
OMIM mapping confirmed by DO. [SN].
Prader-Willi syndrome
An intrinsic cardiomyopathy that is characterized by abnormal thickening (hypertrophy) of the heart without any obvious cause.
DOID:11986
ICD9CM:425.1
KEGG:05410
MESH:D002312
MESH:D024741
NCI:C34449
NCI:C84773
ORDO:217568
SNOMEDCT_US_2020_03_01:389998005
SNOMEDCT_US_2020_03_01:83978005
UMLS_CUI:C0007194
UMLS_CUI:C0949658
familial hypertrophic cardiomyopathy
hypertrophic obstructive cardiomyopathy
disease_ontology
DOID:11984
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hypertrophic cardiomyopathy
An osteosclerosis that results_in numerous bone islands located_in skeleton.
GARD:4158
ICD10CM:Q78.8
ICD9CM:756.53
MESH:D010023
NCI:C84985
SNOMEDCT_US_2020_03_01:9147009
UMLS_CUI:C0029455
disease_ontology
DOID:11991
osteopoikilosis
ICD10CM:N50.0
ICD9CM:608.3
NCI:C123259
SNOMEDCT_US_2020_03_01:155938008
UMLS_CUI:C0156312
disease_ontology
DOID:11994
atrophy of testis
ICD10CM:N44.02
ICD9CM:608.2
MESH:D013086
NCI:C26885
OMIM:187400
SNOMEDCT_US_2020_03_01:198046000
UMLS_CUI:C0037856
Torsion of testicle
Torsion of testis
testicular Torsion
disease_ontology
DOID:11996
spermatic cord torsion
ICD10CM:N43.4
ICD9CM:608.1
MESH:D013088
NCI:C120909
SNOMEDCT_US_2020_03_01:155936007
UMLS_CUI:C0037859
disease_ontology
DOID:11997
spermatocele
A reproductive organ cancer that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva.
DOID:1244
DOID:1281
ICD10CM:C57
ICD9CM:184
MESH:D005833
NCI:C3053
NCI:C4913
SNOMEDCT_US_2020_03_01:126907002
SNOMEDCT_US_2020_03_01:188207007
UMLS_CUI:C0017416
UMLS_CUI:C0153585
UMLS_CUI:C0699889
female reproductive cancer
malignant Gynecologic tumor
malignant neoplasm of female genital organ
disease_ontology
DOID:120
female reproductive organ cancer
GARD:9790
ICD10CM:H47.01
ICD9CM:377.41
MESH:D018917
SNOMEDCT_US_2020_03_01:14357004
UMLS_CUI:C0155305
Ischemic optic neuropathy
disease_ontology
DOID:12010
anterior ischemic optic neuropathy
An adrenal adenoma characterized by the over production of aldosterone.
GARD:7456
ICD10CM:E26.01
ICD9CM:255.12
MESH:D006929
NCI:C34510
SNOMEDCT_US_2020_03_01:13536004
UMLS_CUI:C1384514
Conn syndrome
primary aldosteronism
primary hyperaldosteronism
disease_ontology
DOID:12028
Conn's syndrome
ICD9CM:292.8
UMLS_CUI:C0154325
disease_ontology
DOID:1203
drug-induced mental disorder
An uveitis that is characterized by inflammation of all layers of the uvea (middle layer) of the eye, which includes the iris, ciliary body, and choroid.
GARD:8577
ICD10CM:H44.11
ICD9CM:360.12
MESH:D015864
NCI:C84989
SNOMEDCT_US_2020_03_01:75614007
UMLS_CUI:C0030343
Diffuse uveitis
disease_ontology
DOID:12030
panuveitis
An immune system disease that is an exaggerated immune response to allergens, such as insect venom, dust mites, pollen, pet dander, drugs or some foods.
allergic disease
ICD10CM:T78.40
MESH:D006967
NCI:C3114
SNOMEDCT_US_2020_03_01:257550005
UMLS_CUI:C0020517
allergic hypersensitivity disease
hypersensitivity
hypersensitivity reaction type I disease
disease_ontology
DOID:1205
allergic disease
An opportunistic mycosis that results_in fungal infection and has_material_basis_in Cryptococcus neoformans or Cryptococcus gattii.
GARD:6218
ICD10CM:B45
ICD9CM:117.5
MESH:D003453
NCI:C2967
SNOMEDCT_US_2020_03_01:42386007
UMLS_CUI:C0010414
Busse-Buschke's disease
European cryptococcosis
cryptococcal infection
torula
torulosis
disease_ontology
cryptococcus neoformans infection
DOID:12053
cryptococcosis
MESH:D003453
A pervasive developmental disease that is characterized by normal early growth and development followed by a slowing of development, loss of purposeful use of the hands, distinctive hand movements, slowed brain and head growth, problems with walking, seizures, and intellectual disability.
GARD:5696
ICD10CM:F84.2
MESH:D015518
NCI:C75488
OMIM:312750
OMIM:613454
SNOMEDCT_US_2020_03_01:192583003
UMLS_CUI:C0035372
Rett's disorder
cerebroatrophic hyperammonemia
disease_ontology
DOID:1206
OMIM mapping confirmed by DO. [SN].
Rett syndrome
GARD:7805
ICD10CM:G50.0
ICD9CM:350.1
MESH:D014277
OMIM:190400
SNOMEDCT_US_2020_03_01:155066002
UMLS_CUI:C0040997
Trifacial neuralgia
Trigeminal neuralgia
trifocal neuralgia
disease_ontology
DOID:12098
OMIM mapping confirmed by DO. [LS].
trigeminal neuralgia
A female reproductive system disease that is located_in the vagina.
MESH:D014623
NCI:C26910
SNOMEDCT_US_2020_03_01:25658005
UMLS_CUI:C0042251
disease_ontology
DOID:121
vaginal disease
An optic nerve disease that results_in inflammation located_in optic nerve which may cause a complete or partial loss of vision.
GARD:7320
ICD10CM:H46
ICD9CM:377.3
MESH:D009902
NCI:C84950
SNOMEDCT_US_2020_03_01:194051001
UMLS_CUI:C0029134
disease_ontology
DOID:1210
optic neuritis
A lung disease that is characterized the accumulation of tiny fragments of calcium phosphate gradually accumulate in the alveoli of the lungs.
GARD:11894
ICD10CM:J84.02
ICD9CM:516.2
MESH:C562405
OMIM:265100
SNOMEDCT_US_2020_03_01:196160008
UMLS_CUI:C0155912
disease_ontology
DOID:12117
OMIM mapping confirmed by DO. [SN].
pulmonary alveolar microlithiasis
An iron metabolism disease that has_material_basis_in an accumulation of hemosiderin, an iron-storage complex, resulting in iron overload.
GARD:6595
MESH:D006486
NCI:C82892
SNOMEDCT_US_2020_03_01:39011001
UMLS_CUI:C0019114
haemosiderosis
disease_ontology
DOID:12119
hemosiderosis
A lung disease that is characterized by abnormal accumulation of surfactant occurs within the alveoli, interfering with gas exchange.
ICD10CM:J84.01
ICD9CM:516.0
MESH:D011649
NCI:C85037
OMIM:265120
OMIM:300770
OMIM:610913
OMIM:610921
OMIM:614370
ORDO:264675
SNOMEDCT_US_2020_03_01:10501004
UMLS_CUI:C0034050
disease_ontology
DOID:12120
Xref MGI.
pulmonary alveolar proteinosis
An autoimmune disease that is characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract, glomerulonephritis, vasculitis, and the presence of antineutrophil cytoplasmatic autoantibodies (ANCAs) in patient sera, and is located_in lung, located_in kidney, located_in skin resulting from an autoimmune attack by antineutrophil cytoplasmic antibodies against small and medium-size blood vessels.
GARD:7880
ICD10CM:M31.3
ICD9CM:446.4
MESH:D014890
NCI:C3444
OMIM:608710
SNOMEDCT_US_2020_03_01:195353004
UMLS_CUI:C3495801
Necrotizing respiratory granulomatosis
Wegener granulomatosis, formerly
disease_ontology
DOID:12132
granulomatosis with polyangiitis
A blood coagulation disease that has_material_basis_in Factor VIII deficiency, which results in the formation of fibrin deficient clots which makes coagulation much more prolonged.
GARD:6591
ICD10CM:D66
ICD9CM:286.0
MESH:D006467
NCI:C27146
OMIM:306700
ORDO:98878
SNOMEDCT_US_2020_03_01:28293008
UMLS_CUI:C0019069
Congenital factor VIII disorder
Hemophilia A
Subhemophilia
classic hemophilia A
disease_ontology
DOID:12134
OMIM mapping confirmed by DO. [SN].
factor VIII deficiency
MESH:D006467
A mood disorder that involves the presence of a low mood almost daily over a span of at least two years.
ICD10CM:F34.1
ICD9CM:300.4
MESH:D019263
NCI:C34562
SNOMEDCT_US_2020_03_01:192384008
UMLS_CUI:C0013415
dysthymia
disease_ontology
DOID:12139
dysthymic disorder
A trypanosomiasis that is a tropical parasitic disease caused by the flagellate protozoan Trypanosoma cruzi, which is transmitted to humans and other mammals by an insect vector, the blood-sucking assassin bugs of the subfamily Triatominae (family Reduviidae), most commonly species belonging to the Triatoma, Rhodnius, and Panstrongylus genera. The symptoms include fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, vomiting, swelling of the eyelids and myocarditis.
DOID:0050016
DOID:0050019
DOID:0050020
GARD:6030
ICD9CM:086.2
KEGG:05142
SNOMEDCT_US_2020_03_01:186817003
UMLS_CUI:C0007932
Chagas' disease
chagas' disease with digestive system involvement
chagas' disease with nervous system involvement
chagas' disease with other organ involvement
disease_ontology
American trypanosomiasis
DOID:12140
Chagas disease
ICD9CM:596.54
MESH:D001750
NCI:C79696
SNOMEDCT_US_2020_03_01:192972000
UMLS_CUI:C0005697
Neuropathic bladder
neurogenic dysfunction of the urinary bladder
neurogenic urinary bladder disorder
disease_ontology
DOID:12143
neurogenic bladder
ICD9CM:596.52
SNOMEDCT_US_2020_03_01:9009001
UMLS_CUI:C0489967
Low bladder compliance
hyperactivity of bladder
hypertonic bladder
hypertonicity of bladder
disease_ontology
DOID:12144
low compliance bladder
ICD9CM:596.55
SNOMEDCT_US_2020_03_01:236655005
UMLS_CUI:C0341747
disease_ontology
DOID:12145
detrusor sphincter dyssynergia
A viral infectious disease that results in infection located in brain, or located in meninges, or located in brain and meninges, has_material_basis_in Lymphocytic choriomeningitis virus, which is transmitted by common house mouse, Mus musculus. The infection has symptom fever, has symptom lack of appetite, has symptom headache, has symptom muscle aches, has symptom malaise, has symptom nausea, and has symptom vomiting.
DOID:10662
ICD10CM:A87.2
MESH:D008216
SNOMEDCT_US_2020_03_01:192668002
UMLS_CUI:C0024266
LCM
Lymphocytic choriomeningitis virus encephalomyelitis
Lymphocytic meningitis
Lymphocytic meningoencephalitis
disease_ontology
DOID:12155
lymphocytic choriomeningitis
ICD10CM:H35.4
ICD9CM:362.6
NCI:C34919
SNOMEDCT_US_2020_03_01:193393004
UMLS_CUI:C1320640
peripheral degeneration of retina
disease_ontology
DOID:12161
peripheral retinal degeneration
ICD10CM:G56.2
ICD9CM:354.2
SNOMEDCT_US_2020_03_01:55802003
UMLS_CUI:C1288279
Lesion of ulnar nerve
disease_ontology
DOID:12168
ulnar nerve lesion
ICD10CM:G56.0
ICD9CM:354.0
MESH:D002349
NCI:C34450
OMIM:115430
SNOMEDCT_US_2020_03_01:193126005
UMLS_CUI:C0007286
CTS - Carpal tunnel syndrome
Carpal tunnel syndrome
Median nerve entrapment
carpal tunnel median neuropathy
disease_ontology
DOID:12169
OMIM mapping confirmed by DO. [SN].
carpal tunnel syndrome
ICD10CM:E07.1
ICD9CM:246.1
SNOMEDCT_US_2020_03_01:190304001
UMLS_CUI:C0152077
Dyshormonogenic goiter
Dyshormonogenic goitre
dyshormonogenic goitre
disease_ontology
DOID:12175
dyshormonogenic goiter
A thyroid gland disease that involves an abnormal enlargement of the thyroid gland.
ICD10CM:E04.9
ICD9CM:240.9
MESH:D006042
NCI:C26785
SNOMEDCT_US_2020_03_01:237568003
UMLS_CUI:C0018021
goitre
disease_ontology
DOID:12176
goiter
MESH:D006042
An agammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells.
GARD:6140
ICD10CM:D83
ICD9CM:279.06
MESH:D017074
OMIM:240500
OMIM:607594
OMIM:613493
OMIM:613494
OMIM:613495
OMIM:613496
OMIM:614699
OMIM:614700
OMIM:615577
OMIM:615767
ORDO:1572
SNOMEDCT_US_2020_03_01:191010004
UMLS_CUI:C0009447
CVID
acquired agammaglobulinemia
acquired hypogammaglobulinemia
common variable agammaglobulinemia
sporadic hypogammaglobulinemia
disease_ontology
DOID:12177
Xref MGI.
OMIM mapping confirmed by DO. [SN].
common variable immunodeficiency
An otitis interna characterized by an abnormal bone growth in the middle ear.
EFO:0004213
ICD10CM:H80.80
ICD9CM:387.8
OMIM:166800
OMIM:605727
OMIM:608244
OMIM:608484
OMIM:611571
OMIM:611572
OMIM:612096
OMIM:615589
ORDO:2794
SNOMEDCT_US_2020_03_01:194382008
UMLS_CUI:C0029696
disease_ontology
DOID:12185
Xref MGI.
otosclerosis
MESH:D010040
ICD10CM:C18.7
ICD9CM:153.3
MESH:D012811
SNOMEDCT_US_2020_03_01:94006002
UMLS_CUI:C0153436
Ca sigmoid colon
malignant tumor of sigmoid colon
disease_ontology
DOID:12192
sigmoid colon cancer
ICD10CM:H16.14
ICD9CM:370.21
SNOMEDCT_US_2020_03_01:193767008
UMLS_CUI:C0259799
Punctate keratitis
Thygeson superficial punctate keratitis
Thygeson's superficial punctate keratitis
disease_ontology
DOID:12197
punctate epithelial keratoconjunctivitis
A viral infectious disease that results in infection, has_material_basis_in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.
DOID:0050142
GARD:6254
ICD10CM:A90
ICD9CM:061
MESH:D003715
NCI:C34528
SNOMEDCT_US_2020_03_01:38362002
UMLS_CUI:C0011311
Dengue Fever
breakbone fever
classic dengue
disease_ontology
classical dengue
DOID:12205
dengue disease
A placenta disease that is characterized by a deficiency of amniotic fluid sometimes resulting in an embryonic defect through adherence between embryo and amnion.
DOID:12595
DOID:12596
ICD10CM:O41.0
ICD9CM:658.0
MESH:D016104
NCI:C92839
SNOMEDCT_US_2020_03_01:157051001
UMLS_CUI:C0079924
Oligohydramnios - delivered
antepartum oligohydramnios
delivered oligohydramnios
disease_ontology
DOID:12215
oligohydramnios
A dementia that is characterized by the development of abnormal proteinaceous (alpha-synuclein) cytoplasmic inclusions, called Lewy bodies, throughout the brain that results in progressive decline in mental abilities.
GARD:3243
ICD10CM:G31.83
ICD9CM:331.82
MESH:D020961
NCI:C84826
OMIM:127750
SNOMEDCT_US_2020_03_01:192808003
UMLS_CUI:C0752347
Dementia with Lewy bodies
Diffuse Lewy body disease
Lewy body disease
Senile dementia of the Lewy body type
disease_ontology
DOID:12217
OMIM mapping confirmed by DO. [SN].
Lewy body dementia
A connective tissue disease that is located_in cartilage.
ICD10CM:M94.9
MESH:D002357
SNOMEDCT_US_2020_03_01:50927007
UMLS_CUI:C0007302
Cartilage disorder
Chondropathy
disease_ontology
DOID:1222
cartilage disease
ICD10CM:K31.2
ICD9CM:537.6
SNOMEDCT_US_2020_03_01:54051005
UMLS_CUI:C0267183
Hourglass stricture or stenosis of stomach
disease_ontology
DOID:12234
cascade stomach
A liver cirrhosis characterized by chronic and slow progressive destruction of intrahepatic bile ducts.
DOID:1851
EFO:0004267
GARD:7459
ICD10CM:K74.3
ICD10CM:K74.5
ICD9CM:571.6
MESH:D008105
NCI:C27167
NCI:C51225
OMIM:109720
OMIM:613007
OMIM:613008
OMIM:614220
OMIM:614221
ORDO:186
SNOMEDCT_US_2020_03_01:1761006
SNOMEDCT_US_2020_03_01:31712002
UMLS_CUI:C0008312
UMLS_CUI:C0023892
biliary liver cirrhosis
cholestatic cirrhosis
chronic nonsuppurative destructive cholangitis
primary biliary cirrhosis
disease_ontology
DOID:12236
Xref MGI.
OMIM mapping confirmed by DO. [SN].
primary biliary cholangitis
MESH:D001655
UMLS_CUI:C0005403
disease_ontology
DOID:12237
bile reflux
NCI:C6810
SNOMEDCT_US_2020_03_01:277664004
UMLS_CUI:C0349644
lymphoma of the testis
malignant lymphoma of testis
testicular Lymphoma
disease_ontology
DOID:12253
testicular lymphoma
A blood coagulation disease that has_material_basis_in Factor IX deficiency, which makes coagulation much more prolonged. The disease is inherited as an X-linked recessive trait.
GARD:8732
ICD10CM:D67
ICD9CM:286.1
MESH:D002836
NCI:C26721
OMIM:306900
SNOMEDCT_US_2020_03_01:41788008
UMLS_CUI:C0008533
Congenital factor IX deficiency
Congenital factor IX disorder
deficiency, functional factor IX
factor IX deficiency
disease_ontology
DOID:12259
OMIM mapping confirmed by DO. [SN].
hemophilia B
ICD10CM:D70
ICD9CM:288.0
MESH:D009503
SNOMEDCT_US_2020_03_01:191336001
UMLS_CUI:C0027947
disease_ontology
DOID:1227
neutropenia
An eye disease characterized by missing pieces of tissue in structures that form the eye, such as the iris, retina, choroid or optic disc.
GARD:1433
ICD10CM:Q13.0
MESH:D003103
NCI:C98877
OMIM:120200
OMIM:120300
OMIM:216820
ORDO:194
ORDO:98945
SNOMEDCT_US_2020_03_01:93390002
UMLS_CUI:C0009363
coloboInOwlma of eye
coloboInOwlma of macula
congenital ocular coloboInOwlma
disease_ontology
DOID:12270
Xref MGI.
OMIM mapping confirmed by DO. [SN].
coloboma
An iris disease that is characterized by a complete or partial absence of the colored part of the eye.
GARD:5816
ICD10CM:Q13.1
ICD9CM:743.45
MESH:D015783
NCI:C84563
OMIM:106210
SNOMEDCT_US_2020_03_01:69278003
UMLS_CUI:C0003076
Aplasia of iris
disease_ontology
DOID:12271
OMIM mapping confirmed by DO. [SN].
aniridia
ICD10CM:H52.31
ICD9CM:367.31
MESH:D015858
SNOMEDCT_US_2020_03_01:3289004
UMLS_CUI:C0003081
disease_ontology
DOID:12273
anisometropia
MESH:D015858
NCI:C9277
UMLS_CUI:C1336711
disease_ontology
DOID:12286
testicular leukemia
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Crimean-Congo hemorrhagic fever virus, which is transmitted_by Hyalomma ticks. The infection has_symptom headache, has_symptom high fever, has_symptom back pain, has_symptom joint pain, has_symptom stomach pain, has_symptom vomiting, has_symptom red eyes, has_symptom flushed face, has_symptom red throat, has_symptom petechiae (red spots) on the palate, has_symptom jaundice, has_symptom nosebleeds, and has_symptom blood in the feces and urine.
ICD10CM:A98.0
ICD9CM:065.0
MESH:D006479
NCI:C34682
SNOMEDCT_US_2020_03_01:43489008
UMLS_CUI:C0019099
CHF Congo virus
Congo-Crimean Hemorrhagic Fever
Crimean hemorrhagic fever
disease_ontology
DOID:12287
Crimean-Congo hemorrhagic fever
An autoimmune disease that is caused by T helper cell mediated autoimmune attack of melanocytes resulting in inflammation of the inside of the eye, whitening of hair, skin pigment loss, and meningitis.
GARD:7862
ICD10CM:H20.82
ICD9CM:364.24
MESH:D014607
NCI:C85218
SNOMEDCT_US_2020_03_01:44923005
UMLS_CUI:C0042170
Harada's disease
Vogt-Koyanagi syndrome
uveomeningoencephalitic syndrome
disease_ontology
DOID:12297
Vogt-Koyanagi-Harada disease
An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes.
EFO:0004208
GARD:10751
ICD10CM:L80
ICD9CM:709.01
MESH:D014820
NCI:C26915
OMIM:193200
SNOMEDCT_US_2020_03_01:156437000
UMLS_CUI:C0042900
disease_ontology
DOID:12306
OMIM mapping confirmed by DO. [LS].
vitiligo
A bilirubin metabolic disorder that involves elevated levels of unconjugated bilirubin without elevation of liver alanine transaminase and aspartate transaminase enzymes as a result of the deficient ability of hepatocytes to secrete conjugated bilirubin into the bile.
GARD:6289
ICD10CM:E80.6
MESH:D007566
NCI:C34741
OMIM:237500
SNOMEDCT_US_2020_03_01:44553005
UMLS_CUI:C0022350
Dubin Johnson syndrome
chronic idiopathic jaundice
disease_ontology
DOID:12308
OMIM mapping confirmed by DO. [SN].
Dubin-Johnson syndrome
An epithelial-stromal TGFBI dystrophy that is characterized by progressive accumulation of deposits within the layers of the cornea.
ICD10CM:H18.53
ICD9CM:371.53
MESH:D003317
NCI:C34651
SNOMEDCT_US_2020_03_01:45283008
UMLS_CUI:C0018179
granular corneal dystrophy
disease_ontology
DOID:12318
granular corneal dystrophy
ICD9CM:416.8
SNOMEDCT_US_2020_03_01:194887007
UMLS_CUI:C0155673
disease_ontology
DOID:12326
chronic pulmonary heart disease
ICD10CM:F64.1
ICD9CM:302.3
MESH:D014190
NCI:C94359
SNOMEDCT_US_2020_03_01:472948001
UMLS_CUI:C0040774
Dual-role transvestism
Fetishistic transvestism
Transvestic fetishism
cross dresser
disease_ontology
DOID:1233
transvestism
ICD10CM:N46
ICD9CM:606
MESH:D007248
SNOMEDCT_US_2020_03_01:155924001
UMLS_CUI:C0021364
disease_ontology
DOID:12336
male infertility
ICD10CM:I86.1
ICD9CM:456.4
MESH:D014646
SNOMEDCT_US_2020_03_01:195480007
UMLS_CUI:C0042341
Scrotal varices
disease_ontology
DOID:12337
varicocele
A disease of mental health that involves a conflict between a person's actual physical gender and the gender that person identifies himself or herself as.
ICD10CM:F64.2
ICD9CM:302.6
SNOMEDCT_US_2020_03_01:5095008
UMLS_CUI:C0236802
disease_ontology
DOID:1234
gender identity disorder
A malignant retroperitoneal cancer and sarcoma that is located_in the retroperitoneal space.
NCI:C4832
SNOMEDCT_US_2020_03_01:307219002
UMLS_CUI:C0585129
disease_ontology
DOID:12341
retroperitoneal sarcoma
An osteochondrodysplasia that has_material_basis_in a deficiency in type-I collagen which results_in brittle bones and defective connective tissue.
DOID:14708
GARD:1017
ICD10CM:Q78.0
ICD9CM:756.51
MESH:D010013
NCI:C26837
OMIM:PS166200
ORDO:666
SNOMEDCT_US_2020_03_01:78314001
UMLS_CUI:C0029434
Lobstein's syndrome
Osteopsathyrosis
Vrolik's disease
brittle bone disease
disease_ontology
Fragilitas ossium
DOID:12347
Xref MGI.
OMIM mapping confirmed by DO. [SN].
osteogenesis imperfecta
ICD10CM:F65.0
ICD9CM:302.81
MESH:D005329
NCI:C94353
SNOMEDCT_US_2020_03_01:192513009
UMLS_CUI:C0015957
disease_ontology
DOID:1235
fetishism
DOID:12350
ICD9CM:571.1
NCI:C34352
SNOMEDCT_US_2020_03_01:9953008
UMLS_CUI:C0001306
Alcoholic Hepatitis
Alcoholic hepatitis
acute Alcoholic Hepatitis
acute alcoholic hepatitis
acute alcoholic liver disease
disease_ontology
DOID:12351
alcoholic hepatitis
A eustachian tube disorder with a wider eustachian tube which allows a larger bolus of bacteria-laden material from the nasopharynx during an infection to enter the middle ear, causing a more fulminant infection.
GARD:10812
ICD10CM:H69.0
ICD9CM:381.7
SNOMEDCT_US_2020_03_01:30280005
UMLS_CUI:C0155434
disease_ontology
DOID:12358
patulous eustachian tube
An autoimmune disease of endocrine system that involves production of excessive amount of thyroid hormones, located_in thyroid gland.
EFO:0004237
ICD10CM:E05.0
MESH:D006111
NCI:C3071
SNOMEDCT_US_2020_03_01:154655004
UMLS_CUI:C0018213
Grave's disease
Graves disease
exophthalmic goiter
disease_ontology
Basedow's disease
DOID:12361
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Graves' disease
A parasitic protozoa infectious disease characterized as a vector-borne infectious disease caused by the presence of protozoan parasites of the genus Plasmodium in the red blood cells, transmitted from an infected to an uninfected individual by the bite of anopheline mosquitoes, and characterized by periodic attacks of chills and fever that coincide with mass destruction of blood cells and the release of toxic substances by the parasite at the end of each reproductive cycle.
DOID:12552
EFO:0001068
GARD:6961
ICD10CM:B54
ICD9CM:084
MESH:D008288
NCI:C34797
SNOMEDCT_US_2020_03_01:154374002
UMLS_CUI:C0024530
induced malaria
disease_ontology
DOID:12365
Xref MGI.
malaria
ICD10CM:H18.4
ICD9CM:371.4
SNOMEDCT_US_2020_03_01:111521006
UMLS_CUI:C0155118
disease_ontology
DOID:1237
corneal degeneration
A pneumonia involving inflammation of lungs that begins in the terminal bronchioles, which become clogged with thick mucus that forms consolidated patches in adjacent lobules. It is caused by bacteria and viruses.
ICD10CM:J18.0
ICD9CM:485
MESH:D001996
NCI:C26710
SNOMEDCT_US_2020_03_01:155551009
UMLS_CUI:C0006285
Chest infection - bronchopneumonia
bronchial pneumonia
lobular pneumonia
disease_ontology
DOID:12375
bronchopneumonia
A motor neuron disease that is a degenerative neuromuscular disease characterized by lower motor neuron degeneration associated with progressive muscle weakness and atrophy.
GARD:7674
ICD10CM:G12.9
ICD9CM:335.1
MESH:D009134
NCI:C85075
SNOMEDCT_US_2020_03_01:5262007
UMLS_CUI:C0026847
disease_ontology
DOID:12377
spinal muscular atrophy
MESH:D017029
SNOMEDCT_US_2020_03_01:307358009
UMLS_CUI:C0085417
Complex partial epileptic seizure
Psychomotor epilepsy
epilepsy, psychomotor
psychomotor epilepsy
disease_ontology
DOID:12382
complex partial epilepsy
An intestinal infectious disease that involves inflammation of the intestines, especially colon, due to chemical irritants, bacteria, protozoa, or parasitic worms, which results in severe diarrhea with passage of mucus and blood.
ICD9CM:009.2
MESH:D004403
SNOMEDCT_US_2020_03_01:154268000
UMLS_CUI:C0013369
Infectious diarrhea
disease_ontology
DOID:12384
dysentery
A primary bacterial infectious disease that results_in infection located_in epithelium of colon, has_material_basis_in Shigella boydii, has_material_basis_in Shigella dysenteriae, has_material_basis_in Shigella flexneri, or has_material_basis_in Shigella sonnei, which produce toxins that can attack the lining of the large intestine, causing swelling, ulcers on the intestinal wall, and bloody diarrhea. The bacteria are transmitted_by ingestion of food and water contaminated with feces.
DOID:11378
DOID:12950
DOID:2041
DOID:924
DOID:925
GARD:4818
ICD10CM:A03
ICD10CM:A03.0
ICD10CM:A03.1
ICD10CM:A03.2
ICD9CM:004
ICD9CM:004.0
ICD9CM:004.1
ICD9CM:004.2
KEGG:05131
MESH:D004405
NCI:C157978
SNOMEDCT_US_2020_03_01:111817006
SNOMEDCT_US_2020_03_01:34335000
SNOMEDCT_US_2020_03_01:55760004
SNOMEDCT_US_2020_03_01:66301008
UMLS_CUI:C0013371
UMLS_CUI:C0302358
UMLS_CUI:C0302359
UMLS_CUI:C0302360
Shigella boydii infectious disease
Shigella flexneri infectious disease
Shigella gastroenteritis
Shigella sonnei infectious disease
bacillary dysentery
disease_ontology
DOID:12385
shigellosis
A kidney disease characterized by a complete or partial resistance of the kidneys to vasopressin (ADH).
GARD:7178
ICD10CM:N25.1
ICD9CM:588.1
MESH:D018500
NCI:C84919
OMIM:125800
OMIM:304800
ORDO:223
SNOMEDCT_US_2020_03_01:123294004
UMLS_CUI:C0162283
disease_ontology
vasopressin-resistant diabetes insipidus
DOID:12387
Xref MGI.
OMIM mapping submitted by NeuroDevNet. [LS].
nephrogenic diabetes insipidus
MESH:D020790
NCI:C84933
OMIM:125700
OMIM:304900
SNOMEDCT_US_2020_03_01:267393007
UMLS_CUI:C0687720
Pituitary diabetes insipidus
Vasopressin deficiency
central diabetes insipidus
vasopressin defective diabetes insipidus
disease_ontology
DOID:12388
OMIM mapping confirmed by DO. [SN].
neurohypophyseal diabetes insipidus
DOID:14446
ICD9CM:374.00
MESH:D004774
SNOMEDCT_US_2020_03_01:246821008
UMLS_CUI:C0014390
disease_ontology
DOID:12397
entropion
An impulse control disorder that involves the uncontrollable impulse to gamble, irrespective of the interference the behaviour has on the individual's life.
ICD10CM:F63.0
ICD9CM:312.31
MESH:D005715
NCI:C94335
OMIM:606349
SNOMEDCT_US_2020_03_01:18085000
UMLS_CUI:C0030662
Compulsive gambling
Pathological gambling
disease_ontology
DOID:12399
OMIM mapping confirmed by DO. [SN].
pathological gambling
A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells.
DOID:9145
ICD10CM:C95.90
ICD9CM:208
MESH:D007938
NCI:C3161
SNOMEDCT_US_2020_03_01:255049003
UMLS_CUI:C0023418
disease_ontology
DOID:1240
leukemia
An impulse control disorder that involves the repeated impulse to steal for no great gain, when he or she has sufficient money to pay for the item and no need for what is stolen.
ICD10CM:F63.2
ICD9CM:312.32
MESH:D007174
NCI:C94333
SNOMEDCT_US_2020_03_01:69361009
UMLS_CUI:C0022734
Pathological stealing
disease_ontology
DOID:12400
kleptomania
An impulse control disorder that involves the episodic inability to control violent impulses with a disproportionate degree of aggressiveness.
DOID:9404
ICD10CM:F60.3
ICD10CM:F63.81
ICD9CM:301.3
ICD9CM:312.34
MESH:D007174
NCI:C94332
SNOMEDCT_US_2020_03_01:192096007
SNOMEDCT_US_2020_03_01:268757006
UMLS_CUI:C0021776
UMLS_CUI:C0152183
explosive personality disorder
disease_ontology
DOID:12401
intermittent explosive disorder
An impulse control disorder that involves the uncontrollable impulse to repeatedly set fires with no obvious motive.
ICD10CM:F63.1
ICD9CM:312.33
MESH:D005391
NCI:C94334
SNOMEDCT_US_2020_03_01:600009
UMLS_CUI:C0016142
Pathological firesetting
firesetting behavior
disease_ontology
DOID:12402
pyromania
A dermatophytosis that results_in fungal infection located_in skin of foot, especially between the toes, has_material_basis_in Trichophyton or has_material_basis_in Epidermophyton and has_symptom fissures, has_symptom scaling, has_symptom maceration, and eroded areas between the toes and on the plantar surface of the foot.
ICD10CM:B35.3
ICD9CM:110.4
MESH:D014008
SNOMEDCT_US_2020_03_01:186993002
UMLS_CUI:C0040259
Athlete's foot
Dermatophytosis of foot
disease_ontology
ringworm of foot
DOID:12403
tinea pedis
An eye disease that involves the globe of the eye.
ICD10CM:H44.39
ICD9CM:360.29
SNOMEDCT_US_2020_03_01:194638007
UMLS_CUI:C0154780
disease_ontology
DOID:1242
globe disease
ICD9CM:378.81
SNOMEDCT_US_2020_03_01:1534008
UMLS_CUI:C0702143
Palsy of conjugate gaze
disease_ontology
DOID:12445
conjugate gaze palsy
An anemia that is characterized by a deficiency of red blood cells, white blood cells and platelets produced by bone marrow.
GARD:5836
ICD10CM:D61.9
ICD9CM:284.9
MESH:D000741
NCI:C2870
OMIM:609135
SNOMEDCT_US_2020_03_01:154807001
UMLS_CUI:C0002874
disease_ontology
DOID:12449
OMIM mapping confirmed by DO. [SN].
aplastic anemia
A female reproductive organ cancer that is located_in the vulva.
DOID:1282
GARD:9349
ICD10CM:C51
ICD9CM:184.4
MESH:D014846
NCI:C3443
NCI:C7502
SNOMEDCT_US_2020_03_01:126922007
SNOMEDCT_US_2020_03_01:94143002
UMLS_CUI:C0042995
UMLS_CUI:C0375071
Ca vulva
Vulvar tumor
malignant Vulvar tumor
malignant neoplasm of vulva
malignant tumor of vulva
neoplasm of vulva
vulval cancer
vulval neoplasm
vulvar neoplasm
disease_ontology
DOID:1245
vulva cancer
An anemia that is characterized by a reduction in the number of red blood cells, white blood cells, and platelets.
ICD10CM:D61.81
ICD9CM:284.1
MESH:D010198
NCI:C34889
SNOMEDCT_US_2020_03_01:127034005
UMLS_CUI:C0030312
disease_ontology
DOID:12450
pancytopenia
MESH:D010198
MESH:D013436
SNOMEDCT_US_2020_03_01:32117000
UMLS_CUI:C0038732
Sulfemoglobinemia
Sulfhemoglobinemia
disease_ontology
DOID:12451
sulfhemoglobinemia
A hematopoietic system disease that is characterized by abnormal blood clotting or bleeding.
DOID:13997
DOID:2212
DOID:9474
ICD10CM:D68.9
ICD9CM:286
MESH:D001778
NCI:C2902
SNOMEDCT_US_2020_03_01:64779008
UMLS_CUI:C0005779
coagulation protein disease
postpartum coagulation defect
postpartum coagulation defect with delivery
inherited blood coagulation disease
disease_ontology
DOID:1247
blood coagulation disease
A parasitic helminthiasis infectious disease that involves infection of the intestine, liver and lungs caused by Capillaria species.
ICD10CM:B81.1
ICD9CM:127.5
MESH:D017189
SNOMEDCT_US_2020_03_01:52979002
UMLS_CUI:C0006897
Capillaria infection
disease_ontology
DOID:12474
capillariasis
A facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve).
GARD:5906
ICD10CM:G51.0
ICD9CM:351.0
MESH:D020330
SNOMEDCT_US_2020_03_01:193093009
UMLS_CUI:C0376175
Bell palsy
Bell's (facial) palsy
disease_ontology
DOID:12506
Bell's palsy
An urogenital tuberculosis that is located_in epididymis, has_symptom pain and has_symptom scrotal swelling.
ICD9CM:016.4
SNOMEDCT_US_2020_03_01:83652003
UMLS_CUI:C0152814
disease_ontology
DOID:1251
tuberculous epididymitis
MESH:D012167
NCI:C50732
SNOMEDCT_US_2020_03_01:40024006
UMLS_CUI:C0035321
Retinal break
Retinal dialysis
Retinal tear
disease_ontology
DOID:12514
retinal perforation
A parasitic helminthiasis infectious disease that involves parasitic infection located_in intestine in humans, has_material_basis_in Trichuris trichiura, which is transmitted_by ingestion of food contaminated with egg-carrying soil. The infection has_symptom abdominal pain, has_symptom diarrhea, has_symptom rectal prolapse and has_symptom growth retardation.
GARD:10720
ICD10CM:B79
ICD9CM:127.3
MESH:D014257
NCI:C128399
SNOMEDCT_US_2020_03_01:60570001
UMLS_CUI:C0040954
Infection by Trichuris trichura
Trichuriasis infection
Whipworm disease
trichuris trichiura infection
disease_ontology
DOID:1252
trichuriasis
GARD:7733
ICD10CM:G57.5
ICD9CM:355.5
MESH:D013641
NCI:C85183
SNOMEDCT_US_2020_03_01:155077008
UMLS_CUI:C0039319
disease_ontology
DOID:12526
tarsal tunnel syndrome
A blood coagulation disease that is a hereditary abnormality which slows the blood clotting process. It arises from a qualitative or quantitative deficiency of von Willebrand factor (vWF), a multimeric protein that is required for platelet adhesion.
GARD:7867
ICD10CM:D68.0
ICD9CM:286.4
MESH:D014842
NCI:C68677
SNOMEDCT_US_2020_03_01:11093006
UMLS_CUI:C0042974
vascular hemophilia
vascular pseudohemophilia
von Willebrand disease
von Willebrand disorder
von Willebrand's-Jurgens' disease
von Willebrand-Jrgens disease
disease_ontology
DOID:12531
OMIM mapping confirmed by DO. [SN].
von Willebrand's disease
A trichostrongyloidiasis that involves infection of the small intestine with Trichostrongylus colubriformis or Trichostrongylus axei, which results in abdominal pain, diarrhea, anorexia, headache, fatigue, anemia and eosinophilia.
ICD10CM:B81.2
ICD9CM:127.6
MESH:D014253
SNOMEDCT_US_2020_03_01:33710003
UMLS_CUI:C0040948
Infection by Trichostrongylus
Infection by Trichostrongylus species
Trichostrongyliasis
disease_ontology
DOID:1254
trichostrongylosis
MESH:D014253
A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis A virus, which is transmitted_by ingestion of contaminated food or water, or transmitted_by direct contact with an infected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.
DOID:12547
MESH:D006506
NCI:C3096
SNOMEDCT_US_2020_03_01:40468003
UMLS_CUI:C0019159
Viral hepatitis, type A
disease_ontology
Viral hepatitis A
DOID:12549
hepatitis A
A parasitic helminthiasis infectious disease that involves parasitic infection of animals and humans by nematodes of the superfamily Trichostrongyloidea.
MESH:D014252
UMLS_CUI:C0040947
disease_ontology
DOID:1255
trichostrongyloidiasis
A kidney disease that is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs.
GARD:6588
ICD10CM:D59.3
ICD9CM:283.11
MESH:D006463
NCI:C75545
ORDO:2134
SNOMEDCT_US_2020_03_01:123308008
UMLS_CUI:C0019061
haemolytic-uraemic syndrome
hemolytic uremic syndrome
disease_ontology
DOID:12554
Xref MGI.
hemolytic-uremic syndrome
ICD10CM:H50.81
ICD9CM:378.71
MESH:D004370
NCI:C84678
OMIM:126800
OMIM:604356
ORDO:233
SNOMEDCT_US_2020_03_01:60318001
UMLS_CUI:C0013261
Duane's syndrome
Stilling-Turk-Duane syndrome
disease_ontology
DOID:12557
OMIM mapping confirmed by DO. [SN].
Duane retraction syndrome
GARD:4503
ICD10CM:H49.4
ICD9CM:378.72
MESH:D017246
OMIM:PS157640
SNOMEDCT_US_2020_03_01:194126004
UMLS_CUI:C0162674
progressive external ophthalmoplegia
disease_ontology
DOID:12558
chronic progressive external ophthalmoplegia
An osteoporosis with no known cause that is characterized by pain in the back and extremities, walking difficulties, multiple fractures, and radiological evidence of osteoporosis.
ICD9CM:733.02
OMIM:259750
SNOMEDCT_US_2020_03_01:3345002
UMLS_CUI:C0158447
Idiopathic osteoporosis
juvenile osteoporosis
disease_ontology
DOID:12559
idiopathic juvenile osteoporosis
A learning disability involving a math disability can cause such difficulties as learning math concepts (such as quantity, place value, and time), difficulty memorizing math facts, difficulty organizing numbers, and understanding how problems are organized on the page.
MESH:D060705
Mathematics disorder
disorder of arithmetical skills
disease_ontology
DOID:12568
dyscalculia
A glaucoma characterized by glaucomatous optic atrophy secondary to a lens abnormality and has_symptom progressive decreased vision, especially decreased peripheral vision. Phacogenic glaucoma can be caused by cataracts, trauma to the eye, or age-related damage that obstructs aqueous outflow, leading to inappropriately increased intraocular pressure and eventual optic nerve atrophy with associated vision loss.
ICD9CM:365.59
SNOMEDCT_US_2020_03_01:84333006
UMLS_CUI:C0154959
disease_ontology
DOID:12571
phacogenic glaucoma
ICD10CM:P72.1
ICD9CM:775.3
NCI:C114906
SNOMEDCT_US_2020_03_01:13795004
UMLS_CUI:C0158983
Neonatal thyrotoxicosis
disease_ontology
DOID:12573
neonatal thyrotoxicosis
MESH:D014524
NCI:C79804
SNOMEDCT_US_2020_03_01:95588004
UMLS_CUI:C0041972
Obstruction of urethra
disease_ontology
DOID:12577
urethral obstruction
A syndrome that has_material_basis_in deletion of the end of the chromosome 5 p arm and that is characterized by intellectual disability, delayed development, small head size, low birth weight, weak muscle tone widely set eyes, low-set ears, a small jaw, a rounded face and a high-pitched cry that sounds like that of a cat.
GARD:6213
ICD10CM:Q93.4
ICD9CM:758.31
MESH:D003410
NCI:C34518
OMIM:123450
SNOMEDCT_US_2020_03_01:70173007
UMLS_CUI:C0010314
5p deletion syndrome
5p partial monosomy syndrome
Cri-du-chat syndrome
chromosome 5 short arm deletion syndrome
chromosome 5p deletion syndrome
disease_ontology
DOID:12580
OMIM mapping confirmed by DO. [SN].
Cri-Du-Chat syndrome
A chromosomal deletion disease that has_material_basis_in deletion polymorphisms at chromosome location 22q11 and that is characterized by variable developmental problems and schizoid features.
ICD10CM:Q93.81
ICD9CM:758.32
MESH:D004062
OMIM:192430
SNOMEDCT_US_2020_03_01:205642004
UMLS_CUI:C0220704
22q11 Deletion Syndrome
Shprintzen syndrome
VCF-Velocardiofacial syndrome
deletion 22q11.2 syndrome
disease_ontology
DOID:12583
OMIM mapping confirmed by DO. [LS].
velocardiofacial syndrome
A renal agenesis characterized by the typical physical appearance and associated pulmonary hypoplasia of a newborn as a direct result of kidney failure, oligohydramnios and compression while in the uterus.
GARD:4462
ICD10CM:Q60.6
NCI:C40435
SNOMEDCT_US_2020_03_01:41962002
UMLS_CUI:C0178426
Potter sequence
Potter syndrome
disease_ontology
DOID:12594
Potter's syndrome
MESH:D010249
SNOMEDCT_US_2020_03_01:280483007
UMLS_CUI:C0030455
pelvic cellulitis
disease_ontology
DOID:1260
parametritis
A lymphoid leukemia that occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity producing large numbers of white blood cells to be produced and enter the blood stream.
DOID:12621
ICD10CM:C95.00
ICD9CM:208.0
NCI:C9300
OMIM:308960
SNOMEDCT_US_2020_03_01:24072005
UMLS_CUI:C0085669
UMLS_CUI:C1378511
Stem cell Leukemia
Stem cell leukaemia
disease_ontology
DOID:12603
acute leukemia
ICD10CM:K31.1
MESH:D011707
NCI:C34966
SNOMEDCT_US_2020_03_01:367403001
UMLS_CUI:C0034194
disease_ontology
DOID:12639
pyloric stenosis
ICD10CM:K44
MESH:D006551
NCI:C98945
OMIM:142400
SNOMEDCT_US_2020_03_01:236053002
SNOMEDCT_US_2020_03_01:3662000
SNOMEDCT_US_2020_03_01:84089009
UMLS_CUI:C0267725
UMLS_CUI:C0376710
UMLS_CUI:C3489393
Diaphragmatic - hiatus -hernia
hiatal hernia
disease_ontology
DOID:12642
OMIM mapping confirmed by DO. [SN].
hiatus hernia
ICD10CM:H93.3
ICD9CM:388.5
MESH:D000160
NCI:C27207
SNOMEDCT_US_2020_03_01:77949003
UMLS_CUI:C0001163
acoustic nerve disease
disease_ontology
DOID:12657
vestibulocochlear nerve disease
A primary systemic mycosis that results_in systemic fungal infection located_in mucosa, located_in lymph nodes, located_in bone, located_in skin or located_in lungs, has_material_basis_in Paracoccidioides brasiliensis.
GARD:7323
ICD10CM:B41
ICD9CM:116.1
MESH:D010229
NCI:C34891
SNOMEDCT_US_2020_03_01:59925007
UMLS_CUI:C0030409
Mucocutaneous-lymphangitic paracoccidioidomycosis
Paracoccidioidomycosis
paracoccidioidal mycosis
disease_ontology
DOID:12662
paracoccidioidomycosis
A primary systemic mycosis that results_in a systemic fungal infection, has_material_basis_in Blastomyces dermatitidis, transmitted_by airborne spores and has_symptom skin lesions, has_symptom lung lesions and has_symptom pleural thickening.
DOID:13067
GARD:5931
ICD10CM:B40
ICD9CM:116.0
MESH:D001759
NCI:C34428
SNOMEDCT_US_2020_03_01:266217003
UMLS_CUI:C0005716
Blastomyces Dermatitidis Infection
Blastomycotic infection
Chicago disease
Gilchrist's disease
Infection by Blastomyces dermatitidis
North American blastomycosis
disease_ontology
DOID:12663
blastomycosis
DOID:12671
ICD10CM:H53.30
ICD9CM:368.30
NCI:C34422
SNOMEDCT_US_2020_03_01:83275001
UMLS_CUI:C0005461
simultaneous visual perception without fusion
disease_ontology
DOID:12667
binocular vision disease
ICD10CM:H53.31
ICD9CM:368.34
SNOMEDCT_US_2020_03_01:79195003
UMLS_CUI:C0155010
disease_ontology
DOID:12668
abnormal retinal correspondence
ICD10CM:E83.52
ICD9CM:275.42
MESH:D006934
NCI:C3112
SNOMEDCT_US_2020_03_01:154752005
UMLS_CUI:C0020437
disease_ontology
DOID:12678
hypercalcemia
GARD:7177
MESH:D009397
NCI:C84918
SNOMEDCT_US_2020_03_01:154752005
UMLS_CUI:C0027709
disease_ontology
DOID:12679
nephrocalcinosis
A brain disease that is characterized by damage to neurons of the corticobulbar tract, has_symptom dysarthria, has_symptom dysphagia, has_symptom spasticity located_in tongue, has_symptom abnormal bulbar reflexes, and has_symptom emotional outbursts.
ICD9CM:335.23
MESH:D020828
NCI:C129934
SNOMEDCT_US_2020_03_01:7379000
UMLS_CUI:C0033790
Pseudobulbar palsy
pseudobulbar paralysis
disease_ontology
DOID:12680
pseudobulbar palsy
A inner ear infectious disease caused by a viral infection which involves inflammation of the vestibular nerve. It usually results as a complication of an upper respiratory infection. This causes sudden and severe vertigo, nausea and vomiting. Auditory symptoms are usually absent.
ICD10CM:H81.2
ICD9CM:386.12
MESH:D020338
SNOMEDCT_US_2020_03_01:232293008
UMLS_CUI:C0751908
Epidemic neurolabyrinthitis
Vestibular neuritis
disease_ontology
DOID:12683
vestibular neuronitis
GARD:223
MESH:D009464
NCI:C3276
SNOMEDCT_US_2020_03_01:269643009
UMLS_CUI:C0027859
Vestibular Neurilemmoma
Vestibular schwannoma
disease_ontology
DOID:12689
acoustic neuroma
A nervous system disease that is characterized by complete paralysis of all voluntary muscles except for the ones that control the movements of the eyes.
GARD:6919
ICD10CM:G83.5
ICD9CM:344.81
MESH:D000080422
SNOMEDCT_US_2020_03_01:38023001
UMLS_CUI:C0023944
Locked in syndrome
Locked-in state
disease_ontology
DOID:12697
locked-in syndrome
A disorder of sexual development that is characterized by enlargement or swelling of male breast tissue resulting from elevated male estrogen levels or imbalanced estrogen and testosterone levels.
ICD10CM:N62
MESH:D006177
NCI:C3073
SNOMEDCT_US_2020_03_01:155963008
UMLS_CUI:C0018418
disease_ontology
DOID:12698
gynecomastia
A cell type benign neoplasm that is a benign tumor of smooth muscle cells.
MESH:D007889
NCI:C3157
SNOMEDCT_US_2020_03_01:702978006
UMLS_CUI:C0023267
leiomyomatous neoplasm
leiomyomatous tumor
disease_ontology
DOID:127
leiomyoma
A vascular disease characterized by the presence of multiple arteriovenous malformations that lack intervening capillaries and result in direct connections between arteries and veins.
GARD:6626
ICD10CM:I78.0
ICD9CM:448.0
MESH:D013683
NCI:C35064
OMIM:187300
OMIM:600376
OMIM:601101
OMIM:615506
ORDO:774
SNOMEDCT_US_2020_03_01:266324004
UMLS_CUI:C0039445
Osler hemorrhagic telangiectasia syndrome
Osler-Weber-Rendu disease
Rendu-Osler-Weber disease
disease_ontology
DOID:1270
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hereditary hemorrhagic telangiectasia
An acquired metabolic disease that has_material_basis_in the presence of abnormally-high levels of prolactin in the blood.
DOID:12699
ICD10CM:E22.1
MESH:D002640
MESH:D006966
SNOMEDCT_US_2020_03_01:190468001
SNOMEDCT_US_2020_03_01:85039006
UMLS_CUI:C0008043
UMLS_CUI:C0020514
Chiari-Frommel syndrome
Pregnancy-related A-G syndrome
hyperprolactinaemia
disease_ontology
DOID:12700
hyperprolactinemia
An autosomal recessive cerebellar ataxia that is characterized by cerebellar ataxia, telangiectases, immune defects, and a predisposition to malignancy and that has_material_basis_in homozygous or compound heterozygous mutation in the ATM gene on chromosome 11q22.
GARD:5862
MESH:D001260
NCI:C2887
OMIM:208900
SNOMEDCT_US_2020_03_01:68504005
UMLS_CUI:C0004135
Boder-Sedgwick syndrome
Louis Bar syndrome
disease_ontology
DOID:12704
OMIM mapping confirmed by DO. [SN].
ataxia telangiectasia
MESH:D001260
DOID:0050555
GARD:6468
ICD9CM:334.0
MESH:D005621
NCI:C84718
SNOMEDCT_US_2020_03_01:155011003
UMLS_CUI:C0016719
Friedreich ataxia 1
Friedreich's ataxia
Friedreich's tabes
disease_ontology
DOID:12705
Xref MGI.
Friedreich ataxia
MESH:D005621
A vascular disease that is located_in the capillaries.
ICD10CM:I78
ICD9CM:448
SNOMEDCT_US_2020_03_01:58729003
UMLS_CUI:C0155765
disease of capillaries
disease_ontology
DOID:1271
capillary disease
A kidney disease that is characterized by a chronic tubulointerstitial nephritis that progress to terminal renal failure during the second decade (juvenile form) or before the age of 5 years (infantile form) resulting from dysfunction of ciliary proteins (ciliopathy).
GARD:206
ICD10CM:Q61.5
NCI:C123200
OMIM:PS256100
ORDO:655
SNOMEDCT_US_2020_03_01:204958008
UMLS_CUI:C0687120
medullary cystic disease
medullary cystic kidney
disease_ontology
DOID:12712
Xref MGI.
OMIM mapping confirmed by DO. [SN].
nephronophthisis
A syndrome characterized by short limbs, short ribs, postaxial polydactyly, dysplastic nails and teeth, and in many patients congenital cardiac defects that has_material_basis_in homozygous or compound heterozygous mutation in either EVC or EVC2 on chromosome 4p16.2.
GARD:1301
ICD10CM:Q77.6
ICD9CM:756.55
MESH:D004613
NCI:C84684
OMIM:225500
SNOMEDCT_US_2020_03_01:62501005
UMLS_CUI:C0013903
Chondroectodermal dysplasia
Ellis-van Creveld syndrome
mesoectodermal dysplasia
disease_ontology
DOID:12714
OMIM mapping confirmed by DO. [SN].
Ellis-Van Creveld syndrome
A respiratory failure that is characterized by deficiency of the surfactant coating the inner surface of the lungs, by failure of the lungs to expand and contract properly during breathing with resulting collapse, and by the accumulation of a protein-containing film lining the alveoli and their ducts.
DOID:11395
DOID:13859
ICD10CM:P22.0
MESH:D006819
OMIM:267450
SNOMEDCT_US_2020_03_01:26168007
UMLS_CUI:C0020192
HMD - Hyaline membrane disease
Neonatal respiratory Distress syndrome
hyaline membrane disease
pulmonary hyaline membrane disease
pulmonary hypoperfusion syndrome of newborn
respiratory distress syndrome of newborn
disease_ontology
DOID:12716
newborn respiratory distress syndrome
MESH:D013684
NCI:C28194
SNOMEDCT_US_2020_03_01:112641009
UMLS_CUI:C0039446
telangiectasia
disease_ontology
DOID:1272
telangiectasis
ICD10CM:I67.2
ICD9CM:437.0
MESH:D002537
NCI:C34459
SNOMEDCT_US_2020_03_01:266258005
UMLS_CUI:C0007775
Cerebral atherosclerosis
disease_ontology
DOID:12720
cerebral atherosclerosis
An osteochondrodysplasia that has_material_basis_in defective cartilage mineralization into bone which results in irregular ossification centers of the located in hip or located in knee. The disease has symptom fatigue, has symptom joint pain.
GARD:10756
ICD9CM:756.56
MESH:D010009
ORDO:251
SNOMEDCT_US_2020_03_01:59708000
UMLS_CUI:C0026760
polyepiphyseal dysplasia
disease_ontology
DOID:12721
Xref MGI.
multiple epiphyseal dysplasia
A viral infectious disease that results_in infection located_in upper respiratory tract or located_in lower respiratory tract, has_material_basis_in Human respiratory syncytial virus, which is transmitted_by droplet spread of nasal secretions from an infected person while coughing or sneezing, or transmitted_by contaminated fomites. The infection has_symptom runny nose, has_symptom fever, has_symptom cough, has_symptom wheezing, and has_symptom respiratory distress.
MESH:D018357
NCI:C3354
SNOMEDCT_US_2020_03_01:186750007
UMLS_CUI:C0035235
disease_ontology
DOID:1273
respiratory syncytial virus infectious disease
ICD10CM:K03.4
ICD9CM:521.5
MESH:D006936
SNOMEDCT_US_2020_03_01:78537008
UMLS_CUI:C0020441
Cementation hyperplasia
disease_ontology
DOID:12733
hypercementosis
ICD10CM:H18.72
ICD9CM:371.73
SNOMEDCT_US_2020_03_01:193849005
UMLS_CUI:C0152440
disease_ontology
DOID:12753
corneal staphyloma
DOID:12760
ICD10CM:C69.3
ICD9CM:190.6
MESH:D002830
NCI:C2949
NCI:C3566
SNOMEDCT_US_2020_03_01:127001008
SNOMEDCT_US_2020_03_01:93755007
UMLS_CUI:C0008523
UMLS_CUI:C0153630
Choroidal tumor
choroid neoplasm
malignant tumor of choroid
malignant tumor of the Choroid
neoplasm of choroid
disease_ontology
DOID:12759
choroid cancer
GARD:7777
MESH:D020333
NCI:C85193
SNOMEDCT_US_2020_03_01:75111000
UMLS_CUI:C0040381
Tolosa-Hunt syndrome
disease_ontology
DOID:1278
tolosa-hunt syndrome
ICD9CM:374.14
SNOMEDCT_US_2020_03_01:28914006
UMLS_CUI:C0155196
disease_ontology
DOID:12782
cicatricial ectropion
A migraine that is characterized by migraine headaches that are not accompanied by an aura.
ICD10CM:G43.0
ICD9CM:346.1
MESH:D020326
NCI:C117004
OMIM:607501
SNOMEDCT_US_2020_03_01:56097005
UMLS_CUI:C0338480
common migraine
disease_ontology
DOID:12783
Xref MGI.
migraine without aura
GARD:7061
GARD:7237
ICD9CM:378.9
MESH:D015835
SNOMEDCT_US_2020_03_01:45030009
UMLS_CUI:C0028850
disorder of eye movements
eye movement disorder
disease_ontology
DOID:1279
ocular motility disease
A lysosomal storage disease that involves the accumulation of glycosaminoglycans in the tissues and their excretion in the urine.
DOID:14716
GARD:7065
ICD10CM:E76.3
ICD9CM:277.5
MESH:D009083
NCI:C61259
OMIM:252700
OMIM:PS607014
ORDO:79213
SNOMEDCT_US_2020_03_01:267452003
UMLS_CUI:C0026703
disease_ontology
DOID:12798
Xref MGI.
OMIM mapping submitted by NeuroDevNet. [LS].
mucopolysaccharidosis
A mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme N-acetylgalactosamine 4-sulfatase.
GARD:7095
MESH:D009087
NCI:C61264
OMIM:253200
SNOMEDCT_US_2020_03_01:69463008
UMLS_CUI:C0026709
MPS VI - Maroteaux-Lamy syndrome
Maroteaux - Lamy syndrome
Maroteaux-Lamy syndrome
arylsulfatase B deficiency
deficiency of N-acetylgalactosamine-4-sulfatase
disease_ontology
DOID:12800
OMIM mapping confirmed by DO. [SN].
mucopolysaccharidosis VI
A mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme resulting in incomplete breakdown of the heparan sulfate sugar chain.
DOID:14729
DOID:14788
MESH:D009084
NCI:C61262
OMIM:252940
ORDO:581
SNOMEDCT_US_2020_03_01:190936000
UMLS_CUI:C0026706
Mucopolysaccharidosis, MPS-III
N-sulphoglucosamine sulphohydrolase deficiency
Sanfilippo's syndrome
heparan sulfate sulfatase deficiency
naglu deficiency
disease_ontology
DOID:12801
OMIM mapping confirmed by DO. [SN].
mucopolysaccharidosis III
A mucopolysaccharidosis characterized by a deficiency of the lysosomal enzymes galactose 6-sulfate sulfatase (Type A) or beta-galactosidase (Type B) needed to break down the keratan sulfate sugar chain.
DOID:0050808
DOID:14767
ICD10CM:E76.219
MESH:D009085
NCI:C61263
SNOMEDCT_US_2020_03_01:378007
UMLS_CUI:C0026707
Mucopolysaccharidosis, MPS-IV
deficiency of N-acetylgalactosamine-6-sulphatase
deficiency of chondroitinsulphatase
galactosamine-6-sulfatase deficiency
Osteochondrodystrophy
chondroosteodystrophy
disease_ontology
DOID:12804
OMIM mapping confirmed by DO. [SN].
mucopolysaccharidosis IV
ICD10CM:G82.5
ICD9CM:344.00
MESH:D011782
NCI:C50721
SNOMEDCT_US_2020_03_01:11538006
UMLS_CUI:C0034372
tetraplegia
disease_ontology
DOID:12835
quadriplegia
MESH:D013958
NCI:C112836
SNOMEDCT_US_2020_03_01:190262002
UMLS_CUI:C0040127
Thyroid crisis
Thyrotoxic crisis
disease_ontology
DOID:12837
thyroid crisis
A female reproductive system disease that is characteried by the descent of one or more of the pelvic structures (bladder, uterus, vagina) from the normal anatomic location toward or through the vaginal opening.
ICD9CM:618.8
UMLS_CUI:C0029801
disease_ontology
DOID:1284
prolapse of female genital organ
A parasitic helminthiasis infectious disease that involves infection of skin, eyes, and viscera in humans by the parasitic nematodes Ancylostoma braziliense, Ancylostoma ceylanicum, Ancylostoma duodenale or Ancylostoma caninum. The larvae cause lesions on the skin at the site of penetration. The infection has_symptom intestinal bleeding, has_symptom abdominal pain, has_symptom anemia, has_symptom severe diarrhea and has_symptom malnutrition.
GARD:9742
ICD10CM:B76.0
MESH:D000724
NCI:C35805
SNOMEDCT_US_2020_03_01:85807000
UMLS_CUI:C0002831
disease_ontology
DOID:12841
ancylostomiasis
MESH:D000724
An autoimmune disease of peripheral nervous system that causes body's immune system to attack part of the peripheral nervous system.
GARD:6554
ICD10CM:G61.0
MESH:D020275
NCI:C116345
OMIM:139393
SNOMEDCT_US_2020_03_01:155082001
UMLS_CUI:C0018378
Infectious neuronitis
Post-infectious polyneuritis
Postinfectious polyneuritis
acute infective polyneuritis
acute inflammatory demyelinating polyradiculopathy
acute postinfectious polyneuropathy
disease_ontology
DOID:12842
OMIM mapping confirmed by DO. [SN].
Guillain-Barre syndrome
An autism spectrum disorder that is characterized by symptoms across all three symptom domains (communication, social, restricted repetitive interests and behaviors), delayed language development, and symptom onset prior to age 3 years.
EFO:0003758
ICD10CM:F84.0
ICD9CM:299.0
MESH:D001321
NCI:C97161
OMIM:209850
ORDO:106
SNOMEDCT_US_2020_03_01:38763009
UMLS_CUI:C0004352
Kanner's syndrome
autism
autistic disorder of childhood onset
childhood autism
infantile autism
disease_ontology
DOID:12849
Xref MGI.
OMIM mapping confirmed by DO. [SN].
autistic disorder
MESH:D012002
SNOMEDCT_US_2020_03_01:5964004
UMLS_CUI:C0034882
disease_ontology
DOID:1285
rectal disease
A neurodegenerative disease that has_material_basis_in autosomal dominant inheritance and is characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia and has_material_basis_in expansion of CAG triplet repeats (glutamine) resulting in neuron degeneration affecting muscle coordination, cognitive abilities.
GARD:6677
ICD10CM:G10
ICD9CM:333.4
KEGG:05016
MESH:D006816
NCI:C82342
OMIM:143100
SNOMEDCT_US_2020_03_01:155006000
UMLS_CUI:C0020179
HD
Huntington disease
Huntington's chorea
disease_ontology
DOID:12858
Huntington's disease
A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.
DOID:73
ICD9CM:429.2
MESH:D002318
NCI:C2931
SNOMEDCT_US_2020_03_01:266275004
UMLS_CUI:C0007222
disease of subdivision of hemolymphoid system
disease_ontology
DOID:1287
cardiovascular system disease
A Guillain-Barre syndrome that manifests as a descending paralysis. It usually affects the eye muscles first and presents with the triad of ophthalmoplegia, ataxia, and areflexia.
GARD:3668
ICD10CM:G61.0
MESH:D019846
NCI:C116958
SNOMEDCT_US_2020_03_01:1767005
UMLS_CUI:C0393799
Fisher's syndrome
Miller-Fisher variant of Guillain-Barre syndrome
disease_ontology
DOID:12889
Miller Fisher syndrome
A central nervous system disease that results in the progressive deterioration of function or structure of neurons.
DOID:4874
ICD10CM:G31.9
MESH:D019636
NCI:C27090
SNOMEDCT_US_2020_03_01:362975008
UMLS_CUI:C0524851
UMLS_CUI:C1285162
Neurodegenerative disease
degenerative disease
disease_ontology
DOID:1289
neurodegenerative disease
An autoimmune disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva.
DOID:416
GARD:10252
ICD10CM:M35.0
ICD10CM:M35.00
ICD9CM:710.2
MESH:D012859
NCI:C26883
NCI:C70647
OMIM:270150
SNOMEDCT_US_2020_03_01:267875002
SNOMEDCT_US_2020_03_01:83901003
UMLS_CUI:C0086981
UMLS_CUI:C1527336
Sicca syndrome
Sjogren syndrome
xerodermosteosis
disease_ontology
DOID:12894
OMIM mapping confirmed by DO. [LS].
Sjogren's syndrome
GARD:8444
MESH:D007638
SNOMEDCT_US_2020_03_01:78946008
UMLS_CUI:C0022575
KCS
disease_ontology
DOID:12895
keratoconjunctivitis sicca
An autoimmune disease that is characterized by chronic enlargement of the glands of the head and neck, has_symptom lumps of the face and neck, dry eyes, dry mouth, and intermittent fever, and is often associated with an underlying autoimmune disorder, hematologic malignancy, tuberculosis infection, or syphilis infection.
GARD:7043
ICD10CM:K11.8
MESH:D008882
NCI:C34819
SNOMEDCT_US_2020_03_01:7826003
UMLS_CUI:C0026103
IgG4-related dacryoadenitis and sialadenitis
Mikulicz's disease
disease_ontology
DOID:12900
Mikulicz disease
ICD10CM:K11.8
MESH:D012797
SNOMEDCT_US_2020_03_01:109769000
UMLS_CUI:C0037033
Necrotizing sialometaplasia
disease_ontology
DOID:12901
necrotizing sialometaplasia
ICD10CM:K11.6
ICD9CM:527.6
NCI:C27649
SNOMEDCT_US_2020_03_01:196508008
UMLS_CUI:C0026686
Mucous retention cyst of salivary gland
Ranula
Salivary Cyst
Salivary gland mucocele
disease_ontology
DOID:12904
mucocele of salivary gland
An endocardium disease that is characterized by a thickening of the inmost lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers.
GARD:2121
GARD:6336
ICD10CM:I42.4
ICD9CM:425.3
MESH:D004695
NCI:C98922
OMIM:226000
SNOMEDCT_US_2020_03_01:65457005
UMLS_CUI:C0014117
Elastomyofibrosis
disease_ontology
DOID:12929
OMIM mapping confirmed by DO. [SN].
endocardial fibroelastosis
MESH:D004695
An intrinsic cardiomyopathy that is characterized by an an enlarged heart and damage to the myocardium causing the heart to pump blood inefficiently.
EFO:0000407
GARD:221
ICD10CM:I42.0
KEGG:05414
MESH:D002311
NCI:C84673
OMIM:PS115200
ORDO:217604
SNOMEDCT_US_2020_03_01:74368002
UMLS_CUI:C0007193
primary dilated cardiomyopathy
disease_ontology
Congestive cardiomyopathy
Familial dilated cardiomyopathy
Familial dilated cardiomyopathy
Idiopathic dilation cardiomyopathy
Idiopathic dilation cardiomyopathy
DOID:12930
Xref MGI.
OMIM mapping confirmed by DO. [LS].
dilated cardiomyopathy
GARD:6340
ICD9CM:425.0
MESH:D004719
NCI:C34585
SNOMEDCT_US_2020_03_01:111507009
UMLS_CUI:C0553980
African endomyocardial fibrosis
Becker's disease
Endomyocardial sclerosis
Obscure African cardiomyopathy
obscure African cardiomyopathy
disease_ontology
DOID:12932
endomyocardial fibrosis
GARD:6817
ICD10CM:H49.81
MESH:D007625
NCI:C84798
OMIM:530000
SNOMEDCT_US_2020_03_01:25792000
UMLS_CUI:C0022541
disease_ontology
DOID:12934
OMIM mapping confirmed by DO. [SN].
Kearns-Sayre syndrome
A vulva cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C4866
UMLS_CUI:C0677055
Vulvar carcinoma
disease_ontology
carcinoma of vulva
DOID:1294
vulva carcinoma
ICD10CM:H02.2
ICD9CM:374.2
SNOMEDCT_US_2020_03_01:193936001
UMLS_CUI:C0152226
disease_ontology
DOID:12959
lagophthalmos
A synostosis that results_in craniosynostosis and syndactyly.
DOID:0080004
ICD9CM:755.55
MESH:D000168
NCI:C34348
OMIM:101200
SNOMEDCT_US_2020_03_01:63661009
UMLS_CUI:C1510455
Apert syndrome
disease_ontology
DOID:12960
OMIM mapping confirmed by DO. [SN].
acrocephalosyndactylia
MESH:D000168
A hematologic cancer located_in the central nervous system.
NCI:C5440
UMLS_CUI:C1332884
Leukemia of the CNS
disease_ontology
DOID:12969
central nervous system leukemia
A congenital hemolytic anemia characterized by the production of red blood cells with a sphere shape, rather than the normal biconcave disk shape.
GARD:6639
ICD10CM:D58.0
ICD9CM:282.0
MESH:D013103
NCI:C97074
ORDO:822
SNOMEDCT_US_2020_03_01:154795009
UMLS_CUI:C0037889
Congenital spherocytic hemolytic anemia
Minkowski Chauffard syndrome
spherocytic anemia
disease_ontology
DOID:12971
Xref MGI.
hereditary spherocytosis
MESH:D018921
NCI:C4062
SNOMEDCT_US_2020_03_01:30419000
UMLS_CUI:C0282548
Leukostasis
disease_ontology
DOID:12986
leukostasis
A leukopenia that is characterized by a severe lack of of granulocytes with a drop in granulocyte concentration below 200 cells/mm³ of blood.
ICD10CM:D70
MESH:D000380
SNOMEDCT_US_2020_03_01:154830007
UMLS_CUI:C0001824
Granulocytopenic disorder
Granulopenia
granulocytopenia
disease_ontology
DOID:12987
agranulocytosis
MESH:D000380
A specific developmental disorder marked by a pattern of repetitive behavior wherein the rights of others or social norms are violated.
EFO:0004216
ICD10CM:F91
ICD9CM:312.9
MESH:D019955
NCI:C89329
SNOMEDCT_US_2020_03_01:430909002
UMLS_CUI:C0149654
disease_ontology
DOID:12995
conduct disorder
MESH:D016893
NCI:C95804
SNOMEDCT_US_2020_03_01:195181000
UMLS_CUI:C0007282
Carotid artery stenosis
Stenosis, carotid artery
disease_ontology
DOID:13001
carotid stenosis
ICD9CM:435.2
MESH:D013349
NCI:C35044
SNOMEDCT_US_2020_03_01:15258001
UMLS_CUI:C0038531
Subclavian artery stenosis
subclavian steal phenomenon
subclavian steal steno-occlusive disease
disease_ontology
DOID:13002
subclavian steal syndrome
ICD10CM:G45.0
ICD9CM:435.3
MESH:D014715
SNOMEDCT_US_2020_03_01:195196001
UMLS_CUI:C0042568
Vertebro-basilar insufficiency
Vertebrobasilar arterial insufficiency
Vertebrobasilar artery syndrome
Vertebrobasilar insufficiency
disease_ontology
DOID:13003
vertebrobasilar insufficiency
MESH:D014715
ICD10CM:B30.0
ICD9CM:077.1
NCI:C34590
SNOMEDCT_US_2020_03_01:60548004
UMLS_CUI:C0014493
EKC
Epidemic keratoconjunctivitis
disease_ontology
DOID:13014
shipyard eye
GARD:5695
ICD10CM:H35.1
ICD9CM:362.21
MESH:D012178
NCI:C34982
SNOMEDCT_US_2020_03_01:155110004
UMLS_CUI:C0035344
Retrolental fibroplasia
premature retinopathy
disease_ontology
DOID:13025
retinopathy of prematurity
An amnestic disorder that is characterized by temporary but almost total disruption of short-term memory with a range of problems accessing older memories.
GARD:8172
ICD10CM:G45.4
ICD9CM:437.7
MESH:D020236
NCI:C85198
SNOMEDCT_US_2020_03_01:366963000
UMLS_CUI:C0338591
disease_ontology
DOID:13027
transient global amnesia
ICD10CM:N48.1
MESH:D001446
NCI:C26705
SNOMEDCT_US_2020_03_01:155928003
UMLS_CUI:C0004690
disease_ontology
DOID:13033
balanitis
A primary bacterial infectious disease that results_in infection, has_material_basis_in Borrelia, which is transmitted_by tick or transmitted_by body louse.
ICD10CM:A68
ICD9CM:087
MESH:D012061
SNOMEDCT_US_2020_03_01:186820006
UMLS_CUI:C0035021
disease_ontology
DOID:13034
relapsing fever
A relapsing fever that is characterized by relapsing or recurring episodes of fever, has_material basis_in Borrelia hermsii, has_material basis_in Borrelia parkeri or has_material basis_in Borrelia duttoni, which are transmitted_by soft ticks (Ornithodoros parkeri and Ornithodoros hermsii). The infection has_symptom tachypnea, has_symptom tachycardia, has_symptom hepatosplenomegaly and has_symptom lymphadenopathy.
ICD10CM:A68.1
ICD9CM:087.1
NCI:C34976
SNOMEDCT_US_2020_03_01:10301003
UMLS_CUI:C0035022
Relapsing fever, tick-borne
Tick-borne relapsing fever
disease_ontology
DOID:13036
tick-borne relapsing fever
ICD10CM:P29.3
ICD9CM:747.83
MESH:D010547
NCI:C85006
OMIM:265380
SNOMEDCT_US_2020_03_01:35604006
UMLS_CUI:C0031190
Fetal circulation
Persistent fetal circulation
Persistent fetal circulation syndrome
Persistent foetal circulation
Persistent foetal circulation syndrome
Persistent pulmonary hypertension of the newborn
congenital alveolar capillary dysplasia with misalignment of pulmonary veins
persistent foetal circulation syndrome
persistent pulmonary hypertension of the newborn
disease_ontology
DOID:13042
OMIM mapping confirmed by DO. [SN].
persistent fetal circulation syndrome
ICD10CM:N25.0
ICD9CM:588.0
MESH:D012080
NCI:C114827
SNOMEDCT_US_2020_03_01:266617009
UMLS_CUI:C0035086
renal rickets
disease_ontology
DOID:13068
renal osteodystrophy
A cognitive disorder resulting from a loss of brain function affecting memory, thinking, language, judgement and behavior.
ICD9CM:290.8
UMLS_CUI:C0154319
disease_ontology
DOID:1307
dementia
A dermatophytosis that results_in fungal infection located_in nail, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes, which cause separation of the nail plate from the nail bed and has_symptom thickening of subungueal area. Sometimes, white islands are seen on the external nail plates. These gradually coalesce until the entire nail plate is involved.
DOID:10462
DOID:11399
DOID:11761
DOID:12844
DOID:12845
DOID:12846
DOID:12847
DOID:12848
DOID:13119
DOID:9412
DOID:9690
DOID:9691
ICD9CM:681.9
UMLS_CUI:C0007644
Dermatophytic onychia
Dermatophytosis of nail
Onychomycosis due to dermatophyte
cellulitis and abscess of buttock
cellulitis and abscess of face
cellulitis and abscess of finger
cellulitis and abscess of finger and toe
cellulitis and abscess of gluteal region
cellulitis and abscess of trunk
cellulitis and abscess of upper arm and forearm
dermatophytic onychomycosis
disease_ontology
Tinea unguium
cellulitis and abscess
DOID:13074
tinea unguium
A dermatomycosis that effects skin and subcutaneous tissue located in foot, located in trunk, located in buttocks, located in eyelids, located in lacrimal glands, located in paranasal sinuses, located in mandible, located in scalp, located in neck, located in perineum, or located in testes and has symptom sinus discharge and results in formation of nodules.
ICD10CM:B47
MESH:D008271
NCI:C85505
SNOMEDCT_US_2020_03_01:410039003
UMLS_CUI:C0024449
Madura foot
Maduromycosis, mycotic
Mycotic mycetoma
eumycetoma
maduromycosis
disease_ontology
DOID:13078
eumycotic mycetoma
GARD:10285
ICD10CM:P91.2
ICD9CM:779.7
MESH:D007969
NCI:C99013
SNOMEDCT_US_2020_03_01:230769007
UMLS_CUI:C0023529
disease_ontology
DOID:13088
periventricular leukomalacia
MESH:D020765
UMLS_CUI:C0752138
disease_ontology
DOID:13089
intracranial arterial disease
ICD10CM:H34.23
ICD9CM:362.32
MESH:D015356
NCI:C34436
SNOMEDCT_US_2020_03_01:50821009
UMLS_CUI:C0006123
Arterial retinal branch occlusion
Retinal Arterial Branch Occlusion
Retinal arterial branch occlusion
disease_ontology
DOID:13094
branch retinal artery occlusion
MESH:D014715
UMLS_CUI:C0042560
Vertebral artery syndrome
disease_ontology
DOID:13095
vertebral artery insufficiency
A retinal artery occlusion characterized by blockage of blood flow through the central retinal artery.
ICD10CM:H34.1
ICD9CM:362.31
MESH:D015356
NCI:C34456
SNOMEDCT_US_2020_03_01:38742007
UMLS_CUI:C0007688
disease_ontology
DOID:13098
central retinal artery occlusion
A cerebral arterial disease characterized by constriction of certain arteries at the base of the brain. Blood flow is blocked by the constriction and also by blood clots.
GARD:7064
ICD10CM:I67.5
ICD9CM:437.5
MESH:D009072
NCI:C84895
OMIM:252350
OMIM:300845
OMIM:607151
OMIM:608796
OMIM:614042
OMIM:615750
ORDO:2573
ORDO:280679
ORDO:401945
SNOMEDCT_US_2020_03_01:69116000
UMLS_CUI:C0026654
progressive intracranial arterial occlusion
disease_ontology
DOID:13099
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Moyamoya disease
MESH:D009072
MESH:D020301
UMLS_CUI:C0751895
disease_ontology
DOID:13100
intracranial vasospasm
A bladder benign neoplasm that derives_from smooth muscle cells.
NCI:C6178
UMLS_CUI:C1332560
leiomyoma of the urinary bladder
disease_ontology
DOID:13109
bladder leiomyoma
ICD9CM:374.04
SNOMEDCT_US_2020_03_01:67383002
UMLS_CUI:C0155191
disease_ontology
DOID:13113
cicatricial entropion
DOID:3945
EFO:0004236
GARD:6517
MESH:D005923
NCI:C37308
OMIM:PS603278
SNOMEDCT_US_2020_03_01:25821008
UMLS_CUI:C0017668
FGS
FSGS
focal glomerular sclerosis
focal glomerulosclerosis
disease_ontology
DOID:1312
Xref MGI.
OMIM mapping confirmed by DO. [SN].
focal segmental glomerulosclerosis
ICD10CM:D53.0
ICD9CM:281.4
SNOMEDCT_US_2020_03_01:85746008
UMLS_CUI:C0154290
Anemia due to protein deficiency
Protein-deficiency anaemia
Protein-deficiency anemia
protein-deficiency anaemia
disease_ontology
DOID:13120
protein-deficiency anemia
ICD9CM:281.9
SNOMEDCT_US_2020_03_01:191125001
UMLS_CUI:C0041782
deficiency anemias
disease_ontology
DOID:13121
deficiency anemia
A childhood spinal muscular atrophy that is a severe form and is characterized by muscle weakness onset from birth to six months of age, the inability to sit unassisted.
GARD:7883
ICD10CM:G12.0
ICD9CM:335.0
MESH:D014897
NCI:C98670
OMIM:253300
SNOMEDCT_US_2020_03_01:64383006
UMLS_CUI:C0043116
HMN (Hereditary motor Neuropathy) Proximal type I
SMA1
Spinal muscular atrophy 1
hereditary motor neuropathy proximal type I
infantile muscular atrophy
progressive muscular atrophy of infancy
disease_ontology
DOID:13137
OMIM mapping confirmed by DO. [SN].
Werdnig-Hoffmann disease
ICD9CM:580.0
SNOMEDCT_US_2020_03_01:197579006
UMLS_CUI:C0341692
acute glomerulonephritis with lesion of proliferative glomerulonephritis
disease_ontology
DOID:13138
acute proliferative glomerulonephritis
NCI:C128143
SNOMEDCT_US_2020_03_01:45406000
UMLS_CUI:C0403416
disease_ontology
DOID:13139
crescentic glomerulonephritis
An uveal disease is characterized by inflammation of any of the layers of the uvea of the eye, which includes the iris, ciliary body, and choroid.
ICD10CM:H20.9
MESH:D014605
NCI:C26909
SNOMEDCT_US_2020_03_01:267719008
UMLS_CUI:C0042164
disease_ontology
DOID:13141
uveitis
ICD10CM:H55.04
ICD9CM:379.55
MESH:D009759
SNOMEDCT_US_2020_03_01:9520006
UMLS_CUI:C0155380
Dissociated nystagmus
disease_ontology
DOID:13174
dissociated nystagmus
An arthritis that has_material_basis_in uric acid crystal deposits located_in joint.
DOID:14144
EFO:0004274
ICD10CM:M10
ICD9CM:274
ICD9CM:274.0
MESH:D006073
MESH:D015210
NCI:C34650
SNOMEDCT_US_2020_03_01:201661008
SNOMEDCT_US_2020_03_01:90560007
UMLS_CUI:C0003868
UMLS_CUI:C0018099
Articular gout
Gouty arthropathy
gouty arthritis
disease_ontology
DOID:13189
gout
A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain.
DOID:2125
DOID:2126
DOID:3543
DOID:6649
DOID:911
ICD10CM:C71
ICD9CM:191
ICD9CM:239.6
MESH:D001932
NCI:C2907
NCI:C3568
NCI:C5115
NCI:C7710
SNOMEDCT_US_2020_03_01:126952004
SNOMEDCT_US_2020_03_01:428061005
SNOMEDCT_US_2020_03_01:93727008
UMLS_CUI:C0006118
UMLS_CUI:C0153633
UMLS_CUI:C0220624
UMLS_CUI:C0750974
UMLS_CUI:C0750979
UMLS_CUI:C1334557
BT - Brain tumour
adult brain tumor
adult malignant brain neoplasm
brain neoplasm
brain neoplasm, adult
malignant brain tumour
malignant primary brain neoplasm
malignant primary brain tumor
malignant tumor of Brain
malignant tumor of adult brain
neoplasm of brain
primary brain neoplasm
primary brain tumor
primary malignant neoplasm of brain
tumor of the Brain
disease_ontology
DOID:1319
brain cancer
MESH:D006045
SNOMEDCT_US_2020_03_01:66392007
UMLS_CUI:C0018024
Retrosternal thyroid goiter
Retrosternal thyroid goitre
Substernal goiter
Substernal goitre
substernal goitre
disease_ontology
DOID:13200
substernal goiter
ICD9CM:362.02
NCI:C84457
SNOMEDCT_US_2020_03_01:154679002
UMLS_CUI:C0154830
PDR
disease_ontology
DOID:13207
proliferative diabetic retinopathy
ICD9CM:426.51
SNOMEDCT_US_2020_03_01:46319007
UMLS_CUI:C0155704
Right bundle branch block with left posterior fascicular block
disease_ontology
DOID:13209
right bundle branch block
An uterine benign neoplasm derived from the smooth muscle layer of the uterus.
EFO:0000731
ICD10CM:D25
ICD9CM:218
MESH:D007889
NCI:C3434
OMIM:150699
SNOMEDCT_US_2020_03_01:95315005
UMLS_CUI:C0042133
Plexiform leiomyoma
UTERUS FIBROMA
leiomyoma of Corpus Uteri
uterine leiomyoma
disease_ontology
DOID:13223
OMIM mapping confirmed by DO. [LS].
uterine fibroid
A respiratory system cancer that is located_in the lung.
DOID:13075
DOID:1322
DOID:9881
ICD10CM:C34.1
ICD10CM:C34.2
ICD10CM:C34.3
ICD9CM:162.3
ICD9CM:162.4
ICD9CM:162.5
ICD9CM:162.8
OMIM:211980
OMIM:608935
OMIM:612571
OMIM:612593
OMIM:614210
SNOMEDCT_US_2020_03_01:187860004
SNOMEDCT_US_2020_03_01:187864008
SNOMEDCT_US_2020_03_01:187868006
SNOMEDCT_US_2020_03_01:187874006
UMLS_CUI:C0024624
UMLS_CUI:C0153491
UMLS_CUI:C0153492
UMLS_CUI:C0153493
disease_ontology
lung neoplasm
DOID:1324
lung cancer
ICD10CM:K03.3
ICD9CM:521.4
MESH:D014091
SNOMEDCT_US_2020_03_01:70931000
UMLS_CUI:C0040451
disease_ontology
DOID:13240
tooth resorption
MESH:D014091
A respiratory system cancer that is located_in the bronchus.
ICD10CM:C34
ICD9CM:162.9
SNOMEDCT_US_2020_03_01:187875007
UMLS_CUI:C0348343
malignant neoplasm of bronchus and lung
malignant neoplasm of bronchus or lung
disease_ontology
DOID:1325
bronchus cancer
A gastrointestinal system disease described as the condition of having frequent loose or liquid bowel movements. Acute diarrhea is a common cause of death in developing countries and the second most common cause of infant deaths worldwide. The loss of fluids through diarrhea can cause severe dehydration which is one cause of death in diarrhea sufferers. Along with water, sufferers also lose dangerous amounts of important salts, electrolytes, and other nutrients. There are at least four types of diarrhea: secretory diarrhea, osmotic diarrhea, motility-related diarrhea, and inflammatory diarrhea.
DOID:0050006
ICD9CM:009.2
MESH:D004403
SNOMEDCT_US_2020_03_01:154268000
UMLS_CUI:C0013369
disease_ontology
diarrhea of presumed infectious origin
diarrhoea
DOID:13250
diarrhea is both a disease and a symptom [ms]
diarrhea
A primary bacterial infectious disease that is a communicable systemic illness, has_material_basis_in Salmonella enterica subsp enterica serovar Typhi, which is transmitted_by ingestion of food or water contaminated with the feces of an infected person. The infection has_symptom fever, has_symptom diarrhea, has_symptom prostration, has_symptom headache, has_symptom splenomegaly, has_symptom liver enlargement, has_symptom eruption of rose-colored spots, and has_symptom leukopenia.
DOID:3054
GARD:9564
ICD10CM:A01.0
ICD9CM:002.0
MESH:D014435
NCI:C35089
SNOMEDCT_US_2020_03_01:186091002
UMLS_CUI:C0041466
Typhoid
disease_ontology
DOID:13258
typhoid fever
An inherited metabolic disorder that involves certain enzymes in the heme bio-synthetic pathway resulting in the overproduction and accumulation of the porphyrins.
GARD:10353
ICD10CM:E80.20
ICD9CM:277.1
MESH:D011164
NCI:C97096
SNOMEDCT_US_2020_03_01:190912004
UMLS_CUI:C0032708
Hematoporphyria
Porphyrinopathy
disorder of porphyrin and hem metabolism
disorder of porphyrin metabolism
disease_ontology
DOID:13268
porphyria
GARD:6619
ICD10CM:E80.29
MESH:D046349
NCI:C84759
OMIM:121300
SNOMEDCT_US_2020_03_01:7425008
UMLS_CUI:C0162531
Coproporphyrinogen oxidase deficiency
Hereditary coproporphyria
hereditary coproporphyria porphyria
disease_ontology
DOID:13269
OMIM mapping confirmed by DO. [SN].
hereditary coproporphyria
An acute porphyria characterized by a deficiency in the enzyme ferrochelatase, leading to abnormally high levels of protoporphyrin in the tissue.
GARD:4527
ICD10CM:E80.0
MESH:D046351
NCI:C84698
OMIM:177000
OMIM:300752
ORDO:79278
SNOMEDCT_US_2020_03_01:51022005
UMLS_CUI:C0162568
EPP
Erythropoietic protoporphyria
Protoporphyria
disease_ontology
DOID:13270
Xref MGI.
OMIM mapping confirmed by DO. [SN].
erythropoietic protoporphyria
GARD:4446
ICD10CM:E80.0
MESH:D017092
NCI:C84697
OMIM:263700
SNOMEDCT_US_2020_03_01:67312003
UMLS_CUI:C0162530
Erythropoietic porphyria
disease_ontology
DOID:13271
OMIM mapping confirmed by DO. [SN].
cutaneous porphyria
A viral infectious disease that results_in infection, has_material_basis_in Rift Valley fever virus, which is transmitted_by Aedes mosquitoes. The virus affects domestic animals (cattle, buffalo, sheep, goats, and camels) and humans. The infection has_symptom jaundice, has_symptom vomiting blood, has_symptom passing blood in the feces, has_symptom ecchymoses (caused by bleeding in the skin), has_symptom bleeding from the nose or gums, has_symptom menorrhagia and has_symptom bleeding from venepuncture sites.
ICD10CM:A92.4
MESH:D012295
NCI:C128419
SNOMEDCT_US_2020_03_01:7077006
UMLS_CUI:C0035613
disease_ontology
DOID:1328
Rift Valley fever
A gastrointestinal tuberculosis that involves diffuse mucosal fold thickening, formation of ulcers and fistulae located_in intestine. The infection has_symptom abdominal pain, has_symptom gastrointestinal bleeding, has_symptom nausea and has_symptom vomiting.
ICD9CM:014.8
UMLS_CUI:C0152724
tuberculosis of intestine
disease_ontology
DOID:13282
intestinal tuberculosis
An osteochondrosis that results_in abnormal bone growth and curvature located_in thoracic vertebral column.
GARD:7610
ICD10CM:M42.0
ICD9CM:732.0
MESH:D012544
NCI:C34999
OMIM:181440
SNOMEDCT_US_2020_03_01:53406005
UMLS_CUI:C0036310
Juvenile osteochondritis of the spine
Juvenile osteochondrosis of Scheurermann
Juvenile osteochondrosis of spine
Scheuermann's kyphosis
Sherman's Disease
Scheuermann disease
disease_ontology
DOID:13300
OMIM mapping confirmed by DO. [SN].
Scheuermann's disease
ICD10CM:K86.81
MESH:D010188
NCI:C84316
SNOMEDCT_US_2020_03_01:47367009
UMLS_CUI:C0267963
Exocrine pancreatic insufficiency
disease_ontology
DOID:13316
exocrine pancreatic insufficiency
A carbohydrate metabolic disorder that involves low blood glucose resulting from an excess of insulin.
DOID:9996
ICD10CM:E16.9
MESH:D046768
NCI:C4375
SNOMEDCT_US_2020_03_01:42681006
UMLS_CUI:C0027773
Islet cell hyperplasia
nesidioblastosis
persistent hyperinsulinemia hypoglycemia of infancy
disease_ontology
DOID:13317
OMIM mapping confirmed by DO. [SN].
hyperinsulinemic hypoglycemia
A cataract that is characterized by loss of lens transparency secondary to hyperglycemia related to diabetes mellitus.
ICD9CM:366.41
SNOMEDCT_US_2020_03_01:43959009
UMLS_CUI:C0011876
Cataract - diabetic
disease_ontology
DOID:13328
diabetic cataract
A toxoplasmosis that involves a reactivated infection of the mother transmitted to the fetus during pregnancy. Spontaneous abortion and stillbirth may occur.
GARD:10326
ICD10CM:P37.1
MESH:D014125
NCI:C50503
SNOMEDCT_US_2020_03_01:268875000
UMLS_CUI:C0040560
Congenital toxoplasmosis
Toxoplasmosis - congen.
disease_ontology
DOID:13336
congenital toxoplasmosis
ICD10CM:F65.4
ICD9CM:302.2
MESH:D010378
NCI:C94355
SNOMEDCT_US_2020_03_01:192516001
UMLS_CUI:C0030764
Paedophilia
disease_ontology
DOID:13351
pedophilia
ICD10CM:M22.4
ICD9CM:717.7
MESH:D046789
OMIM:168900
SNOMEDCT_US_2020_03_01:156521009
UMLS_CUI:C0008475
Chondromalacia of patella
Chondromalacia patellae
softening of articular cartilage of patella
disease_ontology
DOID:13357
OMIM mapping confirmed by DO. [SN].
chondromalacia patellae
A collagen disease that is characterized by extremely flexible joints, elastic skin, and excessive bruising caused by a heritable defect in collagen synthesis, which leads to marked healing difficulties. EDS has five cardinal signs, which may be present to some degree in all of the subtypes. These five cardinal signs are skin fragility, blood vessel fragility, skin hyperelasticity, joint hypermobility, and characteristic subcutaneous nodules.
DOID:14696
GARD:6322
ICD10CM:Q79.6
ICD9CM:756.83
MESH:D004535
NCI:C34568
OMIM:PS130000
SNOMEDCT_US_2020_03_01:268352002
UMLS_CUI:C0013720
Cutis hyperelastica
elastic skin
disease_ontology
DOID:13359
OMIM mapping confirmed by DO. [LS].
OMIM mapping by NeuroDevNet. [LS].
Ehlers-Danlos syndrome
A learning disability involing difficulty reading resulting primarily from neurological factors which affect any part of the reading process.
ICD9CM:315.09
UMLS_CUI:C0154631
disease_ontology
DOID:13365
reading disorder
A movement disease that is of unknown etiology characterized by progressive rigidity.
GARD:5023
ICD10CM:G25.82
ICD9CM:333.91
MESH:D016750
NCI:C85170
OMIM:184850
SNOMEDCT_US_2020_03_01:5217008
UMLS_CUI:C0085292
Stiff-man syndrome
stiff man syndrome
disease_ontology
DOID:13366
Stiff-Person syndrome
A dermatophytosis that results_in fungal skin infection located_in hand, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes and has_symptom itching, has_symptom burning, has_symptom cracking, and has_symptom scaling.
ICD10CM:B35.2
ICD9CM:110.2
SNOMEDCT_US_2020_03_01:48971001
UMLS_CUI:C0153246
Dermatophytosis of hand
Tinea manus
disease_ontology
DOID:13369
tinea manuum
A typhus that has_material_basis_in Orientia tsutsugamushi, which is transmitted by trombiculid mites (Leptotrombidium deliense). The infection has symptom fever, has symptom headache, has symptom muscle pain, has symptom cough, has symptom maculopapular rash, has symptom eschar, has symptom splenomegaly and has symptom lymphadenopathy.
ICD10CM:A75.3
ICD9CM:081.2
MESH:D012612
SNOMEDCT_US_2020_03_01:73911003
UMLS_CUI:C0036472
Japanese river fever
Kedani fever
Scrub mite-borne typhus
Tsutsugamushi
Tsutsugamushi disease
disease_ontology
Chigger-borne rickettsiosis
Chigger-borne typhus
Mite-borne rickettsiosis
Mite-borne typhus
Scrub (mite-borne) typhus
Tropical typhus
Tsutsugamushi fever
Typhus fever due to Rickettsia tsutsugamushi
DOID:13371
scrub typhus
A plasma protein metabolism disease that has_material_basis_in defective production of the protease inhibitor alpha 1-antitrypsin (A1AT), leading to decreased A1AT activity in the blood and lungs, and deposition of excessive abnormal A1AT protein in liver cells.
GARD:5784
ICD10CM:E88.01
ICD9CM:273.4
MESH:D019896
NCI:C84397
OMIM:613490
SNOMEDCT_US_2020_03_01:30188007
UMLS_CUI:C0221757
AAT deficiency
disease_ontology
DOID:13372
OMIM mapping confirmed by DO. [SN].
alpha 1-antitrypsin deficiency
MESH:D019896
A connective tissue disease that is characterized by progressive ossification of skeletal muscle, fascia, tendons, and ligaments and has_material_basis_in heterozygous mutation in the ACVR1 gene.
GARD:6445
ICD10CM:M61.1
ICD9CM:728.11
MESH:D009221
NCI:C3040
OMIM:135100
ORDO:337
SNOMEDCT_US_2020_03_01:82725007
UMLS_CUI:C0016037
Stone Man Syndrome
myositis ossificans progressiva
progressive myositis ossificans
progressive ossifying myositis
disease_ontology
DOID:13374
OMIM mapping confirmed by DO. [SN].
fibrodysplasia ossificans progressiva
A lymphadenitis characterized by swelling of cervical lymph nodes in infants and young children and inflammation of medium-sized blood vessels located_in body, has_symptom fever, has_symptom congestion of ocular conjunctivae, has_symptom reddening of lips, has_symptom reddening of oral cavity, has_symptom protuberance of tongue papillae and has_symptom edema of extremities.
EFO:0004246
GARD:6816
ICD10CM:M30.3
ICD9CM:446.1
MESH:D009080
NCI:C34825
OMIM:611775
SNOMEDCT_US_2020_03_01:75053002
UMLS_CUI:C0026691
Kawasaki's disease
MLNS
acute febrile MCLS
acute febrile mucocutaneous lymph node syndrome
mucocutaneous lymph node syndrome
disease_ontology
DOID:13378
OMIM mapping confirmed by DO. [SN].
Kawasaki disease
A congenital hemolytic anemia characterized by ineffective erythropoiesis, and resulting from a decrease in the number of red blood cells (RBCs) in the body and a less than normal quantity of hemoglobin in the blood.
GARD:1999
ICD10CM:D64.4
MESH:D000742
NCI:C84646
OMIM:PS224120
ORDO:85
SNOMEDCT_US_2020_03_01:191272005
UMLS_CUI:C0002876
congenital dyshaematopoietic anaemia
disease_ontology
DOID:1338
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital dyserythropoietic anemia
A nutritional deficiency disease that is characterized by a decrease in red blood cells due to malabsorption of vitamin B12, has_symptom fatigue, pallor, shortness of breath, glossitis, ataxia, and/or paresthesia, has_material_basis_in atrophic gastritis, autoimmune disorder affecting the production or function of intrinsic factor, and/or genetic factors.
GARD:12671
ICD10CM:D51.0
ICD9CM:281.0
MESH:D000752
NCI:C2871
OMIM:170900
SNOMEDCT_US_2020_03_01:191139001
UMLS_CUI:C0002892
ANEMIA PERNICIOUS
Addison's anaemia
Biermer's anaemia
Biermer's anemia
pernicious anaemia
disease_ontology
DOID:13381
OMIM mapping confirmed by DO. [SN].
pernicious anemia
A macrocytic anemia that is characterized by inhibition of DNA synthesis during red blood cell production.
ICD10CM:D53.1
MESH:D000749
NCI:C34382
OMIM:261100
OMIM:613839
SNOMEDCT_US_2020_03_01:191138009
UMLS_CUI:C0002888
Grasbeck-Imerslund syndrome
Imerslund-Grasbeck syndrome
MGA1 Norwegian type
RH-MGA1
megaloblastic anaemia
recessive hereditary megaloblastic anaemia 1
recessive hereditary megaloblastic anemia 1
disease_ontology
IGS
DOID:13382
Xref MGI.
megaloblastic anemia
A congenital hypoplastic anemia that is characterized by anemia (low red blood cell counts) with decreased erythroid progenitors in the bone marrow and has_material_basis_insufficient levels of red blood cells due to bone marrow dysfunction.
GARD:6274
ICD10CM:D61.01
MESH:D029503
NCI:C61236
OMIM:PS105650
ORDO:124
SNOMEDCT_US_2020_03_01:188588001
Blackfan - Diamond syndrome
chronic constitutional pure red cell anaemia
disease_ontology
DOID:1339
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Diamond-Blackfan anemia
A blindness that is characterized by the inability or decreased ability to see color, or perceive color differences, under normal lighting conditions.
ICD10CM:H53.5
ICD9CM:368.5
MESH:D003117
NCI:C3891
SNOMEDCT_US_2020_03_01:193683001
UMLS_CUI:C0242225
BLINDNESS COLOR
Colour blindness
Colour vision deficiency
disease_ontology
DOID:13399
color blindness
GARD:7504
MESH:D012010
NCI:C34974
SNOMEDCT_US_2020_03_01:191252000
UMLS_CUI:C0034902
Pure Red cell Aplasia
Pure red cell aplasia
Red cell hypoplasia
primary red cell aplasia
disease_ontology
DOID:1340
pure red-cell aplasia
MESH:D000793
OMIM:607140
UMLS_CUI:C0002982
disease_ontology
DOID:13401
OMIM mapping confirmed by DO. [SN].
angioid streaks
ICD10CM:D86.3
NCI:C34996
SNOMEDCT_US_2020_03_01:55941000
UMLS_CUI:C0036203
Cutaneous Sarcoidosis
Cutaneous sarcoid
Cutaneous sarcoidosis
disease_ontology
DOID:13402
skin sarcoidosis
A sarcoidosis that is characterized by conduction abnormalities, arrhythmias, and congestive heart failure with noncaseating granulomas present on endomyocardial biopsy, and develops_from a type IV hypersensitivity reaction with noncaseating granulomas infiltrating the myocardial tissue, especially that of the left ventricle.
NCI:C35589
SNOMEDCT_US_2020_03_01:75403004
UMLS_CUI:C0392077
Cardiac sarcoidosis
disease_ontology
DOID:13405
cardiac sarcoidosis
A brain disease that is characterized by loss of brain function, the occurrence of confusion, altered level of consciousness, and coma that results when the liver is unable to remove toxins from the blood.
GARD:10452
ICD10CM:K72
ICD9CM:572.2
MESH:D006501
NCI:C79596
SNOMEDCT_US_2020_03_01:197332007
UMLS_CUI:C0019151
Portal-systemic encephalopathy
disease_ontology
DOID:13413
hepatic encephalopathy
DOID:13639
ICD10CM:D61.0
ICD10CM:D61.01
ICD9CM:284.0
MESH:D029502
SNOMEDCT_US_2020_03_01:191236003
SNOMEDCT_US_2020_03_01:267523003
UMLS_CUI:C0702159
UMLS_CUI:C0949116
congenital aplastic anaemia
congenital aplastic anemia
congenital hypoplastic anaemia
disease_ontology
Constitutional aplastic anaemia
DOID:1342
congenital hypoplastic anemia
DOID:2863
ICD10CM:N34.2
ICD9CM:597.80
MESH:D014526
NCI:C26904
SNOMEDCT_US_2020_03_01:154388003
SNOMEDCT_US_2020_03_01:31822004
UMLS_CUI:C0041976
UMLS_CUI:C0311389
Non-Gonococcal Urethritis
Nongonococcal urethritis
disease_ontology
DOID:1343
urethritis
A primary bacterial infectious disease that results in septicemic infection, has_material_basis_in Burkholderia mallei, which is transmitted by contact with tissues or body fluids of infected animals, or through mucosal surfaces such as the eyes and nose. The infection has symptom fever, has symptom chills, has symptom sweating, has symptom muscle aches, has symptom chest pain, has symptom muscle tightness, has symptom headache, has symptom mucopurulent nasal discharge, and has symptom nodular lesions in the lungs.
GARD:9536
ICD10CM:A24.0
ICD9CM:024
MESH:D005896
NCI:C34638
SNOMEDCT_US_2020_03_01:4639008
UMLS_CUI:C0017589
Farcy pipes
Infection due to Pseudomonas mallei
disease_ontology
DOID:13444
glanders
ICD10CM:I65.1
ICD9CM:433.0
SNOMEDCT_US_2020_03_01:78658006
UMLS_CUI:C0265098
disease_ontology
DOID:13446
basilar artery occlusion
A primary systemic mycosis that results_in systemic fungal infection, has_material_basis_in Coccidioides immitis, transmitted_by airborne spores and has_symptom conjunctivitis, has_symptom arthritis, has_symptom chest pain and results_in_formation_of skin nodules.
DOID:13981
GARD:9525
ICD10CM:B38
ICD9CM:114
MESH:D003047
NCI:C84642
SNOMEDCT_US_2020_03_01:266218008
UMLS_CUI:C0009186
primary extrapulmonary coccidioidomycosis
disease_ontology
DOID:13450
coccidioidomycosis
GARD:12911
ICD10CM:H15.0
ICD9CM:379.00
MESH:D015423
NCI:C119046
SNOMEDCT_US_2020_03_01:155201000
UMLS_CUI:C0036416
disease_ontology
DOID:13452
scleritis
ICD10CM:N36.42
ICD9CM:599.82
SNOMEDCT_US_2020_03_01:16031000119101
UMLS_CUI:C0375381
Intrinsic (urethral) sphincter deficiency [ISD]
disease_ontology
DOID:13461
urethral intrinsic sphincter deficiency
A balantitis characterized by white plaques or patches on genitals.
ICD9CM:607.81
NCI:C3523
SNOMEDCT_US_2020_03_01:198028006
UMLS_CUI:C0152460
Penile Lichen Sclerosus
disease_ontology
DOID:13477
balanitis xerotica obliterans
MESH:D052798
An osteochondrodysplasia that results_in short arms and legs with excess folds of skin.
GARD:85
ICD10CM:Q77.1
MESH:D013796
NCI:C85187
OMIM:187600
OMIM:187601
OMIM:273680
ORDO:1860
ORDO:2655
ORDO:93274
ORDO:93275
SNOMEDCT_US_2020_03_01:29352008
UMLS_CUI:C0039743
disease_ontology
DOID:13481
Xref MGI.
OMIM mapping confirmed by DO. [LS].
thanatophoric dysplasia
MESH:D013796
A syndrome that is characterized by overgrowth of the bones, skin, and other tissues.
GARD:7475
MESH:D016715
NCI:C85032
OMIM:176920
SNOMEDCT_US_2020_03_01:394527003
UMLS_CUI:C0085261
Wiedemann's syndrome
disease_ontology
DOID:13482
OMIM mapping confirmed by DO. [SN].
Proteus syndrome
A pervasive developmental disorder that is a rare condition characterized by late onset (greater than 3 years of age) of developmental delays in language, social function, and motor skills where children who have had previously normal development who then appear to regress.
GARD:6040
ICD10CM:F84.3
ICD9CM:299.1
NCI:C97164
SNOMEDCT_US_2020_03_01:71961003
UMLS_CUI:C0236791
Disintegrative psychosis
Heller's syndrome
Symbiotic psychosis
disease_ontology
DOID:13487
childhood disintegrative disease
ICD10CM:N34.3
ICD9CM:597.81
SNOMEDCT_US_2020_03_01:31273004
UMLS_CUI:C0156279
disease_ontology
DOID:13498
urethral syndrome
MESH:D010255
NCI:C7488
SNOMEDCT_US_2020_03_01:126675008
UMLS_CUI:C0030470
neoplasm of accessory sinus
tumor of Accessory sinus
disease_ontology
DOID:1350
paranasal sinus benign neoplasm
A facial nerve disease characterized by congenital, uni- or bilateral, non-progressive facial weakness and limited abduction of the eye(s).
GARD:8549
ICD10CM:Q87.0
MESH:D020331
NCI:C84893
OMIM:157900
SNOMEDCT_US_2020_03_01:89444000
UMLS_CUI:C0221060
Moebius congenital oculofacial paralysis
Oromandibular-limb hypogenesis spectrum
disease_ontology
DOID:13501
OMIM mapping confirmed by DO. [SN].
Mobius syndrome
ICD10CM:N30.3
ICD9CM:595.3
NCI:C123175
SNOMEDCT_US_2020_03_01:155885003
UMLS_CUI:C1261278
disease_ontology
DOID:13507
trigonitis
A syndrome that is characterized by the growth of numerous noncancerous tumors in many parts of the body.
GARD:7830
ICD10CM:Q85.1
ICD9CM:759.5
MESH:D014402
NCI:C3424
OMIM:PS191100
SNOMEDCT_US_2020_03_01:157033002
UMLS_CUI:C0041341
Bourneville's disease
Epiloia
Tuberose sclerosis
Tuberous sclerosis syndrome
cerebral sclerosis
disease_ontology
DOID:13515
OMIM mapping confirmed by DO. [LS].
tuberous sclerosis
MESH:D010254
NCI:C26843
SNOMEDCT_US_2020_03_01:7393007
UMLS_CUI:C0030469
disorder of nasal sinus
disease_ontology
DOID:1352
paranasal sinus disease
A tetanus that occurs in newborn babies when the birth cord stump gets dirty through cutting it with an unclean blade or applying substances containing bacteria to it. The infection has symptom stiff body, has symptom muscle spasms, has symptom difficulty in breathing, and has symptom exhaustion.
ICD10CM:A33
ICD9CM:771.3
NCI:C116814
SNOMEDCT_US_2020_03_01:43424001
UMLS_CUI:C0343312
Tetanus neonatorum
neonatal tetanus
disease_ontology
DOID:13521
tetanus neonatorum
A filariasis that involves parasitic infection of the skin and eyes caused by the nematode Loa loa, which is transmitted through the bite of a deer fly or mango fly. The disease is characterized by episodic angioedema in the arms and legs, and cyst-like enlargements of the connective tissue around the sheaths of muscle tendons. Dead worms may cause chronic abscesses, which may lead to the formation of granulomatous reactions and fibrosis.
GARD:3283
ICD10CM:B74.3
ICD9CM:125.2
MESH:D008118
NCI:C34784
SNOMEDCT_US_2020_03_01:44250009
UMLS_CUI:C0023968
disease_ontology
DOID:13523
loiasis
An osteosclerosis that has_material_basis_in lack of bone resorption which results_in abnormally hard and brittle bones.
GARD:4155
ICD10CM:Q78.2
ICD9CM:756.52
MESH:D010022
NCI:C26840
OMIM:PS259700
OMIM:PS607634
ORDO:667
SNOMEDCT_US_2020_03_01:205500005
UMLS_CUI:C0029454
Albers-Schonberg disease
marble bone
disease_ontology
DOID:13533
Xref MGI.
OMIM mapping submitted by NeuroDevNet. [LS].
osteopetrosis
A parathyroid gland disease characterized by an overactivity of the parathyroid glands, leading to an excess of parathyroid hormone in the body.
ICD10CM:E21.3
ICD9CM:252.0
MESH:D006961
NCI:C48259
OMIM:145000
OMIM:145001
OMIM:610071
ORDO:99879
SNOMEDCT_US_2020_03_01:190451000
UMLS_CUI:C0020502
disease_ontology
DOID:13543
Xref MGI.
hyperparathyroidism
An open-angle glaucoma characterized by increased intrinsic resistance to aqueous outflow without known secondary causes, an anatomically narrow anterior chamber angle, or elevated intraocular pressure compared to the average population. Normal tension glaucoma has_symptom progressive decreased vision and progressive loss of peripheral vision.
ICD10CM:H40.12
ICD9CM:365.12
MESH:D057066
SNOMEDCT_US_2020_03_01:155124000
UMLS_CUI:C0152136
Normal tension glaucoma
disease_ontology
DOID:13544
low tension glaucoma
A primary angle-closure glaucoma characterized by acute closure of the anterior chamber angle by an intrinsic defect such that aqueous outflow is blocked and the intraocular pressure becomes suddenly inappropriately elevated threatening optic nerve damage and visual field loss; but that typically resolves spontaneously after several hours, even though it may recur. Interval angle-closure glaucoma has_symptom sudden pain, redness, headache, and blurry vision with haloes around lights that resolves spontaneously. Interval angle-closure glaucoma can be caused by exacerbation of chronic primary angle-closure glaucoma, typically by a medication or state that dilates the eyes and thus narrows the anterior chamber angle, blocking any aqueous outflow.
ICD10CM:H40.23
ICD9CM:365.21
SNOMEDCT_US_2020_03_01:65460003
UMLS_CUI:C0154945
Angle-closure glaucoma, subacute
Intermittent angle-closure glaucoma
Prodromal angle closure glaucoma
disease_ontology
DOID:13549
interval angle-closure glaucoma
A glaucoma characterized by closure of the anterior chamber angle such that aqueous outflow is blocked and the intraocular pressure becomes inappropriately elevated leading to optic nerve damage and visual field loss. Angle-closure glaucoma has_symptom progressive peripheral vision loss, decreased vision, and pain, redness, and headache in acute cases. Angle closure glaucoma can be caused by anatomically narrow angle, injury to the trabecular meshwork, and injuries to the anterior chamber, such as neovascularization and uveitis.
MESH:D015812
NCI:C34639
SNOMEDCT_US_2020_03_01:270882001
UMLS_CUI:C0017605
ACG - Angle-closure glaucoma
Angle Closure Glaucoma
Angle-closure glaucoma
Closed angle glaucoma
Narrow cleft glaucoma
primary open-angle glaucoma with narrow angles
disease_ontology
DOID:13550
angle-closure glaucoma
ICD10CM:H47.32
ICD9CM:377.21
MESH:D015594
SNOMEDCT_US_2020_03_01:33629003
UMLS_CUI:C0029128
Drusen of optic disc
optic nerve head drusen
disease_ontology
DOID:13561
optic disk drusen
An opportunistic mycosis that involves a spectrum of diseases of humans and animals caused by members of the genus Aspergillus infecting lungs, brain, kidney, heart, bone, eyes, sinuses, skin and gastrointestinal tract. It is a serious illnesses in people with a weakened immune system.
GARD:5856
ICD10CM:B44
ICD9CM:117.3
MESH:D001228
NCI:C2886
SNOMEDCT_US_2020_03_01:266218008
UMLS_CUI:C0004030
Infection due to Aspergillus
disease_ontology
DOID:13564
aspergillosis
MESH:D001228
ICD10CM:O43.02
MESH:D005330
NCI:C113824
SNOMEDCT_US_2020_03_01:13404009
UMLS_CUI:C2909036
Fetal blood loss from fetal hemorrhage into co-twin
Fetal hemorrhage into co-twin
Twin to twin transfusion
Twin-to-twin blood transfer
disease_ontology
DOID:13576
twin-to-twin transfusion syndrome
A bile duct disease that is characterized by where bile cannot flow from the liver to the duodenum.
ICD10CM:K83.1
ICD9CM:576.2
MESH:D002779
NCI:C83006
SNOMEDCT_US_2020_03_01:33688009
UMLS_CUI:C0008370
Obstruction of bile duct
bile occlusion
disease_ontology
DOID:13580
cholestasis
A pre-eclampsia characterized by the presence of seizures.
DOID:13592
GARD:6316
ICD10CM:O15
MESH:D004461
NCI:C87167
SNOMEDCT_US_2020_03_01:156111007
UMLS_CUI:C0013537
Eclampsia in puerperium
Eclampsia, postpartum
Postpartum eclampsia
disease_ontology
DOID:13593
eclampsia
A cholestasis characterized by blockage of the ducts that carry bile from the liver to the gallbladder.
GARD:12010
ICD10CM:Q44.2
ICD9CM:751.61
MESH:D001656
NCI:C34421
OMIM:210500
ORDO:30391
SNOMEDCT_US_2020_03_01:77480004
UMLS_CUI:C0005411
Atresia of bile duct
Congenital biliary atresia
biliary atresia, congenital
disease_ontology
DOID:13608
biliary atresia
NCI:C4419
SNOMEDCT_US_2020_03_01:126678005
UMLS_CUI:C0345672
neoplasm of frontal sinus
tumor of the Frontal sinus
disease_ontology
DOID:1361
frontal sinus benign neoplasm
ICD10CM:Q21.1
MESH:D054092
NCI:C34619
SNOMEDCT_US_2020_03_01:268316001
UMLS_CUI:C0016522
Atrial septal defect within oval fossa
Defect, Patent or persistent, ostium secundum
Ostium secundum type atrial septal defect
Persistent ostium secundum
foramen ovale patent
disease_ontology
DOID:13620
patent foramen ovale
A primary bacterial infectious disease that results_in infection located_in intestine, has_material_basis_in Campylobacter jejuni, which is transmitted_by ingestion of contaminated food or water or transmitted_by contact with infected people or animals. The infection has_symptom diarrhea or has_symptom dysentery, has_symptom abdominal cramps and pain, and has_symptom fever.
DOID:13621
MESH:D002169
SNOMEDCT_US_2020_03_01:86500004
UMLS_CUI:C0006818
Campylobacteriosis
disease_ontology
DOID:13622
campylobacteriosis
ICD10CM:H16.13
ICD9CM:370.24
NCI:C118750
SNOMEDCT_US_2020_03_01:1714005
UMLS_CUI:C0155078
disease_ontology
DOID:13626
photokeratitis
A glucosephosphate dehydrogenase deficiency characterized by a hemolytic reaction to consumption of broad beans.
ICD10CM:D55.0
MESH:D005236
NCI:C34607
SNOMEDCT_US_2020_03_01:154801000
UMLS_CUI:C0015702
disease_ontology
DOID:13628
favism
ICD9CM:521.32
UMLS_CUI:C1456162
disease_ontology
DOID:13629
dentine erosion
A congenital hypoplastic anemia characterized by progressive pancytopenia with bone marrow failure, variable congenital malformations and predisposition to develop hematological or solid tumors. It is a result of a genetic defect in a cluster of proteins responsible for DNA repair.
GARD:6425
ICD10CM:D61.09
MESH:D005199
NCI:C62505
OMIM:PS227650
ORDO:84
SNOMEDCT_US_2020_03_01:30575002
UMLS_CUI:C0015625
Fanconi anaemia
Fanconi pancytopenia
Fanconi panmyelopathy
Fanconi's anaemia
Fanconi's anemia
disease_ontology
DOID:13636
Xref MGI.
OMIM mapping confirmed by DO. [SN].
OMIM mapping by NeuroDevNet. [LS].
Fanconi anemia
A phacogenic glaucoma that is characterized by open-angle glaucoma related to deposition of extracellular fibrillar material in anterior segment structures, which blocks aqueous fluid outflow, raises intraocular pressure, and leads to eventual optic nerve atrophy and visual field loss. Exfoliation syndrome has_symptom progressive decreased vision, especially peripheral vision. Exfoliation syndrome is caused by age-related deposition of fibrillar material in anterior segment structures.
EFO:0004235
ICD9CM:365.52
MESH:D017889
NCI:C129025
OMIM:177650
SNOMEDCT_US_2020_03_01:111514006
UMLS_CUI:C0206368
Pseudoexfoliation glaucoma
Pseudoexfoliation syndrome
disease_ontology
DOID:13641
OMIM mapping confirmed by DO. [SN].
exfoliation syndrome
MESH:D017889
GARD:7606
MESH:D020083
NCI:C119049
SNOMEDCT_US_2020_03_01:60684003
UMLS_CUI:C0263859
Synovitis, acne, pustulosis palmaris, hyperostosis, osteomyelitis syndrome
disease_ontology
DOID:13677
SAPHO syndrome
ICD10CM:F52.4
ICD9CM:302.75
MESH:D061686
NCI:C94349
SNOMEDCT_US_2020_03_01:123302009
UMLS_CUI:C0033038
disease_ontology
DOID:13709
premature ejaculation
ICD10CM:K00.3
ICD9CM:520.3
MESH:D009050
NCI:C85059
SNOMEDCT_US_2020_03_01:30265004
UMLS_CUI:C0026618
Intrinsic enamel discolouration of fluorosis
Mottled teeth
Mottling of enamel
disease_ontology
DOID:13711
dental fluorosis
A senile cataract that is characterized by full white or brunescent opacification of the lens of the eye such that the red reflex is obscured. It is a later stage of senile cataracts and is caused by a multifactorial etiology related to aging.
SNOMEDCT_US_2020_03_01:193590000
UMLS_CUI:C0152257
Total or mature cataract
Total, mature senile cataract
disease_ontology
DOID:13717
mature cataract
A schistosomiasis that involves parasitic infection of the brain and spinal cord by Schistosoma haematobium, Schistosoma mansoni or Schistosoma japonicum causing acute or subacute myelopathy, focal central nervous system impairment, seizures and increased intracranial pressure.
MESH:D020818
UMLS_CUI:C0752191
disease_ontology
DOID:13722
neuroschistosomiasis
A nutritional deficiency disease that is characterized by vitamin C (ascorbic acid) deficiency and has_symptom fatigue, weakness, anemia, petechiae, corkscrew hair, gingivitis, and poor wound healing.
GARD:10406
ICD10CM:E54
MESH:D012614
NCI:C35010
OMIM:240400
SNOMEDCT_US_2020_03_01:267493006
UMLS_CUI:C0036474
disease_ontology
DOID:13724
OMIM mapping confirmed by DO. [SN].
scurvy
A thiamine deficiency disease that is characterized by being severe and chronic.
GARD:9948
ICD10CM:E51.1
ICD9CM:265.0
MESH:D001602
NCI:C34418
SNOMEDCT_US_2020_03_01:267491008
UMLS_CUI:C0005122
disease_ontology
DOID:13725
beriberi
MESH:D001602
An uterine benign neoplasm that has_material_basis_in cells reminiscent of proliferative phase endometrial stroma.
NCI:C4262
SNOMEDCT_US_2020_03_01:189810002
UMLS_CUI:C0334485
disease_ontology
DOID:1373
endometrial stromal nodule
ICD9CM:360.02
MESH:D010202
SNOMEDCT_US_2020_03_01:33382000
UMLS_CUI:C0030332
disease_ontology
DOID:13732
panophthalmitis
ICD10CM:H04.2
ICD9CM:375.2
MESH:D007766
NCI:C50552
SNOMEDCT_US_2020_03_01:49393005
UMLS_CUI:C0152227
Epiphora
Excessive tear production
Watering eye
disease_ontology
DOID:13757
excessive tearing
A lice infestation that involves parasitic infestation by pubic lice Pthirus pubis, which are found in the pubic hair, less commonly in eyebrows, eyelashes, beard, mustache, armpit, perianal area, groin, trunk and scalp. The symptoms include itching in the pubic and groin area. Intense itching leads to scratching which can cause sores and secondary bacterial infection of the skin.
ICD10CM:B85.3
ICD9CM:132.2
NCI:C35777
SNOMEDCT_US_2020_03_01:71011005
UMLS_CUI:C0030759
Infestation by Phthirus pubis
Pediculosis Pubis
Pediculus pubis
Phthiriasis pubis
Phthirus pubis
Phthirus/pediculus pubis - pubic lice - crabs
crabs
disease_ontology
DOID:13760
Pthirus pubis infestation
A parasitic helminthiasis infectious disease that involves parasitic infection of the bile ducts of the liver by Clonorchis sinensis. The symptoms include abdominal pain, nausea, diarrhea, and eosinophilia. In long-standing infections, cholangitis, cholelithiasis, pancreatitis, and cholangiocarcinoma can develop.
ICD10CM:B66.1
ICD9CM:121.1
MESH:D003003
SNOMEDCT_US_2020_03_01:11938002
UMLS_CUI:C0009021
Oriental liver fluke disease
disease_ontology
DOID:13767
clonorchiasis
A parasitic helminthiasis infectious disease that involves parasitic infection of the liver, pancreas and gall bladder by Opisthorchis viverrini or Opisthorchis felineus. The symptoms include dyspepsia, abdominal pain, diarrhea, constipation, hepatomegaly, cholangitis, cholecystitis, and chlolangiocarcinoma.
GARD:9746
ICD10CM:B66.0
ICD9CM:121.0
MESH:D009889
SNOMEDCT_US_2020_03_01:187124006
UMLS_CUI:C0029106
Infection by Opisthorchis
disease_ontology
DOID:13768
opisthorchiasis
An adrenal cortical hypofunction that is characterized by insufficient steroid hormone production by the adrenal glands.
GARD:5740
ICD10CM:E27.1
MESH:D000224
NCI:C26689
OMIM:103230
OMIM:240200
SNOMEDCT_US_2020_03_01:363732003
UMLS_CUI:C0001403
Addison disease
Addison disease, chronic adrenal insufficiency
HYPOADRENOCORTICISM, FAMILIAL
primary adrenocortical insufficiency
primary hypoadrenalism
disease_ontology
DOID:13774
Addison's disease
A primary immunodeficiency disease that results_in skin squamous cell carcinoma located_in skin, associated with a high risk of carcinoma. It is characterized by abnormal susceptibility to human papillomaviruses of the skin and has_symptom lesions on the body.
GARD:6357
MESH:D004819
NCI:C126877
OMIM:PS226400
ORDO:302
SNOMEDCT_US_2020_03_01:19138001
UMLS_CUI:C0014522
disease_ontology
DOID:13777
OMIM mapping confirmed by DO. [SN].
epidermodysplasia verruciformis
MESH:D004819
A primary bacterial infectious disease that is a sexually transmitted infection located in skin of the genitals, has_material_basis_in Haemophilus ducreyi, which is transmitted by sexual contact. The infection has symptom painful and soft ulcers.
GARD:9522
ICD10CM:A57
ICD9CM:099.0
MESH:D002602
SNOMEDCT_US_2020_03_01:154391003
UMLS_CUI:C0007947
Ulcus molle, skin
disease_ontology
DOID:13778
chancroid
ICD10CM:M35.7
ICD9CM:728.5
SNOMEDCT_US_2020_03_01:85551004
UMLS_CUI:C0152093
benign joint hypermobility
disease_ontology
DOID:13781
hypermobility syndrome
ICD10CM:H73.0
ICD9CM:384.00
SNOMEDCT_US_2020_03_01:297009
UMLS_CUI:C0155460
acute myringitis
disease_ontology
DOID:13790
acute tympanitis
A uterine cancer that is located_in tissues lining the uterus.
DOID:5654
EFO:0004230
GARD:11981
ICD10CM:C54.1
KEGG:05213
MESH:D016889
NCI:C27815
NCI:C3012
OMIM:608089
SNOMEDCT_US_2020_03_01:123844007
UMLS_CUI:C0007103
UMLS_CUI:C0014170
endometrial Ca
endometrial neoplasm
malignant endometrial neoplasm
malignant neoplasm of endometrium
neoplasm of endometrium
primary malignant neoplasm of endometrium
tumor of Endometrium
disease_ontology
DOID:1380
endometrial cancer
A commensal bacterial infectious disease that results_in inflammation, located_in conjunctiva of the eye, has_material_basis_in Chlamydia trachomatis, which is transmitted_by sexual contact. The infection has_symptom swollen conjunctiva and eyelids and has_symptom discharge of pus and mucus.
GARD:6777
ICD10CM:A74.0
ICD9CM:077.0
MESH:D003235
SNOMEDCT_US_2020_03_01:111840005
UMLS_CUI:C0009770
Chlamydial conjunctivitis
Inclusion blennorrhoea
adult inclusion conjunctivitis
inclusion blenorrhea
disease_ontology
Paratrachoma
DOID:13800
inclusion conjunctivitis
ICD10CM:E78.49
MESH:D006950
NCI:C35637
OMIM:144250
SNOMEDCT_US_2020_03_01:48190005
UMLS_CUI:C0020474
familial multiple lipoprotein-type hyperlipidemia
hyperbetalipoproteinemia with prebetalipoproteinemia
mixed hyperlipidaemia
type IIb hyperlipoproteinemia
disease_ontology
DOID:13809
OMIM mapping confirmed by DO. [SN].
familial combined hyperlipidemia
A sweat gland disease that is characterized by dilatation of the follicular infundibulum with hyperkeratosis, acanthosis, and spongiosis with perifollicular inflammation leading to hair loss and has_symptom flesh colored papules with hair loss and pruritis, especially of the axilla.
GARD:6462
ICD10CM:L75.2
ICD9CM:705.82
MESH:D005588
NCI:C84716
SNOMEDCT_US_2020_03_01:254682006
UMLS_CUI:C0016632
Fox Fordyce disease
disease_ontology
DOID:1381
Fox-Fordyce disease
A commensal bacterial infectious disease that results_in infection located_in lymph nodes, has_material_basis_in Chlamydia trachomatis, which is transmitted_by sexual contact, and transmitted_by fomites. The infection has_symptom inguinal lymphadenitis, has_symptom abscesses in the groin area, and has_symptom lymphangitis.
GARD:9545
ICD10CM:A55
ICD9CM:099.1
MESH:D008219
NCI:C26822
SNOMEDCT_US_2020_03_01:266213004
UMLS_CUI:C0024286
Climatic or tropical bubo
Durand-Nicolas-Favre disease
Lymphogranuloma inguinale
Poradenitis inguinale
Strumous bubo
disease_ontology
DOID:13819
lymphogranuloma venereum
A sweat gland disease that is characterized by blocked eccrine sweat glands and ducts.
ICD10CM:L74.3
MESH:D008883
NCI:C34820
SNOMEDCT_US_2020_03_01:63951004
UMLS_CUI:C0026113
eccrine miliaria
heat rash
sweat rash
disease_ontology
DOID:1382
miliaria
A skin disease located_in the sweat glands.
ICD10CM:L74.9
ICD9CM:705.9
MESH:D013543
SNOMEDCT_US_2020_03_01:88232005
UMLS_CUI:C0038986
disease_ontology
DOID:1383
sweat gland disease
GARD:7342
ICD10CM:Q25.0
ICD9CM:747.0
MESH:D004374
NCI:C84492
OMIM:607411
SNOMEDCT_US_2020_03_01:156928009
UMLS_CUI:C0013274
Patent ductus Botalli
disease_ontology
ductus arteriosus, Patent
DOID:13832
OMIM mapping confirmed by DO. [SN].
patent ductus arteriosus
A hypolipoproteinemia that is characterized by an inablility to fully absorb dietary fats, cholesterol and fat-soluble vitamins, has_material_basis_in an autosomal recessive disorder of lipid metabolism that has_material_basis_in mutation in the microsomal triglyceride transfer protein that catalyzes the transport of lipids and is required in the secretion of BETA-LIPOPROTEINS.
GARD:5
ICD10CM:E78.6
MESH:D000012
NCI:C84525
OMIM:200100
SNOMEDCT_US_2020_03_01:83123000
UMLS_CUI:C0000744
familial hypobetalipoproteinemia
microsomal triglyceride transfer protein deficiency disease
disease_ontology
DOID:1386
OMIM mapping confirmed by DO. [SN].
abetalipoproteinemia
MESH:D000012
A primary angle-closure glaucoma characterized by acute closure of the anterior chamber angle by an intrinsic defect such that aqueous outflow is blocked and the intraocular pressure becomes suddenly inappropriately elevated threatening futher optic nerve damage and visual field loss. Acute closed-angle glaucoma has_symptom sudden pain, redness, headache, and blurry vision with haloes around lights. Acute closed-angle glaucoma can be caused by exacerbation of chronic primary angle-closure glaucoma, typically by a medication or state that dilates the eyes and thus narrows the anterior chamber angle, blocking any aqueous outflow.
ICD10CM:H40.21
ICD9CM:365.22
SNOMEDCT_US_2020_03_01:30041005
UMLS_CUI:C0154946
acute angle-closure glaucoma
disease_ontology
DOID:13862
acute closed-angle glaucoma
ICD10CM:G52.7
ICD9CM:352.6
SNOMEDCT_US_2020_03_01:78152008
UMLS_CUI:C0154733
Multiple cranial nerve palsies
Multiple cranial nerve palsy
disease_ontology
DOID:13866
multiple cranial nerve palsy
ICD10CM:F52.0
ICD9CM:302.71
MESH:D020018
NCI:C94337
SNOMEDCT_US_2020_03_01:78889008
UMLS_CUI:C0020594
Lack or loss of sexual desire
disease_ontology
DOID:13868
hypoactive sexual desire disorder
GARD:8394
ICD10CM:E78.6
ICD9CM:272.5
MESH:D007009
SNOMEDCT_US_2020_03_01:363140000
UMLS_CUI:C0020623
Hypolipoproteinaemia
disease_ontology
Lipoprotein deficiencies
DOID:1387
hypolipoproteinemia
GARD:7731
ICD10CM:E78.6
MESH:D013631
NCI:C85182
OMIM:205400
SNOMEDCT_US_2020_03_01:190783007
UMLS_CUI:C0039292
familial alpha-lipoprotein deficiency
familial high density lipoprotein deficiency
familial hypoalphalipoproteinemia
disease_ontology
DOID:1388
OMIM mapping confirmed by DO. [LS].
Tangier disease
MESH:D013631
ICD10CM:I49.5
MESH:D012804
NCI:C62244
OMIM:163800
OMIM:608567
ORDO:166282
SNOMEDCT_US_2020_03_01:266307005
UMLS_CUI:C0037052
sinus node infection
disease_ontology
DOID:13884
Xref MGI.
sick sinus syndrome
MESH:D012804
A peripheral system disease that is characterized by damage affecting peripheral nerves (peripheral neuropathy) in roughly the same areas on both sides of the body, featuring weakness, numbness, pins-and-needles, and burning pain.
ICD10CM:A69.22
MESH:D011115
NCI:C26951
SNOMEDCT_US_2020_03_01:193166009
UMLS_CUI:C0152025
disease_ontology
DOID:1389
polyneuropathy
MESH:D010212
NCI:C3712
SNOMEDCT_US_2020_03_01:63451008
UMLS_CUI:C0205874
Epidermoid papilloma
disease_ontology
DOID:139
squamous cell papilloma
A hypolipoproteinemia characterized by permanently low levels of apolipoprotein B and LDL cholesterol resulting from an impaired ability to absorb and transport fats.
MESH:D006995
SNOMEDCT_US_2020_03_01:190786004
UMLS_CUI:C0020597
Hypo-beta-lipoproteinemia
disease_ontology
DOID:1390
hypobetalipoproteinemia
ICD10CM:E78.6
MESH:D007863
NCI:C84813
OMIM:245900
SNOMEDCT_US_2020_03_01:238091006
UMLS_CUI:C0023195
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY
lecithin acyltransferase deficiency
disease_ontology
DOID:1391
OMIM mapping confirmed by DO. [SN].
Norum disease
ICD9CM:368.51
MESH:D003117
OMIM:303900
SNOMEDCT_US_2020_03_01:51445007
UMLS_CUI:C0155015
Protan defect
Protanopia
disease_ontology
DOID:13910
red color blindness
A color blindness that is characterized by a congenital cone color vision disorder, the inability to perceive color and to achieve satisfactory visual acuity at high light levels has_material_basis_in autosomal recessive inheritance.
ICD10CM:H53.51
ICD9CM:368.54
MESH:D003117
NCI:C84528
ORDO:49382
SNOMEDCT_US_2020_03_01:56852002
UMLS_CUI:C0152200
ACHM
Monochromatism
disease_ontology
DOID:13911
achromatopsia
ICD10CM:H52.21
ICD9CM:367.22
SNOMEDCT_US_2020_03_01:47099006
UMLS_CUI:C0152194
disease_ontology
DOID:13919
irregular astigmatism
ICD9CM:377.24
MESH:C562401
OMIM:177800
SNOMEDCT_US_2020_03_01:57138009
UMLS_CUI:C0155300
disease_ontology
DOID:1392
OMIM mapping confirmed by DO. [SN].
pseudopapilledema
An esophagitis characterized by inflammation involving eosinophils located_in esophagus.
EFO:0004232
ICD10CM:K20.0
ICD9CM:530.13
MESH:D057765
NCI:C27105
OMIM:610247
OMIM:613412
ORDO:73247
SNOMEDCT_US_2020_03_01:235599003
UMLS_CUI:C0341106
disease_ontology
DOID:13922
Xref MGI.
OMIM mapping confirmed by DO. [SN].
eosinophilic esophagitis
MESH:D007767
NCI:C34757
SNOMEDCT_US_2020_03_01:95769009
UMLS_CUI:C0022906
Blocked lacrimal canaliculus
Obstruction of lacrimal canaliculus
Obstruction of lacrimal ducts
disease_ontology
DOID:13929
lacrimal duct obstruction
An eye disease that affects the neural pathway from the optic nerve to the visual cortex, through which light is interpreted as an image.
ICD10CM:H47.9
NCI:C35342
SNOMEDCT_US_2020_03_01:54767005
UMLS_CUI:C0155287
disease_ontology
DOID:1393
visual pathway disease
ICD10CM:G51.0
MESH:D005158
NCI:C26769
SNOMEDCT_US_2020_03_01:90039006
UMLS_CUI:C0015469
Facial Palsy
disease_ontology
DOID:13934
facial paralysis
A female reproductive system disease that is characterized by the absence of menstruation.
ICD10CM:N91.2
ICD9CM:626.0
MESH:D000568
NCI:C61443
SNOMEDCT_US_2020_03_01:156034000
UMLS_CUI:C0002453
absence of menstruation
amenia
disease_ontology
DOID:13938
amenorrhea
MESH:D000568
A schistosomiasis that involves parasitic infection of the urinary tract caused by a digenetic trematode Schistosoma haematobium causing cystitis, ureteritis, fibrosis of the bladder and haematuria, which can progress to bladder cancer.
ICD9CM:120.0
MESH:D012553
NCI:C39294
SNOMEDCT_US_2020_03_01:60979006
UMLS_CUI:C0276926
Schistosoma Hematobium Infection
Schistosoma haematobium
Schistosoma hematobium infectious disease
Schistosomiasis due to schistosoma haematobium
Schistosomiasis of bladder
Vesical schistosomiasis
bladder Schistosomiasis
cystitis with bilharziasis
disease_ontology
Schistosoma haematobium infection
DOID:1394
urinary schistosomiasis
ICD9CM:386.11
MESH:D065635
OMIM:193007
OMIM:613106
SNOMEDCT_US_2020_03_01:111541001
UMLS_CUI:C0155502
benign paroxysmal positional vertigo
disease_ontology
DOID:13941
Xref MGI.
OMIM mapping confirmed by DO. [SN].
benign paroxysmal positional nystagmus
A leukodystrophy characterized by recurrent subcortical ischemic stroke and cognitive impairment.
GARD:1049
ICD10CM:I67.850
MESH:D046589
NCI:C84606
OMIM:600142
OMIM:PS125310
ORDO:136
SNOMEDCT_US_2020_03_01:390723008
UMLS_CUI:C0751587
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
hereditary multi-infarct dementia
disease_ontology
DOID:13945
CADASIL
ICD10CM:N32.0
ICD9CM:596.0
MESH:D001748
NCI:C79541
SNOMEDCT_US_2020_03_01:197859007
UMLS_CUI:C0005694
Obstruction of bladder neck or vesicourethral orifice
disease_ontology
DOID:13948
bladder neck obstruction
GARD:6787
MESH:D018856
NCI:C27189
SNOMEDCT_US_2020_03_01:197834003
UMLS_CUI:C0282488
ulcerative cystitis
disease_ontology
DOID:13949
interstitial cystitis
A parasitic helminthiasis infectious disease that involves infection of the intestine, urinary tract, skin, liver and spleen caused by multiple species of the trematode fluke of the genus Schistosoma. The symptoms include fever, chills, nausea, abdominal pain, diarrhea, malaise, myalgia, liver and spleen enlargement, rash and hematuria.
GARD:9687
ICD9CM:120.8
SNOMEDCT_US_2020_03_01:187116001
UMLS_CUI:C0029827
disease_ontology
DOID:1395
schistosomiasis
A senile cataract that is characterized by dense white opacification of the lens and milky fluid in the lens capsule such that the dense nucleus of the lens sinks in the surrounding fluid. It is the late stage of senile cataracts and is caused by a multifactorial etiology related to aging.
ICD9CM:366.18
SNOMEDCT_US_2020_03_01:247065006
UMLS_CUI:C0152258
hypermature cataract
disease_ontology
DOID:13964
Morgagni cataract
A disease by infectious agent that is carried out by a parasite which by definition is a pathogen that simultaneously injures and derives sustenance from its host.
DOID:11681
DOID:13509
DOID:1396
DOID:1494
DOID:2114
DOID:2293
DOID:2922
DOID:3564
DOID:4191
DOID:886
DOID:948
DOID:9639
DOID:9644
ICD10CM:H44.12
ICD9CM:360.13
NCI:C34587
SNOMEDCT_US_2020_03_01:57100005
UMLS_CUI:C0014238
Ectoparasitic disease
parasitemia
disease_ontology
DOID:1398
parasitic infectious disease
An osteochondrodysplasia that has_material_basis_in mutations in the RUNX2 gene which results_in undeveloped or absent located_in clavicle along with delayed closing of fontanels in the located_in skull.
GARD:6118
ICD10CM:Q74.0
MESH:D002973
NCI:C75020
OMIM:119600
OMIM:216330
ORDO:1452
SNOMEDCT_US_2020_03_01:65976001
UMLS_CUI:C0008928
Marie-Sainton Disease
cleidocranial dysostosis
disease_ontology
DOID:13994
Xref MGI.
OMIM mapping confirmed by DO. [SN].
cleidocranial dysplasia
NCI:C4007
SNOMEDCT_US_2020_03_01:449074003
UMLS_CUI:C0278805
small intestinal Lymphoma
disease_ontology
DOID:13996
small intestine lymphoma
An eye disease that affects the lacrimal apparatus (the lacrimal gland and its related structures) which moisten and drain the eye.
ICD10CM:H04
ICD9CM:375
MESH:D007766
NCI:C26809
SNOMEDCT_US_2020_03_01:267740009
UMLS_CUI:C0022904
disease_ontology
DOID:1400
lacrimal apparatus disease
ICD9CM:442.83
SNOMEDCT_US_2020_03_01:70405009
UMLS_CUI:C0155747
disease_ontology
DOID:14006
splenic artery aneurysm
ICD10CM:K70.3
ICD9CM:571.2
MESH:D008104
NCI:C34782
SNOMEDCT_US_2020_03_01:420054005
UMLS_CUI:C0023891
Alcoholic Cirrhosis
Alcoholic cirrhosis of liver
Laennec's cirrhosis
Laennec's cirrhosis, alcoholic
Portal cirrhosis
disease_ontology
DOID:14018
alcoholic liver cirrhosis
A nutritional deficiency disease that is characterized by a decrease in red blood cells due to lack of folate, has_material_basis in insufficient folic acid in diet, hemolytic anemia, alcoholism, and/or certain medicines.
ICD10CM:D52
ICD9CM:281.2
SNOMEDCT_US_2020_03_01:85649008
UMLS_CUI:C0151482
Folate deficiency anaemia
Folate deficiency anemia
Folate-deficiency anaemia
Folate-deficiency anemia
Folate-deficient megaloblastic anaemia
folic acid deficiency anaemia
disease_ontology
DOID:14026
folic acid deficiency anemia
A blood protein disease that is characterized by polyneuropathy, oranomegaly, endocrinopathy, monoclonal gammopathy, and skin changes, especially hyperpigmentation.
GARD:7411
MESH:D016878
NCI:C80303
SNOMEDCT_US_2020_03_01:79268002
UMLS_CUI:C0085404
disease_ontology
DOID:14039
POEMS syndrome
An autoimmune disease of endocrine system characterized by abnormal functioning of the immune system that causes auto-reactivity against endocrine organs.
ICD10CM:E31.0
MESH:D016884
NCI:C84576
SNOMEDCT_US_2020_03_01:41864002
UMLS_CUI:C0085409
Autoimmune polyglandular failure
Lloyd's syndrome
autoimmune polyendocrinopathy
disease_ontology
DOID:14040
autoimmune polyendocrine syndrome
A bipolar disorder that is characterized by at least one manic or mixed episode.
ICD9CM:296.50
SNOMEDCT_US_2020_03_01:49468007
UMLS_CUI:C0236773
disease_ontology
DOID:14042
bipolar I disorder
A primary systemic mycosis located_in subcutaneous tissues, located_in brain, located_in sinuses, located_in lungs, or located_in peritoneal cavity, has_material_basis_in Exophiala dermatitidis, has_material_basis_in Phialophora, has_material_basis_in Bipolaris hawaiiensis, has_material_basis_in Exserohilum, has_material_basis_in Cladophialophora bantiana, has_material_basis_in Phaeoannellomyces, has_material_basis_in Aureobasidium, has_material_basis_in Cladosporium cladosporoides, has_material_basis_in Alternaria or has_material_basis_in Rhinocladiella mackenziei and results_in_formation_of subcutaneous abscesses arising at the site of minor trauma, and occur in both immunosuppressed and immunocompetent individuals.
GARD:12803
MESH:D060446
Infection by dematiacious fungi
phaehyphomycosis
disease_ontology
DOID:14049
phaeohyphomycosis
An angle-closure glaucoma characterized by closure of the anterior chamber angle by an intrinsic defect such that aqueous outflow is blocked and the intraocular pressure becomes inappropriately elevated leading to optic nerve damage and visual field loss. Primary angle-closure glaucoma has_symptom progressive peripheral vision loss, decreased vision, and pain, redness, and headache in acute cases. Primary angle closure glaucoma can be caused by anatomically narrow angle, defects in the trabecular meshwork, and iris abnormalities. Primary angle-closure glaucoma has a strong genetic component.
ICD10CM:H40.2
ICD9CM:365.2
SNOMEDCT_US_2020_03_01:193544008
UMLS_CUI:C0017606
primary Angle Closure Glaucoma
disease_ontology
DOID:1405
primary angle-closure glaucoma
MESH:D007500
NCI:C50621
SNOMEDCT_US_2020_03_01:65074000
UMLS_CUI:C0022081
disease_ontology
DOID:1406
iritis
NCI:C35443
SNOMEDCT_US_2020_03_01:68544003
UMLS_CUI:C0403414
Post-Streptococcal Glomerulonephritis
disease_ontology
DOID:14064
acute poststreptococcal glomerulonephritis
NCI:C35587
SNOMEDCT_US_2020_03_01:197585004
UMLS_CUI:C0341689
acute Diffuse Glomerulonephritis
disease_ontology
DOID:14066
acute diffuse nephritis
A malaria that presents as a rare febrile complication of repeated malarial attacks characterized by intravascular haemolysis, haemoglobinuria and kidney failure, resulting from destruction of red blood cells caused by heavy parasitization with Plasmodium falciparum or Plasmodium vivax.
ICD9CM:084.8
MESH:D001742
NCI:C34426
SNOMEDCT_US_2020_03_01:56625005
UMLS_CUI:C0005681
Black water fever
Blackwater fever
Hemoglobinuric, malaria
Malarial Hemoglobinuria
disease_ontology
DOID:14068
blackwater fever
GARD:10941
MESH:D014606
NCI:C35109
SNOMEDCT_US_2020_03_01:193500005
UMLS_CUI:C0042165
disease_ontology
DOID:1407
anterior uveitis
ICD9CM:379.54
SNOMEDCT_US_2020_03_01:46888001
UMLS_CUI:C0155379
Nystagmus associated with disorder of the vestibular system
disease_ontology
DOID:14070
vestibular nystagmus
A bone inflammation disease that results_in inflammation located_in epicondyle.
DOID:14162
ICD10CM:M77.1
ICD9CM:726.32
MESH:D013716
NCI:C34589
NCI:C35067
SNOMEDCT_US_2020_03_01:156659008
SNOMEDCT_US_2020_03_01:268088003
UMLS_CUI:C0014488
UMLS_CUI:C0039516
Lateral epicondylitis
andrel epicondylitis
archer's elbow
golfer's elbow
hockey elbow
medial epicondylitis
disease_ontology
shooter's elbow
tennis elbow
DOID:14087
epicondylitis
ICD9CM:521.08
MESH:D017213
SNOMEDCT_US_2020_03_01:30512007
UMLS_CUI:C0162644
Cementum caries
Dental caries of root surface
Root caries
disease_ontology
DOID:14089
root caries
A spotted fever that has_material_basis_in Rickettsia conorii subsp conorii, which is transmitted_by dog tick (Rhipicephalus sanguineus). The infection has_symptom fever, has_symptom eschar (usually single), has_symptom regional adenopathy, has_symptom maculopapular rash on extremities.
DOID:0050039
DOID:0050040
DOID:0050044
DOID:0050045
ICD10CM:A77.1
ICD9CM:082.1
MESH:D001907
SNOMEDCT_US_2020_03_01:186779000
UMLS_CUI:C0006060
African tick typhus
Rickettsia conorii spotted fever
South African tick-bite fever
african tick typhus
kenya tick typhus
marseilles fever
disease_ontology
Boutonneuse disease
Conor and Bruch's disease
Kenya fever
Kenyan tick typhus
Mediterranean spotted fever
Mediterranean tick fever
DOID:14095
boutonneuse fever
A large intestine cancer that is located_in the anus.
DOID:12240
GARD:9300
ICD10CM:C21.0
ICD10CM:C21.1
ICD9CM:154.2
ICD9CM:154.3
NCI:C7379
SNOMEDCT_US_2020_03_01:93669004
SNOMEDCT_US_2020_03_01:93676009
UMLS_CUI:C0153445
UMLS_CUI:C0153446
anal cancer
malignant anal tumor
disease_ontology
DOID:14110
anus cancer
ICD10CM:K14.2
ICD9CM:529.2
SNOMEDCT_US_2020_03_01:7522008
UMLS_CUI:C0155963
Persistent tuberculum impar
disease_ontology
DOID:14111
median rhomboid glossitis
A commensal bacterial infectious disease that results_in infection, has_material_basis_in Streptococcus pyogenes or has_material_basis_in Staphylococcus aureus , which produce toxins that are absorbed systemically and produce the systemic manifestations. The infection has_symptom fever, has_symptom rash, has_symptom hypotension, has_symptom multiorgan failure, has_symptom desquamation, has_symptom vomiting, has_symptom diarrhea, has_symptom headache, and has_symptom nonfocal neurologic abnormalities.
ICD10CM:A48.3
ICD9CM:040.82
MESH:D012772
NCI:C35498
SNOMEDCT_US_2020_03_01:18504008
UMLS_CUI:C0600327
TSS
Toxic Shock syndrome
Toxic shock syndrome
toxic shock
disease_ontology
DOID:14115
toxic shock syndrome
A familial hyperlipemia characterized by a deficiency of the enzyme lipoprotein lipase and the subsequent build up of chylomicrons and increased plasma concentration of triglycerides.
GARD:12241
ICD10CM:E78.3
ICD9CM:272.3
MESH:D008072
NCI:C84771
OMIM:238600
ORDO:309015
SNOMEDCT_US_2020_03_01:34171006
UMLS_CUI:C0023817
Fredrickson type I hyperlipoproteinemia
Fredrickson type I lipaemia
familial LPL deficiency
familial chylomicronemia syndrome
familial hyperlipoproteinemia type I
hypercholesterinaemic xanthomatosis
hyperchylomicronemia
mixed hyperglyceridemia
disease_ontology
DOID:14118
OMIM mapping confirmed by DO. [SN].
familial lipoprotein lipase deficiency
A urinary system disease which consists of the presence of bacteria in urine.
ICD10CM:R82.71
MEDDRA:10004056
MESH:D001437
SNOMEDCT_US_2020_03_01:61373006
UMLS_CUI:C0004659
disease_ontology
DOID:1412
bacteriuria
A prolapse of the female genital organ that is characterized by the descent of the bladder causing a bulge in the anterolateral vaginal walls.
ICD10CM:N81.12
ICD9CM:618.02
SNOMEDCT_US_2020_03_01:441891001
UMLS_CUI:C2711750
disease_ontology
DOID:14130
lateral cystocele
A female reproductive system disease that is characterized by an excessively mobile uterus secondary to lacerations of the broad and cardinal ligaments, specific tenderness with movement of the cervix and previous untoward obstetrics events, such as premature maternal voluntary efforts, precipate delivery, and forceps delivery.
ICD9CM:620.6
SNOMEDCT_US_2020_03_01:69186005
UMLS_CUI:C0152079
Broad ligament laceration syndrome
disease_ontology
DOID:14133
Masters-Allen syndrome
An ovarian disease that is characterized by irregular or absent ovulation.
ICD9CM:256.3
SNOMEDCT_US_2020_03_01:267399006
UMLS_CUI:C0029697
disease_ontology
DOID:1414
ovarian dysfunction
An ureteral disease this is characterized by the formation of stoney concentrations in the ureter.
ICD10CM:N20.1
ICD9CM:592.1
MESH:D053039
NCI:C114696
SNOMEDCT_US_2020_03_01:31054009
UMLS_CUI:C0041952
Ureteric calculus
Ureteric stone
calculus of ureter
disease_ontology
DOID:14146
ureterolithiasis
GARD:6556
MESH:D015799
NCI:C84744
OMIM:258870
SNOMEDCT_US_2020_03_01:314467007
UMLS_CUI:C0018425
Gyrate atrophy of the choroid and/or retina
Ornithinemia with gyrate atrophy
gyrate atrophy of the retina
disease_ontology
DOID:1415
OMIM mapping by NeuroDevNet. [LS].
gyrate atrophy
ICD10CM:H31.9
ICD9CM:363.9
MESH:D015862
NCI:C34468
SNOMEDCT_US_2020_03_01:193480005
UMLS_CUI:C0008521
disease_ontology
DOID:1417
choroid disease
MESH:D018306
NCI:C3791
SNOMEDCT_US_2020_03_01:302832007
UMLS_CUI:C0206719
Neurolipocytoma
disease_ontology
DOID:14174
central neurocytoma
GARD:7855
ICD10CM:Q85.8
MESH:D006623
NCI:C3105
OMIM:193300
SNOMEDCT_US_2020_03_01:46659004
UMLS_CUI:C0019562
Hippel Lindau syndrome
Von Hippel-Lindau syndrome
von Hippel-Lindau syndrome
disease_ontology
DOID:14175
OMIM mapping confirmed by DO. [LS].
von Hippel-Lindau disease
ICD9CM:279.04
SNOMEDCT_US_2020_03_01:190983003
UMLS_CUI:C1457897
Congenital hypogammaglobulinaemia
Congenital hypogammaglobulinemia
disease_ontology
DOID:14177
congenital hypogammaglobulinemia
An agammaglobulinemia that is that has_material_basis_in a mutation in the Bruton's tyrosine kinase (BTK) gene on the X chromosome resulting in X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement.
MESH:C537409
NCI:C3822
OMIM:300755
ORDO:47
SNOMEDCT_US_2020_03_01:65880007
UMLS_CUI:C0221026
BTK deficiency
Bruton agammaglobulinemia tyrosine kinase deficiency
Bruton's Sex-Linked Agammaglobulinemia
Bruton's agammaglobulinaemia
Bruton's type agammaglobulinemia
Bruton-type agammaglobulinemia
disease_ontology
DOID:14179
OMIM mapping confirmed by DO. [SN].
X-linked agammaglobulinemia
ICD10CM:M75.3
ICD9CM:726.11
SNOMEDCT_US_2020_03_01:239957000
UMLS_CUI:C0158303
disease_ontology
DOID:14181
calcific tendinitis
ICD10CM:G62.1
ICD9CM:357.5
MESH:D020269
NCI:C26926
SNOMEDCT_US_2020_03_01:7916009
UMLS_CUI:C0085677
Alcohol-related polyneuropathy
Alcoholic polyneuropathy
disease_ontology
DOID:14183
alcoholic neuropathy
MESH:D020269
A connective tissue disease characterized by restriction of both active and passive range of motion located_in the scapulohumeral joint and has_symptom pain and has_symptom restricted range of motion.
ICD10CM:M75.0
ICD9CM:726.0
MESH:D002062
SNOMEDCT_US_2020_03_01:156664007
UMLS_CUI:C0311223
Adhesive capsulitis of shoulder
adhesions-capsulitis,shoulder
disease_ontology
DOID:14188
frozen shoulder
adult onset dermatomyositis
disease_ontology
DOID:14202
adult dermatomyositis
A syndrome characterized by disruption of mineralization of bones and teeth that has_material_basis_in mutation in ALPL on chromosome 1p36.12.
DOID:14763
GARD:6734
ICD10CM:E83.39
MESH:C562440
MESH:D007014
NCI:C26798
ORDO:436
SNOMEDCT_US_2020_03_01:30174008
SNOMEDCT_US_2020_03_01:70848009
UMLS_CUI:C0020630
UMLS_CUI:C0220743
childhood hypophosphatasia
deficiency of alkaline phosphatase
hypophospatasia, childhood
disease_ontology
DOID:14213
OMIM mapping confirmed by DO. [SN].
hypophosphatasia
A purine-pyrimidine metabolic disorder that is an autosomal recessive metabolic disorder in which there is absent or significantly decreased activity of dihydropyrimidine dehydrogenase, an enzyme involved in the metabolism of uracil and thymine.
GARD:19
MESH:D054067
NCI:C84672
OMIM:274270
SNOMEDCT_US_2020_03_01:238016000
UMLS_CUI:C1959620
UMLS_CUI:C3495551
Dihydropyrimidine dehydrogenase deficiency
Dihydrouracil Dehydrogenase deficiency
familial pyrimidinaemia
thymine-uracilurea
disease_ontology
DOID:14218
dihydropyrimidine dehydrogenase deficiency
A renal tubular transport disease characterized by excess levels of acid in the blood, due to a failure of the kidneys to appropriately acidify the urine.
GARD:7552
ICD10CM:N25.89
MESH:D000141
NCI:C28129
OMIM:179830
OMIM:267200
OMIM:602722
SNOMEDCT_US_2020_03_01:1776003
UMLS_CUI:C0001126
disease_ontology
DOID:14219
Xref MGI.
renal tubular acidosis
An abdominal obesity-metabolic syndrome characterized by insulin resistance and hyperinsulinemia, dyslipidemia, essential hypertension, abdominal obesity, glucose intolerance or noninsulin-dependent diabetes mellitus and an increased risk of cardiovascular events.
EFO:0000195
GARD:9226
ICD10CM:E88.81
ICD9CM:277.7
MESH:D024821
NCI:C84442
OMIM:605552
SNOMEDCT_US_2020_03_01:190394009
UMLS_CUI:C0524620
abdominal obesity-metabolic syndrome 1
dysmetabolic syndrome X
metabolic syndrome X
disease_ontology
DOID:14221
OMIM mapping confirmed by DO. [SN].
abdominal obesity-metabolic syndrome 1
A connective tissue disease characterized by bluish-brown discoloration of connective tissues that develops from the deposition of homogentisic acid and subsequent oxidation and polymerization reactions.
GARD:7231
ICD10CM:E70.29
MESH:D009794
NCI:C84938
SNOMEDCT_US_2020_03_01:21924005
UMLS_CUI:C0028817
disease_ontology
DOID:14223
ochronosis
A frontal sinusitis which lasts for less than 4 weeks.
ICD10CM:J01.1
ICD9CM:461.1
SNOMEDCT_US_2020_03_01:155500003
UMLS_CUI:C0155805
disease_ontology
DOID:14225
acute frontal sinusitis
A male infertility disease characterized by the absence of any measurable level of sperm in semen.
EFO:0000279
ICD10CM:N46.0
ICD9CM:606.0
MESH:D053713
NCI:C80076
ORDO:217034
SNOMEDCT_US_2020_03_01:425558002
UMLS_CUI:C0004509
spermatogenic failure
disease_ontology
DOID:14227
Xref MGI.
azoospermia
MESH:D053713
A male fertility issue defined as a low sperm concentration in the ejaculate.
ICD10CM:N46.1
ICD9CM:606.1
MESH:D009845
NCI:C34860
UMLS_CUI:C0028960
disease_ontology
DOID:14228
oligospermia
A scleral disease that is characterized by a painless severe necrotizing scleritis where the sclera is white, avascular, and thin. The choroid can become exposed leading to infarction and necrosis of related areas; the sclera can also thin such that the dark uvea protrudes through the front of the eye, forming a staphyloma which has_symptom loss of vision and appearance of a dark bulge. Scleromalacia perforans is usually caused by a rare complication of autoimmune disease like rheumatoid arthritis.
ICD10CM:H15.05
ICD9CM:379.04
SNOMEDCT_US_2020_03_01:26664005
UMLS_CUI:C0155354
disease_ontology
DOID:14230
scleromalacia perforans
A suppurative otitis media which is persistent and long-lasting.
ICD10CM:H66.3
ICD9CM:382.3
NCI:C128386
SNOMEDCT_US_2020_03_01:38394007
UMLS_CUI:C0271454
chronic suppurative otitis media
disease_ontology
DOID:14247
chronic purulent otitis media
A chromosomal disease that is characterized by flat-looking facial features and weak muscle tone (hypotonia) in infancy and is caused by trisomy of all or a critical portion of chromosome 21 and is associated with intellectual disability.
GARD:10247
ICD10CM:Q90
ICD9CM:758.0
MESH:D004314
NCI:C2993
OMIM:190685
ORDO:870
SNOMEDCT_US_2020_03_01:41040004
UMLS_CUI:C0013080
Complete trisomy 21 syndrome
Down's syndrome
Down's syndrome - trisomy 21
Downs syndrome
G Trisomy
trisomy 21 syndrome
disease_ontology
DOID:14250
OMIM mapping confirmed by DO. [SN].
Down syndrome
ICD10CM:H35.51
ICD9CM:362.73
SNOMEDCT_US_2020_03_01:79556007
UMLS_CUI:C0154863
Vitreoretinal dystrophies
disease_ontology
DOID:14251
vitreoretinal dystrophy
A rheumatoid arthritis that is characterized by high fevers, rash, sore throat and joint pain.
GARD:436
ICD10CM:M06.1
MESH:D016706
SNOMEDCT_US_2020_03_01:239920006
UMLS_CUI:C0085253
adult onset Still's disease
adult-onset Still disease
disease_ontology
DOID:14256
adult-onset Still's disease
A urinary system disease that is located_in the ureter.
MESH:D014515
UMLS_CUI:C0041954
disease_ontology
DOID:1426
ureteral disease
A syndrome that is characterized by moderate to severe mental retardation, macroorchidism, and distinct facial features, including long face, large ears, and prominent jaw, and has_material_basis_in X-linked inheritance and a loss of FMR1 function.
GARD:6464
ICD10CM:Q99.2
ICD9CM:759.83
MESH:D005600
NCI:C84717
OMIM:300624
ORDO:908
SNOMEDCT_US_2020_03_01:390007001
UMLS_CUI:C0016667
FRAGILE X MENTAL RETARDATION SYNDROME
MARKER X SYNDROME
MARTIN-BELL SYNDROME
disease_ontology
DOID:14261
OMIM mapping confirmed by DO. [SN].
fragile X syndrome
A neonatal period electroclinical syndrome that is characterized by tonic-clonic seizures in newborns occurring within the first seven days of life and ceasing within the first 15 weeks of life and has_material_basis_in autosomal dominant inheritance of voltage-gated potassium channels or a chromosomal inversion.
MESH:D020936
NCI:C84593
OMIM:121200
OMIM:121201
OMIM:269720
ORDO:1949
SNOMEDCT_US_2020_03_01:38281008
UMLS_CUI:C0270851
benign familial neonatal seizures
benign neonatal convulsions
disease_ontology
DOID:14264
Xref MGI.
benign neonatal seizures
A pulmonary valve disease that occurs when the pulmonary valve is not strong enough to prevent backflow into the right ventricle. If it is secondary to pulmonary hypertension it is referred to as a Graham Steell murmur.
DOID:11210
MESH:D011665
NCI:C51447
SNOMEDCT_US_2020_03_01:91434003
UMLS_CUI:C0034088
Pulmonic insufficiency
Pulmonic valve regurgitation
pulmonary incompetence
pulmonary incompetence, non-rheumatic
pulmonary insufficiency following trauma and surgery
pulmonary regurg.
pulmonary regurgitation
disease_ontology
DOID:14265
Replacing outdated UMLS CUI.
pulmonary valve insufficiency
MESH:D011665
EFO:0004268
ICD10CM:K83.09
MESH:D015209
SNOMEDCT_US_2020_03_01:4032000
UMLS_CUI:C0008313
fibrosing cholangitis
disease_ontology
DOID:14268
sclerosing cholangitis
ICD10CM:K83.09
NCI:C35372
SNOMEDCT_US_2020_03_01:26918003
UMLS_CUI:C0311273
Ascending Cholangitis
Ascending cholangitis
disease_ontology
DOID:14270
ascending cholangitis
ICD10CM:E16
ICD9CM:251
SNOMEDCT_US_2020_03_01:190427005
UMLS_CUI:C0154189
disease_ontology
DOID:1428
endocrine pancreas disease
ICD10CM:M89.4
MESH:D010004
NCI:C85023
OMIM:259100
SNOMEDCT_US_2020_03_01:88220006
UMLS_CUI:C0029411
Pachydermoperiostosis of nail
Pachydermoperiostosis syndrome
disease_ontology
DOID:14283
OMIM mapping confirmed by DO. [SN].
primary hypertrophic osteoarthropathy
MESH:D046788
UMLS_CUI:C0877149
disease_ontology
DOID:14284
patellofemoral pain syndrome
A tricuspid valve disease that is a congenital heart defect in which the septal leaflet of the tricuspid valve is displaced towards the apex of the right ventricle of the heart.
GARD:6313
ICD10CM:Q22.5
ICD9CM:746.2
MESH:D004437
NCI:C84681
OMIM:224700
SNOMEDCT_US_2020_03_01:1796006
UMLS_CUI:C0013481
Ebstein's anomaly
Ebstein's anomaly of common atrioventricular valve
Ebstein's anomaly of right atrioventricular valve
Ebstein's anomaly of tricuspid valve
disease_ontology
DOID:14289
OMIM mapping confirmed by DO. [SN].
Ebstein anomaly
A RASopathy that is characterized by autosomal dominant inheritance of brown skin spots called lentigines that are similar to freckles, heart defects, widely spaced eyes a sunken chest or protruding chest and short stature.
GARD:1100
MESH:D044542
NCI:C84820
OMIM:PS151100
ORDO:500
SNOMEDCT_US_2020_03_01:111306001
UMLS_CUI:C0175704
Capute-Rimoin-Konigsmark-Esterly-Richardson syndrome
Generalized lentiginosis
Gorlin syndrome II
LEOPARD syndrome
Lentiginosis profusa syndrome
Moynahan syndrome
Multiple lentigines syndrome
Progressive cardiomyopathic lentiginosis
disease_ontology
DOID:14291
OMIM mapping confirmed by DO. [SN].
Noonan syndrome with multiple lentigines
A pleural empyema which involves presence of pus in the pleural cavity and calcified visceral pleura. It results from a large number of mycobacteria spilling into the pleural space, usually from rupture of a cavity or an adjacent paranchymal focus via a bronchopleural fistula.
MESH:D004654
NCI:C34575
SNOMEDCT_US_2020_03_01:186184002
UMLS_CUI:C0014014
Tuberculous empyema
disease_ontology
DOID:14305
tuberculous empyema
An eye disease characterized by a lack or loss of vision.
ICD10CM:H54
ICD9CM:369
SNOMEDCT_US_2020_03_01:193698004
UMLS_CUI:C0155020
vision impairment
vision loss
visual impairment
disease_ontology
DOID:1432
blindness
An anxiety disorder that is characterized by long-lasting anxiety that is not focused on any one object or situation.
ICD10CM:F41.1
ICD9CM:300.02
NCI:C92622
SNOMEDCT_US_2020_03_01:192401002
UMLS_CUI:C0270549
disease_ontology
DOID:14320
generalized anxiety disorder
A connective tissue disease that is characterized by tall stature, elongated extremities, mitral valve prolapse, aortic dilatation, aortic dissection, and subluxation of the lens.
GARD:6975
ICD10CM:Q87.4
ICD9CM:759.82
MESH:D008382
NCI:C34807
OMIM:154700
SNOMEDCT_US_2020_03_01:19346006
UMLS_CUI:C0024796
Marfan's syndrome
disease_ontology
DOID:14323
OMIM mapping confirmed by DO. [SN].
Marfan syndrome
MESH:D008382
A malaria that involves infection with more than one species of Plasmodium at the same time.
ICD9CM:084.5
SNOMEDCT_US_2020_03_01:21070001
UMLS_CUI:C0153121
Malaria fever by more than one parasite
malaria by more than one parasite
disease_ontology
DOID:14325
mixed malaria
A synucleinopathy that has_material_basis_in degeneration of the central nervous system that often impairs motor skills, speech, and other functions.
EFO:0002508
GARD:10251
ICD10CM:G20
ICD9CM:332
KEGG:05012
MESH:D010300
NCI:C26845
OMIM:PS168600
ORDO:2828
SNOMEDCT_US_2020_03_01:49049000
UMLS_CUI:C0030567
Parkinson disease
paralysis agitans
disease_ontology
DOID:14330
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Parkinson's disease
ICD10CM:E06.0
MESH:D013969
NCI:C129724
SNOMEDCT_US_2020_03_01:3511005
UMLS_CUI:C0040150
Infectious thyroiditis
Suppurative thyroiditis
acute suppurative thyroiditis
disease_ontology
DOID:14350
suppurative thyroiditis
ICD10CM:H18.71
ICD9CM:371.71
SNOMEDCT_US_2020_03_01:14748007
UMLS_CUI:C0155135
disease_ontology
DOID:1436
corneal ectasia
An amino acid metabolic disorder that involves defective proteins called carnitine transporters, which bring carnitine into cells and prevent its escape from the body preventing the body cannot utilize fats for energy.
DOID:1668
ICD10CM:E71.41
ICD9CM:277.81
MESH:C536778
NCI:C98864
OMIM:212140
SNOMEDCT_US_2020_03_01:21764004
UMLS_CUI:C0342788
carnitine transporter deficiency
carnitine uptake defect
deficiency of plasma-membrane carnitine transporter
primary carnitine deficiency
renal carnitine transport defect
disease_ontology
DOID:14365
OMIM mapping confirmed by DO. [SN].
systemic primary carnitine deficiency disease
A scabies that involves infestation of human itch mite Sarcoptes scabiei type hominis in immunocompromised and elderly persons, which is characterized by vesicles and formation of thick crusts over the skin, accompanied by abundant mites but only slight itching.
NCI:C34855
SNOMEDCT_US_2020_03_01:128870005
UMLS_CUI:C0028425
Crusted scabies
disease_ontology
DOID:14374
norwegian scabies
ICD10CM:R82.81
MESH:D011776
NCI:C119028
SNOMEDCT_US_2020_03_01:4800001
UMLS_CUI:C0034359
Pus cells in urine
disease_ontology
DOID:1439
pyuria
An autosomal dominant cerebellar ataxia that is characterized by slow degeneration of the hindbrain and has_material_basis_in expansion of CAG triplet repeats (glutamine) in the ATXN3 gene.
MESH:D017827
NCI:C84830
OMIM:109150
SNOMEDCT_US_2020_03_01:91952008
UMLS_CUI:C0024408
Azorean disease
MJD
SCA3
spinocerebellar ataxia 3
spinocerebellar ataxia type 3
disease_ontology
DOID:1440
OMIM mapping confirmed by DO. [SN].
Machado-Joseph disease
MESH:D017827
MESH:D019559
NCI:C62578
SNOMEDCT_US_2020_03_01:87730004
UMLS_CUI:C0343084
Capillary leak syndrome
disease_ontology
DOID:14400
capillary leak syndrome
MESH:D019559
A cerebellar ataxia that has_material_basis_in autosomal dominant inheritance.
DOID:2478
MESH:D020754
NCI:C82341
OMIM:PS164400
ORDO:94
SNOMEDCT_US_2020_03_01:129609000
UMLS_CUI:C0087012
spinocerebellar ataxia
disease_ontology
DOID:1441
autosomal dominant cerebellar ataxia
An osteochondrosis that results_in death and fracture located_in hip joint.
DOID:14561
GARD:6874
ICD10CM:M91.2
MESH:D007873
NCI:C34766
OMIM:150600
SNOMEDCT_US_2020_03_01:15739006
SNOMEDCT_US_2020_03_01:270545000
UMLS_CUI:C0022441
UMLS_CUI:C0023234
Calve - Perthes' disease
Coxa plana
Juvenile osteochond-hip/pelvis
Juvenile osteochondrosis of hip and/or pelvis
Perthe's disease
Perthes disease
Pseudocoxalgia
juvenile osteochondrosis of hip and pelvis
osteochondrosis of Legg-Calve-Perthes
pseudocoxalgia
disease_ontology
Legg-Calve-Perthes symptom
DOID:14415
OMIM mapping confirmed by DO. [SN].
Legg-Calve-Perthes disease
A parasitic helminthiasis infectious disease that involves parasitic infection by the larvae of the nematode Dracunculus medinensis, which are transmitted to humans by drinking water containing copepods infected with the larvae. The female, which contains larvae, burrows into the deeper connective tissues or adjacent to long bones or joints of the extremities. The worm emerges as a whitish filament in the center of a painful ulcer, accompanied by inflammation and frequently by secondary bacterial infection.
GARD:6286
ICD10CM:B72
ICD9CM:125.7
MESH:D004320
NCI:C84677
SNOMEDCT_US_2020_03_01:48874008
UMLS_CUI:C0013100
Dracontiasis
Infection by Dracunculus medinensis
disease_ontology
DOID:14418
dracunculiasis
GARD:6519
ICD10CM:G52.1
ICD9CM:352.1
MESH:D020435
SNOMEDCT_US_2020_03_01:43763009
UMLS_CUI:C0154731
Glossopharyngeal neuralgia
disease_ontology
DOID:14423
glossopharyngeal neuralgia
A brain disease that is characterized by loss of structure or function of neurons, including death of neurons and loss of brain tissue.
GARD:6019
ICD9CM:331.9
SNOMEDCT_US_2020_03_01:52522001
UMLS_CUI:C0154671
Brain degeneration
disease_ontology
DOID:1443
cerebral degeneration
A physical urticaria induced by sweating.
ICD10CM:L50.5
ICD9CM:708.5
SNOMEDCT_US_2020_03_01:73098005
UMLS_CUI:C0152230
disease_ontology
DOID:14443
cholinergic urticaria
A deep keratitis that is characterized by inflammation of the anterior sclera and subsequent inflammation of the adjacent cornea with opacification of the corneal stroma and has_symptom pain, red eyes, photophobia, tearing, and blurry vision. Sclerosing keratitis is caused by severe anterior scleritis that causes inflammation and injury to the adjacent corneal layer. Anterior scleritis can be caused by autoimmune diseases, connective tissue diseases, and infection.
ICD10CM:H16.33
ICD9CM:370.54
SNOMEDCT_US_2020_03_01:27886001
UMLS_CUI:C0155090
Sclerokeratitis
disease_ontology
DOID:14444
sclerosing keratitis
A disorder of sexual development that is characterized by a progressive loss of germ cells on the developing gonads of an embryo.
GARD:2538
ICD9CM:758.6
MESH:D006059
NCI:C61420
SNOMEDCT_US_2020_03_01:268356004
UMLS_CUI:C0018051
Gonadal dysgenesis syndrome
disease_ontology
DOID:14447
gonadal dysgenesis
A gonadal dysgenesis that is characterized by progressive loss of primordial cells on the developing glands of an embryo, leading to extremely hypoplastic and dysfuctioning gonads resulting in one differentiated gonad and either a streak gonad or streak testis.
MESH:D006060
NCI:C120199
SNOMEDCT_US_2020_03_01:205682006
UMLS_CUI:C0018055
disease_ontology
DOID:14449
mixed gonadal dysgenesis
GARD:195
ICD10CM:G72.3
MESH:D020513
NCI:C123429
OMIM:170500
ORDO:682
SNOMEDCT_US_2020_03_01:304737009
UMLS_CUI:C0238357
familial hyperkalemic periodic paralysis
disease_ontology
DOID:14451
OMIM mapping confirmed by DO. [SN].
hyperkalemic periodic paralysis
GARD:5557
GARD:6729
ICD10CM:G72.3
MESH:D020514
NCI:C84775
OMIM:170400
OMIM:613345
ORDO:681
SNOMEDCT_US_2020_03_01:240093008
UMLS_CUI:C0238358
Hypokalemic familial periodic paralysis
Hypokalemic periodic paralysis
Periodic paralysis I
Westphal disease
familial hypokalemic periodic paralysis
familial periodic paralysis
periodic hypokalemic paralysis
disease_ontology
DOID:14452
OMIM mapping confirmed by DO. [SN].
hypokalemic periodic paralysis
An extrinsic allergic alveolitis which is induced by the inhalation of spores (Aspergillus sp and thermophilic actinomycetes) in dust from moldy hay or straw. It is characterized by sudden onset, fever, cough, expectoration, and breathlessness.
GARD:6427
ICD10CM:J67.0
ICD9CM:495.0
MESH:D005203
NCI:C34605
SNOMEDCT_US_2020_03_01:155581001
UMLS_CUI:C0015634
Farmers lung
farmer lung
disease_ontology
DOID:14453
farmer's lung
A nervous system disease that is characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness and is associated with administration of antipsychotic and other central dopaminergic blockers.
GARD:7195
ICD10CM:G21.0
ICD9CM:333.92
MESH:D009459
NCI:C94829
ORDO:94093
SNOMEDCT_US_2020_03_01:15244003
UMLS_CUI:C0027849
disease_ontology
DOID:14464
neuroleptic malignant syndrome
A viral infectious disease that results in infection located in lung, has_material_basis_in Sin Nombre virus, transmitted by deer mouse (Myodes glareolus), has_material_basis_in Black Creek Canal virus, transmitted by cotton rat (Sigmodon hispidus), has_material_basis_in Bayou virus, transmitted by marsh rice rat (Oryzomys palustris), has_material_basis_in Laguna Negra virus, transmitted by small vesper mouse (Calomys laucha), or has_material_basis_in Andes virus, transmitted by rice rat (Oligoryzomys longicaudatus). The infection has _ymptom fever, has_symptom muscle pain, has_symptom headache, has_symptom cough, has_symptom vomiting, has_symptom chills which rapidly progress to bilateral interstitial pulmonary infiltrates occurrence, pulmonary edema and hypoxia often resulting in death from shock or cardiac complications.
GARD:69
MESH:D018804
NCI:C84747
SNOMEDCT_US_2020_03_01:120639003
UMLS_CUI:C0243025
disease_ontology
DOID:14472
hantavirus pulmonary syndrome
A vesiculobullous skin disease that is characterized by erythematous papules, vesicles, and plaques around the trunk and extremities that develop during pregnancy, particularly during the second and third trimesters, has_symptom pruritis, and has_material_basis_in autoantibodies to the basement membrane, which triggers a complement cascade and attracts eosinophils to the subepidermis.
ICD10CM:O26.4
MESH:D006559
NCI:C85003
SNOMEDCT_US_2020_03_01:86081009
UMLS_CUI:C0019343
Gestational herpes
herpes gestationis
disease_ontology
DOID:14482
pemphigoid gestationis
A primary systemic mycosis that results_in a systemic fungal infection, has_material_basis_in Sporothrix schenckii in animals and humans and results_in_formation_of red papule at the site of inoculation.
GARD:7692
ICD10CM:B42
ICD9CM:117.1
MESH:D013174
SNOMEDCT_US_2020_03_01:266218008
UMLS_CUI:C0038034
disease_ontology
DOID:14484
sporotrichosis
ICD10CM:K91.1
MESH:D004377
NCI:C2994
SNOMEDCT_US_2020_03_01:155785007
UMLS_CUI:C0013288
Dumping (jejunal) syndrome
Jejunal syndrome
disease_ontology
DOID:14495
dumping syndrome
GARD:7899
ICD10CM:E75.5
MESH:D015223
NCI:C61271
SNOMEDCT_US_2020_03_01:82500001
UMLS_CUI:C0043208
Acid esterase deficiency
Acid lipase deficiency
Wolman xanthomatosis
Wolman's disease
Wolman's or triglyceride storage type III disease
Xanthomatosis, familial
disease_ontology
DOID:14497
Wolman disease
GARD:3268
MESH:D008065
NCI:C84829
OMIM:247100
SNOMEDCT_US_2020_03_01:38692000
UMLS_CUI:C0023795
Lipid proteinosis
Lipoid proteinosis
URBACH-WIETHE DISEASE
disease_ontology
DOID:14498
OMIM mapping confirmed by DO. [SN].
lipoid proteinosis
A sphingolipidosis that is characterized by the buildup of globotriaosylceramide in the body's cells and has_material_basis_in X-linked inherited mutations in the GLA gene, encoding alpha-galactosidase A, on chromosome Xq22.
GARD:6400
ICD10CM:E75.21
MESH:D000795
NCI:C84701
OMIM:301500
SNOMEDCT_US_2020_03_01:16652001
UMLS_CUI:C0002986
Alpha-galactosidase A deficiency
Angiokeratoma Corporis Diffusum
Fabry's disease
alpha galactosidase deficiency
deficiency of melibiase
disease_ontology
DOID:14499
OMIM mapping confirmed by DO. [SN].
Fabry disease
GARD:6473
ICD10CM:E77.1
MESH:D005645
NCI:C61274
OMIM:230000
SNOMEDCT_US_2020_03_01:64716005
UMLS_CUI:C0016788
A-fucosidase deficiency
alpha fucosidase deficiency
disease_ontology
DOID:14500
OMIM mapping confirmed by DO. [SN].
fucosidosis
MESH:D015217
SNOMEDCT_US_2020_03_01:57218003
UMLS_CUI:C0008384
disease_ontology
DOID:14502
cholesterol ester storage disease
MESH:D015217
GARD:10739
ICD10CM:E75.4
MESH:D009472
NCI:C61257
OMIM:PS256730
ORDO:216
ORDO:79262
SNOMEDCT_US_2020_03_01:42012007
UMLS_CUI:C0027877
hereditary ceroid lipofuscinosis
disease_ontology
DOID:14503
Xref MGI.
OMIM mapping submitted by NeuroDevNet. [LS].
neuronal ceroid lipofuscinosis
A sphingoliidosis characterized by the accumulation of the lipid sphingomyelin in lysosomes in cells.
DOID:0050442
DOID:0050443
DOID:14770
GARD:13334
ICD10CM:E75.24
MESH:D009542
NCI:C61269
SNOMEDCT_US_2020_03_01:58459009
UMLS_CUI:C0028064
Sphingomyelinase Deficiency Disease
lipoid histiocytosis
sphingomyelin lipidosis
disease_ontology
DOID:14504
OMIM mapping confirmed by DO. [SN].
Niemann-Pick disease
A chromosomal deletion syndrome that is a nephroblastoma that results_in a rare genetic syndrome in which affected children are predisposed to develop Wilms tumor, Aniridia (absence of the colored part of the eye, the iris), genitourinary anomalies, and mental retardation. The condition results from a deletion on chromosome 11 resulting in the loss of several genes. As such, it is one of the best studied examples of a condition caused by loss of neighbouring (contiguous) genes.
GARD:5528
MESH:D017624
NCI:C3718
OMIM:194072
SNOMEDCT_US_2020_03_01:715215007
UMLS_CUI:C0206115
11p partial monosomy syndrome
Wilms tumor-Aniridia-Genitourinary Anomalies-Mental Retardation syndrome
chromosome 11p13 deletion syndrome
disease_ontology
DOID:14515
OMIM mapping confirmed by DO. [LS].
WAGR syndrome
A syndrome characterized by acute brain damage and liver function problems. It has been associated with aspirin consumption by children with viral illness, although it also occurs in the absence of aspirin use.
GARD:7570
ICD10CM:G93.7
ICD9CM:331.81
MESH:D012202
NCI:C34983
SNOMEDCT_US_2020_03_01:74351001
UMLS_CUI:C0035400
Reye's syndrome
disease_ontology
DOID:14525
Reye syndrome
MESH:D012391
UMLS_CUI:C0035851
disease_ontology
DOID:14550
root resorption
A chronic pulmonary heart disease characterized by an increase of blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, among others, has symptoms shortness of breath, dizziness, fainting, leg swelling.
ICD10CM:I27.0
ICD9CM:416.0
NCI:C97119
OMIM:178600
OMIM:265400
OMIM:615342
OMIM:615343
OMIM:615344
ORDO:422
SNOMEDCT_US_2020_03_01:26174007
UMLS_CUI:C0152171
disease_ontology
DOID:14557
Xref MGI.
OMIM mapping confirmed by DO. [SN].
primary pulmonary hypertension
ICD10CM:K14.0
ICD9CM:529.0
MESH:D005928
NCI:C112199
SNOMEDCT_US_2020_03_01:155666003
UMLS_CUI:C0017675
disease_ontology
DOID:1456
glossitis
A disease that is characterized by abnormally rapid cell division.
neoplasm
DOID:0000818
cell process disease
neoplasm
disease_ontology
DOID:14566
disease of cellular proliferation
A thyroid gland disease which involves an underproduction of thyroid hormone.
DOID:11630
EFO:0004705
ICD10CM:E03.9
ICD9CM:244.9
MESH:D007037
NCI:C26800
SNOMEDCT_US_2020_03_01:267465007
UMLS_CUI:C0020676
Thyroid deficiency
Thyroid insufficiency
disease_ontology
DOID:1459
hypothyroidism
GARD:7318
ICD10CM:H47.1
ICD9CM:377.0
MESH:D010211
NCI:C3307
SNOMEDCT_US_2020_03_01:423341008
UMLS_CUI:C0030353
disease_ontology
DOID:146
papilledema
ICD10CM:N41.9
ICD9CM:601.9
MESH:D011472
NCI:C26866
SNOMEDCT_US_2020_03_01:155907007
UMLS_CUI:C0033581
disease_ontology
DOID:14654
prostatitis
A dysostosis that results_in shortening of interphalangeal joints located_in hand or located_in foot along with mental deficiency.
GARD:2015
GARD:5724
MESH:C538179
OMIM:101800
OMIM:614613
ORDO:950
SNOMEDCT_US_2020_03_01:66758006
UMLS_CUI:C0220659
disease_ontology
DOID:14669
OMIM mapping confirmed by DO. [SN].
acrodysostosis
An intestinal disease characterized by the presence of numerous atresic segments in the small and large intestines that has_material_basis_in homozygous or compound heterozygous mutation in TTC7A on chromosome 2p21.
GARD:3013
MESH:C562441
OMIM:243150
ORDO:2300
SNOMEDCT_US_2020_03_01:95472001
UMLS_CUI:C0220744
GIDID
MEDDRA:10028210
Multiple gastrointestinal atresias
familial intestinal polyatresia syndrome
gastrointestinal defects and immunodeficiency syndrome
disease_ontology
DOID:14671
OMIM mapping confirmed by DO. [SN].
multiple intestinal atresia
A syndrome that is characterized by the presence of at least three of the following: vertebral defects, anal atresia, cardiac defects, tracheo-esophageal fistula, renal anomalies, and limb abnormalities.
GARD:5443
ICD10CM:Q87.2
MESH:C536534
OMIM:192350
OMIM:276950
SNOMEDCT_US_2020_03_01:205830006
UMLS_CUI:C0220708
disease_ontology
VATER syndrome
DOID:14679
OMIM mapping confirmed by DO. [LS].
VACTERL association
An otitis interna which involves inflammation of the labyrinths.
ICD10CM:H83.0
ICD9CM:386.3
MESH:D007762
SNOMEDCT_US_2020_03_01:155239008
UMLS_CUI:C0022893
disease_ontology
DOID:1468
labyrinthitis
A physical disorder that is characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations.
GARD:4870
ICD10CM:Q87.19
MESH:D056730
NCI:C85068
OMIM:180860
SNOMEDCT_US_2020_03_01:15069006
UMLS_CUI:C0175693
Silver Russell Dwarfism
disease_ontology
DOID:14681
OMIM mapping confirmed by DO. [LS].
Silver-Russell syndrome
An eye disease characterized by abnormalities of the front part of the eye, the anterior segment.
GARD:5701
ICD10CM:Q13.81
NCI:C131001
ORDO:782
SNOMEDCT_US_2020_03_01:47507006
UMLS_CUI:C0265341
Anomaly, Rieger's
Axenfeld syndrome
RGS - Rieger syndrome
Rieger's anomaly
disease_ontology
Hagedoom syndrome
DOID:14686
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Axenfeld-Rieger syndrome
An osteochondrodysplasia that has_material_basis_in abnormal cartilage development due to mutations in the SLC26A2 gene which results_in short limb dwarfism.
GARD:6275
ICD10CM:Q77.5
MESH:C536170
NCI:C156311
OMIM:222600
SNOMEDCT_US_2020_03_01:58561002
UMLS_CUI:C0220726
disease_ontology
DOID:14687
OMIM mapping confirmed by DO. [SN].
diastrophic dysplasia
DOID:4366
GARD:5683
ICD10CM:E78.72
MESH:D019082
NCI:C85071
OMIM:270400
SNOMEDCT_US_2020_03_01:43929004
UMLS_CUI:C0175694
Rutledge lethal multiple congenital anomaly syndrome
Smith-Opitz-Inborn syndrome
disease_ontology
DOID:14692
OMIM mapping confirmed by DO. [LS].
Smith-Lemli-Opitz syndrome
GARD:2056
MESH:D004476
OMIM:129500
SNOMEDCT_US_2020_03_01:54209007
UMLS_CUI:C0162361
Clouston's hidrotic ectodermal dysplasia
Clouston's syndrome
Hidrotic ectodermal dysplasia syndrome
ectodermal dysplasia 2, Clouston type
hidrotic ectodermal dysplasia
disease_ontology
DOID:14693
OMIM mapping confirmed by DO. [SN].
Clouston syndrome
A syndrome that involves abnormal development of the pancreas, nose and scalp, with mental retardation, hearing loss and growth failure. It is inherited in an autosomal recessive manner.
GARD:80
MESH:C535880
OMIM:243800
ORDO:2315
SNOMEDCT_US_2020_03_01:75979009
UMLS_CUI:C0175692
JBS
disease_ontology
DOID:14694
OMIM mapping confirmed by DO. [SN].
Johanson-Blizzard syndrome
A galactosemia that involves an accumulation of galactose and galactitol secondary to the decreased conversion of galactose to galactose-1-phosphate by galactokinase.
GARD:2422
ICD10CM:E74.29
MESH:D005693
NCI:C114767
OMIM:230200
SNOMEDCT_US_2020_03_01:124302001
UMLS_CUI:C0268155
Galactosemia II
disease_ontology
DOID:14695
OMIM mapping confirmed by DO. [SN].
galactokinase deficiency
A chromosomal deletion syndrome that is characterized by absence of the radius bone and platelet deficiency and bilateral absence of the radii with the presence of both thumbs and generally transient thrombocytopenia (less than 50 platelets/nL) and that has_material_basis_in compound heterozygosity for a rare null mutation involving the RBM8A gene on chromosome 1q12 on 1 allele and 1 of 2 low-frequency noncoding single-nucleotide polymorphisms in RBM8A on the other.
ICD10CM:Q87.2
MESH:C536940
NCI:C99038
OMIM:274000
ORDO:3320
SNOMEDCT_US_2020_03_01:85589009
UMLS_CUI:C0175703
Radial aplasia-thrombocytopenia syndrome
Thrombocytopenia with absent radii (TAR) syndrome
chromosome 1q21.1 deletion syndrome
disease_ontology
DOID:14699
OMIM mapping confirmed by DO. [LS].
thrombocytopenia-absent radius syndrome
An endogenous depression that is characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in normally enjoyable activities.
DOID:10614
DOID:2240
DOID:2241
DOID:7580
ICD10CM:F32
ICD10CM:F33.9
ICD9CM:296.2
ICD9CM:296.3
NCI:C34796
OMIM:608520
OMIM:608691
SNOMEDCT_US_2020_03_01:268621008
SNOMEDCT_US_2020_03_01:36923009
UMLS_CUI:C0024517
UMLS_CUI:C0154409
recurrent major depression
single major depressive episode
disease_ontology
DOID:1470
Xref MGI.
major depressive disorder
An organic acidemia that involes a nonfunctional propionyl CoA carboxylase affecting conversion of aminio acids and fats into sugar for energy.
DOID:14706
GARD:467
ICD10CM:E71.121
MESH:D056693
NCI:C85030
OMIM:606054
SNOMEDCT_US_2020_03_01:69080001
UMLS_CUI:C0268579
UMLS_CUI:C2717876
GLYCINEMIA, KETOTIC
KETOTIC HYPERGLYCINEMIA
ketotic II glycinemia
ketotic glycinemia
propionic aciduria
propionyl-CoA carboxylase deficiency
disease_ontology
DOID:14701
OMIM mapping confirmed by DO. [SN].
propionic acidemia
A syndrome characterized by branchial arch anomalies (branchial fistulas, clefts, or cysts), hearing impairment, structural defects of the outer, middle, and inner ear, and renal abnormalities.
GARD:10147
MEDDRA:10071135
MESH:D019280
NCI:C98983
SNOMEDCT_US_2020_03_01:290006
UMLS_CUI:C0265234
Branchio-Oto-renal syndrome
Branchio-otorenal dysplasia
Melnick-Fraser syndrome
branchiootorenal dysplasia
disease_ontology
DOID:14702
OMIM mapping confirmed by DO. [SN].
branchiootorenal syndrome
A syndrome characterized by retardation, hyperactivity, hypotonia, broad thumbs, big first toes and a characteristic facial appearance including macrocephaly and has an X-linked recessive inheritance pattern.
GARD:2317
MESH:C537923
OMIM:300321
OMIM:300406
OMIM:300422
OMIM:300581
OMIM:305450
ORDO:323
ORDO:93932
SNOMEDCT_US_2020_03_01:49984004
UMLS_CUI:C0220769
Keller syndrome
Opitz-Kaveggia syndrome
disease_ontology
DOID:14711
Xref MGI.
OMIM mapping confirmed by DO. [SN].
FG syndrome
A myopathy characterized by abnormally located nuclei in skeletal muscle cells. The nuclei are located in the center of the cell, instead of their normal location at the periphery.
GARD:101
MESH:D020914
NCI:C84648
ORDO:595
ORDO:596
ORDO:69186
ORDO:69189
SNOMEDCT_US_2020_03_01:193223007
UMLS_CUI:C0175709
myotubular myopathy
disease_ontology
DOID:14717
Xref MGI.
centronuclear myopathy
An amino acid metabolic disorder characterized by inability to process isoleucine and ketones, has_symptom recurrent ketoacidotic attacks in infancy marked by vomitting, lethargy, dehydration, and seizures, and has_material_basis_in mutation in the ACAT1 gene of chromosome 11q22.3 responsible for producing the ACAT1 enzyme in mitochondria, which processes isoleucine and ketones.
GARD:872
MESH:C535818
OMIM:203750
ORDO:134
SNOMEDCT_US_2020_03_01:238067002
UMLS_CUI:C1533628
2-methyl-3-hydroxybutyricacidemia
3-ketothiolase deficiency
3-oxothiolase deficiency
Mitochondrial acetoacetyl-CoA Thiolase deficiency
alpha-methylacetoaceticaciduria
peroxisomal thiolase deficiency
disease_ontology
DOID:14723
OMIM mapping confirmed by DO. [SN].
beta-ketothiolase deficiency
A microcephaly that has_material_basis_in heterozygous mutation in an autosomal gene.
MESH:C537323
OMIM:156580
UMLS_CUI:C0220693
disease_ontology
DOID:14725
OMIM mapping confirmed by DO. [SN].
autosomal dominant microcephaly
A syndrome that is characterized by prenatal and postnatal overgrowth, accelerated osseous maturation, characteristic craniofacial appearance, and developmental delay and has_material_basis_in heterozygous mutation in the EZH2 gene on chromosome 7q36.
GARD:5545
GARD:7878
MESH:C562443
OMIM:277590
UMLS_CUI:C0220765
WEAVER-LIKE SYNDROME
Weaver-Williams syndrome
disease_ontology
DOID:14731
OMIM mapping confirmed by DO. [LS].
Weaver syndrome
A syndrome that has_material_basis_in mutation in the EFNB1 gene on chromosome Xq13 and is characterized in hemizygous males by hypertelorism and with greater severity in females by frontonasal dysplasia, craniofacial asymmetry, craniosynostosis, bifid nasal tip, grooved nails, wiry hair, and abnormalities of the thoracic skeleton.
GARD:1578
MESH:C536456
OMIM:304110
ORDO:1520
SNOMEDCT_US_2020_03_01:715421009
UMLS_CUI:C0220767
CFND
CFNS
craniofrontonasal dysostosis
craniofrontonasal dysplasia
disease_ontology
DOID:14737
OMIM mapping confirmed by DO. [SN].
craniofrontonasal syndrome
A periodontitis that is characterized by rapid attachment loss and bone destruction in the presence of little local factors such as dental plaque and dental calculus resulting in inflammation and a loss of periodontium.
ICD10CM:K05.2
MESH:D010520
OMIM:170650
OMIM:608526
SNOMEDCT_US_2020_03_01:449908004
UMLS_CUI:C0031106
juvenile periodontitis
disease_ontology
DOID:1474
OMIM mapping confirmed by DO. [SN].
aggressive periodontitis
MESH:D010520
A syndrome that is characterized by short stature, sparse hair, a bulbous nasal tip and cone-shaped epiphyses (the growing ends of bones), as well as severe generalized shortening of all finger and toe bones (brachydactyly).
DOID:0050552
MESH:C536820
NCI:C75109
OMIM:190350
SNOMEDCT_US_2020_03_01:239016009
UMLS_CUI:C0432233
trichorhinophalangeal syndrome type 1
type I trichorhinophalangeal syndrome
disease_ontology
Trichorhinophalangeal dysplasia type I
DOID:14743
OMIM mapping confirmed by DO. [LS].
trichorhinophalangeal syndrome type I
A syndrome characterized by intellectual disability, focal dystonia of the hands and dysarthria.
GARD:4235
MESH:C562446
OMIM:309510
ORDO:94083
UMLS_CUI:C0220775
X-linked Russell-Silver syndrome
disease_ontology
DOID:14744
OMIM mapping confirmed by DO. [SN].
OMIM mapping submitted by NeuroDevNet. [LS].
Partington syndrome
A syndrome that occurs rarely and is characterized by excessive physical growth during the first 2 to 3 years of life.
GARD:10091
ICD10CM:Q87.3
MESH:D058495
NCI:C75019
OMIM:PS117550
ORDO:821
SNOMEDCT_US_2020_03_01:75968004
UMLS_CUI:C0175695
cerebral gigantism
disease_ontology
DOID:14748
Xref MGI.
Sotos syndrome
An organic acidemia that involves an accumulation of methylmalonic acid in the blood.
DOID:14782
DOID:14802
GARD:7033
methylmalonic aciduria
disease_ontology
DOID:14749
OMIM mapping confirmed by DO. [SN].
methylmalonic acidemia
A benign vascular tumor that is composed of dilated lymphatic channels.
GARD:9789
ICD10CM:D18.1
ICD9CM:228.1
MESH:D008202
NCI:C8965
SNOMEDCT_US_2020_03_01:154625006
UMLS_CUI:C0024221
Congenital lymphangioma
benign lymphangioma
disease_ontology
DOID:1475
lymphangioma
An organic acidemia that disrupts or prevents normal metabolism of the branched-chain amino acid leucine.
GARD:465
ICD10CM:E71.110
MESH:C538167
NCI:C98964
OMIM:243500
SNOMEDCT_US_2020_03_01:87827003
UMLS_CUI:C0268575
Isovaleryl-CoA dehydrogenase deficiency
isovaleric acid CoA dehydrogenase deficiency
isovaleric aciduria
disease_ontology
DOID:14753
OMIM mapping confirmed by DO. [SN].
isovaleric acidemia
An amino acid metabolic disorder that involves the accumulation of argininosuccinic acid (ASA) in the blood and urine.
GARD:5843
MESH:D056807
NCI:C84569
OMIM:207900
SNOMEDCT_US_2020_03_01:41013004
UMLS_CUI:C0268547
Argininosuccinate lyase deficiency
argininosuccinic acidemia
arginosuccinase deficiency
deficiency of argininosuccinate lyase
disease_ontology
DOID:14755
OMIM mapping confirmed by DO. [SN].
argininosuccinic aciduria
A synostosis characterized by the fusion of carpal and tarsal bones, which causes stiffness and immobility of the hands and the feet.
OMIM:186400
SNOMEDCT_US_2020_03_01:62628008
UMLS_CUI:C0175700
Multiple synostosis syndrome
SYNOSTOSES, TARSAL, CARPAL AND DIGITAL
disease_ontology
DOID:14762
OMIM mapping confirmed by DO. [LS].
calcaneonavicular coalition
Asyndrome that is characterized by autosomal dominant inheritance of large-joint dislocations and characteristic craniofacial abnormalities.
GARD:6860
OMIM:150250
dominant larsen syndrome
disease_ontology
DOID:14764
OMIM mapping confirmed by DO. [SN].
Larsen syndrome
A renal disease that is characterized by the failure of one or both kidneys to develop.
GARD:9228
OMIM:191830
ORDO:93108
hereditary renal aplasia
hereditary urogenital adysplasia
renal adysplasia
renal aplasia
disease_ontology
DOID:14766
renal agenesis
An ectodermal dysplasia characterized by short-limbed short stature and fine, sparse hair that has_material_basis_in homozygous or compound heterozygous mutation in RMRP on chromosome 9p13.3.
DOID:0080022
MESH:C535916
NCI:C61245
OMIM:250250
SNOMEDCT_US_2020_03_01:234421004
UMLS_CUI:C0220748
CHH
McKusick type metaphyseal chondrodysplasia
Metaphyseal chondrodysplasia, McKusick type
disease_ontology
DOID:14773
OMIM mapping confirmed by DO. [SN].
cartilage-hair hypoplasia
A syndrome characterized by blepharophimosis, ptosis, epicanthus inversus, and telecanthus with (type I) or without (premature ovarian failure) that has_material_basis_in heterozygous or rarely homozygous mutation in FOXL2 on chromosome 3q22.3.
MESH:C562419
OMIM:110100
SNOMEDCT_US_2020_03_01:79833006
UMLS_CUI:C0220663
disease_ontology
Blepharophimosis, ptosis, epicanthus inversus syndrome
DOID:14778
OMIM mapping confirmed by DO. [SN].
blepharophimosis, ptosis, and epicanthus inversus syndrome
A syndrome that is characterized by short stature, moderate to severe degrees of mental retardation, developmental abnormalities of the limbs, bones of the spine (vertebrae), extremities, and/or underdevelopment of the bones of the skeleton.
GARD:82
MESH:C537015
OMIM:148050
ORDO:2332
SNOMEDCT_US_2020_03_01:711156009
UMLS_CUI:C0220687
disease_ontology
DOID:14780
OMIM mapping confirmed by DO. [SN].
KBG syndrome
DOID:0080025
GARD:4987
OMIM:183900
Late Spondyloepiphyseal Dysplasia
disease_ontology
DOID:14789
OMIM mapping confirmed by DO. [SN].
spondyloepiphyseal dysplasia congenita
A retinal disease that is characterized by nystagmus, sluggish or no pupillary responses, and severe vision loss or blindness.
GARD:634
MESH:D057130
NCI:C129075
OMIM:PS204000
ORDO:65
SNOMEDCT_US_2020_03_01:193413001
UMLS_CUI:C0339527
LCA
Leber's amaurosis
Leber's congenital amaurosis
Leber's disease
disease_ontology
DOID:14791
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Leber congenital amaurosis
An ectodermal dysplasia that is characterized by malformation of ectodermal (skin, hair, teeth and sweat glands) structures including hypotrichosis (sparseness of scalp and body hair), hypohidrosis (reduced ability to sweat), and hypodontia (congenital absence of teeth).
DOID:0050446
DOID:0050447
GARD:76
MESH:D053358
NCI:C84562
OMIM:129490
OMIM:224900
OMIM:300291
OMIM:305100
ORDO:238468
SNOMEDCT_US_2020_03_01:239007005
UMLS_CUI:C0162359
Christ-Siemens-Touraine Syndrome
Ectodermal Dysplasia 1, Anhydrotic
Hypohidrotic X-linked ectodermal dysplasia
anhidrotic ectodermal dysplasia 3
disease_ontology
DOID:14793
OMIM mapping confirmed by DO. [SN].
hypohidrotic ectodermal dysplasia
A syndrome that is characterized by microcephaly, growth retardation and a characteristic facial appearance including but not limited to narrow or triangular shaped head, micrognathia, ptosis, a broad, wide-tipped nose, and wide-set eyes with drooping eyelids.
GARD:6290
ICD10CM:Q87.19
MEDDRA:10059589
MESH:C535718
NCI:C125591
OMIM:223370
SNOMEDCT_US_2020_03_01:2593002
UMLS_CUI:C0175691
Dubowitz's syndrome
disease_ontology
DOID:14796
OMIM mapping confirmed by DO. [SN].
Dubowitz syndrome
A periodontal disease that is located_in the gums.
MESH:D005882
SNOMEDCT_US_2020_03_01:18718003
UMLS_CUI:C0017563
gum disease
disease_ontology
DOID:1483
gingival disease
A syndrome that is characterized by the buildup of thick, sticky mucus that can damage many organs.
DOID:12447
DOID:13383
DOID:14395
DOID:1484
GARD:6233
ICD10CM:E84
ICD9CM:277.0
MESH:D003550
NCI:C2975
OMIM:219700
ORDO:586
SNOMEDCT_US_2020_03_01:85809002
UMLS_CUI:C0010674
CF
mucoviscidosis
disease_ontology
DOID:1485
OMIM mapping confirmed by DO. [SN].
cystic fibrosis
MESH:D003550
A parasitic helminthiasis infectious disease that involves parasitic infection of humans and domestic animals caused by the larval stages of tapeworms of the genus Echinococcus in the liver, lungs, spleen, brain, heart and kidneys.
DOID:12149
DOID:2783
ICD10CM:B67
ICD9CM:122
MESH:D004443
NCI:C84682
SNOMEDCT_US_2020_03_01:154414008
UMLS_CUI:C0013502
Echinococcosis of liver
echinococcal disease
hepatic echinococcosis
hydatid disease
hydatidosis
liver echinococcus
pulmonary echinococcosis
disease_ontology
DOID:1496
echinococcosis
A primary bacterial infectious disease that is described as an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae, which is characterized by profuse watery diarrhea, vomiting, leg cramps, circulatory collapse and shock.
GARD:6043
ICD10CM:A00
ICD9CM:001
MESH:D002771
SNOMEDCT_US_2020_03_01:186087007
UMLS_CUI:C0008354
Cholera
Cholera - Vibrio cholerae
Cholera due to Vibrio cholerae
Vibrio cholerae
disease_ontology
DOID:1498
cholera
MESH:D002771
A disease of anatomical entity that is located_in reproductive system organs.
DOID:6309
NCI:C27613
UMLS_CUI:C1335037
genital system disease
disease_ontology
DOID:15
reproductive system disease
A disease that involves a psychological or behavioral pattern generally associated with subjective distress or disability that occurs in an individual, and which are not a part of normal development or culture.
ICD10CM:F99
MESH:D001523
NCI:C2893
SNOMEDCT_US_2020_03_01:74732009
UMLS_CUI:C0004936
disease_ontology
DOID:150
disease of mental health
An opportunistic mycosis that involves fungal infection of the mouth, throat, skin, scalp, vagina, fingers, nails, bronchi, lungs, heart and brain by Candida species, of which Candida albicans is the most common. Systemic Candida infections are usually confined to severely immunocompromised persons.
DOID:1507
ICD10CM:B37
ICD9CM:112
MESH:D002177
NCI:C26711
SNOMEDCT_US_2020_03_01:154403005
UMLS_CUI:C0006840
Disseminated candidiasis
systemic candidiasis
disease_ontology
DOID:1508
candidiasis
A personality disorder that is characterized by a pervasive pattern of social inhibition, feelings of inadequacy, extreme sensitivity to negative evaluation, and avoidance of social interaction.
ICD10CM:F60.6
ICD9CM:301.82
MESH:D010554
NCI:C92636
SNOMEDCT_US_2020_03_01:191771004
UMLS_CUI:C0004444
anxious personality disorder
disease_ontology
DOID:1509
avoidant personality disorder
A disease of mental health that involve long-term patterns of thoughts and behaviors that cause serious problems with relationships and work.
ICD9CM:301.8
SNOMEDCT_US_2020_03_01:191770003
UMLS_CUI:C0029707
character disorder
disease_ontology
DOID:1510
personality disorder
An intestinal disease located_in the cecum.
MESH:D002429
SNOMEDCT_US_2020_03_01:128525008
UMLS_CUI:C0007527
disorder of cecum
disease_ontology
DOID:1518
cecal disease
A cecum cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C3491
SNOMEDCT_US_2020_03_01:269538009
UMLS_CUI:C0149640
Caecum carcinoma
Cecal cancer
carcinoma of cecum
disease_ontology
DOID:1519
cecum carcinoma
A large intestine cancer that is located_in the cecum.
ICD10CM:C18.0
ICD9CM:153.4
MESH:D002430
NCI:C9329
SNOMEDCT_US_2020_03_01:93736007
UMLS_CUI:C0153437
malignant neoplasm of caecum
malignant tumor of the cecum
disease_ontology
DOID:1521
cecum cancer
A skin disease that is characterized by inflammation of subcutaneous adipose tissue.
ICD10CM:M79.3
ICD9CM:729.30
MESH:D015434
NCI:C112112
SNOMEDCT_US_2020_03_01:268122002
UMLS_CUI:C0030326
disease_ontology
DOID:1526
panniculitis
ICD10CM:N48.8
ICD9CM:607.8
SNOMEDCT_US_2020_03_01:198558008
UMLS_CUI:C0029785
disease_ontology
DOID:1529
penile disease
A thoracic disease which may involve inflammation of pleura, collection of air within the pleural cavity, abnormal collection of pleural fluid, abnormal growths on the pleura (pleural tumor) and pleural plaques. The main causes of pleural diseases including pleural effusions are congestive heart failure, malignancy, parapneumonic infections and pulmonary embolism.
DOID:1531
MESH:D010995
NCI:C26859
SNOMEDCT_US_2020_03_01:88075009
UMLS_CUI:C0032226
disorder of pleura
non-neoplastic pleural disease
disease_ontology
DOID:1532
pleural disease
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from two germinal layers of tissue.
DOID:1905
MESH:D018198
NCI:C3729
NCI:C6930
SNOMEDCT_US_2020_03_01:8145008
UMLS_CUI:C0206625
UMLS_CUI:C1368354
malignant mixed cancer
malignant mixed neoplasm
mixed tumor
mixed tumor, malignant
disease_ontology
malignant mixed tumor
mixed neoplasm
DOID:154
mixed cell type cancer
An endocrine gland cancer located_in the parathyroid glands located in the neck.
DOID:11006
DOID:1541
GARD:7329
ICD10CM:C75.0
ICD9CM:194.1
MESH:D010282
NCI:C3313
NCI:C4906
NCI:C9322
OMIM:608266
SNOMEDCT_US_2020_03_01:127020005
SNOMEDCT_US_2020_03_01:363481002
UMLS_CUI:C0030521
UMLS_CUI:C0153653
UMLS_CUI:C0687150
Parathyroid gland neoplasm
carcinoma of Parathyroid gland
malignant neoplasm of parathyroid gland
malignant neoplasm of the Parathyroid
malignant tumor of parathyroid gland
neoplasm of parathyroid gland
parathyroid gland cancer
parathyroid neoplasm
disease_ontology
parathyroid gland adenocarcinoma
DOID:1540
OMIM mapping confirmed by DO. [SN].
parathyroid carcinoma
A skin disease characterized by skin rash notable for pale red, raised and itchy bumps, located_in the upper dermis.
ICD9CM:708.8
SNOMEDCT_US_2020_03_01:267817001
UMLS_CUI:C0029839
disease_ontology
DOID:1555
urticaria
A hypersensitivity reaction disease that is characterized by the accumulation of antigen-antibody immune complexes, causing an inflammatory response and injury.
MESH:D007105
UMLS_CUI:C0020951
immune complex disease
disease_ontology
DOID:1557
hypersensitivity reaction type III disease
A skin disease characterized by the rapid swelling of the dermis, subcutaneous tissue, mucosa and submucosal tissues.
ICD10CM:T78.3
MESH:D000799
NCI:C112175
SNOMEDCT_US_2020_03_01:41291007
UMLS_CUI:C0002994
Angioneurotic oedema
Quincke's edema
angioneurotic edema
giant urticaria
disease_ontology
DOID:1558
angioedema
A disease of mental health that affects cognitive functions including memory processing, perception and problem solving.
ICD10CM:F09
MESH:D019965
NCI:C34870
SNOMEDCT_US_2020_03_01:111479008
UMLS_CUI:C0029227
cognitive disease
disease_ontology
Organic Mental disorder
DOID:1561
cognitive disorder
A subcutaneous mycosis that is a chronic subcutaneous fungal infection, which presents as nodular or verrucoid, ulcerated, or crusted skin lesions on exposed areas of skin caused by Fonsecaea pedrosoi, Fonsecaea compacta, Cladophialophora carrionii or Phialophora verrucosa. Histological examination reveals muriform cells (with perpendicular septations) or thick walled, dark-colored, rounded forms (copper pennies) that are characteristic of this infection.
GARD:1319
ICD10CM:B43.9
ICD9CM:117.2
MESH:D002862
SNOMEDCT_US_2020_03_01:187079000
UMLS_CUI:C0008582
Chromomycosis
Mossy foot disease
disease_ontology
DOID:1562
chromoblastomycosis
A cutaneous mycosis that results in fungal infection located in skin or of its appendages, has_material_basis_in Ascomycota fungi other than the dermatophytes.
ICD9CM:111.9
MESH:D003881
SNOMEDCT_US_2020_03_01:47382004
UMLS_CUI:C0011630
disease_ontology
DOID:1563
dermatomycosis
A disease by infectious agent that results_in infection, has_material_basis_in Fungi, which pass the resistance barriers of the human or animal body.
ICD10CM:B49
ICD9CM:110-118.99
MESH:D009181
NCI:C3245
SNOMEDCT_US_2020_03_01:154393000
UMLS_CUI:C0026946
mycosis
disease_ontology
mycoses
DOID:1564
fungal infectious disease
ICD10CM:H02.1
ICD9CM:374.1
MESH:D004483
SNOMEDCT_US_2020_03_01:155178000
UMLS_CUI:C0013592
Ectropion of eyelid
Everted margin
disease_ontology
DOID:1570
ectropion
ICD10CM:G91.2
MESH:D006850
OMIM:236690
SNOMEDCT_US_2020_03_01:30753002
UMLS_CUI:C0020258
Low pressure hydrocephalus
disease_ontology
DOID:1572
OMIM mapping confirmed by DO. [SN].
normal pressure hydrocephalus
ICD10CM:G91.0
ICD9CM:331.3
MESH:D006849
NCI:C34501
SNOMEDCT_US_2020_03_01:59013007
UMLS_CUI:C0009451
disease_ontology
DOID:1573
communicating hydrocephalus
A musculoskeletal system disease that involves inflammation or pain in the muscles, joints, or fibrous tissue.
disease_ontology
DOID:1575
rheumatic disease
A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm.
DOID:3226
ICD10CM:J98
ICD9CM:519
SNOMEDCT_US_2020_03_01:155603009
UMLS_CUI:C0029582
disease_ontology
DOID:1579
respiratory system disease
A pulmonary tuberculosis causing granulomatous leisons in the larynx resulting from an inflammation caused by mycobacteria leading to hoarseness, dysphagia and odynophagia.
ICD10CM:A15.5
ICD9CM:012.3
MESH:D014387
NCI:C26895
SNOMEDCT_US_2020_03_01:70341005
UMLS_CUI:C0041315
disease_ontology
DOID:1583
laryngeal tuberculosis
A lung disease that involves a vasoocclusive crisis of the pulmonary vasculature seen in patients with sickle cell anemia. The crisis is initiated by a lung infection, and the resulting inflammation and loss of oxygen tension leads to sickling of red cells and further vasoocclusion. The disease has_symptom fever, has_symptom pleuritic chest pain, has_symptom tachypnea, has_symptom cough, has_symptom hypoxemia, has_symptom marked leukocytosis, and has_symptom diffuse infiltrates on chest radiograph.
ICD9CM:517.3
MESH:D056586
NCI:C138179
SNOMEDCT_US_2020_03_01:372146004
UMLS_CUI:C0742343
acute chest syndrome in sickle cell disease
disease_ontology
DOID:1584
acute chest syndrome
MESH:D056586
A connective tissue disease that develops from an antecedent Group A Streptococcal pharyngeal infection and has_symptom carditis, has_symptom polyarthritis, has_symptom chorea, has_symptom erythema marginatum, has_symptom subcutaneous nodules, has_symptom arthralgia, has_symptom prolonged PR interval, and/or has_symptom fever.
DOID:1006
DOID:1007
GARD:5699
ICD10CM:I00
ICD10CM:I00-I02
ICD9CM:390
ICD9CM:390-392.99
MESH:D012213
NCI:C34984
SNOMEDCT_US_2020_03_01:155265007
SNOMEDCT_US_2020_03_01:274095001
UMLS_CUI:C0035436
UMLS_CUI:C0264743
ACUTE RHEUMATIC FEVER
RhF - Rheumatic fever
disease_ontology
DOID:1586
rheumatic fever
MESH:D012213
NCI:C3991
SNOMEDCT_US_2020_03_01:2897005
UMLS_CUI:C0272286
Auto-immune thrombocytopenia
Immune thrombocytopenia
Thrombocytopenia Due to Immune Destruction
disease_ontology
DOID:1587
thrombocytopenia due to platelet alloimmunization
A blood platelet disease that is characterized by low a platelet count in the blood.
ICD10CM:D69.6
ICD9CM:287.5
MESH:D013921
OMIM:188000
OMIM:273900
OMIM:300367
OMIM:313900
OMIM:612004
ORDO:852
SNOMEDCT_US_2020_03_01:165556002
UMLS_CUI:C0040034
disease_ontology
DOID:1588
Xref MGI.
thrombocytopenia
A mental depression that is characterized by a dysregulation of the endogenous opioid system and not of the monaminergic system.
DOID:6340
EFO:0003761
MESH:D003866
NCI:C34532
NCI:C35094
OMIM:608516
SNOMEDCT_US_2020_03_01:191599006
UMLS_CUI:C0011573
UMLS_CUI:C0041696
clinical depression
unipolar depression
disease_ontology
DOID:1595
OMIM mapping confirmed by DO. [LS].
endogenous depression
DOID:14672
ICD10CM:F32.9
MESH:D003863
NCI:C2982
SNOMEDCT_US_2020_03_01:41006004
UMLS_CUI:C0011570
disease_ontology
DOID:1596
mental depression
A disease of anatomical entity that is located_in the integumentary system comprising the skin and its appendages.
disease_ontology
DOID:16
integumentary system disease
DOID:1600
DOID:9941
ICD10CM:I88.1
ICD10CM:L04
ICD9CM:289.1
ICD9CM:683
MESH:D008199
NCI:C26821
NCI:C26966
NCI:C26978
SNOMEDCT_US_2020_03_01:154836001
SNOMEDCT_US_2020_03_01:156318008
SNOMEDCT_US_2020_03_01:19471005
UMLS_CUI:C0024205
UMLS_CUI:C0154304
UMLS_CUI:C0157705
Adenitis
Inflammation of lymph node
acute adenitis
acute lymphadenitis
chronic Lymphadenitis
chronic adenitis
disease_ontology
DOID:1602
lymphadenitis
A brain disease that is characterized by coma or unconsciousness, develops from a prolonged insufficient supply of glucose to the brain, has_symptom decreased cognition, has_symptom aberrant behavior, has_symptom seizure, and has_symptom coma.
ICD10CM:E15
ICD9CM:251.0
SNOMEDCT_US_2020_03_01:267476006
UMLS_CUI:C0020617
disease_ontology
DOID:1607
hypoglycemic coma
A skin disease characterized_by growth of keratin on the skin or mucous membranes.
MESH:D007642
NCI:C34747
SNOMEDCT_US_2020_03_01:254666005
UMLS_CUI:C0022593
disease_ontology
DOID:161
keratosis
A thoracic cancer that originates in the mammary gland.
DOID:1648
DOID:4241
ICD10CM:C50
MESH:D001943
NCI:C9335
OMIM:114480
SNOMEDCT_US_2020_03_01:254837009
UMLS_CUI:C0006142
breast tumor
malignant neoplasm of breast
malignant tumor of the breast
mammary cancer
mammary tumor
primary breast cancer
disease_ontology
mammary neoplasm
DOID:1612
Xref MGI.
OMIM mapping confirmed by DO. [SN].
breast cancer
A breast benign neoplasm comprised of fibrous and glandoular tissues located_in breast.
DOID:2684
DOID:2693
DOID:7226
ICD10CM:D24
MESH:D018226
NCI:C3744
NCI:C4276
NCI:C5194
SNOMEDCT_US_2020_03_01:254847007
SNOMEDCT_US_2020_03_01:269640007
SNOMEDCT_US_2020_03_01:65877006
UMLS_CUI:C0178421
UMLS_CUI:C0206650
UMLS_CUI:C0346158
UMLS_CUI:C1333137
Complex Fibroadenoma of breast
Fibroadenoma
Fibroadenoma of breast
Juvenile fibroadenoma
cellular Fibroadenoma
fibroadenoma
juvenile fibroadenoma of breast
disease_ontology
DOID:1618
breast fibroadenoma
A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.
ICD10CM:C80.1
ICD9CM:199
ICDO:M8000/3
MESH:D009369
NCI:C9305
SNOMEDCT_US_2020_03_01:269513004
UMLS_CUI:C0006826
malignant neoplasm
malignant tumor
primary cancer
disease_ontology
DOID:162
Updating out dated UMLS CUI.
cancer
A breast benign neoplasm that is has_material_basis_in epithelial tissue in which tumor cells form glands or glandlike structures.
NCI:C40382
SNOMEDCT_US_2020_03_01:269640007
UMLS_CUI:C1328385
Ademoma - breast
disease_ontology
DOID:1625
breast adenoma
MESH:D018300
NCI:C3785
SNOMEDCT_US_2020_03_01:5244003
UMLS_CUI:C0206713
ductal papilloma
disease_ontology
DOID:1627
intraductal papilloma
A breast myoepithelial neoplasm that affects the breast and is characterized by biphasic proliferation of both epithelial and myoepithelial cells.
DOID:6640
NCI:C5143
NCI:C6899
UMLS_CUI:C1334564
UMLS_CUI:C1510795
breast Adenomyoepithelioma with malignant Change
malignant adenomyoepithelioma of breast
disease_ontology
adenomyoepithelioma of the breast
DOID:1642
breast adenomyoepithelioma
A heart septal defect characterized by an opening in the interventricular septum, causing a shunt between ventricles.
GARD:7853
ICD10CM:Q21.0
ICD9CM:745.4
MESH:D006345
NCI:C84506
OMIM:614429
OMIM:614431
OMIM:614432
ORDO:1480
SNOMEDCT_US_2020_03_01:156914003
UMLS_CUI:C0018818
Interventricular septal defect
Ventricular septal abnormality
disease_ontology
DOID:1657
Xref MGI.
ventricular septal defect
A brain cancer that is located in the supratentorial region.
DOID:1658
ICD10CM:C71.0
MESH:D015173
NCI:C3397
NCI:C4964
UMLS_CUI:C0038874
UMLS_CUI:C0751589
Brain neoplasm, Supratentorial
malignant Supratentorial tumor
disease_ontology
DOID:1659
supratentorial cancer
MESH:D017600
NCI:C3717
SNOMEDCT_US_2020_03_01:1513001
UMLS_CUI:C0206094
Infantile Melanotic neuroectodermal neoplasm
Melanotic neuroectodermal tumor
Melanotic neuroectodermal tumor of infancy
Melanotic neuroectodermal tumour
Melanotic neuroectodermal tumour of infancy
Pigmented neuroectodermal tumour of infancy
melanotic neuroectodermal tumour
disease_ontology
DOID:166
melanotic neuroectodermal tumor
A pineal gland neoplasm located_in the brain.
GARD:9369
MESH:D010871
NCI:C9344
SNOMEDCT_US_2020_03_01:31671006
UMLS_CUI:C0205898
Pineal PNET
disease_ontology
DOID:1664
pineoblastoma
A pleural disease that is characterized as an abnormal collection of air in the pleural space between the lung and the chest wall.
ICD10CM:J93.1
SNOMEDCT_US_2020_03_01:196103008
UMLS_CUI:C0029850
disease_ontology
DOID:1673
pneumothorax
MESH:D011030
A bladder disease that is characterized by inflammation of the bladder.
ICD10CM:N30
ICD9CM:595
MESH:D003556
NCI:C26738
SNOMEDCT_US_2020_03_01:38822007
UMLS_CUI:C0010692
disease_ontology
DOID:1679
cystitis
ICD10CM:Q21.9
MESH:D006343
NCI:C84482
SNOMEDCT_US_2020_03_01:204290008
UMLS_CUI:C0018816
Cardiac septal defects
Congenital septal defect of heart
Septal defect
septal defect
disease_ontology
DOID:1681
heart septal defect
ICD10CM:Q24.9
ICD9CM:746.9
MESH:D006330
NCI:C34666
SNOMEDCT_US_2020_03_01:268315002
UMLS_CUI:C0018798
Congenital Heart Defects
Congenital anomaly of heart
Heart Malformation
congenital heart defect
heart defect
disease_ontology
Heart-congenital defect
DOID:1682
OMIM mapping confirmed by DO. [SN].
congenital heart disease
An eye disease that is characterized by an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function.
EFO:0000516
ICD10CM:H40
ICD9CM:365
MESH:D005901
NCI:C26782
SNOMEDCT_US_2020_03_01:155120009
UMLS_CUI:C0017601
disease_ontology
DOID:1686
glaucoma
A glaucoma characterized by narrowing of the anterior chamber angle secondary to neovascularization along the iris and iridocorneal angle such that the aqueous fluid outflow is blocked and intraocular pressure becomes inappropriately elevated leading to optic nerve damage and visual field loss. Neovascular glaucoma has_symptom progressive peripheral vision loss, decreased vision, and pain, redness, and headache in acute cases. Neovascular glaucoma can be related to abnormal angiogenesis with ischemic retinal diseases, inflammation, diabetes mellitus, intraocular malignancy, and autoinmmune diseases.
MESH:D015355
SNOMEDCT_US_2020_03_01:193564003
UMLS_CUI:C0017609
secondary angle-closure glaucoma with rubeosis
disease_ontology
DOID:1687
neovascular glaucoma
An endocrine gland cancer that has_material_basis_in neuroendocrine cells.
ICD10CM:D3A.8
ICD9CM:209-209.99
MESH:D018358
NCI:C3809
SNOMEDCT_US_2020_03_01:55937004
UMLS_CUI:C0206754
neuroendocrine neoplasm
disease_ontology
DOID:169
neuroendocrine tumor
A skin disease characterized by drying and scaling of skin with the accumulation of thick scales and cracks that may be painful or bleed.
MESH:D007057
ORDO:79354
ichthyoses
non-syndromic ichthyosis
disease_ontology
DOID:1697
ichthyosis
A disease of anatomical entity that occurs in the muscular and/or skeletal system.
MESH:D009140
NCI:C107377
SNOMEDCT_US_2020_03_01:268047003
UMLS_CUI:C0026857
disease_ontology
DOID:17
musculoskeletal system disease
An organ system cancer located_in endocrine system that is characterized by uncontrolled cellular proliferation of the hormone producing glands of the endocrine system.
DOID:10009
ICD10CM:C75.9
ICD9CM:194.9
MESH:D004701
NCI:C3010
NCI:C3575
SNOMEDCT_US_2020_03_01:127015005
SNOMEDCT_US_2020_03_01:93780007
UMLS_CUI:C0014132
UMLS_CUI:C0153658
Endocrine tumor
endocrine neoplasm
malignant Endocrine tumor
malignant neoplasm of endocrine gland
malignant tumour of endocrine gland
neoplasm of endocrine gland
neoplasm of endocrine system
disease_ontology
DOID:170
endocrine gland cancer
An ichthyosis that is characterized by a build-up of scales on the skin, typically on the back of the neck and trunk resulting from skin cells that do not properly separate from the outermost surface of the skin, and has_material_basis_in X-linked recessive mutation or deletion of the STS gene on chromosome Xp22.
GARD:7904
ICD10CM:Q80.1
MESH:D016114
NCI:C84779
OMIM:308100
SNOMEDCT_US_2020_03_01:72523005
UMLS_CUI:C0079588
X-linked ichthyosis with steryl-sulphatase deficiency
X-linked placental steryl-sulphatase deficiency
X-linked recessive ichthyosis
disease_ontology
DOID:1700
OMIM mapping confirmed by DO. [LS].
X-linked ichthyosis
A lipid metabolism disorder that involves defects in steroid metabolism.
MESH:D043202
UMLS_CUI:C1257809
disease_ontology
DOID:1701
steroid inherited metabolic disorder
An ichthyosis that has_material_basis_in heterozygous mutation in the filaggrin gene on chromosome 1q21 and is characterized by dead skin cells accumulate in thick, dry scales on your skin's surface.
GARD:6752
ICD10CM:Q80.0
MESH:D016112
NCI:C84778
OMIM:146700
SNOMEDCT_US_2020_03_01:205551004
UMLS_CUI:C0079584
Dominant congenital ichthyosiform erythroderma
disease_ontology
DOID:1702
OMIM mapping confirmed by DO. [SN].
ichthyosis vulgaris
MESH:D017599
SNOMEDCT_US_2020_03_01:73676002
UMLS_CUI:C0206093
primitive Neuroectodermal neoplasm
disease_ontology
DOID:171
neuroectodermal tumor
An aortic valve disease that is characterized by narrowing of the heart's aortic valve opening.
DOID:12034
DOID:1711
GARD:5830
ICD10CM:I06.0
ICD10CM:Q23.0
ICD10CM:Q25.1
ICD9CM:395.0
ICD9CM:746.3
MESH:D001024
NCI:C50462
SNOMEDCT_US_2020_03_01:155282009
SNOMEDCT_US_2020_03_01:18546004
SNOMEDCT_US_2020_03_01:60573004
UMLS_CUI:C0003507
UMLS_CUI:C0152417
UMLS_CUI:C0155567
Aortic stenosis
Rheumatic aortic stenosis
rheumatic aortic valve stenosis
disease_ontology
DOID:1712
Xref MGI.
OMIM mapping confirmed by DO. [SN].
aortic valve stenosis
MESH:D001024
MESH:D049309
NCI:C97041
SNOMEDCT_US_2020_03_01:65540008
UMLS_CUI:C0333992
Clear cell acanthoma
Pale (Clear cell) acanthoma
disease_ontology
DOID:172
clear cell acanthoma
DOID:10297
DOID:11480
DOID:12880
DOID:13836
DOID:1723
DOID:9780
DOID:9781
DOID:9782
DOID:9783
ICD10CM:K26
ICD9CM:532
MESH:D004381
NCI:C26755
SNOMEDCT_US_2020_03_01:155691003
SNOMEDCT_US_2020_03_01:39755000
UMLS_CUI:C0010474
UMLS_CUI:C0013295
Curling Ulcer
Curling's ulcers
Stress Ulcer
disease_ontology
DOID:1724
Adding UMLS CUI for Curling Ulcer C0013295.
duodenal ulcer
An organ system cancer that is located in the peritoneum.
ICD10CM:C48.1
ICD9CM:158.8
SNOMEDCT_US_2020_03_01:187808008
UMLS_CUI:C0153466
disease_ontology
cancer of peritoneum
peritoneal neoplasm
DOID:1725
peritoneum cancer
MESH:D012170
NCI:C34981
SNOMEDCT_US_2020_03_01:46085004
UMLS_CUI:C0035328
Occlusion, of retinal vein
Retinal vein occlusion
disease_ontology
DOID:1727
retinal vein occlusion
ICD10CM:H34
ICD9CM:362.3
NCI:C34980
SNOMEDCT_US_2020_03_01:267717005
UMLS_CUI:C0035326
Retinal vasc. occlusion
disease_ontology
DOID:1729
retinal vascular occlusion
NCI:C6796
UMLS_CUI:C1333371
Eccrine tumor
eccrine skin neoplasm
disease_ontology
DOID:173
eccrine sweat gland neoplasm
A primary systemic mycosis that results in systemic fungal infection, has_material_basis_in Histoplasma capsulatum var capsulatum or has_material_basis_in Histoplasma capsulatum var duboisii, transmitted_by airborne spores and has_symptom nonproductive cough, has_symptom headache, has_symptom loss of appetite and has_symptom muscle pains.
DOID:351
ICD10CM:B39
ICD9CM:115
MESH:C538362
MESH:D006660
NCI:C34977
NCI:C77201
SNOMEDCT_US_2020_03_01:266218008
UMLS_CUI:C0019655
UMLS_CUI:C0035288
disease_ontology
DOID:1731
histoplasmosis
A coccidiosis that involves a parasitic protozoan infection of the intestine of humans and a wide range of animals caused by Cryptosporidium species, through contaminated water and food, The symptoms include watery diarrhea, dehydration, weight loss, abdominal pain, fever, nausea and vomiting. Cryptosporidium infections have also been found in other digestive tract organs, the lungs, and conjunctiva. Immunocompromised persons are at greater risk of developing the infection.
DOID:1732
GARD:6219
ICD10CM:A07.2
ICD9CM:007.4
MESH:D003457
NCI:C128408
SNOMEDCT_US_2020_03_01:186126003
UMLS_CUI:C0010418
Cryptosporidial gastroenteritis
Infection by Cryptosporidium
intestinal cryptosporidiosis
disease_ontology
DOID:1733
cryptosporidiosis
GARD:8604
MESH:D049309
NCI:C7419
UMLS_CUI:C0846967
disease_ontology
DOID:174
acanthoma
MESH:D049309
ICD9CM:292.1
MESH:D011605
SNOMEDCT_US_2020_03_01:191498001
UMLS_CUI:C0033937
Drug-induced psychosis
Drug-induced psychotic disorder
disease_ontology
DOID:1742
drug psychosis
A carcinoma that derives_from squamous epithelial cells.
DOID:5512
EFO:0000707
GARD:1091
MESH:D002294
MESH:D018307
NCI:C2929
SNOMEDCT_US_2020_03_01:154605007
UMLS_CUI:C0007137
UMLS_CUI:C0751688
epidermoid carcinoma
malignant squamous cell tumor
squamous carcinoma
squamous cell Epithelioma
squamous cell cancer
disease_ontology
DOID:1749
squamous cell carcinoma
A cardiovascular cancer that is located_in blood vessels.
DOID:3339
DOID:5454
DOID:5548
DOID:7019
DOID:7020
DOID:7392
MESH:D019043
NCI:C5348
NCI:C5380
NCI:C5383
NCI:C5388
NCI:C7390
SNOMEDCT_US_2020_03_01:126737003
SNOMEDCT_US_2020_03_01:93817006
UMLS_CUI:C0282607
UMLS_CUI:C0346845
UMLS_CUI:C1290407
UMLS_CUI:C1334616
UMLS_CUI:C1334617
UMLS_CUI:C1334630
UMLS_CUI:C1335753
Blood Vessel neoplasm
Blood vessel tumor
Blood vessel tumors
Blood vessel tumour disorder
Haemangiomatous tumour
blood vessel neoplasm
leiomyosarcoma of the renal Vein
malignant great vessel tumor
malignant tumor of pulmonary Vein
malignant tumor of pulmonary artery
malignant vascular neoplasm
malignant vascular tumor
neoplasm of great vessel
pulmonary artery malignant neoplasm
pulmonary vein malignant neoplasm
renal vein leiomyosarcoma
vascular tissue neoplasm
vascular tumors
disease_ontology
DOID:175
vascular cancer
A mitral valve disease that is characterized by the narrowing of the orifice of the mitral valve of the heart.
MESH:D008946
NCI:C50654
SNOMEDCT_US_2020_03_01:79619009
UMLS_CUI:C0026269
Mitral stenosis
disease_ontology
DOID:1754
mitral valve stenosis
ICD10CM:G51
ICD9CM:351
MESH:D005155
NCI:C27594
SNOMEDCT_US_2020_03_01:90039006
UMLS_CUI:C0015464
disease_ontology
DOID:1756
facial nerve disease
MESH:D005150
NCI:C84703
OMIM:141300
SNOMEDCT_US_2020_03_01:29868009
UMLS_CUI:C0015458
PARRY-ROMBERG SYNDROME
disease_ontology
DOID:1757
OMIM mapping confirmed by DO. [SN].
facial hemiatrophy
An organ system cancer that located_in the heart and blood vessels.
NCI:C4784
SNOMEDCT_US_2020_03_01:721573003
UMLS_CUI:C0497243
Cardiovascular tumors
cardiovascular neoplasm
disease_ontology
DOID:176
cardiovascular cancer
GARD:7010
ICD10CM:G51.2
MESH:D008556
NCI:C84886
OMIM:155900
SNOMEDCT_US_2020_03_01:2511001
UMLS_CUI:C0025235
Cheilitis granulomatosa of Mescher-Melkersson-Rosenthal
Melkersson's syndrome
disease_ontology
DOID:1761
OMIM mapping confirmed by DO. [SN].
Melkersson-Rosenthal syndrome
ICD10CM:K59.31
MESH:D008532
SNOMEDCT_US_2020_03_01:28536002
UMLS_CUI:C0025162
disease_ontology
DOID:1770
toxic megacolon
A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.
DOID:0000405
DOID:2403
DOID:2869
DOID:324
DOID:325
DOID:45
ICD10CM:I72.9
ICD9CM:442.9
MESH:D000783
MESH:D014652
MESH:D020758
MESH:D020760
NCI:C26693
NCI:C35117
SNOMEDCT_US_2020_03_01:27550009
SNOMEDCT_US_2020_03_01:371029002
SNOMEDCT_US_2020_03_01:432119003
UMLS_CUI:C0002940
UMLS_CUI:C0042373
UMLS_CUI:C0752127
UMLS_CUI:C0752130
vascular tissue disease
disease_ontology
DOID:178
vascular disease
An endocrine gland cancer located in the thryoid gland located in the neck below the thyroid cartilage.
DOID:10008
ICD10CM:C73
ICD9CM:193
KEGG:05216
MESH:D013964
NCI:C3414
NCI:C7510
SNOMEDCT_US_2020_03_01:127018007
SNOMEDCT_US_2020_03_01:94098005
UMLS_CUI:C0007115
UMLS_CUI:C0040136
Thyroid gland neoplasm
malignant neoplasm of thyroid gland
malignant tumour of thyroid gland
neoplasm of thyroid gland
thyroid neoplasm
disease_ontology
DOID:1781
thyroid gland cancer
An endocrine gland cancer located_in the pituitary gland located at the base of the brain.
DOID:5671
GARD:9371
ICD10CM:C75.1
MESH:D010911
NCI:C3330
NCI:C4769
SNOMEDCT_US_2020_03_01:127024001
SNOMEDCT_US_2020_03_01:93964007
UMLS_CUI:C0032019
UMLS_CUI:C0496842
Pituitary gland neoplasm
malignant Pituitary neoplasm
malignant tumor of pituitary gland
neoplasm of pituitary gland
pituitary gland cancer
pituitary neoplasm
disease_ontology
DOID:1785
pituitary cancer
MESH:D000314
NCI:C2860
SNOMEDCT_US_2020_03_01:54292009
UMLS_CUI:C0001630
Adrenal Rest neoplasm
disease_ontology
DOID:1786
adrenal rest tumor
MESH:D000314
A pericardium disease that is characterized by an inflammation of the pericardium and has_symptom chest pain.
MESH:D010493
NCI:C34915
SNOMEDCT_US_2020_03_01:3238004
UMLS_CUI:C0031046
disease_ontology
DOID:1787
pericarditis
A peritoneum cancer that develops from cells of the mesothelium and is located_in the peritoneum.
DOID:0050874
DOID:7954
ICD10CM:C45.1
NCI:C8704
NCI:C9350
SNOMEDCT_US_2020_03_01:187806007
UMLS_CUI:C0346109
UMLS_CUI:C0854886
Advanced malignant Mesothelioma of Peritoneum
advanced malignant peritoneal mesothelioma
malignant mesothelioma of peritoneum
disease_ontology
DOID:1788
peritoneal mesothelioma
A cell type cancer that has_material_basis_in mesothelial tissue that develops from the thin layer of tissue that covers many of the internal organs.
DOID:4487
DOID:6965
DOID:7434
MESH:C562839
NCI:C27926
NCI:C4456
NCI:C7865
NCI:C8420
OMIM:156240
SNOMEDCT_US_2020_03_01:109378008
UMLS_CUI:C0278752
UMLS_CUI:C0345967
UMLS_CUI:C0392400
UMLS_CUI:C1332338
Diffuse malignant Mesothelioma
advanced malignant mesothelioma
asbestos-related malignant mesothelioma
malignant tumor of Mesothelium
disease_ontology
DOID:1790
OMIM mapping confirmed by DO. [SN].
malignant mesothelioma
A carcinoma that is located_in the inside of the abdomen.
NCI:C40022
UMLS_CUI:C1514428
primary peritoneal carcinoma
disease_ontology
DOID:1791
peritoneal carcinoma
An endocrine gland cancer located_in the pancreas.
DOID:14356
DOID:1797
DOID:3588
DOID:9859
GARD:9364
ICD10CM:C25.0
ICD10CM:C25.1
ICD10CM:C25.2
ICD9CM:157.0
ICD9CM:157.1
ICD9CM:157.2
ICD9CM:157.8
KEGG:05212
MESH:D010190
NCI:C3305
ORDO:1333
ORDO:217074
SNOMEDCT_US_2020_03_01:126859007
SNOMEDCT_US_2020_03_01:187796007
SNOMEDCT_US_2020_03_01:93715005
SNOMEDCT_US_2020_03_01:93823001
SNOMEDCT_US_2020_03_01:94082003
UMLS_CUI:C0030297
UMLS_CUI:C0153458
UMLS_CUI:C0153459
UMLS_CUI:C0153460
UMLS_CUI:C0153463
Ca body of pancreas
Ca head of pancreas
Ca tail of pancreas
malignant neoplasm of body of pancreas
malignant neoplasm of head of pancreas
malignant neoplasm of tail of pancreas
pancreas neoplasm
pancreatic neoplasm
pancreatic tumor
disease_ontology
DOID:1793
Xref MGI.
pancreatic cancer
A pancreatic cancer that arises from the epithelial cells of the exocrine pancreatic tissue.
DOID:1794
NCI:C7430
SNOMEDCT_US_2020_03_01:255088001
UMLS_CUI:C0346648
malignant neoplasm of the Exocrine pancreas
malignant tumor of exocrine pancreas
malignant tumour of exocrine pancreas
disease_ontology
DOID:1795
malignant exocrine pancreas neoplasm
An islet cell tumor that has_material_basis_in epithelial cells.
GARD:13034
ICD10CM:C25.4
ICD9CM:157.4
MESH:D018273
NCI:C3770
SNOMEDCT_US_2020_03_01:254612002
UMLS_CUI:C1328479
Islet cell carcinoma
carcinoma of endocrine pancreas
malignant neoplasm of islets of Langerhans
pancreatic neuroendocrine carcinoma
disease_ontology
DOID:1798
pancreatic endocrine carcinoma
A pancreatic cancer that is located_in the pancreatic islet cells.
DOID:10165
ICD10CM:C25.4
ICD10CM:D13.7
MESH:D007516
NCI:C27031
SNOMEDCT_US_2020_03_01:254611009
SNOMEDCT_US_2020_03_01:261713004
UMLS_CUI:C0242363
UMLS_CUI:C0496784
Islet cell neoplasm
Islet cell tumor
Islet cell tumour
endocrine pancreas cancer
islet cell tumour
malignant pancreatic Endocrine tumor
malignant pancreatic Endocrine tumour
malignant tumor of endocrine pancreas
malignant tumour of endocrine pancreas
pancreatic Endocrine neoplasm
disease_ontology
DOID:1799
islet cell tumor
A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra.
DOID:579
NCI:C27599
UMLS_CUI:C1335051
Non-neoplastic urinary tract disease
urinary tract disease
disease_ontology
DOID:18
urinary system disease
A bone benign neoplasm that is located_in the mouth and results_in an overgrowth of gingival tissue due to irritation or trauma.
MESH:D018214
NCI:C8422
SNOMEDCT_US_2020_03_01:189896007
UMLS_CUI:C0206640
Fibro-osteoma
disease_ontology
peripheral ossifying fibroma
DOID:180
ossifying fibroma
A carcinoma that derives_from neuroendocrine cells.
MESH:D018278
NCI:C3773
SNOMEDCT_US_2020_03_01:55937004
UMLS_CUI:C0206695
disease_ontology
DOID:1800
neuroendocrine carcinoma
ICD9CM:355.9
MESH:D020422
SNOMEDCT_US_2020_03_01:32595002
UMLS_CUI:C0235880
disease_ontology
DOID:1802
mononeuritis
MESH:D009443
NCI:C116381
SNOMEDCT_US_2020_03_01:247378004
UMLS_CUI:C0027813
peripheral neuritis
disease_ontology
DOID:1803
neuritis
ICD10CM:G90.5
ICD9CM:337.2
MESH:D012019
NCI:C85042
OMIM:604335
SNOMEDCT_US_2020_03_01:203492008
UMLS_CUI:C0034931
disease_ontology
DOID:1811
OMIM mapping confirmed by DO. [SN].
reflex sympathetic dystrophy
A calcium metabolism disease that is the result of the formation of calcium deposits in any soft tissue.
MESH:D002114
NCI:C3672
SNOMEDCT_US_2020_03_01:237881004
UMLS_CUI:C0006663
Pathologically calcified structure
pathologic calcification
disease_ontology
DOID:182
calcinosis
A childhood electroclinical syndrome that is characterized by brief and frequent absence seizures in children with age of onset between four and ten years.
MESH:D004832
NCI:C3023
SNOMEDCT_US_2020_03_01:163596002
UMLS_CUI:C0014553
petit mal seizure
pyknolepsy
disease_ontology
absence seizure
DOID:1825
childhood absence epilepsy
A brain disease that is characterized by the occurrance of at least two unprovoked seizures resulting from a persistent epileptogenic abnormality of the brain that is able to spontaneously generate paroxysmal activity and typically manifested by sudden brief episodes of altered or diminished consciousness, involuntary movements, or convulsions.
EFO:0000474
ICD10CM:G40.909
ICD9CM:345.9
MESH:D004827
NCI:C3020
SNOMEDCT_US_2020_03_01:267698007
UMLS_CUI:C0014544
epilepsy syndrome
epileptic syndrome
disease_ontology
DOID:1826
epilepsy
An epilepsy syndrome that is characterised by generalised seizures with no apparent cause which arise from many independent foci (multifocal epilepsies) or from epileptic circuits that involve the whole brain.
MESH:D004829
NCI:C3021
OMIM:600669
SNOMEDCT_US_2020_03_01:155043003
UMLS_CUI:C0014548
Generalised epilepsy
disease_ontology
DOID:1827
Xref MGI.
idiopathic generalized epilepsy
ICD9CM:598.8
UMLS_CUI:C0029752
disease_ontology
DOID:1829
urethral stricture
MESH:D14525
GARD:1521
MESH:D007706
NCI:C75486
OMIM:309400
SNOMEDCT_US_2020_03_01:59178007
UMLS_CUI:C0022716
COPPER TRANSPORT DISEASE
Menkes kinky-hair syndrome
steely hair syndrome
disease_ontology
DOID:1838
OMIM mapping confirmed by DO. [SN].
Menkes disease
A connective tissue cancer that is located_in bone and is characterized by uncontrolled cellular proliferation that destroys normal bone tissue.
DOID:3348
MESH:D001859
NCI:C9343
SNOMEDCT_US_2020_03_01:126537000
UMLS_CUI:C0005967
CA - bone cancer
bone neoplasm
bone tumour
malignant bone neoplasm
malignant bone tumour
malignant neoplasm of bone
malignant osseous tumor
neoplasm of bone
osseous tumor
disease_ontology
DOID:184
bone cancer
A drug dependence that involves the continued use of cannabis despite problems related to use of the substance.
ICD10CM:F12.2
ICD9CM:304.3
MESH:D002189
NCI:C34445
SNOMEDCT_US_2020_03_01:268766005
UMLS_CUI:C0006870
disease_ontology
DOID:1849
cannabis dependence
A cholestasis characterized by impairment of the bile flow caused by obstruction located_in liver.
GARD:10214
MESH:D002780
NCI:C84400
ORDO:284385
SNOMEDCT_US_2020_03_01:4637005
UMLS_CUI:C0008372
neonatal intrahepatic cholestasis
disease_ontology
DOID:1852
Xref MGI.
intrahepatic cholestasis
A bone disease characterized by replacement of bone in the jaws with fibrous tissue leding to facial swelling that has_material_basis_in heterozygous mutation in SH3BP2 on chromosome 4p16.3.
GARD:6036
ICD10CM:M27.8
MESH:D002636
NCI:C84630
OMIM:118400
SNOMEDCT_US_2020_03_01:76098004
UMLS_CUI:C0008029
disease_ontology
DOID:1856
OMIM mapping confirmed by DO. [SN].
cherubism
A syndrome that is characterized by polyostotic fibrous dysplasia, precocious puberty, and café-au-lait spots and has_material_basis_in spontaneous post zygotic missense mutation at ARG201 or Gln227 of the GNAS gene during embryogenesis.
DOID:11345
GARD:6995
ICD10CM:Q78.1
ICD9CM:756.54
NCI:C34610
OMIM:174800
SNOMEDCT_US_2020_03_01:726029005
UMLS_CUI:C0016065
fibrous dysplasia of bone
osteitis fibrosa disseminata
polyostotic fibrous dysplasia
disease_ontology
DOID:1858
OMIM mapping confirmed by DO. [SN].
McCune Albright syndrome
MESH:D005359
A bone cancer and jaw disease that is located in the jaw and results in a swollen jaw, results in numbness or a tingling sensation in jaw, and results in an abnormal growth of the jaw bone.
MESH:D007573
SNOMEDCT_US_2020_03_01:126634001
UMLS_CUI:C0022364
neoplasm of jaw
disease_ontology
jaw neoplasm
DOID:1862
jaw cancer
MESH:D012888
NCI:C3375
SNOMEDCT_US_2020_03_01:126538005
UMLS_CUI:C0037305
disease_ontology
DOID:1863
skull cancer
ICD10CM:M27.1
ICD9CM:526.3
MESH:D006101
SNOMEDCT_US_2020_03_01:15350006
UMLS_CUI:C0162375
central giant cell (reparative) granuloma
central giant cell granuloma
central giant cell reparative granuloma of jaw
disease_ontology
DOID:1866
giant cell reparative granuloma
EFO:0004234
Sexual impotence
erectile dysfunction
disease_ontology
DOID:1875
impotence
ICD10CM:F52.9
NCI:C3347
SNOMEDCT_US_2020_03_01:39894007
UMLS_CUI:C0549622
disease_ontology
DOID:1876
sexual dysfunction
A heart septal defect located_in in the septum that separates the two atria of the heart.
ICD10CM:Q21.1
MESH:D006344
NCI:C84473
OMIM:PS108800
ORDO:1478
SNOMEDCT_US_2020_03_01:156915002
UMLS_CUI:C0018817
atrial septal defect
atrioseptal defect
auricular septal defect
congenital atrial septal defect
interatrial septal defect
interauricular septal defect
disease_ontology
DOID:1882
Xref MGI.
atrial heart septal defect
A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis C virus, which is transmitted_by blood from an infected person enters the body of an uninfected person. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.
DOID:12430
DOID:12432
DOID:2049
EFO:0003047
ICD10CM:B19.20
ICD9CM:070.7
MESH:D006526
NCI:C3098
SNOMEDCT_US_2020_03_01:154349000
UMLS_CUI:C0019196
NANBH
Viral hepatitis C
chronic hepatitis C
hepatitis C infection
hepatitis nonA nonB
disease_ontology
DOID:1883
hepatitis C
A hepatitis that involves viral infection causing inflammation of the liver.
DOID:12548
DOID:1331
DOID:1885
MESH:D006524
UMLS_CUI:C0019194
Viral hepatitis with hepatic coma
animal viral hepatitis
human viral hepatitis
disease_ontology
DOID:1884
viral hepatitis
A cranial nerve disease that is located_in the optic nerve.
MESH:D009901
NCI:C79698
SNOMEDCT_US_2020_03_01:77157004
UMLS_CUI:C0029132
disorder of the second nerve
optic nerve disorder
optic neuropathy
disease_ontology
DOID:1891
optic nerve disease
MESH:D051677
NCI:C4247
SNOMEDCT_US_2020_03_01:34360000
UMLS_CUI:C0334463
Fibroxanthosarcoma
MFH
disease_ontology
DOID:1907
malignant fibrous histiocytoma
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from melanocytes which are found in skin, the bowel and the eye.
EFO:0000756
KEGG:05218
MESH:D008545
NCI:C3224
SNOMEDCT_US_2020_03_01:2092003
UMLS_CUI:C0025202
Naevocarcinoma
malignant melanoma
disease_ontology
DOID:1909
melanoma
MESH:D008545
A germ cell cancer that has_material_basis_in cells that line the yolk sac of the embryo.
MESH:D018240
NCI:C3011
SNOMEDCT_US_2020_03_01:74409009
UMLS_CUI:C0014145
Hepatoid yolk sac tumour
Yolk Sac neoplasm
Yolk sac tumor
Yolk sac tumour
endodermal sinus tumour
infantile embryonal carcinoma
disease_ontology
DOID:1911
endodermal sinus tumor
ICD10CM:E79.1
MESH:D007926
NCI:C61255
OMIM:300322
SNOMEDCT_US_2020_03_01:190918000
UMLS_CUI:C0023374
Complete hypoxanthine-guanine phosphoribosyltransferase deficiency
HG-PRT deficiency
Hypoxanthine-guanine phosphoribosyltransferase deficiency
Hypoxanthine-guanine-phosphoribosyltransferase deficiency
Lesch - Nyhan syndrome
X-linked hyperuricemia
deficiency of IMP pyrophosphorylase
hypoxanthine guanine phosphoribosyltransferase deficiency
disease_ontology
DOID:1919
OMIM mapping confirmed by DO. [SN].
Lesch-Nyhan syndrome
A reproductive organ cancer that is located_in the sex cord-derived tissues of the ovary or testis and derives_from granulosa cells, Leydig cells, Sertoli cells, and fibroblasts.
DOID:12293
MESH:D018312
NCI:C3794
SNOMEDCT_US_2020_03_01:253028001
UMLS_CUI:C0206724
Sex Cord-Stromal neoplasm
Sex cord stromal tumour
Specialized gonadal neoplasm
Specialized gonadal tumor
Specialized gonadal tumour
sex cord-gonadal stromal tumour
disease_ontology
DOID:192
sex cord-gonadal stromal tumor
An acquired metabolic disease that has_material_basis_in an abnormally high level of uric acid in the blood.
MESH:D033461
NCI:C3961
SNOMEDCT_US_2020_03_01:271198001
UMLS_CUI:C0740394
Blood urate raized
uricacidemia
disease_ontology
DOID:1920
hyperuricemia
A chromosomal duplication syndrome that is characterized by infertility and that has_material_basis_in an extra X chromosome in cells in men.
GARD:8705
ICD10CM:Q98.0
ICD9CM:758.7
MESH:D007713
NCI:C34752
SNOMEDCT_US_2020_03_01:405770005
UMLS_CUI:C0022735
47, XXY
Hypogonadotropic Hypogonadism
Klinefelter's syndrome
XXY syndrome
XXY trisomy
disease_ontology
DOID:1921
No OMIM mapping, confirmed by DO. [LS].
Klinefelter syndrome
A gonadal disease that is characterized by atypical development of chromosomal, gonadal, or anatomic sex.
MESH:D012734
UMLS_CUI:C0036875
sex development disorder
sex differentiation disease
disease_ontology
DOID:1923
disorder of sexual development
A gonadal disease that is characterized by diminished functional activity of the gonads.
MESH:D007006
NCI:C9227
OMIM:241100
OMIM:312300
SNOMEDCT_US_2020_03_01:48130008
UMLS_CUI:C0020619
disease_ontology
DOID:1924
hypogonadism
An autosomal dominant non-syndromic intellectual disability that is characterized by mental retardation associated with coarse facial features, hypertrichosis, sparse scalp hair, and hypoplastic or absent fifth fingernails or toenails.
GARD:6124
MESH:C536436
NCI:C35321
OMIM:PS135900
ORDO:1465
SNOMEDCT_US_2020_03_01:10007009
UMLS_CUI:C0265338
Dwarfism-Onychodysplasia
Fifth Digit Syndrome
Short Stature-Onychodysplasia.
disease_ontology
DOID:1925
OMIM mapping confirmed by DO. [SN].
Coffin-Siris syndrome
A sphingolipidosis characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body, especially within the bone marrow, spleen and liver.
GARD:8233
ICD10CM:E75.22
MESH:D005776
NCI:C61268
ORDO:355
SNOMEDCT_US_2020_03_01:190794006
UMLS_CUI:C0017205
Gaucher disease
acid beta-glucosidase deficiency
glocucerebrosidase deficiency
glucosylceramide beta-glucosidase deficiency
kerasin thesaurismosis
disease_ontology
DOID:1926
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Gaucher's disease
A lipid storage disease characterized by functional deficiencies in the enzymes needed for lysosomal degradation of sphingolipid substrates.
GARD:7672
ICD10CM:E75.3
MESH:D013106
NCI:C117254
SNOMEDCT_US_2020_03_01:58459009
UMLS_CUI:C0037899
Sphingolipidosis
sphingolipidoses
disease_ontology
DOID:1927
sphingolipidosis
A syndrome that is characterized by mild to moderate intellectual disability, a broad forehead, a short nose with a broad tip, full cheeks, and a wide mouth with full lips and difficulty with visual-spatial tasks and has_material_basis_in hemizygous deletion of 1.5 to 1.8 Mb on chromosome 7q11.23.
ICD10CM:Q93.82
MESH:D018980
NCI:C85232
OMIM:194050
SNOMEDCT_US_2020_03_01:63247009
UMLS_CUI:C0175702
Fanconi Schlesinger syndrome
disease_ontology
DOID:1928
OMIM mapping confirmed by DO. [LS].
Williams-Beuren syndrome
An aortic valve stenosis that is characterized by a narrowing of the section of the aorta just above the valve that connects the aorta to the heart.
GARD:743
ICD10CM:Q25.3
MESH:D021921
NCI:C85176
OMIM:185500
SNOMEDCT_US_2020_03_01:204436002
UMLS_CUI:C0003499
Supra-valvular aortic stenosis
disease_ontology
DOID:1929
supravalvular aortic stenosis
An organ system cancer that is manifested in the reproductive organs.
DOID:1900
NCI:C3674
UMLS_CUI:C0178830
Reproductive tumor
malignant reproductive system neoplasm
disease_ontology
cancer of reproductive system
DOID:193
reproductive organ cancer
A syndrome characterized by pituitary dysfunction, childhood onset ataxia, peripheral neuropathy, spastic paraplegia, and chorioretinopathy that has_material_basis_in homozygous or compound heterozygous mutation in PNPLA6 on chromosome 19p13.2.
GARD:12635
MEDDRA:10056710
MESH:D007849
NCI:C34760
OMIM:245800
ORDO:2377
SNOMEDCT_US_2020_03_01:232059000
UMLS_CUI:C0023138
LNMS
disease_ontology
Laurence-Moon-Biedl syndrome
DOID:1930
OMIM mapping confirmed by DO. [SN].
Laurence-Moon syndrome
A syndrome that is characterized by delayed development, intellectual disability, severe speech impairment, and problems with movement and balance.
GARD:5810
ICD10CM:Q93.51
MESH:D017204
NCI:C75462
OMIM:105830
SNOMEDCT_US_2020_03_01:76880004
UMLS_CUI:C0162635
happy puppet syndrome
puppetlike syndrome
disease_ontology
DOID:1932
OMIM mapping confirmed by DO. [SN].
Angelman syndrome
MESH:D017204
A syndrome characterized by short stature, moderate to sever intellectual disability, distinctive facial features and broad thumbs and first toes.
GARD:7593
ICD10CM:Q87.2
MESH:D012415
NCI:C75466
OMIM:180849
OMIM:610543
OMIM:613684
ORDO:783
SNOMEDCT_US_2020_03_01:157032007
UMLS_CUI:C0035934
Broad Thumb-Hallux syndrome
Rubinstein syndrome
proximal chromosome 16p13.3 deletion syndrome
disease_ontology
DOID:1933
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Rubinstein-Taybi syndrome
A bone development disease that results in defective ossification of located in bone.
MESH:D004413
NCI:C34560
SNOMEDCT_US_2020_03_01:109420003
UMLS_CUI:C0013393
disease_ontology
DOID:1934
dysostosis
A syndrome that results from mutations in multiple BBS genes affecting cellular cilia structure or function (ciliopathy) resulting in variable presentation and characterized principally by obesity, retinitis pigmentosa,vision loss, polydactyly, mental retardation, hypogonadism, and renal failure in some cases.
GARD:6866
ICD10CM:Q87.89
MESH:D020788
NCI:C118632
OMIM:PS209900
ORDO:110
SNOMEDCT_US_2020_03_01:5619004
UMLS_CUI:C0752166
disease_ontology
DOID:1935
OMIM mapping confirmed by DO. [SN].
Bardet-Biedl syndrome
EFO:0003914
ICD10CM:I70
ICD9CM:440
MESH:D050197
NCI:C35768
SNOMEDCT_US_2020_03_01:155414001
UMLS_CUI:C0004153
disease_ontology
DOID:1936
atherosclerosis
MESH:D050197
A parasitic protozoa infectious disease that is caused by singled-celled protozoan parasites Trichomonas vaginalis or Trichomonas tenax, which infect the urogenital tract and mouth respectively.
DOID:10996
ICD10CM:A59
ICD9CM:131
MESH:D014245
NCI:C35720
SNOMEDCT_US_2020_03_01:56335008
UMLS_CUI:C0040921
disease_ontology
trichomonas infection
DOID:1947
trichomoniasis
A cholangitis that is characterized by an inflammation that is located in the gallbladder.
DOID:1948
DOID:2829
DOID:9438
GARD:30
ICD10CM:K81
ICD9CM:575.10
MESH:D002764
NCI:C34465
OMIM:600803
SNOMEDCT_US_2020_03_01:76581006
UMLS_CUI:C0008325
acute and chronic cholecystitis
acute cholecystitis
acute on chronic cholecystitis
chronic cholecystitis
disease_ontology
DOID:1949
OMIM mapping confirmed by DO. [SN].
cholecystitis
A female reproductive system disease that is located_in the fallopian tube.
MESH:D005184
NCI:C26771
SNOMEDCT_US_2020_03_01:128134005
UMLS_CUI:C0015556
disease_ontology
DOID:1962
fallopian tube disease
A fallopian tube cancer that is located_in the fallopian tube.
MESH:D005185
NCI:C3867
SNOMEDCT_US_2020_03_01:276870001
UMLS_CUI:C0238122
cancer of the fallopian tube
carcinoma of fallopian tube
fallopian tube Ca
disease_ontology
DOID:1963
fallopian tube carcinoma
A female reproductive organ cancer that is located_in fallopian tube.
DOID:1961
GARD:9162
ICD10CM:C57.0
ICD9CM:183.2
MESH:D005185
NCI:C3032
NCI:C7480
SNOMEDCT_US_2020_03_01:126916003
SNOMEDCT_US_2020_03_01:93794008
UMLS_CUI:C0015558
UMLS_CUI:C0153579
fallopian tube neoplasm
malignant neoplasm of uterine tube
malignant tumor of fallopian tube
malignant tumour of fallopian tube
neoplasm of fallopian tube
tumor of the fallopian tube
tumor, fallopian tube, malignant
disease_ontology
DOID:1964
fallopian tube cancer
A smooth muscle cancer that can arise almost anywhere in the body, but is most common in the uterus, abdomen, or pelvis.
GARD:6880
MESH:D007890
NCI:C3158
SNOMEDCT_US_2020_03_01:443719001
UMLS_CUI:C0023269
Leiomyosarcomas
disease_ontology
DOID:1967
leiomyosarcoma
A brain disease that is caused by damage to the motor control centers of the developing brain during pregnancy, during childbirth or after birth, which affects muscle movement and balance.
DOID:1968
ICD10CM:G80
MESH:D002547
NCI:C34460
SNOMEDCT_US_2020_03_01:155024003
UMLS_CUI:C0007789
infantile cerebral palsy
disease_ontology
DOID:1969
cerebral palsy
A carcinosarcoma that derives_from simultaneously or consecutively in mesodermal tissue and glandular epithelium.
MESH:D018195
NCI:C9474
SNOMEDCT_US_2020_03_01:189804002
UMLS_CUI:C0001442
Adenosarcoma
mullerian Adenosarcoma
disease_ontology
DOID:1974
adenosarcoma
MESH:D018195
MESH:D012004
NCI:C3350
SNOMEDCT_US_2020_03_01:126847008
UMLS_CUI:C0034885
Rectal tumor
neoplasm of rectum
rectum neoplasm
disease_ontology
DOID:1984
rectal benign neoplasm
A colorectal cancer that is located_in the rectum.
DOID:1989
ICD10CM:C20
ICD9CM:154.1
MESH:D012004
NCI:C7418
NCI:C9382
SNOMEDCT_US_2020_03_01:254582000
SNOMEDCT_US_2020_03_01:93984006
UMLS_CUI:C0007113
UMLS_CUI:C0949022
carcinoma of rectum
carcinoma of the rectum
malignant Rectal tumor
malignant neoplasm of rectum
malignant rectum tumor
malignant tumor of rectum
rectal cancer
disease_ontology
cancer of rectum
DOID:1993
rectum cancer
A rectum cancer that derives_from epithelial cells of glandular origin.
NCI:C9383
SNOMEDCT_US_2020_03_01:254582000
UMLS_CUI:C0149978
Rectal adenocarcinoma
disease_ontology
DOID:1996
rectum adenocarcinoma
MESH:D005870
NCI:C3055
SNOMEDCT_US_2020_03_01:443790001
UMLS_CUI:C0017525
disease_ontology
DOID:200
benign giant cell tumor
A nervous system benign neoplasm that is characterized as a nerve tissue tumor.
MESH:D009463
NCI:C3275
SNOMEDCT_US_2020_03_01:25169009
UMLS_CUI:C0027858
disease_ontology
DOID:2001
neuroma
ICD9CM:362.56
MESH:D019773
SNOMEDCT_US_2020_03_01:193391002
UMLS_CUI:C0339543
Macular puckering of retina
Macular retinal puckering
cellophane maculopathy
disease_ontology
DOID:2006
preretinal fibrosis
ICD10CM:H35.3
ICD9CM:362.5
SNOMEDCT_US_2020_03_01:193384000
UMLS_CUI:C0339436
degeneration of macula and posterior pole of retina
degeneration of macula or posterior pole
disease_ontology
DOID:2007
degeneration of macula and posterior pole
A musculoskeletal system cancer that is located_in connective tissue.
MESH:D009372
SNOMEDCT_US_2020_03_01:126598008
UMLS_CUI:C0027656
Tumour of connective tissue
connective tissue neoplasm
neoplasm of connective tissues
disease_ontology
DOID:201
connective tissue cancer
A T cell deficiency that results from the disfunction or underdevelopment of the thymus.
ICD10CM:D81.4
ICD9CM:279.13
OMIM:242700
ORDO:83471
SNOMEDCT_US_2020_03_01:55602000
UMLS_CUI:C0152094
Nezelof's syndrome
T-cell immunodeficiency with thymic aplasia
TIDTA
thymic aplasia
thymic dysplasia with normal immunoglobulins
disease_ontology
DOID:2012
OMIM mapping confirmed by DO. [SN].
Nezelof syndrome
ICD10CM:E16.1
MESH:D006946
SNOMEDCT_US_2020_03_01:154694003
UMLS_CUI:C0020459
hyperinsulinemia
disease_ontology
DOID:2018
hyperinsulinism
A female reproductive organ cancer that is located_in the placenta.
DOID:2023
ICD10CM:C58
ICD9CM:181
NCI:C3555
SNOMEDCT_US_2020_03_01:188187004
UMLS_CUI:C0153572
Placental tumors
malignant Placental tumor
malignant neoplasm of placenta
neoplasm of placenta
placental cancer
primary malignant neoplasm of placenta
disease_ontology
DOID:2021
placenta cancer
A choriocarcicoma that develops in the presence of a preceding gestational event.
NCI:C4646
SNOMEDCT_US_2020_03_01:1884006
UMLS_CUI:C0349557
Gestational choriocarcinoma
Gestational chorionepithelioma
Molar pregnancy with choriocarcinoma
disease_ontology
DOID:2025
gestational choriocarcinoma
A hyperostosis that involves formation of new bone on the surface of preexisting bone.
ICD10CM:M27.8
ICD9CM:726.91
MESH:D005096
NCI:C3029
SNOMEDCT_US_2020_03_01:80400009
UMLS_CUI:C1442903
bone spur
bony outgrowth
orbital exostosis
osteophyte
swimmer's exostosis
disease_ontology
DOID:203
exostosis
A cognitive disorder that involves an excessive, irrational dread of everyday situations.
DOID:12884
ICD10CM:F41.9
MESH:D001008
NCI:C2878
OMIM:607834
SNOMEDCT_US_2020_03_01:65673007
UMLS_CUI:C0003469
anxiety
anxiety state
disease_ontology
DOID:2030
anxiety disorder
A specific developmental disorder that involves specific developmental disorders of speech and language.
ICD10CM:F80.9
MESH:D003147
NCI:C2958
SNOMEDCT_US_2020_03_01:74825008
UMLS_CUI:C0009460
disease_ontology
DOID:2033
communication disorder
A brain disease that is characterized by cerebral softening located_in cerebrum has_material_basis_in injured or dead cells of the central nervous system.
MESH:D004678
NCI:C98920
SNOMEDCT_US_2020_03_01:58762006
UMLS_CUI:C0014068
disease_ontology
DOID:2034
encephalomalacia
A connective tissue disease characterized by damage of tissues located_in the entheses, the site of insertion of tendons or ligaments into bones or joint capsules, with symptoms of pain, swelling and inflammation.
ICD10CM:M77.9
ICD9CM:726.90
MESH:D000070676
SNOMEDCT_US_2020_03_01:278525009
UMLS_CUI:C0242490
disease_ontology
DOID:204
enthesopathy
MESH:D000070676
A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis B virus, which is transmitted_by sexual contact, transmitted_by blood transfusions, and transmitted_by fomites like needles or syringes. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom joint pain, and has_symptom jaundice.
DOID:12591
DOID:12592
DOID:2042
EFO:0004197
MESH:D006509
NCI:C3097
SNOMEDCT_US_2020_03_01:66071002
UMLS_CUI:C0019163
chronic hepatitis B
hepatitis B infection
disease_ontology
Serum hepatitis
DOID:2043
hepatitis B
A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis delta virus, which is an incomplete virus that requires the helper function of Hepatitis B virus to replicate and only occurs among people who are infected with the Hepatitis B virus. The infection has_symptom fatigue, has_symptom lethargy, has_symptom anorexia, has_symptom nausea, has_symptom jaundice, has_symptom clay-colored stools, has_symptom dark urine, has_symptom changes in personality, has_symptom disturbances in sleep, has_symptom confusion, has_symptom abnormal behavior, has_symptom somnolence, and has_symptom coma.
DOID:2046
MESH:D003699
SNOMEDCT_US_2020_03_01:424460009
UMLS_CUI:C0011226
delta hepatitis
disease_ontology
DOID:2047
hepatitis D
An autoimmune disease of gastrointestinal tract that results_in inflammation located_in liver caused by the body's immune system attacking the liver cells.
DOID:4745
GARD:5871
ICD9CM:571.42
MESH:D019693
NCI:C27778
SNOMEDCT_US_2020_03_01:16098491000119109
UMLS_CUI:C0241910
UMLS_CUI:C1332355
Autoimmune Hepatitis
Autoimmune chronic active hepatitis
Autoimmune hepatitis
autoimmune hepatitis with centrilobular necrosis
disease_ontology
DOID:2048
autoimmune hepatitis
A bone remodeling disease that results in an abnormal growth of located in bone.
ICD10CM:M89.3
MESH:D015576
NCI:C34712
SNOMEDCT_US_2020_03_01:13814009
UMLS_CUI:C0020492
bone hypertrophy
hypertrophy of bone
disease_ontology
DOID:205
hyperostosis
A maxillary sinusitis which lasts for less than 4 weeks.
ICD10CM:J01.0
ICD9CM:461.0
SNOMEDCT_US_2020_03_01:155499007
UMLS_CUI:C0155804
acute antritis
disease_ontology
DOID:2050
acute maxillary sinusitis
A sinusitis which involves infection of maxillary sinuses that causes pain or pressure over the cheeks just below the eyes, tooth ache, and headache.
ICD10CM:J32.0
MESH:D015523
NCI:C34809
SNOMEDCT_US_2020_03_01:275484005
UMLS_CUI:C0024959
disease_ontology
DOID:2051
maxillary sinusitis
An anxiety disorder which results from a traumatic experience that results in psychological trauma.
ICD10CM:F43.1
ICD9CM:309.81
MESH:D013313
NCI:C3389
SNOMEDCT_US_2020_03_01:192415000
UMLS_CUI:C0038436
PTSD
traumatic neurosis
disease_ontology
post-traumatic stress disorder
DOID:2055
post-traumatic stress disorder
A candidiasis that refers to a heterogeneous group of disorders characterized by recurrent or persistent superficial fungal infections located_in skin, located_in mucous membrane, or located_in nail due to T-cell defects, has-agent Candida species and has_symptom scaling of skin lesions, has_symptom thickening of nails, has_symptom swollen periungal tissue, and has_symptom scarring of the scalp.
DOID:2056
GARD:12313
MESH:D002178
NCI:C34444
OMIM:114580
OMIM:212050
OMIM:607644
OMIM:613108
OMIM:613956
OMIM:614162
OMIM:615527
OMIM:616445
ORDO:1334
SNOMEDCT_US_2020_03_01:234568006
UMLS_CUI:C0006845
chronic Mucocutaneous Candidiasis
disease_ontology
DOID:2058
chronic mucocutaneous candidiasis
A female reproductive system disease that is located_in the vulva.
MESH:D014845
NCI:C27631
SNOMEDCT_US_2020_03_01:5089007
UMLS_CUI:C0042994
disease_ontology
DOID:2059
vulvar disease
disease_ontology
Eccrine nodular hidradenoma
nodular hidradenoma
DOID:2061
nodular hidradenoma
GARD:10547
MESH:D018252
NCI:C3761
OMIM:186600
SNOMEDCT_US_2020_03_01:189051001
UMLS_CUI:C0206673
disease_ontology
DOID:2065
syringoma
ICD9CM:569.83
MESH:D007416
NCI:C39611
SNOMEDCT_US_2020_03_01:56905009
UMLS_CUI:C0021845
Perforation of intestine
disease_ontology
DOID:2074
intestinal perforation
A bowel dysfunction that is characterized by infrequent or difficult evacuation of feces.
ICD10CM:K59.0
ICD9CM:564.0
MESH:D003248
NCI:C37930
SNOMEDCT_US_2020_03_01:363693003
UMLS_CUI:C0009806
disease_ontology
DOID:2089
constipation
ICD10CM:M12.8
ICD9CM:716.4
NCI:C35761
SNOMEDCT_US_2020_03_01:66191007
UMLS_CUI:C0152083
disease_ontology
DOID:2092
transient arthritis
A vulva cancer that has_material_basis in melanocytes.
NCI:C40329
SNOMEDCT_US_2020_03_01:254896002
UMLS_CUI:C0241989
malignant melanoma of vulva
disease_ontology
DOID:2093
vulvar melanoma
ICD10CM:C44
NCI:C4810
SNOMEDCT_US_2020_03_01:255095005
UMLS_CUI:C1321904
malignant neoplasm of sweat gland
malignant tumor of the Sweat gland
disease_ontology
DOID:2095
sweat gland cancer
A vulva adenocarcinoma that is characterized by distinctive large cells with prominent cytoplasm, referred to as Paget cells and is an intraepithelial neoplasm of epithelial origin expressing apocrine or eccrine glandular-like features.
NCI:C4027
SNOMEDCT_US_2020_03_01:254898001
UMLS_CUI:C1275217
Paget's disease of vulva
Vulval Paget's disease
Vulvar Paget's disease
vulval Paget disease
disease_ontology
DOID:2097
vulval Paget's disease
A vulva carcinoma that derives_from epithelial cells of glandular origin.
NCI:C6380
UMLS_CUI:C1336975
adenocarcinoma of Vulva
disease_ontology
adenocarcinoma of the vulva
DOID:2098
vulva adenocarcinoma
A muscle tissue disease that is characterised by slow muscle relaxation associated with hyperexcitation of the muscle fibres.
GARD:12301
ICD9CM:359.22
MESH:D009224
NCI:C84912
OMIM:160800
OMIM:255700
ORDO:614
UMLS_CUI:C0027127
Congenital myotonia, autosomal dominant form
Thomsen disease
Thomsen's disease
disease_ontology
DOID:2106
OMIM mapping confirmed by DO. [SN].
myotonia congenita
A coccidiosis that involves infection of the epithelial cells of the small intestine with Cystoisospora belli, which results in nonbloody diarrhea with crampy abdominal pain, malabsorption and weight loss.
DOID:4891
ICD10CM:A07.3
MESH:D021865
NCI:C4076
SNOMEDCT_US_2020_03_01:73034009
UMLS_CUI:C0311386
Infection by Isospora belli and Isospora hominis
Isosporosis
isosporiasis
disease_ontology
DOID:2112
cystoisosporiasis
A parasitic protozoa infectious disease that occurs in the intestinal tract of animals and humans caused by Coccidia protozoa. Immunocompromised persons are at greater risk of developing the infection.
MESH:D003048
NCI:C34493
SNOMEDCT_US_2020_03_01:186125004
UMLS_CUI:C0009187
Coccidiosis
disease_ontology
intestinal coccidiosis
DOID:2113
coccidiosis
A primary immunnodeficiency disease that is caused by a lack of infection-fighting antibody producing B cells (immunoglobulins) or B cells that are not functioning properly.
DOID:6026
ICD9CM:279.03
SNOMEDCT_US_2020_03_01:190982008
UMLS_CUI:C0154276
B cell (antibody) deficiencies
Immunoglobulin heavy chain deficiency
immunoglobulin heavy chain deletion
disease_ontology
DOID:2115
B cell deficiency
A syndrome characterized at birth by streaks of very thin skin (dermal hypoplasia), cutis aplasia, and telangiectases, and has_material_basis_in heterozygous mutation in the PORCN gene on chromosome Xp11.23.
GARD:6457
MESH:D005489
NCI:C84715
OMIM:305600
ORDO:2092
SNOMEDCT_US_2020_03_01:205573006
UMLS_CUI:C0016395
FDH
FODH
Goltz syndrome
Goltz-Gorlin syndrome
disease_ontology
DOID:2120
OMIM mapping confirmed by DO. [SN].
focal dermal hypoplasia
A syndrome characterized by abnormal development in 2 or more ectodermal structures (hair, nails, teeth, and sweat glands) without other systemic findings.
GARD:6317
ICD9CM:757.31
MESH:D004476
NCI:C84683
OMIM:PS305100
ORDO:79373
SNOMEDCT_US_2020_03_01:8654005
UMLS_CUI:C0013575
Congenital ectodermal defect
Congenital ectodermal dysplasia
disease_ontology
DOID:2121
ectodermal dysplasia
A primary bacterial infectious disease that has_material_basis_in Francisella tularensis, which is transmitted by dog tick bite (Dermacentor variabilis), transmitted by deer flies (Chrysops sp) or transmitted by contact with infected animal tissues.
GARD:396
ICD9CM:021.8
SNOMEDCT_US_2020_03_01:186298002
UMLS_CUI:C0029835
disease_ontology
DOID:2123
tularemia
A brain cancer that is usually located in the brain, but can occur anywhere in the central nervous system.
NCI:C6906
OMIM:609322
ORDO:99966
SNOMEDCT_US_2020_03_01:128792003
UMLS_CUI:C1266184
Atypical teratoid/rhabdoid tumor
Atypical teratoid/rhabdoid tumour
Rhabdoid tumor of the CNS
Rhabdoid tumour of the CNS
atypical teratoid rhabdoid tumour
disease_ontology
AT/RT
rhabdoid tumor predisposition syndrome
DOID:2129
OMIM mapping confirmed by DO. [SN].
atypical teratoid rhabdoid tumor
ICD10CM:K03.8
ICD9CM:521.8
SNOMEDCT_US_2020_03_01:197505001
UMLS_CUI:C0029770
disease_ontology
DOID:214
teeth hard tissue disease
An extrapulmonary tuberculosis that is located_in urogenital system.
ICD10CM:A18.1
ICD9CM:016
MESH:D014401
SNOMEDCT_US_2020_03_01:4445009
UMLS_CUI:C0041333
disease_ontology
Genitourinary tuberculosis
DOID:2149
urogenital tuberculosis
An ovary epithelial cancer that has_material_basis_in epithelial and stromal tissue and arises from the surface epithelium of the ovary.
NCI:C40026
UMLS_CUI:C1518236
disease_ontology
DOID:2151
malignant ovarian surface epithelial-stromal neoplasm
An ovarian cancer that is derives_from ovarian surface epithelium.
NCI:C4381
SNOMEDCT_US_2020_03_01:237057005
UMLS_CUI:C0341823
Ovarian Surface epithelial-Stromal tumor
disease_ontology
DOID:2152
ovary epithelial cancer
A kidney cancer that affects the kidneys and typically located_in children.
DOID:5177
DOID:5180
ICDO:M8960/3
MESH:D009396
NCI:C27730
NCI:C3267
NCI:C6180
OMIM:194070
SNOMEDCT_US_2020_03_01:25081006
UMLS_CUI:C0027708
UMLS_CUI:C1332219
UMLS_CUI:C1333015
adult nephroblastoma
disease_ontology
Wilms' tumor
DOID:2154
OMIM mapping confirmed by DO. [SN].
nephroblastoma
An ovarian cancer that originates in the germ (egg) cells of the ovary.
GARD:9330
NCI:C3873
OMIM:603737
SNOMEDCT_US_2020_03_01:237059008
UMLS_CUI:C0238324
germ cell neoplasm of Ovary
germ cell tumor of ovary
disease_ontology
ovarian germ cell tumor
DOID:2156
OMIM mapping confirmed by DO. [SN].
ovarian germ cell cancer
A teeth hard tissue disease that is characterized by damage to a tooth that can happen when decay-causing bacteria in your mouth make acids that attack the tooth’s surface, or enamel.
DOID:10785
DOID:10870
DOID:11913
EFO:0003819
ICD10CM:K02
ICD10CM:K02.6
ICD9CM:521.0
ICD9CM:521.07
MESH:D003731
NCI:C52593
SNOMEDCT_US_2020_03_01:155632007
UMLS_CUI:C0011334
UMLS_CUI:C1456145
Dental caries extending into pulp
Dental caries of smooth surface
Dental caries pit and fissure
disease_ontology
DOID:216
dental caries
DOID:4728
NCI:C27102
SNOMEDCT_US_2020_03_01:232340005
UMLS_CUI:C0339820
disease_ontology
DOID:2163
nasal cavity disease
ICD9CM:521.01
SNOMEDCT_US_2020_03_01:80353004
UMLS_CUI:C0266853
Dental caries limited to enamel
primary dental caries
simple dental cavity
disease_ontology
DOID:217
enamel caries
A vaginal disease that is characterized by inflammation of the vagina.
DOID:10769
ICD9CM:616.1
MESH:D014627
NCI:C26911
SNOMEDCT_US_2020_03_01:198212006
SNOMEDCT_US_2020_03_01:393596009
UMLS_CUI:C0042267
UMLS_CUI:C0042268
disease_ontology
DOID:2170
vaginitis
A sensory system cancer located_in the eye that is characterized by uncontrolled cellular proliferation in the eye.
DOID:9985
ICD9CM:190.8
MESH:D005134
NCI:C3030
SNOMEDCT_US_2020_03_01:126995000
SNOMEDCT_US_2020_03_01:188277006
UMLS_CUI:C0015414
UMLS_CUI:C0153632
Ocular tumor
eye neoplasm
malignant eye neoplasm
neoplasm of eye
neoplasm of eye proper
disease_ontology
DOID:2174
ocular cancer
ICD10CM:C18.2
ICD9CM:153.6
SNOMEDCT_US_2020_03_01:93683002
UMLS_CUI:C0153439
Ca ascending colon
malignant neoplasm of right colon
malignant tumor of ascending colon
disease_ontology
DOID:218
ascending colon cancer
A dental enamel hypoplasia characterized by abnormal enamel formation.
GARD:5791
ICD10CM:K00.5
MESH:D000567
OMIM:PS104500
ORDO:88661
SNOMEDCT_US_2020_03_01:78494001
UMLS_CUI:C0002452
disease_ontology
DOID:2187
Xref MGI.
amelogenesis imperfecta
A colorectal cancer that is located_in the colon.
ICD10CM:C18
ICD9CM:153
MESH:D003110
NCI:C9242
SNOMEDCT_US_2020_03_01:363406005
UMLS_CUI:C0007102
disease_ontology
DOID:219
colon cancer
A blood coagulation disease that is characterized by easy bleeding, has_symptom prolonged umbilical cord bleeding, epistaxis, bleeding of the gums, menorrhagia, recurrent miscarriages, abnormal scar formation and wound healing, and hemarthrosis, and has_material_basis_in autosomal recessive inheritance of mutation of the F13A1 or F13B gene, which encodes Factor XIII, formally known as fibrin stabilizing factor.
GARD:10766
MESH:D005177
NCI:C98941
OMIM:613225
OMIM:613235
SNOMEDCT_US_2020_03_01:50189006
UMLS_CUI:C0015530
Factor XIII deficiency disease
Hereditary factor XIII deficiency disease
deficiency, Laki-Lorand factor
disease_ontology
DOID:2211
OMIM mapping confirmed by DO. [SN].
factor XIII deficiency
ICD10CM:D69.9
ICD9CM:287.9
MESH:D006474
SNOMEDCT_US_2020_03_01:268884000
UMLS_CUI:C0019087
Hemorrhagic diathesis
Hemorrhagic disease
disease_ontology
DOID:2213
hemorrhagic disease
A blood coagulation disease that is characterized by easy bleeding, has_symptom epistaxis, bleeding of the gums, menorrhagia, and occasionally hemarthrosis, and has_material_basis_in autosomal recessive inheritance of mutation in the F7 gene, which encodes coagulation factor VII, an important factor in the clotting cascade.
GARD:2238
ICD10CM:D68.2
MESH:D005168
NCI:C131631
SNOMEDCT_US_2020_03_01:154820003
UMLS_CUI:C0015503
Factor VII deficiency
deficiency, stable
disease_ontology
DOID:2215
factor VII deficiency
GARD:2237
ICD10CM:D68.2
MESH:D005166
NCI:C98938
OMIM:227400
SNOMEDCT_US_2020_03_01:191284007
UMLS_CUI:C0015499
Hereditary hypoproaccelerinaemia
Labile factor deficiency
Proaccelerin deficiency
deficiency, labile
disease_ontology
DOID:2216
OMIM mapping confirmed by DO. [SN].
factor V deficiency
A blood coagulation disease characterized by autosomal recessive inheritance of mucosal bleeding, purpuric skin bleeding, epistaxis, and menorrhagia with prolonged bleeding times, enlarged platelets and absence of platelet aggregation in response to von Willebrand factor that has material_basis_in mutation in the GP1BA gene, the GP1BB gene, or the GP9 gene which are subunits of the platelet membrane von Willebrand factor receptor complex, glycoprotein Ib.
MESH:D001606
NCI:C84595
OMIM:231200
ORDO:274
SNOMEDCT_US_2020_03_01:54569005
UMLS_CUI:C0005129
Bernard - Soulier thrombopathy
Bernard Soulier syndrome
Giant platelet syndrome
Hemorrhagic dystrophic thrombocytopenia
Thrombopathy, Bernard-Soulier
disease_ontology
DOID:2217
OMIM mapping confirmed by DO. [SN].
Bernard-Soulier syndrome
A blood coagulation disease that is characterized by an abnormal increase or decrease in platelets or platelet dysfunction.
MESH:D001791
NCI:C131634
SNOMEDCT_US_2020_03_01:22716005
UMLS_CUI:C0005818
Thrombocytopathy
platelet disorder
disease_ontology
DOID:2218
blood platelet disease
A blood coagulation disease characterized by autosomal recessive inheritance of failure of platelet aggregation and absent or diminished clot retraction that has material_basis_in mutation in the ITGA2B or ITGB3 genes on chromosome 17q21.32.
GARD:2478
ICD10CM:D69.1
MESH:D013915
NCI:C61249
OMIM:273800
ORDO:849
SNOMEDCT_US_2020_03_01:32942005
UMLS_CUI:C0040015
BDPLT2
Glanzmann thrombasthenia
Glycoprotein IIb/IIIa defect
Thrombocytasthenia
deficiency of GP IIb-IIIa complex
deficiency of glycoprotein complex IIb-IIIa
deficiency of platelet fibrinogen receptor
platelet glycoprotein IIb-IIIa deficiency
platelet-type bleeding disorder 2
thrombasthenia of Glanzmann and Naegeli
disease_ontology
DOID:2219
OMIM mapping confirmed by DO. [LS].
Glanzmann's thrombasthenia
A blood coagulation disease that is characterized by the partial or complete absence of factor X activity in the blood.
GARD:6404
MESH:D005171
NCI:C131632
SNOMEDCT_US_2020_03_01:76642003
UMLS_CUI:C0015519
Factor X deficiency
disease, Stuart-Prower
disease_ontology
DOID:2222
factor X deficiency
GARD:5034
MESH:D010981
OMIM:185050
SNOMEDCT_US_2020_03_01:234474009
UMLS_CUI:C0032197
Dense body defect
Platelet dense granule deficiency
Platelet storage pool defect
disease_ontology
DOID:2223
platelet storage pool deficiency
A myeloproliferative neoplasm that is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage and that results_in the overproduction of platelets.
GARD:6594
ICD10CM:D47.3
ICD9CM:238.71
MESH:D013920
NCI:C3407
OMIM:187950
OMIM:601977
OMIM:614521
ORDO:3318
ORDO:71493
SNOMEDCT_US_2020_03_01:234499005
UMLS_CUI:C0040028
Essential thrombocythaemia
familial thrombocytosis
hemorrhagic thrombocythemia
hereditary thrombocythemia
primary Thrombocytosis
disease_ontology
DOID:2224
Xref MGI.
OMIM mapping confirmed by DO. [SN].
essential thrombocythemia
A myeloid neoplasm that is characterized by a group of slow growing blood cancers in which large numbers of abnormal red blood cells, white blood cells, or platelets grow and spread in the bone marrow and the peripheral blood.
DOID:6002
ICD10CM:D47.1
NCI:C4345
SNOMEDCT_US_2020_03_01:115248004
UMLS_CUI:C1292778
CMPD
CMPD, U
chronic myeloproliferative disease
disease_ontology
DOID:2226
myeloproliferative neoplasm
A blood platelet disease that is characterized by the presence of high platelet counts in the blood.
MESH:D013922
NCI:C35530
SNOMEDCT_US_2020_03_01:165557006
UMLS_CUI:C0836924
Thrombocythaemia
disease_ontology
DOID:2228
thrombocytosis
A blood coagulation disease that is characterized by deficiency of factor XI clotting factor and mild prolonged bleeding, especially of mucosal sites following trauma, and has_material_basis_in homozygous, compound heterozygous, or heterozygous mutation of the coagulation factor XI gene of chromosome 4q35.2.
GARD:9670
ICD10CM:D68.1
ICD9CM:286.2
MESH:D005173
NCI:C84705
OMIM:612416
SNOMEDCT_US_2020_03_01:49762007
UMLS_CUI:C0015523
Congenital factor XI deficiency
Hereditary factor XI deficiency disease
Rosenthal's disease
hemophilia C
plasma thromboplastin antecedent deficiency
disease_ontology
DOID:2229
OMIM mapping confirmed by DO. [SN].
factor XI deficiency
A blood coagulation disease that is characterized by prolonged PTT time without clinical symptoms, and has_material_basis_in a mutation in the F12 gene on chromosome 5q33.
GARD:6558
MESH:D005175
NCI:C131740
OMIM:234000
ORDO:330
SNOMEDCT_US_2020_03_01:46981006
UMLS_CUI:C0015526
Factor XII deficiency disease
Hageman Factor deficiency
deficiency, Hageman
disease_ontology
DOID:2231
OMIM mapping confirmed by DO. [SN].
factor XII deficiency
An epilepsy syndrome that is characterised by seizures that are preceded by an isolated disturbance of a cerebral function and arise from an epileptic focus, a small portion of the brain that serves as the irritant driving the epileptic response.
MESH:D004828
NCI:C122812
SNOMEDCT_US_2020_03_01:230381009
UMLS_CUI:C0014547
localisation-related epilepsy
partial epilepsy
disease_ontology
DOID:2234
focal epilepsy
A blood coagulation disease that is characterized by an impaired blood clotting resulting from a lack deficiency of a the fibrinogen protein (coagulation factor I).
GARD:5761
MESH:D000347
NCI:C98130
OMIM:202400
SNOMEDCT_US_2020_03_01:278504009
UMLS_CUI:C0001733
Factor I deficiency
Fibrinogen deficiency
disease_ontology
DOID:2236
OMIM mapping confirmed by DO. [SN].
congenital afibrinogenemia
DOID:12352
DOID:14551
DOID:1706
DOID:1707
DOID:2238
ICD10CM:K73.9
ICD9CM:570
ICD9CM:571.4
ICD9CM:571.41
MESH:D006521
NCI:C82978
SNOMEDCT_US_2020_03_01:155813004
SNOMEDCT_US_2020_03_01:197268000
SNOMEDCT_US_2020_03_01:266539002
UMLS_CUI:C0001308
UMLS_CUI:C0019189
UMLS_CUI:C0149519
acute and subacute liver necrosis
acute hepatitis
acute/subac. necrosis of liver
animal hepatitis
chronic hepatitis
chronic persistent hepatitis
disease_ontology
DOID:2237
hepatitis
A brain ischemia that is characterized by ischemia of brief duration and without resultant tissue death.
DOID:2315
ICD10CM:G45.9
MESH:D002546
NCI:C50781
SNOMEDCT_US_2020_03_01:195196001
UMLS_CUI:C0007787
TIA
TIA - Transient ischaemic attack
TRANSIENT ISCHEMIC ATTACK
Transient cerebral ischaemia
Transient cerebral ischemia
Transient ischemic attacks
transient ischemic attack
disease_ontology
DOID:224
transient cerebral ischemia
An bone structure disease that involves degeneration between vertebra located_in vertebral column.
DOID:8708
DOID:8709
DOID:8888
DOID:8905
DOID:9949
ICD10CM:M47
ICD9CM:721.9
MESH:D055009
OMIM:184300
SNOMEDCT_US_2020_03_01:8847002
UMLS_CUI:C0038019
Lumbar spondylosis with myelopathy
Spondylogenic compression of lumbar spinal cord
Spondylogenic compression of thoracic spinal cord
Spondylosis with myelopathy
Thoracic or lumbar spondylosis with myelopathy
lumbosacral spondylosis without myelopathy
spondylosis with myelopathy
disease_ontology
DOID:2247
spondylosis
A disease characterized by a group of signs and symptoms that occur together and characterize a particular abnormality.
MESH:D013577
NCI:C28193
SNOMEDCT_US_2020_03_01:64572001
UMLS_CUI:C0039082
disease_ontology
DOID:225
syndrome
A uterine disease that is located_in the cervix.
MESH:D002577
NCI:C40241
SNOMEDCT_US_2020_03_01:63339007
UMLS_CUI:C0007867
disease_ontology
DOID:2253
cervix disease
A bone development disease that results_in defective development of cartilage or bone.
DOID:1764
ICD10CM:Q78.9
ICD9CM:756.4
MESH:D010009
NCI:C34466
NCI:C84978
SNOMEDCT_US_2020_03_01:205510001
SNOMEDCT_US_2020_03_01:67988000
UMLS_CUI:C0008449
UMLS_CUI:C0029422
Cartilage Development disorder
Congenital anomaly of cartilage
Osteochondrodysplasia syndrome
chondrodystrophy
skeletal dysplasia
disease_ontology
DOID:2256
osteochondrodysplasia
Ankylosis is a arthropathy where there is a stiffness of a joint, the result of injury or disease. The rigidity may be complete or partial and may be due to inflammation of the tendinous or muscular structures outside the joint or of the tissues of the joint itself.
ICD10CM:M24.6
ICD9CM:718.5
MESH:D000844
SNOMEDCT_US_2020_03_01:36504009
UMLS_CUI:C0003090
disease_ontology
DOID:227
ankylosis
MESH:D000844
A candidiasis that involves fungal infection of the vaginal mucous membranes in women caused by Candida albicans. The symptoms include intense vulval pruritus, burning, erythema and dyspareunia associated with a creamy white, curd-like discharge.
ICD10CM:B37.3
ICD9CM:112.1
MESH:D002181
NCI:C2914
SNOMEDCT_US_2020_03_01:154404004
UMLS_CUI:C0700345
Candidal vulvovaginitis
Candidal: cervix
Candidiasis of vulva and vagina
Monilial vulvovaginitis
Vulvovaginal Candidiasis
disease_ontology
DOID:2272
vulvovaginal candidiasis
An upper respiratory tract disease involving inflammation of the throat or pharynx resulting from bacterial, viral, fungal infections or irritants like pollutants or chemical substances and smoking. The infection is often referred to as sore throat. The symptoms include pain during swallowing, enlarged tonsils coated with a white discharge, runny nose, cough and slight fever.
DOID:10455
DOID:11586
DOID:11588
DOID:938
DOID:939
ICD10CM:J02
ICD9CM:462
ICD9CM:472
ICD9CM:478.20
MESH:D010608
MESH:D010612
NCI:C26850
NCI:C26851
NCI:C34355
SNOMEDCT_US_2020_03_01:195654001
SNOMEDCT_US_2020_03_01:195763009
SNOMEDCT_US_2020_03_01:37616004
SNOMEDCT_US_2020_03_01:75860007
UMLS_CUI:C0001344
UMLS_CUI:C0031345
UMLS_CUI:C0031350
UMLS_CUI:C0155824
Inflamed throat
Persistent sore throat
Pharyngeal disorder
Pharyngitis - acute
Sore throat - chronic
acute pharyngitis
acute sore throat
chronic pharyn/nasopharyngitis
chronic pharyngitis
chronic pharyngitis and nasopharyngitis
chronic sore throat
disease_ontology
pharyngeal disease
DOID:2275
pharyngitis
An endocrine system disease that is located_in the gonads.
MESH:D006058
NCI:C26786
UMLS_CUI:C0018050
disease_ontology
DOID:2277
gonadal disease
A hidradenitis that is characterized by chronic inflammation of the apocrine sweat glands, has_symptom painful nodules, abscesses, sinus tract formation, scarring, erythema, pruritis, and pain, and has_material_basis_in chronic inflammation of the apocrine sweat glands leading to recurrent folliculitis and an accompanying immune response that worsens inflammation.
GARD:6658
ICD10CM:L73.2
MESH:D017497
NCI:C128429
OMIM:142690
OMIM:613736
OMIM:613737
SNOMEDCT_US_2020_03_01:201204008
UMLS_CUI:C0162836
Acne inversa, familial
Hidradenitis suppurativa
disease_ontology
DOID:2280
OMIM mapping confirmed by DO. [SN].
hidradenitis suppurativa
A sweat gland disease that is characterized by inflammation of the apocrine sweat glands and has_symptom erythema, edema, papules, plaques, pruritis, and pain.
ICD9CM:705.83
MESH:D016575
NCI:C112190
SNOMEDCT_US_2020_03_01:267866004
UMLS_CUI:C0085160
Hidradenitis
Hydradenitis
disease_ontology
DOID:2282
hidradenitis
NCI:C27012
UMLS_CUI:C0235270
disease_ontology
DOID:2283
keratopathy
A reproductive system disease that impairs the ability to reproduce and is located in the uterus, vagina, cervix, ovaries or fallopian tubes.
ICD9CM:629.9
MESH:D005831
SNOMEDCT_US_2020_03_01:38233001
UMLS_CUI:C0017411
disease_ontology
DOID:229
female reproductive system disease
A primary bacterial infectious disease that involves systemic infection, has_material_basis_in Leptospira, which is transmitted by contact with water, food, or soil containing urine from the infected animals. The infection has symptom jaundice, has symptom chills, has symptom fever, has symptom muscle pain, and has symptom hepatomegaly.
DOID:11348
GARD:7881
ICD10CM:A27
ICD10CM:A27.0
ICD9CM:100
ICD9CM:100.0
MESH:D007922
MESH:D014895
NCI:C84825
SNOMEDCT_US_2020_03_01:154391003
SNOMEDCT_US_2020_03_01:398067003
UMLS_CUI:C0023364
UMLS_CUI:C0043102
Fort Bragg fever
Leptospirosis icterohaemorrhagica
Rat Catcher's Yellows
Weil's disease
nanukayami fever
spirochetal jaundice
disease_ontology
DOID:2297
leptospirosis
A motor neuron disease characterized by painless but progressive weakness and stiffness of the muscles of the legs.
ICD10CM:G12.23
ICD9CM:335.24
MESH:D016472
NCI:C129933
OMIM:611637
ORDO:35689
SNOMEDCT_US_2020_03_01:81211007
UMLS_CUI:C0154682
adult-onset primary lateral sclerosis
primary lateral sclerosis
disease_ontology
DOID:230
Xref MGI.
lateral sclerosis
A bone structure disease that involves a defect located_in lumbar vertebral column.
ICD10CM:M43.0
MESH:D013169
NCI:C35034
SNOMEDCT_US_2020_03_01:203688008
UMLS_CUI:C0038018
disease_ontology
DOID:2300
spondylolysis
A specific developmental disorder that is characterized by repeated, rhythmic, purposeless movements or activities such as head banging, nail biting, or body rocking.
ICD10CM:F98.4
ICD9CM:307.3
MESH:D019956
SNOMEDCT_US_2020_03_01:5507002
UMLS_CUI:C0038273
Stereotyped repetitive movements
Stereotypy habit disorder
disease_ontology
DOID:2303
stereotypic movement disorder
A neurodegenerative disease that is located_in the motor neurones.
ICD10CM:G12.2
ICD9CM:335.2
MESH:D016472
SNOMEDCT_US_2020_03_01:37340000
UMLS_CUI:C0085084
disease_ontology
DOID:231
motor neuron disease
An opportunistic bacterial infectious disease that results_in disseminated infection in immunocompromised hosts, has_material_basis_in Nocardia asteroides. The infection has_symptom pneumonia, has_symptom cellulitis, has_symptom lesions in the brain or meninges, and has_symptom ascending regional lymphadenopathy.
GARD:7210
ICD10CM:A43
MESH:D009617
SNOMEDCT_US_2020_03_01:29227009
UMLS_CUI:C0028242
Nocardia infectious disease
disease_ontology
DOID:2312
nocardiosis
An ischemia that is characterized by insufficient blood flow to the brain to meet metabolic demand.
MESH:D002545
SNOMEDCT_US_2020_03_01:193049009
UMLS_CUI:C0007786
Ischaemic encephalopathy
Ischemic encephalopathy
cerebral ischemia
disease_ontology
DOID:2316
brain ischemia
A lung disease that is characterized by narrowing of pulmonary airways.
MESH:D008173
UMLS_CUI:C0600260
respiratory airway obstruction
disease_ontology
DOID:2320
obstructive lung disease
A gastrointestinal system infectious disease that involves inflammation of the lining of the stomach and small and large intestines, which is caused by viruses, bacteria, or parasites. Chemicals and drugs also cause gastroenteritis. The symptoms include diarrhea, loss of appetite, nausea, vomiting, cramps, and discomfort in the abdomen.
DOID:4094
DOID:5269
ICD10CM:K52.9
MESH:D005759
NCI:C34632
SNOMEDCT_US_2020_03_01:154278002
UMLS_CUI:C0017160
cholera morbus
infectious colitis, enteritis and gastroenteritis
disease_ontology
DOID:2326
gastroenteritis
MESH:D005759
A jaw cancer and mandibular disease that affects your lower jawbone.
DOID:12408
ICD10CM:C41.1
ICD9CM:170.1
MESH:D008339
NCI:C35178
SNOMEDCT_US_2020_03_01:126551000
SNOMEDCT_US_2020_03_01:448668007
UMLS_CUI:C0024694
UMLS_CUI:C0153511
malignant neoplasm of inferior maxilla
malignant neoplasm of lower Jaw bone
mandible cancer
neoplasm of mandible
disease_ontology
malignant neoplasm of mandible
mandibular neoplasm
DOID:2338
mandibular cancer
A synostosis that results_in premature fusion located_in skull.
GARD:6209
ICD10CM:Q75.0
MESH:D003398
NCI:C84655
OMIM:123100
OMIM:182212
OMIM:600593
OMIM:600775
OMIM:604757
OMIM:615314
ORDO:1531
SNOMEDCT_US_2020_03_01:205414007
UMLS_CUI:C0010278
Premature closure of cranial sutures
disease_ontology
DOID:2340
Xref MGI.
OMIM mapping confirmed by DO. [SN].
OMIM mapping by NeuroDevNet. [LS].
craniosynostosis
ICD10CM:D89.0
ICD9CM:273.0
NCI:C35885
SNOMEDCT_US_2020_03_01:190808009
UMLS_CUI:C0154254
Polyclonal hypergammaglobulinemia
disease_ontology
DOID:2344
polyclonal hypergammaglobulinemia
An inherited metabolic disorder that involves plasma protein metabolism malfunction.
ICD9CM:273.8
SNOMEDCT_US_2020_03_01:190822009
UMLS_CUI:C0029594
disease_ontology
DOID:2345
plasma protein metabolism disease
ICD10CM:I70
ICD9CM:440
MESH:D050197
NCI:C34403
NCI:C35768
SNOMEDCT_US_2020_03_01:155414001
SNOMEDCT_US_2020_03_01:39468009
UMLS_CUI:C0004153
UMLS_CUI:C3665365
Cardiovascular arteriosclerosis
disease_ontology
DOID:2348
arteriosclerotic cardiovascular disease
An artery disease that is characterized by a thickening and hardening of arterial walls in the arteries.
ICD10CM:I70
MESH:D001161
NCI:C34398
SNOMEDCT_US_2020_03_01:195251000
UMLS_CUI:C0003850
Arteriosclerosis
Arteriosclerotic vascular disease
disease_ontology
DOID:2349
arteriosclerosis
An intestinal benign neoplasm that is located_in the colon.
MESH:D003110
NCI:C2953
SNOMEDCT_US_2020_03_01:126838000
UMLS_CUI:C0009375
Colonic Mass
Colonic tumor
colon neoplasm
neoplasm of colon
disease_ontology
DOID:235
colonic benign neoplasm
ICD10CM:E83.1
ICD9CM:275.0
MESH:D019189
SNOMEDCT_US_2020_03_01:30913008
UMLS_CUI:C0012715
Iron disorder
disorder of iron metabolism
iron disorder
disease_ontology
DOID:2351
iron metabolism disease
A metal metabolism disorder characterized by the accumulation of iron in various organs of the body.
ICD10CM:E83.11
MESH:D006432
NCI:C84481
OMIM:231100
OMIM:PS235200
ORDO:139498
SNOMEDCT_US_2020_03_01:86781004
UMLS_CUI:C0018995
Haemochromatosis
diabetes bronze
iron storage disorder
disease_ontology
DOID:2352
Xref MGI.
hemochromatosis
An aplastic anemia that is characterized by displacement of hemopoietic bone-marrow tissue either by fibrosis, tumors or granulomas.
ICD10CM:D61.82
MESH:D000750
SNOMEDCT_US_2020_03_01:2694001
UMLS_CUI:C0002890
ANEMIA LEUKOERYTHROBLASTIC
Anemia, leukoerythroblastic
Leukoerythroblastosis
disease_ontology
myelophthisis
DOID:2354
myelophthisic anemia
A hematopoietic system disease that is characterized by a decrease in the normal number of red blood cells.
EFO:0004272
ICD10CM:D64.9
ICD9CM:285.9
MESH:D000740
NCI:C2869
SNOMEDCT_US_2020_03_01:64593003
UMLS_CUI:C0002871
anaemia
disease_ontology
DOID:2355
PRISM.
anemia
MESH:D000740
MESH:D000748
NCI:C34381
SNOMEDCT_US_2020_03_01:83414005
UMLS_CUI:C0002886
ANEMIA MACROCYTIC
Macrocytic anaemia
disease_ontology
DOID:2361
macrocytic anemia
A viral infectious disease that results in inflammation located in brain, has_material_basis_in West Nile virus, which is transmitted_by Culex, transmitted by Aedes, and transmitted_by Anopheles species of mosquitoes. The infection has_symptom high fever, has_symptom headache, has_symptom neck stiffness, has_symptom stupor, has_symptom disorientation, has_symptom coma, has_symptom tremors, has_symptom convulsions, has_symptom muscle weakness, has_symptom vision loss, has_symptom numbness, and has_symptom paralysis.
GARD:9959
ICD10CM:A92.31
ICD9CM:066.41
MESH:D014901
SNOMEDCT_US_2020_03_01:392662004
UMLS_CUI:C0751583
West Nile Fever with encephalitis
West Nile fever encephalitis
disease_ontology
DOID:2365
West Nile encephalitis
A viral infectious disease that results_in infection, has_material_basis_in West Nile virus, which is transmitted_by Culex and transmitted_by Aedes mosquitoes. The infection has_symptom fever, has_symptom sore throat, has_symptom headache, has_symptom body ache, has_symptom nausea, has_symptom maculopapular rash and has_symptom vomiting.
ICD10CM:A92.3
ICD9CM:066.4
MESH:D014901
SNOMEDCT_US_2020_03_01:12381007
UMLS_CUI:C0043124
disease_ontology
DOID:2366
West Nile fever
MESH:D019150
NCI:C161542
SNOMEDCT_US_2020_03_01:230365004
UMLS_CUI:C0338473
disease_ontology
DOID:2367
neuroaxonal dystrophy
A sphingolipidosis that is characterized by the accumulation of lipids known as gangliosides.
GARD:12510
ICD10CM:E75.10
MESH:D005733
ORDO:309144
SNOMEDCT_US_2020_03_01:50967008
UMLS_CUI:C0017083
disease_ontology
DOID:2368
gangliosidosis
A hematopoietic system disease characterized by oval or elliptical red blood cells, slight or absent hemolysis with little or no anemia; splenomegaly is often present.
GARD:6621
ICD10CM:D58.1
ICD9CM:282.1
MESH:D004612
NCI:C35882
OMIM:130600
OMIM:611804
ORDO:288
SNOMEDCT_US_2020_03_01:154801000
UMLS_CUI:C0013902
Congenital elliptocytosis
ovalocytosis
disease_ontology
DOID:2373
Xref MGI.
OMIM mapping confirmed by DO. [SN].
hereditary elliptocytosis
A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring.
EFO:0003885
GARD:10255
ICD10CM:G35
ICD9CM:340
MESH:D009103
NCI:C3243
OMIM:612594
OMIM:612595
OMIM:612596
SNOMEDCT_US_2020_03_01:155023009
UMLS_CUI:C0026769
Generalized multiple sclerosis
insular sclerosis
disease_ontology
DOID:2377
OMIM mapping confirmed by DO. [LS].
multiple sclerosis
MESH:D009103
A brain disease that is characterized by hyperbilirubinemia-induced brain dysfunction.
GARD:6830
ICD10CM:P57
MESH:D007647
NCI:C84799
SNOMEDCT_US_2020_03_01:157135006
UMLS_CUI:C0022610
bilirubin encephalopathy
disease_ontology
DOID:2382
kernicterus
A pigmentation disease characterized by a high level of bilirubin in the blood, causing a yellowing of the skin and other tissues of a newborn infant.
ICD10CM:P59.9
MESH:D007567
NCI:C99246
SNOMEDCT_US_2020_03_01:299968002
UMLS_CUI:C0022353
neonatal hyperbilirubinemia
neonatal icterus
disease_ontology
DOID:2383
neonatal jaundice
A brain disease that is characterised by the presence of neurological symptoms of ophthalmoplegia, ataxia, and confusion caused by biochemical lesions of the central nervous system after exhaustion of B-vitamin reserves, in particular thiamine (vitamin B1).
ICD10CM:E51.2
MESH:D014899
SNOMEDCT_US_2020_03_01:190627001
UMLS_CUI:C0043121
Wernicke's disease
Wernicke's encephalopathy
disease_ontology
DOID:2384
Wernicke encephalopathy
ICD9CM:593.81
NCI:C35338
SNOMEDCT_US_2020_03_01:16934004
UMLS_CUI:C0268790
renal vascular disease
vascular disorder of kidney
disease_ontology
DOID:2388
renal artery disease
A female reproductive organ cancer that is located_in the ovary.
DOID:0060070
DOID:2144
DOID:9595
GARD:7295
ICD10CM:C56
ICD9CM:183.0
MESH:D010051
NCI:C4984
NCI:C7431
OMIM:167000
OMIM:607893
ORDO:213500
ORDO:213517
SNOMEDCT_US_2020_03_01:123843001
SNOMEDCT_US_2020_03_01:372117006
SNOMEDCT_US_2020_03_01:93934004
UMLS_CUI:C0919267
UMLS_CUI:C1140680
UMLS_CUI:C1299247
malignant Ovarian tumor
malignant tumour of ovary
ovarian neoplasm
ovary neoplasm
primary ovarian cancer
tumor of the Ovary
disease_ontology
DOID:2394
Xref MGI.
OMIM mapping confirmed by DO. [SN].
ovarian cancer
MESH:D007499
NCI:C34737
SNOMEDCT_US_2020_03_01:85478004
UMLS_CUI:C0022078
disease_ontology
DOID:240
iris disease
GARD:9618
MESH:D016586
NCI:C3474
SNOMEDCT_US_2020_03_01:12169001
UMLS_CUI:C0085167
neoplasm of granular cell
disease_ontology
DOID:2411
granular cell tumor
NCI:C4481
SNOMEDCT_US_2020_03_01:254766004
UMLS_CUI:C0346063
Cutaneous Ganglioneuroma
Ganglioneuroma of skin
disease_ontology
DOID:2425
cutaneous ganglioneuroma
A central nervous system benign neoplasm that has_material_basis_in mature neurons, and is classified by the absence of neoplastic glial cells.
GARD:10638
MESH:D005729
NCI:C6934
SNOMEDCT_US_2020_03_01:78268004
gangliocytoma of central nervous system
disease_ontology
DOID:2426
gangliocytoma
NCI:C4463
SNOMEDCT_US_2020_03_01:126489007
UMLS_CUI:C0345988
neoplasm of skin with adnexal differentiation
neoplasm of the skin Appendage
skin appendage tumour
disease_ontology
DOID:2433
epidermal appendage tumor
MESH:D005918
NCI:C4222
SNOMEDCT_US_2020_03_01:7429002
UMLS_CUI:C0334421
disease_ontology
DOID:2436
glomangioma
NCI:C4475
SNOMEDCT_US_2020_03_01:254735005
UMLS_CUI:C0346041
dermis tumour
neoplasm of Dermis
tumor of dermis
tumour of dermis
disease_ontology
DOID:2438
dermis tumor
MESH:D006964
SNOMEDCT_US_2020_03_01:10649000
UMLS_CUI:C0020506
disease_ontology
DOID:2444
hyperpituitarism
MESH:D006964
A disease of metabolism that has_material_basis_in excessive growth hormone production which results_in enlargement located_in limb.
GARD:5725
MESH:D000172
NCI:C84533
SNOMEDCT_US_2020_03_01:154698000
UMLS_CUI:C0001206
disease_ontology
DOID:2449
acromegaly
ICD10CM:H34.81
ICD9CM:362.35
MESH:D012170
NCI:C118859
SNOMEDCT_US_2020_03_01:193378003
UMLS_CUI:C0154841
disease_ontology
DOID:2450
central retinal vein occlusion
GARD:4524
ICD10CM:D68.59
MESH:D018455
NCI:C99026
SNOMEDCT_US_2020_03_01:1563006
UMLS_CUI:C0242666
Protein S deficiency
Protein S deficiency disease
disease_ontology
DOID:2451
protein S deficiency
A blood coagulation disease that is characterized by an increased tendency to form clots.
ICD10CM:D68.59
MESH:D019851
NCI:C84479
OMIM:PS188050
SNOMEDCT_US_2020_03_01:191302007
UMLS_CUI:C0398623
hypercoagulability state
disease_ontology
DOID:2452
OMIM mapping confirmed by DO. [LS].
thrombophilia
MESH:D019851
NCI:C35170
SNOMEDCT_US_2020_03_01:57534004
UMLS_CUI:C0154833
retina circulation disorder
disease_ontology
DOID:2462
retinal vascular disease
A cognitive disorder that involves abnormal thinking and perceptions resulting in a disconnection with reality.
EFO:0000677
ICD9CM:298.8
UMLS_CUI:C0029516
mental or behavioural disorder
disease_ontology
DOID:2468
psychotic disorder
A systemic mycosis that results_in fungal infection located_in human body of immunocompromised individuals, has_material_basis_in Fungi. The organisms invade via the respiratory tract, alimentary tract, or intravascular devices.
DOID:0050137
ICD9CM:118
SNOMEDCT_US_2020_03_01:78999002
UMLS_CUI:C0029119
Opportunistic mycoses
Opportunistic mycosis
opportunistic systemic mycoses
disease_ontology
DOID:2473
opportunistic mycosis
ICD10CM:H10.4
ICD9CM:372.1
NCI:C35197
SNOMEDCT_US_2020_03_01:155163007
UMLS_CUI:C0155145
chronic Conjunctivitis
disease_ontology
DOID:2475
chronic conjunctivitis
ICD10CM:G60.0
MESH:D015417
NCI:C75467
SNOMEDCT_US_2020_03_01:128202008
UMLS_CUI:C0027888
HSMN
HSMN - Hereditary sensory and motor neuropathy
Hereditary motor and sensory neuropathy
neuropathic muscular atrophy
disease_ontology
DOID:2477
motor peripheral neuropathy
A brain disease that is characterized by vertigo caused by hemorrhagic insult, ischemic insult or mass lesion of the cerebellum, the vestibular nuclei, and the brainstem, has_symptom dizziness, has_symptom nausea, has_symptom vomiting and has_symptom difficulty walking.
ICD10CM:H81.4
ICD9CM:386.2
MESH:D014717
SNOMEDCT_US_2020_03_01:20425006
UMLS_CUI:C0155503
Vertigo of central origin
central vestibular vertigo
disease_ontology
DOID:2479
central nervous system origin vertigo
A respiratory system benign neoplasm that derives_from smooth muscle cells and is located_in the trachea.
DOID:246
MESH:D014134
NCI:C3419
NCI:C6049
SNOMEDCT_US_2020_03_01:126703006
UMLS_CUI:C0040582
UMLS_CUI:C1336772
leiomyoma of the Trachea
disease_ontology
DOID:248
trachea leiomyoma
ICD9CM:275.3
MESH:D010760
NCI:C97095
SNOMEDCT_US_2020_03_01:190858002
UMLS_CUI:C0031707
Phosphorus disorder
disorder of phosphorus metabolism
phosphorus metabolism disorder
disease_ontology
DOID:2485
phosphorus metabolism disease
ICD9CM:742
SNOMEDCT_US_2020_03_01:204018008
UMLS_CUI:C0158538
congenital neurologic anomaly
disease_ontology
DOID:2490
congenital nervous system abnormality
A neuropathy that involves damage to nerves of the peripheral nervous system.
DOID:10596
ICD9CM:356.2
MESH:D009477
NCI:C3501
SNOMEDCT_US_2020_03_01:193163001
SNOMEDCT_US_2020_03_01:95662005
UMLS_CUI:C0151313
UMLS_CUI:C0699739
Sensory neuropathy
peripheral Sensory Neuropathy
sensory neuropathy
disease_ontology
DOID:2491
sensory peripheral neuropathy
MESH:D020252
NCI:C84724
SNOMEDCT_US_2020_03_01:412795008
UMLS_CUI:C0267211
Watermelon stomach
disease_ontology
DOID:2493
gastric antral vascular ectasia
A vascular disease that is characterized as a small vascular malformation of the gut.
DOID:12071
MESH:D016888
SNOMEDCT_US_2020_03_01:71072006
UMLS_CUI:C0085411
angiodysplasia of stomach and duodenum with hemorrhage
disease_ontology
DOID:2494
angiodysplasia
MESH:D016888
NCI:C4390
SNOMEDCT_US_2020_03_01:5050001
UMLS_CUI:C0343082
Senile hemangioma
Senile naevus of skin
disease_ontology
DOID:2495
senile angioma
ICD9CM:521.31
UMLS_CUI:C1456161
disease_ontology
DOID:2497
enamel erosion
DOID:11509
DOID:12687
ICD10CM:K03.2
ICD9CM:521.3
MESH:D014077
SNOMEDCT_US_2020_03_01:82212003
UMLS_CUI:C0040436
generalized erosion
localized erosion
disease_ontology
DOID:2498
tooth erosion
A vasculitis that involves inflammation of the aorta that carries blood from the heart to the rest of the body.
DOID:13377
GARD:7730
ICD10CM:M31.4
ICD9CM:446.7
MESH:D001015
MESH:D013625
NCI:C34391
NCI:C35062
OMIM:207600
SNOMEDCT_US_2020_03_01:359789008
SNOMEDCT_US_2020_03_01:42153001
UMLS_CUI:C0003490
UMLS_CUI:C0039263
Aortic Arch syndrome
Aortic arch arteritis
Aortic arch syndrome
Idiopathic aortitis
Takayasu arteritis
Takayasu's disease
disease_ontology
DOID:2508
OMIM mapping confirmed by DO. [SN].
Takayasu's arteritis
ICD9CM:291.89
UMLS_CUI:C1456283
disease_ontology
DOID:251
alcohol-induced mental disorder
A syndrome characterized by multiple early-onset basal cell carcinoma, multiple jaw keratocysts and skeletal abnormalities that has_material_basis_in heterozygous mutation in either PTCH1, PTCH2, or SUFU on chromosome 9q22, 1p32, or 10q24-q25, respectively.
GARD:7166
MEDDRA:10062804
MESH:D001478
NCI:C2892
OMIM:109400
ORDO:377
SNOMEDCT_US_2020_03_01:69408002
UMLS_CUI:C0004779
Gorlin syndrome
NBCCS
basal cell nevus syndrome
disease_ontology
DOID:2512
OMIM mapping confirmed by DO. [SN].
nevoid basal cell carcinoma syndrome
A skin carcinoma affecting basal cells.
DOID:4275
DOID:4276
EFO:0004193
KEGG:05217
MESH:D018295
NCI:C156767
NCI:C3784
NCI:C7586
SNOMEDCT_US_2020_03_01:127570002
SNOMEDCT_US_2020_03_01:154507009
SNOMEDCT_US_2020_03_01:252995000
UMLS_CUI:C0007117
UMLS_CUI:C0206710
UMLS_CUI:C1368295
Basal cell cancer
Basal cell carcinoma of skin
Basal cell neoplasm
Basal cell tumor
Epithelioma basal cell
Rodent ulcer
malignant Basal cell neoplasm
malignant basal cell tumor
disease_ontology
DOID:2513
Xref MGI.
basal cell carcinoma
ICD10CM:N45.2
MESH:D009920
NCI:C97145
SNOMEDCT_US_2020_03_01:367112009
UMLS_CUI:C0029191
Inflammation of testis
Orchititis
disease_ontology
DOID:2518
orchitis
MESH:D013733
NCI:C26890
SNOMEDCT_US_2020_03_01:236763001
UMLS_CUI:C0039584
disorder of testis
testis disorder
disease_ontology
DOID:2519
testicular disease
An alcohol-induced mental disorder involving prominent hallucinations and delusions occurring during or shortly after acute alcohol intoxication or withdrawal.
ICD9CM:291.9
MESH:D011604
SNOMEDCT_US_2020_03_01:154852003
UMLS_CUI:C0033936
Alcoholic psychoses
disease_ontology
DOID:252
alcoholic psychosis
A proteinuria that is characterized by the leaking of blood protein into the urine, swelling or edema, and degenerative lesions without inflammation.
MESH:D009401
SNOMEDCT_US_2020_03_01:90708001
UMLS_CUI:C0027720
disease_ontology
DOID:2527
nephrosis
DOID:0000815
ICD10CM:D73
ICD9CM:289.50
MESH:D013158
NCI:C35823
SNOMEDCT_US_2020_03_01:51244008
UMLS_CUI:C0037997
Dyssplenism
Spleen disease
disease_ontology
DOID:2529
splenic disease
ICD10CM:D73.3
NCI:C35347
SNOMEDCT_US_2020_03_01:82053000
UMLS_CUI:C0272412
disease_ontology
DOID:2530
splenic abscess
An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes.
DOID:1034
DOID:2532
MESH:D019337
NCI:C27134
SNOMEDCT_US_2020_03_01:414388001
UMLS_CUI:C0376544
Hematologic malignancy
Hematologic neoplasm
Hematological tumors
blood cancer
hematopoietic and lymphoid system tumor
hematopoietic cancer
hematopoietic neoplasm
hematopoietic tumors
malignant hematopoietic neoplasm
disease_ontology
DOID:2531
hematologic cancer
GARD:9973
ICD10CM:D73.5
MESH:D013159
SNOMEDCT_US_2020_03_01:22996003
UMLS_CUI:C0037998
Splenic infarct
Splenic infarction
disease_ontology
DOID:2533
splenic infarction
ICD10CM:G61.81
ICD9CM:357.81
MESH:D020277
NCI:C84636
SNOMEDCT_US_2020_03_01:128209004
UMLS_CUI:C0393819
disease_ontology
DOID:2536
chronic inflammatory demyelinating polyneuritis
ICD9CM:357
SNOMEDCT_US_2020_03_01:193172009
UMLS_CUI:C0154758
disease_ontology
DOID:2537
inflammatory and toxic neuropathy
GARD:6855
ICD10CM:G40.8
MESH:D018887
NCI:C84806
OMIM:245570
ORDO:98818
SNOMEDCT_US_2020_03_01:230438007
UMLS_CUI:C0282512
acquired epileptic aphasia
disease_ontology
DOID:2538
OMIM mapping confirmed by DO. [SN].
Landau-Kleffner syndrome
An epilepsy syndrome that is located_in an area of the brain other than the temporal lobe.
NCI:C7760
SNOMEDCT_US_2020_03_01:111498005
UMLS_CUI:C0270849
Extratemporal epilepsy
disease_ontology
DOID:2544
extratemporal epilepsy
A cardiovascular organ benign neoplasm that has_material_basis_in endothelial cells that line blood vessels and is characterised by increased number of normal or abnormal vessels filled with blood.
ICD10CM:D18.0
ICD9CM:228.00
MESH:D006391
NCI:C3085
SNOMEDCT_US_2020_03_01:154625006
UMLS_CUI:C0018916
disease_ontology
DOID:255
hemangioma
A chondromalacia that is characterized by recurrent inflammation of cartilage and other tissues throughout the body.
GARD:7417
ICD10CM:M94.1
MESH:D011081
NCI:C157268
SNOMEDCT_US_2020_03_01:72275000
UMLS_CUI:C0032453
Chondromalacia, systemic
disease_ontology
DOID:2556
relapsing polychondritis
A cartilage disease that is characterized by softening and breakdown of cartilage inside a joint.
ICD10CM:M94.2
ICD9CM:733.92
MESH:D002357
SNOMEDCT_US_2020_03_01:63198006
UMLS_CUI:C0085700
disease_ontology
DOID:2557
chondromalacia
A drug dependence that involves the continued use of opiate drugs despite despite problems related to use of the substance.
ICD10CM:F11.2
ICD9CM:304.00
MESH:D009293
SNOMEDCT_US_2020_03_01:75544000
UMLS_CUI:C0524662
Opioid type dependence
disease_ontology
DOID:2559
opiate dependence
An opiate dependence that involves the continued use of morphine despite despite problems related to use of the substance.
MESH:D009021
SNOMEDCT_US_2020_03_01:286934009
UMLS_CUI:C0026552
disease_ontology
DOID:2560
morphine dependence
A corneal dystrophy that is characterized by corneal haze, bilateral loss of vision, eventually necessitating corneal transplantation resulting from progressive punctate opacities in the cornea.
ICD10CM:H18.55
ICD9CM:371.55
MESH:D003317
NCI:C34793
OMIM:217800
SNOMEDCT_US_2020_03_01:60258001
UMLS_CUI:C0024439
Fehr corneal dystrophy
MACULAR DYSTROPHY, CORNEAL, 1
disease_ontology
DOID:2565
macular corneal dystrophy
DOID:8944
ICD10CM:H18.5
ICD9CM:371.5
MESH:D003317
NCI:C34512
NCI:C34513
SNOMEDCT_US_2020_03_01:5587004
SNOMEDCT_US_2020_03_01:77797009
UMLS_CUI:C0010035
UMLS_CUI:C0010036
disease_ontology
DOID:2566
corneal dystrophy
A cervix disease that is characterized by inflammation of the cervix.
DOID:10110
ICD10CM:N72
ICD9CM:616.0
MESH:D002575
NCI:C26716
SNOMEDCT_US_2020_03_01:198199009
SNOMEDCT_US_2020_03_01:237081003
UMLS_CUI:C0007860
UMLS_CUI:C0007861
disease_ontology
DOID:2568
cervicitis
ICD9CM:362.57
MESH:D015593
SNOMEDCT_US_2020_03_01:141199000
UMLS_CUI:C0035312
disease_ontology
DOID:2569
OMIM mapping confirmed by DO. [SN].
retinal drusen
A histiocytosis that is characterized by clonal proliferation of Langerhans cells.
DOID:10617
DOID:10618
DOID:10620
DOID:10623
DOID:10624
DOID:10625
DOID:2553
DOID:2554
DOID:9582
ICD10CM:C96.0
ICD10CM:C96.6
ICD9CM:202.5
MESH:C538636
MESH:D006646
NCI:C3107
NCI:C3160
OMIM:246400
OMIM:604856
SNOMEDCT_US_2020_03_01:154583006
SNOMEDCT_US_2020_03_01:234439008
UMLS_CUI:C0019621
UMLS_CUI:C0023381
Histiocytosis X
Langerhan's cell histiocytosis
Langerhans cell granulomatosis
Letterer-Siwe disease
Letterer-Siwe disease involving intra-abdominal lymph nodes
Letterer-Siwe disease involving intrapelvic lymph nodes
Letterer-Siwe disease involving intrathoracic lymph nodes
Letterer-Siwe disease involving lymph nodes of axilla and upper limb
Letterer-Siwe disease involving lymph nodes of head, face and neck
Letterer-Siwe disease involving lymph nodes of head, face, and neck
Letterer-Siwe disease involving lymph nodes of inguinal region and lower limb
Letterer-Siwe disease involving lymph nodes of multiple sites
Letterer-Siwe disease involving spleen
Letterer-Siwe disease of intra-abdominal lymph nodes
Letterer-Siwe disease of intrapelvic lymph nodes
Letterer-Siwe disease of intrathoracic lymph nodes
Letterer-Siwe disease of lymph nodes of axilla and upper limb
Letterer-Siwe disease of lymph nodes of axilla and/or upper limb
Letterer-Siwe disease of lymph nodes of head, face and neck
Letterer-Siwe disease of lymph nodes of head, face and/or neck
Letterer-Siwe disease of lymph nodes of inguinal region amd/or lower limb
Letterer-Siwe disease of lymph nodes of inguinal region and lower limb
Letterer-Siwe disease of lymph nodes of inguinal region and/or lower limb
Letterer-Siwe disease of lymph nodes of multiple sites
Letterer-Siwe disease of spleen
disease_ontology
DOID:2571
OMIM mapping confirmed by DO. [SN].
Langerhans-cell histiocytosis
A drug dependence that involves the continued use of barbiturates despite problems related to use of the substance.
ICD9CM:304.11
UMLS_CUI:C0154482
disease_ontology
DOID:2575
barbiturate dependence
A chondrodysplasia punctata that is characterized by disproportionately short stature primarily affecting the proximal parts of the extremities, a typical facial appearance including a broad nasal bridge, epicanthus, high-arched palate, dysplastic external ears, and micrognathia, congenital contractures, characteristic ocular involvement, dwarfism, and severe mental retardation with spasticity.
GARD:13160
ICD10CM:E71.540
MESH:D018902
NCI:C85047
OMIM:PS215100
ORDO:177
SNOMEDCT_US_2020_03_01:56692003
UMLS_CUI:C0282529
Chondrodysplasia Punctata, Rhizomelic Form
disease_ontology
DOID:2580
OMIM mapping confirmed by DO. [SN].
rhizomelic chondrodysplasia punctata
A syndrome that is characterized by abnormal calcification of the epiphyses, causing stippling in radiography.
GARD:8542
ICD10CM:Q77.3
MESH:D002806
NCI:C84632
OMIM:215105
ORDO:93442
SNOMEDCT_US_2020_03_01:205486004
UMLS_CUI:C0008445
Chondrodysplasia punctata congenita
disease_ontology
DOID:2581
DeObs MGI.
chondrodysplasia punctata
MESH:D002806
GARD:363
MESH:D020642
NCI:C84526
OMIM:614097
SNOMEDCT_US_2020_03_01:190954001
UMLS_CUI:C0268419
deficiency of catalase
disease_ontology
DOID:2582
acatalasia
A B cell deficiency that is caused by a reduction in all types of gamma globulins.
DOID:618
ICD10CM:D80.1
ICD9CM:279.00
MESH:D000361
NCI:C26931
OMIM:601495
OMIM:612692
OMIM:613500
OMIM:613501
OMIM:615214
OMIM:PS601495
SNOMEDCT_US_2020_03_01:119250001
SNOMEDCT_US_2020_03_01:267512002
UMLS_CUI:C0001768
UMLS_CUI:C0086438
IGHM
hypogammaglobulinemia
mu heavy chain deficiency
disease_ontology
DOID:2583
OMIM mapping confirmed by DO. [SN].
agammaglobulinemia
MESH:D000361
ICD10CM:C32.0
ICD9CM:161.0
NCI:C3544
SNOMEDCT_US_2020_03_01:187841006
UMLS_CUI:C0153483
Ca larynx - glottis
malignant tumor of glottis
malignant tumor of the Glottis
disease_ontology
DOID:2595
glottis cancer
A respiratory system cancer that is located_in the larynx.
GARD:6862
ICD10CM:C32
ICD9CM:161
MESH:D007822
NCI:C7484
SNOMEDCT_US_2020_03_01:93859007
UMLS_CUI:C0007107
disease_ontology
DOID:2596
larynx cancer
MESH:D007822
NCI:C3156
SNOMEDCT_US_2020_03_01:126692004
UMLS_CUI:C0023055
laryngeal tumor
larynx neoplasm
neoplasm of larynx
disease_ontology
DOID:2598
laryngeal benign neoplasm
NCI:C4923
SNOMEDCT_US_2020_03_01:372103002
UMLS_CUI:C0740083
Glottic carcinoma
carcinoma of glottis
disease_ontology
DOID:2599
glottis carcinoma
An endocrine system disease that is located_in the pancreas.
ICD10CM:K86.8
ICD9CM:577.8
SNOMEDCT_US_2020_03_01:197566002
UMLS_CUI:C0029771
disease_ontology
DOID:26
pancreas disease
A larynx cancer that has_material_basis_in epithelial cells.
NCI:C4855
SNOMEDCT_US_2020_03_01:154480006
UMLS_CUI:C0595989
cancer of Larynx
cancer of larynx
carcinoma of larynx
disease_ontology
DOID:2600
laryngeal carcinoma
A cell type benign neoplasm that is a cartilaginous tumor encapsulated with a lobular growing pattern.
GARD:6052
MESH:D002812
NCI:C53459
SNOMEDCT_US_2020_03_01:269638002
UMLS_CUI:C0936248
central Chondroma
disease_ontology
DOID:2602
chondroma
A cell type benign neoplam that is composed of epithelial tissue on papillae of vascularized connective tissue.
DOID:1635
MESH:D010212
NCI:C3713
NCI:C7440
SNOMEDCT_US_2020_03_01:711329002
SNOMEDCT_US_2020_03_01:82049002
UMLS_CUI:C0030354
UMLS_CUI:C0205875
papillomatosis
disease_ontology
DOID:2615
papilloma
A kidney cancer which is manifested in the kidney.
NCI:C4527
SNOMEDCT_US_2020_03_01:254923001
UMLS_CUI:C0346256
hemangiopericytoma of kidney
renal hemangiopericytoma
disease_ontology
DOID:262
kidney hemangiopericytoma
A peripheral nervous system neoplasm that is located_in the autonomic nervous system.
NCI:C5112
UMLS_CUI:C1332356
tumor of Autonomic nervous system
disease_ontology
DOID:2621
autonomic nervous system neoplasm
DOID:3661
GARD:4214
MESH:D020288
NCI:C3698
NCI:C5800
OMIM:260500
SNOMEDCT_US_2020_03_01:18021007
UMLS_CUI:C0205770
UMLS_CUI:C1332963
childhood choroid plexus papilloma
disease_ontology
DOID:2626
OMIM mapping confirmed by DO. [SN].
choroid plexus papilloma
A urinary system cancer that is located_in the kidney.
DOID:11834
DOID:3676
ICD10CM:C64
ICD9CM:189.0
MESH:D007680
NCI:C120456
NCI:C3150
NCI:C7548
SNOMEDCT_US_2020_03_01:126880001
SNOMEDCT_US_2020_03_01:93849006
UMLS_CUI:C0022665
UMLS_CUI:C0494158
UMLS_CUI:C0740457
malignant neoplasm of kidney except pelvis
malignant tumour of kidney
renal cancer
disease_ontology
DOID:263
kidney cancer
An adenoma that forms a cyst.
MESH:D003537
NCI:C2972
SNOMEDCT_US_2020_03_01:189680006
UMLS_CUI:C0010633
Cystadenoma
Cystoma
disease_ontology
DOID:2634
cystadenoma
An ovarian benign neoplasm that has_material_basis_in the surface epithelium of the ovary.
GARD:9397
MESH:D001948
NCI:C39954
SNOMEDCT_US_2020_03_01:74739000
UMLS_CUI:C0006160
benign ovarian Brenner tumor
benign ovarian Brenner tumour
ovarian Brenner tumour
disease_ontology
DOID:2636
ovarian Brenner tumor
A breast fibroadenoma that is characterized by stromal proliferation around epithelial structures.
NCI:C4272
SNOMEDCT_US_2020_03_01:41382006
UMLS_CUI:C0334497
Pericanalicular Fibroadenoma of breast
Pericanalicular fibroadenoma
disease_ontology
DOID:2639
breast pericanalicular fibroadenoma
A soft tissue cancer that is a soft tissue sarcoma and originates in the pericytes in the walls of capillaries.
DOID:5372
GARD:2627
MESH:D006393
NCI:C3087
SNOMEDCT_US_2020_03_01:134335004
UMLS_CUI:C0018922
Haemangiopericytic meningioma
hemangiopericytoma, malignant
malignant hemangiopericytoma
disease_ontology
DOID:264
hemangiopericytoma
An ovarian germ cell monodermal and highly specialized teratoma that is composed either exclusively or predominantly of thyroid tissue.
MESH:D013330
NCI:C7468
SNOMEDCT_US_2020_03_01:24327009
UMLS_CUI:C0038478
Struma ovarii
disease_ontology
DOID:2640
struma ovarii
A monodermal teratoma that has_material_basis in germ cells that are highly specialized and is located_in the ovary.
NCI:C8113
UMLS_CUI:C0280134
Ovarian Monodermal and Highly Specialized teratoma
disease_ontology
DOID:2641
ovarian germ cell monodermal and highly specialized teratoma
MESH:D054973
NCI:C38150
SNOMEDCT_US_2020_03_01:388601000
UMLS_CUI:C1300127
PEComa
neoplasm with Perivascular epithelioid cell differentiation
disease_ontology
DOID:2643
perivascular epithelioid cell tumor
A cell type benign neoplasm that has_material_basis_in mesothelium.
DOID:2644
ICD10CM:C45
MESH:D008654
NCI:C3234
SNOMEDCT_US_2020_03_01:154491004
UMLS_CUI:C0025500
benign tumor of Mesothelium
disease_ontology
DOID:2645
benign mesothelioma
NCI:C6581
SNOMEDCT_US_2020_03_01:404086000
UMLS_CUI:C1266175
disease_ontology
DOID:2647
parachordoma
DOID:7387
NCI:C4174
SNOMEDCT_US_2020_03_01:78424008
UMLS_CUI:C1368816
Sebaceous adenoma
adenoma of the Sebaceous gland
skin appendage sebaceous adenoma
disease_ontology
DOID:2648
sebaceous adenoma
A connective tissue benign neoplasm that derives_from chondroblasts and begins in cartilage at the ends of long bones (thighbone, shinbone, humerus) close to the joints.
GARD:6047
MESH:D002804
NCI:C2945
SNOMEDCT_US_2020_03_01:9001003
UMLS_CUI:C0008441
Chondroblastoma of bone
disease_ontology
DOID:2649
chondroblastoma
A cystic teratoma that is composed exclusively of mature tissues derived from two or three germ layers (ectoderm, mesoderm and endoderm).
ICD10CM:K09.8
MESH:D003884
NCI:C9011
SNOMEDCT_US_2020_03_01:189117002
UMLS_CUI:C0011649
Dermoid choristoma
Dermoid tumour
Mature cystic teratoma
cystic dermoid choristoma
teratoma, benign
disease_ontology
DOID:2658
dermoid cyst
A benign teratoma that is characterized by the presence of cysts or cystic spaces.
NCI:C9014
SNOMEDCT_US_2020_03_01:42717009
UMLS_CUI:C1368903
disease_ontology
DOID:2660
cystic teratoma
A sweat gland benign neoplasm that is composed_of outgrowths of myoepithelial cells from a sweat gland.
MESH:D009208
NCI:C40392
SNOMEDCT_US_2020_03_01:69291002
UMLS_CUI:C0027070
Myoepithelial adenoma
Myoepithelial neoplasm
benign myoepithelioma
disease_ontology
DOID:2661
myoepithelioma
MESH:D013544
NCI:C3398
SNOMEDCT_US_2020_03_01:126490003
UMLS_CUI:C0038987
Sweat gland tumor
neoplasm of sweat gland
tumor of the Sweat gland
disease_ontology
DOID:2664
sweat gland benign neoplasm
MESH:D008637
NCI:C3233
SNOMEDCT_US_2020_03_01:44524009
UMLS_CUI:C0025464
disease_ontology
DOID:2668
mesenchymoma
A carcinoma that derives_from transitional epithelial cells.
DOID:3995
GARD:7794
MESH:D002295
NCI:C2930
NCI:C6783
SNOMEDCT_US_2020_03_01:118287003
SNOMEDCT_US_2020_03_01:27090000
UMLS_CUI:C0007138
UMLS_CUI:C0334265
transitional carcinoma
transitional cell tumor
urothelial cell carcinoma
disease_ontology
transitional cell neoplasm
DOID:2671
transitional cell carcinoma
A nephroma that is characterized as a localized, well-circumscribed multilocular tumor lined by hobnail epithelium.
NCI:C7504
multilocular cystic nephroma, mixed epithelial stromal tumour and renal epithelial stromal tumour
disease_ontology
DOID:2673
adult cystic nephroma
GARD:10640
NCI:C9505
SNOMEDCT_US_2020_03_01:87211000119104
UMLS_CUI:C1266177
Dysembryoplastic Neuroepithelial neoplasm
Dysembryoplastic neuroepithelial tumor
Dysembryoplastic neuroepithelial tumour
dysembryoplastic neuroepithelial tumour
disease_ontology
DOID:2679
dysembryoplastic neuroepithelial tumor
A cell type benign neoplasm that is composed_of glandular and fibrous tissues, with a relatively large proportion of glands.
MESH:D000232
SNOMEDCT_US_2020_03_01:189823009
UMLS_CUI:C0001422
disease_ontology
DOID:2683
adenofibroma
MESH:D000232
NCI:C6582
SNOMEDCT_US_2020_03_01:404076001
UMLS_CUI:C1266128
Ossifying Fibromyxoma
Ossifying fibromyxoid tumor
Ossifying fibromyxoid tumour
ossifying fibromyxoid tumour
disease_ontology
DOID:2685
ossifying fibromyxoid tumor
A lymphatic system cancer that has_material_basis_in endothelial cells located_in lymphatic vessels.
DOID:2686
MESH:C537491
MESH:D008204
NCI:C3205
NCI:C4490
SNOMEDCT_US_2020_03_01:403986008
SNOMEDCT_US_2020_03_01:62497000
UMLS_CUI:C0024224
UMLS_CUI:C0346082
Lymphangiosarcoma of Stewart and Treves
Stewart-Treves syndrome
malignant Lymphangioendothelioma
skin lymphangiosarcoma
disease_ontology
DOID:2689
lymphangiosarcoma
A muscle benign neoplasm that is characterized as benign hyperplastic lesions of uterine smooth muscle cells.
ICD10CM:D21
MESH:D009214
NCI:C4882
SNOMEDCT_US_2020_03_01:66357004
UMLS_CUI:C0027086
benign neoplasm of the Muscle
disease_ontology
DOID:2691
myoma
A sex cord-gonadal stromal tumor that secretes testosterone characterized by excessive proliferation of Leydig cells located_in ovary or testicle.
DOID:0050616
MESH:D007984
NCI:C3188
NCI:C4213
SNOMEDCT_US_2020_03_01:45002009
SNOMEDCT_US_2020_03_01:77870005
UMLS_CUI:C0023601
UMLS_CUI:C0334410
Leydig cell neoplasm
disease_ontology
DOID:2696
Leydig cell tumor
NCI:C8383
SNOMEDCT_US_2020_03_01:41627005
UMLS_CUI:C0334684
renal cell adenoma
disease_ontology
DOID:2697
renal adenoma
NCI:C39812
SNOMEDCT_US_2020_03_01:128760004
UMLS_CUI:C1266141
Metanephric adenofibroma
disease_ontology
DOID:2698
nephrogenic adenofibroma
A sarcoma and malignant non-epithelial hepatic and intrahepatic bile duct neoplasm sthat is located_in the liver.
NCI:C4437
SNOMEDCT_US_2020_03_01:254601002
UMLS_CUI:C0345906
hepatic sarcoma
disease_ontology
DOID:270
liver sarcoma
DOID:2665
MESH:D000070779
NCI:C3829
NCI:C6532
SNOMEDCT_US_2020_03_01:5178002
SNOMEDCT_US_2020_03_01:71508003
UMLS_CUI:C0221289
UMLS_CUI:C0588125
Synovioma, benign
benign synovioma
benign tumor of Synovium
localized Giant cell tumor of Tenosynovium
disease_ontology
DOID:2701
nodular tenosynovitis
GARD:7396
ICD10CM:M12.2
MESH:D013586
NCI:C3401
SNOMEDCT_US_2020_03_01:202903009
UMLS_CUI:C0039106
Diffuse Giant cell tumor of Tenosynovium
villous tenosynovitis
disease_ontology
DOID:2702
pigmented villonodular synovitis
A connective tissue disease that results_in inflammation located_in synovial membrane that lines a synovial joint which causes pain and swelling.
GARD:7722
MESH:D013585
NCI:C50766
SNOMEDCT_US_2020_03_01:268092005
UMLS_CUI:C0039103
disease_ontology
DOID:2703
synovitis
NCI:C6531
UMLS_CUI:C1334624
malignant tumor of Synovium
disease_ontology
DOID:2706
synovium cancer
An extrinsic allergic alveolitis that is characterized by a set of symptoms such as headache, fatigue, eye irritation, and breathing difficulties that affect workers in modern airtight office buildings. The disease is caused by indoor pollutants (as formaldehyde fumes, particulate matter, or microorganisms), and the symptoms tend to disappear when affected individuals leave the building.
MESH:D018877
SNOMEDCT_US_2020_03_01:19076009
UMLS_CUI:C0037050
disease_ontology
DOID:2710
sick building syndrome
ICD10CM:N47.1
MESH:D010688
NCI:C26852
SNOMEDCT_US_2020_03_01:449826002
UMLS_CUI:C0031538
Tight foreskin
Tight frenulum
disease_ontology
DOID:2712
phimosis
A syndrome characterized by sun sensitivity, short stature, predisposition to the development of cancer and genomic instability.
MESH:D001816
NCI:C2903
OMIM:210900
ORDO:125
SNOMEDCT_US_2020_03_01:4434006
UMLS_CUI:C0005859
Bloom-Torre-Machacek syndrome
Congenital Telangiectatic Erythema syndrome
disease_ontology
DOID:2717
OMIM mapping confirmed by DO. [SN].
Bloom syndrome
A pneumothorax that is characterized by having air in the chest cavity and blood in the chest cavity.
ICD10CM:J94.2
MESH:D006468
SNOMEDCT_US_2020_03_01:16632002
UMLS_CUI:C0019077
haemopneumothorax
disease_ontology
DOID:2718
hemopneumothorax
A vascular disease that is located_in the liver.
NCI:C35442
SNOMEDCT_US_2020_03_01:235878005
UMLS_CUI:C0400923
vascular disorder of liver
disease_ontology
DOID:272
hepatic vascular disease
A dermatitis that selectively affects the hands and feet.
GARD:5722
MESH:D000169
NCI:C84532
SNOMEDCT_US_2020_03_01:8197001
UMLS_CUI:C0001197
disease_ontology
DOID:2722
acrodermatitis
MESH:D000169
A skin disease characterized by itchy, erythematous, vesicular, weeping and crusting patches of skin.
DOID:8614
DOID:8917
ICD10CM:L30.9
MESH:D003872
NCI:C2983
SNOMEDCT_US_2020_03_01:238538009
UMLS_CUI:C0011603
eczema
skin inflammation
disease_ontology
DOID:2723
dermatitis
ICD10CM:Q82.5
MESH:D018324
NCI:C7457
SNOMEDCT_US_2020_03_01:56975005
UMLS_CUI:C0206733
Capillary hemangioma
Congenital vascular hamartoma
Congenital vascular naevus
Infantile hemangioma
Juvenile hemangioma
Strawberry haemangioma
Strawberry nevus
Strawberry nevus of skin
cellular hemangioma of Infancy
disease_ontology
DOID:2725
capillary hemangioma
A skin disease characterized by cutaneous pigmentation, premature graying, dystrophy of the nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers and predisposition to cancer.
GARD:10905
MESH:D019871
NCI:C111802
OMIM:PS127550
ORDO:1775
SNOMEDCT_US_2020_03_01:74911008
UMLS_CUI:C0265965
disease_ontology
DOID:2729
Xref MGI.
OMIM mapping by NeuroDevNet. [LS].
dyskeratosis congenita
A vesiculobullous skin disease that is characterized by formation of blisters with only minor skin trauma, which can cause widespread wounds, dehydration, electrolyte abnormalities, and severe infection, frequently develops_from mutations in connective tissue elements, including genes encoding keratin, collagen, and laminin.
GARD:6359
ICD10CM:Q81
MESH:D004820
NCI:C67383
SNOMEDCT_US_2020_03_01:205580008
UMLS_CUI:C0014527
Epidermolysis bullosa
acantholysis bullosa
disease_ontology
DOID:2730
epidermolysis bullosa
A skin disease that is characterized by fluid filled blisters.
MESH:D012872
UMLS_CUI:C0037275
disease_ontology
DOID:2731
vesiculobullous skin disease
GARD:4392
ICD10CM:Q82.8
MESH:D011038
NCI:C3335
OMIM:268400
SNOMEDCT_US_2020_03_01:205572001
UMLS_CUI:C0032339
Congenital poikiloderma
RTS
disease_ontology
DOID:2732
OMIM mapping confirmed by DO. [SN].
Rothmund-Thomson syndrome
MESH:D011038
ICD10CM:L90
NCI:C35163
SNOMEDCT_US_2020_03_01:16343004
UMLS_CUI:C0151514
Atrophoderma
Atrophy - skin
atrophic condition of skin
disease_ontology
DOID:2733
skin atrophy
ICD10CM:E50.8
MESH:D007644
NCI:C84665
OMIM:124200
SNOMEDCT_US_2020_03_01:157017000
UMLS_CUI:C0022595
DARIER-WHITE DISEASE
Darier's disease
Keratosis follicularis
disease_ontology
DOID:2734
OMIM mapping confirmed by DO. [SN].
keratosis follicularis
A bone disease characterized by short stature, coarse and dysmorphic facies, bowing of the long bones, and vertebral anomalies that has_material_basis_in heterozygous mutation in NOTCH2 on chromosome 1p12.
DOID:2735
GARD:508
MESH:D030981
MESH:D031845
NCI:C35545
NCI:C84745
OMIM:102500
SNOMEDCT_US_2020_03_01:63122002
UMLS_CUI:C0917715
UMLS_CUI:C0917990
Cheney syndrome
HJCYS
SFPKS
acroosteolysis with osteoporosis and changes in skull and mandible
arthrodentoosteodysplasia
serpentine fibula-polycystic kidney syndrome
disease_ontology
DOID:2736
OMIM mapping confirmed by DO. [SN].
Hajdu-Cheney syndrome
A connective tissue disease that is characterized by the accumulation of deposits of calcium and other minerals in elastic fibers, which are a component of connective tissue, this can result in changes in the skin, eyes, cardiovascular system and gastrointestinal system.
GARD:9643
MESH:D011561
NCI:C85036
OMIM:177850
OMIM:264800
ORDO:758
SNOMEDCT_US_2020_03_01:7109007
UMLS_CUI:C0033847
Gronblad-Strandberg syndrome
disease_ontology
DOID:2738
Xref MGI.
OMIM mapping confirmed by DO. [SN].
pseudoxanthoma elasticum
A bilirubin metabolic disorder that involves elevated levels of unconjugated bilirubin as bilirubin is not being conjugated as a result of reduced glucuronyltransferase activity.
GARD:6507
ICD10CM:E80.4
MESH:D005878
NCI:C84729
OMIM:143500
SNOMEDCT_US_2020_03_01:27503000
UMLS_CUI:C0017551
Constitutional hyperbilirubinemia
Gilbert's disease
Gilbert's syndrome
Gilbert-Meulengracht syndrome
hereditary nonhemolytic jaundice
disease_ontology
DOID:2739
OMIM mapping confirmed by DO. [SN].
Gilbert syndrome
An inherited metabolic disorder that involves elevated levels of bilirubin resulting from disruption of bilirubin metabolism.
DOID:2740
MESH:D006932
MESH:D006933
NCI:C84761
SNOMEDCT_US_2020_03_01:154770008
UMLS_CUI:C0020433
UMLS_CUI:C0020435
hereditary hyperbilirubinemia
hyperbilirubinemia
disease_ontology
hyperbilirubinaemia
DOID:2741
bilirubin metabolic disorder
A sensory system disease that is characterized by auditory dysfunction located_in the auditory system.
DOID:1490
DOID:2011
ICD10CM:H93.9
ICD9CM:388.9
MESH:D004427
NCI:C26757
SNOMEDCT_US_2020_03_01:194193002
UMLS_CUI:C0013447
ear and mastoid disease
disease_ontology
DOID:2742
auditory system disease
ICD10CM:N12
MESH:D011702
NCI:C34964
SNOMEDCT_US_2020_03_01:27174002
UMLS_CUI:C0034183
disease_ontology
DOID:2744
pyelitis
A personality disorder that involves an excessive preoccupation with issues of personal adequacy, power, prestige and vanity.
ICD10CM:F60.81
ICD9CM:301.81
MESH:D010554
NCI:C92635
SNOMEDCT_US_2020_03_01:80711002
UMLS_CUI:C0027402
disease_ontology
DOID:2745
narcissistic personality disorder
GARD:6528
ICD10CM:E74.04
MESH:D006012
NCI:C84738
OMIM:232600
SNOMEDCT_US_2020_03_01:55912009
UMLS_CUI:C0017924
Glycogen storage disease, type V
McArdle's disease
glycogen storage disease type V
myophosphorylase deficiency
disease_ontology
DOID:2746
OMIM mapping confirmed by DO. [SN].
glycogen storage disease V
A glycogen metabolism disorder that has_material_basis_in enzymes deficiencies necessary in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types.
ICD10CM:E74.0
ICD9CM:271.0
MESH:D006008
NCI:C61272
SNOMEDCT_US_2020_03_01:267498002
UMLS_CUI:C0017919
glycogenosis
glycogenoses
disease_ontology
DOID:2747
glycogen storage disease
GARD:2520
ICD10CM:E74.09
MESH:D006011
NCI:C84737
OMIM:232500
SNOMEDCT_US_2020_03_01:11179002
UMLS_CUI:C0017923
Amylopectinosis
Branching-transferase deficiency glycogenosis
Glycogen storage disease, type IV
brancher deficiency glycogenosis
deficiency of 1,4-alpha-glucan branching enzyme
disease_ontology
DOID:2750
OMIM mapping confirmed by DO. [SN].
glycogen storage disease IV
A glycogen storage disease that has_material_basis_in deficiency of the lysosomal acid alpha-glucosidase enzyme resulting in damage to muscle and nerve cells due to an accumulation of glycogen in the lysosome.
GARD:5714
ICD10CM:E74.02
MESH:D006009
NCI:C84734
OMIM:232300
SNOMEDCT_US_2020_03_01:237967002
UMLS_CUI:C0017921
Generalized glycogenosis
Glycogen storage disease, type II
Glycogenosis, type 2
Lysosomal alpha-1,4-glucosidase deficiency
Pompe's disease
acid maltase deficiency
deficiency of glucoamylase
deficiency of maltase
glycogen storage disease type II
disease_ontology
DOID:2752
OMIM mapping confirmed by DO. [SN].
glycogen storage disease II
A primary bacterial infectious disease that results_in infection, has_material_basis_in Mycobacterium avium complex (MAC), which is transmitted_by inhalation or transmitted_by ingestion of via the respiratory or gastrointestinal tract respectively. The bacteria cause disseminated infection in HIV infected people, while pulmonary disease in immunocompetent persons.
GARD:7123
MESH:D015270
NCI:C36197
SNOMEDCT_US_2020_03_01:14009004
UMLS_CUI:C0026916
Infection due to Mycobacterium intracellulare
MAC disease
Mycobacterium Avium Infection
Mycobacterium avium Complex
disease_ontology
DOID:2755
Mycobacterium avium complex disease
MESH:D015270
A specific developmental disorder that is characterized by the persistent presence of involuntary brief movements or sounds occuring intermittently and unpredictably out of a background of normal motor activity.
ICD10CM:F95
ICD9CM:307.20
MESH:D013981
SNOMEDCT_US_2020_03_01:155005001
UMLS_CUI:C0040188
disease_ontology
DOID:2769
tic disorder
A contact dermatitis that is characterized by a cutaneous inflammatory reaction to repeated contact with an irritant substance, friction, liquid, or adverse temperature that interacts with the skin and often has_symptom erythema, edema, scaling, pain, pruritis, or burning sensation.
ICD10CM:L24.9
MESH:D017453
NCI:C27151
SNOMEDCT_US_2020_03_01:110979008
UMLS_CUI:C0162823
Irritant Contact Dermatitis
Irritant contact dermatitis
primary irritant dermatitis
disease_ontology
DOID:2772
irritant dermatitis
ICD10CM:L25.9
MESH:D003877
NCI:C26743
SNOMEDCT_US_2020_03_01:156338009
UMLS_CUI:C0011616
Contact dermatitis
Contact dermatitis/eczema
Contact eczema
Dermatitis, venenata
dermatitis venenata
disease_ontology
DOID:2773
contact dermatitis
A bone cancer that is located_in almost exclusively in the long bones.
MESH:D050398
NCI:C7644
ORDO:55881
UMLS_CUI:C1367554
disease_ontology
DOID:2776
adamantinoma
MESH:D050398
A lung cancer that is located_in the lung and that arises from transformed cells of mesenchymal origin.
NCI:C4860
UMLS_CUI:C0598790
pulmonary sarcoma
disease_ontology
DOID:2784
lung sarcoma
A cerebellar disease that is characterized by hypoplasia and upward rotation of the cerebellar vermis and cystic dilation of the fourth ventricle.
GARD:6242
ICD10CM:Q03.1
MESH:D003616
NCI:C75012
OMIM:220200
SNOMEDCT_US_2020_03_01:14447001
UMLS_CUI:C0010964
Atresia of foramina of Magendie and Luschka
disease_ontology
DOID:2785
OMIM mapping confirmed by DO. [SN].
Dandy-Walker syndrome
A brain disease that is characterized by damage to brain substance located_in cerebellum; has_symptom ataxia, has_symptom dysarthria, and has_symptom cerebellar cognitive affective syndrome.
MESH:D002526
SNOMEDCT_US_2020_03_01:267691001
UMLS_CUI:C0007760
disease_ontology
DOID:2786
cerebellar disease
A parasitic infectious disease that is caused by parasitic protozoa which are microorganisms classified as unicellular eukaryotes.
DOID:0060003
DOID:10553
DOID:3734
DOID:3804
DOID:947
ICD10CM:B64
MESH:D011528
NCI:C34953
SNOMEDCT_US_2020_03_01:95896000
UMLS_CUI:C0033740
mastigophora infectious disease
sarcomastigophora infectious disease
disease_ontology
DOID:2789
parasitic protozoa infectious disease
A parasitic helminthiasis infectious disease that involves infection of the small intestine of humans, dogs and cats by the nematode Necator americanus causing abdominal pain, diarrhea, cramps, weight loss and anemia. Cutaneous larvae migrans in humans is characterized by skin ruptures and severe itching.
DOID:13048
ICD10CM:B76.1
MESH:D009332
NCI:C34838
SNOMEDCT_US_2020_03_01:36667009
UMLS_CUI:C0027528
disease_ontology
DOID:2790
necatoriasis
A pneumonia located_in the lung parenchyma of unknown cause.
ICD10CM:J84.114
MESH:D000080203
SNOMEDCT_US_2020_03_01:129459004
UMLS_CUI:C0085786
Diffuse idiopathic pulmonary fibrosis
Idiopathic fibrosing alveolitis
disease_ontology
IPF
DOID:2797
idiopathic interstitial pneumonia
A obstructive lung disease involving obstruction of the bronchioles due to inflammation and fibrosis which occurs as a complication of various lung conditions or physiological insults.
GARD:9551
MESH:D001989
NCI:C62580
SNOMEDCT_US_2020_03_01:40100001
UMLS_CUI:C0006272
Bronchiolitis exudativa
Bronchiolitis fibrosa obliterans
Obliterative bronchiolitis
disease_ontology
DOID:2799
bronchiolitis obliterans
A disease of anatomical entity that is located_in endocrine glands which secretes a type of hormone directly into the bloodstream to regulate the body.
ICD10CM:E34.9
ICD9CM:259.9
MESH:D004700
NCI:C3009
SNOMEDCT_US_2020_03_01:67432001
UMLS_CUI:C0014130
disease_ontology
DOID:28
endocrine system disease
ICD10CM:C72.50
ICD9CM:192.0
MESH:D003390
NCI:C3571
SNOMEDCT_US_2020_03_01:188311003
UMLS_CUI:C0153644
malignant neoplasm of cranial nerve
malignant neoplasm of cranial nerves
malignant tumor of cranial nerve
malignant tumor of the Cranial nerve
disease_ontology
DOID:2815
cranial nerve malignant neoplasm
MESH:D009668
SNOMEDCT_US_2020_03_01:89488007
UMLS_CUI:C0028432
disorder of the nose
nasal disorder
disease_ontology
DOID:2825
nose disease
DOID:2827
MESH:D042101
NCI:C35578
SNOMEDCT_US_2020_03_01:19968009
UMLS_CUI:C0267841
acute acalculous cholecystitis
acute cholecystitis without calculus
cholecystitis without calculus
disease_ontology
DOID:2828
acalculous cholecystitis
MESH:D042101
A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors. The disease has_symptom recurring periods of wheezing (a whistling sound while breathing), has_symptom chest tightness, has_symptom shortness of breath, has_symptom mucus production and has_symptom coughing.
DOID:12703
DOID:13829
DOID:13830
DOID:2840
DOID:5783
EFO:0000270
GARD:10246
ICD10CM:J45
ICD9CM:493
KEGG:05310
MESH:D001249
NCI:C28397
OMIM:600807
SNOMEDCT_US_2020_03_01:187687003
UMLS_CUI:C0004096
Exercise induced asthma
bronchial hyperreactivity
chronic obstructive asthma
chronic obstructive asthma with acute exacerbation
chronic obstructive asthma with status asthmaticus
exercise-induced asthma
disease_ontology
DOID:2841
Xref MGI.
asthma
MESH:D001249
An autosomal genetic disease that is characterized by delayed repolarization of the heart following a heartbeat increases the risk of episodes of torsade de pointes (TDP, a form of irregular heartbeat that originates from the ventricles).
DOID:4069
GARD:6922
ICD10CM:I45.81
ICD9CM:426.82
MESH:D008133
NCI:C34786
OMIM:PS192500
ORDO:101016
ORDO:768
SNOMEDCT_US_2020_03_01:20852007
SNOMEDCT_US_2020_03_01:9651007
UMLS_CUI:C0023976
UMLS_CUI:C0035828
LQT
Romano-Ward syndrome
long Q-T syndrome
disease_ontology
DOID:2843
OMIM mapping confirmed by DO. [SN].
long QT syndrome
MESH:D003866
NCI:C34812
SNOMEDCT_US_2020_03_01:35489007
UMLS_CUI:C0025193
disease_ontology
DOID:2848
melancholia
A chronic lymphocytic leukemia that is characterized by over production of B cells (lymphocytes) by the bone marrow where the B cells appear hairy under a microscope.
GARD:6560
ICD10CM:C91.4
ICD9CM:202.4
MESH:D007943
NCI:C7402
SNOMEDCT_US_2020_03_01:118613001
UMLS_CUI:C0023443
disease_ontology
DOID:285
hairy cell leukemia
A thyroid gland disease that is characterized by elevated thyroxine levels in the blood.
MESH:D006981
NCI:C131850
UMLS_CUI:C0020551
disease_ontology
DOID:2855
hyperthyroxinemia
MESH:D006981
ICD10CM:E07.81
ICD9CM:790.94
MESH:D005067
NCI:C113170
SNOMEDCT_US_2020_03_01:237542005
UMLS_CUI:C0015190
Euthyroid sick syndrome
Sick-euthyroid syndrome
disease_ontology
DOID:2856
euthyroid sick syndrome
GARD:12455
ICD10CM:D58.2
MESH:D006453
NCI:C3092
SNOMEDCT_US_2020_03_01:154794008
UMLS_CUI:C0019045
hemoglobinopathies
disease_ontology
DOID:2860
hemoglobinopathy
A carbohydrate metabolic disorder that is characterised by abnormally low levels of glucose-6-phosphate dehydrogenase (abbreviated G6PD or G6PDH).
GARD:6520
MESH:D005955
NCI:C98933
SNOMEDCT_US_2020_03_01:124134002
UMLS_CUI:C2939465
Glucose-6-phosphate dehydrogenase deficiency
deficiency of G-6PD
disease_ontology
DOID:2862
glucosephosphate dehydrogenase deficiency
An endometrial carcinoma that derives_from epithelial cells of glandular origin.
DOID:5827
DOID:6650
NCI:C6287
NCI:C6290
NCI:C7359
SNOMEDCT_US_2020_03_01:123845008
SNOMEDCT_US_2020_03_01:762458004
UMLS_CUI:C0279763
UMLS_CUI:C1153706
UMLS_CUI:C1336905
adenocarcinoma of endometrium
adenocarcinoma of the Endometrium
adenocarcinoma of uterus
endometrial adenoacanthoma
endometrial endometrioid adenocarcinoma
endometrial endometrioid adenocarcinoma with squamous differentiation
endometrioid adenoma or carcinoma
endometrioid adenomas and carcinomas
endometrioid carcinoma of Endometrium
disease_ontology
DOID:2870
endometrial adenocarcinoma
A endometrial cancer that is located_in the tissue lining the uterus.
DOID:3000
MESH:D016889
MESH:D018269
NCI:C3769
NCI:C7558
SNOMEDCT_US_2020_03_01:30289006
SNOMEDCT_US_2020_03_01:93781006
UMLS_CUI:C0206687
UMLS_CUI:C0476089
carcinoma of the Endometrium
endometrioid carcinoma
endometrioid carcinoma of female Reproductive system
disease_ontology
DOID:2871
OMIM mapping confirmed by DO. [SN].
endometrial carcinoma
A laryngeal carcinoma that has_material_basis_in squamous cells.
NCI:C4044
SNOMEDCT_US_2020_03_01:707358000
UMLS_CUI:C0280324
Epidermoid carcinoma of the Larynx
squamous cell carcinoma of larynx
disease_ontology
DOID:2876
laryngeal squamous cell carcinoma
A uterine disease that is characterized by the presence of endometrial tissue grows outside of the endometrium, such as into the myometrium.
ICD10CM:N80.0
ICD9CM:617.0
MESH:D062788
NCI:C6996
OMIM:600458
SNOMEDCT_US_2020_03_01:76376003
UMLS_CUI:C0341858
Endometriosis interna
Endometriosis of myometrium
Endometriosis, myometrium
adenomyosis
uterine Adenomyosis
disease_ontology
DOID:288
OMIM mapping confirmed by DO. [SN].
endometriosis of uterus
A male reproductive organ benign neoplasm that derives_from glandular epithelial cells and that is located_in the prostate.
MESH:D011470
NCI:C4795
SNOMEDCT_US_2020_03_01:21173002
UMLS_CUI:C0520477
adenoma - prostate
adenoma of prostate
benign adenoma of prostate
prostate adenoma
disease_ontology
DOID:2883
prostatic adenoma
MESH:D012181
UMLS_CUI:C0035352
disease_ontology
DOID:2889
retrocochlear disease
A female reproductive system disease characterized by the growth of endometrial tissue outside the uterine body.
EFO:0001065
ICD10CM:N80
ICD9CM:617
MESH:D004715
NCI:C3014
SNOMEDCT_US_2020_03_01:11871002
UMLS_CUI:C0014175
disease_ontology
DOID:289
endometriosis
An endocrine organ benign neoplasm that is located_in the thyroid and derives_from glandular epithelial cells.
MESH:D013964
NCI:C3502
SNOMEDCT_US_2020_03_01:189174004
UMLS_CUI:C0151468
adenoma of thyroid gland
disease_ontology
DOID:2891
thyroid adenoma
A cervical cancer that is located_in the cervix uteri or located_in the cervical area and that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C9039
SNOMEDCT_US_2020_03_01:285432005
UMLS_CUI:C0302592
cancer of cervix
carcinoma cervix uteri
carcinoma of cervix
carcinoma of the Cervix Uteri
disease_ontology
DOID:2893
OMIM mapping confirmed by DO. [SN].
cervix carcinoma
A syndrome that is characterized by incomplete development of the ear, nose, soft palate, lip, and mandible. It is associated with anomalous development of the first branchial arch and second branchial arch.
GARD:6540
ICD10CM:Q87.0
MESH:D006053
NCI:C84740
OMIM:164210
ORDO:374
SNOMEDCT_US_2020_03_01:46567003
UMLS_CUI:C0265240
Facio-auriculo-vertebral spectrum
First AND second branchial arch syndrome
First arch syndrome
HEMIFACIAL MICROSOMIA
OAV (oculoauriculovertebral) dysplasia
Otomandibular dysostosis
disease_ontology
DOID:2907
OMIM mapping confirmed by DO. [SN].
Goldenhar syndrome
A syndrome that is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities.
GARD:9124
ICD10CM:Q75.4
MESH:D008342
NCI:C75018
OMIM:PS154500
SNOMEDCT_US_2020_03_01:205416009
UMLS_CUI:C0242387
Franceschetti syndrome
Mandibulofacial dysostosis
mandibulofacial dysostosis
disease_ontology
DOID:2908
OMIM mapping confirmed by DO. [SN].
Treacher Collins syndrome
MESH:D008342
DOID:2912
ICD10CM:K85
ICD9CM:577.0
MESH:D010195
NCI:C95437
SNOMEDCT_US_2020_03_01:39726008
UMLS_CUI:C0001339
PANCREATITIS NECROTIZING
acute necrotizing pancreatitis
disease_ontology
DOID:2913
acute pancreatitis
A disease of anatomical entity that is located_in the immune system.
EFO:0000540
ICD10CM:D89.9
ICD9CM:279.9
SNOMEDCT_US_2020_03_01:154782004
UMLS_CUI:C0041806
disease_ontology
DOID:2914
immune system disease
A hypersensitivity reaction disease that is characterized by a cell-mediated response to antigens, where Th1 helper T cells react with antigens on antigen-presenting cells and cause a delayed type immune response.
ICD10CM:C88.9
MESH:D007160
SNOMEDCT_US_2020_03_01:127071007
UMLS_CUI:C0021070
disease_ontology
immunoproliferative disease
DOID:2916
hypersensitivity reaction type IV disease
A hypersensitivity reaction type IV disease that involves large amounts of cryoglobulins in the blood which become thick or gel-like in cold temperatures.
GARD:6217
ICD10CM:D89.1
MESH:D003449
NCI:C26736
SNOMEDCT_US_2020_03_01:30911005
UMLS_CUI:C0010403
CRYOGLOBULINEMIA
Cryoimmunoglobulinaemia
disease_ontology
DOID:2917
cryoglobulinemia
NCI:C5102
SNOMEDCT_US_2020_03_01:416510003
UMLS_CUI:C1334361
lacrimal system neoplasm
neoplasm of lacrimal system
tumor of the lacrimal system
disease_ontology
DOID:292
lacrimal system cancer
GARD:11982
MESH:D015432
NCI:C34644
OMIM:305800
SNOMEDCT_US_2020_03_01:80321008
UMLS_CUI:C0017662
Lobular glomerulonephritis
chronic glomerulonephritis, lobular
disease_ontology
DOID:2920
membranoproliferative glomerulonephritis
A nephritis that causes inflammation of the glomeruli located_in kidney.
GARD:6516
ICD10CM:N08
MESH:D005921
NCI:C26784
SNOMEDCT_US_2020_03_01:36171008
UMLS_CUI:C0017658
disease_ontology
DOID:2921
glomerulonephritis
A syndrome that is characterized by large cutaneous hemangiomata with hypertrophy of the related bones and soft tissues.
ICD10CM:Q87.2
MESH:D007715
NCI:C84801
OMIM:149000
SNOMEDCT_US_2020_03_01:59078009
UMLS_CUI:C0022739
Haemangiectatic hypertrophy
Klippel-Trenaunay-Weber syndrome
angioosteohypertrophy syndrome
disease_ontology
DOID:2926
OMIM mapping confirmed by DO. [SN].
Klippel-Trenaunay syndrome
A viral infectious disease that results_in infection in birds and humans, has_material_basis_in Newcastle disease virus, which is transmitted_by contact with feces and urine of an infected bird, or transmitted_by fomites. The infection has_symptom conjunctivitis, has_symptom headache, and has_symptom lacrimation in humans, and has_symptom gasping, has_symptom coughing, has_symptom twisting of head and neck, has_symptom circling, has_symptom complete paralysis, has_symptom watery diarrhea, and has_symptom reduced egg production in birds.
MESH:D009521
NCI:C34849
SNOMEDCT_US_2020_03_01:258300000
UMLS_CUI:C0027983
Newcastle's disease
Pseudo-fowlpest
disease_ontology
DOID:2929
Newcastle disease
A syndrome characterized by oculocutaneous albinism, immune deficiency, coagulation deficiency and neuropathy; it is that has_material_basis_in mutations in the CHS1 gene.
GARD:6035
ICD10CM:E70.330
MESH:D002609
NCI:C2941
OMIM:214500
ORDO:167
SNOMEDCT_US_2020_03_01:111396008
UMLS_CUI:C0007965
CHS
Chediak - Steinbrinck anomaly
disease_ontology
DOID:2935
OMIM mapping confirmed by DO. [SN].
Chediak-Higashi syndrome
DOID:291
ICD9CM:190.2
NCI:C3563
NCI:C4360
SNOMEDCT_US_2020_03_01:127004000
SNOMEDCT_US_2020_03_01:188271007
UMLS_CUI:C0153627
UMLS_CUI:C0339124
malignant neoplasm of lacrimal gland
malignant tumour of lacrimal gland
neoplasm of lacrimal gland
tumor of the lacrimal gland
disease_ontology
DOID:294
lacrimal gland cancer
A lung disease that is an inflammation of the bronchioles, the smallest air passages of the lungs. It is caused by viruses and bacteria. The disease has_symptom cough, has_symptom wheezing, has_symptom shortness of breath, has_symptom fever, has_symptom nasal flaring in infants and has_symptom bluish skin due to lack of oxygen.
MESH:D001988
NCI:C39658
SNOMEDCT_US_2020_03_01:4120002
UMLS_CUI:C0006271
disease_ontology
DOID:2942
bronchiolitis
A Coronavirus infection that results_in infection located_in respiratory tract, has_material_basis_in SARS coronavirus (SARS-CoV), which is transmitted_by droplet spread of respiratory secretions, transmitted_by ingestion of contaminated food, or transmitted_by fomites. The infection has_symptom fever, has_symptom headache, has_symptom body aches, has_symptom dry cough, and has_symptom hypoxia.
GARD:9237
ICD10CM:J12.81
ICD9CM:079.82
MESH:D045169
NCI:C85064
SNOMEDCT_US_2020_03_01:398447004
UMLS_CUI:C1175175
SARS
SARS-CoV infection
disease_ontology
DOID:2945
severe acute respiratory syndrome
ICD10CM:T75.3
ICD9CM:994.6
MESH:D009041
NCI:C34824
OMIM:158280
SNOMEDCT_US_2020_03_01:37031009
UMLS_CUI:C0026603
Travel Sickness
disease_ontology
DOID:2951
OMIM mapping confirmed by DO. [SN].
motion sickness
ICD10CM:H83.9
MESH:D007759
NCI:C128369
NCI:C27166
SNOMEDCT_US_2020_03_01:194690003
SNOMEDCT_US_2020_03_01:20425006
UMLS_CUI:C0022890
UMLS_CUI:C0494559
labyrinthine disease
disease_ontology
DOID:2952
inner ear disease
A B cell deficiency that is characterized by relative predominance of certain immunoglobulin subtypes and deficiencies of others.
NCI:C27579
UMLS_CUI:C1334069
disease_ontology
DOID:2959
hyperimmunoglobulin syndrome
A trichothiodystrophy characterized by skin that is extremely sensitive to ultraviolet (UV) rays from sunlight.
MESH:D054463
NCI:C4924
OMIM:PS601675
SNOMEDCT_US_2020_03_01:723551003
IBIDS syndrome
TTD-P
Tay syndrome
sulfur-deficient brittle hair syndrome
trichothiodystrophy with congenital ichthyosis
disease_ontology
DOID:2960
OMIM mapping confirmed by DO. [SN].
photosensitive trichothiodystrophy
A syndrome that has_material_basis_in rare mutations in two DNA excision repair proteins, ERCC-8 and ERCC-6, and characterized by growth failure, impaired development of the nervous system, abnormal sensitivity to sunlight (photosensitivity), and premature aging.
GARD:6122
ICD10CM:Q87.19
MESH:D003057
NCI:C9460
OMIM:133540
OMIM:216400
ORDO:191
ORDO:90321
ORDO:90322
ORDO:90324
SNOMEDCT_US_2020_03_01:205832003
UMLS_CUI:C0009207
Neill-Dingwall syndrome
disease_ontology
Cockayne's syndrome
DOID:2962
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Cockayne syndrome
ICD10CM:M71.9
MESH:D002062
NCI:C94407
SNOMEDCT_US_2020_03_01:156677003
UMLS_CUI:C0006444
disease_ontology
DOID:2965
bursitis
NCI:C4397
SNOMEDCT_US_2020_03_01:17264009
UMLS_CUI:C0344460
carcinoma ex pleomorphic adenoma
carcinoma in pleomorphic adenoma
disease_ontology
DOID:297
pleomorphic adenoma carcinoma
MESH:D052177
UMLS_CUI:C0022679
renal Cyst
disease_ontology
DOID:2975
cystic kidney disease
A carbohydrate metabolic disorder characterized by impaired glyoxylate metabolism resulting in accumulation of oxalate throughout the body typically manifesting as kidney and bladder stones.
DOID:2979
ICD10CM:E72.53
ICD10CM:R82.992
MESH:D006959
MESH:D006960
NCI:C123158
OMIM:PS259900
ORDO:416
SNOMEDCT_US_2020_03_01:190766003
SNOMEDCT_US_2020_03_01:367621000119107
UMLS_CUI:C0020500
UMLS_CUI:C0020501
disease_ontology
DOID:2977
OMIM mapping confirmed by DO. [SN].
primary hyperoxaluria
An inherited metabolic disorder that affect the catabolism and anabolism of carbohydrates.
DOID:9434
MESH:D002239
UMLS_CUI:C0007001
disorder of carbohydrate transport and metabolism
inborn carbohydrate metabolism disorder
inborn errors of carbohydrate metabolism
disease_ontology
DOID:2978
carbohydrate metabolic disorder
MESH:D010501
SNOMEDCT_US_2020_03_01:111404004
UMLS_CUI:C0031065
disease_ontology
DOID:2982
perinephritis
MESH:D001002
NCI:C114699
SNOMEDCT_US_2020_03_01:139460001
UMLS_CUI:C0003460
Suppression of urinary secretion
disease_ontology
DOID:2983
anuria
A glomerulonephritis characterized by build up of IgA antibody in the glomerulus.
EFO:0004194
GARD:863
MESH:D005922
NCI:C34643
OMIM:161950
SNOMEDCT_US_2020_03_01:236407003
UMLS_CUI:C0017661
Berger's IgA or IgG nephropathy
Focal Glomerulonephritis
IGA glomerulonephritis
IgA nephropathy
primary IgA nephropathy
segmental glomerulonephritis
disease_ontology
DOID:2986
OMIM mapping confirmed by DO. [SN].
IgA glomerulonephritis
An autoimmune disease characterized by recurrent episodes of fever and acute inflammation of the membranes lining the abdomen, joints and lungs; that has_material_basis_in mutations in the MEFV gene, which encodes the protein pyrin.
GARD:6421
ICD10CM:M04.1
ICD9CM:277.31
MESH:D010505
NCI:C84707
OMIM:134610
OMIM:249100
ORDO:342
SNOMEDCT_US_2020_03_01:12579009
UMLS_CUI:C0031069
benign paroxysmal peritonitis
disease_ontology
DOID:2987
Xref MGI.
OMIM mapping confirmed by DO. [SN].
familial Mediterranean fever
An autoimmune disease that is characterized by recurrent venous or arterial thrombosis and/or fetal losses associated with characteristic elevated levels of antibodies directed against membrane anionic phospholipids (anticardiolipin).
GARD:5824
ICD10CM:D68.61
MESH:D016736
NCI:C61283
OMIM:107320
SNOMEDCT_US_2020_03_01:201450008
UMLS_CUI:C0085278
Antiphospholipid syndrome
antiphospholipid antibody syndrome
disease_ontology
DOID:2988
OMIM mapping confirmed by DO. [SN].
antiphospholipid syndrome
MESH:D016736
A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue.
MESH:D000230
NCI:C2852
SNOMEDCT_US_2020_03_01:443961001
UMLS_CUI:C0001418
disease_ontology
DOID:299
adenocarcinoma
MESH:D000230
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from germ cells.
DOID:2157
MESH:D009373
NCI:C3708
SNOMEDCT_US_2020_03_01:302853003
UMLS_CUI:C0205851
malignant tumor of the germ cell
disease_ontology
germ cell neoplasm
germ cell tumour
DOID:2994
germ cell cancer
A sex cord-gonadal stromal tumor characterized by variable proportions of Sertoli cells, Leydig cells, primitive gonadal stroma and/or heterologous elements located_in the ovaries and testicles.
DOID:0050618
GARD:9967
MESH:D018310
SNOMEDCT_US_2020_03_01:34110004
UMLS_CUI:C0206723
disease_ontology
DOID:2997
Sertoli-Leydig cell tumor
A male reproductive system cancer that is located_in the testicles.
DOID:12231
DOID:5554
GARD:7746
ICD10CM:C62
ICD9CM:186
MESH:D013736
NCI:C3404
NCI:C5053
NCI:C7251
SNOMEDCT_US_2020_03_01:126900000
SNOMEDCT_US_2020_03_01:94087009
UMLS_CUI:C0039590
UMLS_CUI:C0153594
UMLS_CUI:C1333010
childhood neoplasm of the testis
neoplasm of testis
pediatric testicular neoplasm
testicular tumor
testis cancer
testis neoplasm
disease_ontology
DOID:2998
OMIM mapping confirmed by DO. [SN].
testicular cancer
A sex cord-gonadal stromal tumor that has_material_basis_in granulosa cells and arises from the sex cord stroma.
DOID:5333
MESH:D006106
NCI:C3070
NCI:C4205
SNOMEDCT_US_2020_03_01:18861007
SNOMEDCT_US_2020_03_01:46585005
UMLS_CUI:C0018206
UMLS_CUI:C0334401
Granulosa cell neoplasm
Granulosa cell tumor, adult type
Granulosa cell tumour, sarcomatoid
malignant granulosa cell neoplasm
disease_ontology
DOID:2999
granulosa cell tumor
A breast cancer that arises from myoepithelial cells, which are a normal constituent of the salivary acini and ducts and are found between the epithelial cells and the basement membrane.
NCI:C40389
UMLS_CUI:C1511319
disease_ontology
DOID:3004
breast myoepithelial neoplasm
A breast carcinoma in situ that is characterized by abnormal cells are found in the lobules (glands that make milk) of the breast.
NCI:C27939
UMLS_CUI:C0861352
Lobular Intraepithelial Neoplasia
lobular carcinoma in situ
disease_ontology
DOID:3010
lobular neoplasia
A syndrome characterized by autosomal dominant inheritance of increased risk of developing several types of cancer, including breast cancer, osteosarcomata and soft tissue sarcomata.
GARD:6902
MESH:D016864
NCI:C3476
OMIM:PS151623
ORDO:524
SNOMEDCT_US_2020_03_01:428850001
UMLS_CUI:C0085390
Li-Fraumeni Familiar cancer Susceptibility syndrome
SBLA syndrome
sarcoma, breast, leukaemia and adrenal gland syndrome
disease_ontology
DOID:3012
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Li-Fraumeni syndrome
A breast benign neoplasm that is located_in the breast ducts.
NCI:C36083
UMLS_CUI:C0948967
disease_ontology
DOID:3013
intraductal breast benign neoplasm
A breast cancer that is characterized by a prominent infiltrative border, unequivocal sarcomatous areas, and stromal overgrowth and arises_from the stroma, lined by an epithelial and myoepithelial bilayer, forming a leaflike structure. They tend to grow rapidly and present in middle-aged women (40s-50s).
DOID:1632
DOID:3018
MESH:D003557
NCI:C4275
NCI:C4504
NCI:C7575
SNOMEDCT_US_2020_03_01:254844000
SNOMEDCT_US_2020_03_01:712989008
SNOMEDCT_US_2020_03_01:87913009
UMLS_CUI:C0238031
UMLS_CUI:C0346154
UMLS_CUI:C0600066
Phyllodes breast neoplasm
Phyllodes tumor, malignant
breast malignant phyllodes tumour
malignant Mammary Phyllodes tumor
malignant Mammary Phyllodes tumour
malignant Phyllodes neoplasm
malignant cystosarcoma phyllodes
malignant phyllodes tumor
malignant phyllodes tumor of breast
malignant phyllodes tumour
malignant phyllodes tumour of breast
phyllodes breast tumor
phyllodes breast tumour
disease_ontology
DOID:3016
breast malignant phyllodes tumor
A breast cancer that has_material_basis_in abnormally proliferating cells derives_from mesenchymal cells.
NCI:C4670
SNOMEDCT_US_2020_03_01:278050001
UMLS_CUI:C0349667
sarcoma of breast
disease_ontology
DOID:3017
breast sarcoma
A substance-related disorder that involves a maladaptive pattern of substance use leading to significant impairment in functioning.
MESH:D019966
NCI:C16522
SNOMEDCT_US_2020_03_01:26416006
UMLS_CUI:C0013146
disease_ontology
DOID:302
substance abuse
A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from spindle cells and/or derives_from giant cells.
GARD:8568
MESH:D018267
NCI:C3768
SNOMEDCT_US_2020_03_01:45410002
UMLS_CUI:C0206685
acinic cell carcinoma
disease_ontology
DOID:3025
acinar cell carcinoma
A disease of mental health involving the abuse or dependence on a substance that is ingested in order to produce a high, alter one's senses, or otherwise affect functioning.
MESH:D019966
NCI:C92203
UMLS_CUI:C0236969
disease_ontology
DOID:303
substance-related disorder
An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which produce mucin.
DOID:4532
MESH:D002288
NCI:C26712
NCI:C27379
SNOMEDCT_US_2020_03_01:72495009
SNOMEDCT_US_2020_03_01:900006
UMLS_CUI:C0007130
UMLS_CUI:C0334368
Mucin-Secreting adenocarcinoma
Mucin-Secreting carcinoma
Mucin-producing adenocarcinoma
Mucous carcinoma
Pseudomyxoma peritonei with unknown primary site
mucin-producing adenocarcinoma
disease_ontology
DOID:3030
mucinous adenocarcinoma
A contact dermatitis that is an allergic skin reaction to foreign chemical or substances leading to red, itchy, weepy reaction where the skin has come into contact with a substance that the immune system recognizes as foreign.
ICD10CM:L23
MESH:D017449
NCI:C26998
SNOMEDCT_US_2020_03_01:200841005
UMLS_CUI:C0162820
disease_ontology
DOID:3042
allergic contact dermatitis
A hypersensitivity reaction type I disease that is an abnormal response to a food, triggered by the body's immune system.
MESH:D005512
SNOMEDCT_US_2020_03_01:213018006
UMLS_CUI:C0016470
food hypersensitivity
disease_ontology
DOID:3044
food allergy
A vasculitits that is systemic vasculitis realized as blood vessel inflammation and has_symptom asthma along with hay fever, rash and gastrointestinal bleeding.
ICD10CM:M30.1
MESH:D015267
NCI:C34481
SNOMEDCT_US_2020_03_01:82275008
UMLS_CUI:C0008728
Allergic Granulomatous Angiitis
Allergic granulomatosis angiitis
Churg-Strauss vasculitis
disease_ontology
DOID:3049
Churg-Strauss syndrome
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
DOID:2428
DOID:6570
MESH:D002277
MESH:D009375
NCI:C2916
NCI:C3709
SNOMEDCT_US_2020_03_01:188083002
SNOMEDCT_US_2020_03_01:269513004
SNOMEDCT_US_2020_03_01:71298006
UMLS_CUI:C0007097
UMLS_CUI:C0553707
UMLS_CUI:C1368683
epithelial cancer
epithelioma
malignant Epithelioma
disease_ontology
DOID:305
carcinoma
A primary bacterial infectious disease that results_in infection located_in intestine, has_material_basis_in Salmonella enterica subsp enterica serovar Paratyphi A, B or C, which are transmitted_by ingestion of contaminated food. The infection has_symptom fever, has_symptom headache, has_symptom abdominal pain, has_symptom malaise, has_symptom anorexia, has_symptom constipation, has_symptom rosy spots on the central body, has_symptom non productive cough (in early stage of illness), has_symptom bradycardia, and has_symptom hepatosplenomegaly.
DOID:13324
DOID:13325
DOID:3053
ICD10CM:A01.1
ICD10CM:A01.2
ICD10CM:A01.3
ICD10CM:A01.4
ICD9CM:002.1
ICD9CM:002.2
ICD9CM:002.3
ICD9CM:002.9
MESH:D010284
NCI:C34894
NCI:C34895
NCI:C34896
NCI:C34897
SNOMEDCT_US_2020_03_01:51254007
SNOMEDCT_US_2020_03_01:71085009
SNOMEDCT_US_2020_03_01:76623002
SNOMEDCT_US_2020_03_01:85904008
UMLS_CUI:C0030528
UMLS_CUI:C0343375
UMLS_CUI:C0343376
UMLS_CUI:C0343377
Paratyphoid
Paratyphoid A fever
Paratyphoid B fever
Paratyphoid C fever
Paratyphoid Fever A
Paratyphoid Fever B
Paratyphoid Fever C
Paratyphoid fever A
Paratyphoid fever B
Paratyphoid fever C
paratyphoid a
paratyphoid b
paratyphoid c
disease_ontology
DOID:3055
paratyphoid fever
An astrocytoma characterized by the presence of small areas of necrotizing tissue that is surrounded by anaplastic cells as well as the presence of hyperplastic blood vessels, and that has_material_basis_in abnormally proliferating cells derives_from multiple cell types including astrocytes and oligondroctyes.
DOID:3075
DOID:3080
GARD:2491
MESH:D005909
NCI:C3058
NCI:C39750
NCI:C9094
SNOMEDCT_US_2020_03_01:63634009
UMLS_CUI:C0017636
UMLS_CUI:C0278878
UMLS_CUI:C1514422
GBM
adult glioblastoma multiforme
glioblastoma multiforme
grade IV adult Astrocytic tumor
primary glioblastoma multiforme
spongioblastoma multiforme
disease_ontology
DOID:3068
glioblastoma
A malignant glioma that is has_material_basis_in astrocyte cells, a type of star-shaped glial cell, located in the brain and spinal cord.
DOID:4861
ICDO:M9400/3
MESH:D001254
NCI:C4951
NCI:C60781
SNOMEDCT_US_2020_03_01:189914005
SNOMEDCT_US_2020_03_01:99131000119108
UMLS_CUI:C0004114
UMLS_CUI:C0750935
Astrocytic tumor
Astrocytoma, NOS
astrocytoma of Cerebrum
astrocytoma of brain
astroglioma
cerebral astrocytoma
disease_ontology
DOID:3069
astrocytoma
MESH:D001254
A cell type cancer that has_material_basis_in glial cells and is located in brain or located in spine.
DOID:2627
ICDO:M9380/3
KEGG:05214
MESH:D005910
NCI:C4822
OMIM:PS137800
ORDO:182067
SNOMEDCT_US_2020_03_01:393564001
SNOMEDCT_US_2020_03_01:74532006
UMLS_CUI:C0017638
UMLS_CUI:C0555198
Neuroglial tumor
glial cell tumor
glioma, malignant
malignant Neuroglial tumor
disease_ontology
DOID:3070
Xref MGI.
OMIM mapping confirmed by DO. [SN].
malignant glioma
A gliomablastoma that is characterized by a biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation.
GARD:5653
MESH:D018316
NCI:C3796
SNOMEDCT_US_2020_03_01:35262004
UMLS_CUI:C0206726
Glioblastoma with sarcomatous component
disease_ontology
DOID:3071
gliosarcoma
MESH:D004831
UMLS_CUI:C0014550
Epileptic seizures - myoclonic
Epileptic seizures, myoclonic
Myoclonic seizure
Myoclonic seizure disorder
myoclonia epileptica
myoclonic epilepsy
disease_ontology
DOID:308
early myoclonic encephalopathy
GARD:6234
MESH:D018191
NCI:C3724
OMIM:257350
SNOMEDCT_US_2020_03_01:40225001
UMLS_CUI:C0206620
cystic Hygroma
disease_ontology
DOID:3081
cystic lymphangioma
A lung disease that is characterized by inflammation and altered lung interstitium compromising pulmonary function and often has_symptom shortness of breath, dyspnea, and/or cough.
GARD:13336
ICD10CM:J84.9
MESH:D017563
SNOMEDCT_US_2020_03_01:64667001
UMLS_CUI:C0206062
ILD
disease_ontology
DOID:3082
interstitial lung disease
An obstructive lung disease that is characterized by irreversible airflow obstruction due to chronic bronchitis, emphysema, and/or small airways disease.
DOID:11500
DOID:6144
EFO:0000341
ICD10CM:J44.9
MESH:D029424
NCI:C3199
OMIM:606963
SNOMEDCT_US_2020_03_01:13645005
UMLS_CUI:C0024117
COLD
COPD
chronic obstructive airway disease
chronic obstructive lung disease
disease_ontology
DOID:3083
chronic obstructive pulmonary disease
ICD10CM:K06.1
MESH:D019214
SNOMEDCT_US_2020_03_01:54711002
UMLS_CUI:C0376480
Gingival enlargement
disease_ontology
DOID:3086
gingival overgrowth
DOID:10422
DOID:10424
ICD10CM:K05.0
ICD10CM:K05.1
ICD10CM:K05.10
ICD9CM:523.0
ICD9CM:523.1
MESH:D005891
NCI:C34474
NCI:C34636
SNOMEDCT_US_2020_03_01:155643004
SNOMEDCT_US_2020_03_01:196355002
SNOMEDCT_US_2020_03_01:266490003
UMLS_CUI:C0008684
UMLS_CUI:C0017574
UMLS_CUI:C0155937
acute gingivitis
chronic gingivitis
disease_ontology
DOID:3087
gingivitis
An organ system cancer located_in the nervous system that affects the central or peripheral nervous system.
DOID:1193
DOID:3195
DOID:4695
ICD9CM:192.9
MESH:D009380
NCI:C35562
SNOMEDCT_US_2020_03_01:188306000
UMLS_CUI:C0027665
UMLS_CUI:C0153643
UMLS_CUI:C1334956
malignant neoplasm of nervous system
neoplasm of nervous system
nervous system neoplasm
neural neoplasm
neural tumor
tumor of the nervous system
disease_ontology
DOID:3093
nervous system cancer
A germ cell cancer that is derives_from a mixture of germs cells and embryonal cells.
MESH:D009373
UMLS_CUI:C0027658
disease_ontology
germ cell and embryonal neoplasm
DOID:3095
germ cell and embryonal cancer
A vascular disease that is characterized by compression at the superior thoracic outlet[1] resulting from excess pressure placed on a neurovascular bundle passing between the anterior scalene and middle scalene muscles.
GARD:7759
ICD10CM:G54.0
MESH:D013901
NCI:C85188
SNOMEDCT_US_2020_03_01:2040007
UMLS_CUI:C0039984
TOS - Thoracic outlet syndrome
disease_ontology
DOID:3103
thoracic outlet syndrome
A parasitic helminthiasis infectious disease that involves infection of the intestine of humans and birds with nematodes of the genus Ascaridia.
MESH:D001198
SNOMEDCT_US_2020_03_01:2435008
UMLS_CUI:C0003952
disease_ontology
DOID:3108
ascaridiasis
An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, in which cystic accumulations of retained secretions are formed.
MESH:D003536
NCI:C2971
SNOMEDCT_US_2020_03_01:21008007
UMLS_CUI:C0010631
disease_ontology
DOID:3111
cystadenocarcinoma
An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which form complex papillary structures and exhibit compressive, destructive growth that replaces the normal tissue.
DOID:5596
MESH:D000231
NCI:C2853
SNOMEDCT_US_2020_03_01:4797003
UMLS_CUI:C0001420
Infiltrating and papillary adenocarcinoma
Papillary adenocarcinoma
infiltrating papillary adenocarcinoma
disease_ontology
DOID:3112
papillary adenocarcinoma
A cystadenocarcinoma that derives_from epithelial cells originating in glandular tissue forming serous lesions.
MESH:D018284
NCI:C3778
SNOMEDCT_US_2020_03_01:90725004
UMLS_CUI:C0206701
serous adenocarcinoma
serous carcinoma
disease_ontology
DOID:3114
serous cystadenocarcinoma
NCI:C7514
UMLS_CUI:C1334323
renal and ureteral tumor
disease_ontology
DOID:3116
kidney benign neoplasm
A gastrointestinal system benign neoplasm located_in the hepatobiliary system.
NCI:C8614
UMLS_CUI:C0854196
hepatobiliary tumors
disease_ontology
DOID:3117
hepatobiliary benign neoplasm
A gastrointestinal system disease that is located_in the liver and/or biliary tract.
MESH:D004066
NCI:C3959
UMLS_CUI:C0267792
liver and biliary tract disease
disease_ontology
DOID:3118
hepatobiliary disease
An organ system cancer located_in gastrointestinal tract that is manifested in organs of the gastrointestinal system.
DOID:4945
DOID:8377
ICD10CM:C26.9
ICD9CM:239.0
MESH:D004067
MESH:D005770
NCI:C3052
NCI:C4890
SNOMEDCT_US_2020_03_01:128348002
SNOMEDCT_US_2020_03_01:276806006
SNOMEDCT_US_2020_03_01:428905002
UMLS_CUI:C0012243
UMLS_CUI:C0017185
UMLS_CUI:C0685938
GI tumor
digestive system cancer
gastrointestinal tract cancer
disease_ontology
DOID:3119
gastrointestinal system cancer
A biliary tract cancer that is located_in the gallbladder.
DOID:8090
DOID:8157
GARD:9328
ICD10CM:C23
ICD9CM:156.0
MESH:D005706
NCI:C3048
NCI:C35676
NCI:C7481
SNOMEDCT_US_2020_03_01:126854002
SNOMEDCT_US_2020_03_01:93810008
UMLS_CUI:C0016978
UMLS_CUI:C0153452
UMLS_CUI:C0278806
gallbladder Ca
gallbladder neoplasm
localized malignant gallbladder neoplasm
malignant neoplasm of gallbladder
malignant tumor of the gallbladder
malignant tumour of gallbladder
tumor of the gallbladder
disease_ontology
DOID:3121
gallbladder cancer
MESH:D017219
SNOMEDCT_US_2020_03_01:196759006
UMLS_CUI:C0162651
gastric outflow obstruction
disease_ontology
DOID:3122
gastric outlet obstruction
A syndrome that is characterized by tumors in at least two endocrine glands.
Multiple endocrine adenomatosis
disease_ontology
DOID:3125
multiple endocrine neoplasia
A rectal disease that involves inflammation of the rectal mucosa, which results from infection, inflammatory bowel disease, or radiation. Sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamydia trachomatis, herpes simplex virus 1 and 2, Treponema pallidum) and enteric pathogens (Campylobacter, Shigella, Salmonella) are involved in the disease. Symptoms are rectal discomfort and bleeding.
ICD10CM:K62.89
MESH:D011349
NCI:C38011
SNOMEDCT_US_2020_03_01:266534007
UMLS_CUI:C0033246
ulcerative proctitis
disease_ontology
DOID:3127
proctitis
DOID:11479
DOID:11993
MESH:D001004
NCI:C26695
SNOMEDCT_US_2020_03_01:32110003
UMLS_CUI:C0003462
Nontraumatic tear of anus
Solitary anal ulcer
Ulcer of anus
anal disease
anal fissure
anal fissure and fistula
anal ulcer
fissure in ano
disease_ontology
DOID:3128
anus disease
An acute porphyria characterized by painful, blistering skin lesions that develop on sun-exposed skin.
GARD:7433
ICD10CM:E80.1
MESH:D017119
NCI:C27725
OMIM:176090
OMIM:176100
ORDO:101330
SNOMEDCT_US_2020_03_01:61860000
UMLS_CUI:C0162566
disease_ontology
DOID:3132
Xref MGI.
OMIM mapping confirmed by DO. [SN].
porphyria cutanea tarda
A porphyria that has_symptom abdominal pain, has_symptom neuropathy, has_symptom autonomic instability and has_symptom psychosis.
MESH:D017094
OMIM:612740
ORDO:100924
SNOMEDCT_US_2020_03_01:55056006
UMLS_CUI:C0162533
hepatic porphyria
disease_ontology
DOID:3133
Xref MGI.
acute porphyria
MESH:D005148
UMLS_CUI:C0015456
disease_ontology
DOID:3134
facial dermatosis
MESH:D012536
SNOMEDCT_US_2020_03_01:402694007
UMLS_CUI:C0036271
Dermatosis of scalp
disease_ontology
DOID:3136
scalp dermatosis
GARD:8603
ICD10CM:L83
MESH:D000052
NCI:C26687
OMIM:100600
OMIM:200170
SNOMEDCT_US_2020_03_01:72129000
UMLS_CUI:C0000889
AN - Acanthosis nigricans
Acanthosis nigricans
Keratosis nigricans
keratosis nigricans
disease_ontology
DOID:3138
OMIM mapping confirmed by DO. [SN].
acanthosis nigricans
MESH:D000052
A connective tissue disease characterized by accumulation of glycosaminoglycan located_in the dermal tissue.
MESH:D017520
SNOMEDCT_US_2020_03_01:11528001
UMLS_CUI:C0162855
disease_ontology
DOID:3141
mucinoses
A skin disease characterized by loose, hanging, wrinkled skin lacking in elasticity.
GARD:6227
ICD10CM:Q82.8
MESH:D003483
NCI:C84663
OMIM:PS123700
ORDO:209
SNOMEDCT_US_2020_03_01:238825007
UMLS_CUI:C0010495
Cutis laxa
loose skin
disease_ontology
DOID:3144
Xref MGI.
cutis laxa
An inherited metabolic disorder that involves the creation and degradation of lipids.
MESH:D008052
UMLS_CUI:C0023772
dyslipidemia
fatty acid metabolism disorder
disease_ontology
DOID:3146
lipid metabolism disorder
ICD10CM:E88.2
MESH:D008068
SNOMEDCT_US_2020_03_01:37095002
UMLS_CUI:C0023801
disease_ontology
DOID:3153
lipomatosis
MESH:D006229
UMLS_CUI:C0018567
disease_ontology
DOID:3158
hand dermatosis
MESH:D012878
NCI:C3372
SNOMEDCT_US_2020_03_01:126488004
UMLS_CUI:C0037286
neoplasm of skin
neoplasm of skin by site
skin neoplasm
tumor of the skin
disease_ontology
DOID:3165
skin benign neoplasm
A cell type benign neoplasm composed_of epithelial cells located_in the ectodermal or endodermal cells linking body cavities.
MESH:D018307
NCI:C3792
SNOMEDCT_US_2020_03_01:118286007
UMLS_CUI:C0206720
Epidermoid cell tumor
squamous cell tumor
disease_ontology
DOID:3168
squamous cell neoplasm
MESH:D000236
NCI:C79951
SNOMEDCT_US_2020_03_01:86143001
UMLS_CUI:C0205650
Papillary adenoma
glandular papilloma
disease_ontology
DOID:3172
papillary adenoma
NCI:C4101
SNOMEDCT_US_2020_03_01:48218007
UMLS_CUI:C0334243
disease_ontology
DOID:3177
verrucous papilloma
NCI:C4614
SNOMEDCT_US_2020_03_01:189051001
UMLS_CUI:C0347390
Cutaneous papilloma
cutaneous papilloma
papilloma of skin
disease_ontology
DOID:3178
skin papilloma
MESH:D018308
NCI:C3793
SNOMEDCT_US_2020_03_01:104081000119103
UMLS_CUI:C0206721
Inverted papilloma
Inverted papilloma, squamous cell
disease_ontology
DOID:3179
inverted papilloma
ICD9CM:335.21
MESH:D009134
NCI:C85027
SNOMEDCT_US_2020_03_01:88923002
UMLS_CUI:C0917981
Pure progressive muscular atrophy
progressive spinal muscular atrophy
disease_ontology
DOID:318
progressive muscular atrophy
DOID:3182
GARD:9953
MESH:D009837
NCI:C129319
NCI:C6960
SNOMEDCT_US_2020_03_01:73348003
UMLS_CUI:C0028945
UMLS_CUI:C1335110
oligodendroglial neoplasm
oligodendroglial tumor
disease_ontology
DOID:3181
oligodendroglioma
A spinal cancer that is located in the spinal cord and has_material_basis_in glial cells.
NCI:C4534
SNOMEDCT_US_2020_03_01:254946004
UMLS_CUI:C2937245
Glial neoplasm Spinal Cord
Glial tumor of spinal cord
glioma of spinal cord
disease_ontology
DOID:3185
spinal cord glioma
ICD10CM:G95.9
ICD9CM:336.9
MESH:D013118
NCI:C97110
SNOMEDCT_US_2020_03_01:48522003
UMLS_CUI:C0037928
disease_ontology
myelopathy
DOID:319
spinal cord disease
A congenital structural myopathy characterized by generally non-progressive muscle weakness of varying severity; certain muscle fibers show the presence of rod-like structures called nemaline bodies.
GARD:12033
ICD10CM:G71.2
MESH:D017696
OMIM:PS161800
ORDO:607
SNOMEDCT_US_2020_03_01:75072002
UMLS_CUI:C0206157
Nemaline body disease
nemaline rod myopathy
rod myopathy
disease_ontology
DOID:3191
Xref MGI.
nemaline myopathy
MESH:D009442
NCI:C3269
SNOMEDCT_US_2020_03_01:985004
UMLS_CUI:C0027809
Psammomatous schwannoma
schwannoma
disease_ontology
DOID:3192
A neuroma that is characterized as a benign nerve sheath tumor that is composed of Schwann cells.
neurilemmoma
A peripheral nervous system neoplasm that is located in the connective tissue surrounding nerves.
MESH:D018317
UMLS_CUI:C0751689
neoplasm of the nerve Sheath
nerve sheath tumour
disease_ontology
DOID:3193
peripheral nerve sheath neoplasm
A brain stem cancer that is characterized by neoplasms in the fossa located_in cerebellopotine angle.
NCI:C5414
Cerebellopontine angle tumor
Cerebellopontine angle tumour
cerebellopontine angle tumour
neoplasm of the Cerebellopontine Angle
disease_ontology
DOID:3200
cerebellopontine angle tumor
NCI:C6970
SNOMEDCT_US_2020_03_01:253088003
UMLS_CUI:C1306247
Melanotic Schwannoma
Melanotic neurilemmoma
Pigmented Neurilemmoma
Pigmented schwannoma
disease_ontology
DOID:3205
melanotic neurilemmoma
An epidermolysis bullosa that is characterized by recurrent blistering located in the lamina lucida of the basement membrane secondary to minor trauma, which can cause limited wounds, dehydration, electrolyte abnormalities, severe infection, among other issues, and has_material_basis_in mutation in genes related to laminin 332, which strengthens the skin.
GARD:2152
MESH:D016109
NCI:C90598
SNOMEDCT_US_2020_03_01:76905008
UMLS_CUI:C0079301
congenital junctional epidermolysis bullosa
disease_ontology
DOID:3209
Xref MGI.
junctional epidermolysis bullosa
A viral infectious disease that results in inflammation located in spinal cord, has_material_basis_in Human T-lymphotropic virus 1, which is transmitted by sexual contact, and transmitted by breast feeding. The infection has symptom spastic weakness of both legs, has symptom muscle stiffness, has symptom sensory disturbance, and has symptom spasms.
ICD10CM:G04.1
MESH:D015493
OMIM:159580
SNOMEDCT_US_2020_03_01:45129002
UMLS_CUI:C0030481
HTLV-associated myelopathy
Tropical spastic paralysis
Tropical spastic paraplegia
disease_ontology
DOID:321
OMIM mapping confirmed by DO. [LS].
tropical spastic paraparesis
A hypomyelinating leukodystrophy characterized by impaired myelin formation, nystagmus, spastic quadriplegia, ataxia, and developmental delay that has_material_basis_in mutation in the PLP1 gene on chromosome Xq22.
GARD:4265
MESH:D020371
NCI:C75487
OMIM:312080
ORDO:702
SNOMEDCT_US_2020_03_01:64855000
UMLS_CUI:C0205711
HLD1
Leukodystrophy, sudanophilic
PMD
Pelizaeus Merzbacher brain sclerosis
Pelizaeus-Merzbacher brain sclerosis
diffuse familial brain sclerosis
hypomyelinating leukodystrophy 1
sudanophilic leukodystrophy, Paelizeus-Merzbacher type
disease_ontology
DOID:3210
Pelizaeus-Merzbacher disease
An inherited metabolic disorder that involve an abnormal accumulation of substances inside the lysosome resulting from defects in lysosomal function.
MESH:D016464
NCI:C61250
SNOMEDCT_US_2020_03_01:23585005
UMLS_CUI:C0085078
disorder of lysosomal enzyme
inborn lysosomal enzyme disorder
lysosomal storage metabolism disorder
disease_ontology
DOID:3211
lysosomal storage disease
A neurodegenerative disease that is characterized by damage to the myelin sheath present around nerve axons.
MESH:D003711
NCI:C34527
UMLS_CUI:C0011303
demyelinating disorder
disease_ontology
DOID:3213
demyelinating disease
A spinal cord disease that is characterized by inflammation of the white matter or gray matter of the spinal cord.
GARD:7130
MESH:D009187
NCI:C26832
SNOMEDCT_US_2020_03_01:192682002
UMLS_CUI:C0026975
disease_ontology
DOID:322
myelitis
GARD:4647
MESH:D020918
SNOMEDCT_US_2020_03_01:128200000
UMLS_CUI:C0458219
Complex regional pain syndromes
disease_ontology
DOID:3223
complex regional pain syndrome
ICD10CM:S12.8
MESH:D014133
NCI:C35079
SNOMEDCT_US_2020_03_01:47125007
UMLS_CUI:C0040580
disease_ontology
DOID:3225
tracheal disease
MESH:D014135
NCI:C78646
SNOMEDCT_US_2020_03_01:11296007
UMLS_CUI:C0040583
Stenosis of trachea
disease_ontology
DOID:3227
tracheal stenosis
MESH:D014135
MESH:D013271
UMLS_CUI:C0038353
stomach dilatation
disease_ontology
DOID:3229
gastric dilatation
MESH:D006610
UMLS_CUI:C0019537
disease_ontology
DOID:3230
high pressure neurological syndrome
A hematologic cancer that has_material_basis_in lymphoma located_in central nervous system.
DOID:3233
ICD9CM:200.5
NCI:C9301
SNOMEDCT_US_2020_03_01:307649006
UMLS_CUI:C0280803
Microglioma
primary CNS lymphoma
disease_ontology
DOID:3234
central nervous system lymphoma
A pneumonia that is defined as an acute lung injury after the inhalation of foreign material such as regurgitated acidic gastric contents, petroleum products and laxative oils. This syndrome occurs in patients who have a marked disturbance of consciousness such as that resulting from a drug overdose, seizures, a massive cerebrovascular accident, or the use of anesthesia. Aspiration of gastric contents results in a chemical burn of the tracheobronchial tree and pulmonary parenchyma, causing an intense parenchymal inflammatory reaction. The disease has_symptom non-productive cough, has_symptom tachypnea, has_symptom bronchospasm, has_symptom bloody sputum, has_symptom frothy sputum, or has_symptom respiratory distress, 2-5 hrs after aspiration.
DOID:13016
DOID:13506
ICD10CM:J69.0
MESH:D011015
SNOMEDCT_US_2020_03_01:47839005
UMLS_CUI:C0032290
Chemical pneumonitis
Mendelson's Syndrome
disease_ontology
DOID:3240
aspiration pneumonitis
An aspiration pneumonitis resulting from the aspiration of lipids. It is the result of a foreign body-type reaction to the presence of lipid material within the lung parenchyma. It is caused by inhalation of nasal drops with oil base or cosmetic oil and aspiration of mineral oil when used as a laxative agent.
DOID:13015
ICD10CM:J69.1
MESH:D011017
SNOMEDCT_US_2020_03_01:196038008
UMLS_CUI:C0032298
Exogenous lipoid pneumonia
Lipoid pneumonitis
disease_ontology
DOID:3241
lipid pneumonia
A rhabdomyosarcoma wherein the mesenchymally-derived malignant cells resemble the primitive developing skeletal muscle of the embryo; it occurs most often in the head and neck area or in the genital or urinary organs.
GARD:4702
MESH:D018233
NCI:C8971
OMIM:268210
ORDO:99757
SNOMEDCT_US_2020_03_01:404051002
UMLS_CUI:C0206656
disease_ontology
DOID:3246
Xref MGI.
embryonal rhabdomyosarcoma
A skeletal muscle cancer that arise from skeletal muscle progenitors.
MESH:D012208
NCI:C3359
SNOMEDCT_US_2020_03_01:302847003
UMLS_CUI:C0035412
disease_ontology
DOID:3247
rhabdomyosarcoma
A rhabdomyosarcoma and sarcoma of prostate that is located_in the prostate.
NCI:C5522
UMLS_CUI:C1335518
Rhabdomyosarcoma of the prostate
disease_ontology
DOID:3252
prostate rhabdomyosarcoma
A vascular disease that is characterized by a restriction in blood supply to tissues.
MESH:D007511
NCI:C34738
SNOMEDCT_US_2020_03_01:52674009
UMLS_CUI:C0022116
disease_ontology
DOID:326
ischemia
A hyper IgE syndrome that has_material_basis_in heterozygous mutation in the STAT3 gene on chromosome 17q21.
GARD:6800
MESH:D007589
NCI:C126342
OMIM:147060
ORDO:2314
UMLS_CUI:C1968689
UMLS_CUI:C2936739
Job syndrome
Job's syndrome
hyperimmunoglobulin E syndrome
disease_ontology
DOID:3261
OMIM mapping confirmed by DO. [SN].
hyper IgE recurrent infection syndrome 1
A primary immunodeficiency disease where phagocytes have a diminished ability to fight bacterial infection.
MESH:D010585
UMLS_CUI:C0031306
phagocytic dysfunction
disease_ontology
DOID:3262
phagocyte bactericidal dysfunction
MESH:D010585
An integumentary system disease characterized by congenital absence of melanocytes in areas of the skin and hair that has_material_basis_in heterozygous mutation in either KIT or SNAI2 on chromosome 4q12 or 8q11.21, respectively.
GARD:4344
ICD10CM:E70.39
MESH:D016116
NCI:C85009
OMIM:172800
ORDO:2884
SNOMEDCT_US_2020_03_01:718122005
UMLS_CUI:C0080024
PIEBALD TRAIT
Partial albinism
disease_ontology
DOID:3263
OMIM mapping confirmed by DO. [SN].
piebaldism
A phagocyte bactericidal dysfunction characterized by an inability to resist repeated infectious diseases and a tendency to develop chronic inflammation. Life-threatening recurrent fungal and bacterial infections affecting the skin, lungs, and bones may occur along with swollen areas of inflamed tissues known as granulomas that can be widely distributed.
GARD:6100
ICD10CM:D71
MESH:D006105
NCI:C26788
ORDO:379
SNOMEDCT_US_2020_03_01:11210002
UMLS_CUI:C0018203
Bridges-Good syndrome
CGD
Congenital dysphagocytosis
Quie syndrome
disease_ontology
DOID:3265
Xref MGI.
OMIM mapping confirmed by DO. [SN].
chronic granulomatous disease
An ovarian benign neoplasm that has_material_basis_in glandular epithelial tissue in which cystic accumulations of retained secretions are formed.
NCI:C4060
SNOMEDCT_US_2020_03_01:198297004
UMLS_CUI:C0346169
Cystoma Serosum simplex
simple cystoma of ovary
simple cystoma of the ovary
disease_ontology
DOID:3269
ovarian cystadenoma
GARD:7725
MESH:D013595
NCI:C85179
OMIM:186700
ORDO:3280
SNOMEDCT_US_2020_03_01:155020007
UMLS_CUI:C0039144
disease_ontology
DOID:327
syringomyelia
A thymus cancer that derives_from epithelial cells located_in the thymus. The tumor cells in a thymoma look similar to the normal cells of the thymus, grow slowly, and rarely spread beyond the thymus.
MESH:D013945
NCI:C3411
SNOMEDCT_US_2020_03_01:444231005
UMLS_CUI:C0040100
disease_ontology
DOID:3275
thymoma
An immune system cancer located_in the thymus.
DOID:10143
ICD10CM:C37
ICD9CM:164.0
MESH:D013953
NCI:C4962
SNOMEDCT_US_2020_03_01:94096009
UMLS_CUI:C0751552
Thymic tumor
neoplasm of thymus
thymic neoplasm
disease_ontology
DOID:3277
thymus cancer
NCI:C7114
UMLS_CUI:C1328042
epithelioid Thymoma
disease_ontology
DOID:3282
dendritic cell thymoma
A thymus cancer that derives_from epithelial cells. The tumor cells in a thymic carcinoma look very different from the normal cells of the thymus, grow more quickly, and have usually spread to other parts of the body when the cancer is found.
MESH:D013945
NCI:C7569
SNOMEDCT_US_2020_03_01:128717008
UMLS_CUI:C0205969
Thymic carcinoma
Thymoma, malignant
malignant Thymoma
disease_ontology
DOID:3284
thymic carcinoma
A viral infectious disease that results in infection of primates, rodents and humans, located in skin, has_material_basis_in Monkeypox virus, which is transmitted by contact with the animal's blood, body fluids, rash, or with the body fluids of a sick person, transmitted by fomites, and transmitted by respiratory droplets. The infection has symptom fever, has symptom muscle ache, has symptom headache, and has symptom lymphadenopathy.
GARD:10722
ICD10CM:B04
ICD9CM:059.01
MESH:D045908
NCI:C128421
SNOMEDCT_US_2020_03_01:240466002
UMLS_CUI:C0276180
disease_ontology
DOID:3292
monkeypox
A viral infectious disease that results_in infection, located_in skin, has_material_basis_in Vaccinia virus, which is used as a live vaccine against smallpox. The virus is transmitted_by contact with the vaccination site before it has healed, or transmitted_by fomites that have been contaminated with live virus from the vaccination site. The infection has_symptom rash, has_symptom fever, and has_symptom body aches.
MESH:D014615
SNOMEDCT_US_2020_03_01:111852003
UMLS_CUI:C0042214
disease_ontology
DOID:3298
vaccinia
A cell type benign neoplasm that is composed_of a mixture of gonadal elements, such as large primordial germ cells, immature Sertoli cells or granulosa cells of the sex cord, and gonadal stromal cells (which comprises the granulosa, theca, and fibrocyte cells).
MESH:D018238
NCI:C3754
OMIM:424500
SNOMEDCT_US_2020_03_01:74751003
UMLS_CUI:C0206661
disease_ontology
DOID:3301
OMIM mapping confirmed by DO. [SN].
gonadoblastoma
A notochordal cancer that derives_from cellular remnants of the notochord.
GARD:1303
MESH:D002817
NCI:C2947
SNOMEDCT_US_2020_03_01:50007008
UMLS_CUI:C0008487
notochordoma
disease_ontology
DOID:3302
OMIM mapping confirmed by DO. [SN].
chordoma
An embryonal cancer and bone cancer and mesenchymal cell neoplasm that is located_in the notochord.
NCI:C7063
UMLS_CUI:C1335069
disease_ontology
notochordal tumor
DOID:3303
notochordal cancer
A germ cell cancer that lacks histologic differentiation. It usually refers to a tumor in the brain.
MESH:D018237
NCI:C3753
SNOMEDCT_US_2020_03_01:154603000
UMLS_CUI:C0206660
disease_ontology
DOID:3304
germinoma
A mixed germ cell tumor that is a mixture of teratoma with embryonal carcinoma, or with choriocarcinoma, or with both.
MESH:D018243
NCI:C3756
SNOMEDCT_US_2020_03_01:67830002
UMLS_CUI:C0206664
Teratocarcinoma
mixed Embryonal carcinoma and teratoma
disease_ontology
DOID:3305
teratocarcinoma
A germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers.
MESH:D013724
NCI:C3403
SNOMEDCT_US_2020_03_01:36591000119102
UMLS_CUI:C0039538
disease_ontology
DOID:3307
teratoma
An embryonal cancer that is a type of germ cell tumour that is located_in the ovaries or located_in the testes.
DOID:5676
GARD:5140
MESH:D018236
NCI:C3752
NCI:C8880
SNOMEDCT_US_2020_03_01:28047004
UMLS_CUI:C0206659
UMLS_CUI:C0855159
primary extragonadal embryonal carcinoma
disease_ontology
DOID:3308
embryonal carcinoma
A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system.
ICD10CM:G96.9
MESH:D002493
NCI:C2934
SNOMEDCT_US_2020_03_01:267144009
UMLS_CUI:C0007682
disease_ontology
DOID:331
central nervous system disease
An allergic contact dermatitis that is a chronically relapsing inflammatory allergic response located_in the skin that causes itching and flaking.
EFO:0000274
ICD10CM:L20
MESH:D003876
OMIM:603165
OMIM:PS603165
SNOMEDCT_US_2020_03_01:156331003
UMLS_CUI:C0011615
Atopic dermatitis
Atopic neurodermatitis
Besnier's prurigo
allergic dermatitis
atopic eczema
disease_ontology
DOID:3310
Xref MGI.
OMIM mapping confirmed by DO. [SN].
atopic dermatitis
A mood disorder that involves alternating periods of mania and depression.
DOID:3311
DOID:9554
DOID:9555
EFO:0000289
GARD:10249
ICD10CM:F31
ICD9CM:296.40
ICD9CM:296.60
ICD9CM:296.80
MESH:D001714
NCI:C34423
NCI:C34424
NCI:C34805
SNOMEDCT_US_2020_03_01:16506000
SNOMEDCT_US_2020_03_01:191627008
SNOMEDCT_US_2020_03_01:192355004
SNOMEDCT_US_2020_03_01:68569003
UMLS_CUI:C0005586
UMLS_CUI:C0005587
UMLS_CUI:C0024713
UMLS_CUI:C0236780
Manic Bipolar Affective disorder
Manic Depressive disorder
Manic bipolar I disorder
bipolar depression
bipolar disorder manic phase
manic depression
manic disorder
mixed bipolar disorder
disease_ontology
Depressive-manic psych.
DOID:3312
bipolar disorder
A cell type benign neoplasm that is primarily located in the kidneys but may be found in the lungs, liver or other organs and is derived from perivascular epithelioid cells.
MESH:D018207
NCI:C3734
SNOMEDCT_US_2020_03_01:19929002
UMLS_CUI:C0206633
Angiomyolipoma
disease_ontology
DOID:3314
angiomyolipoma
MESH:D018207
A cell type benign neoplasm that is composed of lipocytes.
DOID:3154
DOID:9291
ICD10CM:D17
ICD10CM:D17.9
ICD9CM:214
MESH:D008067
MESH:D018205
NCI:C3192
NCI:C4248
NCI:C4502
OMIM:151900
SNOMEDCT_US_2020_03_01:115227001
SNOMEDCT_US_2020_03_01:154612003
SNOMEDCT_US_2020_03_01:254830006
UMLS_CUI:C0023798
UMLS_CUI:C0206631
UMLS_CUI:C0346118
LIPOMATOSIS, FAMILIAL MULTIPLE
Lipomatous neoplasm
Lipomatous tumor
benign lipomatous tumor
benign tumor of Adipose tissue
multiple lipomatosis
tumor of adipose tissue
disease_ontology
DOID:3315
OMIM mapping confirmed by DO. [SN].
lipoma
DOID:5234
NCI:C6528
NCI:C6530
UMLS_CUI:C1334611
UMLS_CUI:C1335392
malignant perivascular cancer
disease_ontology
DOID:3316
perivascular tumor
A lung disease that is characterized by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas.
DOID:3682
GARD:3319
NCI:C38153
OMIM:606690
ORDO:538
SNOMEDCT_US_2020_03_01:277844007
UMLS_CUI:C0349649
lung lymphangioleiomyomatosis
lymphangiomyomatosis
pulmonary lymphangioleiomyomatosis
disease_ontology
DOID:3319
lymphangioleiomyomatosis
MESH:D018192
A motor neuron disease that is characterized by muscle spasticity, rapidly progressive weakness due to muscle atrophy, difficulty in speaking, swallowing, and breathing.
EFO:0000253
GARD:5786
ICD10CM:G12.21
ICD9CM:335.20
KEGG:05014
MESH:D000690
NCI:C34373
OMIM:PS105400
ORDO:803
SNOMEDCT_US_2020_03_01:86044005
UMLS_CUI:C0002736
ALS
Lou Gehrig's disease
motor neuron disease, bulbar
disease_ontology
DOID:332
amyotrophic lateral sclerosis
MESH:D000690
GARD:7737
ICD10CM:E75.02
MESH:D013661
NCI:C85184
OMIM:272800
SNOMEDCT_US_2020_03_01:111385000
UMLS_CUI:C0039373
A GM2 gangliosidosis that is characterized the onset in infancy of developmental retardation, followed by paralysis, dementia and blindness, with death in the second or third year of life and has_material_basis_in homozygous or compound heterozygous mutation in the alpha subunit of the hexosaminidase A gene (HEXA) on chromosome 15q23.
GM2 gangliosidosis, type 1
hexosaminidase A deficiency
disease_ontology
DOID:3320
OMIM mapping confirmed by DO. [SN].
Tay-Sachs disease
A gangliosidosis that is characterized by excessive accumulation of ganglioside GM2 and related glycolipids in the lysosomes.
ICD10CM:E75.0
MESH:D020143
SNOMEDCT_US_2020_03_01:33316007
UMLS_CUI:C0268274
gangliosidosis GM2
disease_ontology
DOID:3321
GM2 gangliosidosis
A GM2 gangliosidosis that is characterized by an accumulation of GM2 gangliosides, particularly in neurons, and that has_material_basis_in mutation in the beta subunit of hexosaminidase (HEXB) on chromosome 5q13.
GARD:7604
ICD10CM:E75.01
MESH:D012497
NCI:C85052
OMIM:268800
SNOMEDCT_US_2020_03_01:23849003
UMLS_CUI:C0036161
Sandhoff Jatzkewitz disease
disease_ontology
DOID:3323
OMIM mapping confirmed by DO. [SN].
Sandhoff disease
MESH:D012497
A cognitive disorder that involves a disturbance in mood as the predominant underlying feature.
EFO:0004247
ICD10CM:F39
MESH:D019964
NCI:C92200
SNOMEDCT_US_2020_03_01:46206005
UMLS_CUI:C0525045
episodic mood disorder
disease_ontology
DOID:3324
Updating outdated UMLS CUI.
mood disorder
MESH:D011694
SNOMEDCT_US_2020_03_01:402852007
UMLS_CUI:C0034151
disease_ontology
DOID:3325
hyperglobulinemic purpura
ICD10CM:D69.2
MESH:D011693
NCI:C78787
SNOMEDCT_US_2020_03_01:423902002
UMLS_CUI:C0034150
Purpuric disorder
disease_ontology
DOID:3326
purpura
MESH:D011693
MESH:D019305
OMIM:117100
UMLS_CUI:C0376532
BCECTS
benign Rolandic epilepsy
benign childhood epilepsy with centrotemporal spike
rolandic epilepsy
sylvan seizures
disease_ontology
DOID:3329
benign epilepsy with centrotemporal spikes
A personality disorder that is characterized by a pattern of excessive emotionality and attention-seeking, including an excessive need for approval and inappropriately seductive behavior, usually beginning in early adulthood.
ICD10CM:F60.4
ICD9CM:301.5
MESH:D006677
NCI:C92634
SNOMEDCT_US_2020_03_01:192489002
UMLS_CUI:C0019681
disease_ontology
DOID:334
histrionic personality disorder
A bone resorption disease that has_material_basis_in hyperparathyroidism which results_in hyperactivity in osteoclasts, deformity, and loss of mass located_in bone.
MESH:D010002
NCI:C34875
SNOMEDCT_US_2020_03_01:190451000
UMLS_CUI:C0029405
Osteitis fibrosa cystica generalisata
Von Recklinghausen's bone disease
hyperparathyroid bone disease
disease_ontology
DOID:3341
osteitis fibrosa
A bone disease that results_in inflammation of the located_in bone.
MESH:D010000
SNOMEDCT_US_2020_03_01:274144001
UMLS_CUI:C0029400
Inflammatory disorder of bone
bone inflammatory disease
osteitis
disease_ontology
DOID:3342
bone inflammation disease
A mucolipidosis that is characterized by a deficiency of the enzyme alpha-N -acetyl neuraminidase (sialidase).
GARD:10670
MESH:D009081
NCI:C61267
OMIM:256550
SNOMEDCT_US_2020_03_01:70528007
UMLS_CUI:C0026697
Mucolipidosis type I
sialidosis
disease_ontology
DOID:3343
OMIM mapping submitted by NeuroDevNet. [LS].
glycoproteinosis
A lipid storage disease that is characterized by the desposition of yellowish cholesterol-rich material in tendons or other body parts.
MESH:D014973
SNOMEDCT_US_2020_03_01:63103006
UMLS_CUI:C0043325
xanthelasmatosis
disease_ontology
DOID:3345
xanthomatosis
A bone sarcoma that is located_in bone that has_material_basis_in cells of mesenchymal origin.
DOID:183
GARD:7284
MESH:D012516
MESH:D018213
NCI:C9145
OMIM:259500
ORDO:668
SNOMEDCT_US_2020_03_01:189878003
UMLS_CUI:C0029463
UMLS_CUI:C0206639
Osteogenic sarcoma
Skeletal sarcoma
bone tissue neoplasm
osteoid sarcoma
disease_ontology
DOID:3347
OMIM mapping confirmed by DO. [SN].
osteosarcoma
A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic connective tissue that is capable of developing into connective tissue, such as bone, and cartilage, the lymphatic system, and the circulatory system.
DOID:1630
NCI:C6587
NCI:C7059
UMLS_CUI:C1332517
UMLS_CUI:C1334699
benign miscellaneous mesenchymal tumor
mesenchymal tumor
disease_ontology
DOID:3350
mesenchymal cell neoplasm
A connective tissue cancer that has_material_basis_in fibrous connective tissue and characterized by the presence of immature proliferating fibroblasts or undifferentiated anaplastic spindle cells in a storiform pattern.
DOID:156
DOID:3509
GARD:2327
MESH:D005354
MESH:D018218
NCI:C3043
NCI:C6605
NCI:C7075
SNOMEDCT_US_2020_03_01:443250000
UMLS_CUI:C0016057
UMLS_CUI:C0206643
UMLS_CUI:C1336021
Fibrocytic tumor
fibrosarcoma of soft tissue
fibrous tissue neoplasm
disease_ontology
DOID:3355
fibrosarcoma
NCI:C7780
UMLS_CUI:C0278511
localised Osteogenic sarcoma
localised osteosarcoma
localized Osteogenic sarcoma
disease_ontology
DOID:3356
localized osteosarcoma
GARD:6200
ICD10CM:I25.41
ICD9CM:414.11
MESH:D003323
SNOMEDCT_US_2020_03_01:50570003
UMLS_CUI:C0010051
Aneurysm of coronary vessels
Aneurysmal lesion of coronary artery
Arteriovenous aneurysm of coronary vessels
disease_ontology
DOID:3362
coronary aneurysm
A connective tissue cancer that has_material_basis in neural crest cells derives_from undeveloped, undifferentiated neuroectoderm.
DOID:0050607
DOID:4158
DOID:4390
DOID:4391
DOID:4392
DOID:4980
GARD:6390
MESH:C563168
MESH:D012512
MESH:D018241
NCI:C27901
NCI:C27903
NCI:C4817
NCI:C7542
NCI:C7806
NCI:C9341
OMIM:612219
SNOMEDCT_US_2020_03_01:134210007
SNOMEDCT_US_2020_03_01:73676002
SNOMEDCT_US_2020_03_01:76909002
UMLS_CUI:C0553580
UMLS_CUI:C0684337
UMLS_CUI:C0796547
UMLS_CUI:C0863029
UMLS_CUI:C0877849
UMLS_CUI:C1334408
Ewing's family localized tumor
Ewing's sarcoma/peripheral primitive neuroectodermal tumor
Ewing's tumor
Ewings sarcoma
Ewings sarcoma-primitive neuroectodermal tumor
PNET of Thoracopulmonary Region
localized Ewing sarcoma
localized Ewing's sarcoma
localized Ewing's sarcoma/peripheral primitive neuroectodermal tumor
localized Ewing's tumor
localized peripheral primitive neuroectodermal tumor
peripheral primitive neuroectodermal tumor
disease_ontology
DOID:3369
OMIM mapping confirmed by DO. [SN].
Ewing sarcoma
A bone sarcoma that has_material_basis_in cells derived from transformed cells that produce cartilage.
DOID:3370
GARD:6004
GARD:6055
MESH:D002813
NCI:C2946
NCI:C7155
OMIM:215300
SNOMEDCT_US_2020_03_01:443520009
SNOMEDCT_US_2020_03_01:735679005
UMLS_CUI:C0008479
UMLS_CUI:C1335473
Cartilaginous cancer
chondrosarcoma of bone
primary chondrosarcoma of the bone
disease_ontology
DOID:3371
OMIM mapping confirmed by DO. [SN].
chondrosarcoma
MESH:D018217
NCI:C8969
SNOMEDCT_US_2020_03_01:91242000
UMLS_CUI:C0206642
Parosteal Osteogenic sarcoma
Parosteal Osteosarcoma
disease_ontology
DOID:3373
juxtacortical osteosarcoma
NCI:C7134
UMLS_CUI:C1332591
Surface Osteosarcoma
disease_ontology
DOID:3374
peripheral osteosarcoma
DOID:8580
NCI:C53707
SNOMEDCT_US_2020_03_01:307576001
UMLS_CUI:C0585442
Osteosarcoma of bone
primary Osteosarcoma of bone
disease_ontology
DOID:3376
bone osteosarcoma
NCI:C4023
SNOMEDCT_US_2020_03_01:12302002
UMLS_CUI:C0279622
Round cell osteosarcoma
small cell Osteosarcoma
disease_ontology
DOID:3377
small cell osteogenic sarcoma
Medullary Osteosarcoma
Medullary osteosarcoma
conventional Osteosarcoma
disease_ontology
DOID:3378
conventional central osteosarcoma
A central nervous system cancer develops from schwann cells located_in cranial nerves, has_material_basis_in abnormally proliferating cells.
MESH:D003390
NCI:C2963
SNOMEDCT_US_2020_03_01:126966009
UMLS_CUI:C0010267
neoplasm of cranial nerve
disease_ontology
DOID:338
cranial nerve neoplasm
A lipomatous cancer that arises in fat cells in deep soft tissue retroperitoneum and the extremities.
GARD:6913
MESH:D008080
NCI:C3194
SNOMEDCT_US_2020_03_01:254829001
UMLS_CUI:C0023827
disease_ontology
DOID:3382
liposarcoma
A vaginitis that is characterized by a grayish vaginal discharge usually of foul odor and the presence of Gardnerella vaginalis.
MESH:D016585
NCI:C116973
SNOMEDCT_US_2020_03_01:237092002
UMLS_CUI:C0085166
disease_ontology
DOID:3385
bacterial vaginosis
A mouth disease that is relating to or affecting the structures surrounding and supporting the teeth.
ICD10CM:K05.6
MESH:D010510
NCI:C63743
SNOMEDCT_US_2020_03_01:196354003
UMLS_CUI:C0031090
Periodontal disease
disease of supporting structures of teeth
periodontium disorder
disease_ontology
DOID:3388
periodontal disease
An ectodermal dysplasia that is characterized by palmoplantar keratoderma associated with early-onset periodontitis and has_material_basis_in homozygous or compound heterozygous mutation in the cathepsin C gene on chromosome 11q14.
GARD:3100
MESH:D010214
NCI:C84992
OMIM:245000
ORDO:678
SNOMEDCT_US_2020_03_01:40158001
UMLS_CUI:C0030360
Papillon Lefevre syndrome
Papillon-Lefvre syndrome
disease_ontology
DOID:3389
OMIM mapping confirmed by DO. [SN].
Papillon-Lefevre disease
A keratosis characterized by abnormal thickening of the palms and the soles.
GARD:8167
ICD10CM:L85.2
SNOMEDCT_US_2020_03_01:28596004
UMLS_CUI:C0022596
Keratosis palmaris et plantaris
Palmoplantar Keratoderma
palmo-plantar keratodermas
disease_ontology
DOID:3390
palmoplantar keratosis
An artery disease that is characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles.
DOID:10506
DOID:3363
DOID:3394
DOID:9420
EFO:0001645
ICD10CM:I20-I25
ICD10CM:I25
ICD10CM:I25.1
ICD10CM:I25.10
ICD9CM:410-414.99
ICD9CM:414.0
ICD9CM:414.9
MESH:D003324
MESH:D003327
MESH:D017202
NCI:C35505
NCI:C50625
OMIM:300464
OMIM:607339
OMIM:608316
OMIM:608318
OMIM:608320
OMIM:610947
OMIM:611139
OMIM:612030
OMIM:614293
SNOMEDCT_US_2020_03_01:194852007
SNOMEDCT_US_2020_03_01:233822007
SNOMEDCT_US_2020_03_01:41702007
SNOMEDCT_US_2020_03_01:53741008
UMLS_CUI:C0010054
UMLS_CUI:C0010068
UMLS_CUI:C0151744
UMLS_CUI:C0264694
CHD
Coronary disease
coronary arteriosclerosis
coronary heart disease
disease_ontology
DOID:3393
Xref MGI.
coronary artery disease
ICD10CM:E22.2
MESH:D007177
NCI:C3988
SNOMEDCT_US_2020_03_01:55004003
UMLS_CUI:C0021141
syndrome of Inappropriate Antidiuretic Hormone Secretion
syndrome of inappropriate secretion of ADH
syndrome of inappropriate secretion of antidiuretic hormone
syndrome of inappropriate vasopressin secretion
disease_ontology
DOID:3401
inappropriate ADH syndrome
MESH:D007177
A lymphatic system disease that is characterized by an excessive number of histiocytes.
DOID:3344
MESH:D015614
NCI:C3106
SNOMEDCT_US_2020_03_01:60657004
UMLS_CUI:C0019618
Hand Schuller Christian disease
chronic Histiocytosis X
disease_ontology
DOID:3405
histiocytosis
MESH:D002340
NCI:C84476
SNOMEDCT_US_2020_03_01:371160000
UMLS_CUI:C0007273
disorder of carotid artery
disease_ontology
DOID:3407
carotid artery disease
A vascular disease that is characterized by obstruction of larger arteries not within the coronary, aortic arch vasculature, or brain.
DOID:2868
ICD9CM:443.81
MESH:D001157
SNOMEDCT_US_2020_03_01:195624006
SNOMEDCT_US_2020_03_01:2929001
UMLS_CUI:C0003838
UMLS_CUI:C0031115
arterial occlusive disease
disease_ontology
DOID:341
peripheral vascular disease
A lysosomal storage disease that has_material_basis_in deficiency of the alpha-D-manosidase enzyme resulting in the impairment of cell function from a build up of complex sugars derived from glycoproteins in the lysosome.
GARD:6968
MESH:D008363
NCI:C84548
OMIM:248500
SNOMEDCT_US_2020_03_01:65524005
UMLS_CUI:C0024748
Alpha-D-mannosidosis
alpha-mannosidase deficiency
deficiency of alpha-mannosidase
disease_ontology
DOID:3413
OMIM mapping confirmed by DO. [SN].
alpha-mannosidosis
MESH:D008363
A cranial nerve disease that is located_in the ninth cranial nerve or its nuclei in the medulla.
ICD10CM:G52
ICD9CM:352
SNOMEDCT_US_2020_03_01:193098000
UMLS_CUI:C0154730
ninth cranial nerve disease
disease_ontology
DOID:3418
glossopharyngeal nerve disease
MESH:D019574
NCI:C4801
SNOMEDCT_US_2020_03_01:126968005
UMLS_CUI:C0524802
Tumour of optic nerve
neoplasm of optic nerve
tumor of Second Cranial nerve
disease_ontology
DOID:3419
optic nerve neoplasm
ICD9CM:442.82
SNOMEDCT_US_2020_03_01:40136003
UMLS_CUI:C0155746
disease_ontology
DOID:342
subclavian artery aneurysm
ICD10CM:H81.9
MESH:D015837
SNOMEDCT_US_2020_03_01:20425006
UMLS_CUI:C0042594
Vertigo, vestibular disorder
disease_ontology
DOID:3426
vestibular disease
A myositis that is characterized by late onset of skeletal muscle inflammation, weakness, and atrophy with cytoplasmic granules and vacuoles in the muscle.
GARD:3896
ICD10CM:G72.41
ICD9CM:359.71
MESH:D018979
NCI:C84786
OMIM:147421
ORDO:611
SNOMEDCT_US_2020_03_01:72315009
UMLS_CUI:C0238190
disease_ontology
DOID:3429
OMIM mapping confirmed by DO. [SN].
inclusion body myositis
MESH:D018979
A laryngeal disease involving an inflammation of the larynx leading to hoarse voice or a complete loss of voice due to irritation of the vocal cords caused by viral, bacterial or fungal infection, inflammation due to overuse of the vocal cords and excessive coughing, smoking, or alcohol consumption.
MESH:D007827
NCI:C26811
SNOMEDCT_US_2020_03_01:45913009
UMLS_CUI:C0023067
disease_ontology
DOID:3437
laryngitis
A breast adenocarcinoma that has_material_basis_in epidermal Paget cells, which are malignant glandular epithelial cells with abundant and clear cytoplasm, usually containing mucin, and pleomorphic and hyperchromatic nucleus.
NCI:C7073
UMLS_CUI:C1368019
Paget cell neoplasm
Paget's disease
Paget's disease of the breast
mammary Paget disease
disease_ontology
DOID:3443
mammary Paget's disease
NCI:C5598
UMLS_CUI:C1332274
Paget's disease of anus
anal Paget disease
disease_ontology
Paget's disease of the anus
DOID:3446
anal Paget's disease
An anal carcinoma that originating in the cortex of the adrenal gland and derives_from epithelial cells of glandular origin.
NCI:C5600
SNOMEDCT_US_2020_03_01:423607006
UMLS_CUI:C1332257
adenocarcinoma of anus
disease_ontology
adenocarcinoma of the anus
DOID:3447
anus adenocarcinoma
A penile cancer that is located_in the skin or tissues of the penis.
NCI:C9061
SNOMEDCT_US_2020_03_01:372106005
UMLS_CUI:C0853105
Penile carcinoma
carcinoma of penis
disease_ontology
DOID:3449
penis carcinoma
A female reproductive system disease that is located_in the uterus.
ICD10CM:N85.9
ICD9CM:621.9
MESH:D014591
NCI:C26907
SNOMEDCT_US_2020_03_01:237068005
UMLS_CUI:C0042131
disease_ontology
DOID:345
uterine disease
A skin cancer that is located_in tissues of the skin and develops from epithelial cells.
NCI:C4914
UMLS_CUI:C0699893
carcinoma of skin
disease_ontology
DOID:3451
skin carcinoma
A cerebrovascular disease that is characterized by tissue necrosis located_in the brain, resulting from inadequate blood flow through the brain.
MESH:D020520
UMLS_CUI:C0751955
disease_ontology
DOID:3454
brain infarction
A breast lobular carcinoma that is characterized by infiltration into the tissue of the breast outside of the lobule where it originated.
MESH:D018275
NCI:C3771
SNOMEDCT_US_2020_03_01:89740008
UMLS_CUI:C0206692
Lobular carcinoma
Lobular carcinoma of breast
Lobular carcinoma of the breast
disease_ontology
DOID:3457
invasive lobular carcinoma
A breast carcinoma that originates in the milk ducts and/or lobules (glandular tissue) of the breast.
NCI:C5214
UMLS_CUI:C0858252
Mammary adenocarcinoma
disease_ontology
adenocarcinoma of breast
DOID:3458
breast adenocarcinoma
A breast cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
EFO:0000305
MESH:D001943
NCI:C4872
SNOMEDCT_US_2020_03_01:154513000
UMLS_CUI:C0678222
Mammary carcinoma
carcinoma of breast
disease_ontology
DOID:3459
breast carcinoma
A thoracic disease that is located_in the breast.
ICD10CM:N64.9
ICD9CM:610-612.99
MESH:D001941
NCI:C26709
SNOMEDCT_US_2020_03_01:79604008
UMLS_CUI:C0006145
disease_ontology
DOID:3463
breast disease
An ocular cancer that is located_in the uvea, which are the pigmented layers of the eye consisting of the iris, ciliary body, and choroid. The uvea is the most common location of intraocular malignancy in adults and may commonly be caused by a subtype of cancer that arises from melanocytes.
DOID:12754
MESH:D014604
NCI:C3436
NCI:C6105
UMLS_CUI:C0042162
UMLS_CUI:C1334629
Uveal tumor
malignant Uveal tumor
malignant uvea neoplasm
disease_ontology
DOID:3479
uveal cancer
An eyelid disease that is characterized by exacerbations and remissions of eyelid edema, which results in a stretching and subsequent atrophy of the eyelid tissue, leading to the formation of redundant folds over the lid margins.
ICD10CM:H02.3
ICD9CM:374.34
SNOMEDCT_US_2020_03_01:193944001
UMLS_CUI:C0005742
disease_ontology
DOID:348
blepharochalasis
An eye disease affecting the uvea, which are the pigmented layers of the eye consisting of the iris, ciliary body, and choroid.
GARD:8192
MESH:D014603
NCI:C26908
SNOMEDCT_US_2020_03_01:95678007
UMLS_CUI:C0042161
disease_ontology
DOID:3480
uveal disease
A primary bacterial infectious disease that results_in infection, located_in lymph node, located_in vasculature or located_in lungs, has_material_basis_in Yersinia pestis, which is transmitted_by oriental rat flea (Xenopsylla cheopis) infected by feeding on rodents and other mammals, transmitted_by air, transmitted_by direct contact or transmitted_by ingestion of contaminated undercooked food.
ICD10CM:A20
ICD9CM:020
MESH:D010930
NCI:C85015
SNOMEDCT_US_2020_03_01:58750007
UMLS_CUI:C0032064
disease_ontology
DOID:3482
plague
GARD:8616
ICD10CM:D47.02
MESH:D034721
NCI:C9235
SNOMEDCT_US_2020_03_01:123310005
UMLS_CUI:C0221013
SMCD - systemic mast cell disease
systemic tissue mast cell disease
disease_ontology
DOID:349
systemic mastocytosis
A RASopathy that is characterized by mildly unusual facial features, short stature, heart defects, bleeding problems, skeletal malformations, and many other signs and symptoms.
GARD:10955
ICD10CM:Q87.19
MESH:D009634
NCI:C34854
OMIM:PS163950
ORDO:648
SNOMEDCT_US_2020_03_01:88327006
UMLS_CUI:C0028326
Turner's phenotype, karyotype normal
disease_ontology
DOID:3490
OMIM mapping confirmed by DO. [SN].
Noonan syndrome
A gonadal dysgenesis that is characterized by short stature and early loss of ovarian function resulting from ovarian hypofunction or premature ovarian failure and has_material_basis_in one missing or structurally altered X chromosome.
DOID:5448
GARD:2540
GARD:7831
ICD10CM:Q96
MESH:D014424
NCI:C26900
NCI:C34434
SNOMEDCT_US_2020_03_01:38804009
UMLS_CUI:C0041408
UMLS_CUI:C1527168
Bonnevie-Ullrich syndrome
Gonadal dysgenesis - Turner
Karyotype 45, X
Monosomy X
XO syndrome
monosomy X syndrome
disease_ontology
DOID:3491
No OMIM mapping, confirmed by DO. [LS].
Turner syndrome
A collagen disease that is considered an overlap of three diseases, systemic lupus erythematosus, scleroderma, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen.
GARD:7051
ICD10CM:M35.1
MESH:D008947
NCI:C84892
SNOMEDCT_US_2020_03_01:33110008
UMLS_CUI:C0026272
Connective tissue disease overlap syndrome
mixed collagen vascular disease
disease_ontology
DOID:3492
mixed connective tissue disease
An adenocarcinoma that derives_from epithelial cells originating in glandular tissue, which have signet ring appearance.
MESH:D018279
NCI:C3774
SNOMEDCT_US_2020_03_01:189701002
UMLS_CUI:C0206696
Signet Ring cell adenocarcinoma
Signet ring carcinoma
Signet ring cell carcinoma
disease_ontology
DOID:3493
signet ring cell adenocarcinoma
A pancreatic adenocarcinoma that derives_from pancreatic duct cells.
NCI:C9120
SNOMEDCT_US_2020_03_01:792907004
UMLS_CUI:C1335302
ductal adenocarcinoma of the pancreas
disease_ontology
DOID:3498
pancreatic ductal adenocarcinoma
GARD:6987
ICD10CM:D47.09
MESH:D008415
NCI:C84269
OMIM:154800
SNOMEDCT_US_2020_03_01:78745000
UMLS_CUI:C0024899
mast cell hyperplasia
disease_ontology
DOID:350
OMIM mapping confirmed by DO. [LS].
mastocytosis
A fibrosarcoma that is located_in the dermis laryer of the skin and that begins as a hard nodule and grows slowly.
GARD:9569
MESH:D018223
OMIM:607907
SNOMEDCT_US_2020_03_01:302844005
UMLS_CUI:C0206647
disease_ontology
DOID:3507
MESH:C538219 added from NeuroDevNet [WAK].
dermatofibrosarcoma protuberans
GARD:8211
MESH:D018319
SNOMEDCT_US_2020_03_01:19897006
UMLS_CUI:C0206729
Neurosarcoma
disease_ontology
DOID:3512
neurofibrosarcoma
NCI:C8088
UMLS_CUI:C0279981
disease_ontology
DOID:3520
pediatric fibrosarcoma
MESH:D020244
UMLS_CUI:C0740392
disease_ontology
DOID:3525
middle cerebral artery infarction
A cerebrovascular disease that is characterized by an area of necrotic tissue in the brain resulting from a blockage or narrowing in the arteries supplying blood and oxygen to the brain.
ICD10CM:I63
MESH:D002544
NCI:C50486
OMIM:601367
SNOMEDCT_US_2020_03_01:195188006
UMLS_CUI:C0007785
CVA - Cerebral infarction
Cerebral infarct
Cerebral infarction
disease_ontology
DOID:3526
cerebral infarction
MESH:D002539
UMLS_CUI:C0007774
disease_ontology
DOID:3527
cerebral arterial disease
ICD10CM:G71.2
MESH:D020512
NCI:C83010
OMIM:117000
SNOMEDCT_US_2020_03_01:43152001
UMLS_CUI:C0751951
central core disease
disease_ontology
DOID:3529
OMIM mapping confirmed by DO. [SN].
central core myopathy
MESH:D034081
UMLS_CUI:C1135993
disease_ontology
DOID:3530
chronic wasting disease
A progressive myoclonus epilepsy characterized by onset between 6 and 13 years of age of action- and stimulus-sensitive myoclonus, tonic-clonic seizures with ataxia, and a mild cognitive decline.
GARD:3876
MESH:D020194
SNOMEDCT_US_2020_03_01:192847001
UMLS_CUI:C0751785
Unverricht - Lundborg disease
Unverricht's disease
Unverricht-Lundborg disease
disease_ontology
DOID:3535
OMIM mapping confirmed by DO. [LS].
Unverricht-Lundborg syndrome
A cerebral ventricle cancer that is located_in the plexus located_in the ventricles of the brain.
MESH:D016545
NCI:C3473
SNOMEDCT_US_2020_03_01:254942002
UMLS_CUI:C0085138
tumor of choroid plexus
tumor of the Choroid Plexus
disease_ontology
choroid plexus neoplasm
DOID:3540
choroid plexus cancer
A cerebrum cancer that is located_in the cerebral ventricles.
DOID:10856
GARD:6025
ICD10CM:C71.5
ICD9CM:191.5
MESH:D002551
NCI:C2937
SNOMEDCT_US_2020_03_01:126958000
SNOMEDCT_US_2020_03_01:363471001
UMLS_CUI:C0007798
UMLS_CUI:C0346906
Intraventricular tumor of brain
cerebral ventricle neoplasm
disease_ontology
DOID:3541
cerebral ventricle cancer
A sarcoma that has_material_basis in mast cells.
ICD10CM:C96.22
ICD9CM:202.6
MESH:D012515
NCI:C9348
SNOMEDCT_US_2020_03_01:118615008
UMLS_CUI:C0036221
disease_ontology
DOID:355
mast-cell sarcoma
GARD:7712
MESH:D013478
NCI:C85175
SNOMEDCT_US_2020_03_01:24988007
UMLS_CUI:C0038828
Superior mesenteric artery syndrome
disease_ontology
DOID:3557
superior mesenteric artery syndrome
ICD10CM:K31.5
MESH:D004380
NCI:C79548
SNOMEDCT_US_2020_03_01:95532008
UMLS_CUI:C0013292
disease_ontology
DOID:3558
duodenal obstruction
An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis.
GARD:7488
MESH:D011553
NCI:C3345
SNOMEDCT_US_2020_03_01:307601000
UMLS_CUI:C0033822
Pseudomyxoma peritonei
mucinous Ascites
disease_ontology
DOID:3559
pseudomyxoma peritonei
A central nervous system cancer that are manifested in the central nervous system and arise from the arachnoid cap cells of the arachnoid villi in the meninges.
DOID:1137
DOID:3554
DOID:3567
DOID:4750
GARD:7015
ICD10CM:D32.9
ICDO:M9530/3
MESH:D008577
MESH:D008579
NCI:C3229
NCI:C3230
NCI:C4656
NCI:C6971
NCI:C7048
SNOMEDCT_US_2020_03_01:127579001
SNOMEDCT_US_2020_03_01:269643009
SNOMEDCT_US_2020_03_01:302820008
UMLS_CUI:C0025284
UMLS_CUI:C0025286
UMLS_CUI:C0349604
UMLS_CUI:C1334698
UMLS_CUI:C1336537
intracranial meningioma
meningeal neoplasm
meningothelial cell tumor
neoplasm of the meninges
primary Meningeal tumor
supratentorial meningioma
disease_ontology
DOID:3565
meningioma
A hepatobiliary system cancer that is located_in the liver.
DOID:12300
DOID:269
DOID:7330
DOID:915
DOID:919
ICD10CM:C22.0
ICD10CM:C22.9
ICD9CM:155.0
ICD9CM:155.2
MESH:D008113
NCI:C34803
NCI:C7692
SNOMEDCT_US_2020_03_01:126851005
SNOMEDCT_US_2020_03_01:187771009
SNOMEDCT_US_2020_03_01:93870000
UMLS_CUI:C0023903
UMLS_CUI:C0024620
UMLS_CUI:C0345904
UMLS_CUI:C0854795
Ca liver - primary
Resectable malignant neoplasm of Liver
ca liver - primary
hepatic cancer
hepatic neoplasm
malignant hepato-biliary neoplasm
malignant neoplasm of liver
malignant neoplasm of liver, not specified as primary or secondary
malignant neoplasm of liver, primary
malignant tumor of liver
neoplasm of liver
non-resectable primary hepatic malignant neoplasm
primary liver cancer
primary malignant neoplasm of Liver
primary malignant neoplasm of liver
resectable malignant neoplasm of the liver
disease_ontology
DOID:3571
liver cancer
MESH:D012851
UMLS_CUI:C0037198
disease_ontology
DOID:3572
intracranial sinus thrombosis
MESH:D020227
SNOMEDCT_US_2020_03_01:21258007
UMLS_CUI:C0270639
Thrombosis of lateral venous sinus
Thrombosis transverse sinus
disease_ontology
DOID:3574
lateral sinus thrombosis
MESH:D020225
SNOMEDCT_US_2020_03_01:70607008
UMLS_CUI:C0338575
Thrombosis of superior longitudinal sinus
Thrombosis of superior sagittal sinus
disease_ontology
DOID:3576
sagittal sinus thrombosis
A sex cord-gonadal stromal tumor characterized by excessive proliferation of Sertoli cells.
DOID:0050617
MESH:D012707
NCI:C39976
SNOMEDCT_US_2020_03_01:89089007
UMLS_CUI:C0036769
tubular androblastoma
disease_ontology
DOID:3577
Sertoli cell tumor
NCI:C39911
UMLS_CUI:C1515283
disease_ontology
DOID:3579
testicular gonadoblastoma
DOID:14071
DOID:3598
ICD10CM:O01
ICD9CM:630
MESH:D006828
MESH:D031901
NCI:C3110
NCI:C4699
NCI:C7887
OMIM:231090
SNOMEDCT_US_2020_03_01:156085008
SNOMEDCT_US_2020_03_01:417475006
UMLS_CUI:C0020217
UMLS_CUI:C0278796
UMLS_CUI:C1135868
gestational trophoblastic neoplasia
hydatidiform mole
molar pregnancy
disease_ontology
DOID:3590
OMIM mapping confirmed by DO. [SN].
gestational trophoblastic neoplasm
NCI:C6900
SNOMEDCT_US_2020_03_01:128767001
UMLS_CUI:C1266159
disease_ontology
DOID:3593
epithelioid trophoblastic tumor
A placenta cancer that has_material_basis_in trophoblastic cells.
GARD:6059
ICD10CM:C58
MESH:D002822
NCI:C2948
SNOMEDCT_US_2020_03_01:189444004
UMLS_CUI:C0008497
Chorioepithelioma
disease_ontology
DOID:3594
choriocarcinoma
A choriocarcinoma that is characterized by low beta-hCG levels and arises from neoplastic transformation of intermediate trophoblastic cells.
MESH:D018245
NCI:C3757
SNOMEDCT_US_2020_03_01:75320001
UMLS_CUI:C0206666
Placental site trophoblastic tumor
Placental site trophoblastic tumour
Placental-Site Gestational Trophoblastic neoplasm
placental site trophoblastic tumour
disease_ontology
DOID:3596
placental site trophoblastic tumor
A nervous system disease that results from exposure to neurotoxicants and is characterized by an altered mental status, memory loss, and visual problems.
MESH:D020258
NCI:C27961
SNOMEDCT_US_2020_03_01:19466003
UMLS_CUI:C0235032
neurotoxicity
neurotoxicity syndrome
disease_ontology
DOID:3602
toxic encephalopathy
A cystadenocarcinoma that derives_from epithelial cells originating in glandular tissue, with a capsulated structure and mucus-producing cells.
MESH:D018282
NCI:C3776
SNOMEDCT_US_2020_03_01:79143006
UMLS_CUI:C0206699
Pseudomucinous cystadenocarcinoma
disease_ontology
DOID:3603
mucinous cystadenocarcinoma
An ovarian cystadenocarcinoma that is characterized by the presence of mucin.
NCI:C4026
SNOMEDCT_US_2020_03_01:254851009
UMLS_CUI:C0279665
Ovarian mucinous cystadenocarcinoma
mucinous cystadenocarcinoma of ovary
disease_ontology
DOID:3604
ovarian mucinous cystadenocarcinoma
An ovary adenocarcinoma that is characterized by the presence of cysts or cystic spaces.
NCI:C5228
SNOMEDCT_US_2020_03_01:314191009
UMLS_CUI:C1096638
cystadenocarcinoma of ovary
cystadenocarcinoma of the Ovary
disease_ontology
DOID:3605
ovarian cystadenocarcinoma
An ovary adenocarcinoma that is characterized by the presence of mucin.
NCI:C5243
UMLS_CUI:C1335167
mucinous carcinoma of Ovary
disease_ontology
DOID:3606
ovarian mucinous adenocarcinoma
An appendix carcinoma that derives_from epithelial cells of glandular origin.
NCI:C7718
SNOMEDCT_US_2020_03_01:413445002
UMLS_CUI:C0238003
Appendiceal adenocarcinoma
disease_ontology
DOID:3608
appendix adenocarcinoma
A cervix disease that is characterized by the growth endometrial tissue that is located on the cervix.
NCI:C27623
SNOMEDCT_US_2020_03_01:61640006
UMLS_CUI:C0269107
Endometriosis of cervix
cervical Endometriosis
disease_ontology
DOID:361
cervix endometriosis
ICD10CM:H30.9
MESH:D012173
NCI:C115993
SNOMEDCT_US_2020_03_01:35426003
UMLS_CUI:C0035333
disease_ontology
DOID:3612
retinitis
GARD:5984
MESH:D017825
NCI:C84611
OMIM:271900
SNOMEDCT_US_2020_03_01:80544005
UMLS_CUI:C0206307
CANAVAN-VAN BOGAERT-BERTRAND DISEASE
Spongy degeneration of central nervous system
disease_ontology
DOID:3613
OMIM mapping confirmed by DO. [SN].
Canavan disease
A hypogonadotropic hypogonadism with a defective sense of smell (anosmia or hyposmia).
GARD:10771
ICD10CM:E23.0
MESH:D017436
NCI:C75479
ORDO:478
SNOMEDCT_US_2020_03_01:190559001
UMLS_CUI:C0162809
Hypogonadism with anosmia
Kallman syndrome
Kallman's syndrome
familial hypogonadism with anosmia
disease_ontology
DOID:3614
Kallmann syndrome
A lipoma that is a painful subcutaneous nodule, having all other features of a typical lipoma.
MESH:D018206
NCI:C3733
SNOMEDCT_US_2020_03_01:404057003
UMLS_CUI:C0206632
disease_ontology
DOID:3616
angiolipoma
MESH:D018206
A nervous system cancer that is located_in the central nervous system.
DOID:0060093
DOID:1318
EFO:0000326
ICD10CM:C72.9
MESH:D016543
NCI:C4627
NCI:C9293
SNOMEDCT_US_2020_03_01:126951006
SNOMEDCT_US_2020_03_01:93744007
UMLS_CUI:C0085136
UMLS_CUI:C0348374
CNS neoplasm
central nervous system tumor
central nervous system tumors
malignant neoplasm of central nervous system
malignant tumor of CNS
neoplasm of central nervous system
disease_ontology
DOID:3620
central nervous system cancer
An aortic disease that is characterized by an enlargement (dilation) of the aorta to greater than 1.5 times normal size.
DOID:11138
DOID:7682
DOID:7692
DOID:7703
ICD10CM:I71.1
ICD10CM:I71.3
ICD10CM:I71.5
ICD10CM:I71.8
ICD10CM:I71.9
ICD9CM:441.1
ICD9CM:441.3
ICD9CM:441.5
ICD9CM:441.6
MESH:D001014
MESH:D001019
NCI:C26697
NCI:C27046
NCI:C27198
NCI:C27299
SNOMEDCT_US_2020_03_01:14336007
SNOMEDCT_US_2020_03_01:155419006
SNOMEDCT_US_2020_03_01:195265003
SNOMEDCT_US_2020_03_01:34365005
SNOMEDCT_US_2020_03_01:73067008
UMLS_CUI:C0003486
UMLS_CUI:C0265010
UMLS_CUI:C0265012
UMLS_CUI:C0741160
UMLS_CUI:C1305122
ruptured aortic aneurysm
disease_ontology
DOID:3627
aortic aneurysm
MESH:D001014
MESH:D001019
A female reproductive organ cancer that is located_in the uterus.
DOID:4363
ICD10CM:C55
ICD9CM:179
MESH:D014594
NCI:C3435
NCI:C3552
SNOMEDCT_US_2020_03_01:126908007
SNOMEDCT_US_2020_03_01:371973000
UMLS_CUI:C0042138
UMLS_CUI:C0153567
CA - cancer of uterus
Tumour of uterus
malignant neoplasm of uterus
malignant uterine tumor
neoplasm of uterus
uterine tumor
uterus neoplasm
disease_ontology
DOID:363
uterine cancer
A lysosomal storage disease that has_material_basis_in deficiency of the beta-A-manosidase enzyme resulting in the disruption of N-linked glycoprotein oligosaccharide catabolism.
MESH:D044905
NCI:C84596
OMIM:248510
SNOMEDCT_US_2020_03_01:238047006
UMLS_CUI:C4048196
Beta-D-mannosidosis
beta-mannosidase deficiency
lysosomal beta-mannosidase deficiency
disease_ontology
DOID:3633
OMIM mapping confirmed by DO. [SN].
beta-mannosidosis
A neuromuscular junction disease that is characterized by weakness and easy fatiguability resulting from a genetic defect at the junction where the nerve stimulates muscle activity that result in muscle weakness and may affect nerve cells (presynaptic), muscle cells (postsynaptic) or the space between nerve and muscle cells (synaptic).
GARD:11902
MESH:D020294
NCI:C84647
OMIM:PS601462
ORDO:590
SNOMEDCT_US_2020_03_01:230672006
UMLS_CUI:C0751882
disease_ontology
DOID:3635
Xref MGI.
congenital myasthenic syndrome
A teratoma that is located_in the central nervous system.
NCI:C5441
UMLS_CUI:C1332895
CNS teratoma
disease_ontology
DOID:3640
central nervous system teratoma
GARD:6331
MESH:D004652
NCI:C84686
SNOMEDCT_US_2020_03_01:393569006
UMLS_CUI:C0014008
Empty sella syndrome
disease_ontology
DOID:3642
empty sella syndrome
MESH:D004652
NCI:C27066
SNOMEDCT_US_2020_03_01:59572000
UMLS_CUI:C0271558
Pituitary necrosis
disease_ontology
DOID:3646
necrosis of pituitary
A carbohydrate metabolic disorder characterized by the buildup of lactic acid in the body and a variety of neurological problems and caused by a deficiency of one of the three enzymes in the pyruvate dehydrogenase complex.
GARD:4620
GARD:7513
ICD10CM:E74.4
MESH:D015325
NCI:C103968
OMIM:245348
OMIM:245349
OMIM:312170
OMIM:608782
OMIM:614111
ORDO:79243
SNOMEDCT_US_2020_03_01:46683007
UMLS_CUI:C0034345
deficiency of pyruvic dehydrogenase
pyruvate dehydrogenase complex deficiency disease
pyruvate dehydrogenase deficiency
disease_ontology
DOID:3649
Xref MGI.
OMIM mapping confirmed by DO. [SN].
pyruvate decarboxylase deficiency
A urinary system disease that is located_in the bladder.
ICD10CM:N32.9
ICD9CM:596.9
MESH:D001745
NCI:C2900
SNOMEDCT_US_2020_03_01:42643001
UMLS_CUI:C0005686
Urinary Bladder Disease
disease_ontology
DOID:365
bladder disease
A metabolic acidosis characterized by buildup of lactate.
ICD10CM:E87.2
MESH:D000140
NCI:C98969
SNOMEDCT_US_2020_03_01:91273001
UMLS_CUI:C0001125
disease_ontology
DOID:3650
lactic acidosis
A mitochondrial metabolism disease characterized by progressive loss of mental and movement abilities. Symptoms usually begin between ages of three months and two years and include loss of appetite, vomiting, irritability and seizure activity.
GARD:6877
ICD10CM:G31.82
MESH:D007888
NCI:C84814
OMIM:256000
ORDO:506
SNOMEDCT_US_2020_03_01:29570005
UMLS_CUI:C0023264
Infantile necrotizing encephalomyelopathy
Leigh syndrome
juvenile subacute necrotizing encephalomyelopathy
disease_ontology
subacute necrotizing encephalomyelopathy
DOID:3652
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Leigh disease
A lysosomal storage disease characterized by increased sialic acid in the urine.
MESH:D029461
NCI:C85067
OMIM:269921
OMIM:604369
SNOMEDCT_US_2020_03_01:238051008
UMLS_CUI:C0342853
disease_ontology
DOID:3659
OMIM mapping confirmed by DO. [LS].
OMIM mapping submitted by NeuroDevNet. [LS].
sialuria
NCI:C5121
SNOMEDCT_US_2020_03_01:126967000
UMLS_CUI:C0346319
neoplasm of olfactory nerve
tumor of Olfactory nerve
disease_ontology
DOID:366
olfactory nerve neoplasm
A hematologic cancer that has_material_basis_in mast cells.
ICD10CM:D47.09
NCI:C9295
SNOMEDCT_US_2020_03_01:127581004
UMLS_CUI:C0334664
Mast cell Proliferative disease
mast cell tumor
mastocytoma
disease_ontology
DOID:3664
mast cell neoplasm
ICD10CM:I73.9
MESH:D007383
SNOMEDCT_US_2020_03_01:195312007
UMLS_CUI:C0021775
Charcot's syndrome
Intermittent claudication
disease_ontology
DOID:3669
intermittent claudication
A childhood kidney neoplasm that is located_in the kidney, liver, muscle, heart, lung, soft tissues, skin and central nervous system.
GARD:7572
MESH:D018335
NCI:C3808
SNOMEDCT_US_2020_03_01:83118000
UMLS_CUI:C0206743
Rhabdoid sarcoma
malignant rhabdoid tumour
disease_ontology
rhabdoid tumor
DOID:3672
rhabdoid cancer
MESH:D018335
NCI:C6563
UMLS_CUI:C1333003
pediatric renal tumor
disease_ontology
DOID:3675
childhood kidney cancer
A supratentorial cancer that is located_in the cerebrum.
DOID:912
ICD9CM:191.8
NCI:C4874
SNOMEDCT_US_2020_03_01:126953009
SNOMEDCT_US_2020_03_01:188300006
UMLS_CUI:C0153642
UMLS_CUI:C1263885
cerebral cancer
neoplasm of cerebrum
tumor of Cerebrum
disease_ontology
DOID:368
cerebrum cancer
MESH:D008175
NCI:C3200
SNOMEDCT_US_2020_03_01:126713003
UMLS_CUI:C0024121
tumor of the lung
disease_ontology
DOID:3683
lung benign neoplasm
A mitochondrial encephalomyopathy that is characterized by mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, has_symptom myalgia, motor weakness, headaches, seizures, and stroke-like episodes with acute hemiparesis and severe headaches, and develops_from mutation in mitochondrial genes including MT-TL1, which encodes tRNA proteins.
ICD10CM:E88.41
MESH:D017241
NCI:C84885
OMIM:540000
SNOMEDCT_US_2020_03_01:39925003
UMLS_CUI:C0162671
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES
disease_ontology
DOID:3687
OMIM mapping confirmed by DO. [SN].
MELAS syndrome
ICD10CM:G54.5
MESH:D020968
NCI:C84600
SNOMEDCT_US_2020_03_01:26609002
UMLS_CUI:C0221759
Brachial neuritis
Parsonage-Aldren-Turner syndrome
disease_ontology
DOID:3689
brachial plexus neuritis
GARD:2197
MESH:D018304
NCI:C3789
SNOMEDCT_US_2020_03_01:76060004
UMLS_CUI:C0206717
Asthesioneuroblastoma
Esthesioneuroblastoma
Esthesioneuroepithelioma
Olfactory Esthesioneuroblastoma
paranasal sinus Olfactory neuroblastoma
disease_ontology
DOID:369
olfactory neuroblastoma
ICD10CM:G54.0
MESH:D020516
NCI:C27194
SNOMEDCT_US_2020_03_01:3548001
UMLS_CUI:C0700251
Brachial plexus disorder
brachial plexopathy
disease_ontology
DOID:3690
brachial plexus neuropathy
An integumentary system disease that is located_in skin.
DOID:1576
DOID:1698
DOID:187
DOID:6486
DOID:8948
ICD9CM:702
MESH:D012871
MESH:D012873
NCI:C156032
NCI:C3371
SNOMEDCT_US_2020_03_01:201095006
SNOMEDCT_US_2020_03_01:5613003
SNOMEDCT_US_2020_03_01:95320005
UMLS_CUI:C0029574
UMLS_CUI:C0037274
UMLS_CUI:C0037277
Genodermatosis
skin and subcutaneous tissue disease
disease_ontology
DOID:37
skin disease
A fallopian tube carcinoma that derives_from epithelial cells of glandular origin.
NCI:C6265
UMLS_CUI:C1333590
adenocarcinoma of the fallopian tube
disease_ontology
DOID:3706
fallopian tube adenocarcinoma
A bladder carcinoma that derives_from epithelial cells of glandular origin.
NCI:C4032
SNOMEDCT_US_2020_03_01:255110003
UMLS_CUI:C0279682
adenocarcinoma of bladder
adenocarcinoma of the urinary bladder
bladder adenocarcinoma, Not Otherwise Specified
disease_ontology
DOID:3711
bladder adenocarcinoma
An ovarian carcinoma that derives_from epithelial cells of glandular origin.
DOID:7816
NCI:C7700
UMLS_CUI:C0948216
Ovarian adenocarcinoma
ovarian adenoacanthoma
disease_ontology
adenocarcinoma of the ovary
DOID:3713
ovary adenocarcinoma
A stomach carcinoma that derives_from epithelial cells of glandular origin.
NCI:C4004
SNOMEDCT_US_2020_03_01:408647009
UMLS_CUI:C0278701
adenocarcinoma of stomach
stomach adenocarcinoma
disease_ontology
DOID:3717
gastric adenocarcinoma
ICD10CM:C90.3
MESH:D010954
NCI:C9349
SNOMEDCT_US_2020_03_01:302852008
UMLS_CUI:C0032131
Myeloma - solitary
Myeloma, solitary
Solitary myeloma
Solitary plasmacytoma
disease_ontology
DOID:3721
plasmacytoma
A parasitic protozoa infectious disease that involves infection of humans and cattle caused by a genus of parasitic protozoa Theileria, which is transmitted by ixodid ticks.
MESH:D013801
SNOMEDCT_US_2020_03_01:68771000
UMLS_CUI:C0039753
Infection by Theileria
theileriosis
disease_ontology
DOID:3733
theileriasis
A squamous cell carcinoma that is a diffuse, papillary, non metastasizing, well differentiated, malignant neoplasm of epidermis or oral epithelium.
MESH:D018289
NCI:C3781
SNOMEDCT_US_2020_03_01:89906000
UMLS_CUI:C0206706
Warty carcinoma
verrucous squamous carcinoma
verrucous squamous cell carcinoma
disease_ontology
DOID:3737
verrucous carcinoma
An acquired metabolic disease that is characterized by an insufficient intake of food or of certain nutrients, by an inability of the body to absorb and use nutrients, or by overconsumption of certain foods.
MESH:D009748
NCI:C26836
SNOMEDCT_US_2020_03_01:191077005
UMLS_CUI:C3714509
Nutritional disorder
disease_ontology
DOID:374
nutrition disease
A cervix carcinoma that has_material_basis_in squamous cells of the cervix.
NCI:C4028
SNOMEDCT_US_2020_03_01:254886006
UMLS_CUI:C0279671
squamous cell carcinoma of cervix
squamous cell carcinoma of the Cervix Uteri
disease_ontology
DOID:3744
cervical squamous cell carcinoma
An esophageal carcinoma that derives_from epithelial squamous cells located_in the esophagus.
MESH:D000077277
NCI:C4024
SNOMEDCT_US_2020_03_01:276804009
UMLS_CUI:C0279626
SCC of esophagus
SCC of oesophagus
oesophagus squamous cell carcinoma
disease_ontology
DOID:3748
OMIM mapping confirmed by DO. [SN].
esophagus squamous cell carcinoma
NCI:C8188
UMLS_CUI:C0280328
verrucous carcinoma of the Larynx
disease_ontology
DOID:3752
larynx verrucous carcinoma
A syndrome characterized by oculocutaneous albinism, bleeding problems due to platelet storage pool defect, visual impairment and lysosomal accumulation of ceroid lipofuscin.
GARD:6643
ICD10CM:E70.331
MESH:D022861
NCI:C37261
OMIM:PS203300
ORDO:231531
ORDO:231537
ORDO:280663
ORDO:79430
SNOMEDCT_US_2020_03_01:60255003
UMLS_CUI:C0079504
disease_ontology
DOID:3753
Xref MGI.
OMIM mapping confirmed by DO. [SN].
Hermansky-Pudlak syndrome
A thrombophilia that is characterized by the tendency to form clots in the veins.
ICD10CM:D68.59
MESH:D020152
NCI:C98815
OMIM:613118
SNOMEDCT_US_2020_03_01:36351005
UMLS_CUI:C0272375
AT III deficiency
hereditary thrombophilia due to congenital antithrombin deficiency
disease_ontology
DOID:3755
Xref MGI.
antithrombin III deficiency
A thrombophilia that is characterized by recurrent venous thrombosis and that has_material_basis_in heterozygous mutation in the PROC gene on chromosome 2q14.
GARD:4521
ICD10CM:D68.59
MESH:D020151
NCI:C99025
ORDO:745
SNOMEDCT_US_2020_03_01:76407009
UMLS_CUI:C0398625
disease_ontology
DOID:3756
protein C deficiency
MESH:D012734
NCI:C45909
SNOMEDCT_US_2020_03_01:52572004
UMLS_CUI:C0019269
disease_ontology
DOID:3763
hermaphroditism
A syndrome that is characterized by the association of diffuse mesangial sclerosis (DMS), male pseudohermaphroditism with a 46,XY karyotype, and nephroblastoma that derives_from an abnormality in the WT1 gene (Wilms' tumor suppressor gene).
GARD:5576
MESH:D030321
NCI:C84668
OMIM:194080
SNOMEDCT_US_2020_03_01:236385009
UMLS_CUI:C0950121
disease_ontology
DOID:3764
OMIM mapping confirmed by DO. [SN].
Denys-Drash syndrome
DOID:11226
ICD10CM:Q56
ICD10CM:Q56.3
ICD9CM:752.7
MESH:D012734
NCI:C124575
SNOMEDCT_US_2020_03_01:204895009
SNOMEDCT_US_2020_03_01:268328009
UMLS_CUI:C0021193
UMLS_CUI:C0033804
Indeterminate sex and pseudohermaphroditism
disease_ontology
DOID:3765
pseudohermaphroditism
A vaginal discharge that is characterized by a whitish or yellow color.
ICD10CM:N89.8
MESH:D007973
NCI:C34775
SNOMEDCT_US_2020_03_01:156017008
UMLS_CUI:C0023533
Leukorrhea of vagina
discharge - leukorrhea
disease_ontology
DOID:3766
leukorrhea
A vaginal disease that is characterized by the presence of discharge.
MESH:D019522
NCI:C50795
SNOMEDCT_US_2020_03_01:70856007
UMLS_CUI:C0227791
disease_ontology
DOID:3767
vaginal discharge
An interstitial lung disease that is characterized by destruction, scarring, and thickening of the interstitial lung tissues and progressive pulmonary function loss in a restrictive pattern, has_symptom progressive shortness of breath, fatigue, and chronic cough, possibly has_material_basis_in exposure to certain chemicals, autoimmune conditions, and radiation.
MESH:D011658
NCI:C26869
SNOMEDCT_US_2020_03_01:155613001
UMLS_CUI:C0034069
Fibrosis of lung
disease_ontology
DOID:3770
pulmonary fibrosis
NCI:C5592
SNOMEDCT_US_2020_03_01:128789002
UMLS_CUI:C1322252
Chordoid glioma
disease_ontology
DOID:3774
chordoid glioma
An ovarian disease that is characterized by the absence of ovulation.
MESH:D000858
NCI:C34388
SNOMEDCT_US_2020_03_01:34571000
UMLS_CUI:C0003128
disease_ontology
DOID:3781
anovulation
A syndrome that is characterized by skeletal malformations, growth retardation, hearing deficit, paroxysmal movement disorders, and cognitive impairment in affected males and some carrier females, and has_material_basis_in mutation in the RSK2 gene on chromosome Xp22.
GARD:6123
MESH:D038921
NCI:C84643
OMIM:303600
SNOMEDCT_US_2020_03_01:15182000
UMLS_CUI:C0265252
disease_ontology
DOID:3783
OMIM mapping confirmed by DO. [SN].
Coffin-Lowry syndrome
DOID:13122
DOID:835
ICD10CM:H61.9
ICD9CM:380
NCI:C26972
SNOMEDCT_US_2020_03_01:49130001
UMLS_CUI:C0155388
Preauricular cyst
Preauricular sinus and fistula
Preauricular sinus or fistula
disease_ontology
DOID:379
external ear disease
A soft tissue infectious disease that involves accumulation of pus in the pleural cavity as a result of infection within the lung (pneumonia) or a lung abscess spreading into the space. The symptoms include cough, fever, chest pain, sweating and shortness of breath.
DOID:11023
DOID:13630
DOID:14304
ICD10CM:J86
MESH:D016724
NCI:C45692
SNOMEDCT_US_2020_03_01:196069007
UMLS_CUI:C0014013
Empyema
Empyema of pleura
Empyema of pleura without fistula
Empyema with fistula
Empyema with no fistula
Empyema with pleural fistula
Empyema without mention of fistula
Empyema, chest
Pleural empyema with fistula
Purulent pleurisy
Thorax abscess
abscess of pleural cavity
abscess of thorax
empyema
empyema with fistula
lung empyema
pleural empyema with no fistula
purulent pleuritis
pyothorax
disease_ontology
DOID:3798
Updating outdated UMLS CUI.
pleural empyema
A bone disease that is located_in the joint.
DOID:13871
DOID:13960
DOID:1843
DOID:1903
DOID:226
DOID:2317
DOID:2318
DOID:546
DOID:9489
ICD10CM:M00-M02
ICD10CM:M12.9
ICD9CM:711
ICD9CM:719.90
MESH:D007592
NCI:C35760
NCI:C78402
SNOMEDCT_US_2020_03_01:48548006
SNOMEDCT_US_2020_03_01:8316001
UMLS_CUI:C0022408
UMLS_CUI:C0157749
Ankylosis of joint of ankle and/or foot
Ankylosis of joint of forearm
Ankylosis of joint of hand
Ankylosis of joint of lower leg
Ankylosis of joint of multiple sites
Ankylosis of joint of shoulder region
Ankylosis of joint of upper arm
Ankylosis of multiple joints
Infectious arthropathy
Joint ankylosis of the ankle and foot
Joint ankylosis of the ankle and/or foot
Joint ankylosis of the forearm
Joint ankylosis of the hand
Joint ankylosis of the lower leg
Joint ankylosis of the pelvic region and thigh
Joint ankylosis of the shoulder region
Joint ankylosis of the upper arm
ankylosis of ankle and foot joint
ankylosis of forearm joint
ankylosis of hand joint
ankylosis of joint of multiple sites
ankylosis of joint of pelvic region and thigh
ankylosis of joint of shoulder region
ankylosis of lower leg joint
ankylosis of upper arm joint
disease_ontology
DOID:381
arthropathy
An allergic contact dermatitis that is characterized by a delayed-type hypersensitivity cutaneous reaction in response to a photoantigen applied to the skin in individuals previously sensitized to the same substance, and has_symptom erythematous papules, vesicles, or eczema.
MESH:D017454
SNOMEDCT_US_2020_03_01:111209006
UMLS_CUI:C0162824
Photoallergic contact dermatitis
Photoallergic dermatitis
Photoallergic eczema
disease_ontology
DOID:3818
photoallergic dermatitis
A diaphragm disease characterized by the lack of development of all or part of the diaphragm, which results in an abnormal opening that allows the stomach and intestines to move into the chest cavity and crowd the heart and lungs.
GARD:1481
ICD10CM:K44
MESH:D006548
NCI:C34687
OMIM:142340
OMIM:222400
OMIM:610187
ORDO:2140
SNOMEDCT_US_2020_03_01:155748004
UMLS_CUI:C0019284
Diaphragmatic Hernia
disease_ontology
DOID:3827
Xref MGI.
OMIM mapping confirmed by DO. [SN].
congenital diaphragmatic hernia
ICD10CM:Q79.0
A pituitary gland benign neoplasm that derives_from glandular epithelial cells.
MESH:D010911
NCI:C3329
OMIM:PS102200
SNOMEDCT_US_2020_03_01:154621002
UMLS_CUI:C0032000
adenoma of the Pituitary gland
disease_ontology
DOID:3829
pituitary adenoma
DOID:10392
GARD:7897
ICD10CM:I45.6
ICD9CM:426.7
MESH:D014927
NCI:C35132
OMIM:194200
SNOMEDCT_US_2020_03_01:195057009
SNOMEDCT_US_2020_03_01:74390002
UMLS_CUI:C0043202
UMLS_CUI:C0392470
Anomalous A-V excitation
Wolff-Parkinson-White pattern
anomalous atrioventricular excitation
disease_ontology
DOID:384
OMIM mapping confirmed by DO. [LS].
OMIM mapping confirmed by DO. [SN].
Wolff-Parkinson-White syndrome
GARD:10486
MESH:D003397
NCI:C2964
SNOMEDCT_US_2020_03_01:189179009
UMLS_CUI:C0010276
neoplasm of Rathke's Pouch
disease_ontology
DOID:3840
craniopharyngioma
MESH:D019292
NCI:C4676
UMLS_CUI:C0376527
tumors of Skull Base
disease_ontology
DOID:3842
skull base cancer
DOID:6097
NCI:C5125
NCI:C5126
UMLS_CUI:C1333286
UMLS_CUI:C1334576
malignant Diencephalic tumor
malignant diencephalic neoplasm
tumor of Diencephalon
disease_ontology
DOID:3843
diencephalic neoplasm
DOID:4133
DOID:4134
DOID:6252
DOID:6253
GARD:7378
ICD10CM:Q85.8
MESH:D010580
NCI:C3324
NCI:C4733
NCI:C7755
OMIM:175200
ORDO:2869
SNOMEDCT_US_2020_03_01:157029009
SNOMEDCT_US_2020_03_01:277161008
SNOMEDCT_US_2020_03_01:53633000
UMLS_CUI:C0031269
UMLS_CUI:C0265323
UMLS_CUI:C0456487
Colonic hamartomatous polyp
Peutz Jeghers colon polyp
Peutz Jeghers polyp
Peutz-Jeghers polyp of small Intestine
gastric Peutz-Jeghers polyp
peutz-jeghers small bowel hamartoma
disease_ontology
DOID:3852
OMIM mapping confirmed by DO. [SN].
Peutz-Jeghers syndrome
NCI:C39908
SNOMEDCT_US_2020_03_01:236740006
UMLS_CUI:C0341767
Seminal Vesicle neoplasm
seminal vesicle tumour
tumor of seminal vesicle
tumour of seminal vesicle
disease_ontology
DOID:3855
seminal vesicle tumor
A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
DOID:10284
ICD10CM:C63.9
ICD9CM:187.9
MESH:D005834
NCI:C3054
NCI:C8561
SNOMEDCT_US_2020_03_01:126895004
SNOMEDCT_US_2020_03_01:363515000
UMLS_CUI:C0017417
UMLS_CUI:C0153606
male genital cancer
male reproductive system neoplasm
malignant neoplasm of male genital organ
malignant neoplasm of male genital organ or tract
malignant neoplasm of male genital organs
malignant tumor of male Reproductive system
malignant tumor of male genital organ
neoplasm of male genital organ
tumor of male Reproductive system
disease_ontology
male genital neoplasm
DOID:3856
male reproductive organ cancer
A medulloblastoma that is characterized by cells that are larger than would be normally expected.
NCI:C6904
SNOMEDCT_US_2020_03_01:128790006
UMLS_CUI:C1266180
large cell Medulloblastoma
disease_ontology
DOID:3857
large cell medulloblastoma
MESH:D008527
NCI:C3706
SNOMEDCT_US_2020_03_01:24604009
UMLS_CUI:C0205833
Medullomyoblastoma
disease_ontology
DOID:3861
medullomyoblastoma
DOID:6380
MESH:D008527
NCI:C4011
NCI:C9373
UMLS_CUI:C0278876
UMLS_CUI:C1332188
adult brain medulloblastoma
disease_ontology
DOID:3864
adult medulloblastoma
MESH:D008527
NCI:C3997
UMLS_CUI:C0278510
pediatric Medulloblastoma
disease_ontology
DOID:3869
childhood medulloblastoma
MESH:D003109
UMLS_CUI:C0009374
disease_ontology
DOID:3877
functional colonic disease
A syndrome that is characterized by an increased risk for colon cancer and cancers of the endometrium, ovary, stomach, small intestine, hepatobiliary tract, urinary tract, brain, and skin and has_material_basis_in mutation of mismatch repair genes that increases the risk of many types of cancers.
DOID:0050586
DOID:3040
GARD:9905
MESH:D003123
NCI:C120083
OMIM:PS120435
ORDO:144
SNOMEDCT_US_2020_03_01:315058005
UMLS_CUI:C0009405
UMLS_CUI:C1333990
COCA 1
HNPCC - hereditary nonpolyposis colon cancer
Hereditary Defective Mismatch Repair syndrome
hereditary nonpolyposis colorectal cancer
hereditary nonpolyposis colorectal neoplasm
disease_ontology
DOID:3883
OMIM mapping confirmed by DO. [SN].
Lynch syndrome
GARD:5732
MESH:D017118
NCI:C84536
OMIM:176000
SNOMEDCT_US_2020_03_01:190914003
UMLS_CUI:C0162565
AIP - acute intermittent porphyria
Pyrroloporphyria
porphyria intermittent acute
disease_ontology
DOID:3890
acute intermittent porphyria
A placenta disease that is characterized by insufficient blood flow to the placenta during pregnancy.
MESH:D010927
SNOMEDCT_US_2020_03_01:156185006
UMLS_CUI:C0032051
disease_ontology
DOID:3891
placental insufficiency
A pancreatic cystadenoma that is characterized by the overproduction of insulin.
DOID:3903
GARD:3010
MESH:D007340
MESH:D007516
NCI:C65184
NCI:C95598
SNOMEDCT_US_2020_03_01:189586007
SNOMEDCT_US_2020_03_01:25324008
UMLS_CUI:C0021670
UMLS_CUI:C0022134
Insulin-Producing tumor of Islet cells
Islet cell adenoma
disease_ontology
DOID:3892
insulinoma
MESH:D018251
NCI:C3760
SNOMEDCT_US_2020_03_01:80549000
UMLS_CUI:C0206672
Apocrine Cystadenoma
Apocrine cystadenoma
Eccrine Cystadenoma
Eccrine hidrocystoma of skin
Hidrocystoma
disease_ontology
DOID:3893
hidrocystoma
MESH:D018251
NCI:C4168
SNOMEDCT_US_2020_03_01:307596009
UMLS_CUI:C0334345
tubular Apocrine adenoma
disease_ontology
DOID:3895
apocrine adenoma
A sweat gland benign neoplasm that is located_in an apical sweat gland.
MESH:D006607
NCI:C7560
SNOMEDCT_US_2020_03_01:81393009
UMLS_CUI:C0019522
Hidradenoma of skin
Sweat gland adenoma
Syringoadenoma
disease_ontology
DOID:3896
hidradenoma
A vulvar disease that is characterized by inflammation of the vulva.
ICD10CM:N76.2
MESH:D014847
SNOMEDCT_US_2020_03_01:63144007
UMLS_CUI:C0042996
disease_ontology
DOID:3901
vulvitis
A bronchus cancer that has_material_basis_in epithelial cells.
MESH:D002283
NCI:C35875
SNOMEDCT_US_2020_03_01:254622008
UMLS_CUI:C0007121
BC - Bronchogenic carcinoma
disease_ontology
DOID:3904
bronchus carcinoma
A lung cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the lungs and has_symptom cough and has_symptom chest discomfort or pain and has_symptom weight loss and has_symptom hemoptysis.
EFO:0001071
NCI:C4878
SNOMEDCT_US_2020_03_01:154485001
UMLS_CUI:C0684249
cancer of lung
disease_ontology
carcinoma of lung
DOID:3905
OMIM mapping confirmed by DO. [SN].
lung carcinoma
MESH:D001984
SNOMEDCT_US_2020_03_01:126705004
UMLS_CUI:C0006264
bronchus neoplasm
neoplasm of bronchus
disease_ontology
DOID:3906
bronchial benign neoplasm
A non-small cell lung carcinoma that has_material_basis_in the squamous cell.
NCI:C3493
SNOMEDCT_US_2020_03_01:254634000
UMLS_CUI:C0149782
Epidermoid cell carcinoma of the lung
disease_ontology
squamous cell carcinoma of lung
DOID:3907
lung squamous cell carcinoma
A lung carcinoma that is characterized as any type of epithelial lung cancer other than small cell lung carcinoma.
EFO:0003060
KEGG:05223
MESH:D002289
NCI:C2926
SNOMEDCT_US_2020_03_01:254637007
UMLS_CUI:C0007131
NSCLC
Non-small cell lung cancer
non-small cell lung carcinoma
disease_ontology
DOID:3908
lung non-small cell carcinoma
A syndrome characterized by extreme short stature, low body weight, early loss of hair, lipodystrophy, scleroderma, decreased joint mobility, osteolysis, and facial features that resemble aged persons that has_material_basis_in mutation in LMNA on chromosome 1q22.
GARD:7467
ICD10CM:E34.8
MEDDRA:10036794
MESH:D011371
NCI:C34951
OMIM:176670
ORDO:740
SNOMEDCT_US_2020_03_01:190590004
UMLS_CUI:C0033300
HGPS
Hutchinson Gilford syndrome
Hutchinson-Gilford Progeria syndrome
Hutchinson-Gilford disease
disease_ontology
DOID:3911
OMIM mapping confirmed by DO. [SN].
progeria
NCI:C4374
SNOMEDCT_US_2020_03_01:235967003
UMLS_CUI:C0341486
disease_ontology
DOID:3918
pancreatic cystadenoma
NCI:C6504
UMLS_CUI:C1333298
disease_ontology
DOID:3923
diffuse lipomatosis
GARD:7350
MESH:C535549
NCI:C27486
SNOMEDCT_US_2020_03_01:190802005
UMLS_CUI:C0406608
disease_ontology
DOID:3927
pelvic lipomatosis
An inner ear disease which involves inflammation of the inner ear.
NCI:C27339
UMLS_CUI:C1168225
inner ear infection
disease_ontology
DOID:3930
otitis interna
NCI:C4501
SNOMEDCT_US_2020_03_01:254828009
UMLS_CUI:C0346117
malignant lipomatous tumor
malignant tumor of Adipose tissue
disease_ontology
DOID:3939
lipomatous cancer
ICD10CM:E24.0
MESH:D047748
NCI:C113210
SNOMEDCT_US_2020_03_01:190502001
UMLS_CUI:C0221406
Overproduction of ACTH
pituitary-dependent Cushing disease
disease_ontology
DOID:3946
pituitary-dependent Cushing's disease
MESH:D000308
NCI:C113208
SNOMEDCT_US_2020_03_01:47270006
UMLS_CUI:C0001622
Adrenocortical hyperfunction
hyperadrenalism
hypercortisolism
disease_ontology
DOID:3947
adrenal gland hyperfunction
An adrenal cortex cancer that forms in the outer layer of tissue of the adrenal gland and that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
GARD:558
MESH:D018268
NCI:C9325
OMIM:202300
SNOMEDCT_US_2020_03_01:255035007
UMLS_CUI:C0206686
Adrenal cortical carcinoma
carcinoma of the Adrenal cortex
disease_ontology
DOID:3948
adrenocortical carcinoma
MESH:D018268
An adrenal cancer that is located_in the cortex (steroid hormone-producing tissue) of the adrenal gland and that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
carcinoma of the Adrenal gland
disease_ontology
DOID:3950
adrenal carcinoma
ICD10CM:I40
ICD9CM:422
NCI:C35206
SNOMEDCT_US_2020_03_01:155336004
UMLS_CUI:C0155686
disease_ontology
DOID:3951
acute myocarditis
MESH:D000303
SNOMEDCT_US_2020_03_01:129636003
UMLS_CUI:C0001614
disease_ontology
DOID:3952
adrenal cortex disease
An endocrine gland cancer located_in the adrenal glands which are located above the kidneys.
DOID:11007
GARD:5751
ICD10CM:C74
ICD9CM:194.0
MESH:D000310
NCI:C2859
NCI:C9338
SNOMEDCT_US_2020_03_01:127021009
SNOMEDCT_US_2020_03_01:93665005
UMLS_CUI:C0001624
UMLS_CUI:C0750887
adrenal cancer
adrenal neoplasm
malignant Adrenal tumor
malignant neoplasm of adrenal gland
neoplasm of adrenal gland
tumor of the Adrenal gland
disease_ontology
DOID:3953
adrenal gland cancer
A thyroid gland cancer that has_material_basis_in epithelial cells.
EFO:0002892
MESH:D013964
NCI:C4815
UMLS_CUI:C0549473
head and neck cancer, Thyroid
thyroid gland carcinoma
disease_ontology
DOID:3963
thyroid gland carcinoma
GARD:9266
NCI:C4068
SNOMEDCT_US_2020_03_01:29792007
UMLS_CUI:C0302182
Trabecular adenocarcinoma
trabecular carcinoma
disease_ontology
DOID:3965
Merkel cell carcinoma
A differentiated thyroid gland carcinoma that is characterized by the small mushroom shape of the tumor which has a stem attached to the epithelial layer abd arises from the follicular cells of the thyroid gland.
GARD:12027
MESH:D000077273
NCI:C4035
OMIM:188550
SNOMEDCT_US_2020_03_01:255029007
UMLS_CUI:C0238463
Papillary carcinoma of the Thyroid gland
disease_ontology
DOID:3969
OMIM mapping confirmed by DO. [SN].
thyroid gland papillary carcinoma
An intrinsic cardiomyopathy characterized by impaired ventricular filling, with normal or decreased diastolic volume of either or both ventricles typically resulting from increased stiffness of the myocardium.
ICD10CM:I42.5
MESH:D002313
NCI:C62798
OMIM:115210
OMIM:PS115210
ORDO:75249
SNOMEDCT_US_2020_03_01:389996009
UMLS_CUI:C0007196
Cardiomyopathy, constrictive
Restrictive cardiomyopathy
primary restrictive cardiomyopathy
disease_ontology
Familial restrictive cardiomyopathy
Familial restrictive cardiomyopathy
DOID:397
Xref MGI.
OMIM mappings 115210, 612422 added from NeuroDevNet [WAK].
restrictive cardiomyopathy
A thyroid gland carcinoma that has_material_basis_in parafollicular cells.
MESH:C536914
NCI:C3879
SNOMEDCT_US_2020_03_01:255032005
UMLS_CUI:C0238462
Medullary carcinoma of the Thyroid gland
Medullary thyroid carcinoma
Ultimobranchial thyroid tumor
Ultimobranchial thyroid tumour
medullary thyroid carcinoma
disease_ontology
DOID:3973
thyroid gland medullary carcinoma
A cardiomyopathy that is characterized by the pathology occuring outside of the myocardium.
ICD9CM:425.8
SNOMEDCT_US_2020_03_01:195580005
UMLS_CUI:C0155699
disease_ontology
DOID:3978
extrinsic cardiomyopathy
A neurodegeneration with brain iron accumulation that has_material_basis_in autosomal recessive inheritance of mutation in the PANK2 gene on chromosome 20p13.
GARD:6564
ICD10CM:G23.0
MESH:D006211
NCI:C8967
OMIM:234200
ORDO:157850
SNOMEDCT_US_2020_03_01:2992000
UMLS_CUI:C0018523
Hallervorden-Spatz disease
Hallervorden-Spatz syndrome
NBIA1
Pigmentary pallidal degeneration
brain Iron Accumulation type I syndrome
neurodegeneration with brain iron accumulation 1
disease_ontology
DOID:3981
OMIM mapping confirmed by DO. [SN].
pantothenate kinase-associated neurodegeneration
A cranio-facial dystonia that is accompanied by blepharospasm.
GARD:7008
MESH:D008538
SNOMEDCT_US_2020_03_01:230325003
UMLS_CUI:C0025183
disease_ontology
DOID:3982
Meige syndrome
A trichostrongyloidiasis that involves parasitic infection of the ruminant gastrointestinal tract by nematodes of the genus Ostertagia.
MESH:D010029
UMLS_CUI:C0029471
disease_ontology
DOID:3985
ostertagiasis
A primary bacterial infectious disease that is located_in lungs, located_in lymph nodes, located_in pericardium, located_in brain, located_in pleura or located_in gastrointestinal tract, has_material_basis_in Mycobacterium tuberculosis, which is transmitted_by droplets released into the air when an infected person coughs or sneezes.
DOID:10096
DOID:12688
DOID:12691
DOID:415
DOID:9901
DOID:9902
GARD:7827
MESH:D014375
SNOMEDCT_US_2020_03_01:15202009
UMLS_CUI:C0041295
disease_ontology
DOID:399
tuberculosis
MESH:D014376
An organ system cancer that is located_in the kidneys, ureteres, bladder or urethra.
ICD10CM:C68.9
ICD9CM:189.9
SNOMEDCT_US_2020_03_01:448233000
UMLS_CUI:C0348371
disease_ontology
DOID:3996
urinary system cancer
A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.
MESH:D004194
NCI:C2991
SNOMEDCT_US_2020_03_01:64572001
UMLS_CUI:C0012634
disease_ontology
DOID:4
disease
An ovarian cancer that has_material_basis_in epithelial tissue and is located_in the ovary.
EFO:0001075
UMLS_CUI:C0677886
Ovarian carcinoma
disease_ontology
DOID:4001
OMIM mapping confirmed by DO. [SN].
ovarian carcinoma
A bladder carcinoma that has_material_basis_in transitional cells located_in the lining of the bladder.
NCI:C39851
SNOMEDCT_US_2020_03_01:393562002
UMLS_CUI:C0279680
bladder transitional cell carcinoma
transitional cell carcinoma of bladder
urinary bladder urothelial carcinoma
urothelial bladder carcinoma
disease_ontology
DOID:4006
bladder urothelial carcinoma
A urinary bladder cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
EFO:0000292
NCI:C4912
SNOMEDCT_US_2020_03_01:269607003
UMLS_CUI:C0699885
carcinoma of urinary bladder
disease_ontology
DOID:4007
bladder carcinoma
A tuberculosis that is resistant to isoniazid and rifampicin, the two most powerful first-line anti-TB drugs.
MESH:D018088
NCI:C128415
SNOMEDCT_US_2020_03_01:423092005
UMLS_CUI:C0206526
disease_ontology
DOID:401
multidrug-resistant tuberculosis
A transitional cell carcinoma that has several papillary fronds with central fibrovascular core lined by transitional type epithelium.
NCI:C4122
SNOMEDCT_US_2020_03_01:12400006
UMLS_CUI:C0334274
Papillary transitional cell carcinoma
disease_ontology
DOID:4012
papillary transitional carcinoma
A ureteral disease that is characterized_as a congenital anomaly in which the distal end of the ureter swells as it enters the bladder.
MESH:D014518
NCI:C123159
OMIM:191650
SNOMEDCT_US_2020_03_01:12818004
UMLS_CUI:C0041960
disease_ontology
DOID:4022
OMIM mapping confirmed by DO. [LS].
ureterocele
A skin hemangioma that is characterized by the presence of small red dots that cluster together to form a linear or snake-like array or ring-shaped pattern located_in the blood vessels of the skin.
ICD10CM:L81.7
NCI:C3926
OMIM:106050
OMIM:300652
ORDO:95429
SNOMEDCT_US_2020_03_01:49465005
UMLS_CUI:C0263637
Angioma serpiginosum of skin
disease_ontology
DOID:4028
Xref MGI.
angioma serpiginosum
A stomach disease that is an inflammation of the lining of the stomach.
DOID:4032
DOID:8697
DOID:8845
DOID:9190
ICD10CM:K29.7
MESH:D005756
NCI:C26780
SNOMEDCT_US_2020_03_01:155711008
UMLS_CUI:C0017152
Erosive Gastritis
Erosive gastropathy
acute gastric mucosal erosion
disease_ontology
DOID:4029
gastritis
A gastrointestinal system disease that is located_in the mouth.
MESH:D009059
NCI:C27641
SNOMEDCT_US_2020_03_01:118938008
UMLS_CUI:C0026636
disease_ontology
DOID:403
mouth disease
ICD9CM:558.41
NCI:C35330
SNOMEDCT_US_2020_03_01:359804008
UMLS_CUI:C1262481
Eosinophilic Gastroenteritis
Eosinophilic gastroenteritis
disease_ontology
DOID:4031
eosinophilic gastroenteritis
NCI:C27051
SNOMEDCT_US_2020_03_01:235658000
UMLS_CUI:C1283271
disease_ontology
DOID:4035
lymphocytic gastritis
An abdominal tuberculosis that results_in infection located_in gastrointestinal tract. The infection has_symptom abdominal pain, has_symptom weight loss, has_symptom fever, has_symptom anorexia, has_symptom change in bowel habits, has_symptom nausea, and has_symptom vomiting.
DOID:9802
MESH:D014385
SNOMEDCT_US_2020_03_01:154286002
UMLS_CUI:C0041312
Tuberculosis of gastrointestinal tract
Tuberculosis of intestines, peritoneum and mesenteric glands
Tuberculosis of intestines, peritoneum, and mesenteric glands
tuberculosis of intestines, peritoneum and mesenteric glands
disease_ontology
DOID:404
gastrointestinal tuberculosis
NCI:C6516
UMLS_CUI:C1334619
malignant tumor of Skeletal Muscle
disease_ontology
DOID:4043
skeletal muscle cancer
NCI:C6514
SNOMEDCT_US_2020_03_01:699955004
UMLS_CUI:C1335971
tumor of Skeletal Muscle
disease_ontology
DOID:4044
skeletal muscle neoplasm
A musculoskeletal system cancer that is located_in muscle.
DOID:4046
ICD10CM:C49
MESH:D009217
MESH:D019042
NCI:C4883
SNOMEDCT_US_2020_03_01:20667008
SNOMEDCT_US_2020_03_01:93913006
UMLS_CUI:C0027095
UMLS_CUI:C0684743
malignant neoplasm of muscle
malignant tumor of muscle
malignant tumor of the Muscle
myosarcoma
disease_ontology
DOID:4045
muscle cancer
DOID:4382
GARD:4701
MESH:D018232
NCI:C3749
NCI:C7958
OMIM:268220
SNOMEDCT_US_2020_03_01:404053004
UMLS_CUI:C0206655
UMLS_CUI:C0279613
Alveolar rhabdomyosarcoma
alveolar childhood rhabdomyosarcoma
disease_ontology
DOID:4051
OMIM mapping confirmed by DO. [SN].
alveolar rhabdomyosarcoma
A prostate cancer that is located_in the prostate.
NCI:C7731
UMLS_CUI:C0238393
sarcoma of the prostate
disease_ontology
DOID:4054
prostate sarcoma
NCI:C4716
SNOMEDCT_US_2020_03_01:128750008
UMLS_CUI:C0431111
Rhabdomyosarcoma with ganglionic differentiation
disease_ontology
DOID:4055
ectomesenchymoma
MESH:D004383
SNOMEDCT_US_2020_03_01:9733003
UMLS_CUI:C0013299
Duodenogastric reflux
disease_ontology
DOID:4071
duodenogastric reflux
MESH:D004378
SNOMEDCT_US_2020_03_01:196598004
UMLS_CUI:C0013289
duodenal disease
duodenum disorder
disease_ontology
DOID:4072
duodenum disease
NCI:C3874
SNOMEDCT_US_2020_03_01:235966007
UMLS_CUI:C0238337
cystadenocarcinoma of pancreas
disease_ontology
DOID:4073
pancreatic cystadenocarcinoma
A pancreatic carcinoma that derives_from epithelial cells of glandular origin.
NCI:C8294
SNOMEDCT_US_2020_03_01:700423003
UMLS_CUI:C0281361
pancreas adenocarcinoma
disease_ontology
adenocarcinoma of the pancreas
DOID:4074
pancreatic adenocarcinoma
A tricuspid valve disease that is characterized by the narrowing of the orifice of the tricuspid valve of the heart. This causes increased resistance to blood flow through the valve.
MESH:D014264
NCI:C50783
SNOMEDCT_US_2020_03_01:49915006
UMLS_CUI:C0040963
Tricuspid stenosis
disease_ontology
DOID:4078
tricuspid valve stenosis
A heart disease involving one or more of the four valves of the heart (the aortic and mitral valves on the left and the pulmonary and tricuspid valves on the right).
DOID:989
MESH:D006349
MESH:D016127
NCI:C45525
SNOMEDCT_US_2020_03_01:368009
SNOMEDCT_US_2020_03_01:398995000
UMLS_CUI:C0018824
UMLS_CUI:C0079485
Valvular heart disease
disease_ontology
DOID:4079
heart valve disease
A tricuspid valve disease that is characterized by failure of the heart's tricuspid valve to close properly during systole. As a result, with each heart beat, blood is pumped out from the right side of the heart in the opposite direction to normal.
MESH:D014262
NCI:C50842
SNOMEDCT_US_2020_03_01:111287006
UMLS_CUI:C0040961
Tricuspid incompetence
Tricuspid regurgitation
Tricuspid valve regurgitation
disease_ontology
DOID:4080
tricuspid valve insufficiency
A germ cell and embryonal cancer that derives_from trophoblastic tissue.
MESH:D014328
NCI:C3422
SNOMEDCT_US_2020_03_01:115234004
UMLS_CUI:C0041182
Trophoblastic neoplasm
Trophoblastic tumor
disease_ontology
DOID:4085
trophoblastic neoplasm
DOID:2164
DOID:2165
DOID:46
ICD10CM:K76.9
ICD9CM:573.9
MESH:D008107
NCI:C3196
SNOMEDCT_US_2020_03_01:62857009
UMLS_CUI:C0023895
disorder of liver
hepatic disorder
disease_ontology
DOID:409
liver disease
A communication disorder that is a loss of ability to recognize objects, persons, sounds, shapes, or smells while the specific sense is not defective nor is there any significant memory loss.
DOID:4019
GARD:8
ICD10CM:R48.1
MESH:D000377
NCI:C84542
SNOMEDCT_US_2020_03_01:42341009
UMLS_CUI:C0001816
Dyspraxia
Dyspraxia syndrome
disease_ontology
DOID:4090
agnosia
MESH:D000377
A parasitic ectoparasitic infectious disease that involves parasitic infestation of blood feeding ticks of the families Ixodidae and Argasidae on animals and humans. Ticks are vectors of a number diseases, including Lyme disease, Q fever, Colorado tick fever, tularemia, tick-borne relapsing fever, babesiosis, ehrlichiosis and tick-borne meningoencephalitis, as well as anaplasmosis in cattle and canine jaundice.
MESH:D013984
UMLS_CUI:C0040196
disease_ontology
DOID:4109
tick infestation
A parasitic infectious disease that is caused by organisms that live primarily on the surface of the host.
MESH:D004478
UMLS_CUI:C0013578
ectoparasitism
disease_ontology
DOID:4110
parasitic ectoparasitic infectious disease
An integumentary system disease that is located_in nail.
ICD10CM:L60
ICD9CM:703
MESH:D009260
SNOMEDCT_US_2020_03_01:17790008
UMLS_CUI:C0027339
disease_ontology
DOID:4123
nail disease
MESH:D003137
UMLS_CUI:C0009440
disease_ontology
DOID:4137
common bile duct disease
MESH:D001649
NCI:C96716
SNOMEDCT_US_2020_03_01:118926004
UMLS_CUI:C0005395
bile duct disorder
disorder of bile duct
disease_ontology
DOID:4138
bile duct disease
A gallbladder disease characterized by altered tonus of the sphincter of Oddi, disturbance in the coordination of contraction of the biliary ducts, and/or reduction in the speed of emptying of the biliary tree.
DOID:4139
MESH:D001657
SNOMEDCT_US_2020_03_01:43469007
UMLS_CUI:C0005416
sphincter of oddi dysfunction
disease_ontology
DOID:4140
biliary dyskinesia
A bone cancer that is located_in the area behind the eye and derives_from the orbit or secondarily derives_from an adjacent source (eyelid, paranasal sinus, or intracranial compartment). It results_in the eye pushing forward causing a bulging of the eye called proptosis.
DOID:9984
ICD10CM:C69.6
ICD9CM:190.1
MESH:D009918
NCI:C3290
NCI:C3562
SNOMEDCT_US_2020_03_01:127003006
SNOMEDCT_US_2020_03_01:363462005
UMLS_CUI:C0029185
UMLS_CUI:C0153626
malignant neoplasm of orbit
neoplasm of orbit proper
orbit cancer
orbital tumor
disease_ontology
DOID:4143
orbital cancer
GARD:6258
ICD10CM:K00.5
MESH:D003811
NCI:C84667
OMIM:125490
OMIM:125500
ORDO:49042
SNOMEDCT_US_2020_03_01:367461002
UMLS_CUI:C0011436
disease_ontology
DOID:4154
OMIM mapping confirmed by DO. [SN].
dentinogenesis imperfecta
A syphilis that is the first stage of syphilis, marked by the development of a chancre, which is characterized by mononuclear leukocytic infiltration, macrophages, and lymphocytes.
ICD9CM:091
SNOMEDCT_US_2020_03_01:186846005
UMLS_CUI:C0153139
Symptomatic early syphilis
early symptomatic syphilis
early syphilis, symptomatic
disease_ontology
DOID:4156
primary syphilis
An integumentary system cancer located_in the skin that is the uncontrolled growth of abnormal skin cells.
GARD:10421
MESH:D012878
NCI:C2920
SNOMEDCT_US_2020_03_01:94047004
UMLS_CUI:C0007114
CA - skin cancer
malignant neoplasm of skin
melanoma and Non-melanoma skin cancer
disease_ontology
cancer of skin
DOID:4159
skin cancer
NCI:C42048
UMLS_CUI:C1511934
disease_ontology
DOID:4160
differentiating neuroblastoma
MESH:D018305
NCI:C3790
SNOMEDCT_US_2020_03_01:116381000119105
UMLS_CUI:C0206718
Ganglioneuroblastoma
disease_ontology
DOID:4163
ganglioneuroblastoma
A primary bacterial infectious disease that is a sexually transmitted systemic disease, has_material_basis_in Treponema pallidum subsp pallidum, which is transmitted_by sexual contact, transmitted_by blood product transfusion, transmitted_by congenital method from mother to fetus or transmitted_by contact with infectious lesions. If left untreated, produces chancres, rashes, and systemic lesions in a clinical course with three stages continued over many years.
DOID:11095
ICD10CM:A51.0
MESH:D002601
SNOMEDCT_US_2020_03_01:736686006
UMLS_CUI:C0007939
syphilitic chancre
disease_ontology
DOID:4166
syphilis
An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.
autoimmune disease
ICD9CM:720
OMIM:109100
UMLS_CUI:C0003089
autoimmune hypersensitivity disease
hypersensitivity reaction type II disease
disease_ontology
DOID:417
Xref MGI.
autoimmune disease
MESH:D012203
NCI:C113150
SNOMEDCT_US_2020_03_01:199580004
UMLS_CUI:C0035404
Rh incompatibility affecting management of mother
disease_ontology
DOID:4175
Rh isoimmunization
MESH:D001787
UMLS_CUI:C0005806
disease_ontology
DOID:4176
blood group incompatibility
A scleroderma that is characterized by fibrosis (or hardening) of the skin and major organs, as well as vascular alterations, and autoantibodies.
EFO:0000717
GARD:9748
ICD10CM:M34.0
ICD9CM:710.1
MESH:D012595
NCI:C72070
OMIM:181750
SNOMEDCT_US_2020_03_01:89155008
UMLS_CUI:C0036421
Scleroderma
Scleroderma syndrome
progressive systemic sclerosis
systemic sclerosis
disease_ontology
DOID:418
systemic scleroderma
GARD:7860
MESH:D011556
NCI:C129722
OMIM:612463
SNOMEDCT_US_2020_03_01:190867002
UMLS_CUI:C0033835
Normocalcemic pseudohypoparathyroidism
Pseudopseudohypoparathyroidism
disease_ontology
DOID:4183
OMIM mapping confirmed by DO. [SN].
pseudopseudohypoparathyroidism
GARD:10758
ICD10CM:E20.1
MESH:D011547
NCI:C99027
OMIM:612462
SNOMEDCT_US_2020_03_01:190867002
UMLS_CUI:C0033806
disease_ontology
DOID:4184
OMIM mapping confirmed by DO. [SN].
pseudohypoparathyroidism
MESH:D011547
A speech disorder that involves mispronouncing speech sounds by omitting, distorting, substituting, or adding sounds which can make speech difficult to understand.
MESH:D001184
SNOMEDCT_US_2020_03_01:8187005
UMLS_CUI:C0003910
Articulation impairment
Phonological disorder
disease_ontology
DOID:4186
articulation disorder
A speech disorder that involves a complete inability to speak.
MESH:D009155
SNOMEDCT_US_2020_03_01:267771000
UMLS_CUI:C0026884
disease_ontology
DOID:4189
mutism
A rheumatic disease that involves the abnormal growth of connective tissue, which supports the skin and internal organs.
MESH:D012594
NCI:C26746
SNOMEDCT_US_2020_03_01:201440007
UMLS_CUI:C0011644
dermatosclerosis
disease_ontology
DOID:419
scleroderma
DOID:12751
ICD9CM:434.0
MESH:D020767
SNOMEDCT_US_2020_03_01:155401002
UMLS_CUI:C0079102
UMLS_CUI:C0752143
cerebral thrombosis
disease_ontology
DOID:4193
intracranial thrombosis
MESH:D044882
NCI:C53655
SNOMEDCT_US_2020_03_01:126877002
UMLS_CUI:C1257958
disorder of glucose metabolism
disease_ontology
DOID:4194
glucose metabolism disease
ICD10CM:R73.9
MESH:D006943
NCI:C26797
SNOMEDCT_US_2020_03_01:144187006
UMLS_CUI:C0020456
disease_ontology
DOID:4195
hyperglycemia
A hair disease characterized by hair growth that is abnormal in quantity or location.
ICD10CM:L68
MESH:D006983
NCI:C79597
ORDO:79365
SNOMEDCT_US_2020_03_01:201164001
UMLS_CUI:C0020555
disease_ontology
DOID:420
hypertrichosis
MESH:D020427
NCI:C27596
UMLS_CUI:C0747533
Peroneal Neuropathy
disease_ontology
DOID:4201
peroneal neuropathy
A brain stem cancer that is characterized by mass lesion of the brainstem, associated cranial nerve nuclei and long tracts, has_material_basis_in abnormally proliferating cells, derives_from glial cells.
NCI:C8501
SNOMEDCT_US_2020_03_01:444545003
UMLS_CUI:C0677865
Brainstem Neuroglial tumor
disease_ontology
DOID:4202
brain stem glioma
DOID:13974
DOID:4204
DOID:4208
GARD:8244
ICD10CM:C71.7
ICD9CM:191.7
MESH:D020295
NCI:C3570
NCI:C4869
NCI:C4975
NCI:C5967
SNOMEDCT_US_2020_03_01:126961004
SNOMEDCT_US_2020_03_01:93726004
UMLS_CUI:C0153641
UMLS_CUI:C0677866
UMLS_CUI:C0751886
UMLS_CUI:C1332192
malignant neoplasm of brain stem
malignant neoplasm of brainstem
neoplasm of adult brain stem
neoplasm of brain stem
primary brain Stem tumor
primary brain stem neoplasm
disease_ontology
DOID:4203
brain stem cancer
DOID:12786
ICD10CM:C71.6
ICD9CM:191.6
MESH:D002528
NCI:C2935
NCI:C3569
SNOMEDCT_US_2020_03_01:126960003
SNOMEDCT_US_2020_03_01:449420002
UMLS_CUI:C0007762
UMLS_CUI:C0153640
cerebellar cancer
malignant tumor of Cerebellum
disease_ontology
DOID:4205
cerebellum cancer
An integumentary system disease that is located_in hair.
MESH:D006201
NCI:C34656
SNOMEDCT_US_2020_03_01:267862002
UMLS_CUI:C0018500
disease_ontology
DOID:421
hair disease
A malignant ovarian surface epithelial-stromal neoplasm that has_material_basis_in the surface epithelium of the ovary.
MESH:D001948
NCI:C4270
SNOMEDCT_US_2020_03_01:42194009
UMLS_CUI:C0334495
disease_ontology
DOID:4217
malignant ovarian Brenner tumor
MESH:D020914
NCI:C84648
UMLS_CUI:C0752282
disease_ontology
DOID:422
congenital structural myopathy
A dermatitis that is characterized by a pyogenic infection causing the formation of pus.
ICD10CM:L08.0
ICD9CM:686.0
MESH:D011711
SNOMEDCT_US_2020_03_01:267838007
UMLS_CUI:C0034212
disease_ontology
DOID:4223
pyoderma
An endometrial stromal tumor that has_material_basis in connective tissue.
GARD:6339
MESH:D018203
NCI:C8973
SNOMEDCT_US_2020_03_01:70555003
UMLS_CUI:C0206630
ESS
Undifferentiated endometrial sarcoma
endometrial stromal sarcoma, high grade
disease_ontology
DOID:4226
endometrial stromal sarcoma
A muscular disease in which the muscle fibers do not function resulting in muscular weakness.
ICD10CM:G72.9
ICD9CM:359.9
MESH:D009135
NCI:C101216
SNOMEDCT_US_2020_03_01:155094005
UMLS_CUI:C0026848
disease_ontology
DOID:423
myopathy
NCI:C6511
UMLS_CUI:C1334620
malignant tumor of Smooth Muscle
disease_ontology
DOID:4230
smooth muscle cancer
MESH:D051642
NCI:C35765
SNOMEDCT_US_2020_03_01:154614002
UMLS_CUI:C1509147
disease_ontology
DOID:4231
histiocytoma
A Ewing sarcoma that is morphologically indistinguishable from skeletal Ewing sarcoma but is located in extraosseous locations.
NCI:C27293
ORDO:370334
UMLS_CUI:C1333514
extraosseous Ewing's sarcoma
extraosseous Ewing's sarcoma/peripheral primitive neuroectodermal tumor
extraskeletal Ewing sarcom
disease_ontology
DOID:4232
extraosseous Ewing sarcoma
A sarcoma that is characterized by solid nests and fascicles of tumor cells with clear cytoplasm and prominent nucleoli. It presents as a slow growing mass that especially affects tendons and aponeuroses and it is deeply situated.
DOID:4881
MESH:D018227
NCI:C27370
NCI:C3745
SNOMEDCT_US_2020_03_01:12622007
UMLS_CUI:C0206651
UMLS_CUI:C1332198
Clear cell sarcoma
Clear cell sarcoma of soft Parts
adult soft part clear cell sarcoma
malignant melanoma of soft tissues
melanoma, malignant, of soft parts
disease_ontology
malignant melanoma of soft parts
DOID:4233
clear cell sarcoma
A sarcoma that results_in cells that are spindle-shaped. They are usually resistant to radiation therapy.
MESH:D012509
NCI:C27005
SNOMEDCT_US_2020_03_01:9801004
UMLS_CUI:C0205945
disease_ontology
DOID:4235
spindle cell sarcoma
A mixed cell type cancer that has_material_basis_in carcinomatous (epithelial tissue) and sarcomatous (connective tissue) components.
DOID:1971
DOID:2610
DOID:4234
MESH:D002296
MESH:D018199
MESH:D018200
NCI:C34448
NCI:C3730
NCI:C8975
SNOMEDCT_US_2020_03_01:112684005
SNOMEDCT_US_2020_03_01:63264007
SNOMEDCT_US_2020_03_01:84427001
UMLS_CUI:C0007140
UMLS_CUI:C0206627
UMLS_CUI:C1334603
MMMT
Mesodermal mixed tumor
malignant mixed Mullerian tumor
malignant mixed mesodermal (mullerian) tumor
mesodermal mixed tumor
mixed Mesodermal (mullerian) tumor
mullerian mixed tumor
disease_ontology
DOID:4236
carcinosarcoma
A soft tissue cancer that is a slow growing tumor of an unknown origin that effects children and effects young adults.
DOID:5315
DOID:5318
GARD:5654
MESH:D018234
NCI:C3750
NCI:C7943
NCI:C8092
OMIM:606243
ORDO:163699
SNOMEDCT_US_2020_03_01:88195001
UMLS_CUI:C0206657
UMLS_CUI:C0279544
UMLS_CUI:C0279985
Alveolar Soft Part sarcoma
disease_ontology
DOID:4239
OMIM mapping confirmed by DO. [SN].
alveolar soft part sarcoma
A lung disease that is characterized by pulmonary collapse, accompanied by hypoventilation which can affect a lobe, segment, or all of the lung, resulting in a decrease in the ventilation/perfusion ratio.
ICD10CM:P28.0
ICD9CM:770.4
SNOMEDCT_US_2020_03_01:42908004
UMLS_CUI:C0270163
primary atelectasis of newborn
primary atelectasis, in perinatal period
disease_ontology
DOID:424
pulmonary immaturity
A kidney cancer that is located in the kidney's connective tissue.
NCI:C4525
SNOMEDCT_US_2020_03_01:254918001
UMLS_CUI:C0346251
renal sarcoma
sarcoma of kidney
disease_ontology
DOID:4242
kidney sarcoma
MESH:D023903
UMLS_CUI:C0948480
disease_ontology
DOID:4247
coronary restenosis
MESH:D023921
NCI:C80427
SNOMEDCT_US_2020_03_01:233970002
UMLS_CUI:C0242231
Coronary artery stenosis
disease_ontology
DOID:4248
coronary stenosis
A prion disease characterized by adult onset of memory loss, dementia, ataxia, and pathologic deposition of amyloid-like plaques in the brain.
GARD:7690
ICD10CM:A81.82
ICD9CM:046.71
MESH:D016098
NCI:C84727
OMIM:137440
SNOMEDCT_US_2020_03_01:67155006
UMLS_CUI:C0017495
Gerstmann-Straussler-Scheinker disease
PRION DEMENTIA
disease_ontology
DOID:4249
OMIM mapping confirmed by DO. [SN].
Gerstmann-Straussler-Scheinker syndrome
ICD10CM:H11.82
ICD9CM:372.81
SNOMEDCT_US_2020_03_01:408663001
UMLS_CUI:C0878693
disease_ontology
DOID:4250
conjunctivochalasis
An eye disease affecting the conjunctiva, which is the mucous membrane surrounding the eye and interior of the eyelids.
ICD10CM:H11.9
ICD9CM:372.9
MESH:D003229
NCI:C27605
SNOMEDCT_US_2020_03_01:194583004
UMLS_CUI:C0009759
disease_ontology
DOID:4251
conjunctival disease
A leukodystrophy that is characterized by the destruction of white matter and the formation of Rosenthal fibers consisting of abnormal clumps of protein that accumulate in astrocytes.
GARD:5774
MESH:D038261
NCI:C84545
OMIM:203450
SNOMEDCT_US_2020_03_01:81854007
UMLS_CUI:C0270726
Alexander's disease
disease_ontology
DOID:4252
OMIM mapping confirmed by DO. [SN].
Alexander disease
MESH:D038261
An osteosclerosis that has_material_basis_in a mutation of the LEMD3 gene which results_in a hyperdense bony cortex.
GARD:9474
MESH:D008557
NCI:C84887
OMIM:155950
SNOMEDCT_US_2020_03_01:240173003
UMLS_CUI:C0025239
disease_ontology
DOID:4253
OMIM mapping confirmed by DO. [SN].
melorheostosis
MESH:D008557
A bone remodeling disease that results_in abnormal elevated bone density or mass.
ICD10CM:Q78.2
MESH:D010026
NCI:C41236
SNOMEDCT_US_2020_03_01:49347007
UMLS_CUI:C0029464
disease_ontology
DOID:4254
osteosclerosis
A bone inflammation disease that causes bone changes, soft tissue swelling and irritability in infants. The disease has been associated with COL1A1 gene. It has symptom soft-tissue swelling, has symptom bone lesions, and has symptom irritability.
GARD:1051
ICD10CM:M89.8
MESH:D006958
NCI:C84645
OMIM:114000
SNOMEDCT_US_2020_03_01:24752008
UMLS_CUI:C0020497
cortical congenital hyperostosis
infantile cortical hyperostosis
disease_ontology
DOID:4257
OMIM mapping confirmed by DO. [SN].
Caffey disease
MESH:D020235
SNOMEDCT_US_2020_03_01:30767006
UMLS_CUI:C1510417
disease_ontology
DOID:4260
gait apraxia
MESH:D020235
A brain disease characterized by marked reduction of nearly all motor functions including facial expressions, gestures and speech output, but with some degree of alertness.
MESH:D000405
SNOMEDCT_US_2020_03_01:53333005
UMLS_CUI:C0001889
Coma vigilans
disease_ontology
DOID:4267
akinetic mutism
MESH:D000405
A microsporidiosis that is a zoonotic infectious disease results_in disseminated fungal infection in dogs, cats, hamsters, guinea pigs, rats, mice and humans, has_material_basis_in Encephalitozoon cuniculi, has_material_basis_in Encephalitozoon intestinalis or has_material_basis_in Encephalitozoon hellem.
MESH:D016890
SNOMEDCT_US_2020_03_01:12825006
UMLS_CUI:C0085412
Infection by Encephalitozoon
disease_ontology
DOID:4270
encephalitozoonosis
An opportunistic mycosis that results_in systemic fungal infection in immunocompromised people, has_material_basis_in Microsporidia phylum members.
GARD:3655
ICD10CM:B60.8
MESH:D016881
NCI:C84891
SNOMEDCT_US_2020_03_01:61842000
UMLS_CUI:C0085407
Infection by Microspora
Infection by Microsporea
Infection by Microsporida
disease_ontology
DOID:4271
microsporidiosis
A basal cell carcinoma characterized by elevated, pearl shaped nodules with telengactisae on the surface and periphery.
DOID:4296
NCI:C62282
SNOMEDCT_US_2020_03_01:716274007
UMLS_CUI:C1304300
Basal cell carcinoma, nodular
Circumscribed solid basal cell carcinoma
skin nodulo-ulcerative basal cell carcinoma
skin solid (nodular) Basal cell carcinoma
disease_ontology
DOID:4280
nodular basal cell carcinoma
An external ear cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C6081
UMLS_CUI:C1333492
carcinoma of the External ear
disease_ontology
carcinoma of external ear
DOID:4288
external ear carcinoma
A congenital heart disease that is characterized by partial or entire anomalous curved venous drainage of the right lung to the inferior vena cava, association with variable right lung and pulmonary artery hypoplasia, dextraposition of the heart and an anomalous systemic blood supply to the ipsilateral lung.
ICD10CM:Q26.8
MESH:D012587
NCI:C85056
OMIM:106700
ORDO:185
SNOMEDCT_US_2020_03_01:39905002
UMLS_CUI:C0036400
Halasz syndrome
congenital venolobar syndrome
hypogenetic lung syndrome
mirror-image lung syndrome
pulmonary venolobar syndrome
total anomalous pulmonary venous return
vena cava bronchovascular syndrome
disease_ontology
DOID:4297
scimitar syndrome
A benign giant cell tumor that results_in the presence of multinucleated giant cells.
MESH:D018212
NCI:C121932
SNOMEDCT_US_2020_03_01:697970009
UMLS_CUI:C0206638
Giant cell neoplasm of bone
Giant cell tumor of bone
Giant cell tumour of bone
bone giant cell tumour
disease_ontology
giant cell myeloma
osteoclastoma
DOID:4305
bone giant cell tumor
A peripheral nervous system disease that is characterized by the pinching of a nerve root in the spine and has symptoms of pain, weakness, numbness and tingling.
ICD10CM:M54.1
MESH:D011843
SNOMEDCT_US_2020_03_01:394640000
UMLS_CUI:C0700594
pinched nerve
disease_ontology
DOID:4306
radiculopathy
MESH:D009209
UMLS_CUI:C0027073
disease_ontology
DOID:431
myofascial pain syndrome
MESH:D018235
NCI:C3751
SNOMEDCT_US_2020_03_01:75109009
UMLS_CUI:C0206658
disease_ontology
DOID:4310
smooth muscle tumor
An acquired epidermolysis bullosa that is characterized by formation of recurrent blisters secondary to minor trauma in the skin and mucosa, and has_material_basis_in the development of autoantibodies to type VII collagen.
ICD10CM:L12.3
MESH:D016107
NCI:C84690
SNOMEDCT_US_2020_03_01:2772003
UMLS_CUI:C0079293
acquired epidermolysis bullosa
disease_ontology
DOID:4313
epidermolysis bullosa acquisita
NCI:C27516
SNOMEDCT_US_2020_03_01:733892008
UMLS_CUI:C1333414
disease_ontology
DOID:4323
epidermolytic acanthoma
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Zaire ebolavirus, has_material_basis_in Sudan ebolavirus, has_material_basis_in Cote d'Ivoire ebolavirus, or has_material_basis_in Bundibugyo ebolavirus, which are transmitted_by contact with the body fluids of an infected animal or person, transmitted by contaminated fomites, or transmitted by infected medical equipment. The infection has_symptom fever, has_symptom headache, has_symptom joint pain, has_symptom muscle aches, has_symptom sore throat, has_symptom weakness, has_symptom diarrhea, has_symptom vomiting, has_symptom stomach pain, has_symptom rash, has_symptom red eyes, has_symptom hiccups, and has_symptom internal and external bleeding.
GARD:2035
ICD10CM:A98.4
MESH:D019142
NCI:C36171
SNOMEDCT_US_2020_03_01:123323003
UMLS_CUI:C0282687
Ebola virus disease
disease_ontology
DOID:4325
Ebola hemorrhagic fever
A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Marburgvirus, which is transmitted_by contact with the body fluids of an infected person. The infection has_symptom fever, has_symptom chills, has_symptom headache, has_symptom myalgia, has_symptom maculopapular rash on the trunk, has_symptom nausea, has_symptom vomiting, has_symptom chest pain, has_symptom sore throat, has_symptom abdominal pain, has_symptom diarrhea, and has_symptom bleeding.
GARD:9444
ICD10CM:A98.3
MESH:D008379
NCI:C84883
SNOMEDCT_US_2020_03_01:123322008
UMLS_CUI:C0024788
Marburg disease
Marburg virus disease
disease_ontology
DOID:4327
Marburg hemorrhagic fever
GARD:8231
MESH:D015616
SNOMEDCT_US_2020_03_01:127069007
UMLS_CUI:C0019624
disease_ontology
DOID:4330
non-Langerhans-cell histiocytosis
A female reproductive system disease that is characterized by epithelium-lined fluid-filled cysts in the adnexa adjacent to the fallopian tube and ovary.
ICD10CM:Q50.5
MESH:D010310
SNOMEDCT_US_2020_03_01:204831002
UMLS_CUI:C0030584
Cyst, fimbrial
Embryonic fimbrial cyst
disease_ontology
DOID:4333
parovarian cyst
A tinea capitis that results_in fungal infection located_in scalp, located_in glabrous skin or located_in nail, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes and results_in_formation_of scutula, yellowish cup-shaped crusts of dense masses of mycelium and epithelial debris, which develop at the surface of a hair follicle with the shaft in the center of the raised lesion. Removal of these crusts reveals an oozing, moist, red base. Later, atrophy of the skin occurs leaving a cicatricial alopecia and scarring.
DOID:0050109
ICD10CM:B35
MESH:D014007
NCI:C35072
SNOMEDCT_US_2020_03_01:85375000
UMLS_CUI:C0040254
favus
disease_ontology
DOID:4336
tinea favosa
A dermatophytosis that results_in contagious fungal infection located_in scalp, located_in hair of head, located_in eyebrow or located_in eyelash, has_material_basis_in Ascomycota fungi that belong to a group called dermatophytes and has_symptom itching of the scalp, has_symptom pus filled lesions on the scalp, and has_symptom patches of hair loss, sometimes with a 'black dot' pattern.
DOID:0050114
DOID:12319
ICD9CM:110.0
NCI:C34536
SNOMEDCT_US_2020_03_01:186985002
UMLS_CUI:C0011640
Scalp ringworm
Trichophyton rubrum tinea capitis
dermatophytosis of scalp or beard
tinea capitis due to Trichophyton rubrum
disease_ontology
Dermatophytosis of scalp
DOID:4337
tinea capitis
GARD:7848
MESH:D046350
NCI:C85219
OMIM:176200
SNOMEDCT_US_2020_03_01:58275005
UMLS_CUI:C0162532
Protocoproporphyria
Protoporphyrinogen oxidase deficiency
Variegate porphyria
disease_ontology
DOID:4346
variegate porphyria
MESH:D008210
NCI:C78442
SNOMEDCT_US_2020_03_01:234109007
UMLS_CUI:C0024248
Lymph cyst
disease_ontology
DOID:4347
lymphocele
A female reproductive organ cancer that is located_in the cervix.
DOID:4361
ICD10CM:C53
ICD9CM:180
MESH:D002583
NCI:C2940
NCI:C9311
OMIM:603956
SNOMEDCT_US_2020_03_01:123841004
SNOMEDCT_US_2020_03_01:254885005
UMLS_CUI:C0007847
UMLS_CUI:C0007873
cervical neoplasm
cervix cancer
cervix uteri cancer
neoplasm of uterine cervix
tumor of the Cervix Uteri
uterine cervical neoplasm
disease_ontology
DOID:4362
cervical cancer
A steroid inherited metabolic disorder characterized by decreased conversion of biologically active cortisol to inactive cortisone resulting in low aldosterone levels, metabolic alkalosis, hypernatremia, hypokalemia and early-onset severe hypertension that has_material_basis_in homozygous or compound heterozygous mutation in the HSD11B2 gene on chromosome 16.
DOID:0090121
GARD:433
MESH:D043204
NCI:C123231
OMIM:218030
ORDO:320
SNOMEDCT_US_2020_03_01:237770005
UMLS_CUI:C0342488
11-beta-hydroxysteroid dehydrogenase deficiency type 2
Ulick syndrome
cortisol 11-beta-ketoreductase deficiency
syndrome of apparent mineralocorticoid excess
disease_ontology
DOID:4367
apparent mineralocorticoid excess syndrome
An autoimmune disease of the nervous system that has_material_basis_in antibodies to acetylcholine receptors at the neuromuscular junction, has_symptom ptosis, has_symptom diplopia, has_symptom dysphagia, has_symptom dysarthria, has_symptom muscle weakness and has_symptom shortness of breath.
DOID:443
DOID:444
GARD:7122
ICD10CM:G70.0
ICD10CM:G70.00
ICD9CM:358.0
ICD9CM:358.00
MESH:D009157
NCI:C60989
OMIM:254200
SNOMEDCT_US_2020_03_01:155092009
UMLS_CUI:C0026896
UMLS_CUI:C1260409
disease_ontology
DOID:437
OMIM mapping confirmed by DO. [SN].
myasthenia gravis
A hypersensitivity reaction type IV disease that is characterized by chronic urticarial rash and monoclonal IgM gammopathy, has_symptom rash, intermittent fever, arthralgia, and lymphadenopathy.
GARD:12390
MESH:D019873
SNOMEDCT_US_2020_03_01:402415001
UMLS_CUI:C0524988
disease_ontology
DOID:4371
Schnitzler syndrome
DOID:1957
DOID:1958
ICD10CM:I66
ICD9CM:434.1
MESH:D020766
SNOMEDCT_US_2020_03_01:75543006
UMLS_CUI:C0007780
UMLS_CUI:C0752140
Cerebral embolism with cerebral infarction
cerebral embolism
disease_ontology
DOID:4372
intracranial embolism
A food allergy that is an allergy or hypersensitivity to dietary substances from the yolk or whites of eggs, causing an overreaction of the immune system which may lead to severe physical symptoms.
MESH:D021181
SNOMEDCT_US_2020_03_01:91930004
UMLS_CUI:C0559469
Allergy to eggs
disease_ontology
DOID:4377
egg allergy
A legume allergy that is an allergy or hypersensitivity to dietary substances from peanuts causing an overreaction of the immune system which in a small percentage of people may lead to severe physical symptoms.
MESH:D021183
SNOMEDCT_US_2020_03_01:91935009
UMLS_CUI:C0559470
allergy to peanuts
peanut allergic reaction
disease_ontology
DOID:4378
peanut allergy
An autoimmune disease affecting the nervous system.
MESH:D020274
NCI:C99383
UMLS_CUI:C0751871
disease_ontology
autoimmune nervous system disorder
DOID:438
autoimmune disease of the nervous system
MESH:D047708
SNOMEDCT_US_2020_03_01:128917003
UMLS_CUI:C1266121
Lipoleiomyoma
Myofibroma
disease_ontology
DOID:4386
myofibroma
A neuromuscular disease that is characterized by the disfunction of conduction through the neuromuscular junction.
MESH:D020511
SNOMEDCT_US_2020_03_01:128213006
UMLS_CUI:C0751950
disease_ontology
DOID:439
neuromuscular junction disease
ICD10CM:L40.3
MESH:D011565
NCI:C34888
SNOMEDCT_US_2020_03_01:238610005
UMLS_CUI:C0030246
Acropustulosis
Palmoplantar Pustulosis
Pustular psoriasis of the palms and/or soles
disease_ontology
DOID:4398
pustulosis of palm and sole
NCI:C35277
UMLS_CUI:C0234894
disease_ontology
DOID:4399
acneiform dermatitis
A neuropathy that affect the nerves that control the voluntary muscles.
ICD10CM:G70.9
ICD9CM:358
MESH:D009468
SNOMEDCT_US_2020_03_01:1664005
UMLS_CUI:C0027868
disease_ontology
DOID:440
neuromuscular disease
MESH:D005499
NCI:C94408
SNOMEDCT_US_2020_03_01:156411003
UMLS_CUI:C0016436
disease_ontology
DOID:4409
folliculitis
A viral infectious disease that results_in inflammation located_in liver, has_material_basis_in Hepatitis E virus, which is transmitted_by ingestion of contaminated food. The infection has_symptom fever, has_symptom fatigue, has_symptom loss of appetite, has_symptom nausea, has_symptom vomiting, has_symptom abdominal pain, has_symptom clay-colored bowel movements, has_symptom dark urine, has_symptom joint pain, and has_symptom jaundice.
DOID:12431
GARD:9541
MESH:D016751
SNOMEDCT_US_2020_03_01:7111000119109
UMLS_CUI:C0085293
disease_ontology
DOID:4411
hepatitis E
MESH:D018219
NCI:C3739
SNOMEDCT_US_2020_03_01:25889007
UMLS_CUI:C0206644
Fibroxanthoma
benign fibrous histiocytoma
fibrous Histiocytoma
disease_ontology
DOID:4415
fibrous histiocytoma
DOID:4417
GARD:9807
MESH:D018219
NCI:C6801
NCI:C8402
SNOMEDCT_US_2020_03_01:254749001
SNOMEDCT_US_2020_03_01:403999006
UMLS_CUI:C0002991
UMLS_CUI:C0346049
Dermatofibroma
Fibrohistiocytic tumor
Pleomorphic fibroma
Sclerosing angioma
Sclerosing angioma of skin
benign Cutaneous fibrous Histiocytoma
dermatofibroma
fibrohistiocytic tumor
fibrous histiocytoma of skin
fibrous xanthoma of skin
disease_ontology
DOID:4418
cutaneous fibrous histiocytoma
A sphingolipidosis characterized by dysfunctional metabolism of sphingolipids.
MESH:D012618
NCI:C85062
OMIM:269600
SNOMEDCT_US_2020_03_01:37821003
UMLS_CUI:C0036489
Sea-blue histiocyte syndrome
disease_ontology
DOID:4423
OMIM mapping confirmed by DO. [SN].
sea-blue histiocytosis
MESH:D014972
NCI:C3451
SNOMEDCT_US_2020_03_01:71709009
UMLS_CUI:C0043324
Multiple eruptive juvenile xanthogranuloma
Naevoxanthoendothelioma
Xanthoma neviforme
disease_ontology
DOID:4424
juvenile xanthogranuloma
A reading disorder resulting from a developmental reading disability involving the inability to process graphic symbols resulting in impairment of reading ability.
ICD10CM:F81.0
MESH:D004410
NCI:C96410
OMIM:300509
OMIM:600202
OMIM:604254
OMIM:606616
OMIM:606896
OMIM:608995
SNOMEDCT_US_2020_03_01:154954003
UMLS_CUI:C0476254
disease_ontology
DOID:4428
Xref MGI.
dyslexia
GARD:4900
MESH:D013005
NCI:C3379
SNOMEDCT_US_2020_03_01:128642005
UMLS_CUI:C0037661
Somatostatin cell neoplasm
Somatostatin cell tumour
disease_ontology
DOID:4430
somatostatinoma
NCI:C5272
UMLS_CUI:C1335976
meningioma of the Skull Base
disease_ontology
DOID:4437
skull base meningioma
A central nervous system cancer that is characterized by tumors near the pineal gland, the pituitary gland and the tissue just above it, develops from mismigrational pluripotent embryonic cells that remain in the brain after birth, has_material_basis_in abnormally proliferating cells derives_from germ cells.
NCI:C5461
UMLS_CUI:C1332880
central nervous system germ cell tumour
germ cell tumor of the CNS
germ cell tumour of the CNS
disease_ontology
DOID:4439
central nervous system germ cell tumor
A germinoma that has_material_basis_in cells that make sperm and eggs.
MESH:D018239
NCI:C9309
SNOMEDCT_US_2020_03_01:443675005
UMLS_CUI:C0036631
Seminoma, Pure
disease_ontology
DOID:4440
OMIM mapping confirmed by DO. [LS].
seminoma
A germ cell cancer that derives_from cells that give rise to egg cells.
MESH:D004407
NCI:C2996
SNOMEDCT_US_2020_03_01:60718004
UMLS_CUI:C0013377
disease_ontology
DOID:4441
dysgerminoma
MESH:D008269
NCI:C34794
OMIM:153880
SNOMEDCT_US_2020_03_01:193387007
UMLS_CUI:C0024440
disease_ontology
DOID:4447
OMIM mapping confirmed by DO. [SN].
cystoid macular edema
A retinal degeneration characterized by gradual deterioration of light-sensing cells in the tissues at the back of the eye and has_symptom vision loss.
MESH:D008268
NCI:C123330
ORDO:279
SNOMEDCT_US_2020_03_01:302891003
UMLS_CUI:C0024437
Macular degeneration of retina
disease_ontology
DOID:4448
Xref MGI.
macular degeneration
MESH:D008269
NCI:C35468
SNOMEDCT_US_2020_03_01:37231002
UMLS_CUI:C0271051
macular edema
macular oedema
macular retinal oedema
disease_ontology
DOID:4449
macular retinal edema
GARD:5893
ICD10CM:E26.81
ICD9CM:255.13
MESH:D001477
NCI:C34412
OMIM:PS601678
SNOMEDCT_US_2020_03_01:707742001
UMLS_CUI:C0004775
Aldosteronism with hyperplasia of the adrenal cortex
Bartter's syndrome
disease_ontology
DOID:445
Bartter disease
A renal carcinoma that has_material_basis_in the lining of the proximal convoluted renal tubule of the kidney.
EFO:0000681
GARD:13215
MESH:D002292
NCI:C9385
OMIM:300854
ORDO:217071
SNOMEDCT_US_2020_03_01:254915003
UMLS_CUI:C0007134
RCC
adenocarcinoma of kidney
hypernephroma
disease_ontology
DOID:4450
Xref MGI.
renal cell carcinoma
A kidney cancer that derives_from the lining of the proximal convoluted tubule (the very small tubes in the kidney that filter the blood and remove waste products).
NCI:C9384
SNOMEDCT_US_2020_03_01:254915003
UMLS_CUI:C1378703
carcinoma of kidney
kidney carcinoma
disease_ontology
DOID:4451
renal carcinoma
GARD:9571
disease_ontology
DOID:4455
hereditary renal cell carcinoma
An adrenal gland hyperfunction disease that results in the overproduction of aldosterone by the adrenal glands.
DOID:12252
ICD10CM:E24
ICD10CM:E26
ICD9CM:255.0
ICD9CM:255.1
MESH:D003480
MESH:D006929
NCI:C113213
NCI:C2969
OMIM:605635
OMIM:613677
ORDO:235936
SNOMEDCT_US_2020_03_01:154705004
SNOMEDCT_US_2020_03_01:88213004
UMLS_CUI:C0010481
UMLS_CUI:C0020428
Cushing syndrome
Cushing's syndrome
hyperaldosteronism
disease_ontology
DOID:446
Xref MGI.
primary hyperaldosteronism
NCI:C4524
SNOMEDCT_US_2020_03_01:254916002
UMLS_CUI:C0346249
cystadenocarcinoma of kidney
renal cystadenocarcinoma
disease_ontology
DOID:4463
multilocular clear cell renal cell carcinoma
A renal cell carcinoma that begins in distal collecting ducts of the kidney with a tubulopapillary morphology and intracytoplasmic mucicarminophilic material.
GARD:9573
MESH:D002292
NCI:C6194
SNOMEDCT_US_2020_03_01:733470002
UMLS_CUI:C1266044
carcinoma of renal Collecting duct
renal Medullary carcinoma
renal carcinoma, collecting duct type
disease_ontology
DOID:4464
collecting duct carcinoma
A renal cell carcinoma that is characterized by the development of multiple, bilateral papillary renal tumors.
DOID:8063
GARD:9572
MESH:C538614
MESH:D002292
NCI:C27890
NCI:C6975
OMIM:605074
SNOMEDCT_US_2020_03_01:4797003
UMLS_CUI:C1306837
UMLS_CUI:C1336078
Chromophil carcinoma of kidney
Papillary renal cell carcinoma
papillary kidney carcinoma
sporadic papillary renal cell carcinoma
disease_ontology
DOID:4465
OMIM mapping confirmed by DO. [SN].
papillary renal cell carcinoma
A renal cell carcinoma that has_material_basis_in cells that appear very pale or clear when examined under microscope.
GARD:9574
MESH:D002292
NCI:C4033
SNOMEDCT_US_2020_03_01:254915003
UMLS_CUI:C0279702
Clear cell carcinoma of kidney
clear cell kidney carcinoma
conventional (Clear cell) renal cell carcinoma
conventional renal cell carcinoma
renal clear cell carcinoma
disease_ontology
Clear-cell metastatic renal cell carcinoma
Clear-cell metastatic renal cell carcinoma
DOID:4467
MESH:C538445 added from NeuroDevNet [WAK].
clear cell renal cell carcinoma
An adenocarcinoma that derives_from epithelial cells which have clear cytoplasm.
DOID:2617
DOID:4940
MESH:D008649
MESH:D018262
NCI:C36815
NCI:C4072
NCI:C4156
SNOMEDCT_US_2020_03_01:2221008
SNOMEDCT_US_2020_03_01:30546008
SNOMEDCT_US_2020_03_01:80727009
UMLS_CUI:C0025490
UMLS_CUI:C0206681
UMLS_CUI:C0334322
Clear cell adenocarcinoma
Mesonephroid Clear cell carcinoma
Mesonephroma
Mesonephroma, malignant
Water-Clear cell adenocarcinoma
Water-clear cell adenocarcinoma
Water-clear cell carcinoma
Wolffian duct neoplasm
malignant Mesonephroma
mesonephroma
disease_ontology
DOID:4468
clear cell adenocarcinoma
MESH:D015499
UMLS_CUI:C0035091
inborn renal tubular transport disorder
disease_ontology
DOID:447
renal tubular transport disease
A renal cell carcinoma that has_material_basis_in chromophobe cell that appear pale when viewed under microscope, but that are larger and display different features than clear cells.
GARD:6064
MESH:D002292
NCI:C4146
SNOMEDCT_US_2020_03_01:128667008
UMLS_CUI:C1266042
Chromophobe carcinoma of kidney
chromophobe adenocarcinoma
kidney chromophobe
renal cell carcinoma, chromophobe cell
disease_ontology
DOID:4471
chromophobe renal cell carcinoma
MESH:D011546
NCI:C85034
SNOMEDCT_US_2020_03_01:77098009
UMLS_CUI:C0033805
disease_ontology
DOID:4479
pseudohypoaldosteronism
An osteochondrodysplasia that results_in dwarfism which has_material_basis_in abnormal ossification of cartilage in located_in long bone.
GARD:8173
ICD10CM:Q77.4
MESH:D000130
NCI:C34345
OMIM:100800
SNOMEDCT_US_2020_03_01:268273004
UMLS_CUI:C0001080
Achondroplastic physique
Chondrodystrophia
osteosclerosis congenita
disease_ontology
DOID:4480
OMIM mapping confirmed by DO. [SN].
achondroplasia
MESH:D000130
A rhinitis that is an allergic inflammation and irritation of the nasal airways involving sneezing, runny nose, nasal congestion, itching and tearing of the eyes caused by exposure to an allergen such as pollen, dust, mold, animal dander and droppings of cockroaches or house dust mites.
DOID:12089
DOID:14030
DOID:8241
DOID:8242
EFO:0003956
NCI:C34987
OMIM:607154
SNOMEDCT_US_2020_03_01:38103000
UMLS_CUI:C0002103
Non-seasonal allergic rhinitis
Perenial allergic rhinitis
atopic rhinitis
hay fever
pollenosis
seasonal allergic rhinitis
disease_ontology
DOID:4481
allergic rhinitis
MESH:D065631
A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.
MESH:D012220
NCI:C34986
SNOMEDCT_US_2020_03_01:70076002
UMLS_CUI:C0035455
disease_ontology
runny nose
DOID:4483
rhinitis
An influenza that results in infection located in respiratory tract of humans, domestic and wild birds, has_material_basis_in Influenza A virus, which is transmitted by contact with infected poultry. Five strains of avian influenza A viruses (H5N1, H7N3, H7N2, H7N7 and H9N2) are known to cause human infections. The infection has_symptom fever, has_symptom cough, has_symptom sore throat, has_symptom muscle aches, has_symptom nausea, has_symptom diarrhea, has_symptom vomiting, has_symptom neurologic changes, has_symptom pneumonia, and has_symptom acute respiratory distress.
ICD10CM:J09.X
MESH:D005585
SNOMEDCT_US_2020_03_01:55604004
UMLS_CUI:C0016627
avian flu
bird flu
disease_ontology
DOID:4492
avian influenza
A muscular dystrophy that is characterized by progressive muscle wasting and weakness.
ICD10CM:G71.1
ICD9CM:359.2
MESH:D020967
NCI:C84913
SNOMEDCT_US_2020_03_01:155096007
UMLS_CUI:C0553604
disease_ontology
DOID:450
myotonic disease
MESH:D009223
MESH:D020967
NCI:C34939
UMLS_CUI:C1514284
hypopotassemia
potassium deficiency disorder
disease_ontology
DOID:4500
hypokalemia
A syndrome that is characterized by malformations of the face, oral cavity, and digits.
ICD10CM:Q87.0
MESH:D009958
SNOMEDCT_US_2020_03_01:52868006
UMLS_CUI:C0029294
oral-facial-digital syndrome
disease_ontology
DOID:4501
Xref MGI.
OMIM mapping confirmed by DO. [SN].
orofaciodigital syndrome
A gastrointestinal system benign neoplasm that is a located_in the salivary glands.
MESH:D008949
NCI:C35691
OMIM:181030
SNOMEDCT_US_2020_03_01:8360001
UMLS_CUI:C0026277
Pleomorphic adenoma
mixed tumor of the Salivary gland
disease_ontology
DOID:452
pleomorphic adenoma
A salivary gland carcinoma that is characterized by squamous cells, mucus-secreting cells, and intermediate cells.
GARD:10671
MESH:D018277
NCI:C3772
SNOMEDCT_US_2020_03_01:4079000
UMLS_CUI:C0206694
MEC
Mucoepidermoid carcinoma
disease_ontology
DOID:4531
mucoepidermoid carcinoma
A syndrome that affects growth, cranial development, hair growth and dental development.
GARD:288
MESH:D006210
NCI:C84746
OMIM:234100
ORDO:2108
SNOMEDCT_US_2020_03_01:7903009
UMLS_CUI:C0018522
Francois dyscephalic syndrome
Hallerman - Streiff syndrome
Hallermann's syndrome
disease_ontology
DOID:4534
OMIM mapping confirmed by DO. [SN].
Hallermann-Streiff syndrome
A hair disease that is characterized by sparse hair on the scalp resulting from abnormal hair follicle development and has_material_basis in mutations in proteins involved in hair growth, division or proliferation of cells within hair follicles.
MESH:D007039
OMIM:PS605389
ORDO:55654
SNOMEDCT_US_2020_03_01:53602002
UMLS_CUI:C0020678
disease_ontology
DOID:4535
Xref MGI.
hypotrichosis
A writing disorder that involves a deficiency in the ability to write where the writing is distorted or incorrect, spelling difficulty, poor handwriting or trouble putting thoughts on paper.
ICD10CM:R48.8
MESH:D000381
SNOMEDCT_US_2020_03_01:27206009
UMLS_CUI:C0001825
disease_ontology
DOID:4540
dysgraphia
An amnestic disorder that involves a loss of one's pre-existing memories to conscious recollection.
ICD10CM:R41.2
MESH:D000648
NCI:C34372
SNOMEDCT_US_2020_03_01:51921000
UMLS_CUI:C0002624
disease_ontology
DOID:4543
retrograde amnesia
MESH:D018211
NCI:C3737
SNOMEDCT_US_2020_03_01:56565002
UMLS_CUI:C0206637
disease_ontology
DOID:4545
mesenchymal chondrosarcoma
NCI:C27481
SNOMEDCT_US_2020_03_01:404080006
UMLS_CUI:C1275279
mesenchymal extraosseous chondrosarcoma
disease_ontology
DOID:4548
extraskeletal mesenchymal chondrosarcoma
A chondrosarcoma that is located_in exclusively soft tissue.
disease_ontology
DOID:4549
extraosseous chondrosarcoma
MESH:D001005
NCI:C2877
SNOMEDCT_US_2020_03_01:126849006
UMLS_CUI:C0003463
anal neoplasm
anal tumors
neoplasm of anus
disease_ontology
DOID:4551
anus benign neoplasm
NCI:C4450
SNOMEDCT_US_2020_03_01:254629004
UMLS_CUI:C0345958
large cell carcinoma of lung
large cell lung carcinoma
disease_ontology
DOID:4556
lung large cell carcinoma
A parasitic helminthiasis infectious disease that involves infection of the intestine with the nematode Ascaris lumbricoides. Larvae migrating through the lungs cause cough, wheezing and hemoptysis. Bowel or biliary obstruction causes cramping abdominal pain, nausea, and vomiting. Peritonitis, enlargement of the liver or spleen, toxicity and pneumonia are observed when larvae get into the portal circulation.
ICD10CM:B77
ICD9CM:127.0
MESH:D001196
NCI:C128392
SNOMEDCT_US_2020_03_01:2435008
UMLS_CUI:C0003950
Ascariasis - roundworm
disease_ontology
Ascaris lumbricoides infection
DOID:456
ascariasis
MESH:D008579
NCI:C4055
SNOMEDCT_US_2020_03_01:724171006
UMLS_CUI:C0281784
meningioma, benign
disease_ontology
DOID:4587
benign meningioma
NCI:C4720
SNOMEDCT_US_2020_03_01:19453003
UMLS_CUI:C0431119
Lymphoplasmacyte-Rich meningioma
Lymphoplasmocyte-rich meningioma
disease_ontology
DOID:4591
lymphoplasmacyte-rich meningioma
GARD:1039
ICD10CM:Q80.3
MESH:D017488
NCI:C62569
OMIM:113800
SNOMEDCT_US_2020_03_01:20512000
UMLS_CUI:C0079153
Bullous ichthyosiform erythroderma
Epidermolytic palmoplantar hyperkeratosis
bullous congenital ichthyosiform erythroderma
disease_ontology
DOID:4603
OMIM mapping confirmed by DO. [SN].
epidermolytic hyperkeratosis
A biliary tract cancer that is located_in the bile duct.
DOID:10019
ICD10CM:C24.0
ICD9CM:156.1
MESH:D001650
NCI:C2898
NCI:C7483
SNOMEDCT_US_2020_03_01:93790004
UMLS_CUI:C0005396
UMLS_CUI:C0153453
Ca extrahepatic bile ducts
bile duct tumor
malignant neoplasm of the extrahepatic bile duct
disease_ontology
DOID:4606
bile duct cancer
A hepatobiliary system cancer that results_in malignant growth located_in the gallbladder or located_in the bile duct.
DOID:8092
GARD:5924
GARD:9304
ICD10CM:C24.9
ICD9CM:156.9
MESH:D001661
SNOMEDCT_US_2020_03_01:126853008
SNOMEDCT_US_2020_03_01:93688006
UMLS_CUI:C0005426
UMLS_CUI:C0750952
malignant tumour of biliary tract
disease_ontology
DOID:4607
biliary tract cancer
DOID:2692
MESH:D009379
MESH:D019042
NCI:C4063
SNOMEDCT_US_2020_03_01:115228006
UMLS_CUI:C0027664
UMLS_CUI:C0282606
Myomatous neoplasm
Myomatous tumor
muscle neoplasm
muscle tissue neoplasm
neoplasm of muscle
disease_ontology
DOID:461
muscle benign neoplasm
A gastrointestinal system benign neoplasm that is located_in the intestine.
MESH:D007414
NCI:C3141
SNOMEDCT_US_2020_03_01:126769007
UMLS_CUI:C0021841
intestinal tumors
intestine growth
neoplasm of intestinal tract
disease_ontology
DOID:4610
intestinal benign neoplasm
MESH:D020424
SNOMEDCT_US_2020_03_01:55802003
UMLS_CUI:C0154743
Ulnar neuropathy
disease_ontology
DOID:4613
ulnar neuropathy
A congenital nervous system abnormality characterized by failed or incomplete separation of the forebrain early in gestation; it is accompanied by a spectrum of characteristic craniofacial anomalies.
GARD:6665
ICD10CM:Q04.2
MESH:D016142
NCI:C74988
OMIM:PS236100
ORDO:2162
SNOMEDCT_US_2020_03_01:30915001
UMLS_CUI:C0079541
Holoprosencephaly sequence
disease_ontology
DOID:4621
Xref MGI.
OMIM mapping confirmed by DO. [SN].
holoprosencephaly
A syndrome that is characterized by an asymmetric distribution of cartilagenous tumors, which may lead to skeletal deformities and limb-length discrepancy. This condition primarily affects the long bones and cartilage of the joints of the arms and legs, specifically the area where the shaft and head of a long bone meet.
GARD:7251
ICD10CM:Q78.4
MESH:D004687
NCI:C3213
OMIM:166000
ORDO:296
SNOMEDCT_US_2020_03_01:46041001
UMLS_CUI:C0024454
DYSCHONDROPLASIA
ENCHONDROMATOSIS, MULTIPLE
Enchondromatosis with haemangiomata
Kast's syndrome
OSTEOCHONDROMATOSIS
disease_ontology
DOID:4624
OMIM mapping confirmed by DO. [SN].
Ollier disease
GARD:6681
ICD10CM:Q04.3
MESH:D006832
NCI:C98949
SNOMEDCT_US_2020_03_01:30023002
UMLS_CUI:C0020225
disease_ontology
DOID:4626
hydranencephaly
MESH:D020240
SNOMEDCT_US_2020_03_01:39746003
UMLS_CUI:C0234523
Classic apraxia
Ideomotor dyspraxia
Limb-kinetic apraxia
Transcortical apraxia
disease_ontology
DOID:4627
ideomotor apraxia
NCI:C26937
SNOMEDCT_US_2020_03_01:3502005
UMLS_CUI:C0149642
cervical Lymphadenitis
cervical lymphadenitis
disease_ontology
DOID:4637
cervical adenitis
NCI:C27135
SNOMEDCT_US_2020_03_01:48573006
UMLS_CUI:C0392051
Suppurative lymphadenopathy
disease_ontology
DOID:4639
suppurative lymphadenitis
An epidermolysis bullosa that is characterized by recurrent blistering at the level of the epidermis secondary to minor trauma, which can cause limited wounds, dehydration, electrolyte abnormalities, severe infection, among other issues, and has_material_basis_in mutation in the KRT5, KRT14, or PLEC genes, which encode keratin and plectin proteins that provide resilience in skin.
GARD:10752
ICD10CM:Q81.0
MESH:D016110
NCI:C84692
OMIM:601001
OMIM:615425
ORDO:304
SNOMEDCT_US_2020_03_01:205585003
UMLS_CUI:C0079298
Epidermolysis bullosa simplex
disease_ontology
DOID:4644
epidermolysis bullosa simplex
DOID:770
ICD10CM:C69.2
ICD9CM:190.5
MESH:D019572
NCI:C3216
NCI:C4800
SNOMEDCT_US_2020_03_01:127002001
SNOMEDCT_US_2020_03_01:93987004
UMLS_CUI:C0024622
UMLS_CUI:C0524801
Retinal tumor
malignant Retinal neoplasm
malignant neoplasm of retina
malignant tumor of retina
neoplasm of retina
disease_ontology
DOID:4645
retinal cancer
MESH:D012175
NCI:C8495
UMLS_CUI:C0751483
Hereditary Retinoblastoma
disease_ontology
DOID:4648
familial retinoblastoma
A retinoblastoma that develops in both eyes.
NCI:C8713
UMLS_CUI:C0854914
disease_ontology
DOID:4650
bilateral retinoblastoma
ICD10CM:D47.02
MESH:D034721
NCI:C9286
SNOMEDCT_US_2020_03_01:70910003
UMLS_CUI:C0272203
ISM
Indolent systemic mastocytosis
disease_ontology
DOID:4660
indolent systemic mastocytosis
A syndrome that is an adverse physical reaction to low levels of many common chemicals.
MESH:D018777
SNOMEDCT_US_2020_03_01:702772003
UMLS_CUI:C0242992
20th century disease
chemical AIDS
environmental illness
idiopathic environmental illness
total allergy syndrome
disease_ontology
DOID:4661
multiple chemical sensitivity
A disorder of sexual developement that is characterized by the inability of the cell to respond to androgens in individuals with a karyotype of 46,XY resulting in female physical traits but male genetic makeup.
DOID:4672
GARD:5803
ICD10CM:E34.5
ICD9CM:259.51
NCI:C27226
OMIM:300068
ORDO:754
SNOMEDCT_US_2020_03_01:12313004
UMLS_CUI:C0039585
Androgen resistance syndrome
Androgen-Insensitivity Syndrome
Feminisation - testicular
Goldberg - Maxwell syndrome
Goldberg-Maxwell syndrome
testicular Feminization syndrome
testicular feminization
disease_ontology
DOID:4674
OMIM mapping confirmed by DO. [SN].
androgen insensitivity syndrome
MESH:D013734
A corneal disease that is characterized by inflammation of the cornea.
ICD10CM:H16
ICD9CM:370
MESH:D007634
NCI:C26805
SNOMEDCT_US_2020_03_01:193757003
UMLS_CUI:C0022568
disease_ontology
DOID:4677
keratitis
MESH:D006391
NCI:C3699
SNOMEDCT_US_2020_03_01:54249004
UMLS_CUI:C0205789
Intramuscular Angioma
Intramuscular hemangioma
disease_ontology
DOID:468
intramuscular hemangioma
A breast carcinoma that represents a mixed group of malignant neoplasms characterized by the histologic presence of two or more cellular types.
GARD:10804
NCI:C5164
SNOMEDCT_US_2020_03_01:763479005
UMLS_CUI:C1334708
Metaplastic carcinoma of the breast
disease_ontology
metaplastic carcinoma of breast
DOID:4680
breast metaplastic carcinoma
NCI:C3860
SNOMEDCT_US_2020_03_01:372101000
UMLS_CUI:C0238019
carcinoma of extrahepatic bile duct
extrahepatic bile duct cancer
disease_ontology
DOID:4682
extrahepatic bile duct carcinoma
NCI:C4472
SNOMEDCT_US_2020_03_01:254713002
UMLS_CUI:C0346019
Mucoepidermoid carcinoma of skin
Mucoepidermoid skin carcinoma
disease_ontology
DOID:4683
cutaneous mucoepidermoid carcinoma
A globe disease that is characterized by inflammation of the inside of the eye.
MESH:D009877
NCI:C34586
SNOMEDCT_US_2020_03_01:1847009
UMLS_CUI:C0014236
disease_ontology
DOID:4692
endophthalmitis
DOID:8371
GARD:12698
MESH:D018317
NCI:C4973
NCI:C6912
SNOMEDCT_US_2020_03_01:128795001
UMLS_CUI:C0751691
UMLS_CUI:C1370657
soft tissue Perineurioma
disease_ontology
DOID:4697
perineurioma
ICD10CM:N42.9
ICD9CM:602.9
MESH:D011469
NCI:C26865
SNOMEDCT_US_2020_03_01:30281009
UMLS_CUI:C0033575
disease_ontology
DOID:47
prostate disease
MESH:D049328
NCI:C3945
SNOMEDCT_US_2020_03_01:40467008
UMLS_CUI:C0265985
Mongolian Macula
disease_ontology
DOID:4702
mongolian spot
A brain cancer that is located_in the infratentorial region.
DOID:4789
ICD10CM:C71.7
MESH:D015192
NCI:C3139
NCI:C4966
UMLS_CUI:C0021432
UMLS_CUI:C0751593
brain neoplasm, Infratentorial
malignant Infratentorial tumors
disease_ontology
DOID:4706
infratentorial cancer
NCI:C5280
UMLS_CUI:C1333630
meningioma of the Foramen Magnum
disease_ontology
DOID:4708
foramen magnum meningioma
NCI:C4905
SNOMEDCT_US_2020_03_01:254773009
UMLS_CUI:C0687140
Angioma of the skin
Angiomatous naevus of skin
disease_ontology
DOID:471
skin hemangioma
A brain disease that is characterized by low pressure inside the skull, and thus in the brain tissue and cerebrospinal fluid; may occur as a result of an occult or iatrogenically caused leak of CSF into another body cavity; may result in the downward displacement of the cerebellar tonsils through the foramen magnum or Chiari malformation; has_symptom orthostatic headache; other symptoms are related to compression of cranial nerves due to brain sagging.
MESH:D019585
SNOMEDCT_US_2020_03_01:433691000124104
UMLS_CUI:C0524812
disease_ontology
DOID:4723
intracranial hypotension
A brain disease that is characterized by excess accumulation of fluid in the intracellular and/or extracellular spaces of the brain, has_symptom nausea, has_symptom vomiting, has_symptom blurred vision, has_symptom seizure, has_symptom coma.
MESH:D001929
SNOMEDCT_US_2020_03_01:85974009
UMLS_CUI:C1527311
intracranial swelling
wet brain
disease_ontology
DOID:4724
brain edema
A disease of mental health that involves physical symptoms suggesting a physical illness where the biological or medical cause of the symptoms is indeterminate.
DOID:10133
DOID:144
ICD10CM:F45
ICD10CM:F45.0
ICD9CM:300.8
ICD9CM:300.81
MESH:D013001
NCI:C34956
SNOMEDCT_US_2020_03_01:192430009
SNOMEDCT_US_2020_03_01:60368009
UMLS_CUI:C0037650
UMLS_CUI:C0520482
physiological malfunction arising from mental factor
psychophysiologic disorder
psychosomatic disorder
disease_ontology
DOID:4737
somatoform disorder
MESH:D006391
NCI:C4298
SNOMEDCT_US_2020_03_01:253054009
UMLS_CUI:C0205788
Angiolymphoid hyperplasia with eosinophilia
epithelioid haemangioma
epithelioid hemangioma
disease_ontology
DOID:474
histiocytoid hemangioma
A placenta disease that is characterized by an abnormally deep attachment of the placenta, through the endometrium and into the myometrium.
ICD10CM:O43.21
MESH:D010921
NCI:C26856
SNOMEDCT_US_2020_03_01:70129008
UMLS_CUI:C0032044
disease_ontology
DOID:4744
placenta accreta
ICD10CM:G23.2
MESH:D020955
NCI:C125695
OMIM:271930
OMIM:500003
OMIM:609161
SNOMEDCT_US_2020_03_01:29618004
UMLS_CUI:C0270733
disease_ontology
DOID:4751
OMIM mapping confirmed by DO. [LS].
striatonigral degeneration
DOID:11510
GARD:7079
MESH:D012791
MESH:D019578
NCI:C84909
SNOMEDCT_US_2020_03_01:16576004
SNOMEDCT_US_2020_03_01:230297002
UMLS_CUI:C0037019
UMLS_CUI:C0393571
Multiple system atrophy
Shy-Drager syndrome
disease_ontology
DOID:4752
OMIM mapping confirmed by DO. [LS].
multiple system atrophy
A lung cancer that has_material_basis_in tissues of the lung and has_material_basis_in pleural tissues. It is most commonly effects children.
MESH:D018202
NCI:C3732
SNOMEDCT_US_2020_03_01:189815007
UMLS_CUI:C0206629
Blastoma of lung
disease_ontology
DOID:4765
pulmonary blastoma
A pulmonary blastoma that derives_from the lung or pleural cavity.
GARD:8757
MESH:C537516
NCI:C5669
OMIM:601200
SNOMEDCT_US_2020_03_01:707670009
UMLS_CUI:C1266144
Pleuropulmonary blastoma
disease_ontology
DOID:4769
OMIM mapping confirmed by DO. [SN].
pleuropulmonary blastoma
A kidney cancer that is characterized by the presence of fibroblastic cells.
DOID:4772
GARD:1493
MESH:D018201
NCI:C6569
UMLS_CUI:C1332965
disease_ontology
DOID:4773
congenital mesoblastic nephroma
NCI:C35799
UMLS_CUI:C0859036
disease_ontology
DOID:4781
diffuse glomerulonephritis
NCI:C5817
UMLS_CUI:C1334246
intracranial PNET
disease_ontology
DOID:4788
intracranial primitive neuroectodermal tumor
DOID:665
MESH:D000794
NCI:C2874
NCI:C4488
SNOMEDCT_US_2020_03_01:254788004
SNOMEDCT_US_2020_03_01:26810009
UMLS_CUI:C0002985
UMLS_CUI:C0346075
Angiokeratoma
Angiokeratoma of skin
Cutaneous Angiokeratoma
skin angiokeratoma
disease_ontology
DOID:479
angiokeratoma
MESH:D018242
NCI:C4327
SNOMEDCT_US_2020_03_01:715903004
UMLS_CUI:C0334596
Diktyoma, malignant
Medulloepithelioma
Medulloepithelioma, central nervous system
disease_ontology
DOID:4790
medulloepithelioma
GARD:7366
NCI:C6968
SNOMEDCT_US_2020_03_01:699318007
UMLS_CUI:C1336538
Supratentorial PNET
disease_ontology
DOID:4791
supratentorial primitive neuroectodermal tumor
MESH:D018242
NCI:C4915
SNOMEDCT_US_2020_03_01:253070006
UMLS_CUI:C0700367
disease_ontology
DOID:4794
ependymoblastoma
MESH:D018489
SNOMEDCT_US_2020_03_01:21162009
UMLS_CUI:C0242700
disease_ontology
DOID:4796
space motion sickness
NCI:C9284
SNOMEDCT_US_2020_03_01:397357000
UMLS_CUI:C1301365
systemic mastocytosis with associated clonal haematological non-mast cell lineage disease
systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease
disease_ontology
DOID:4797
SM-AHNMD
A reproductive system disease that affects male reproductive organs.
ICD10CM:N50.9
ICD9CM:608.9
MESH:D005832
SNOMEDCT_US_2020_03_01:64557000
UMLS_CUI:C0017412
disease_ontology
DOID:48
male reproductive system disease
A brain disease that is characterized by a clinical syndrome of either hyperkinetic movement or hyperkinetic movement unrelated to weakness or spasticity.
MESH:D009069
NCI:C116757
SNOMEDCT_US_2020_03_01:60342002
UMLS_CUI:C0026650
disease_ontology
DOID:480
movement disease
A xanthomatosis that is characterized by a deficiency in the production of the bile acid, chenodeoxycholic acid that has_material_basis_in autosomal recessive inheritance and results in cholestanol deposition in the brain and other tissues and with elevated levels of cholesterol in plasma.
GARD:5622
MESH:D019294
NCI:C84628
OMIM:213700
SNOMEDCT_US_2020_03_01:63246000
UMLS_CUI:C0238052
Cholestanol storage disease
disease_ontology
DOID:4810
OMIM mapping confirmed by DO. [SN].
cerebrotendinous xanthomatosis
An autonomic nervous system benign neoplasm that is characterized by the presence of mature ganglion cells and a mature Schwannian stroma and arises from the sympathetic trunk in the mediastinum.
MESH:D005729
NCI:C3049
NCI:C42065
SNOMEDCT_US_2020_03_01:189929007
UMLS_CUI:C0017075
UMLS_CUI:C1513025
disease_ontology
DOID:4817
ganglioneuroma
ICD10CM:D18.0
MESH:D006392
NCI:C3086
SNOMEDCT_US_2020_03_01:67668002
UMLS_CUI:C0018920
Cavernoma
Cavernous haemangioma
Cavernous hemangioma
disease_ontology
DOID:483
cavernous hemangioma
A squamous cell carcinoma that contains squamous cells and gland-like cells.
MESH:D018196
NCI:C3727
SNOMEDCT_US_2020_03_01:403902008
UMLS_CUI:C0206623
Adenosquamous carcinoma
Adenosquamous cell carcinoma
mixed adenocarcinoma and squamous carcinoma
disease_ontology
DOID:4830
adenosquamous carcinoma
A syndrome that is characterized by bone loss (osteolysis) which is often associated with swelling or abnormal blood vessel growth (angiomatous proliferation). Bone loss can occur in just one bone or spread to soft tissue and adjacent bones.
GARD:6542
MESH:D010015
SNOMEDCT_US_2020_03_01:240161003
UMLS_CUI:C0029436
Disappearing bone disease
Gorham disease
essential osteolysis
massive osteolysis
phantom bone disease
disease_ontology
Gorham-Stout Syndrome
DOID:4837
Gorham's disease
A carcinoma that derives_from myoepithelial cells.
GARD:10558
NCI:C7596
SNOMEDCT_US_2020_03_01:24292006
UMLS_CUI:C0334699
disease_ontology
DOID:4838
myoepithelial carcinoma
MESH:D020141
SNOMEDCT_US_2020_03_01:21112004
UMLS_CUI:C0600502
disease_ontology
DOID:484
vascular hemostatic disease
ICD10CM:C44
NCI:C8409
SNOMEDCT_US_2020_03_01:188083002
UMLS_CUI:C1382026
malignant Sebaceous tumor
malignant neoplasm of sebaceous gland
disease_ontology
DOID:4840
sebaceous carcinoma
MESH:D018315
NCI:C3795
SNOMEDCT_US_2020_03_01:4553004
UMLS_CUI:C0206725
Subependymal astrocytoma
WHO grade I Ependymal tumor
mixed subependymoma-ependymoma
disease_ontology
DOID:4843
subependymal glioma
MESH:D004806
NCI:C3017
SNOMEDCT_US_2020_03_01:443643007
UMLS_CUI:C0014474
WHO grade II Ependymal tumor
epithelial ependymoma
disease_ontology
DOID:4844
benign ependymoma
NCI:C40315
SNOMEDCT_US_2020_03_01:388600004
UMLS_CUI:C1519086
disease_ontology
DOID:4845
pilomyxoid astrocytoma
NCI:C9475
UMLS_CUI:C0740480
astrocytoma of Cerebellum
disease_ontology
DOID:4848
cerebellar astrocytoma
A pediatric low-grade glioma that is characterized by cells that look like fibers when viewed under a microscope and is located_in the brain.
GARD:9808
MESH:D001254
NCI:C4047
SNOMEDCT_US_2020_03_01:67859002
UMLS_CUI:C0334583
Piloid astrocytoma
grade I Astrocytic tumor
disease_ontology
DOID:4851
pilocytic astrocytoma
A salivary gland carcinoma that is characterized by a distinctive pattern in which abnormal nests or cords of epithelial cells surround and/or infiltrate ducts or glandular structures within the affected organ. These structures are typically filled with a mucous-like material or contain abnormal fibrous membranes.
MESH:D003528
NCI:C2970
SNOMEDCT_US_2020_03_01:11671000
UMLS_CUI:C0010606
Cylindroma
adenoid cystic cancer
adenoid cystic carcinoma
disease_ontology
DOID:4866
salivary gland adenoid cystic carcinoma
ICD9CM:335
MESH:D016472
SNOMEDCT_US_2020_03_01:267693003
UMLS_CUI:C0154681
disease_ontology
DOID:4873
anterior horn cell disease
A viral infectious disease that results_in infection, has_material_basis_in Colorado tick fever virus, which is transmitted_by rocky mountain wood tick, Dermacentor andersoni. The infection has_symptom fever for 2-3 days, followed by an afebrile period of similar duration and then another 2-3 days of fever, has_symptom headache, has_symptom myalgia, and has_symptom fatigue.
ICD10CM:A93.2
MESH:D003121
SNOMEDCT_US_2020_03_01:186607005
UMLS_CUI:C0009400
Tick fever, American mountain
disease_ontology
DOID:4885
Colorado tick fever
An extrapulmonary tuberculosis that is located_in lymph node, and has_symptom lymphadenopathy, has_symptom fever, has_symptom weight loss, has_symptom fatigue, has_symptom night sweats and has_symptom cough.
DOID:4888
ICD10CM:A18.2
MESH:D014388
MESH:D018601
NCI:C26896
SNOMEDCT_US_2020_03_01:10893003
UMLS_CUI:C0041316
UMLS_CUI:C0242830
Lymph Node Tuberculosis
Tuberculous adenitis
Tuberculous lymphadenopathy
king's evil
scrofula
disease_ontology
DOID:4889
lymph node tuberculosis
A bile duct carcinoma that derives_from epithelial cells of glandular origin.
NCI:C27813
SNOMEDCT_US_2020_03_01:70179006
UMLS_CUI:C1370800
disease_ontology
DOID:4896
bile duct adenocarcinoma
A bile duct cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
MESH:D001650
NCI:C27814
SNOMEDCT_US_2020_03_01:70179006
UMLS_CUI:C0740277
disease_ontology
DOID:4897
bile duct carcinoma
pulmonary hemangioma
disease_ontology
DOID:490
hemangioma of lung
An appendix cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C9330
SNOMEDCT_US_2020_03_01:269541000
UMLS_CUI:C0728951
Ca appendix
carcinoma of appendix
disease_ontology
DOID:4902
appendix carcinoma
A pancreas cancer that derives_from epithelial cells located_in the pancreas.
EFO:0002618
MESH:C562463
NCI:C3850
OMIM:260350
SNOMEDCT_US_2020_03_01:154475002
UMLS_CUI:C0235974
Exocrine pancreas carcinoma
carcinoma of pancreas
disease_ontology
Pancreatic carcinoma, familial
Pancreatic carcinoma, familial
exocrine cancer
DOID:4905
OMIM mapping confirmed by DO. [SN].
pancreatic carcinoma
A small intestine carcinoma that derives_from epithelial cells of glandular origin.
GARD:13090
NCI:C7888
SNOMEDCT_US_2020_03_01:424440001
UMLS_CUI:C0278803
small intestinal adenocarcinoma
disease_ontology
adenocarcinoma of small Intestine
DOID:4906
small intestine adenocarcinoma
A small intestine cancer that develops from epithelial cells and is located_in the small intestine.
NCI:C7724
UMLS_CUI:C0238196
small intestinal carcinoma
disease_ontology
cancer of the small bowel
small bowel cancer
DOID:4907
small intestine carcinoma
A anus cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the anus.
MESH:D001005
NCI:C9291
SNOMEDCT_US_2020_03_01:187762000
UMLS_CUI:C0279637
Ca anus
carcinoma of anus
disease_ontology
DOID:4908
anal carcinoma
MESH:D010911
NCI:C4536
SNOMEDCT_US_2020_03_01:128665000
UMLS_CUI:C0346300
carcinoma of the Pituitary gland
disease_ontology
DOID:4916
pituitary carcinoma
DOID:12343
ICD10CM:C65
ICD9CM:189.1
NCI:C6142
NCI:C7525
SNOMEDCT_US_2020_03_01:363457009
UMLS_CUI:C0153618
UMLS_CUI:C1335749
carcinoma of kidney Pelvis
malignant neoplasm of renal pelvis
malignant renal Pelvis neoplasm
malignant tumor of renal pelvis
renal pelvis cancer
disease_ontology
DOID:4919
renal pelvis carcinoma
NCI:C5559
UMLS_CUI:C1334577
malignant Eccrine tumor
malignant eccrine skin neoplasm
disease_ontology
DOID:4921
eccrine sweat gland cancer
A thymic carcinoma that derives_from epithelial cells of glandular origin.
NCI:C6459
UMLS_CUI:C1336743
adenocarcinoma of the Thymus
disease_ontology
DOID:4923
thymus adenocarcinoma
An intrahepatic cholangiocarcinoma arising near or at the confluence of the right and left hepatic ducts.
DOID:5246
GARD:10175
MESH:D018285
NCI:C36077
SNOMEDCT_US_2020_03_01:253017000
UMLS_CUI:C0206702
Klatskin tumor
Klatskin tumour
Klatskin's tumour
Perihilar extrahepatic bile duct carcinoma
hilar cholangiocarcinoma
hilar cholangiocellular carcinoma
disease_ontology
DOID:4927
Klatskin's tumor
GARD:6042
ICD10CM:C22.1
MESH:D018281
NCI:C35417
SNOMEDCT_US_2020_03_01:109842005
UMLS_CUI:C0345905
Intrahepatic bile duct carcinoma
peripheral Cholangiocarcinoma
disease_ontology
DOID:4928
intrahepatic cholangiocarcinoma
An ampulla of Vater cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
NCI:C3908
SNOMEDCT_US_2020_03_01:254609000
UMLS_CUI:C0262401
ampulla of vater cancer
ampullary carcinoma
carcinoma of ampulla of vater
disease_ontology
DOID:4932